data_1c2n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c2n _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.099 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.98 85.07 2.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.943 -0.74 . . . . 0.0 110.21 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.33 -35.88 40.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.739 0.816 . . . . 0.0 112.496 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.02 65.54 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.78 -0.575 . . . . 0.0 110.067 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -57.84 -41.53 82.51 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.82 -48.07 68.45 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -57.06 -50.37 72.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.285 0.543 . . . . 0.0 110.585 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -59.37 -51.04 71.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.234 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -56.07 -31.49 63.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.398 1.879 . . . . 0.0 110.621 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.88 -19.73 7.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.586 0.754 . . . . 0.0 112.125 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -51.0 -34.35 28.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.454 0.57 . . . . 0.0 110.667 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -77.7 -49.23 14.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -48.3 -49.09 35.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.307 1.043 . . . . 0.0 110.654 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.82 -11.5 27.72 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.6 m -56.63 -33.63 66.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.7 m -113.99 -39.64 3.9 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.437 0.695 . . . . 0.0 110.341 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -95.47 -172.42 2.63 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -159.96 172.83 16.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.984 2.113 . . . . 0.0 107.648 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -132.67 132.43 59.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 tp -116.32 143.9 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.853 1.661 . . . . 0.0 109.164 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.37 159.11 82.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.27 -42.44 47.35 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.138 2.559 . . . . 0.0 112.863 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -73.0 -11.91 60.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.311 1.444 . . . . 0.0 113.671 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -14.32 34.57 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.977 -0.901 . . . . 0.0 113.682 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.7 m -57.77 125.63 23.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.532 1.666 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.21 82.16 1.0 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 110.724 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.1 mm -57.7 -61.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.43 98.32 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.8 67.83 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.051 0.94 . . . . 0.0 109.188 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.22 -162.99 28.53 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.53 176.43 9.05 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -130.49 33.07 4.33 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -71.06 -35.9 72.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.745 1.218 . . . . 0.0 108.191 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.88 161.86 12.61 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 174.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.44 125.54 18.23 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.848 3.032 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.16 114.86 1.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 108.759 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.6 mt -72.19 -16.44 61.96 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -168.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -52.97 120.39 5.78 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.732 1.151 . . . . 0.0 108.946 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.6 12.31 72.65 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.809 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.44 -42.34 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.31 1.555 . . . . 0.0 109.544 174.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.73 118.09 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.195 0.598 . . . . 0.0 110.612 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.96 57.2 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.167 0.889 . . . . 0.0 112.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -70.7 148.69 47.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.059 1.429 . . . . 0.0 110.482 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -76.09 59.48 1.33 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.815 1.246 . . . . 0.0 110.424 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 36.57 -123.54 0.17 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.164 1.786 . . . . 0.0 113.465 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.67 73.16 0.0 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.017 1.77 . . . . 0.0 115.298 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.1 t -160.18 9.13 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.31 1.055 . . . . 0.0 113.433 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -64.24 134.53 95.99 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 120.979 -1.076 . . . . 0.0 108.63 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -64.32 157.22 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.416 1.41 . . . . 0.0 111.31 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 47.68 58.46 4.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.149 1.38 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -154.83 119.98 4.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.148 0.499 . . . . 0.0 109.873 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -73.1 77.25 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.475 1.11 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.83 -176.93 1.17 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 110.515 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -113.25 173.71 6.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.158 0.983 . . . . 0.0 108.799 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.25 -41.64 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.202 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 p -60.22 -64.88 0.79 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.975 1.31 . . . . 0.0 111.719 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -38.82 75.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.121 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.54 -49.28 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.16 91.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.571 0.349 . . . . 0.0 111.005 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.7 tp -55.96 -52.58 63.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.37 -54.63 28.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.68 48.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.53 1.132 . . . . 0.0 112.585 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -71.15 2.12 5.0 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.92 34.07 8.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.663 1.125 . . . . 0.0 110.923 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -97.54 117.4 31.73 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.206 0.503 . . . . 0.0 109.849 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.11 137.92 45.26 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.632 1.173 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -73.79 95.77 2.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.587 0.355 . . . . 0.0 111.915 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 p -78.77 167.55 21.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -55.97 -43.63 77.73 Favored 'General case' 0 N--CA 1.459 -0.017 0 CA-C-O 121.923 0.868 . . . . 0.0 109.893 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.58 -51.75 67.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.059 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.42 -49.38 78.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.361 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.98 -52.91 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.83 -42.0 75.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.078 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.5 m -67.26 -51.48 52.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.243 0.217 . . . . 0.0 110.54 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -43.62 -56.36 3.77 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 125.266 1.427 . . . . 0.0 112.9 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 m -52.35 -30.18 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -73.12 -28.68 62.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.005 0.522 . . . . 0.0 112.008 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -151.95 62.63 4.82 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 124.432 1.093 . . . . 0.0 111.215 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.78 159.14 53.61 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.53 -63.83 3.64 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.53 67.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.198 0.999 . . . . 0.0 110.464 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -52.41 -48.27 65.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.089 0.556 . . . . 0.0 110.554 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.63 -59.31 5.39 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -45.3 -48.39 13.03 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.633 1.173 . . . . 0.0 110.727 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.37 -70.46 0.17 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.303 1.041 . . . . 0.0 110.712 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -63.15 -31.53 72.69 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -171.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.48 -7.42 59.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.396 0.679 . . . . 0.0 111.256 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.24 54.37 10.38 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 109.286 -175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -138.62 152.16 47.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.588 1.155 . . . . 0.0 109.776 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -48.63 6.86 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.779 1.632 . . . . 0.0 108.13 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -80.96 30.18 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.07 67.27 8.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.277 -0.889 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.83 154.68 40.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.964 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -123.17 149.82 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.4 -26.25 74.45 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 15.5 ttp -68.48 80.78 0.26 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.642 0.721 . . . . 0.0 112.146 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 57.94 3.12 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.48 146.89 13.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -143.1 160.7 39.91 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.3 tp -161.05 112.49 1.82 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.2 33.92 0.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.662 -0.649 . . . . 0.0 112.56 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -159.49 179.54 8.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.202 2.201 . . . . 0.0 106.848 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.46 -55.13 4.39 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.05 -57.15 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 126.209 1.861 . . . . 0.0 114.075 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -52.75 -58.2 7.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.038 1.335 . . . . 0.0 113.004 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.92 -40.51 79.03 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.781 -0.574 . . . . 0.0 111.019 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.97 -41.11 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.928 -0.483 . . . . 0.0 110.418 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.04 -46.64 87.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.754 -0.591 . . . . 0.0 109.749 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.18 -43.78 95.6 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.85 -49.22 77.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.37 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 mt -57.87 -45.54 86.19 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.222 0.465 . . . . 0.0 110.593 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.71 79.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.826 0.451 . . . . 0.0 110.642 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -70.15 -39.61 75.24 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.135 -0.353 . . . . 0.0 110.866 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.92 -38.93 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.677 1.591 . . . . 0.0 112.596 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.54 0.566 0 CA-C-N 119.499 1.045 . . . . 0.0 110.574 -179.493 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 CA-C-O 121.115 0.286 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -81.71 88.84 6.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.199 1.0 . . . . 0.0 108.853 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.53 -42.51 2.42 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.807 1.243 . . . . 0.0 112.978 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.59 73.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.597 0.759 . . . . 0.0 111.467 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -69.42 -37.21 77.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -51.47 -43.03 52.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.421 1.01 . . . . 0.0 111.228 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -52.5 -46.94 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.459 0.704 . . . . 0.0 110.848 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.96 -46.47 65.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.518 0.727 . . . . 0.0 109.567 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.21 -35.5 67.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.097 0.959 . . . . 0.0 110.579 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -56.91 -16.95 7.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.128 0.971 . . . . 0.0 112.428 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -52.2 -29.61 23.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.562 -0.711 . . . . 0.0 110.545 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -72.76 -55.61 6.49 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.46 -46.19 56.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.421 1.089 . . . . 0.0 112.889 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -55.86 -21.81 21.98 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -59.4 -26.12 64.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.3 m -118.83 -43.81 2.65 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.524 0.729 . . . . 0.0 111.09 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -97.98 -172.17 2.31 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.272 1.029 . . . . 0.0 112.85 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -151.04 169.05 22.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.571 1.548 . . . . 0.0 109.057 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.9 mt -133.31 124.08 48.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -145.61 134.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.932 0.893 . . . . 0.0 110.012 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.11 161.98 68.78 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -54.58 -37.0 90.62 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 110.982 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.41 -0.57 6.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.711 1.604 . . . . 0.0 113.315 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.85 -7.32 81.6 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 120.848 -1.158 . . . . 0.0 112.415 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -64.82 103.19 0.67 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.457 1.128 . . . . 0.0 109.125 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.03 120.78 14.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.699 0.4 . . . . 0.0 111.255 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.43 -45.92 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.84 106.37 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -72.16 56.5 0.33 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.039 1.336 . . . . 0.0 110.172 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.26 -173.61 13.0 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 167.94 7.46 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.098 -0.648 . . . . 0.0 111.085 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -117.09 30.66 7.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.731 0.812 . . . . 0.0 109.261 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -67.27 -44.11 80.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.53 171.72 17.65 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 107.636 -2.185 . . . . 0.0 107.636 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.77 177.27 1.87 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.243 3.295 . . . . 0.0 113.087 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 114.1 21.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.45 -16.93 62.39 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.75 116.0 2.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.99 15.27 70.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.56 -1.133 . . . . 0.0 114.837 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.5 -44.96 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.928 1.864 . . . . 0.0 108.892 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.65 113.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 -15.17 59.75 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.832 1.206 . . . . 0.0 112.744 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -90.31 144.65 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.541 1.17 . . . . 0.0 110.919 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -58.69 133.35 55.84 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.628 1.171 . . . . 0.0 109.126 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.81 159.33 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.534 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.92 23.53 31.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.975 1.274 . . . . 0.0 114.477 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.1 p -145.31 22.94 1.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.888 1.344 . . . . 0.0 113.01 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -67.32 137.44 93.84 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.06 154.35 10.64 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.311 2.007 . . . . 0.0 114.565 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 45.06 59.35 3.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.276 1.83 . . . . 0.0 113.269 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.31 118.57 2.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -82.88 98.27 9.1 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.028 0.931 . . . . 0.0 109.725 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -82.68 -172.83 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 111.152 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -96.35 -176.91 3.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.924 1.29 . . . . 0.0 108.546 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.77 -34.47 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.928 0.891 . . . . 0.0 113.12 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 p -60.42 -65.38 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.46 1.104 . . . . 0.0 110.387 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.54 -40.28 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.156 1.383 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.8 t -59.82 -50.74 78.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.2 97.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.123 0.42 . . . . 0.0 111.108 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -53.31 53.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.73 64.59 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 123.766 0.698 . . . . 0.0 111.836 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.72 -26.82 47.24 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.488 1.515 . . . . 0.0 112.033 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.2 m -69.56 0.59 5.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.01 0.368 . . . . 0.0 111.938 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.97 38.4 5.76 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 125.446 1.498 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -107.11 110.06 22.06 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.378 0.589 . . . . 0.0 111.676 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 128.11 43.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.218 1.407 . . . . 0.0 107.55 174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -62.75 151.76 37.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 110.796 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.0 p -129.82 162.56 28.23 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.949 1.7 . . . . 0.0 106.452 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.38 -39.68 80.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.061 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.55 -52.53 64.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.551 0.741 . . . . 0.0 110.216 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -61.03 -45.34 95.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.431 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.1 -53.03 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 118.675 0.671 . . . . 0.0 109.335 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.75 -46.45 64.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.462 0.705 . . . . 0.0 110.052 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.5 m -62.24 -54.4 41.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 109.915 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -50.08 -48.45 53.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.816 1.246 . . . . 0.0 113.04 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.3 m -60.47 -28.13 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.331 0.969 . . . . 0.0 112.689 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.24 -13.4 52.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.663 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -139.54 57.71 10.59 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.989 1.716 . . . . 0.0 112.07 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.08 138.43 78.15 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.926 2.418 . . . . 0.0 109.663 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.6 -65.17 2.49 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.42 -45.65 9.14 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 125.924 1.69 . . . . 0.0 111.529 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -55.1 -55.49 30.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.898 0.479 . . . . 0.0 110.664 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -56.74 -53.03 62.46 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.208 0.603 . . . . 0.0 109.997 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -52.35 -44.2 65.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.765 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.09 -67.15 0.45 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.605 0.762 . . . . 0.0 110.22 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -53.86 -42.74 68.9 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.16 -4.05 59.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.117 0.567 . . . . 0.0 111.847 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.3 t0 47.6 45.11 17.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.094 1.358 . . . . 0.0 110.009 -174.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.24 111.61 11.01 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.459 1.104 . . . . 0.0 110.52 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -57.46 -26.05 60.63 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.002 2.521 . . . . 0.0 111.787 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -96.49 9.61 40.84 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.22 72.71 7.06 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.502 -0.749 . . . . 0.0 110.357 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -91.73 126.79 36.94 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.701 0.8 . . . . 0.0 109.976 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -80.78 161.94 24.29 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.15 0.5 . . . . 0.0 110.498 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.13 -22.76 70.35 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 169.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ttp -68.26 81.02 0.24 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.991 0.895 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.0 58.04 3.31 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -160.19 150.43 18.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.539 1.536 . . . . 0.0 107.387 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -141.98 158.34 43.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.319 1.048 . . . . 0.0 108.543 173.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.71 102.81 11.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.08 67.73 1.79 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.889 1.276 . . . . 0.0 109.958 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 89.3 139.45 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 129.195 2.998 . . . . 0.0 109.35 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.9 -21.76 7.83 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -49.48 -41.59 33.33 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.492 1.044 . . . . 0.0 112.63 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.45 -46.56 88.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.443 0.622 . . . . 0.0 110.868 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.6 -49.2 77.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.283 1.433 . . . . 0.0 110.17 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.59 -44.96 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.66 91.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.87 -0.518 . . . . 0.0 110.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.06 94.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -57.22 -49.42 76.07 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.908 -0.495 . . . . 0.0 110.269 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.27 -44.21 88.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.429 -0.794 . . . . 0.0 111.206 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.47 73.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.442 0.697 . . . . 0.0 110.752 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -72.38 -37.73 68.66 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.123 -0.36 . . . . 0.0 110.679 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -69.27 -47.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.806 1.242 . . . . 0.0 112.43 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 122.566 1.174 . . . . 0.0 111.841 -176.766 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -77.08 84.14 3.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -39.06 -41.6 0.81 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.604 1.561 . . . . 0.0 113.601 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.29 36.74 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.455 0.57 . . . . 0.0 110.627 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -57.25 -38.47 73.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.308 0.643 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.52 -52.05 47.75 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.74 -50.37 73.44 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.15 0.98 . . . . 0.0 110.165 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.57 -51.62 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.459 -0.201 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.95 -38.33 70.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.828 0.851 . . . . 0.0 109.627 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -56.97 -29.95 63.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -33.54 67.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.025 -0.422 . . . . 0.0 110.231 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -87.66 -48.66 7.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.742 0.817 . . . . 0.0 109.006 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.2 t -49.22 -37.57 23.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.588 1.555 . . . . 0.0 112.038 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 5.01 0.68 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -55.83 -30.53 61.58 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.798 -1.189 . . . . 0.0 110.213 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.18 -37.28 5.37 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.563 0.745 . . . . 0.0 112.593 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -105.71 -174.43 2.53 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.676 0.791 . . . . 0.0 112.337 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 m -150.67 171.25 17.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.015 1.326 . . . . 0.0 109.619 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -133.16 133.28 58.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tp -117.14 141.86 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.537 1.535 . . . . 0.0 109.247 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.26 154.76 88.22 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.53 -38.84 45.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.12 2.547 . . . . 0.0 113.537 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.57 -16.25 62.84 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.738 1.215 . . . . 0.0 113.779 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.48 -13.52 23.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.667 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.3 m -60.63 124.85 21.61 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.625 1.712 . . . . 0.0 110.014 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -72.74 77.35 1.12 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.673 0.789 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.2 mm -52.94 -55.43 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.17 86.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.28 65.25 0.84 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.143 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.24 -158.53 33.57 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.53 174.09 11.38 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -121.92 28.44 7.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 109.201 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -66.9 -43.42 83.45 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.13 171.03 18.38 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 170.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.69 -173.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.61 2.873 . . . . 0.0 114.049 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -117.63 89.99 3.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 108.594 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 6.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 119.208 3.04 . . . . 0.0 119.208 -169.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -59.75 102.44 0.15 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 121.29 1.859 . . . . 0.0 108.736 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.36 21.81 31.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.485 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.98 -40.69 89.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-N 118.599 1.199 . . . . 0.0 109.4 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.06 98.71 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -16.06 9.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.506 2.003 . . . . 0.0 111.569 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -71.48 136.19 47.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 117.987 0.893 . . . . 0.0 110.409 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -71.4 67.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.598 1.559 . . . . 0.0 111.794 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 62.54 -149.86 0.36 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.314 1.046 . . . . 0.0 111.621 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.84 80.99 0.18 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 123.155 0.407 . . . . 0.0 113.173 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 t -150.32 21.02 0.85 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -68.12 143.14 95.73 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.29 153.9 20.58 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.39 1.393 . . . . 0.0 114.012 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 47.47 65.24 1.32 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.25 1.82 . . . . 0.0 112.875 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -158.7 120.93 3.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.137 0.494 . . . . 0.0 110.607 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -75.21 78.12 2.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.37 1.068 . . . . 0.0 110.7 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -67.41 178.19 1.65 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.884 0.474 . . . . 0.0 111.315 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -112.15 174.91 5.66 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.735 1.214 . . . . 0.0 109.663 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.28 -39.49 87.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.298 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.1 p -65.89 -62.72 1.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.677 1.227 . . . . 0.0 110.835 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -61.75 -21.25 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.087 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.01 -47.92 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.73 64.17 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.134 0.974 . . . . 0.0 111.014 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.73 -51.54 48.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.944 0.897 . . . . 0.0 108.751 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.39 90.8 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.54 -39.59 73.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -71.98 -7.78 50.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.46 9.57 43.73 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.373 0.987 . . . . 0.0 113.054 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -74.46 142.21 44.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.186 1.493 . . . . 0.0 109.204 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.87 135.03 41.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.923 1.289 . . . . 0.0 107.682 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -64.14 128.47 35.95 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -113.87 167.3 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.868 1.667 . . . . 0.0 106.806 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -52.65 45.3 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.949 0.88 . . . . 0.0 109.834 172.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.76 -48.3 82.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.547 -176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -63.69 -41.4 98.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.491 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.48 -53.2 47.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.62 -47.07 67.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.495 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -61.43 -54.93 37.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.751 0.31 . . . . 0.0 110.751 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -55.13 -42.18 72.67 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.456 -0.777 . . . . 0.0 111.925 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.68 -28.1 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.241 0.616 . . . . 0.0 111.506 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -90.25 -31.78 16.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.555 0.742 . . . . 0.0 111.067 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.61 69.17 72.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 124.664 1.186 . . . . 0.0 112.518 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -67.28 153.9 75.74 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.07 -64.38 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.06 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.854 1.262 . . . . 0.0 110.317 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -52.67 -50.37 63.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.948 0.499 . . . . 0.0 111.402 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.29 -49.5 69.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.622 -0.674 . . . . 0.0 109.824 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -51.14 -48.37 61.82 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.118 0.567 . . . . 0.0 111.341 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -43.49 -54.64 4.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.118 0.967 . . . . 0.0 111.553 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -84.26 -50.8 7.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.959 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -76.13 -23.05 54.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.961 0.904 . . . . 0.0 113.436 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 44.74 63.65 1.63 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.653 1.981 . . . . 0.0 111.725 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -150.29 137.34 19.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -52.13 -38.7 58.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.977 0.911 . . . . 0.0 110.646 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -82.44 13.07 3.86 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.65 61.2 4.25 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.235 -0.915 . . . . 0.0 109.178 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.78 -174.55 2.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.823 1.249 . . . . 0.0 110.057 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -152.57 151.7 30.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.72 -13.05 71.41 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.1 ttp -69.75 78.9 0.44 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 118.166 0.983 . . . . 0.0 113.21 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.56 56.83 2.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -164.21 144.6 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.869 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -152.7 171.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 tp -144.73 113.56 6.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.55 41.44 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.065 0.546 . . . . 0.0 111.367 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 pttp 179.71 178.87 0.53 Allowed 'General case' 0 C--O 1.231 0.11 0 C-N-CA 127.61 2.364 . . . . 0.0 105.793 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.98 -52.96 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 119.038 -0.868 . . . . 0.0 113.184 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.4 -54.01 0.09 OUTLIER Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.221 2.343 . . . . 0.0 115.102 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -64.96 -45.04 87.39 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.032 0.916 . . . . 0.0 111.578 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.38 -47.69 78.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 108.839 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.22 -43.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.872 1.269 . . . . 0.0 109.603 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.98 88.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.954 -0.466 . . . . 0.0 110.219 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.12 -52.45 65.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.1 mt -55.59 -48.01 75.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.053 0.541 . . . . 0.0 110.718 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.87 -40.05 69.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 110.75 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 m -77.52 -14.05 59.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 t -87.05 -38.19 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 108.737 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.539 0.522 0 O-C-N 121.742 -0.599 . . . . 0.0 109.859 176.578 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.104 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.12 82.54 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.899 -0.765 . . . . 0.0 109.293 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -45.1 -40.37 6.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 112.313 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.95 81.25 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.283 0.633 . . . . 0.0 111.165 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -64.46 -43.68 93.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.34 -48.57 33.42 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.8 1.19 . . . . 0.0 111.526 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.01 -54.61 36.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.716 0.758 . . . . 0.0 110.213 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.67 -48.39 81.86 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.888 -0.508 . . . . 0.0 110.662 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -56.54 -33.82 66.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.876 1.271 . . . . 0.0 110.821 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.13 -21.05 7.72 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.041 0.937 . . . . 0.0 111.615 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -46.2 -36.25 5.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.846 0.748 . . . . 0.0 110.754 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -69.09 -57.88 4.83 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.59 -40.51 52.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.257 1.023 . . . . 0.0 111.292 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -45.22 -35.3 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.552 2.341 . . . . 0.0 112.394 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 m -55.16 -29.88 58.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.588 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.6 m -123.36 -27.2 4.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.517 1.127 . . . . 0.0 113.387 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.1 167.94 11.32 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.539 1.136 . . . . 0.0 112.639 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 p -145.57 168.49 20.5 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.202 1.801 . . . . 0.0 109.562 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mp -136.04 107.73 7.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 tt -129.04 137.31 57.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 124.212 1.005 . . . . 0.0 110.548 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 152.52 92.86 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.42 -40.06 44.59 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.438 2.759 . . . . 0.0 113.497 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.69 -13.31 61.99 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.798 1.239 . . . . 0.0 113.802 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.07 -7.29 29.08 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.703 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.8 m -61.15 102.34 0.21 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.002 1.901 . . . . 0.0 109.299 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.66 76.37 5.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.844 2.058 . . . . 0.0 111.471 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.49 -46.71 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.292 0.637 . . . . 0.0 109.381 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.43 106.79 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -75.38 55.41 0.79 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.737 1.615 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.6 -174.33 30.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.21 0.91 . . . . 0.0 111.2 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.58 -174.69 5.12 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.804 0.811 . . . . 0.0 112.046 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.51 28.27 3.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 110.242 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 m -61.67 -35.09 76.97 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.04 162.87 12.45 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 169.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -55.4 153.1 29.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.592 2.195 . . . . 0.0 113.441 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -66.03 127.45 32.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.76 16.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -63.43 87.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.243 0.929 . . . . 0.0 110.045 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.75 46.67 5.63 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.11 -31.65 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.77 118.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.711 0.804 . . . . 0.0 108.862 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.91 -10.18 74.74 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.024 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.85 136.78 53.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.44 1.12 . . . . 0.0 109.327 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -62.53 135.39 57.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.52 131.3 45.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.757 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.03 35.22 61.27 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.562 -1.132 . . . . 0.0 113.764 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.1 p -136.33 2.68 2.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.123 1.461 . . . . 0.0 114.644 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.35 128.01 90.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.409 1.459 . . . . 0.0 107.106 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -54.57 157.85 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.901 2.401 . . . . 0.0 114.479 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 49.97 66.19 1.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.373 1.869 . . . . 0.0 112.415 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -164.44 123.78 1.92 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.815 0.446 . . . . 0.0 109.868 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -79.93 93.79 5.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.041 0.936 . . . . 0.0 109.922 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -77.97 -170.24 1.85 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.649 0.738 . . . . 0.0 110.662 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -117.08 172.44 7.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.291 1.836 . . . . 0.0 108.495 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.58 -36.71 84.69 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.979 0.912 . . . . 0.0 113.383 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -60.99 -65.76 0.64 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 111.089 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.21 -37.96 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.37 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -48.04 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.73 91.65 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.652 0.66 . . . . 0.0 111.141 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -48.36 73.69 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.57 28.16 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.13 -27.79 55.36 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.629 1.572 . . . . 0.0 112.282 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -68.03 -4.6 13.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.77 35.8 4.19 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 125.32 1.438 . . . . 0.0 110.52 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -103.39 124.19 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 117.408 0.604 . . . . 0.0 110.957 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.58 130.25 56.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.154 1.782 . . . . 0.0 107.603 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -60.74 143.62 54.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 118.177 0.444 . . . . 0.0 110.613 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.0 p -128.27 170.13 13.4 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.004 1.722 . . . . 0.0 106.917 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -58.59 -45.23 89.55 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 122.978 0.511 . . . . 0.0 110.606 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.36 -46.9 75.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.576 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.27 -46.68 87.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.99 -52.74 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -47.31 69.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.616 0.367 . . . . 0.0 110.277 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.6 m -64.37 -44.23 92.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.815 -0.553 . . . . 0.0 110.829 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -55.75 -53.47 56.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.063 0.945 . . . . 0.0 111.286 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 m -56.99 -40.13 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.593 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -65.04 -24.55 67.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -158.02 73.35 4.04 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.732 1.151 . . . . 0.0 113.005 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.13 146.74 79.71 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.522 2.148 . . . . 0.0 110.636 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.9 -64.18 4.35 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.78 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 117.318 0.559 . . . . 0.0 110.297 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -51.78 -51.23 57.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.959 0.504 . . . . 0.0 111.656 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.41 -56.39 16.61 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.321 0.648 . . . . 0.0 109.296 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -46.58 -46.4 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.499 1.12 . . . . 0.0 110.747 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -51.88 -40.53 60.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.043 0.937 . . . . 0.0 111.973 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -90.9 -45.68 8.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.305 0.642 . . . . 0.0 112.129 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 -17.87 39.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.472 1.109 . . . . 0.0 113.189 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 48.25 62.66 2.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.399 1.88 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -143.76 150.14 38.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.679 1.592 . . . . 0.0 108.926 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -66.97 -48.33 68.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 108.432 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -80.3 11.58 3.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.03 -1.441 . . . . 0.0 114.619 -173.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.41 63.58 6.65 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.691 -1.256 . . . . 0.0 110.517 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -102.52 170.45 8.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.197 0.999 . . . . 0.0 109.942 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -131.7 154.07 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.61 -12.44 64.15 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.0 ttp -67.97 79.75 0.22 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 56.6 2.66 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.572 0.749 . . . . 0.0 110.122 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -154.28 116.06 4.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.839 1.256 . . . . 0.0 108.712 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -100.94 -179.14 3.97 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.6 156.89 47.94 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.49 53.32 0.8 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? 75.66 164.12 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.875 1.67 . . . . 0.0 110.619 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.98 -15.22 33.85 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.05 -35.62 33.36 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.425 1.488 . . . . 0.0 112.29 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.65 -47.37 86.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 117.518 0.659 . . . . 0.0 110.586 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -64.32 -44.39 91.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.42 -47.1 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.5 -48.14 77.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.955 -0.466 . . . . 0.0 109.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.18 -46.09 79.5 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -57.0 -51.23 70.06 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.073 -0.392 . . . . 0.0 110.869 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.37 -43.58 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.848 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.67 91.61 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.325 -0.234 . . . . 0.0 110.964 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.5 m -69.85 -50.05 46.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.603 ' CG1' ' H ' ' A' ' 115' ' ' VAL . 11.4 p -59.68 -81.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.603 ' H ' ' CG1' ' A' ' 114' ' ' VAL . 7.2 p . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 129.722 3.209 . . . . 0.0 113.655 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.89 74.59 0.62 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.62 1.168 . . . . 0.0 111.449 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.39 -40.64 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.509 1.124 . . . . 0.0 112.618 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.54 85.79 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.733 -0.604 . . . . 0.0 111.044 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -63.98 -38.16 90.06 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.67 -48.35 82.16 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.19 -49.81 72.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.74 0.816 . . . . 0.0 109.736 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.7 -48.33 82.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.435 0.16 . . . . 0.0 110.691 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.15 -34.56 68.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.491 1.116 . . . . 0.0 110.464 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.98 -16.67 7.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.958 0.903 . . . . 0.0 112.564 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -51.28 -30.84 19.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.449 0.7 . . . . 0.0 110.387 172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -76.96 -59.02 2.95 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.62 -0.675 . . . . 0.0 109.349 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.9 m -45.36 -47.68 13.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.768 1.627 . . . . 0.0 111.961 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -51.02 -26.27 5.92 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.924 1.29 . . . . 0.0 113.805 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -58.6 -40.57 83.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.472 0.578 . . . . 0.0 109.56 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.1 m -99.39 -48.69 4.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.419 1.088 . . . . 0.0 112.133 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -84.07 176.83 8.55 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.159 0.983 . . . . 0.0 112.473 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.4 m -147.98 159.23 44.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.818 0.847 . . . . 0.0 108.764 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -142.93 122.19 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.36 130.52 60.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 O-C-N 121.86 -0.525 . . . . 0.0 110.009 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.04 158.87 60.36 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.98 -39.25 79.74 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.269 2.646 . . . . 0.0 112.53 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.7 -8.6 55.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.375 1.47 . . . . 0.0 113.717 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.49 -13.25 51.07 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -59.92 114.81 3.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.66 1.73 . . . . 0.0 109.677 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.24 118.74 11.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.467 0.707 . . . . 0.0 109.949 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 mm -89.86 -42.52 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.9 t -141.19 129.58 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -127.6 74.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.69 -168.4 3.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.28 44.22 1.01 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.977 -1.307 . . . . 0.0 110.11 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 tptp 13.79 57.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 130.648 3.579 . . . . 0.0 113.79 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -89.48 -30.95 17.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.69 0.796 . . . . 0.0 108.915 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.5 170.27 13.98 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.84 167.22 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 112.21 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.49 125.7 30.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -92.9 4.43 53.92 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -67.55 87.15 0.2 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.296 0.953 . . . . 0.0 109.483 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.05 23.14 5.66 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.947 0.784 . . . . 0.0 111.577 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.91 -42.73 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.519 1.16 . . . . 0.0 110.05 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.63 114.44 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.11 63.56 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.013 1.292 . . . . 0.0 111.654 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -68.92 138.61 54.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.6 1.2 . . . . 0.0 109.897 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 m -67.4 70.4 0.11 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.781 1.632 . . . . 0.0 111.508 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.53 -144.91 0.64 Allowed 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.875 -0.516 . . . . 0.0 110.232 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.62 73.73 0.61 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.514 1.054 . . . . 0.0 112.645 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.4 p -138.81 2.73 2.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.239 1.015 . . . . 0.0 111.922 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -62.22 132.9 94.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.57 161.67 11.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.151 1.9 . . . . 0.0 114.006 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 57.55 58.64 3.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.794 1.638 . . . . 0.0 112.916 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -165.88 123.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.746 0.418 . . . . 0.0 110.488 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.24 88.93 4.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.976 0.91 . . . . 0.0 109.553 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.91 -174.17 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.521 0.677 . . . . 0.0 111.455 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -106.12 -178.46 3.66 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.492 1.517 . . . . 0.0 108.322 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.65 -38.03 67.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.713 0.805 . . . . 0.0 112.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -60.74 -63.06 1.43 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 111.078 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.54 -35.65 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.9 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.55 -48.27 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.91 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 110.586 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.3 tp -55.77 -49.65 72.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.45 -52.75 48.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.84 -36.83 65.46 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.2 1.0 . . . . 0.0 112.591 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -67.32 -11.58 57.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.89 10.92 15.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.889 1.233 . . . . 0.0 112.595 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -77.0 141.27 40.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.739 1.27 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.51 34.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.454 1.501 . . . . 0.0 107.923 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -62.54 143.26 57.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.33 166.45 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.035 1.734 . . . . 0.0 106.596 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.98 -43.76 77.91 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.304 0.573 . . . . 0.0 110.775 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.62 -47.69 68.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.102 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.11 -46.05 90.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.252 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.3 mt -57.22 -54.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.69 -46.13 29.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.636 0.774 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -63.43 -65.32 0.7 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.255 0.622 . . . . 0.0 110.472 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -43.38 -48.83 7.06 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.011 1.724 . . . . 0.0 112.811 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 t -53.2 -25.73 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.64 14.87 15.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.601 1.091 . . . . 0.0 112.32 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -159.37 56.79 0.95 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.576 1.15 . . . . 0.0 111.904 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -66.82 157.39 61.55 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 108.75 -1.288 . . . . 0.0 108.75 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 -66.82 3.04 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.04 -47.68 53.22 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.411 1.084 . . . . 0.0 111.342 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -51.59 -52.39 47.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.64 -56.2 24.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.622 1.169 . . . . 0.0 109.73 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.02 -47.62 44.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.575 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -63.95 -66.96 0.47 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.467 0.707 . . . . 0.0 110.369 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -53.99 -39.81 66.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.7 tp -92.24 -0.41 57.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.938 0.895 . . . . 0.0 111.982 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 43.45 58.39 3.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.327 1.451 . . . . 0.0 109.94 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -143.68 157.88 44.08 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 124.305 1.042 . . . . 0.0 110.836 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -92.41 -50.22 5.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.272 1.829 . . . . 0.0 108.115 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -79.53 42.2 0.51 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.89 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.37 90.94 3.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -131.46 132.72 44.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.054 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.92 154.48 19.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.12 -16.9 62.86 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttp -64.96 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.244 1.022 . . . . 0.0 113.309 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.56 59.21 4.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -160.43 150.72 18.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.329 1.851 . . . . 0.0 107.426 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -143.81 164.23 31.1 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.846 1.259 . . . . 0.0 107.812 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.88 169.38 9.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.92 37.51 4.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -147.33 170.52 17.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.217 1.807 . . . . 0.0 106.172 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.75 -10.05 57.41 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.874 -0.959 . . . . 0.0 112.622 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.67 13.56 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 118.708 1.254 . . . . 0.0 113.889 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -61.71 -46.1 91.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.362 1.081 . . . . 0.0 109.452 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -55.28 -52.61 62.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.296 1.438 . . . . 0.0 110.57 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.21 -46.2 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.451 1.101 . . . . 0.0 110.184 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.37 90.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.148 -0.345 . . . . 0.0 110.376 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.25 99.17 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.499 0.319 . . . . 0.0 110.309 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -57.66 -52.26 66.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.7 -44.13 90.26 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.854 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.35 76.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.5 m -61.58 -38.13 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.012 -0.43 . . . . 0.0 111.094 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -37.06 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.855 -0.528 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 CA--C 1.531 0.225 0 C-N-CA 124.305 1.042 . . . . 0.0 110.235 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 N-CA-C 114.043 0.377 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.69 72.48 0.77 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.461 1.505 . . . . 0.0 111.506 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.1 -39.97 10.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.679 1.191 . . . . 0.0 112.591 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.26 94.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.541 0.736 . . . . 0.0 111.452 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.38 -43.6 69.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.86 -44.61 40.34 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.99 -46.13 71.64 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 111.659 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -71.36 -47.99 52.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.659 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -57.62 -30.66 65.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.935 0.894 . . . . 0.0 110.719 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.67 -16.46 4.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.618 1.167 . . . . 0.0 112.144 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -53.52 -33.22 53.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.333 0.969 . . . . 0.0 111.087 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -72.85 -26.64 61.54 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.77 -0.581 . . . . 0.0 111.391 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.9 m -77.4 -45.62 25.31 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -46.23 -32.88 3.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 111.904 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -53.0 -31.31 40.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.121 0.968 . . . . 0.0 111.76 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -120.2 -38.34 2.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.487 1.515 . . . . 0.0 112.366 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -103.7 -173.47 2.32 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 125.634 1.574 . . . . 0.0 111.386 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -157.24 168.48 27.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.408 1.483 . . . . 0.0 109.01 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 133.07 54.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.06 1.744 . . . . 0.0 106.692 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -111.6 149.74 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.653 1.981 . . . . 0.0 109.16 -175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 161.95 48.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.76 -36.99 27.28 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.592 2.861 . . . . 0.0 112.124 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.09 13.68 0.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.996 1.718 . . . . 0.0 113.325 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.44 31.98 60.42 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.664 1.125 . . . . 0.0 111.656 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -112.2 126.24 55.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -63.44 121.82 14.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.538 0.335 . . . . 0.0 110.469 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.1 mm -98.62 -60.18 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.67 77.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.62 70.61 0.19 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.749 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.42 -158.17 30.76 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 173.82 11.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.9 33.06 5.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.468 1.107 . . . . 0.0 108.977 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.7 m -69.38 -38.12 77.88 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.7 165.27 12.03 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -59.45 141.66 97.81 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.891 3.061 . . . . 0.0 111.199 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.07 119.4 7.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -85.86 15.91 4.51 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -170.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -75.54 80.41 2.56 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.563 -1.335 . . . . 0.0 109.442 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.93 46.35 0.34 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.127 0.87 . . . . 0.0 113.453 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.89 -48.43 33.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 t -53.52 112.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.786 0.835 . . . . 0.0 110.431 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 -15.68 61.39 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.922 1.249 . . . . 0.0 113.058 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -68.12 140.56 56.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.94 1.37 . . . . 0.0 110.789 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 m -70.2 72.73 0.46 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 110.611 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.07 -139.47 1.02 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.942 0.497 . . . . 0.0 109.707 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.96 77.51 1.13 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 123.731 0.682 . . . . 0.0 112.536 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 p -136.21 16.36 3.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.713 0.805 . . . . 0.0 112.121 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -67.08 141.81 96.73 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.022 -1.049 . . . . 0.0 108.928 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.37 155.98 23.18 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.279 1.319 . . . . 0.0 113.916 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 46.73 62.57 2.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.475 1.51 . . . . 0.0 113.587 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -158.44 120.5 3.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.867 -0.52 . . . . 0.0 110.023 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -73.49 82.18 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.446 0.698 . . . . 0.0 110.495 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.11 169.69 11.45 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.165 0.507 . . . . 0.0 110.513 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -96.52 175.58 6.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.87 -35.78 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.272 0.629 . . . . 0.0 112.635 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -59.24 -66.47 0.5 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.228 1.411 . . . . 0.0 111.173 -174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 tt -58.1 -37.94 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.806 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.11 -49.41 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.55 87.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.923 0.329 . . . . 0.0 110.711 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -47.26 84.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.58 -56.65 22.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 173.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.93 -32.61 54.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.08 1.352 . . . . 0.0 113.387 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.7 p -66.68 -12.97 60.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.86 0.755 . . . . 0.0 112.056 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.73 33.43 1.88 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.398 1.475 . . . . 0.0 110.861 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -96.11 143.61 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.787 0.794 . . . . 0.0 109.532 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.44 128.59 31.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -61.01 99.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.016 0.526 . . . . 0.0 111.831 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.4 p -83.19 167.85 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -58.17 -37.81 75.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.045 0.45 . . . . 0.0 109.846 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -64.41 -49.57 71.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -56.88 -52.74 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.15 -53.53 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.59 -46.28 63.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.499 0.72 . . . . 0.0 111.184 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.9 m -66.88 -54.91 17.56 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -51.78 -42.82 62.71 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.413 1.085 . . . . 0.0 113.068 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.6 t -53.98 -31.67 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.118 0.567 . . . . 0.0 111.519 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -105.6 14.13 28.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.28 1.432 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -161.21 49.16 0.26 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.269 1.027 . . . . 0.0 111.809 -175.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -56.16 136.08 73.27 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.67 2.914 . . . . 0.0 110.04 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.63 -55.39 2.08 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.55 -0.583 . . . . 0.0 111.959 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 -38.55 68.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.501 1.151 . . . . 0.0 111.26 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -63.46 -44.74 93.6 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 110.721 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.97 -54.72 41.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.702 0.801 . . . . 0.0 108.941 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -47.8 -48.46 30.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.881 1.272 . . . . 0.0 110.244 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -61.03 -68.43 0.31 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.056 0.942 . . . . 0.0 110.513 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.27 -37.04 81.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 tp -85.86 -3.69 58.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.6 0.76 . . . . 0.0 111.344 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 t0 44.13 54.2 6.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.435 1.494 . . . . 0.0 110.017 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -145.95 119.24 8.94 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.534 0.734 . . . . 0.0 111.85 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.94 -32.23 69.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.241 1.016 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -80.51 4.93 16.7 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.39 65.28 6.46 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.485 -0.76 . . . . 0.0 111.355 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.54 136.83 32.81 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.382 -0.824 . . . . 0.0 109.253 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.6 t -87.91 155.13 20.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.36 -25.31 72.48 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 21.2 ttp -65.44 82.63 0.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.976 0.888 . . . . 0.0 112.324 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 58.29 3.24 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -163.61 145.93 9.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.328 1.851 . . . . 0.0 107.044 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.84 155.14 46.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.9 109.54 13.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.38 46.72 0.76 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.532 -0.73 . . . . 0.0 111.669 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? 175.59 -165.63 0.03 OUTLIER 'General case' 0 C--O 1.231 0.117 0 C-N-CA 128.091 2.556 . . . . 0.0 106.225 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.22 -59.01 3.63 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.993 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -4.77 -70.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.372 2.891 . . . . 0.0 115.294 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.23 -57.22 13.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.181 0.992 . . . . 0.0 112.639 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.64 -35.18 80.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.092 0.557 . . . . 0.0 110.904 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.92 -46.55 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.281 0.632 . . . . 0.0 109.632 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.34 94.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.889 -0.507 . . . . 0.0 109.702 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -43.46 86.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -59.2 -51.47 69.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.8 mt -56.46 -38.23 71.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.792 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.78 -52.46 60.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.152 0.887 . . . . 0.0 109.573 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.6 m -53.88 -34.88 60.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 112.618 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.14 -30.82 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.863 1.265 . . . . 0.0 111.697 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 CA--C 1.536 0.411 0 CA-C-N 119.064 0.847 . . . . 0.0 110.482 -178.691 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -92.08 106.93 18.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.315 1.046 . . . . 0.0 108.498 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.72 -34.75 5.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.672 1.189 . . . . 0.0 112.476 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.04 74.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.761 0.71 . . . . 0.0 110.324 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.61 -38.52 87.94 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.49 -52.24 51.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.08 -49.15 77.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.232 0.613 . . . . 0.0 110.553 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -55.87 -50.92 69.32 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.4 -35.52 72.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.422 0.689 . . . . 0.0 109.951 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.87 -19.93 32.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -52.98 -31.82 42.82 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.604 0.638 . . . . 0.0 110.985 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -52.72 6.06 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.06 -38.18 10.7 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.563 1.945 . . . . 0.0 113.645 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -52.43 -25.18 9.34 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.15 . . . . 0.0 112.817 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 m -61.91 -21.97 65.19 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.612 -0.68 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -119.16 -38.76 3.0 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.85 0.86 . . . . 0.0 112.619 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.75 169.7 8.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 112.404 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.3 p -141.38 164.21 30.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.785 1.234 . . . . 0.0 111.272 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.43 119.05 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -139.5 133.63 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.229 0.612 . . . . 0.0 110.86 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 162.85 63.03 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.83 -37.82 95.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.14 2.56 . . . . 0.0 112.394 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.25 -15.94 58.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.979 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.2 -3.11 56.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.41 110.96 2.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.6 114.57 13.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.888 0.875 . . . . 0.0 111.48 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.0 -45.16 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.7 t -135.2 103.31 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -76.96 54.79 1.05 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.781 1.232 . . . . 0.0 109.043 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.19 -176.4 50.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.21 177.94 6.12 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.327 0.584 . . . . 0.0 110.923 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -125.95 39.88 3.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.09 0.956 . . . . 0.0 109.368 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.2 m -65.57 -34.65 78.74 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.36 13.42 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 168.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.46 173.24 0.76 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.444 2.096 . . . . 0.0 113.494 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -83.32 135.09 34.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.77 10.84 37.64 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -64.8 88.61 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.275 0.943 . . . . 0.0 109.478 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.91 40.94 5.11 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -72.58 -36.39 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.39 107.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.72 -13.51 50.19 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.308 1.432 . . . . 0.0 112.069 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -73.07 137.5 45.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.841 0.821 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -63.47 128.9 37.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.39 154.89 12.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.829 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.07 22.76 72.65 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.867 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.1 t -156.16 28.72 0.35 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.539 1.67 . . . . 0.0 113.416 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -72.26 129.35 87.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 167.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -45.49 154.7 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.166 2.577 . . . . 0.0 116.094 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 54.7 65.57 1.47 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.298 1.439 . . . . 0.0 112.605 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -166.83 125.42 1.39 Allowed 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.854 -0.529 . . . . 0.0 111.713 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -79.36 90.7 5.01 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.64 1.176 . . . . 0.0 109.66 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -73.55 -177.57 2.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.464 0.705 . . . . 0.0 112.509 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -105.55 -178.03 3.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.004 1.322 . . . . 0.0 108.167 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.32 -37.17 66.25 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.512 -0.742 . . . . 0.0 112.792 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -62.24 -66.2 0.57 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.506 1.122 . . . . 0.0 111.167 -173.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -55.5 -38.09 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.897 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.01 -43.58 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 O-C-N 121.813 -0.555 . . . . 0.0 109.512 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.8 87.74 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.299 0.5 . . . . 0.0 110.318 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.04 -52.43 65.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.15 -48.29 10.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.096 1.331 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.14 29.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.237 1.415 . . . . 0.0 113.819 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -73.3 -0.5 14.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.471 1.032 . . . . 0.0 112.183 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 33.88 9.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -79.19 80.82 5.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.069 -0.665 . . . . 0.0 110.916 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.14 115.0 11.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.002 1.321 . . . . 0.0 107.865 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -56.3 146.77 22.89 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 109.259 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.2 p -127.18 164.0 22.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.08 -40.65 73.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.069 0.548 . . . . 0.0 110.213 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.61 -52.42 57.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.317 0.647 . . . . 0.0 110.604 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -61.03 -45.48 94.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.56 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.8 mm -56.18 -53.7 36.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.34 -47.16 66.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.678 0.391 . . . . 0.0 110.612 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 m -62.35 -55.49 27.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.21 0.528 . . . . 0.0 110.454 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.39 -44.63 45.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.331 1.453 . . . . 0.0 112.143 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.4 t -54.26 -30.5 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.41 0.684 . . . . 0.0 111.906 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -95.37 -26.38 15.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.616 0.766 . . . . 0.0 111.37 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -127.43 63.7 59.78 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 125.204 1.402 . . . . 0.0 112.693 -171.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.77 143.27 60.87 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.779 1.653 . . . . 0.0 108.809 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -63.57 3.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.25 -45.22 44.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.688 1.195 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -54.85 -53.03 60.61 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.686 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.6 -53.48 57.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.123 -0.361 . . . . 0.0 110.32 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -47.64 -50.6 24.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.98 0.912 . . . . 0.0 110.491 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.0 -58.32 6.35 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.01 0.524 . . . . 0.0 111.025 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -67.45 -51.47 51.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.86 -25.59 40.66 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.755 1.222 . . . . 0.0 114.219 -172.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.81 55.51 7.75 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.405 1.482 . . . . 0.0 109.892 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -136.21 135.92 39.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.248 1.419 . . . . 0.0 109.543 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.88 -41.35 97.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.411 1.084 . . . . 0.0 111.107 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -85.69 18.76 2.71 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 70.41 4.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.442 0.697 . . . . 0.0 110.444 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -113.41 128.46 56.46 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.54 1.536 . . . . 0.0 109.121 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.2 t -82.18 158.52 23.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.65 -19.85 69.53 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.5 ttp -68.76 82.72 0.29 Allowed 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.996 -0.708 . . . . 0.0 112.797 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.62 3.09 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -160.21 149.73 17.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.168 1.787 . . . . 0.0 108.084 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -156.3 172.57 18.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.142 1.377 . . . . 0.0 108.861 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -143.29 115.72 8.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.031 1.332 . . . . 0.0 107.625 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.48 45.58 0.78 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.665 -0.647 . . . . 0.0 111.868 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? 175.04 -172.22 0.06 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 128.301 2.64 . . . . 0.0 105.705 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.37 -52.49 2.25 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.686 -1.064 . . . . 0.0 113.523 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -24.84 -55.1 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.179 2.323 . . . . 0.0 114.997 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -62.14 -52.38 64.1 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.526 0.73 . . . . 0.0 111.493 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.72 -48.35 79.82 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.5 1.12 . . . . 0.0 109.456 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.22 -46.38 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.653 1.181 . . . . 0.0 109.697 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.71 87.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.874 -0.516 . . . . 0.0 110.07 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.8 93.91 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -58.5 -50.41 73.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.979 -0.45 . . . . 0.0 110.534 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.94 -46.13 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.954 0.902 . . . . 0.0 110.434 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.7 78.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.021 0.528 . . . . 0.0 110.556 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -69.07 -38.71 79.18 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.964 -0.46 . . . . 0.0 111.07 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -42.49 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 125.329 1.452 . . . . 0.0 111.46 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 122.069 0.937 . . . . 0.0 110.363 -179.696 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 121.798 0.665 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -73.67 80.59 1.53 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.863 -0.786 . . . . 0.0 111.152 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.52 63.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.9 0.88 . . . . 0.0 111.741 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.15 74.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.635 0.374 . . . . 0.0 110.407 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -63.87 -44.56 92.71 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -48.05 -45.53 26.56 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.13 0.871 . . . . 0.0 112.001 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -54.05 -47.22 71.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.285 0.634 . . . . 0.0 110.938 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -69.19 -44.74 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.94 -34.93 57.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.207 1.403 . . . . 0.0 109.641 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.52 -20.34 2.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.02 -27.67 33.45 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.816 -0.553 . . . . 0.0 111.456 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.35 -55.04 5.74 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.01 -42.82 29.12 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.993 1.317 . . . . 0.0 112.33 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -57.32 -21.07 32.67 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -54.52 -32.63 58.51 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.731 -0.606 . . . . 0.0 110.288 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 m -112.48 -44.35 3.37 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.338 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -90.84 -176.15 4.58 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 m -156.3 165.41 36.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.147 1.779 . . . . 0.0 108.732 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.6 mt -131.95 126.86 57.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -118.85 135.75 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.322 1.449 . . . . 0.0 109.998 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.24 82.34 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 119.015 0.825 . . . . 0.0 108.973 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.07 -41.25 73.19 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.16 2.573 . . . . 0.0 112.561 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -72.66 -10.96 60.42 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.172 1.389 . . . . 0.0 113.407 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.85 -17.15 35.96 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.023 -0.876 . . . . 0.0 113.443 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.8 m -60.71 116.32 4.31 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.522 1.661 . . . . 0.0 109.923 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -64.4 122.17 16.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.822 0.449 . . . . 0.0 110.341 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.44 -52.15 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.45 97.98 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -78.11 70.14 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.825 1.25 . . . . 0.0 107.801 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.39 -151.34 27.4 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.58 -179.33 5.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -123.51 22.45 9.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 108.89 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -30.13 70.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.225 1.01 . . . . 0.0 108.998 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.18 172.08 14.49 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.7 175.05 0.64 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 124.108 3.205 . . . . 0.0 113.307 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -105.4 81.77 1.74 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.055 0.942 . . . . 0.0 111.086 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mp -37.32 -0.91 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.542 1 C-N-CA 133.424 4.689 . . . . 0.0 121.464 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -69.07 80.86 0.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 121.058 1.754 . . . . 0.0 110.049 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.22 32.76 0.95 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.903 -0.943 . . . . 0.0 115.014 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.67 -49.12 81.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.7 1.75 . . . . 0.0 111.789 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.38 121.56 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 121.5 -0.75 . . . . 0.0 110.537 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.02 -19.21 54.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.744 1.164 . . . . 0.0 111.737 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -64.8 135.43 55.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.136 0.968 . . . . 0.0 110.042 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.2 m -73.15 80.75 1.27 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 51.68 -145.1 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.099 0.959 . . . . 0.0 110.963 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.0 78.81 0.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 124.82 1.2 . . . . 0.0 111.945 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.0 p -134.57 5.38 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.832 0.853 . . . . 0.0 111.805 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.06 134.99 93.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.07 164.75 9.76 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.486 2.124 . . . . 0.0 114.426 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.98 52.95 7.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.846 1.658 . . . . 0.0 112.057 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -161.49 118.42 2.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.991 -0.443 . . . . 0.0 111.81 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -78.77 79.9 5.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.064 0.946 . . . . 0.0 109.599 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -64.31 163.88 12.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.958 0.503 . . . . 0.0 111.385 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -96.47 176.39 6.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.144 0.973 . . . . 0.0 110.986 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.15 -36.62 73.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.804 1.641 . . . . 0.0 113.584 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 p -64.07 -67.61 0.42 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.029 0.919 . . . . 0.0 109.823 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 tt -59.25 -33.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.64 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.99 -50.89 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.637 -0.664 . . . . 0.0 109.663 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -40.3 82.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.416 0.553 . . . . 0.0 110.283 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -57.42 -44.33 84.55 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.86 -49.21 80.38 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.19 -35.47 64.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.335 0.568 . . . . 0.0 111.719 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.1 p -76.34 5.92 6.36 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 30.65 36.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.362 0.982 . . . . 0.0 112.33 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -74.99 82.61 2.22 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.77 -0.841 . . . . 0.0 112.296 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.81 107.97 5.52 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -52.35 116.48 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.627 0.771 . . . . 0.0 111.719 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.5 p -94.33 161.89 14.06 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.95 -38.0 81.16 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.91 -54.7 44.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.965 0.906 . . . . 0.0 109.249 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -58.44 -47.11 85.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.787 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -54.03 -53.65 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.67 62.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.008 0.523 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -60.07 -53.58 56.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -52.5 -44.56 65.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.191 0.996 . . . . 0.0 111.575 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.41 -20.15 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.096 0.958 . . . . 0.0 112.418 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -103.33 -14.11 16.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.561 1.144 . . . . 0.0 111.988 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -142.08 58.81 8.38 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.632 1.173 . . . . 0.0 111.929 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.67 135.62 70.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.109 2.539 . . . . 0.0 109.585 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.51 -59.04 4.11 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.562 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.25 -42.28 66.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.991 0.896 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -51.43 -59.62 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.366 1.066 . . . . 0.0 111.042 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.31 -50.17 73.79 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.245 1.018 . . . . 0.0 110.935 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -59.69 -35.95 75.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 110.264 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.79 -59.93 2.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.625 0.77 . . . . 0.0 109.188 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -54.44 -44.99 72.96 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.75 0.23 56.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.962 0.505 . . . . 0.0 111.738 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 46.73 49.94 13.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.203 1.401 . . . . 0.0 110.666 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -138.23 117.18 12.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.455 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -51.64 -37.34 49.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.554 1.142 . . . . 0.0 111.272 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -89.14 4.34 48.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.88 86.38 7.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -116.05 153.93 30.82 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.656 1.182 . . . . 0.0 110.228 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -97.27 157.29 16.03 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 123.904 0.882 . . . . 0.0 110.439 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.48 -19.99 79.21 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.6 ttt -65.02 81.68 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.521 1.128 . . . . 0.0 112.777 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 58.13 3.03 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.85 143.88 5.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.099 1.36 . . . . 0.0 108.877 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -141.24 166.87 23.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.554 1.542 . . . . 0.0 107.106 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.02 165.92 13.75 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.6 56.8 3.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.392 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 75.54 -172.11 0.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.839 2.055 . . . . 0.0 111.349 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.32 -78.37 1.93 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.22 -53.87 0.18 Allowed Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.99 1.281 . . . . 0.0 112.96 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -44.73 -37.88 4.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.397 1.879 . . . . 0.0 113.31 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -58.96 -48.13 82.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.412 0.685 . . . . 0.0 110.551 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.69 -39.71 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.32 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.303 -0.248 . . . . 0.0 110.629 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.52 95.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.558 0.743 . . . . 0.0 109.599 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.27 -51.01 69.73 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.49 -44.95 89.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.71 -0.619 . . . . 0.0 110.823 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.94 79.12 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.968 -0.457 . . . . 0.0 110.083 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -61.8 -41.09 97.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.634 0.373 . . . . 0.0 110.68 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.54 -31.23 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.752 0.821 . . . . 0.0 111.26 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 121.686 0.755 . . . . 0.0 109.133 178.228 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.869 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.0 92.21 5.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.6 -40.88 20.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.894 0.877 . . . . 0.0 112.94 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.63 72.97 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.898 -0.502 . . . . 0.0 110.126 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.18 -39.64 90.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.75 -47.12 38.92 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.011 1.291 . . . . 0.0 111.255 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.94 -48.19 73.49 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.113 0.456 . . . . 0.0 110.237 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -65.34 -46.17 81.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.403 0.281 . . . . 0.0 110.373 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -57.28 -33.18 67.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.607 1.163 . . . . 0.0 110.261 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.89 -21.39 57.41 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -27.49 56.26 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.585 0.629 . . . . 0.0 109.82 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -80.58 -49.78 10.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.9 m -53.11 -41.92 65.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.701 0.801 . . . . 0.0 112.358 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -62.19 -11.5 14.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.6 m -59.05 -22.92 61.5 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.8 m -129.74 -46.25 1.16 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.885 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.82 -173.53 3.53 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.689 0.757 . . . . 0.0 112.976 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.4 m -159.89 167.99 26.8 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.504 1.922 . . . . 0.0 109.838 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.8 mm -140.73 126.07 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.416 1.487 . . . . 0.0 108.508 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 tp -120.78 136.73 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.898 1.279 . . . . 0.0 109.244 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.11 47.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.273 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.96 -34.53 92.34 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.961 2.44 . . . . 0.0 110.696 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.83 14.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.988 1.715 . . . . 0.0 112.821 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.01 63.16 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.975 -1.078 . . . . 0.0 111.832 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -107.99 123.36 48.53 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.51 114.9 5.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.809 0.444 . . . . 0.0 111.355 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.42 -43.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.98 97.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -81.63 66.85 7.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.85 174.56 54.21 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.31 72.75 7.18 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.802 -0.822 . . . . 0.0 109.033 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -40.87 71.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.963 3.705 . . . . 0.0 114.478 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -100.56 -27.33 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.701 2.4 . . . . 0.0 108.261 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.94 173.11 14.55 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.14 1.829 . . . . 0.0 108.736 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.46 171.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.604 3.536 . . . . 0.0 114.706 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -94.21 126.43 39.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.9 mt -97.22 7.4 46.66 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.31 82.66 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.928 1.24 . . . . 0.0 111.058 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.21 28.9 5.64 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.233 0.921 . . . . 0.0 113.145 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.22 -35.83 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 118.76 1.28 . . . . 0.0 108.652 171.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.08 115.23 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.799 0.839 . . . . 0.0 110.259 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.4 -14.83 62.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.069 1.319 . . . . 0.0 112.6 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -84.51 146.89 27.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.382 1.091 . . . . 0.0 111.213 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -60.12 132.12 52.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.854 0.862 . . . . 0.0 109.085 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.36 149.18 29.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.932 -0.48 . . . . 0.0 110.965 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 29.49 73.93 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.265 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.7 p -131.43 -6.96 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.073 1.437 . . . . 0.0 114.27 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -64.44 129.93 94.42 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.02 1.282 . . . . 0.0 108.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -59.66 166.68 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.282 1.988 . . . . 0.0 113.403 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 59.28 51.14 7.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.133 1.373 . . . . 0.0 112.021 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -164.14 120.43 1.62 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.86 87.29 6.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -70.0 -172.07 0.5 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.664 0.745 . . . . 0.0 111.405 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.33 157.94 22.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.732 1.613 . . . . 0.0 110.259 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -51.83 -36.02 46.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.7 1.2 . . . . 0.0 113.545 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -63.71 -66.77 0.5 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.076 0.95 . . . . 0.0 110.01 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -58.76 -35.77 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.486 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.57 -50.7 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.92 93.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.443 0.565 . . . . 0.0 110.602 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.54 -47.32 79.66 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.81 -55.33 28.19 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.445 1.022 . . . . 0.0 111.007 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.42 -31.44 55.17 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.782 1.233 . . . . 0.0 111.522 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -72.1 6.04 2.4 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.24 28.63 22.19 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.949 1.262 . . . . 0.0 111.646 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -80.74 82.5 6.72 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.868 -0.783 . . . . 0.0 111.356 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.55 120.33 20.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -65.29 107.59 1.66 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -86.66 165.44 16.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.07 -41.85 84.25 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.495 0.664 . . . . 0.0 109.6 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -60.09 -51.87 67.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.976 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -59.14 -49.92 76.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.9 mt -54.37 -53.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.2 -41.99 72.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.647 0.779 . . . . 0.0 111.564 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.74 -53.49 15.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.37 0.268 . . . . 0.0 110.522 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -45.88 -46.99 16.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.069 1.347 . . . . 0.0 113.588 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.6 -31.42 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -82.89 -14.99 53.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.158 0.983 . . . . 0.0 111.925 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -145.28 54.17 2.3 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.752 1.221 . . . . 0.0 112.693 -173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.41 141.17 94.94 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.253 1.969 . . . . 0.0 109.313 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.75 -63.8 3.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -48.69 -44.59 38.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 111.242 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -53.42 -54.47 36.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 110.445 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.23 -48.75 80.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.061 0.544 . . . . 0.0 110.377 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -54.64 -49.59 70.17 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.283 0.633 . . . . 0.0 110.757 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -50.01 -47.92 52.77 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.53 0.732 . . . . 0.0 111.234 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.27 -55.56 4.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.9 tp -74.93 -24.13 58.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.483 1.113 . . . . 0.0 113.69 -173.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 t0 52.23 56.78 7.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.717 1.607 . . . . 0.0 111.414 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -146.45 135.42 22.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.363 1.065 . . . . 0.0 108.198 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.116 0.566 . . . . 0.0 109.935 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.86 3.72 11.39 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.99 61.23 3.12 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.688 0.795 . . . . 0.0 110.029 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -95.65 -178.57 4.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.871 1.268 . . . . 0.0 109.559 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 t -147.66 150.02 33.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -17.69 68.23 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 ttt -66.83 78.4 0.12 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.044 0.938 . . . . 0.0 113.023 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.45 58.1 3.06 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.003 0.921 . . . . 0.0 109.163 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -165.79 140.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.547 1.539 . . . . 0.0 107.452 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.61 163.32 31.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.4 tp -155.98 111.32 2.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.19 32.51 0.28 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.7 -0.625 . . . . 0.0 112.347 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -160.02 -178.01 6.71 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 127.589 2.355 . . . . 0.0 106.432 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.2 -56.01 3.2 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.387 -0.674 . . . . 0.0 112.829 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -18.78 -63.9 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.892 2.663 . . . . 0.0 115.933 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -61.92 -46.36 89.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.146 0.979 . . . . 0.0 111.622 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -62.77 -48.14 80.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.137 0.975 . . . . 0.0 108.719 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.33 -44.32 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.0 0.52 . . . . 0.0 109.754 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.46 -47.28 82.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.813 0.733 . . . . 0.0 110.617 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.36 93.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.898 0.38 . . . . 0.0 110.753 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -56.17 -52.16 65.4 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.869 0.468 . . . . 0.0 109.873 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.85 -45.06 90.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.579 -0.7 . . . . 0.0 110.984 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.99 87.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.622 0.769 . . . . 0.0 111.28 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.1 p -71.8 -34.75 69.62 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.049 -0.407 . . . . 0.0 111.256 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.96 -47.66 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.768 1.227 . . . . 0.0 111.916 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.831 0.824 . . . . 0.0 112.35 -175.913 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.228 0.349 . . . . 0.0 113.619 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.04 84.11 0.98 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 109.94 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.85 -37.25 29.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.851 0.86 . . . . 0.0 112.443 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.36 -52.51 63.35 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.657 -0.652 . . . . 0.0 109.94 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -57.97 -39.22 77.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.6 -48.61 69.87 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.7 -49.03 74.09 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.973 0.509 . . . . 0.0 109.741 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -61.61 -47.96 83.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.625 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -54.31 -38.77 66.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 110.323 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -56.08 -17.39 6.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.709 0.804 . . . . 0.0 112.984 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -56.03 -26.06 47.31 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.286 -0.884 . . . . 0.0 111.297 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -77.8 -51.58 10.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.0 m -50.96 -42.08 59.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.311 1.044 . . . . 0.0 111.941 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -56.68 -21.91 31.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 m -56.4 -27.71 57.16 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.922 -0.486 . . . . 0.0 110.304 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -118.66 -43.83 2.67 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.613 0.765 . . . . 0.0 111.441 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -93.85 174.94 6.92 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 124.767 1.227 . . . . 0.0 113.32 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -141.27 161.76 37.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.717 1.207 . . . . 0.0 109.872 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.1 mt -138.15 106.88 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 103.412 -2.811 . . . . 0.0 103.412 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -122.77 125.69 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.463 1.105 . . . . 0.0 109.9 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 159.17 20.61 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.406 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.18 -38.38 81.16 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.775 2.317 . . . . 0.0 110.916 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.52 3.89 4.43 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.513 1.525 . . . . 0.0 113.128 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.52 65.98 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 120.733 -1.23 . . . . 0.0 112.873 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -57.07 114.45 2.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.556 1.178 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -74.29 73.12 1.81 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.455 0.702 . . . . 0.0 111.356 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.1 mm -50.27 -48.19 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.774 0.83 . . . . 0.0 109.175 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.3 102.46 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -76.12 58.51 1.23 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 108.963 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.81 174.21 42.43 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.92 176.11 3.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.161 0.505 . . . . 0.0 111.529 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -118.59 24.11 11.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.369 1.068 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -64.37 -38.29 90.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.98 169.88 13.35 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 169.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.63 178.24 1.02 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.717 3.612 . . . . 0.0 114.431 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -92.61 89.53 6.74 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.804 1.242 . . . . 0.0 111.356 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.36 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.687 2.395 . . . . 0.0 116.19 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -64.22 85.31 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 120.653 1.57 . . . . 0.0 109.61 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.58 56.9 3.73 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -33.34 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 117.673 0.737 . . . . 0.0 109.796 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.6 t -54.29 118.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.096 0.958 . . . . 0.0 110.265 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 -17.29 59.58 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.576 1.084 . . . . 0.0 112.33 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 138.88 40.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.139 1.469 . . . . 0.0 110.005 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.3 m -62.43 133.39 54.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.36 137.42 52.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.002 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.56 29.88 65.11 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.272 -1.293 . . . . 0.0 114.23 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.3 p -133.89 -3.78 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.403 1.602 . . . . 0.0 115.076 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.68 122.36 76.1 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.777 1.626 . . . . 0.0 107.341 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -56.29 162.12 8.21 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.386 2.057 . . . . 0.0 114.418 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 61.3 56.39 2.68 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.848 1.659 . . . . 0.0 111.871 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -164.22 121.12 1.65 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.88 0.371 . . . . 0.0 111.828 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -74.93 87.46 2.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.664 0.786 . . . . 0.0 109.456 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.47 167.69 14.28 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -99.78 156.39 17.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.925 0.89 . . . . 0.0 110.122 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -48.88 -43.28 38.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.085 1.354 . . . . 0.0 113.69 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 m -65.14 -52.99 51.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.845 0.355 . . . . 0.0 111.085 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 tt -65.05 -36.72 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.548 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.64 -48.45 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.14 96.72 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.035 -0.416 . . . . 0.0 111.246 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -50.61 65.93 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.06 -53.01 47.87 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.028 0.823 . . . . 0.0 111.94 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.88 -26.67 37.24 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 125.286 1.435 . . . . 0.0 111.874 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -71.83 3.71 3.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 175.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.76 40.51 7.64 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.383 1.468 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -102.79 105.23 15.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.79 129.07 40.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.986 1.314 . . . . 0.0 108.501 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -62.78 109.53 1.46 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.119 0.418 . . . . 0.0 111.751 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.3 p -91.35 164.07 13.98 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.43 -43.38 75.31 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.401 0.619 . . . . 0.0 110.876 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.97 -46.16 72.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.62 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -57.13 -50.09 73.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.671 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.74 -55.58 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.325 0.511 . . . . 0.0 109.851 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.89 -37.4 60.56 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.447 0.699 . . . . 0.0 111.628 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.6 m -72.53 -63.44 1.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -36.17 -54.08 0.8 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.448 2.299 . . . . 0.0 113.8 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 m -48.78 -32.97 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.27 -33.53 65.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.483 0.713 . . . . 0.0 112.684 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -135.98 57.05 16.44 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -60.41 145.78 98.01 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.29 1.327 . . . . 0.0 110.835 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.07 -64.04 4.11 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.44 80.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.94 0.496 . . . . 0.0 110.131 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -54.46 -53.85 48.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.961 0.904 . . . . 0.0 110.327 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -57.57 -53.83 53.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.601 0.36 . . . . 0.0 110.427 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -47.78 -47.38 30.74 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 110.601 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.03 -66.31 0.56 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.091 0.556 . . . . 0.0 110.51 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -53.9 -43.12 69.42 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -84.79 -5.22 59.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.968 0.907 . . . . 0.0 111.825 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t0 48.63 56.36 7.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.024 1.33 . . . . 0.0 109.609 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -142.49 157.13 45.07 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.097 0.959 . . . . 0.0 110.298 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -95.1 -46.83 6.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.94 2.096 . . . . 0.0 107.628 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -76.43 43.71 0.32 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.485 1.514 . . . . 0.0 111.78 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.73 118.25 29.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.006 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -151.23 140.3 21.13 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.12 0.968 . . . . 0.0 108.738 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -103.55 156.22 17.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -24.16 58.44 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.6 ttp -63.21 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.789 0.795 . . . . 0.0 113.095 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.62 57.3 3.29 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -160.44 149.91 17.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.444 1.898 . . . . 0.0 106.372 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -143.42 158.81 43.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.5 tp -130.89 115.75 16.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.94 50.47 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.159 0.984 . . . . 0.0 112.067 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -133.82 135.21 43.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.33 1.452 . . . . 0.0 107.839 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.12 61.26 4.38 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.558 -2.617 . . . . 0.0 106.558 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.94 65.01 0.0 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 129.794 3.569 . . . . 0.0 117.192 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.66 -34.58 78.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.087 0.955 . . . . 0.0 109.255 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -61.09 -52.09 66.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.098 1.359 . . . . 0.0 109.618 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.66 -45.52 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 123.784 0.834 . . . . 0.0 109.592 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.25 85.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.141 -0.349 . . . . 0.0 110.777 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.036 -0.415 . . . . 0.0 110.544 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -58.55 -54.23 49.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.77 -32.88 67.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.247 0.619 . . . . 0.0 111.522 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.9 -54.21 24.37 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.547 0.612 . . . . 0.0 109.783 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 97.4 p -57.75 -32.29 67.32 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.906 -0.497 . . . . 0.0 112.236 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.28 -26.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.715 0.806 . . . . 0.0 111.412 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 t . . . . . 0 CA--C 1.538 0.507 0 CA-C-N 119.122 0.874 . . . . 0.0 108.965 176.594 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 CA-C-O 122.025 0.792 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.0 68.95 0.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.153 1.781 . . . . 0.0 111.659 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.073 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.55 79.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.749 0.82 . . . . 0.0 111.594 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -71.78 -41.0 68.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.43 -44.09 45.03 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.179 0.895 . . . . 0.0 111.751 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -51.51 -53.46 37.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.732 0.813 . . . . 0.0 110.446 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -65.34 -46.62 79.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.476 0.711 . . . . 0.0 109.971 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.63 -39.77 65.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.305 1.042 . . . . 0.0 109.604 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -57.66 -19.37 26.18 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -30.76 62.43 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.327 -0.858 . . . . 0.0 109.775 174.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.79 -54.97 9.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.2 m -50.23 -41.06 49.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.636 1.574 . . . . 0.0 111.274 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -46.98 -31.69 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.389 1.875 . . . . 0.0 112.663 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.0 m -56.51 -28.98 61.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.384 0.673 . . . . 0.0 111.557 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.5 m -121.66 -36.19 3.09 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.952 0.901 . . . . 0.0 112.646 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -105.64 168.77 8.88 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.77 1.228 . . . . 0.0 112.791 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.2 p -138.13 166.82 23.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.956 1.302 . . . . 0.0 110.359 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.4 114.37 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 tp -109.8 134.45 51.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.636 1.174 . . . . 0.0 110.072 -175.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.92 159.97 82.07 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 121.126 -0.984 . . . . 0.0 108.416 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.18 -40.93 68.11 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.906 2.404 . . . . 0.0 112.519 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.5 -8.06 55.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.373 1.469 . . . . 0.0 113.58 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.89 -17.24 45.61 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.947 -0.918 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.2 m -58.63 121.83 11.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.66 1.73 . . . . 0.0 109.44 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.99 113.55 5.78 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.24 -50.36 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.24 99.65 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -74.5 56.76 0.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.503 1.921 . . . . 0.0 109.507 176.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.61 -179.06 42.28 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.72 174.04 5.55 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.116 0.484 . . . . 0.0 111.419 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -118.36 26.88 9.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 109.896 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -65.44 -42.16 92.69 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.18 173.37 20.53 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.74 -177.1 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.163 3.242 . . . . 0.0 112.227 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -100.71 104.96 16.26 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.5 14.04 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -71.1 81.6 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.261 1.391 . . . . 0.0 109.254 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 53.79 1.01 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.794 0.711 . . . . 0.0 114.175 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.13 -41.84 31.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 117.461 0.63 . . . . 0.0 109.711 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t -52.56 119.41 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 121.215 -0.928 . . . . 0.0 110.896 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 -18.88 56.69 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.879 1.228 . . . . 0.0 111.832 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -65.78 138.9 58.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.9 0.85 . . . . 0.0 111.074 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -71.66 70.82 0.7 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 0.0 111.058 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 58.08 -143.58 0.64 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.638 0.775 . . . . 0.0 109.938 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.3 83.35 0.13 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.54 1.067 . . . . 0.0 113.284 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.2 t -147.51 40.98 1.03 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.016 0.408 . . . . 0.0 111.9 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.97 128.89 58.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -55.97 155.29 23.81 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.374 1.383 . . . . 0.0 112.395 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 54.58 57.94 5.32 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 0.0 112.62 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -158.45 119.11 3.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.785 0.434 . . . . 0.0 110.001 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -79.15 86.72 4.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.387 0.675 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -68.17 -174.63 0.51 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.47 0.652 . . . . 0.0 110.967 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -114.75 172.74 6.85 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.991 1.316 . . . . 0.0 109.83 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.55 -41.92 86.68 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.958 1.303 . . . . 0.0 112.435 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 p -63.17 -65.42 0.69 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.286 1.435 . . . . 0.0 110.564 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.23 -35.01 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.638 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.82 -50.57 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.28 81.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.068 -0.395 . . . . 0.0 111.311 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -55.72 -50.76 69.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.3 -53.93 39.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.36 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.831 0.852 . . . . 0.0 112.742 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.8 p -68.63 -9.16 48.22 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.68 7.62 23.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.436 1.017 . . . . 0.0 112.805 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -68.44 138.25 55.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.744 1.272 . . . . 0.0 109.26 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.27 128.03 39.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 106.994 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -60.49 147.42 41.29 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -142.25 166.43 24.72 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.415 1.886 . . . . 0.0 106.207 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.48 -41.47 73.04 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.799 0.272 . . . . 0.0 110.48 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.62 -51.48 62.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.351 0.66 . . . . 0.0 110.595 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.13 -48.08 81.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.181 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mm -57.22 -55.6 19.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.72 -41.08 42.75 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.828 1.251 . . . . 0.0 111.19 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -71.52 -55.86 7.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.831 0.348 . . . . 0.0 110.224 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -50.68 -45.62 58.29 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.3 -33.58 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.95 2.98 53.86 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.423 0.689 . . . . 0.0 112.761 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -148.3 62.68 6.73 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.229 1.012 . . . . 0.0 112.428 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.16 140.69 93.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.171 1.914 . . . . 0.0 109.772 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.38 -64.7 1.03 Allowed Glycine 0 CA--C 1.533 1.18 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.0 -45.61 7.94 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.991 1.716 . . . . 0.0 111.346 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.0 -55.92 25.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.165 0.586 . . . . 0.0 110.938 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -57.95 -46.42 85.13 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.389 0.675 . . . . 0.0 110.693 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -53.81 -53.01 58.37 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -54.13 -57.36 11.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.221 0.608 . . . . 0.0 111.009 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.31 -54.54 39.15 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -88.87 -25.06 22.35 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -170.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 54.44 49.5 18.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.749 1.219 . . . . 0.0 110.036 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -117.42 128.57 55.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 108.761 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -51.37 -43.52 61.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.651 1.18 . . . . 0.0 111.057 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -91.13 27.09 1.96 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.79 65.46 1.03 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.599 0.714 . . . . 0.0 111.845 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -91.0 -177.94 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.785 2.034 . . . . 0.0 109.434 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 t -158.46 150.47 21.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.41 -26.18 71.66 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 16.4 ttp -65.32 82.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.36 58.36 4.06 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.206 -0.934 . . . . 0.0 109.201 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -165.89 151.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.404 1.482 . . . . 0.0 107.184 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -143.42 166.51 24.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.225 0.466 . . . . 0.0 110.205 170.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.11 115.97 28.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.75 52.81 2.0 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.594 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.93 169.8 17.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.345 1.458 . . . . 0.0 107.764 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.33 -17.89 68.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.382 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.53 1.99 73.13 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 118.157 0.978 . . . . 0.0 114.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -46.29 88.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.674 1.237 . . . . 0.0 111.194 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -55.08 -51.43 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.264 1.426 . . . . 0.0 110.72 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.89 -50.87 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.76 1.224 . . . . 0.0 110.247 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.72 -46.49 81.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.391 -0.193 . . . . 0.0 110.615 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.48 93.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.852 0.461 . . . . 0.0 110.17 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -59.33 -49.04 79.37 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.036 -0.415 . . . . 0.0 110.67 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.3 mt -60.02 -45.74 91.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.647 0.658 . . . . 0.0 110.758 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.22 79.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.387 0.275 . . . . 0.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.7 m -66.59 -40.66 89.01 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.123 -0.361 . . . . 0.0 111.321 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.1 -43.56 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.747 1.219 . . . . 0.0 112.675 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.481 0.658 . . . . 0.0 112.291 -175.131 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.06 93.32 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.785 -0.832 . . . . 0.0 109.005 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.39 34.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 112.808 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.83 -54.99 22.35 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.913 0.778 . . . . 0.0 109.695 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -56.69 -41.2 76.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 0.0 110.123 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.64 -49.56 57.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -54.97 -52.2 63.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.551 0.74 . . . . 0.0 110.041 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -57.67 -53.13 61.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.2 -26.11 62.41 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 126.478 1.911 . . . . 0.0 112.09 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -56.63 -18.97 13.93 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.184 0.447 . . . . 0.0 110.98 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -53.38 -32.9 51.6 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.657 -0.652 . . . . 0.0 111.134 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.73 -53.16 29.67 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -51.46 -45.01 62.58 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.308 1.043 . . . . 0.0 110.889 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -47.85 -30.54 4.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 113.061 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -52.59 -38.03 59.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.057 0.543 . . . . 0.0 110.978 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -112.61 -40.3 4.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -100.55 -174.01 2.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.247 1.019 . . . . 0.0 113.233 -170.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -152.16 173.17 15.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.574 1.549 . . . . 0.0 109.025 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.95 131.41 52.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 tp -116.79 145.37 22.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.753 1.621 . . . . 0.0 109.536 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.19 160.01 76.76 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 119.432 1.015 . . . . 0.0 108.321 173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.99 -36.86 93.6 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.439 2.093 . . . . 0.0 110.214 172.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.13 -1.4 7.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.398 1.879 . . . . 0.0 113.135 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.22 -18.36 45.72 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 120.728 -1.232 . . . . 0.0 112.362 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -53.99 122.13 9.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.205 1.002 . . . . 0.0 110.906 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.86 78.74 1.14 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.326 0.65 . . . . 0.0 110.616 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.85 -60.47 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.01 98.75 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.09 63.23 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.735 1.214 . . . . 0.0 109.738 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.87 -156.77 32.98 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.88 6.7 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -124.68 33.84 5.14 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.53 -34.88 76.63 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.27 176.8 17.69 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 168.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.0 -171.07 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.676 2.917 . . . . 0.0 111.698 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -117.48 101.37 8.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -68.55 0.94 3.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.01 109.87 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.97 1.259 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.53 20.02 55.31 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.573 -0.571 . . . . 0.0 112.391 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.87 -37.82 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.354 1.077 . . . . 0.0 109.047 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.4 107.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.059 0.944 . . . . 0.0 110.428 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 -5.7 72.08 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 112.482 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -92.41 138.16 31.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.84 0.82 . . . . 0.0 110.367 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -56.41 127.21 29.95 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.937 1.295 . . . . 0.0 111.347 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.99 149.29 19.22 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.615 -0.678 . . . . 0.0 111.153 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.47 42.43 99.0 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.332 -1.26 . . . . 0.0 115.187 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.7 p -142.17 1.04 1.4 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.465 1.632 . . . . 0.0 114.846 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -69.19 134.71 89.27 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 120.445 1.475 . . . . 0.0 109.723 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.27 154.37 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.989 2.46 . . . . 0.0 115.685 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.27 60.8 3.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.078 1.751 . . . . 0.0 112.66 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -154.66 118.9 4.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.026 0.441 . . . . 0.0 110.837 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.29 80.28 1.84 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.99 0.916 . . . . 0.0 110.586 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -68.55 176.26 3.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.484 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -107.45 170.58 7.88 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.937 0.895 . . . . 0.0 109.942 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.1 -46.41 89.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.173 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 p -60.96 -65.39 0.7 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.845 1.258 . . . . 0.0 111.069 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.99 -42.88 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.095 0.958 . . . . 0.0 110.837 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -44.83 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.997 . . . . 0.0 110.032 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.4 82.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.705 0.684 . . . . 0.0 110.528 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.9 tp -57.85 -48.26 80.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.28 -56.29 17.88 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 123.887 0.756 . . . . 0.0 111.755 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.88 55.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.438 1.495 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 m -71.53 5.18 2.51 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.88 21.33 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.146 1.355 . . . . 0.0 111.242 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -82.54 77.9 9.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.788 -0.83 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 116.6 13.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -57.81 139.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -122.64 162.9 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.208 1.403 . . . . 0.0 107.385 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -54.2 -43.29 70.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -53.46 54.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.589 0.756 . . . . 0.0 110.407 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -60.48 -45.13 94.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.993 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.1 mt -58.0 -55.94 18.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.65 -40.17 62.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.868 0.867 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.7 m -68.04 -63.99 0.95 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.51 -51.87 2.87 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.094 1.757 . . . . 0.0 112.925 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.0 m -54.67 -33.59 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -72.39 -29.56 63.85 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.77 -0.581 . . . . 0.0 111.862 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -138.47 61.89 27.2 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -65.35 153.59 77.53 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 CA-C-N 120.086 1.066 . . . . 0.0 110.588 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.43 -66.65 2.62 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.07 -44.2 51.61 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.284 1.034 . . . . 0.0 111.243 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -51.95 -57.17 10.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.647 0.779 . . . . 0.0 110.106 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.82 -54.21 49.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.857 0.463 . . . . 0.0 110.755 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -50.37 -42.4 53.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.04 0.536 . . . . 0.0 110.989 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.75 -66.35 0.57 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.354 0.662 . . . . 0.0 110.19 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -54.5 -43.38 71.79 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -88.85 1.07 55.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.703 1.201 . . . . 0.0 111.255 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t0 41.92 54.44 3.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.964 1.706 . . . . 0.0 110.967 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -147.91 122.06 9.53 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.631 0.772 . . . . 0.0 112.534 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -53.47 -45.23 69.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.626 1.57 . . . . 0.0 110.301 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -73.92 5.63 4.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.08 72.15 9.13 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.377 -1.452 . . . . 0.0 111.715 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -82.46 164.3 21.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.459 1.104 . . . . 0.0 108.827 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.4 t -142.02 149.45 40.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.29 -29.84 72.44 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 ttp -62.05 83.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.8 57.38 3.79 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -159.73 149.85 18.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -139.37 153.26 47.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.8 tp -113.37 107.81 16.37 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.08 66.72 3.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.918 0.887 . . . . 0.0 109.89 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 84.14 146.13 0.07 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 128.583 2.753 . . . . 0.0 109.988 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.77 -26.54 5.1 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.02 -40.76 10.18 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.401 1.476 . . . . 0.0 113.085 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.57 -48.9 79.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.717 0.758 . . . . 0.0 110.579 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -61.14 -48.33 82.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.211 1.004 . . . . 0.0 109.456 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.41 -40.87 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.701 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.6 89.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.604 -0.685 . . . . 0.0 109.963 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.42 90.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.08 -53.23 59.54 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.1 mt -55.27 -47.81 74.95 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.117 0.417 . . . . 0.0 110.913 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.38 77.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.4 m -70.36 -40.58 73.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.032 -0.417 . . . . 0.0 110.674 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.23 -44.68 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.468 1.507 . . . . 0.0 112.698 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 121.744 0.783 . . . . 0.0 112.592 -176.247 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.079 0.266 . . . . 0.0 112.814 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.19 76.69 0.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.717 1.607 . . . . 0.0 111.044 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.11 10.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.432 1.093 . . . . 0.0 112.18 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.4 -54.17 49.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.535 0.734 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.03 -34.47 74.89 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.89 -56.24 24.95 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.31 -37.4 87.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.165 0.983 . . . . 0.0 111.357 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -60.96 -50.9 71.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.729 0.695 . . . . 0.0 109.737 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -57.2 -34.11 68.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.7 1.2 . . . . 0.0 110.273 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -56.16 -21.73 24.59 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -55.38 -36.3 66.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.668 0.667 . . . . 0.0 110.278 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -69.82 -52.68 22.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.9 m -50.72 -40.8 55.29 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.378 1.071 . . . . 0.0 111.749 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -48.35 -30.93 5.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 112.31 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.6 m -59.32 -22.46 61.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.497 0.719 . . . . 0.0 111.505 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.4 m -124.84 -34.58 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.378 1.071 . . . . 0.0 112.771 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -110.21 170.33 8.15 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.581 1.152 . . . . 0.0 114.081 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.4 m -141.89 166.05 25.78 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.427 1.091 . . . . 0.0 110.295 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mp -139.65 124.47 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 106.865 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.14 132.21 58.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.514 1.126 . . . . 0.0 110.175 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 154.01 71.74 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.58 -35.37 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.036 2.491 . . . . 0.0 112.097 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.81 -9.27 58.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.351 1.06 . . . . 0.0 113.144 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.31 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.999 -0.889 . . . . 0.0 113.404 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.7 m -62.39 108.28 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.489 1.644 . . . . 0.0 110.331 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.49 134.53 57.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.64 0.776 . . . . 0.0 110.659 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 mm -105.29 -50.34 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.08 96.47 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -84.21 70.17 10.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.94 -154.12 26.86 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.26 175.53 10.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -125.77 32.57 5.26 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.944 0.897 . . . . 0.0 109.232 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.3 m -64.73 -36.98 86.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.35 173.02 14.61 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.56 179.6 1.23 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.372 3.382 . . . . 0.0 113.91 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -92.34 103.85 16.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.261 1.024 . . . . 0.0 110.036 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.64 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -70.03 85.12 0.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.268 1.849 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.96 58.37 2.65 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.36 0.981 . . . . 0.0 113.265 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.37 -39.33 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 O-C-N 122.219 -0.577 . . . . 0.0 110.966 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.56 119.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.014 0.525 . . . . 0.0 110.504 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.08 -21.94 41.38 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.673 1.13 . . . . 0.0 111.602 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -68.26 138.24 55.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.441 1.12 . . . . 0.0 110.886 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 m -65.02 72.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.434 1.894 . . . . 0.0 111.675 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.59 -145.25 0.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.461 -0.774 . . . . 0.0 109.431 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.04 78.25 1.26 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -138.7 14.62 2.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.591 0.756 . . . . 0.0 111.621 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -64.96 127.01 92.33 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.36 172.12 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.403 2.068 . . . . 0.0 115.779 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 46.01 57.47 5.16 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.256 1.822 . . . . 0.0 111.825 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -164.37 122.46 1.77 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.489 0.316 . . . . 0.0 110.761 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.26 95.32 4.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.057 0.943 . . . . 0.0 110.24 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.2 -178.69 5.21 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.353 0.661 . . . . 0.0 111.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.92 177.48 4.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.23 -35.23 75.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.021 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 p -63.29 -66.65 0.51 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.556 1.142 . . . . 0.0 110.627 -173.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tt -57.43 -37.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.123 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.7 -47.58 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.55 84.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.056 0.389 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.8 tp -55.41 -50.11 70.61 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.11 -54.86 29.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.95 -31.56 60.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.113 0.965 . . . . 0.0 112.225 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -72.03 3.07 4.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.14 29.38 10.4 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.142 0.877 . . . . 0.0 111.616 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -90.76 140.44 29.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -60.37 148.37 37.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 123.053 0.541 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.7 p -142.71 166.31 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -54.8 -41.06 70.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.72 -56.13 15.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.108 0.963 . . . . 0.0 109.719 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.03 -52.15 61.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.278 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.5 mt -56.87 -54.69 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.67 -40.32 53.31 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.054 0.942 . . . . 0.0 111.667 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -70.75 -60.95 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -43.49 -51.92 6.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.061 1.344 . . . . 0.0 113.602 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.6 m -51.28 -38.49 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -90.81 -8.49 49.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.23 55.17 3.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.878 0.871 . . . . 0.0 111.576 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.66 147.17 85.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.917 1.745 . . . . 0.0 109.868 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.36 -64.46 4.26 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.7 61.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.389 0.676 . . . . 0.0 109.993 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -48.52 -51.54 26.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.774 1.23 . . . . 0.0 111.338 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.49 -58.94 4.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -49.5 -38.91 32.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 111.615 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -53.42 -39.91 64.7 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.456 0.702 . . . . 0.0 111.842 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -97.21 -53.32 3.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.318 1.047 . . . . 0.0 111.741 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.7 tp -78.86 -22.92 45.33 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.776 1.23 . . . . 0.0 113.228 -175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t0 41.57 63.62 1.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.486 1.914 . . . . 0.0 113.216 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.43 145.29 45.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 108.282 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.38 -38.46 58.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.188 0.995 . . . . 0.0 110.842 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.21 21.71 13.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.0 0.92 . . . . 0.0 112.855 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.84 5.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -126.22 142.52 51.5 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.429 1.492 . . . . 0.0 108.636 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -94.37 150.08 20.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.965 0.906 . . . . 0.0 109.164 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -55.02 -27.03 43.93 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.974 -0.454 . . . . 0.0 111.994 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.2 ttp -59.64 86.5 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 113.343 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.39 57.93 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.91 155.79 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.537 1.935 . . . . 0.0 106.331 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -145.35 170.94 15.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.2 tp -97.23 166.48 11.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.55 37.88 4.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -143.93 170.79 15.25 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.661 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -12.97 35.28 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.707 -1.052 . . . . 0.0 113.35 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.04 -32.07 1.76 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 118.475 1.138 . . . . 0.0 114.638 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.23 -38.41 3.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 113.281 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -61.13 -49.21 78.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.674 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.56 -41.72 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.39 90.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.699 0.4 . . . . 0.0 110.546 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.47 94.48 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.79 0.436 . . . . 0.0 109.932 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -55.9 -54.3 46.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.1 mt -57.32 -37.12 72.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.426 0.69 . . . . 0.0 111.716 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.4 89.06 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.457 -0.777 . . . . 0.0 109.146 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.4 t -59.73 -29.31 68.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.73 -0.606 . . . . 0.0 111.924 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.45 -29.35 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 O-C-N 121.845 -0.534 . . . . 0.0 110.749 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 124.501 1.12 . . . . 0.0 109.748 178.121 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.107 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.92 73.84 0.6 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.584 1.154 . . . . 0.0 111.707 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.98 -39.08 25.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.195 0.998 . . . . 0.0 111.949 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.43 82.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.391 0.676 . . . . 0.0 111.231 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.89 -41.72 77.9 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.88 -46.65 40.4 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.021 0.82 . . . . 0.0 111.94 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -52.52 -54.27 34.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.475 0.71 . . . . 0.0 110.527 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.47 -47.53 83.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.901 0.48 . . . . 0.0 110.159 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -53.86 -39.19 65.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.353 1.061 . . . . 0.0 109.849 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.16 -22.3 27.89 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.43 -31.29 54.99 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.646 -0.659 . . . . 0.0 110.048 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -71.33 -52.75 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 m -51.18 -43.0 61.22 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.656 1.182 . . . . 0.0 110.637 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -49.16 -25.88 2.46 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.131 1.772 . . . . 0.0 112.279 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -53.95 -42.58 69.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.211 1.368 . . . . 0.0 110.281 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.8 m -106.95 -42.22 4.97 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.743 0.817 . . . . 0.0 112.401 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -92.7 167.27 12.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.583 1.153 . . . . 0.0 112.885 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -140.15 147.21 39.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.32 124.98 73.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.86 133.99 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.332 1.853 . . . . 0.0 107.853 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.56 158.04 86.45 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.46 -38.7 74.78 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.943 2.429 . . . . 0.0 112.646 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -74.29 -10.54 59.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.164 1.385 . . . . 0.0 113.663 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.33 -18.65 32.84 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.83 -0.984 . . . . 0.0 113.63 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -57.18 118.71 5.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.698 . . . . 0.0 109.556 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.61 125.66 26.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.819 0.447 . . . . 0.0 110.405 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 mm -85.06 -52.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.0 m -146.57 136.12 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -113.36 135.55 53.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.72 -172.87 19.93 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 124.434 1.016 . . . . 0.0 110.977 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.02 44.89 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.596 -0.944 . . . . 0.0 109.611 175.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 tptp 15.94 57.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 130.28 3.432 . . . . 0.0 113.61 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.12 -32.16 14.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.3 167.85 12.46 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 174.05 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.421 3.414 . . . . 0.0 113.526 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.44 115.52 17.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.36 7.02 44.75 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -48.73 106.78 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.091 0.86 . . . . 0.0 111.58 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.03 42.96 95.26 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.12 -36.86 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 117.274 0.537 . . . . 0.0 111.565 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.5 116.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.57 -19.15 55.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.256 0.931 . . . . 0.0 111.802 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.05 148.09 32.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 117.731 0.765 . . . . 0.0 109.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 m -61.48 127.02 29.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.796 0.838 . . . . 0.0 109.931 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.88 154.8 41.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 111.758 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.52 27.1 63.04 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.023 -0.876 . . . . 0.0 114.749 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.8 t -155.32 20.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.676 1.238 . . . . 0.0 112.77 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.22 126.11 92.31 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.54 171.75 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 CA-C-N 121.099 1.428 . . . . 0.0 115.735 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 50.64 55.18 9.91 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.749 1.62 . . . . 0.0 111.404 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -166.04 123.4 1.42 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.169 -0.332 . . . . 0.0 111.377 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -83.42 99.64 10.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.498 1.119 . . . . 0.0 109.089 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -85.0 -170.39 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.856 0.862 . . . . 0.0 111.962 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.71 175.89 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.959 1.703 . . . . 0.0 109.552 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.93 -43.67 82.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.357 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 t -70.85 -47.93 56.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.091 0.472 . . . . 0.0 111.145 -173.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -67.02 -34.91 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.08 -45.56 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.79 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 111.406 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 mt -55.86 -49.16 74.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.41 39.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -37.29 74.31 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.274 1.029 . . . . 0.0 110.779 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 t -72.88 4.05 4.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.19 61.44 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 119.14 0.882 . . . . 0.0 111.934 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -71.99 108.28 5.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.984 0.892 . . . . 0.0 109.517 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.61 122.46 37.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -57.44 153.31 12.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p -133.77 169.8 16.51 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.554 1.141 . . . . 0.0 108.153 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -57.59 -46.42 84.04 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.665 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.1 -47.72 73.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.03 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.55 -49.73 76.65 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.87 -50.95 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 118.116 0.416 . . . . 0.0 110.106 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.38 -38.29 52.62 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.074 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -73.45 -58.29 3.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -44.68 -47.24 10.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.176 1.391 . . . . 0.0 113.74 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.44 -36.41 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 119.138 0.881 . . . . 0.0 113.308 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -100.14 2.26 42.88 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.842 0.857 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -142.35 56.52 5.46 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.408 1.483 . . . . 0.0 110.997 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.04 138.97 64.88 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.244 1.962 . . . . 0.0 109.436 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.1 -60.45 2.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.58 -45.47 9.48 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.692 1.597 . . . . 0.0 111.876 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.07 -44.74 96.02 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.151 -0.619 . . . . 0.0 111.663 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.92 -51.09 70.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.792 0.837 . . . . 0.0 109.012 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -52.56 -52.37 55.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.586 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -55.96 -53.36 57.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 111.12 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -66.92 -52.13 46.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.57 -18.54 48.01 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.7 t0 56.35 53.83 8.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.33 1.452 . . . . 0.0 109.275 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -134.27 128.41 33.77 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.615 1.166 . . . . 0.0 109.87 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.22 -37.2 79.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.525 1.13 . . . . 0.0 110.527 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -85.72 15.93 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.9 65.54 8.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.892 0.853 . . . . 0.0 110.439 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.37 108.25 19.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 109.666 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -63.11 156.4 25.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.75 -21.69 79.52 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.7 ttp -68.94 82.01 0.31 Allowed 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.725 -0.867 . . . . 0.0 112.755 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.99 57.33 2.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.474 0.71 . . . . 0.0 109.479 174.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -163.13 148.19 11.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.808 1.643 . . . . 0.0 107.789 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -142.54 164.95 28.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.21 1.004 . . . . 0.0 109.589 173.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.32 115.56 26.15 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.25 55.05 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.89 0.476 . . . . 0.0 110.034 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -132.43 168.08 18.8 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 125.624 1.57 . . . . 0.0 108.721 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.06 -19.42 59.11 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.752 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.85 1.9 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.061 0.93 . . . . 0.0 113.703 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -41.11 -44.11 2.41 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.072 1.749 . . . . 0.0 113.832 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -62.14 -45.55 92.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.117 0.967 . . . . 0.0 110.986 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.32 -45.0 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.11 0.964 . . . . 0.0 108.897 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.02 91.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.346 0.658 . . . . 0.0 110.339 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.22 97.28 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.875 0.47 . . . . 0.0 110.01 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.86 -52.58 64.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.66 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -57.29 -42.36 81.54 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.011 -0.431 . . . . 0.0 111.117 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.48 -41.45 73.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.918 0.487 . . . . 0.0 110.174 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -63.19 -30.01 71.24 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.968 -0.457 . . . . 0.0 111.912 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.83 -29.97 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.063 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.342 0.26 0 C-N-CA 125.522 1.529 . . . . 0.0 112.72 -176.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.065 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -90.37 106.01 18.2 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.876 1.27 . . . . 0.0 108.777 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.7 -31.43 26.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.329 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.54 12.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.354 0.979 . . . . 0.0 110.248 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -56.28 -38.56 71.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.768 -0.583 . . . . 0.0 109.551 174.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.99 -51.1 52.13 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.67 -47.89 82.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.279 1.032 . . . . 0.0 110.279 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -57.25 -52.71 64.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.164 0.185 . . . . 0.0 110.677 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.93 -35.96 67.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.518 1.127 . . . . 0.0 110.211 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.52 -27.16 62.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.069 0.548 . . . . 0.0 112.134 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -30.47 63.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.383 0.538 . . . . 0.0 110.043 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -93.13 -50.26 5.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.036 0.934 . . . . 0.0 109.48 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -33.92 42.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -58.58 -14.81 9.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 114.347 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -56.09 -17.76 7.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.246 -0.909 . . . . 0.0 112.338 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.4 m -124.02 -27.27 3.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.966 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -117.81 165.9 13.11 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.922 0.783 . . . . 0.0 112.941 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -140.39 164.68 29.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.289 1.035 . . . . 0.0 111.629 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.18 121.87 24.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 125.661 1.584 . . . . 0.0 107.854 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -116.54 134.39 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.602 1.561 . . . . 0.0 108.169 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.66 160.24 77.92 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 119.114 0.87 . . . . 0.0 108.94 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.31 -40.95 69.11 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.108 2.538 . . . . 0.0 112.7 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -74.52 -8.28 55.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.145 1.378 . . . . 0.0 113.594 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.79 -18.85 42.81 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.963 -0.909 . . . . 0.0 113.394 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -60.51 117.64 5.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.6 1.7 . . . . 0.0 108.867 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -68.18 129.97 41.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.83 -46.09 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.2 93.48 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -77.0 90.67 3.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.81 -148.28 23.95 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.73 177.84 8.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -129.34 34.11 4.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.676 0.79 . . . . 0.0 109.558 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -64.18 -41.1 97.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.81 164.14 13.33 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.96 164.06 3.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.497 2.798 . . . . 0.0 115.276 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -72.89 121.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.83 6.41 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.95 115.82 3.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.545 1.066 . . . . 0.0 108.561 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.36 23.68 72.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.965 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.61 -38.23 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 118.859 1.329 . . . . 0.0 109.553 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.15 103.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.86 -7.94 42.23 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.5 1.524 . . . . 0.0 112.205 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -72.6 142.79 48.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 117.971 0.885 . . . . 0.0 111.418 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -70.91 68.17 0.42 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.946 1.698 . . . . 0.0 113.508 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.74 -154.56 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 111.944 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.83 70.96 1.15 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 123.697 0.665 . . . . 0.0 112.777 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.8 p -137.93 23.16 2.84 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.381 0.672 . . . . 0.0 111.355 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.78 134.85 90.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.04 168.98 3.05 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.828 1.685 . . . . 0.0 114.846 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 42.46 56.47 3.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.609 1.964 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.9 118.53 2.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -79.7 109.16 13.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.891 0.876 . . . . 0.0 109.439 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -95.64 -172.26 2.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.573 0.749 . . . . 0.0 111.5 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.18 169.75 9.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.535 1.934 . . . . 0.0 107.682 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.97 -41.25 97.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.6 p -62.79 -60.62 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.665 1.586 . . . . 0.0 111.994 -171.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 tp -57.63 -27.98 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.278 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -76.17 -50.34 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.65 -38.05 53.08 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.431 1.093 . . . . 0.0 111.897 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.45 -50.48 69.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.0 0.818 . . . . 0.0 109.269 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.25 86.89 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.77 69.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.454 0.301 . . . . 0.0 111.112 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.2 t -74.36 1.04 12.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.943 0.897 . . . . 0.0 112.795 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.81 14.9 55.91 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 119.13 0.877 . . . . 0.0 112.973 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.44 156.56 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.415 1.107 . . . . 0.0 109.674 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.04 124.39 11.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.642 1.577 . . . . 0.0 107.121 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -59.82 150.66 27.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.1 p -137.0 166.45 23.64 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.526 1.53 . . . . 0.0 107.009 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -52.63 -49.79 64.43 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.718 0.807 . . . . 0.0 108.884 173.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.47 -61.04 2.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.135 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -54.54 -46.63 73.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.773 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -60.38 -53.67 45.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.96 -42.69 63.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.04 0.936 . . . . 0.0 110.335 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.9 m -66.72 -59.32 3.68 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -44.31 -50.44 9.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.694 1.598 . . . . 0.0 113.224 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -54.82 -35.35 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.113 0.87 . . . . 0.0 113.034 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -82.71 -18.9 39.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.748 -0.595 . . . . 0.0 112.141 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.34 56.39 7.34 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 124.456 1.102 . . . . 0.0 112.709 -172.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.63 143.44 87.2 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.161 1.241 . . . . 0.0 109.22 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.93 -60.98 4.61 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.82 -42.69 65.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.872 0.869 . . . . 0.0 110.479 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -50.37 -50.78 50.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 111.037 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -67.76 -52.88 32.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.218 0.607 . . . . 0.0 110.23 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -49.12 -33.67 12.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.334 0.653 . . . . 0.0 110.751 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.29 -64.18 1.08 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.177 0.591 . . . . 0.0 110.191 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.49 -56.21 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.33 -41.98 84.34 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.402 0.681 . . . . 0.0 110.929 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 55.15 65.97 1.35 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.088 1.355 . . . . 0.0 111.094 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -129.15 139.88 51.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.291 1.836 . . . . 0.0 107.807 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -50.51 -40.35 51.23 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.271 1.029 . . . . 0.0 110.502 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.46 37.42 2.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.76 0.824 . . . . 0.0 111.42 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.5 66.15 3.18 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.595 0.758 . . . . 0.0 110.557 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -113.72 178.68 4.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.346 1.058 . . . . 0.0 109.29 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 t -144.99 149.84 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -14.33 57.28 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.1 ttt -65.98 77.36 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.531 1.132 . . . . 0.0 113.174 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 58.2 3.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.902 0.881 . . . . 0.0 109.308 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -163.19 137.55 6.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.669 1.588 . . . . 0.0 107.65 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -122.65 160.18 26.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tp -103.04 139.57 38.41 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.89 57.5 1.11 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.807 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 79.99 154.23 0.13 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 126.618 1.967 . . . . 0.0 110.141 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.72 38.27 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.53 -35.38 44.79 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.708 1.147 . . . . 0.0 111.572 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.46 -48.11 82.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.482 0.713 . . . . 0.0 110.298 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.34 -48.25 82.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.933 0.893 . . . . 0.0 109.514 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.71 -42.79 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.84 0.456 . . . . 0.0 110.162 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.19 97.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.769 -0.582 . . . . 0.0 110.109 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.98 95.42 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -58.77 -48.58 80.75 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.848 -0.533 . . . . 0.0 110.049 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.92 -45.12 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.891 -0.506 . . . . 0.0 110.712 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -42.08 85.25 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.692 -0.63 . . . . 0.0 110.328 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -67.49 -30.13 69.74 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.768 -0.583 . . . . 0.0 111.671 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.75 -39.61 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.585 1.154 . . . . 0.0 111.651 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 121.64 0.733 . . . . 0.0 112.871 -175.867 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 N-CA-C 113.82 0.288 . . . . 0.0 113.82 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.54 91.28 2.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.7 11.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.789 0.836 . . . . 0.0 113.14 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.35 -49.36 67.19 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.799 0.727 . . . . 0.0 110.017 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.64 -35.58 76.55 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.72 46.17 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -54.55 -53.89 48.49 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.751 0.82 . . . . 0.0 109.657 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -52.02 -55.47 20.34 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -54.97 -40.33 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.524 1.129 . . . . 0.0 110.693 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -55.82 -25.74 43.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.324 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -58.98 -31.3 68.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 110.894 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -93.78 -49.22 5.94 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.188 0.595 . . . . 0.0 109.865 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.97 -34.23 41.43 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.929 0.892 . . . . 0.0 110.634 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -41.7 -40.27 1.92 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.679 2.392 . . . . 0.0 115.002 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.1 m -25.81 -48.73 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.198 2.199 . . . . 0.0 114.044 -171.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.61 -25.96 13.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.892 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -100.6 -172.0 2.12 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-O 121.467 0.651 . . . . 0.0 112.201 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 m -157.11 161.03 39.4 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.692 1.597 . . . . 0.0 108.645 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.98 122.71 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.891 1.676 . . . . 0.0 107.354 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.5 tp -106.25 131.53 55.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 C-N-CA 125.162 1.385 . . . . 0.0 108.607 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 160.21 82.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.35 -38.31 62.47 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.01 2.474 . . . . 0.0 112.785 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.8 -9.83 56.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.482 1.513 . . . . 0.0 114.099 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.47 57.71 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.174 0.897 . . . . 0.0 113.637 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 m -69.81 126.28 29.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.641 1.721 . . . . 0.0 108.991 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.02 96.62 5.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.81 0.844 . . . . 0.0 110.14 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.06 -48.25 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.7 126.46 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -124.91 82.09 2.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.237 1.815 . . . . 0.0 110.216 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.55 -168.18 40.14 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.09 43.26 0.85 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.885 -1.362 . . . . 0.0 111.771 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 13.45 59.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 129.84 3.256 . . . . 0.0 113.969 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -32.11 13.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.159 1.384 . . . . 0.0 109.086 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.48 162.14 12.55 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.9 140.01 77.25 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.375 3.384 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -55.25 119.87 6.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.72 -2.15 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -64.8 84.08 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.445 1.02 . . . . 0.0 111.718 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.61 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.23 1.395 . . . . 0.0 112.182 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.91 -46.26 96.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-N 119.415 1.607 . . . . 0.0 109.523 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.25 118.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.341 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -29.79 10.85 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.741 1.638 . . . . 0.0 111.028 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -73.78 147.94 42.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.624 0.712 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.7 m -71.11 136.78 48.38 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.48 141.34 37.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.727 -0.608 . . . . 0.0 109.888 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.99 77.37 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.945 -1.475 . . . . 0.0 114.043 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 p -137.33 -0.56 2.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.879 1.839 . . . . 0.0 115.48 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -62.26 129.4 92.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 121.57 1.987 . . . . 0.0 107.641 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -44.62 154.53 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.662 2.908 . . . . 0.0 116.58 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 50.27 66.52 1.12 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.561 1.945 . . . . 0.0 113.631 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -163.41 122.84 2.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.98 0.419 . . . . 0.0 111.112 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.91 83.73 2.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.111 0.964 . . . . 0.0 109.821 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.09 178.16 1.96 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.918 0.487 . . . . 0.0 111.804 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -111.0 171.4 7.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.54 1.162 . . . . 0.0 110.767 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -53.91 15.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 111.986 -2.37 . . . . 0.0 113.013 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.3 m -62.23 -52.89 61.94 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.067 0.937 . . . . 0.0 111.579 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 tt -69.81 -38.84 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.456 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.69 -39.45 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.2 88.44 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.077 -0.389 . . . . 0.0 110.341 177.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.35 -49.81 76.39 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.43 -45.81 8.43 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.519 1.533 . . . . 0.0 112.695 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.3 -28.04 17.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.569 1.548 . . . . 0.0 113.695 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.4 p -73.63 2.74 7.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.118 0.872 . . . . 0.0 112.259 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.75 35.76 21.24 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -77.21 86.6 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.244 -0.562 . . . . 0.0 111.039 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.91 120.32 18.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.499 1.12 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -62.98 122.48 16.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.276 0.23 . . . . 0.0 110.419 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 p -100.31 159.1 15.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -54.65 -37.8 66.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.011 0.434 . . . . 0.0 110.357 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.76 -51.11 68.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.997 0.919 . . . . 0.0 110.171 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -59.71 -47.45 85.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.967 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.6 mt -55.07 -52.16 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.782 0.719 . . . . 0.0 109.284 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.87 65.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.452 0.701 . . . . 0.0 110.743 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -64.99 -54.37 31.57 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.835 0.454 . . . . 0.0 110.239 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -46.2 -52.06 13.09 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.701 1.6 . . . . 0.0 111.253 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -51.3 -28.61 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.669 0.788 . . . . 0.0 112.993 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -78.2 -26.67 47.6 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.711 0.687 . . . . 0.0 112.645 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -154.54 69.16 5.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.992 0.814 . . . . 0.0 111.889 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.11 145.95 97.28 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.198 1.932 . . . . 0.0 110.868 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.27 -59.99 4.79 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.05 70.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -47.89 -52.25 20.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.699 0.8 . . . . 0.0 111.377 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.8 mt -61.49 -56.87 15.31 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.409 1.084 . . . . 0.0 109.704 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.5 -38.76 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.591 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -72.36 -59.5 2.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.875 0.47 . . . . 0.0 109.739 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.03 -41.03 82.32 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.5 tp -86.2 -4.39 59.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.222 1.009 . . . . 0.0 111.876 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 t0 48.06 43.69 18.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.988 1.315 . . . . 0.0 110.366 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.24 107.92 12.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.005 1.322 . . . . 0.0 109.29 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -57.14 -26.27 60.27 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 128.738 2.815 . . . . 0.0 111.752 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -104.85 15.51 27.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.835 0.854 . . . . 0.0 113.264 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.2 113.75 20.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -132.44 131.68 41.99 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.344 1.057 . . . . 0.0 111.151 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -85.02 156.2 21.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.96 -18.71 72.94 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 170.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.73 80.79 0.07 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.593 1.157 . . . . 0.0 113.089 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.72 57.8 2.61 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.057 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -160.84 139.33 9.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.8 1.64 . . . . 0.0 106.606 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -142.53 155.19 44.99 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.5 tp -150.2 111.28 4.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.066 0.947 . . . . 0.0 108.57 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.86 30.99 0.2 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.285 -0.884 . . . . 0.0 112.908 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -161.83 176.7 10.59 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 127.502 2.321 . . . . 0.0 106.1 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.87 -51.52 2.74 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.525 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.72 -56.52 0.12 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.71 2.1 . . . . 0.0 114.732 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -59.98 -51.67 68.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.616 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.25 -48.37 80.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 109.631 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.63 -44.16 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.564 1.146 . . . . 0.0 110.601 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.57 -45.68 93.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.881 -0.512 . . . . 0.0 109.912 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.42 96.11 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -57.81 -52.81 63.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.216 0.606 . . . . 0.0 109.693 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.2 mt -54.17 -53.63 50.78 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.57 65.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.555 0.342 . . . . 0.0 111.443 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.8 m -64.63 -44.76 89.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.668 0.387 . . . . 0.0 111.556 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.96 -39.06 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.815 1.246 . . . . 0.0 111.522 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.437 -1.091 0 C-N-CA 125.516 1.527 . . . . 0.0 111.193 -177.251 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -82.04 99.51 9.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.09 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.062 0.945 . . . . 0.0 113.241 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.53 -48.56 66.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.251 0.932 . . . . 0.0 110.011 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -56.84 -42.48 79.74 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.37 -49.0 66.16 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.67 -51.15 70.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.59 0.695 . . . . 0.0 110.597 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -59.73 -46.85 87.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.515 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -61.29 -27.86 68.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.443 1.097 . . . . 0.0 110.742 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -57.75 -18.13 19.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 111.344 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -55.67 -28.68 56.82 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.427 1.012 . . . . 0.0 110.627 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -68.68 -54.25 17.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.453 -0.779 . . . . 0.0 109.002 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.41 -47.29 56.55 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.023 1.729 . . . . 0.0 109.93 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -47.41 -31.62 4.27 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.296 2.638 . . . . 0.0 112.92 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -53.33 -32.16 47.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.6 m -121.82 -37.01 2.92 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.911 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -101.14 -176.01 3.03 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.673 0.789 . . . . 0.0 112.212 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t -153.13 179.46 8.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.953 1.301 . . . . 0.0 109.788 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -143.49 115.12 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.919 2.488 . . . . 0.0 106.985 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 tp -102.22 148.52 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.667 1.587 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.01 158.09 87.64 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.01 -34.07 98.97 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.063 1.842 . . . . 0.0 111.264 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -75.14 -11.62 60.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.442 1.097 . . . . 0.0 113.324 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 -13.54 35.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.139 -0.812 . . . . 0.0 114.063 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -60.88 127.61 32.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.71 1.755 . . . . 0.0 110.404 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -70.75 82.96 0.63 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.624 0.769 . . . . 0.0 111.191 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.33 -59.99 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 C-N-CA 122.577 0.351 . . . . 0.0 110.07 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.54 -39.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.197 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 57.43 47.32 16.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.94 0.876 . . . . 0.0 109.855 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.91 -172.16 48.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.09 170.8 14.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 110.407 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -124.83 30.81 5.82 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.767 . . . . 0.0 109.385 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -69.92 -40.82 75.34 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.83 167.15 13.31 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 170.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.27 173.25 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.16 2.573 . . . . 0.0 114.337 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -84.68 121.77 28.14 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.64 -2.0 56.85 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.42 113.79 2.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.03 20.41 59.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.954 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.66 -39.65 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 119.105 1.452 . . . . 0.0 108.935 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.37 106.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.543 0.737 . . . . 0.0 109.561 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.12 -17.37 31.97 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.833 1.682 . . . . 0.0 111.902 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -68.2 141.27 56.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.43 1.115 . . . . 0.0 111.217 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -71.88 74.31 0.87 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.907 1.283 . . . . 0.0 111.11 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 52.13 -144.81 0.58 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.889 0.876 . . . . 0.0 112.406 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.34 75.83 0.64 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 123.554 0.597 . . . . 0.0 113.064 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 p -130.24 5.66 4.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.582 1.153 . . . . 0.0 112.196 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 126.56 91.65 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.46 172.77 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.113 1.209 . . . . 0.0 113.274 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 47.0 46.89 16.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.16 1.384 . . . . 0.0 111.853 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -156.42 111.45 2.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.14 -0.35 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.08 89.1 5.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.634 0.773 . . . . 0.0 109.813 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -74.76 -174.81 2.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.594 0.711 . . . . 0.0 111.344 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.34 166.51 13.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.139 1.376 . . . . 0.0 108.675 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.55 -35.0 79.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.31 0.644 . . . . 0.0 112.498 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -58.19 -62.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.971 1.308 . . . . 0.0 111.256 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.56 -35.33 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.932 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -48.84 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.81 90.47 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.898 0.479 . . . . 0.0 110.319 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.59 -45.3 89.4 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.045 0.538 . . . . 0.0 109.735 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.28 -53.19 42.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.6 67.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.329 0.651 . . . . 0.0 111.731 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -67.41 -14.89 63.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.053 0.541 . . . . 0.0 111.952 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.77 14.16 12.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.981 1.277 . . . . 0.0 112.793 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.78 118.29 15.52 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.87 1.335 . . . . 0.0 111.158 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.3 129.45 54.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -66.1 126.88 30.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 159.52 37.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 107.863 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -42.57 -51.77 5.02 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.212 1.405 . . . . 0.0 112.885 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.38 -47.45 85.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.262 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.63 -48.3 81.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.66 0.784 . . . . 0.0 109.647 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.85 -54.03 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.59 -38.21 59.6 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.316 1.046 . . . . 0.0 111.504 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -72.93 -60.23 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -46.73 -43.79 18.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.054 1.342 . . . . 0.0 114.055 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.8 m -52.91 -34.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 119.445 1.02 . . . . 0.0 113.575 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -101.74 -3.38 28.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.059 0.944 . . . . 0.0 111.563 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -133.68 54.54 12.96 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.665 1.586 . . . . 0.0 111.634 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.16 138.19 70.87 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.366 2.711 . . . . 0.0 108.761 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.68 -64.1 3.34 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -45.01 -48.53 11.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.019 1.327 . . . . 0.0 112.646 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.32 -43.71 96.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.088 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.03 -55.51 28.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -49.01 -44.54 41.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.789 1.235 . . . . 0.0 110.432 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -63.8 -68.51 0.34 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.626 0.771 . . . . 0.0 110.304 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -54.84 -40.93 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 -0.55 57.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.666 1.186 . . . . 0.0 111.487 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t0 43.84 53.25 6.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.529 1.531 . . . . 0.0 110.702 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.65 115.36 9.09 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.341 1.056 . . . . 0.0 111.526 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -57.45 -29.41 64.19 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.722 1.209 . . . . 0.0 111.943 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -92.66 11.66 25.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.01 76.84 5.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.522 -0.736 . . . . 0.0 111.734 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.28 152.89 21.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.453 0.701 . . . . 0.0 109.964 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -112.33 151.62 29.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.98 -21.41 61.29 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 170.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ttt -68.13 74.98 0.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 112.438 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.86 58.87 2.98 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 175.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -168.7 146.79 4.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.797 1.639 . . . . 0.0 107.275 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.16 150.09 45.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.11 0.964 . . . . 0.0 108.399 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -111.92 106.37 15.05 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 44.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.159 -0.338 . . . . 0.0 111.633 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -177.41 -171.01 0.31 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.197 1.799 . . . . 0.0 107.444 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.27 -51.54 3.61 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.55 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.64 -75.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 C-N-CA 128.313 2.863 . . . . 0.0 115.952 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.23 -48.43 81.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.339 0.569 . . . . 0.0 112.472 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.79 -49.66 72.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.17 0.988 . . . . 0.0 109.447 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.49 -41.45 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.044 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.07 -48.84 79.84 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.912 -0.492 . . . . 0.0 110.117 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.32 80.91 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.57 -51.05 71.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.03 -36.57 68.15 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.101 0.56 . . . . 0.0 111.616 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.33 -52.3 48.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -53.99 -37.37 63.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.998 0.919 . . . . 0.0 112.593 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.98 -28.67 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.184 1.794 . . . . 0.0 111.961 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 CA--C 1.537 0.454 0 CA-C-N 118.434 0.561 . . . . 0.0 110.327 179.603 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 N-CA-C 113.971 0.348 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -72.68 84.19 1.17 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.19 0.996 . . . . 0.0 109.517 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.45 -35.46 8.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.753 0.821 . . . . 0.0 112.859 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.21 69.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.61 0.641 . . . . 0.0 110.169 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -58.47 -40.96 84.12 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.06 -51.61 52.64 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.05 -50.94 71.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.936 0.894 . . . . 0.0 110.519 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -54.19 -54.03 45.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.01 -35.38 69.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.504 1.122 . . . . 0.0 110.87 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -58.52 -20.91 50.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -61.77 -23.25 66.06 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.647 -0.658 . . . . 0.0 111.027 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.04 -48.96 7.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 t -47.56 -38.55 14.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.321 1.848 . . . . 0.0 113.023 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -22.59 3.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.254 1.022 . . . . 0.0 113.304 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 m -58.76 -22.48 58.1 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -120.91 -34.27 3.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.885 0.874 . . . . 0.0 112.568 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -111.74 174.31 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.059 0.944 . . . . 0.0 113.544 -174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.5 t -145.41 161.75 38.94 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.599 0.76 . . . . 0.0 109.225 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -129.02 135.58 61.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.84 139.49 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.984 1.714 . . . . 0.0 108.946 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 161.08 79.42 Favored Pre-proline 0 C--O 1.232 0.159 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.71 -29.31 88.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.375 1.383 . . . . 0.0 109.434 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.23 -5.64 33.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.66 50.94 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.793 -1.192 . . . . 0.0 112.534 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -58.2 120.96 9.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.77 84.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.648 -0.658 . . . . 0.0 111.158 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.97 -66.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.45 80.44 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -69.69 56.14 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.291 1.436 . . . . 0.0 110.269 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.71 -170.34 46.95 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 164.7 26.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.356 0.598 . . . . 0.0 109.902 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -116.65 37.67 3.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -63.8 -39.48 94.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.51 167.81 12.41 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 171.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.0 151.57 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.755 2.97 . . . . 0.0 112.538 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.18 126.37 27.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.35 11.3 28.73 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.73 82.93 0.45 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.769 -1.207 . . . . 0.0 110.272 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.9 41.29 1.21 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.211 0.91 . . . . 0.0 113.23 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.3 -45.52 93.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -51.3 112.31 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.656 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 -18.17 57.95 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.585 1.088 . . . . 0.0 113.065 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.65 139.08 57.85 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.183 1.491 . . . . 0.0 110.425 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -67.38 72.82 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.265 1.426 . . . . 0.0 112.218 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.85 -148.12 0.49 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.62 -0.675 . . . . 0.0 109.88 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.45 1.1 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.5 p -136.39 10.98 3.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 0.0 111.204 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.26 133.33 94.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.09 155.74 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.026 2.484 . . . . 0.0 115.646 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 49.82 65.65 1.36 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.009 1.724 . . . . 0.0 113.603 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -162.04 123.45 2.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.62 89.44 2.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.965 0.906 . . . . 0.0 109.796 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -73.53 -172.03 1.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.836 0.827 . . . . 0.0 112.087 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.92 166.54 11.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.886 2.075 . . . . 0.0 107.358 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.96 -36.01 80.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.48 0.712 . . . . 0.0 112.18 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 -67.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.51 1.524 . . . . 0.0 110.976 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tp -54.2 -36.79 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.894 1.277 . . . . 0.0 110.935 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.88 -51.0 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.381 0.672 . . . . 0.0 109.38 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.82 69.34 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.903 0.481 . . . . 0.0 110.775 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.32 -48.83 75.92 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.21 70.07 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.37 53.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.067 0.547 . . . . 0.0 111.269 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -75.52 13.03 0.84 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.97 27.74 52.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.167 0.889 . . . . 0.0 112.752 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -88.75 123.2 32.94 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.755 0.777 . . . . 0.0 109.692 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.1 131.31 55.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -64.32 93.35 0.09 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.022 0.374 . . . . 0.0 111.659 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.8 p -79.92 168.71 18.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -57.71 -41.05 80.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.829 -0.545 . . . . 0.0 109.87 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.15 -49.36 72.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.317 1.047 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -58.13 -51.76 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.1 mt -54.77 -54.57 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.63 67.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.799 0.44 . . . . 0.0 111.321 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 m -67.95 -44.07 77.61 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.281 -0.262 . . . . 0.0 110.995 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -54.84 -44.37 73.87 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.317 -0.865 . . . . 0.0 111.062 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.15 -26.88 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.832 0.453 . . . . 0.0 111.475 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -89.23 -33.54 16.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.868 0.867 . . . . 0.0 111.577 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -137.59 67.34 51.64 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.65 144.67 97.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.956 1.771 . . . . 0.0 110.585 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.68 -63.37 4.01 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.61 67.36 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.552 0.741 . . . . 0.0 110.77 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.34 -40.44 90.68 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.642 0.258 . . . . 0.0 111.673 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.14 -60.29 3.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -41.82 -50.22 4.38 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.379 1.472 . . . . 0.0 110.995 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -39.88 -52.17 2.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.095 1.358 . . . . 0.0 112.128 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -89.6 -52.78 4.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.973 0.909 . . . . 0.0 112.322 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.7 tp -73.09 -21.74 60.7 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -172.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t0 45.2 46.3 9.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.771 2.029 . . . . 0.0 111.894 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.07 129.91 52.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -31.21 71.04 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 126.182 1.793 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -88.26 17.31 5.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 0.0 111.719 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.95 64.93 6.86 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.442 -1.411 . . . . 0.0 110.246 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -103.55 -176.73 3.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.412 1.485 . . . . 0.0 108.619 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.71 150.94 38.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.83 -18.74 57.51 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 ttt -65.0 81.2 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.572 1.149 . . . . 0.0 113.635 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.8 3.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.531 0.732 . . . . 0.0 109.343 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -161.73 142.15 10.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.739 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -152.41 175.1 13.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.428 1.091 . . . . 0.0 108.814 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -158.38 122.07 3.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.86 50.19 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.692 0.797 . . . . 0.0 111.443 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? 166.03 -174.1 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 129.6 3.16 . . . . 0.0 105.528 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.95 -54.29 4.44 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 111.534 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -36.17 -50.08 1.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.592 1.568 . . . . 0.0 113.342 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -55.11 -60.63 3.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.503 1.121 . . . . 0.0 112.348 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.34 -41.23 98.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.383 0.673 . . . . 0.0 111.066 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.8 t -59.59 -42.09 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.02 79.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.936 0.789 . . . . 0.0 110.147 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.31 86.21 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.384 -0.198 . . . . 0.0 110.499 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.44 -55.11 35.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.71 -40.12 68.89 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.376 0.67 . . . . 0.0 111.649 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.59 7.01 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.694 0.679 . . . . 0.0 109.871 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.8 p -56.24 -32.81 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.1 -32.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 111.595 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -86.55 103.21 14.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.91 -33.2 4.36 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 112.762 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.16 71.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.181 0.9 . . . . 0.0 110.167 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -38.72 90.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.81 -49.81 71.1 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -54.5 -53.44 54.29 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.673 0.789 . . . . 0.0 109.441 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -58.0 -49.06 78.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.649 0.261 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.25 -31.13 67.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.576 1.15 . . . . 0.0 110.92 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.47 -18.17 17.17 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.072 -0.392 . . . . 0.0 111.849 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -52.18 -29.15 20.97 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.384 0.674 . . . . 0.0 110.735 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.67 -55.86 5.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.8 m -48.69 -43.73 37.3 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.19 1.396 . . . . 0.0 112.415 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -52.73 -25.35 10.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 113.157 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 -25.77 59.95 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.866 -0.521 . . . . 0.0 110.745 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.03 -45.14 2.38 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.238 0.615 . . . . 0.0 110.81 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -91.8 -176.85 4.58 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -151.73 167.77 27.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.303 1.841 . . . . 0.0 110.139 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.3 mm -136.3 117.7 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.768 1.627 . . . . 0.0 108.043 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tp -115.72 126.97 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.159 1.384 . . . . 0.0 109.045 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 163.95 29.5 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.221 -0.924 . . . . 0.0 108.685 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.58 -36.92 98.34 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.446 2.097 . . . . 0.0 110.323 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.01 3.55 6.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.685 1.594 . . . . 0.0 113.119 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.88 90.53 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.688 -1.257 . . . . 0.0 112.7 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -71.44 114.12 9.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.6 1.2 . . . . 0.0 109.171 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.15 104.02 1.09 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.795 -0.566 . . . . 0.0 109.815 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.9 mm -76.21 -47.44 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.98 96.74 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 58.66 1.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.485 1.514 . . . . 0.0 108.216 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.44 -158.91 27.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 175.97 10.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -124.58 30.48 5.97 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -38.43 83.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.52 171.56 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -63.74 174.62 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.265 3.31 . . . . 0.0 112.387 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -87.24 121.2 29.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.6 mt -86.61 1.33 52.19 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.34 99.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.35 0.977 . . . . 0.0 109.616 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.97 33.16 21.81 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 119.085 -0.841 . . . . 0.0 113.32 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.75 -31.04 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.753 1.276 . . . . 0.0 108.69 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.44 113.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.198 0.999 . . . . 0.0 110.461 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.16 -10.26 75.42 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.177 1.37 . . . . 0.0 112.749 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.95 144.64 29.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.158 0.979 . . . . 0.0 110.005 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 m -63.86 134.1 54.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.31 141.45 54.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.659 -0.651 . . . . 0.0 110.613 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.61 33.78 81.97 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.968 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.2 p -132.03 -0.77 3.74 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.897 1.348 . . . . 0.0 114.151 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -64.56 126.72 91.31 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 120.342 1.428 . . . . 0.0 107.153 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.76 161.32 18.54 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.402 2.068 . . . . 0.0 113.327 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 56.27 55.08 7.01 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.411 1.485 . . . . 0.0 112.282 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -162.55 120.18 2.07 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.151 -0.343 . . . . 0.0 110.576 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -79.15 98.45 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.254 1.022 . . . . 0.0 110.246 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.99 -171.69 3.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.8 0.809 . . . . 0.0 111.553 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -105.28 157.91 16.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 109.279 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.53 -34.39 72.58 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.419 0.687 . . . . 0.0 112.43 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.8 p -63.95 -64.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.751 1.22 . . . . 0.0 109.779 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.2 tt -58.2 -37.22 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.624 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.55 -49.9 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.83 88.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.436 0.562 . . . . 0.0 110.802 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 tp -56.33 -47.34 78.94 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.1 -56.29 21.92 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.232 0.92 . . . . 0.0 111.012 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -31.22 61.74 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.265 1.426 . . . . 0.0 111.807 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 m -69.05 -0.63 6.01 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.57 27.77 8.89 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.374 1.464 . . . . 0.0 111.477 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -84.45 96.76 9.2 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 117.978 0.889 . . . . 0.0 111.18 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.62 127.44 35.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -67.35 103.98 1.41 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.977 0.353 . . . . 0.0 111.615 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.5 p -84.45 162.09 20.07 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -57.61 -37.11 72.7 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.738 0.415 . . . . 0.0 110.332 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -63.69 -55.42 23.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.76 -50.27 68.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.48 -54.52 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.05 -41.12 71.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.334 0.653 . . . . 0.0 111.842 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.8 m -69.76 -56.08 8.14 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -43.3 -51.93 6.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.714 1.606 . . . . 0.0 113.461 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.6 m -53.41 -30.98 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.81 -23.9 63.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.797 -0.621 . . . . 0.0 112.07 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -160.95 68.04 2.5 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 119.086 0.857 . . . . 0.0 112.56 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.58 151.79 81.35 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 120.979 1.12 . . . . 0.0 109.412 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.83 -61.09 4.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.15 78.88 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.282 -0.54 . . . . 0.0 109.673 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -51.52 -56.36 13.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.124 0.97 . . . . 0.0 110.523 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 mp -57.64 -48.66 78.85 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.167 0.587 . . . . 0.0 110.901 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -54.87 -51.27 66.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.154 0.433 . . . . 0.0 110.291 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -54.48 -51.9 63.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.856 0.863 . . . . 0.0 111.015 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -72.87 -49.66 28.64 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 tp -77.91 -24.2 48.42 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.511 1.125 . . . . 0.0 113.46 -174.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.09 50.64 16.14 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.564 1.546 . . . . 0.0 110.048 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -135.29 130.02 34.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.448 1.499 . . . . 0.0 109.514 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -58.52 -35.25 71.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.291 0.636 . . . . 0.0 110.53 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -84.47 15.67 3.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.22 66.18 4.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.639 0.775 . . . . 0.0 110.992 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -94.32 -179.71 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.118 1.367 . . . . 0.0 110.27 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -155.83 157.64 36.77 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.92 -11.95 84.9 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 172.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.3 ttt -69.35 77.22 0.38 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 118.787 1.293 . . . . 0.0 113.144 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.51 58.17 3.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.28 1.032 . . . . 0.0 109.606 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -162.94 139.69 7.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -138.82 160.53 39.48 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -157.19 107.1 2.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.48 43.8 0.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.517 0.727 . . . . 0.0 112.242 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -177.52 -177.99 0.72 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.006 1.723 . . . . 0.0 107.243 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.32 -50.22 2.75 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.604 -0.553 . . . . 0.0 113.367 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -28.1 -51.65 0.1 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 127.319 2.39 . . . . 0.0 115.329 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -61.22 -48.56 80.95 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.796 0.798 . . . . 0.0 111.012 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.52 -46.7 84.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.86 0.864 . . . . 0.0 109.152 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.49 -43.41 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.517 0.727 . . . . 0.0 110.329 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.86 92.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.864 -0.523 . . . . 0.0 109.603 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.31 91.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.527 0.203 . . . . 0.0 110.458 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.8 -52.99 62.9 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.928 0.491 . . . . 0.0 110.058 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.8 mt -57.11 -45.53 83.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.059 0.391 . . . . 0.0 110.776 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.28 81.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.237 0.615 . . . . 0.0 110.8 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.2 m -68.92 -42.37 76.9 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.029 -0.42 . . . . 0.0 110.691 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.26 -44.17 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.141 1.377 . . . . 0.0 112.247 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.0 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.46 115.17 27.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.32 1.448 . . . . 0.0 108.765 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.13 -33.78 53.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.511 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.97 -53.5 38.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.541 1.064 . . . . 0.0 110.06 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -54.77 -41.55 70.65 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.72 -50.72 56.75 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -56.17 -49.58 73.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.403 0.681 . . . . 0.0 109.268 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.2 -50.28 74.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.477 0.18 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -58.18 -32.45 68.24 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 124.953 1.301 . . . . 0.0 110.634 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -58.95 -21.26 57.98 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -21.55 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.829 -0.544 . . . . 0.0 110.284 174.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -86.71 -49.43 7.48 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.286 -0.884 . . . . 0.0 109.157 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.9 m -51.2 -40.17 58.1 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.478 1.111 . . . . 0.0 111.912 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.11 -21.45 4.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 113.254 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -56.81 -23.74 45.9 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.536 -0.728 . . . . 0.0 110.409 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m -125.54 -49.62 1.65 Allowed 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 122.984 0.513 . . . . 0.0 109.844 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.17 -174.78 4.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.194 0.997 . . . . 0.0 113.49 -172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 m -158.69 164.9 35.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.468 1.907 . . . . 0.0 108.737 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.9 mm -136.9 119.57 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.913 1.685 . . . . 0.0 107.23 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.98 132.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.201 0.6 . . . . 0.0 110.753 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.21 152.84 83.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.95 -34.05 90.84 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.96 2.44 . . . . 0.0 112.103 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.59 -9.11 57.72 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.406 1.082 . . . . 0.0 113.346 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.17 -14.07 44.2 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.837 -0.979 . . . . 0.0 113.576 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -60.06 112.27 1.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.651 1.725 . . . . 0.0 109.908 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.23 121.41 16.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.012 0.925 . . . . 0.0 109.794 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.08 -45.77 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.61 100.61 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -88.11 72.13 9.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.39 -178.67 45.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.87 68.95 7.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.78 -0.835 . . . . 0.0 109.081 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -35.47 62.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 1 C-N-CA 133.541 4.737 . . . . 0.0 115.934 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -96.17 -30.16 13.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.842 2.057 . . . . 0.0 108.586 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.8 169.66 13.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.54 163.71 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.945 3.097 . . . . 0.0 114.04 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -85.14 117.43 24.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.6 0.95 44.54 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.13 106.36 0.6 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.01 15.09 49.99 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.406 -1.219 . . . . 0.0 113.604 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.17 -38.67 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.938 1.869 . . . . 0.0 110.184 176.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.86 112.22 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -20.73 49.05 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.077 1.322 . . . . 0.0 112.024 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -72.96 140.54 47.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.045 0.923 . . . . 0.0 109.918 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 m -64.2 121.95 15.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.49 150.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.252 0.549 . . . . 0.0 111.789 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.73 13.16 60.77 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.09 -1.395 . . . . 0.0 113.753 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -142.44 35.27 1.48 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.679 1.74 . . . . 0.0 113.67 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -80.58 135.06 53.34 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 165.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -57.63 155.94 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.314 1.343 . . . . 0.0 113.144 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 55.86 64.14 1.82 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.898 1.679 . . . . 0.0 113.852 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -163.59 123.67 2.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.76 -0.587 . . . . 0.0 110.974 172.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -77.0 77.48 3.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.197 0.999 . . . . 0.0 110.149 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -69.31 -172.66 0.46 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.308 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -113.89 160.56 18.64 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.804 1.641 . . . . 0.0 110.857 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.57 -38.67 60.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.559 1.144 . . . . 0.0 113.525 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -65.91 -55.6 16.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.595 0.712 . . . . 0.0 110.67 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 tt -66.68 -35.26 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.75 -49.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.92 88.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.868 0.467 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.6 tp -56.15 -46.43 79.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.35 -55.66 25.56 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.29 0.948 . . . . 0.0 110.91 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.01 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.569 1.148 . . . . 0.0 111.497 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 m -72.67 6.48 2.45 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.43 25.42 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.196 1.379 . . . . 0.0 112.091 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -80.99 78.83 7.77 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.658 -0.907 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.55 116.8 14.55 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -59.58 121.2 11.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.0 p -99.87 164.97 11.79 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -55.91 -46.45 78.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.909 0.862 . . . . 0.0 109.639 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -58.83 -52.47 65.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.16 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -60.47 -46.76 88.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.57 -53.24 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.82 -37.99 64.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.178 0.991 . . . . 0.0 111.484 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 m -72.74 -58.91 2.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -43.98 -47.98 8.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.899 1.679 . . . . 0.0 113.245 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 m -51.93 -34.42 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -75.09 -25.05 58.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.0 112.095 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -145.63 61.79 7.93 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.892 0.877 . . . . 0.0 113.043 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.18 148.09 93.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.668 1.578 . . . . 0.0 109.446 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.96 -65.64 3.22 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.2 62.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.773 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -51.61 -54.48 27.29 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.656 0.782 . . . . 0.0 110.471 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 mp -60.34 -49.27 78.26 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 122.969 0.508 . . . . 0.0 111.174 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.35 -46.27 66.04 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.954 0.343 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.16 -65.94 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.25 0.62 . . . . 0.0 110.345 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -56.38 -41.24 75.92 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.7 -6.63 59.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.721 0.808 . . . . 0.0 111.581 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 48.28 52.87 12.73 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.291 1.436 . . . . 0.0 109.604 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -143.72 155.74 44.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.998 0.919 . . . . 0.0 110.801 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -91.44 -41.3 10.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.945 1.698 . . . . 0.0 108.619 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.03 39.7 0.51 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.857 0.863 . . . . 0.0 111.99 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.26 111.44 22.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.537 0.735 . . . . 0.0 109.412 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -124.46 -176.04 3.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.862 0.865 . . . . 0.0 112.066 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -159.75 147.05 16.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.37 64.15 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.6 ttt -66.98 79.84 0.12 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 118.452 1.126 . . . . 0.0 113.651 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.02 57.49 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.655 0.782 . . . . 0.0 109.438 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -165.22 125.92 1.94 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.648 1.179 . . . . 0.0 108.565 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -115.47 159.9 20.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.29 103.74 3.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.92 44.44 0.55 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.191 0.596 . . . . 0.0 111.413 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -174.85 -176.57 1.01 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.814 1.646 . . . . 0.0 107.581 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.15 -52.93 3.41 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.272 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -11.75 -72.07 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 128.525 2.965 . . . . 0.0 116.045 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.5 -45.97 90.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.126 0.963 . . . . 0.0 112.412 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.49 -49.7 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 109.116 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.69 -43.04 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.423 0.689 . . . . 0.0 109.945 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.39 93.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.998 -0.439 . . . . 0.0 110.102 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.77 93.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.041 0.382 . . . . 0.0 110.418 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -57.08 -53.1 61.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.95 -41.54 83.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.115 -0.366 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.58 85.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.638 0.775 . . . . 0.0 110.585 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -69.58 -41.04 76.35 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.039 -0.413 . . . . 0.0 110.343 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.52 -38.12 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.732 1.213 . . . . 0.0 112.425 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.538 0.511 0 CA-C-N 119.238 0.926 . . . . 0.0 111.672 -178.69 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.099 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.98 85.07 2.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.943 -0.74 . . . . 0.0 110.21 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.33 -35.88 40.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.739 0.816 . . . . 0.0 112.496 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.02 65.54 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.78 -0.575 . . . . 0.0 110.067 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -57.84 -41.53 82.51 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.82 -48.07 68.45 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -57.06 -50.37 72.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.285 0.543 . . . . 0.0 110.585 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -59.37 -51.04 71.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.234 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -56.07 -31.49 63.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.398 1.879 . . . . 0.0 110.621 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.88 -19.73 7.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.586 0.754 . . . . 0.0 112.125 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -51.0 -34.35 28.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.454 0.57 . . . . 0.0 110.667 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -77.7 -49.23 14.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -48.3 -49.09 35.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.307 1.043 . . . . 0.0 110.654 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.82 -11.5 27.72 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.6 m -56.63 -33.63 66.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.7 m -113.99 -39.64 3.9 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.437 0.695 . . . . 0.0 110.341 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -95.47 -172.42 2.63 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -159.96 172.83 16.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.984 2.113 . . . . 0.0 107.648 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -132.67 132.43 59.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 tp -116.32 143.9 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.853 1.661 . . . . 0.0 109.164 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.37 159.11 82.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.27 -42.44 47.35 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.138 2.559 . . . . 0.0 112.863 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -73.0 -11.91 60.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.311 1.444 . . . . 0.0 113.671 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -14.32 34.57 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.977 -0.901 . . . . 0.0 113.682 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.7 m -57.77 125.63 23.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.532 1.666 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.21 82.16 1.0 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 110.724 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.1 mm -57.7 -61.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.43 98.32 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.8 67.83 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.051 0.94 . . . . 0.0 109.188 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.22 -162.99 28.53 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.53 176.43 9.05 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -130.49 33.07 4.33 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -71.06 -35.9 72.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.745 1.218 . . . . 0.0 108.191 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.88 161.86 12.61 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 174.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.44 125.54 18.23 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.848 3.032 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.16 114.86 1.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 108.759 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.6 mt -72.19 -16.44 61.96 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -168.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -52.97 120.39 5.78 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.732 1.151 . . . . 0.0 108.946 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.6 12.31 72.65 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.809 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.44 -42.34 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.31 1.555 . . . . 0.0 109.544 174.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.73 118.09 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.195 0.598 . . . . 0.0 110.612 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.96 57.2 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.167 0.889 . . . . 0.0 112.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -70.7 148.69 47.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.059 1.429 . . . . 0.0 110.482 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -76.09 59.48 1.33 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.815 1.246 . . . . 0.0 110.424 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 36.57 -123.54 0.17 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.164 1.786 . . . . 0.0 113.465 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.67 73.16 0.0 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.017 1.77 . . . . 0.0 115.298 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.1 t -160.18 9.13 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.31 1.055 . . . . 0.0 113.433 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -64.24 134.53 95.99 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 120.979 -1.076 . . . . 0.0 108.63 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -64.32 157.22 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.416 1.41 . . . . 0.0 111.31 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 47.68 58.46 4.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.149 1.38 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -154.83 119.98 4.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.148 0.499 . . . . 0.0 109.873 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -73.1 77.25 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.475 1.11 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.83 -176.93 1.17 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 110.515 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -113.25 173.71 6.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.158 0.983 . . . . 0.0 108.799 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.25 -41.64 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.202 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 p -60.22 -64.88 0.79 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.975 1.31 . . . . 0.0 111.719 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -38.82 75.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.121 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.54 -49.28 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.16 91.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.571 0.349 . . . . 0.0 111.005 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.7 tp -55.96 -52.58 63.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.37 -54.63 28.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.68 48.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.53 1.132 . . . . 0.0 112.585 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -71.15 2.12 5.0 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.92 34.07 8.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.663 1.125 . . . . 0.0 110.923 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -97.54 117.4 31.73 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.206 0.503 . . . . 0.0 109.849 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.11 137.92 45.26 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.632 1.173 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -73.79 95.77 2.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.587 0.355 . . . . 0.0 111.915 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 p -78.77 167.55 21.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -55.97 -43.63 77.73 Favored 'General case' 0 N--CA 1.459 -0.017 0 CA-C-O 121.923 0.868 . . . . 0.0 109.893 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.58 -51.75 67.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.059 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.42 -49.38 78.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.361 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.98 -52.91 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.83 -42.0 75.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.078 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.5 m -67.26 -51.48 52.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.243 0.217 . . . . 0.0 110.54 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -43.62 -56.36 3.77 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 125.266 1.427 . . . . 0.0 112.9 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 m -52.35 -30.18 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -73.12 -28.68 62.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.005 0.522 . . . . 0.0 112.008 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -151.95 62.63 4.82 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 124.432 1.093 . . . . 0.0 111.215 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.78 159.14 53.61 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.53 -63.83 3.64 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.53 67.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.198 0.999 . . . . 0.0 110.464 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -52.41 -48.27 65.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.089 0.556 . . . . 0.0 110.554 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.63 -59.31 5.39 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -45.3 -48.39 13.03 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.633 1.173 . . . . 0.0 110.727 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.37 -70.46 0.17 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.303 1.041 . . . . 0.0 110.712 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -63.15 -31.53 72.69 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -171.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.48 -7.42 59.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.396 0.679 . . . . 0.0 111.256 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.24 54.37 10.38 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 109.286 -175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -138.62 152.16 47.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.588 1.155 . . . . 0.0 109.776 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -48.63 6.86 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.779 1.632 . . . . 0.0 108.13 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -80.96 30.18 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.07 67.27 8.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.277 -0.889 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.83 154.68 40.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.964 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -123.17 149.82 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.4 -26.25 74.45 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 15.5 ttp -68.48 80.78 0.26 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.642 0.721 . . . . 0.0 112.146 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 57.94 3.12 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.48 146.89 13.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -143.1 160.7 39.91 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.3 tp -161.05 112.49 1.82 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.2 33.92 0.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.662 -0.649 . . . . 0.0 112.56 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -159.49 179.54 8.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.202 2.201 . . . . 0.0 106.848 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.46 -55.13 4.39 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.05 -57.15 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 126.209 1.861 . . . . 0.0 114.075 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -52.75 -58.2 7.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.038 1.335 . . . . 0.0 113.004 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.92 -40.51 79.03 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.781 -0.574 . . . . 0.0 111.019 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.97 -41.11 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.928 -0.483 . . . . 0.0 110.418 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.04 -46.64 87.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.754 -0.591 . . . . 0.0 109.749 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.18 -43.78 95.6 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.85 -49.22 77.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.37 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 mt -57.87 -45.54 86.19 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.222 0.465 . . . . 0.0 110.593 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.71 79.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.826 0.451 . . . . 0.0 110.642 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -70.15 -39.61 75.24 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.135 -0.353 . . . . 0.0 110.866 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.92 -38.93 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.677 1.591 . . . . 0.0 112.596 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.6 82.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.499 1.045 . . . . 0.0 110.574 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.1 pttp . . . . . 0 C--O 1.249 1.041 0 C-N-CA 127.964 2.506 . . . . 0.0 107.696 -178.934 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 CA-C-O 121.115 0.286 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -81.71 88.84 6.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.199 1.0 . . . . 0.0 108.853 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.53 -42.51 2.42 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.807 1.243 . . . . 0.0 112.978 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.59 73.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.597 0.759 . . . . 0.0 111.467 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -69.42 -37.21 77.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -51.47 -43.03 52.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.421 1.01 . . . . 0.0 111.228 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -52.5 -46.94 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.459 0.704 . . . . 0.0 110.848 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.96 -46.47 65.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.518 0.727 . . . . 0.0 109.567 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.21 -35.5 67.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.097 0.959 . . . . 0.0 110.579 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -56.91 -16.95 7.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.128 0.971 . . . . 0.0 112.428 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -52.2 -29.61 23.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.562 -0.711 . . . . 0.0 110.545 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -72.76 -55.61 6.49 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.46 -46.19 56.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.421 1.089 . . . . 0.0 112.889 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -55.86 -21.81 21.98 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -59.4 -26.12 64.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.3 m -118.83 -43.81 2.65 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.524 0.729 . . . . 0.0 111.09 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -97.98 -172.17 2.31 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.272 1.029 . . . . 0.0 112.85 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -151.04 169.05 22.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.571 1.548 . . . . 0.0 109.057 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.9 mt -133.31 124.08 48.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -145.61 134.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.932 0.893 . . . . 0.0 110.012 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.11 161.98 68.78 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -54.58 -37.0 90.62 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 110.982 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.41 -0.57 6.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.711 1.604 . . . . 0.0 113.315 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.85 -7.32 81.6 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 120.848 -1.158 . . . . 0.0 112.415 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -64.82 103.19 0.67 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.457 1.128 . . . . 0.0 109.125 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.03 120.78 14.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.699 0.4 . . . . 0.0 111.255 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.43 -45.92 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.84 106.37 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -72.16 56.5 0.33 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.039 1.336 . . . . 0.0 110.172 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.26 -173.61 13.0 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 167.94 7.46 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.098 -0.648 . . . . 0.0 111.085 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -117.09 30.66 7.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.731 0.812 . . . . 0.0 109.261 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -67.27 -44.11 80.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.53 171.72 17.65 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 107.636 -2.185 . . . . 0.0 107.636 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.77 177.27 1.87 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.243 3.295 . . . . 0.0 113.087 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 114.1 21.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.45 -16.93 62.39 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.75 116.0 2.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.99 15.27 70.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.56 -1.133 . . . . 0.0 114.837 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.5 -44.96 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.928 1.864 . . . . 0.0 108.892 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.65 113.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 -15.17 59.75 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.832 1.206 . . . . 0.0 112.744 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -90.31 144.65 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.541 1.17 . . . . 0.0 110.919 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -58.69 133.35 55.84 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.628 1.171 . . . . 0.0 109.126 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.81 159.33 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.534 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.92 23.53 31.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.975 1.274 . . . . 0.0 114.477 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.1 p -145.31 22.94 1.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.888 1.344 . . . . 0.0 113.01 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -67.32 137.44 93.84 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.06 154.35 10.64 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.311 2.007 . . . . 0.0 114.565 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 45.06 59.35 3.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.276 1.83 . . . . 0.0 113.269 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.31 118.57 2.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -82.88 98.27 9.1 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.028 0.931 . . . . 0.0 109.725 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -82.68 -172.83 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 111.152 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -96.35 -176.91 3.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.924 1.29 . . . . 0.0 108.546 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.77 -34.47 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.928 0.891 . . . . 0.0 113.12 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 p -60.42 -65.38 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.46 1.104 . . . . 0.0 110.387 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.54 -40.28 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.156 1.383 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.8 t -59.82 -50.74 78.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.2 97.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.123 0.42 . . . . 0.0 111.108 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -53.31 53.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.73 64.59 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 123.766 0.698 . . . . 0.0 111.836 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.72 -26.82 47.24 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.488 1.515 . . . . 0.0 112.033 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.2 m -69.56 0.59 5.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.01 0.368 . . . . 0.0 111.938 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.97 38.4 5.76 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 125.446 1.498 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -107.11 110.06 22.06 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.378 0.589 . . . . 0.0 111.676 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 128.11 43.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.218 1.407 . . . . 0.0 107.55 174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -62.75 151.76 37.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 110.796 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.0 p -129.82 162.56 28.23 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.949 1.7 . . . . 0.0 106.452 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.38 -39.68 80.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.061 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.55 -52.53 64.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.551 0.741 . . . . 0.0 110.216 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -61.03 -45.34 95.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.431 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.1 -53.03 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 118.675 0.671 . . . . 0.0 109.335 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.75 -46.45 64.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.462 0.705 . . . . 0.0 110.052 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.5 m -62.24 -54.4 41.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 109.915 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -50.08 -48.45 53.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.816 1.246 . . . . 0.0 113.04 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.3 m -60.47 -28.13 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.331 0.969 . . . . 0.0 112.689 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.24 -13.4 52.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.663 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -139.54 57.71 10.59 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.989 1.716 . . . . 0.0 112.07 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.08 138.43 78.15 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.926 2.418 . . . . 0.0 109.663 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.6 -65.17 2.49 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.42 -45.65 9.14 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 125.924 1.69 . . . . 0.0 111.529 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -55.1 -55.49 30.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.898 0.479 . . . . 0.0 110.664 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -56.74 -53.03 62.46 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.208 0.603 . . . . 0.0 109.997 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -52.35 -44.2 65.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.765 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.09 -67.15 0.45 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.605 0.762 . . . . 0.0 110.22 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -53.86 -42.74 68.9 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.16 -4.05 59.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.117 0.567 . . . . 0.0 111.847 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.3 t0 47.6 45.11 17.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.094 1.358 . . . . 0.0 110.009 -174.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.24 111.61 11.01 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.459 1.104 . . . . 0.0 110.52 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -57.46 -26.05 60.63 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.002 2.521 . . . . 0.0 111.787 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -96.49 9.61 40.84 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.22 72.71 7.06 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.502 -0.749 . . . . 0.0 110.357 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -91.73 126.79 36.94 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.701 0.8 . . . . 0.0 109.976 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -80.78 161.94 24.29 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.15 0.5 . . . . 0.0 110.498 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.13 -22.76 70.35 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 169.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ttp -68.26 81.02 0.24 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.991 0.895 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.0 58.04 3.31 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -160.19 150.43 18.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.539 1.536 . . . . 0.0 107.387 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -141.98 158.34 43.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.319 1.048 . . . . 0.0 108.543 173.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.71 102.81 11.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.08 67.73 1.79 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.889 1.276 . . . . 0.0 109.958 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 89.3 139.45 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 129.195 2.998 . . . . 0.0 109.35 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.9 -21.76 7.83 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -49.48 -41.59 33.33 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.492 1.044 . . . . 0.0 112.63 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.45 -46.56 88.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.443 0.622 . . . . 0.0 110.868 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.6 -49.2 77.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.283 1.433 . . . . 0.0 110.17 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.59 -44.96 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.66 91.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.87 -0.518 . . . . 0.0 110.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.06 94.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -57.22 -49.42 76.07 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.908 -0.495 . . . . 0.0 110.269 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.27 -44.21 88.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.429 -0.794 . . . . 0.0 111.206 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.47 73.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.442 0.697 . . . . 0.0 110.752 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -72.38 -37.73 68.66 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.123 -0.36 . . . . 0.0 110.679 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -69.27 -47.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.806 1.242 . . . . 0.0 112.43 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.36 118.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 122.566 1.174 . . . . 0.0 111.841 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.376 0 C-N-CA 129.391 3.076 . . . . 0.0 106.789 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -77.08 84.14 3.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -39.06 -41.6 0.81 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.604 1.561 . . . . 0.0 113.601 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.29 36.74 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.455 0.57 . . . . 0.0 110.627 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -57.25 -38.47 73.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.308 0.643 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.52 -52.05 47.75 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.74 -50.37 73.44 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.15 0.98 . . . . 0.0 110.165 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.57 -51.62 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.459 -0.201 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.95 -38.33 70.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.828 0.851 . . . . 0.0 109.627 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -56.97 -29.95 63.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -33.54 67.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.025 -0.422 . . . . 0.0 110.231 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -87.66 -48.66 7.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.742 0.817 . . . . 0.0 109.006 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.2 t -49.22 -37.57 23.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.588 1.555 . . . . 0.0 112.038 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 5.01 0.68 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -55.83 -30.53 61.58 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.798 -1.189 . . . . 0.0 110.213 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.18 -37.28 5.37 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.563 0.745 . . . . 0.0 112.593 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -105.71 -174.43 2.53 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.676 0.791 . . . . 0.0 112.337 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 m -150.67 171.25 17.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.015 1.326 . . . . 0.0 109.619 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -133.16 133.28 58.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tp -117.14 141.86 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.537 1.535 . . . . 0.0 109.247 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.26 154.76 88.22 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.53 -38.84 45.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.12 2.547 . . . . 0.0 113.537 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.57 -16.25 62.84 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.738 1.215 . . . . 0.0 113.779 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.48 -13.52 23.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.667 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.3 m -60.63 124.85 21.61 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.625 1.712 . . . . 0.0 110.014 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -72.74 77.35 1.12 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.673 0.789 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.2 mm -52.94 -55.43 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.17 86.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.28 65.25 0.84 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.143 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.24 -158.53 33.57 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.53 174.09 11.38 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -121.92 28.44 7.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 109.201 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -66.9 -43.42 83.45 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.13 171.03 18.38 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 170.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.69 -173.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.61 2.873 . . . . 0.0 114.049 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -117.63 89.99 3.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 108.594 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 6.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 119.208 3.04 . . . . 0.0 119.208 -169.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -59.75 102.44 0.15 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 121.29 1.859 . . . . 0.0 108.736 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.36 21.81 31.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.485 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.98 -40.69 89.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-N 118.599 1.199 . . . . 0.0 109.4 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.06 98.71 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -16.06 9.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.506 2.003 . . . . 0.0 111.569 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -71.48 136.19 47.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 117.987 0.893 . . . . 0.0 110.409 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -71.4 67.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.598 1.559 . . . . 0.0 111.794 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 62.54 -149.86 0.36 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.314 1.046 . . . . 0.0 111.621 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.84 80.99 0.18 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 123.155 0.407 . . . . 0.0 113.173 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 t -150.32 21.02 0.85 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -68.12 143.14 95.73 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.29 153.9 20.58 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.39 1.393 . . . . 0.0 114.012 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 47.47 65.24 1.32 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.25 1.82 . . . . 0.0 112.875 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -158.7 120.93 3.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.137 0.494 . . . . 0.0 110.607 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -75.21 78.12 2.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.37 1.068 . . . . 0.0 110.7 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -67.41 178.19 1.65 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.884 0.474 . . . . 0.0 111.315 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -112.15 174.91 5.66 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.735 1.214 . . . . 0.0 109.663 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.28 -39.49 87.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.298 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.1 p -65.89 -62.72 1.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.677 1.227 . . . . 0.0 110.835 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -61.75 -21.25 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.087 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.01 -47.92 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.73 64.17 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.134 0.974 . . . . 0.0 111.014 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.73 -51.54 48.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.944 0.897 . . . . 0.0 108.751 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.39 90.8 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.54 -39.59 73.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -71.98 -7.78 50.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.46 9.57 43.73 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.373 0.987 . . . . 0.0 113.054 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -74.46 142.21 44.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.186 1.493 . . . . 0.0 109.204 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.87 135.03 41.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.923 1.289 . . . . 0.0 107.682 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -64.14 128.47 35.95 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -113.87 167.3 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.868 1.667 . . . . 0.0 106.806 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -52.65 45.3 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.949 0.88 . . . . 0.0 109.834 172.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.76 -48.3 82.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.547 -176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -63.69 -41.4 98.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.491 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.48 -53.2 47.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.62 -47.07 67.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.495 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -61.43 -54.93 37.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.751 0.31 . . . . 0.0 110.751 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -55.13 -42.18 72.67 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.456 -0.777 . . . . 0.0 111.925 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.68 -28.1 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.241 0.616 . . . . 0.0 111.506 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -90.25 -31.78 16.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.555 0.742 . . . . 0.0 111.067 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.61 69.17 72.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 124.664 1.186 . . . . 0.0 112.518 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -67.28 153.9 75.74 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.07 -64.38 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.06 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.854 1.262 . . . . 0.0 110.317 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -52.67 -50.37 63.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.948 0.499 . . . . 0.0 111.402 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.29 -49.5 69.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.622 -0.674 . . . . 0.0 109.824 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -51.14 -48.37 61.82 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.118 0.567 . . . . 0.0 111.341 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -43.49 -54.64 4.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.118 0.967 . . . . 0.0 111.553 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -84.26 -50.8 7.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.959 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -76.13 -23.05 54.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.961 0.904 . . . . 0.0 113.436 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 44.74 63.65 1.63 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.653 1.981 . . . . 0.0 111.725 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -150.29 137.34 19.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -52.13 -38.7 58.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.977 0.911 . . . . 0.0 110.646 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -82.44 13.07 3.86 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.65 61.2 4.25 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.235 -0.915 . . . . 0.0 109.178 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.78 -174.55 2.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.823 1.249 . . . . 0.0 110.057 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -152.57 151.7 30.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.72 -13.05 71.41 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.561 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 3.1 ttp -69.75 78.9 0.44 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 118.166 0.983 . . . . 0.0 113.21 -177.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.56 56.83 2.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -164.21 144.6 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.869 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -152.7 171.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 tp -144.73 113.56 6.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.55 41.44 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.065 0.546 . . . . 0.0 111.367 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 pttp 179.71 178.87 0.53 Allowed 'General case' 0 C--O 1.231 0.11 0 C-N-CA 127.61 2.364 . . . . 0.0 105.793 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.98 -52.96 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 119.038 -0.868 . . . . 0.0 113.184 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.4 -54.01 0.09 OUTLIER Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.221 2.343 . . . . 0.0 115.102 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -64.96 -45.04 87.39 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.032 0.916 . . . . 0.0 111.578 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.38 -47.69 78.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 108.839 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.22 -43.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.872 1.269 . . . . 0.0 109.603 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.98 88.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.954 -0.466 . . . . 0.0 110.219 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.12 -52.45 65.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.1 mt -55.59 -48.01 75.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.053 0.541 . . . . 0.0 110.718 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.87 -40.05 69.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 110.75 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 m -77.52 -14.05 59.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 t -87.05 -38.19 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 108.737 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.55 66.73 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.742 -0.599 . . . . 0.0 109.859 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? . . . . . 0 C--O 1.251 1.136 0 CA-C-O 115.969 -1.967 . . . . 0.0 109.73 -177.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . 0.561 ' CHD' ' HG3' ' A' ' 96' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.104 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.12 82.54 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.899 -0.765 . . . . 0.0 109.293 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -45.1 -40.37 6.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 112.313 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.95 81.25 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.283 0.633 . . . . 0.0 111.165 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -64.46 -43.68 93.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.34 -48.57 33.42 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.8 1.19 . . . . 0.0 111.526 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.01 -54.61 36.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.716 0.758 . . . . 0.0 110.213 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.67 -48.39 81.86 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.888 -0.508 . . . . 0.0 110.662 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -56.54 -33.82 66.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.876 1.271 . . . . 0.0 110.821 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.13 -21.05 7.72 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.041 0.937 . . . . 0.0 111.615 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -46.2 -36.25 5.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.846 0.748 . . . . 0.0 110.754 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -69.09 -57.88 4.83 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.59 -40.51 52.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.257 1.023 . . . . 0.0 111.292 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -45.22 -35.3 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.552 2.341 . . . . 0.0 112.394 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 m -55.16 -29.88 58.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.588 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.6 m -123.36 -27.2 4.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.517 1.127 . . . . 0.0 113.387 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.1 167.94 11.32 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.539 1.136 . . . . 0.0 112.639 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 p -145.57 168.49 20.5 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.202 1.801 . . . . 0.0 109.562 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mp -136.04 107.73 7.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 tt -129.04 137.31 57.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 124.212 1.005 . . . . 0.0 110.548 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 152.52 92.86 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.42 -40.06 44.59 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.438 2.759 . . . . 0.0 113.497 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.69 -13.31 61.99 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.798 1.239 . . . . 0.0 113.802 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.07 -7.29 29.08 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.703 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.8 m -61.15 102.34 0.21 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.002 1.901 . . . . 0.0 109.299 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.66 76.37 5.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.844 2.058 . . . . 0.0 111.471 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.49 -46.71 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.292 0.637 . . . . 0.0 109.381 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.43 106.79 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -75.38 55.41 0.79 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.737 1.615 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.6 -174.33 30.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.21 0.91 . . . . 0.0 111.2 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.58 -174.69 5.12 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.804 0.811 . . . . 0.0 112.046 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.51 28.27 3.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 110.242 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 m -61.67 -35.09 76.97 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.04 162.87 12.45 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 169.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -55.4 153.1 29.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.592 2.195 . . . . 0.0 113.441 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -66.03 127.45 32.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.76 16.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -63.43 87.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.243 0.929 . . . . 0.0 110.045 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.75 46.67 5.63 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.11 -31.65 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.77 118.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.711 0.804 . . . . 0.0 108.862 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.91 -10.18 74.74 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.024 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.85 136.78 53.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.44 1.12 . . . . 0.0 109.327 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -62.53 135.39 57.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.52 131.3 45.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.757 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.03 35.22 61.27 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.562 -1.132 . . . . 0.0 113.764 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.1 p -136.33 2.68 2.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.123 1.461 . . . . 0.0 114.644 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.35 128.01 90.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.409 1.459 . . . . 0.0 107.106 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -54.57 157.85 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.901 2.401 . . . . 0.0 114.479 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 49.97 66.19 1.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.373 1.869 . . . . 0.0 112.415 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -164.44 123.78 1.92 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.815 0.446 . . . . 0.0 109.868 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -79.93 93.79 5.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.041 0.936 . . . . 0.0 109.922 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -77.97 -170.24 1.85 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.649 0.738 . . . . 0.0 110.662 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -117.08 172.44 7.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.291 1.836 . . . . 0.0 108.495 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.58 -36.71 84.69 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.979 0.912 . . . . 0.0 113.383 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -60.99 -65.76 0.64 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 111.089 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.21 -37.96 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.37 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -48.04 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.73 91.65 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.652 0.66 . . . . 0.0 111.141 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -48.36 73.69 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.57 28.16 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.13 -27.79 55.36 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.629 1.572 . . . . 0.0 112.282 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -68.03 -4.6 13.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.77 35.8 4.19 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 125.32 1.438 . . . . 0.0 110.52 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -103.39 124.19 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 117.408 0.604 . . . . 0.0 110.957 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.58 130.25 56.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.154 1.782 . . . . 0.0 107.603 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -60.74 143.62 54.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 118.177 0.444 . . . . 0.0 110.613 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.0 p -128.27 170.13 13.4 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.004 1.722 . . . . 0.0 106.917 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -58.59 -45.23 89.55 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 122.978 0.511 . . . . 0.0 110.606 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.36 -46.9 75.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.576 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.27 -46.68 87.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.99 -52.74 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -47.31 69.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.616 0.367 . . . . 0.0 110.277 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.6 m -64.37 -44.23 92.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.815 -0.553 . . . . 0.0 110.829 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -55.75 -53.47 56.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.063 0.945 . . . . 0.0 111.286 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 m -56.99 -40.13 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.593 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -65.04 -24.55 67.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -158.02 73.35 4.04 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.732 1.151 . . . . 0.0 113.005 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.13 146.74 79.71 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.522 2.148 . . . . 0.0 110.636 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.9 -64.18 4.35 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.78 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 117.318 0.559 . . . . 0.0 110.297 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -51.78 -51.23 57.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.959 0.504 . . . . 0.0 111.656 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.41 -56.39 16.61 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.321 0.648 . . . . 0.0 109.296 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -46.58 -46.4 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.499 1.12 . . . . 0.0 110.747 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -51.88 -40.53 60.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.043 0.937 . . . . 0.0 111.973 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -90.9 -45.68 8.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.305 0.642 . . . . 0.0 112.129 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 -17.87 39.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.472 1.109 . . . . 0.0 113.189 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 48.25 62.66 2.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.399 1.88 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -143.76 150.14 38.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.679 1.592 . . . . 0.0 108.926 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -66.97 -48.33 68.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 108.432 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -80.3 11.58 3.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.03 -1.441 . . . . 0.0 114.619 -173.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.41 63.58 6.65 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.691 -1.256 . . . . 0.0 110.517 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -102.52 170.45 8.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.197 0.999 . . . . 0.0 109.942 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -131.7 154.07 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.61 -12.44 64.15 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.566 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 4.0 ttp -67.97 79.75 0.22 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 56.6 2.66 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.572 0.749 . . . . 0.0 110.122 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -154.28 116.06 4.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.839 1.256 . . . . 0.0 108.712 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -100.94 -179.14 3.97 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.6 156.89 47.94 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.49 53.32 0.8 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? 75.66 164.12 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.875 1.67 . . . . 0.0 110.619 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.98 -15.22 33.85 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.05 -35.62 33.36 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.425 1.488 . . . . 0.0 112.29 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.65 -47.37 86.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 117.518 0.659 . . . . 0.0 110.586 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -64.32 -44.39 91.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.42 -47.1 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.5 -48.14 77.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.955 -0.466 . . . . 0.0 109.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.18 -46.09 79.5 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -57.0 -51.23 70.06 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.073 -0.392 . . . . 0.0 110.869 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.37 -43.58 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.848 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.67 91.61 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.325 -0.234 . . . . 0.0 110.964 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.5 m -69.85 -50.05 46.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.603 ' CG1' ' H ' ' A' ' 115' ' ' VAL . 11.4 p -59.68 -81.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.603 ' H ' ' CG1' ' A' ' 114' ' ' VAL . 7.2 p 8.28 70.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 129.722 3.209 . . . . 0.0 113.655 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.237 0 CA-C-O 113.901 -2.952 . . . . 0.0 104.203 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . 0.566 ' CHD' ' HG3' ' A' ' 96' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.89 74.59 0.62 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.62 1.168 . . . . 0.0 111.449 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.39 -40.64 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.509 1.124 . . . . 0.0 112.618 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.54 85.79 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.733 -0.604 . . . . 0.0 111.044 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -63.98 -38.16 90.06 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.67 -48.35 82.16 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.19 -49.81 72.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.74 0.816 . . . . 0.0 109.736 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.7 -48.33 82.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.435 0.16 . . . . 0.0 110.691 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.15 -34.56 68.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.491 1.116 . . . . 0.0 110.464 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.98 -16.67 7.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.958 0.903 . . . . 0.0 112.564 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -51.28 -30.84 19.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.449 0.7 . . . . 0.0 110.387 172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -76.96 -59.02 2.95 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.62 -0.675 . . . . 0.0 109.349 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.9 m -45.36 -47.68 13.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.768 1.627 . . . . 0.0 111.961 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -51.02 -26.27 5.92 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.924 1.29 . . . . 0.0 113.805 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -58.6 -40.57 83.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.472 0.578 . . . . 0.0 109.56 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.1 m -99.39 -48.69 4.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.419 1.088 . . . . 0.0 112.133 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -84.07 176.83 8.55 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.159 0.983 . . . . 0.0 112.473 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.4 m -147.98 159.23 44.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.818 0.847 . . . . 0.0 108.764 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -142.93 122.19 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.36 130.52 60.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 O-C-N 121.86 -0.525 . . . . 0.0 110.009 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.04 158.87 60.36 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.98 -39.25 79.74 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.269 2.646 . . . . 0.0 112.53 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.7 -8.6 55.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.375 1.47 . . . . 0.0 113.717 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.49 -13.25 51.07 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -59.92 114.81 3.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.66 1.73 . . . . 0.0 109.677 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.24 118.74 11.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.467 0.707 . . . . 0.0 109.949 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 mm -89.86 -42.52 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.9 t -141.19 129.58 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -127.6 74.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.69 -168.4 3.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.28 44.22 1.01 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.977 -1.307 . . . . 0.0 110.11 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 tptp 13.79 57.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 130.648 3.579 . . . . 0.0 113.79 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -89.48 -30.95 17.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.69 0.796 . . . . 0.0 108.915 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.5 170.27 13.98 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.84 167.22 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 112.21 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.49 125.7 30.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -92.9 4.43 53.92 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -67.55 87.15 0.2 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.296 0.953 . . . . 0.0 109.483 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.05 23.14 5.66 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.947 0.784 . . . . 0.0 111.577 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.91 -42.73 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.519 1.16 . . . . 0.0 110.05 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.63 114.44 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.11 63.56 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.013 1.292 . . . . 0.0 111.654 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -68.92 138.61 54.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.6 1.2 . . . . 0.0 109.897 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 m -67.4 70.4 0.11 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.781 1.632 . . . . 0.0 111.508 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.53 -144.91 0.64 Allowed 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.875 -0.516 . . . . 0.0 110.232 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.62 73.73 0.61 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.514 1.054 . . . . 0.0 112.645 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.4 p -138.81 2.73 2.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.239 1.015 . . . . 0.0 111.922 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -62.22 132.9 94.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.57 161.67 11.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.151 1.9 . . . . 0.0 114.006 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 57.55 58.64 3.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.794 1.638 . . . . 0.0 112.916 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -165.88 123.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.746 0.418 . . . . 0.0 110.488 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.24 88.93 4.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.976 0.91 . . . . 0.0 109.553 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.91 -174.17 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.521 0.677 . . . . 0.0 111.455 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -106.12 -178.46 3.66 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.492 1.517 . . . . 0.0 108.322 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.65 -38.03 67.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.713 0.805 . . . . 0.0 112.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -60.74 -63.06 1.43 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 111.078 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.54 -35.65 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.9 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.55 -48.27 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.91 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 110.586 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.3 tp -55.77 -49.65 72.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.45 -52.75 48.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.84 -36.83 65.46 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.2 1.0 . . . . 0.0 112.591 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -67.32 -11.58 57.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.89 10.92 15.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.889 1.233 . . . . 0.0 112.595 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -77.0 141.27 40.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.739 1.27 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.51 34.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.454 1.501 . . . . 0.0 107.923 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -62.54 143.26 57.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.33 166.45 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.035 1.734 . . . . 0.0 106.596 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.98 -43.76 77.91 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.304 0.573 . . . . 0.0 110.775 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.62 -47.69 68.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.102 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.11 -46.05 90.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.252 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.3 mt -57.22 -54.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.69 -46.13 29.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.636 0.774 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -63.43 -65.32 0.7 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.255 0.622 . . . . 0.0 110.472 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -43.38 -48.83 7.06 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.011 1.724 . . . . 0.0 112.811 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 t -53.2 -25.73 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.64 14.87 15.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.601 1.091 . . . . 0.0 112.32 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -159.37 56.79 0.95 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.576 1.15 . . . . 0.0 111.904 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -66.82 157.39 61.55 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 108.75 -1.288 . . . . 0.0 108.75 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 -66.82 3.04 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.04 -47.68 53.22 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.411 1.084 . . . . 0.0 111.342 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -51.59 -52.39 47.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.64 -56.2 24.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.622 1.169 . . . . 0.0 109.73 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.02 -47.62 44.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.575 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -63.95 -66.96 0.47 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.467 0.707 . . . . 0.0 110.369 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -53.99 -39.81 66.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.7 tp -92.24 -0.41 57.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.938 0.895 . . . . 0.0 111.982 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 43.45 58.39 3.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.327 1.451 . . . . 0.0 109.94 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -143.68 157.88 44.08 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 124.305 1.042 . . . . 0.0 110.836 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -92.41 -50.22 5.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.272 1.829 . . . . 0.0 108.115 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -79.53 42.2 0.51 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.89 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.37 90.94 3.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -131.46 132.72 44.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.054 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.92 154.48 19.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.12 -16.9 62.86 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttp -64.96 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.244 1.022 . . . . 0.0 113.309 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.56 59.21 4.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -160.43 150.72 18.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.329 1.851 . . . . 0.0 107.426 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -143.81 164.23 31.1 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.846 1.259 . . . . 0.0 107.812 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.88 169.38 9.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.92 37.51 4.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -147.33 170.52 17.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.217 1.807 . . . . 0.0 106.172 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.75 -10.05 57.41 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.874 -0.959 . . . . 0.0 112.622 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.67 13.56 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 118.708 1.254 . . . . 0.0 113.889 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -61.71 -46.1 91.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.362 1.081 . . . . 0.0 109.452 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -55.28 -52.61 62.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.296 1.438 . . . . 0.0 110.57 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.21 -46.2 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.451 1.101 . . . . 0.0 110.184 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.37 90.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.148 -0.345 . . . . 0.0 110.376 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.25 99.17 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.499 0.319 . . . . 0.0 110.309 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -57.66 -52.26 66.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.7 -44.13 90.26 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.854 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.35 76.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.5 m -61.58 -38.13 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.012 -0.43 . . . . 0.0 111.094 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -37.06 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.855 -0.528 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t -69.88 94.07 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.305 1.042 . . . . 0.0 110.235 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.0 pttm . . . . . 0 C--O 1.253 1.253 0 CA-C-O 115.229 -2.32 . . . . 0.0 107.436 175.88 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 N-CA-C 114.043 0.377 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.69 72.48 0.77 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.461 1.505 . . . . 0.0 111.506 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.1 -39.97 10.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.679 1.191 . . . . 0.0 112.591 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.26 94.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.541 0.736 . . . . 0.0 111.452 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.38 -43.6 69.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.86 -44.61 40.34 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.99 -46.13 71.64 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 111.659 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -71.36 -47.99 52.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.659 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -57.62 -30.66 65.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.935 0.894 . . . . 0.0 110.719 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.67 -16.46 4.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.618 1.167 . . . . 0.0 112.144 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -53.52 -33.22 53.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.333 0.969 . . . . 0.0 111.087 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -72.85 -26.64 61.54 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.77 -0.581 . . . . 0.0 111.391 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.9 m -77.4 -45.62 25.31 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -46.23 -32.88 3.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 111.904 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -53.0 -31.31 40.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.121 0.968 . . . . 0.0 111.76 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -120.2 -38.34 2.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.487 1.515 . . . . 0.0 112.366 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -103.7 -173.47 2.32 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 125.634 1.574 . . . . 0.0 111.386 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -157.24 168.48 27.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.408 1.483 . . . . 0.0 109.01 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 133.07 54.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.06 1.744 . . . . 0.0 106.692 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -111.6 149.74 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.653 1.981 . . . . 0.0 109.16 -175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 161.95 48.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.76 -36.99 27.28 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.592 2.861 . . . . 0.0 112.124 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.09 13.68 0.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.996 1.718 . . . . 0.0 113.325 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.44 31.98 60.42 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.664 1.125 . . . . 0.0 111.656 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -112.2 126.24 55.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -63.44 121.82 14.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.538 0.335 . . . . 0.0 110.469 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.1 mm -98.62 -60.18 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.67 77.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.62 70.61 0.19 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.749 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.42 -158.17 30.76 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 173.82 11.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.9 33.06 5.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.468 1.107 . . . . 0.0 108.977 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.7 m -69.38 -38.12 77.88 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.7 165.27 12.03 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -59.45 141.66 97.81 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.891 3.061 . . . . 0.0 111.199 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.07 119.4 7.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -85.86 15.91 4.51 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -170.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -75.54 80.41 2.56 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.563 -1.335 . . . . 0.0 109.442 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.93 46.35 0.34 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.127 0.87 . . . . 0.0 113.453 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.89 -48.43 33.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 t -53.52 112.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.786 0.835 . . . . 0.0 110.431 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 -15.68 61.39 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.922 1.249 . . . . 0.0 113.058 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -68.12 140.56 56.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.94 1.37 . . . . 0.0 110.789 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 m -70.2 72.73 0.46 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 110.611 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.07 -139.47 1.02 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.942 0.497 . . . . 0.0 109.707 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.96 77.51 1.13 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 123.731 0.682 . . . . 0.0 112.536 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 p -136.21 16.36 3.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.713 0.805 . . . . 0.0 112.121 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -67.08 141.81 96.73 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.022 -1.049 . . . . 0.0 108.928 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.37 155.98 23.18 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.279 1.319 . . . . 0.0 113.916 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 46.73 62.57 2.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.475 1.51 . . . . 0.0 113.587 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -158.44 120.5 3.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.867 -0.52 . . . . 0.0 110.023 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -73.49 82.18 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.446 0.698 . . . . 0.0 110.495 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.11 169.69 11.45 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.165 0.507 . . . . 0.0 110.513 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -96.52 175.58 6.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.87 -35.78 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.272 0.629 . . . . 0.0 112.635 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -59.24 -66.47 0.5 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.228 1.411 . . . . 0.0 111.173 -174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 tt -58.1 -37.94 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.806 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.11 -49.41 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.55 87.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.923 0.329 . . . . 0.0 110.711 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -47.26 84.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.58 -56.65 22.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 173.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.93 -32.61 54.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.08 1.352 . . . . 0.0 113.387 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.7 p -66.68 -12.97 60.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.86 0.755 . . . . 0.0 112.056 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.73 33.43 1.88 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.398 1.475 . . . . 0.0 110.861 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -96.11 143.61 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.787 0.794 . . . . 0.0 109.532 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.44 128.59 31.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -61.01 99.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.016 0.526 . . . . 0.0 111.831 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.4 p -83.19 167.85 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -58.17 -37.81 75.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.045 0.45 . . . . 0.0 109.846 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -64.41 -49.57 71.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -56.88 -52.74 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.15 -53.53 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.59 -46.28 63.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.499 0.72 . . . . 0.0 111.184 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.9 m -66.88 -54.91 17.56 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -51.78 -42.82 62.71 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.413 1.085 . . . . 0.0 113.068 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.6 t -53.98 -31.67 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.118 0.567 . . . . 0.0 111.519 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -105.6 14.13 28.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.28 1.432 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -161.21 49.16 0.26 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.269 1.027 . . . . 0.0 111.809 -175.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -56.16 136.08 73.27 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.67 2.914 . . . . 0.0 110.04 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.63 -55.39 2.08 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.55 -0.583 . . . . 0.0 111.959 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 -38.55 68.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.501 1.151 . . . . 0.0 111.26 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -63.46 -44.74 93.6 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 110.721 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.97 -54.72 41.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.702 0.801 . . . . 0.0 108.941 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -47.8 -48.46 30.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.881 1.272 . . . . 0.0 110.244 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -61.03 -68.43 0.31 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.056 0.942 . . . . 0.0 110.513 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.27 -37.04 81.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 tp -85.86 -3.69 58.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.6 0.76 . . . . 0.0 111.344 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 t0 44.13 54.2 6.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.435 1.494 . . . . 0.0 110.017 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -145.95 119.24 8.94 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.534 0.734 . . . . 0.0 111.85 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.94 -32.23 69.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.241 1.016 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -80.51 4.93 16.7 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.39 65.28 6.46 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.485 -0.76 . . . . 0.0 111.355 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.54 136.83 32.81 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.382 -0.824 . . . . 0.0 109.253 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.6 t -87.91 155.13 20.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.36 -25.31 72.48 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 21.2 ttp -65.44 82.63 0.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.976 0.888 . . . . 0.0 112.324 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 58.29 3.24 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -163.61 145.93 9.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.328 1.851 . . . . 0.0 107.044 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.84 155.14 46.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.9 109.54 13.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.38 46.72 0.76 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.532 -0.73 . . . . 0.0 111.669 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? 175.59 -165.63 0.03 OUTLIER 'General case' 0 C--O 1.231 0.117 0 C-N-CA 128.091 2.556 . . . . 0.0 106.225 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.22 -59.01 3.63 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.993 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -4.77 -70.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.372 2.891 . . . . 0.0 115.294 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.23 -57.22 13.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.181 0.992 . . . . 0.0 112.639 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.64 -35.18 80.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.092 0.557 . . . . 0.0 110.904 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.92 -46.55 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.281 0.632 . . . . 0.0 109.632 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.34 94.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.889 -0.507 . . . . 0.0 109.702 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -43.46 86.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -59.2 -51.47 69.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.8 mt -56.46 -38.23 71.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.792 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.78 -52.46 60.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.152 0.887 . . . . 0.0 109.573 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.6 m -53.88 -34.88 60.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 112.618 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.14 -30.82 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.863 1.265 . . . . 0.0 111.697 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 t -69.07 82.78 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.064 0.847 . . . . 0.0 110.482 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.353 0 C-N-CA 127.532 2.333 . . . . 0.0 106.743 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -92.08 106.93 18.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.315 1.046 . . . . 0.0 108.498 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.72 -34.75 5.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.672 1.189 . . . . 0.0 112.476 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.04 74.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.761 0.71 . . . . 0.0 110.324 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.61 -38.52 87.94 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.49 -52.24 51.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.08 -49.15 77.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.232 0.613 . . . . 0.0 110.553 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -55.87 -50.92 69.32 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.4 -35.52 72.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.422 0.689 . . . . 0.0 109.951 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.87 -19.93 32.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -52.98 -31.82 42.82 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.604 0.638 . . . . 0.0 110.985 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -52.72 6.06 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.06 -38.18 10.7 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.563 1.945 . . . . 0.0 113.645 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -52.43 -25.18 9.34 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.15 . . . . 0.0 112.817 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 m -61.91 -21.97 65.19 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.612 -0.68 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -119.16 -38.76 3.0 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.85 0.86 . . . . 0.0 112.619 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.75 169.7 8.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 112.404 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.3 p -141.38 164.21 30.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.785 1.234 . . . . 0.0 111.272 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.43 119.05 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -139.5 133.63 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.229 0.612 . . . . 0.0 110.86 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 162.85 63.03 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.83 -37.82 95.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.14 2.56 . . . . 0.0 112.394 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.25 -15.94 58.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.979 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.2 -3.11 56.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.41 110.96 2.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.6 114.57 13.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.888 0.875 . . . . 0.0 111.48 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.0 -45.16 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.7 t -135.2 103.31 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -76.96 54.79 1.05 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.781 1.232 . . . . 0.0 109.043 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.19 -176.4 50.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.21 177.94 6.12 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.327 0.584 . . . . 0.0 110.923 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -125.95 39.88 3.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.09 0.956 . . . . 0.0 109.368 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.2 m -65.57 -34.65 78.74 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.36 13.42 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 168.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.46 173.24 0.76 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.444 2.096 . . . . 0.0 113.494 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -83.32 135.09 34.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.77 10.84 37.64 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -64.8 88.61 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.275 0.943 . . . . 0.0 109.478 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.91 40.94 5.11 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -72.58 -36.39 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.39 107.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.72 -13.51 50.19 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.308 1.432 . . . . 0.0 112.069 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -73.07 137.5 45.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.841 0.821 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -63.47 128.9 37.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.39 154.89 12.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.829 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.07 22.76 72.65 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.867 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.1 t -156.16 28.72 0.35 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.539 1.67 . . . . 0.0 113.416 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -72.26 129.35 87.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 167.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -45.49 154.7 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.166 2.577 . . . . 0.0 116.094 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 54.7 65.57 1.47 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.298 1.439 . . . . 0.0 112.605 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -166.83 125.42 1.39 Allowed 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.854 -0.529 . . . . 0.0 111.713 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -79.36 90.7 5.01 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.64 1.176 . . . . 0.0 109.66 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -73.55 -177.57 2.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.464 0.705 . . . . 0.0 112.509 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -105.55 -178.03 3.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.004 1.322 . . . . 0.0 108.167 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.32 -37.17 66.25 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.512 -0.742 . . . . 0.0 112.792 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -62.24 -66.2 0.57 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.506 1.122 . . . . 0.0 111.167 -173.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -55.5 -38.09 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.897 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.01 -43.58 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 O-C-N 121.813 -0.555 . . . . 0.0 109.512 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.8 87.74 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.299 0.5 . . . . 0.0 110.318 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.04 -52.43 65.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.15 -48.29 10.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.096 1.331 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.14 29.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.237 1.415 . . . . 0.0 113.819 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -73.3 -0.5 14.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.471 1.032 . . . . 0.0 112.183 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 33.88 9.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -79.19 80.82 5.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.069 -0.665 . . . . 0.0 110.916 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.14 115.0 11.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.002 1.321 . . . . 0.0 107.865 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -56.3 146.77 22.89 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 109.259 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.2 p -127.18 164.0 22.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.08 -40.65 73.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.069 0.548 . . . . 0.0 110.213 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.61 -52.42 57.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.317 0.647 . . . . 0.0 110.604 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -61.03 -45.48 94.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.56 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.8 mm -56.18 -53.7 36.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.34 -47.16 66.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.678 0.391 . . . . 0.0 110.612 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 m -62.35 -55.49 27.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.21 0.528 . . . . 0.0 110.454 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.39 -44.63 45.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.331 1.453 . . . . 0.0 112.143 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.4 t -54.26 -30.5 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.41 0.684 . . . . 0.0 111.906 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -95.37 -26.38 15.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.616 0.766 . . . . 0.0 111.37 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -127.43 63.7 59.78 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 125.204 1.402 . . . . 0.0 112.693 -171.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.77 143.27 60.87 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.779 1.653 . . . . 0.0 108.809 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -63.57 3.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.25 -45.22 44.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.688 1.195 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -54.85 -53.03 60.61 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.686 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.6 -53.48 57.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.123 -0.361 . . . . 0.0 110.32 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -47.64 -50.6 24.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.98 0.912 . . . . 0.0 110.491 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.0 -58.32 6.35 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.01 0.524 . . . . 0.0 111.025 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -67.45 -51.47 51.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.86 -25.59 40.66 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.755 1.222 . . . . 0.0 114.219 -172.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.81 55.51 7.75 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.405 1.482 . . . . 0.0 109.892 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -136.21 135.92 39.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.248 1.419 . . . . 0.0 109.543 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.88 -41.35 97.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.411 1.084 . . . . 0.0 111.107 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -85.69 18.76 2.71 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 70.41 4.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.442 0.697 . . . . 0.0 110.444 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -113.41 128.46 56.46 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.54 1.536 . . . . 0.0 109.121 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.2 t -82.18 158.52 23.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.65 -19.85 69.53 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.539 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 26.5 ttp -68.76 82.72 0.29 Allowed 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.996 -0.708 . . . . 0.0 112.797 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.62 3.09 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -160.21 149.73 17.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.168 1.787 . . . . 0.0 108.084 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -156.3 172.57 18.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.142 1.377 . . . . 0.0 108.861 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -143.29 115.72 8.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.031 1.332 . . . . 0.0 107.625 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.48 45.58 0.78 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.665 -0.647 . . . . 0.0 111.868 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? 175.04 -172.22 0.06 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 128.301 2.64 . . . . 0.0 105.705 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.37 -52.49 2.25 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.686 -1.064 . . . . 0.0 113.523 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -24.84 -55.1 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.179 2.323 . . . . 0.0 114.997 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -62.14 -52.38 64.1 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.526 0.73 . . . . 0.0 111.493 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.72 -48.35 79.82 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.5 1.12 . . . . 0.0 109.456 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.22 -46.38 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.653 1.181 . . . . 0.0 109.697 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.71 87.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.874 -0.516 . . . . 0.0 110.07 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.8 93.91 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -58.5 -50.41 73.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.979 -0.45 . . . . 0.0 110.534 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.94 -46.13 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.954 0.902 . . . . 0.0 110.434 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.7 78.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.021 0.528 . . . . 0.0 110.556 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -69.07 -38.71 79.18 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.964 -0.46 . . . . 0.0 111.07 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -42.49 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 125.329 1.452 . . . . 0.0 111.46 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.46 80.48 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.069 0.937 . . . . 0.0 110.363 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.3 pttm . . . . . 0 C--O 1.253 1.271 0 C-N-CA 128.178 2.591 . . . . 0.0 106.953 179.181 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . 0.539 ' CHD' ' HG3' ' A' ' 96' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 121.798 0.665 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -73.67 80.59 1.53 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.863 -0.786 . . . . 0.0 111.152 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.52 63.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.9 0.88 . . . . 0.0 111.741 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.15 74.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.635 0.374 . . . . 0.0 110.407 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -63.87 -44.56 92.71 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -48.05 -45.53 26.56 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.13 0.871 . . . . 0.0 112.001 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -54.05 -47.22 71.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.285 0.634 . . . . 0.0 110.938 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -69.19 -44.74 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.491 ' OE1' HBB2 ' A' ' 117' ' ' HEC . 2.0 tm-20 -52.94 -34.93 57.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.207 1.403 . . . . 0.0 109.641 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.52 -20.34 2.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.02 -27.67 33.45 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.816 -0.553 . . . . 0.0 111.456 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.35 -55.04 5.74 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.01 -42.82 29.12 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.993 1.317 . . . . 0.0 112.33 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -57.32 -21.07 32.67 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -54.52 -32.63 58.51 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.731 -0.606 . . . . 0.0 110.288 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 m -112.48 -44.35 3.37 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.338 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -90.84 -176.15 4.58 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 m -156.3 165.41 36.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.147 1.779 . . . . 0.0 108.732 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.6 mt -131.95 126.86 57.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -118.85 135.75 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.322 1.449 . . . . 0.0 109.998 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.24 82.34 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 119.015 0.825 . . . . 0.0 108.973 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.07 -41.25 73.19 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.16 2.573 . . . . 0.0 112.561 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -72.66 -10.96 60.42 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.172 1.389 . . . . 0.0 113.407 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.85 -17.15 35.96 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.023 -0.876 . . . . 0.0 113.443 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.8 m -60.71 116.32 4.31 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.522 1.661 . . . . 0.0 109.923 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -64.4 122.17 16.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.822 0.449 . . . . 0.0 110.341 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.44 -52.15 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.45 97.98 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -78.11 70.14 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.825 1.25 . . . . 0.0 107.801 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.39 -151.34 27.4 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.58 -179.33 5.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -123.51 22.45 9.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 108.89 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -30.13 70.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.225 1.01 . . . . 0.0 108.998 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.18 172.08 14.49 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.7 175.05 0.64 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 124.108 3.205 . . . . 0.0 113.307 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -105.4 81.77 1.74 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.055 0.942 . . . . 0.0 111.086 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mp -37.32 -0.91 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.542 1 C-N-CA 133.424 4.689 . . . . 0.0 121.464 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -69.07 80.86 0.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 121.058 1.754 . . . . 0.0 110.049 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.22 32.76 0.95 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.903 -0.943 . . . . 0.0 115.014 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.67 -49.12 81.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.7 1.75 . . . . 0.0 111.789 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.38 121.56 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 121.5 -0.75 . . . . 0.0 110.537 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.02 -19.21 54.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.744 1.164 . . . . 0.0 111.737 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -64.8 135.43 55.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.136 0.968 . . . . 0.0 110.042 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.2 m -73.15 80.75 1.27 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 51.68 -145.1 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.099 0.959 . . . . 0.0 110.963 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.0 78.81 0.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 124.82 1.2 . . . . 0.0 111.945 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.0 p -134.57 5.38 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.832 0.853 . . . . 0.0 111.805 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.06 134.99 93.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.07 164.75 9.76 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.486 2.124 . . . . 0.0 114.426 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.98 52.95 7.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.846 1.658 . . . . 0.0 112.057 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -161.49 118.42 2.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.991 -0.443 . . . . 0.0 111.81 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -78.77 79.9 5.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.064 0.946 . . . . 0.0 109.599 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -64.31 163.88 12.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.958 0.503 . . . . 0.0 111.385 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -96.47 176.39 6.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.144 0.973 . . . . 0.0 110.986 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.15 -36.62 73.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.804 1.641 . . . . 0.0 113.584 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 p -64.07 -67.61 0.42 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.029 0.919 . . . . 0.0 109.823 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 tt -59.25 -33.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.64 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.99 -50.89 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.637 -0.664 . . . . 0.0 109.663 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -40.3 82.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.416 0.553 . . . . 0.0 110.283 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -57.42 -44.33 84.55 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.86 -49.21 80.38 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.19 -35.47 64.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.335 0.568 . . . . 0.0 111.719 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.1 p -76.34 5.92 6.36 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 30.65 36.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.362 0.982 . . . . 0.0 112.33 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -74.99 82.61 2.22 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.77 -0.841 . . . . 0.0 112.296 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.81 107.97 5.52 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -52.35 116.48 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.627 0.771 . . . . 0.0 111.719 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.5 p -94.33 161.89 14.06 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.95 -38.0 81.16 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.91 -54.7 44.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.965 0.906 . . . . 0.0 109.249 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -58.44 -47.11 85.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.787 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -54.03 -53.65 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.67 62.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.008 0.523 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -60.07 -53.58 56.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -52.5 -44.56 65.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.191 0.996 . . . . 0.0 111.575 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.41 -20.15 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.096 0.958 . . . . 0.0 112.418 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -103.33 -14.11 16.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.561 1.144 . . . . 0.0 111.988 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -142.08 58.81 8.38 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.632 1.173 . . . . 0.0 111.929 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.67 135.62 70.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.109 2.539 . . . . 0.0 109.585 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.51 -59.04 4.11 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.562 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.25 -42.28 66.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.991 0.896 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -51.43 -59.62 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.366 1.066 . . . . 0.0 111.042 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.31 -50.17 73.79 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.245 1.018 . . . . 0.0 110.935 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -59.69 -35.95 75.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 110.264 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.79 -59.93 2.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.625 0.77 . . . . 0.0 109.188 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -54.44 -44.99 72.96 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.75 0.23 56.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.962 0.505 . . . . 0.0 111.738 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 46.73 49.94 13.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.203 1.401 . . . . 0.0 110.666 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -138.23 117.18 12.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.455 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -51.64 -37.34 49.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.554 1.142 . . . . 0.0 111.272 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -89.14 4.34 48.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.88 86.38 7.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -116.05 153.93 30.82 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.656 1.182 . . . . 0.0 110.228 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -97.27 157.29 16.03 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 123.904 0.882 . . . . 0.0 110.439 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.48 -19.99 79.21 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.6 ttt -65.02 81.68 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.521 1.128 . . . . 0.0 112.777 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 58.13 3.03 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.85 143.88 5.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.099 1.36 . . . . 0.0 108.877 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -141.24 166.87 23.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.554 1.542 . . . . 0.0 107.106 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.02 165.92 13.75 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.6 56.8 3.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.392 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 75.54 -172.11 0.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.839 2.055 . . . . 0.0 111.349 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.32 -78.37 1.93 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.22 -53.87 0.18 Allowed Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.99 1.281 . . . . 0.0 112.96 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -44.73 -37.88 4.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.397 1.879 . . . . 0.0 113.31 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -58.96 -48.13 82.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.412 0.685 . . . . 0.0 110.551 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.69 -39.71 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.32 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.303 -0.248 . . . . 0.0 110.629 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.52 95.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.558 0.743 . . . . 0.0 109.599 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.27 -51.01 69.73 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.49 -44.95 89.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.71 -0.619 . . . . 0.0 110.823 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.94 79.12 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.968 -0.457 . . . . 0.0 110.083 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -61.8 -41.09 97.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.634 0.373 . . . . 0.0 110.68 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.54 -31.23 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.752 0.821 . . . . 0.0 111.26 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.08 87.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.686 0.755 . . . . 0.0 109.133 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? . . . . . 0 C--O 1.253 1.281 0 C-N-CA 128.135 2.574 . . . . 0.0 106.887 178.286 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . 0.491 HBB2 ' OE1' ' A' ' 9' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.869 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.0 92.21 5.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.6 -40.88 20.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.894 0.877 . . . . 0.0 112.94 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.63 72.97 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.898 -0.502 . . . . 0.0 110.126 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.18 -39.64 90.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.75 -47.12 38.92 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.011 1.291 . . . . 0.0 111.255 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.94 -48.19 73.49 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.113 0.456 . . . . 0.0 110.237 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -65.34 -46.17 81.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.403 0.281 . . . . 0.0 110.373 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -57.28 -33.18 67.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.607 1.163 . . . . 0.0 110.261 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.89 -21.39 57.41 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -27.49 56.26 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.585 0.629 . . . . 0.0 109.82 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -80.58 -49.78 10.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.9 m -53.11 -41.92 65.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.701 0.801 . . . . 0.0 112.358 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -62.19 -11.5 14.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.6 m -59.05 -22.92 61.5 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.8 m -129.74 -46.25 1.16 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.885 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.82 -173.53 3.53 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.689 0.757 . . . . 0.0 112.976 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.4 m -159.89 167.99 26.8 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.504 1.922 . . . . 0.0 109.838 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.8 mm -140.73 126.07 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.416 1.487 . . . . 0.0 108.508 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 tp -120.78 136.73 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.898 1.279 . . . . 0.0 109.244 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.11 47.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.273 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.96 -34.53 92.34 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.961 2.44 . . . . 0.0 110.696 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.83 14.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.988 1.715 . . . . 0.0 112.821 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.01 63.16 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.975 -1.078 . . . . 0.0 111.832 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -107.99 123.36 48.53 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.51 114.9 5.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.809 0.444 . . . . 0.0 111.355 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.42 -43.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.98 97.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -81.63 66.85 7.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.85 174.56 54.21 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.31 72.75 7.18 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.802 -0.822 . . . . 0.0 109.033 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -40.87 71.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.963 3.705 . . . . 0.0 114.478 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -100.56 -27.33 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.701 2.4 . . . . 0.0 108.261 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.94 173.11 14.55 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.14 1.829 . . . . 0.0 108.736 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.46 171.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.604 3.536 . . . . 0.0 114.706 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -94.21 126.43 39.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.9 mt -97.22 7.4 46.66 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.31 82.66 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.928 1.24 . . . . 0.0 111.058 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.21 28.9 5.64 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.233 0.921 . . . . 0.0 113.145 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.22 -35.83 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 118.76 1.28 . . . . 0.0 108.652 171.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.08 115.23 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.799 0.839 . . . . 0.0 110.259 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.4 -14.83 62.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.069 1.319 . . . . 0.0 112.6 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -84.51 146.89 27.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.382 1.091 . . . . 0.0 111.213 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -60.12 132.12 52.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.854 0.862 . . . . 0.0 109.085 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.36 149.18 29.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.932 -0.48 . . . . 0.0 110.965 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 29.49 73.93 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.265 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.7 p -131.43 -6.96 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.073 1.437 . . . . 0.0 114.27 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -64.44 129.93 94.42 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.02 1.282 . . . . 0.0 108.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -59.66 166.68 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.282 1.988 . . . . 0.0 113.403 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 59.28 51.14 7.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.133 1.373 . . . . 0.0 112.021 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -164.14 120.43 1.62 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.86 87.29 6.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -70.0 -172.07 0.5 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.664 0.745 . . . . 0.0 111.405 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.33 157.94 22.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.732 1.613 . . . . 0.0 110.259 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -51.83 -36.02 46.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.7 1.2 . . . . 0.0 113.545 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -63.71 -66.77 0.5 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.076 0.95 . . . . 0.0 110.01 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -58.76 -35.77 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.486 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.57 -50.7 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.92 93.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.443 0.565 . . . . 0.0 110.602 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.54 -47.32 79.66 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.81 -55.33 28.19 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.445 1.022 . . . . 0.0 111.007 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.42 -31.44 55.17 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.782 1.233 . . . . 0.0 111.522 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -72.1 6.04 2.4 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.24 28.63 22.19 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.949 1.262 . . . . 0.0 111.646 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -80.74 82.5 6.72 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.868 -0.783 . . . . 0.0 111.356 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.55 120.33 20.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -65.29 107.59 1.66 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -86.66 165.44 16.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.07 -41.85 84.25 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.495 0.664 . . . . 0.0 109.6 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -60.09 -51.87 67.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.976 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -59.14 -49.92 76.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.9 mt -54.37 -53.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.2 -41.99 72.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.647 0.779 . . . . 0.0 111.564 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.74 -53.49 15.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.37 0.268 . . . . 0.0 110.522 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -45.88 -46.99 16.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.069 1.347 . . . . 0.0 113.588 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.6 -31.42 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -82.89 -14.99 53.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.158 0.983 . . . . 0.0 111.925 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -145.28 54.17 2.3 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.752 1.221 . . . . 0.0 112.693 -173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.41 141.17 94.94 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.253 1.969 . . . . 0.0 109.313 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.75 -63.8 3.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -48.69 -44.59 38.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 111.242 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -53.42 -54.47 36.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 110.445 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.23 -48.75 80.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.061 0.544 . . . . 0.0 110.377 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -54.64 -49.59 70.17 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.283 0.633 . . . . 0.0 110.757 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -50.01 -47.92 52.77 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.53 0.732 . . . . 0.0 111.234 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.27 -55.56 4.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.9 tp -74.93 -24.13 58.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.483 1.113 . . . . 0.0 113.69 -173.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 t0 52.23 56.78 7.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.717 1.607 . . . . 0.0 111.414 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -146.45 135.42 22.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.363 1.065 . . . . 0.0 108.198 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.116 0.566 . . . . 0.0 109.935 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.86 3.72 11.39 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.99 61.23 3.12 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.688 0.795 . . . . 0.0 110.029 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -95.65 -178.57 4.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.871 1.268 . . . . 0.0 109.559 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 t -147.66 150.02 33.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -17.69 68.23 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 ttt -66.83 78.4 0.12 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.044 0.938 . . . . 0.0 113.023 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.45 58.1 3.06 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.003 0.921 . . . . 0.0 109.163 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -165.79 140.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.547 1.539 . . . . 0.0 107.452 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.61 163.32 31.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.4 tp -155.98 111.32 2.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.19 32.51 0.28 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.7 -0.625 . . . . 0.0 112.347 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -160.02 -178.01 6.71 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 127.589 2.355 . . . . 0.0 106.432 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.2 -56.01 3.2 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.387 -0.674 . . . . 0.0 112.829 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -18.78 -63.9 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.892 2.663 . . . . 0.0 115.933 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -61.92 -46.36 89.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.146 0.979 . . . . 0.0 111.622 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -62.77 -48.14 80.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.137 0.975 . . . . 0.0 108.719 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.33 -44.32 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.0 0.52 . . . . 0.0 109.754 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.46 -47.28 82.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.813 0.733 . . . . 0.0 110.617 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.36 93.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.898 0.38 . . . . 0.0 110.753 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -56.17 -52.16 65.4 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.869 0.468 . . . . 0.0 109.873 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.85 -45.06 90.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.579 -0.7 . . . . 0.0 110.984 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.99 87.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.622 0.769 . . . . 0.0 111.28 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.1 p -71.8 -34.75 69.62 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.049 -0.407 . . . . 0.0 111.256 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.96 -47.66 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.768 1.227 . . . . 0.0 111.916 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.84 89.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.831 0.824 . . . . 0.0 112.35 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt . . . . . 0 C--O 1.248 1.02 0 C-N-CA 126.619 1.968 . . . . 0.0 109.63 176.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.228 0.349 . . . . 0.0 113.619 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.04 84.11 0.98 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 109.94 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.85 -37.25 29.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.851 0.86 . . . . 0.0 112.443 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.36 -52.51 63.35 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.657 -0.652 . . . . 0.0 109.94 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -57.97 -39.22 77.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.6 -48.61 69.87 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.7 -49.03 74.09 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.973 0.509 . . . . 0.0 109.741 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -61.61 -47.96 83.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.625 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -54.31 -38.77 66.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 110.323 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -56.08 -17.39 6.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.709 0.804 . . . . 0.0 112.984 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -56.03 -26.06 47.31 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.286 -0.884 . . . . 0.0 111.297 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -77.8 -51.58 10.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.0 m -50.96 -42.08 59.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.311 1.044 . . . . 0.0 111.941 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -56.68 -21.91 31.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 m -56.4 -27.71 57.16 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.922 -0.486 . . . . 0.0 110.304 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -118.66 -43.83 2.67 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.613 0.765 . . . . 0.0 111.441 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -93.85 174.94 6.92 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 124.767 1.227 . . . . 0.0 113.32 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -141.27 161.76 37.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.717 1.207 . . . . 0.0 109.872 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.1 mt -138.15 106.88 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 103.412 -2.811 . . . . 0.0 103.412 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -122.77 125.69 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.463 1.105 . . . . 0.0 109.9 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 159.17 20.61 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.406 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.18 -38.38 81.16 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.775 2.317 . . . . 0.0 110.916 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.52 3.89 4.43 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.513 1.525 . . . . 0.0 113.128 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.52 65.98 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 120.733 -1.23 . . . . 0.0 112.873 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -57.07 114.45 2.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.556 1.178 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -74.29 73.12 1.81 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.455 0.702 . . . . 0.0 111.356 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.1 mm -50.27 -48.19 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.774 0.83 . . . . 0.0 109.175 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.3 102.46 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -76.12 58.51 1.23 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 108.963 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.81 174.21 42.43 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.92 176.11 3.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.161 0.505 . . . . 0.0 111.529 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -118.59 24.11 11.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.369 1.068 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -64.37 -38.29 90.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.98 169.88 13.35 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 169.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.63 178.24 1.02 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.717 3.612 . . . . 0.0 114.431 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -92.61 89.53 6.74 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.804 1.242 . . . . 0.0 111.356 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.36 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.687 2.395 . . . . 0.0 116.19 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -64.22 85.31 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 120.653 1.57 . . . . 0.0 109.61 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.58 56.9 3.73 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -33.34 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 117.673 0.737 . . . . 0.0 109.796 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.6 t -54.29 118.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.096 0.958 . . . . 0.0 110.265 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 -17.29 59.58 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.576 1.084 . . . . 0.0 112.33 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 138.88 40.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.139 1.469 . . . . 0.0 110.005 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.3 m -62.43 133.39 54.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.36 137.42 52.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.002 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.56 29.88 65.11 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.272 -1.293 . . . . 0.0 114.23 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.3 p -133.89 -3.78 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.403 1.602 . . . . 0.0 115.076 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.68 122.36 76.1 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.777 1.626 . . . . 0.0 107.341 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -56.29 162.12 8.21 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.386 2.057 . . . . 0.0 114.418 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 61.3 56.39 2.68 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.848 1.659 . . . . 0.0 111.871 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -164.22 121.12 1.65 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.88 0.371 . . . . 0.0 111.828 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -74.93 87.46 2.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.664 0.786 . . . . 0.0 109.456 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.47 167.69 14.28 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -99.78 156.39 17.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.925 0.89 . . . . 0.0 110.122 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -48.88 -43.28 38.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.085 1.354 . . . . 0.0 113.69 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 m -65.14 -52.99 51.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.845 0.355 . . . . 0.0 111.085 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 tt -65.05 -36.72 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.548 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.64 -48.45 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.14 96.72 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.035 -0.416 . . . . 0.0 111.246 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -50.61 65.93 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.06 -53.01 47.87 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.028 0.823 . . . . 0.0 111.94 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.88 -26.67 37.24 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 125.286 1.435 . . . . 0.0 111.874 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -71.83 3.71 3.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 175.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.76 40.51 7.64 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.383 1.468 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -102.79 105.23 15.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.79 129.07 40.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.986 1.314 . . . . 0.0 108.501 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -62.78 109.53 1.46 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.119 0.418 . . . . 0.0 111.751 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.3 p -91.35 164.07 13.98 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.43 -43.38 75.31 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.401 0.619 . . . . 0.0 110.876 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.97 -46.16 72.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.62 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -57.13 -50.09 73.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.671 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.74 -55.58 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.325 0.511 . . . . 0.0 109.851 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.89 -37.4 60.56 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.447 0.699 . . . . 0.0 111.628 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.6 m -72.53 -63.44 1.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -36.17 -54.08 0.8 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.448 2.299 . . . . 0.0 113.8 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 m -48.78 -32.97 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.27 -33.53 65.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.483 0.713 . . . . 0.0 112.684 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -135.98 57.05 16.44 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -60.41 145.78 98.01 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.29 1.327 . . . . 0.0 110.835 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.07 -64.04 4.11 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.44 80.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.94 0.496 . . . . 0.0 110.131 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -54.46 -53.85 48.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.961 0.904 . . . . 0.0 110.327 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -57.57 -53.83 53.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.601 0.36 . . . . 0.0 110.427 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -47.78 -47.38 30.74 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 110.601 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.03 -66.31 0.56 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.091 0.556 . . . . 0.0 110.51 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -53.9 -43.12 69.42 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -84.79 -5.22 59.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.968 0.907 . . . . 0.0 111.825 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t0 48.63 56.36 7.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.024 1.33 . . . . 0.0 109.609 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -142.49 157.13 45.07 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.097 0.959 . . . . 0.0 110.298 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -95.1 -46.83 6.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.94 2.096 . . . . 0.0 107.628 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -76.43 43.71 0.32 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.485 1.514 . . . . 0.0 111.78 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.73 118.25 29.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.006 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -151.23 140.3 21.13 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.12 0.968 . . . . 0.0 108.738 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -103.55 156.22 17.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -24.16 58.44 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.6 ttp -63.21 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.789 0.795 . . . . 0.0 113.095 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.62 57.3 3.29 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -160.44 149.91 17.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.444 1.898 . . . . 0.0 106.372 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -143.42 158.81 43.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.5 tp -130.89 115.75 16.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.94 50.47 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.159 0.984 . . . . 0.0 112.067 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -133.82 135.21 43.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.33 1.452 . . . . 0.0 107.839 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.12 61.26 4.38 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.558 -2.617 . . . . 0.0 106.558 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.94 65.01 0.0 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 129.794 3.569 . . . . 0.0 117.192 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.66 -34.58 78.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.087 0.955 . . . . 0.0 109.255 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -61.09 -52.09 66.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.098 1.359 . . . . 0.0 109.618 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.66 -45.52 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 123.784 0.834 . . . . 0.0 109.592 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.25 85.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.141 -0.349 . . . . 0.0 110.777 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.036 -0.415 . . . . 0.0 110.544 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -58.55 -54.23 49.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.77 -32.88 67.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.247 0.619 . . . . 0.0 111.522 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.9 -54.21 24.37 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.547 0.612 . . . . 0.0 109.783 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 97.4 p -57.75 -32.29 67.32 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.906 -0.497 . . . . 0.0 112.236 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.28 -26.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.715 0.806 . . . . 0.0 111.412 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 t -66.38 84.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 119.122 0.874 . . . . 0.0 108.965 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 C--O 1.253 1.25 0 CA-C-O 115.254 -2.308 . . . . 0.0 107.657 178.277 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 CA-C-O 122.025 0.792 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.0 68.95 0.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.153 1.781 . . . . 0.0 111.659 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.073 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.55 79.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.749 0.82 . . . . 0.0 111.594 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -71.78 -41.0 68.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.43 -44.09 45.03 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.179 0.895 . . . . 0.0 111.751 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -51.51 -53.46 37.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.732 0.813 . . . . 0.0 110.446 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -65.34 -46.62 79.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.476 0.711 . . . . 0.0 109.971 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' OE1' HBB3 ' A' ' 117' ' ' HEC . 3.1 tm-20 -53.63 -39.77 65.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.305 1.042 . . . . 0.0 109.604 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -57.66 -19.37 26.18 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -30.76 62.43 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.327 -0.858 . . . . 0.0 109.775 174.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.79 -54.97 9.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.2 m -50.23 -41.06 49.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.636 1.574 . . . . 0.0 111.274 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -46.98 -31.69 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.389 1.875 . . . . 0.0 112.663 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.0 m -56.51 -28.98 61.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.384 0.673 . . . . 0.0 111.557 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.5 m -121.66 -36.19 3.09 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.952 0.901 . . . . 0.0 112.646 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -105.64 168.77 8.88 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.77 1.228 . . . . 0.0 112.791 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.2 p -138.13 166.82 23.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.956 1.302 . . . . 0.0 110.359 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.4 114.37 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 tp -109.8 134.45 51.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.636 1.174 . . . . 0.0 110.072 -175.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.92 159.97 82.07 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 121.126 -0.984 . . . . 0.0 108.416 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.18 -40.93 68.11 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.906 2.404 . . . . 0.0 112.519 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.5 -8.06 55.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.373 1.469 . . . . 0.0 113.58 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.89 -17.24 45.61 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.947 -0.918 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.2 m -58.63 121.83 11.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.66 1.73 . . . . 0.0 109.44 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.99 113.55 5.78 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.24 -50.36 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.24 99.65 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -74.5 56.76 0.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.503 1.921 . . . . 0.0 109.507 176.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.61 -179.06 42.28 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.72 174.04 5.55 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.116 0.484 . . . . 0.0 111.419 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -118.36 26.88 9.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 109.896 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -65.44 -42.16 92.69 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.18 173.37 20.53 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.74 -177.1 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.163 3.242 . . . . 0.0 112.227 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -100.71 104.96 16.26 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.5 14.04 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -71.1 81.6 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.261 1.391 . . . . 0.0 109.254 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 53.79 1.01 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.794 0.711 . . . . 0.0 114.175 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.13 -41.84 31.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 117.461 0.63 . . . . 0.0 109.711 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t -52.56 119.41 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 121.215 -0.928 . . . . 0.0 110.896 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 -18.88 56.69 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.879 1.228 . . . . 0.0 111.832 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -65.78 138.9 58.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.9 0.85 . . . . 0.0 111.074 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -71.66 70.82 0.7 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 0.0 111.058 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 58.08 -143.58 0.64 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.638 0.775 . . . . 0.0 109.938 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.3 83.35 0.13 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.54 1.067 . . . . 0.0 113.284 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.2 t -147.51 40.98 1.03 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.016 0.408 . . . . 0.0 111.9 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.97 128.89 58.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -55.97 155.29 23.81 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.374 1.383 . . . . 0.0 112.395 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 54.58 57.94 5.32 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 0.0 112.62 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -158.45 119.11 3.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.785 0.434 . . . . 0.0 110.001 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -79.15 86.72 4.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.387 0.675 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -68.17 -174.63 0.51 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.47 0.652 . . . . 0.0 110.967 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -114.75 172.74 6.85 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.991 1.316 . . . . 0.0 109.83 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.55 -41.92 86.68 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.958 1.303 . . . . 0.0 112.435 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 p -63.17 -65.42 0.69 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.286 1.435 . . . . 0.0 110.564 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.23 -35.01 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.638 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.82 -50.57 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.28 81.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.068 -0.395 . . . . 0.0 111.311 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -55.72 -50.76 69.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.3 -53.93 39.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.36 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.831 0.852 . . . . 0.0 112.742 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.8 p -68.63 -9.16 48.22 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.68 7.62 23.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.436 1.017 . . . . 0.0 112.805 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -68.44 138.25 55.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.744 1.272 . . . . 0.0 109.26 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.27 128.03 39.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 106.994 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -60.49 147.42 41.29 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -142.25 166.43 24.72 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.415 1.886 . . . . 0.0 106.207 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.48 -41.47 73.04 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.799 0.272 . . . . 0.0 110.48 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.62 -51.48 62.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.351 0.66 . . . . 0.0 110.595 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.13 -48.08 81.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.181 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mm -57.22 -55.6 19.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.72 -41.08 42.75 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.828 1.251 . . . . 0.0 111.19 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -71.52 -55.86 7.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.831 0.348 . . . . 0.0 110.224 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -50.68 -45.62 58.29 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.3 -33.58 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.95 2.98 53.86 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.423 0.689 . . . . 0.0 112.761 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -148.3 62.68 6.73 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.229 1.012 . . . . 0.0 112.428 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.16 140.69 93.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.171 1.914 . . . . 0.0 109.772 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.38 -64.7 1.03 Allowed Glycine 0 CA--C 1.533 1.18 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.0 -45.61 7.94 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.991 1.716 . . . . 0.0 111.346 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.0 -55.92 25.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.165 0.586 . . . . 0.0 110.938 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -57.95 -46.42 85.13 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.389 0.675 . . . . 0.0 110.693 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -53.81 -53.01 58.37 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -54.13 -57.36 11.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.221 0.608 . . . . 0.0 111.009 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.31 -54.54 39.15 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -88.87 -25.06 22.35 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -170.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 54.44 49.5 18.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.749 1.219 . . . . 0.0 110.036 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -117.42 128.57 55.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 108.761 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -51.37 -43.52 61.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.651 1.18 . . . . 0.0 111.057 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -91.13 27.09 1.96 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.79 65.46 1.03 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.599 0.714 . . . . 0.0 111.845 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -91.0 -177.94 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.785 2.034 . . . . 0.0 109.434 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 t -158.46 150.47 21.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.41 -26.18 71.66 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 16.4 ttp -65.32 82.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.36 58.36 4.06 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.206 -0.934 . . . . 0.0 109.201 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -165.89 151.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.404 1.482 . . . . 0.0 107.184 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -143.42 166.51 24.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.225 0.466 . . . . 0.0 110.205 170.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.11 115.97 28.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.75 52.81 2.0 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.594 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.93 169.8 17.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.345 1.458 . . . . 0.0 107.764 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.33 -17.89 68.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.382 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.53 1.99 73.13 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 118.157 0.978 . . . . 0.0 114.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -46.29 88.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.674 1.237 . . . . 0.0 111.194 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -55.08 -51.43 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.264 1.426 . . . . 0.0 110.72 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.89 -50.87 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.76 1.224 . . . . 0.0 110.247 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.72 -46.49 81.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.391 -0.193 . . . . 0.0 110.615 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.48 93.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.852 0.461 . . . . 0.0 110.17 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -59.33 -49.04 79.37 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.036 -0.415 . . . . 0.0 110.67 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.3 mt -60.02 -45.74 91.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.647 0.658 . . . . 0.0 110.758 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.22 79.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.387 0.275 . . . . 0.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.7 m -66.59 -40.66 89.01 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.123 -0.361 . . . . 0.0 111.321 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.1 -43.56 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.747 1.219 . . . . 0.0 112.675 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.86 78.69 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.481 0.658 . . . . 0.0 112.291 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.333 0 CA-C-O 116.04 -1.933 . . . . 0.0 108.767 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . 0.409 HBB3 ' OE1' ' A' ' 9' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.06 93.32 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.785 -0.832 . . . . 0.0 109.005 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.39 34.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 112.808 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.83 -54.99 22.35 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.913 0.778 . . . . 0.0 109.695 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -56.69 -41.2 76.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 0.0 110.123 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.64 -49.56 57.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -54.97 -52.2 63.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.551 0.74 . . . . 0.0 110.041 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -57.67 -53.13 61.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.2 -26.11 62.41 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 126.478 1.911 . . . . 0.0 112.09 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -56.63 -18.97 13.93 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.184 0.447 . . . . 0.0 110.98 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -53.38 -32.9 51.6 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.657 -0.652 . . . . 0.0 111.134 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.73 -53.16 29.67 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -51.46 -45.01 62.58 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.308 1.043 . . . . 0.0 110.889 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -47.85 -30.54 4.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 113.061 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -52.59 -38.03 59.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.057 0.543 . . . . 0.0 110.978 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -112.61 -40.3 4.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -100.55 -174.01 2.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.247 1.019 . . . . 0.0 113.233 -170.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -152.16 173.17 15.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.574 1.549 . . . . 0.0 109.025 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.95 131.41 52.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 tp -116.79 145.37 22.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.753 1.621 . . . . 0.0 109.536 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.19 160.01 76.76 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 119.432 1.015 . . . . 0.0 108.321 173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.99 -36.86 93.6 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.439 2.093 . . . . 0.0 110.214 172.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.13 -1.4 7.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.398 1.879 . . . . 0.0 113.135 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.22 -18.36 45.72 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 120.728 -1.232 . . . . 0.0 112.362 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -53.99 122.13 9.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.205 1.002 . . . . 0.0 110.906 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.86 78.74 1.14 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.326 0.65 . . . . 0.0 110.616 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.85 -60.47 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.01 98.75 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.09 63.23 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.735 1.214 . . . . 0.0 109.738 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.87 -156.77 32.98 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.88 6.7 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -124.68 33.84 5.14 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.53 -34.88 76.63 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.27 176.8 17.69 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 168.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.0 -171.07 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.676 2.917 . . . . 0.0 111.698 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -117.48 101.37 8.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -68.55 0.94 3.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.01 109.87 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.97 1.259 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.53 20.02 55.31 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.573 -0.571 . . . . 0.0 112.391 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.87 -37.82 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.354 1.077 . . . . 0.0 109.047 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.4 107.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.059 0.944 . . . . 0.0 110.428 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 -5.7 72.08 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 112.482 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -92.41 138.16 31.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.84 0.82 . . . . 0.0 110.367 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -56.41 127.21 29.95 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.937 1.295 . . . . 0.0 111.347 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.99 149.29 19.22 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.615 -0.678 . . . . 0.0 111.153 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.47 42.43 99.0 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.332 -1.26 . . . . 0.0 115.187 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.7 p -142.17 1.04 1.4 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.465 1.632 . . . . 0.0 114.846 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -69.19 134.71 89.27 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 120.445 1.475 . . . . 0.0 109.723 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.27 154.37 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.989 2.46 . . . . 0.0 115.685 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.27 60.8 3.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.078 1.751 . . . . 0.0 112.66 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -154.66 118.9 4.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.026 0.441 . . . . 0.0 110.837 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.29 80.28 1.84 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.99 0.916 . . . . 0.0 110.586 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -68.55 176.26 3.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.484 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -107.45 170.58 7.88 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.937 0.895 . . . . 0.0 109.942 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.1 -46.41 89.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.173 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 p -60.96 -65.39 0.7 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.845 1.258 . . . . 0.0 111.069 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.99 -42.88 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.095 0.958 . . . . 0.0 110.837 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -44.83 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.997 . . . . 0.0 110.032 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.4 82.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.705 0.684 . . . . 0.0 110.528 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.9 tp -57.85 -48.26 80.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.28 -56.29 17.88 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 123.887 0.756 . . . . 0.0 111.755 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.88 55.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.438 1.495 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 m -71.53 5.18 2.51 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.88 21.33 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.146 1.355 . . . . 0.0 111.242 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -82.54 77.9 9.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.788 -0.83 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 116.6 13.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -57.81 139.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -122.64 162.9 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.208 1.403 . . . . 0.0 107.385 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -54.2 -43.29 70.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -53.46 54.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.589 0.756 . . . . 0.0 110.407 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -60.48 -45.13 94.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.993 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.1 mt -58.0 -55.94 18.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.65 -40.17 62.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.868 0.867 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.7 m -68.04 -63.99 0.95 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.51 -51.87 2.87 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.094 1.757 . . . . 0.0 112.925 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.0 m -54.67 -33.59 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -72.39 -29.56 63.85 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.77 -0.581 . . . . 0.0 111.862 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -138.47 61.89 27.2 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -65.35 153.59 77.53 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 CA-C-N 120.086 1.066 . . . . 0.0 110.588 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.43 -66.65 2.62 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.07 -44.2 51.61 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.284 1.034 . . . . 0.0 111.243 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -51.95 -57.17 10.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.647 0.779 . . . . 0.0 110.106 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.82 -54.21 49.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.857 0.463 . . . . 0.0 110.755 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -50.37 -42.4 53.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.04 0.536 . . . . 0.0 110.989 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.75 -66.35 0.57 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.354 0.662 . . . . 0.0 110.19 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -54.5 -43.38 71.79 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -88.85 1.07 55.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.703 1.201 . . . . 0.0 111.255 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t0 41.92 54.44 3.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.964 1.706 . . . . 0.0 110.967 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -147.91 122.06 9.53 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.631 0.772 . . . . 0.0 112.534 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -53.47 -45.23 69.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.626 1.57 . . . . 0.0 110.301 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -73.92 5.63 4.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.08 72.15 9.13 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.377 -1.452 . . . . 0.0 111.715 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -82.46 164.3 21.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.459 1.104 . . . . 0.0 108.827 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.4 t -142.02 149.45 40.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.29 -29.84 72.44 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 ttp -62.05 83.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.8 57.38 3.79 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -159.73 149.85 18.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -139.37 153.26 47.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.8 tp -113.37 107.81 16.37 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.08 66.72 3.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.918 0.887 . . . . 0.0 109.89 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 84.14 146.13 0.07 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 128.583 2.753 . . . . 0.0 109.988 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.77 -26.54 5.1 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.02 -40.76 10.18 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.401 1.476 . . . . 0.0 113.085 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.57 -48.9 79.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.717 0.758 . . . . 0.0 110.579 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -61.14 -48.33 82.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.211 1.004 . . . . 0.0 109.456 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.41 -40.87 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.701 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.6 89.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.604 -0.685 . . . . 0.0 109.963 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.42 90.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.08 -53.23 59.54 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.1 mt -55.27 -47.81 74.95 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.117 0.417 . . . . 0.0 110.913 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.38 77.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.4 m -70.36 -40.58 73.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.032 -0.417 . . . . 0.0 110.674 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.23 -44.68 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.468 1.507 . . . . 0.0 112.698 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.86 94.64 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.744 0.783 . . . . 0.0 112.592 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.5 pttt . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.637 1.975 . . . . 0.0 109.661 173.482 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.079 0.266 . . . . 0.0 112.814 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.19 76.69 0.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.717 1.607 . . . . 0.0 111.044 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.11 10.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.432 1.093 . . . . 0.0 112.18 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.4 -54.17 49.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.535 0.734 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.03 -34.47 74.89 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.89 -56.24 24.95 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.31 -37.4 87.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.165 0.983 . . . . 0.0 111.357 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -60.96 -50.9 71.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.729 0.695 . . . . 0.0 109.737 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -57.2 -34.11 68.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.7 1.2 . . . . 0.0 110.273 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -56.16 -21.73 24.59 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -55.38 -36.3 66.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.668 0.667 . . . . 0.0 110.278 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -69.82 -52.68 22.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.9 m -50.72 -40.8 55.29 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.378 1.071 . . . . 0.0 111.749 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -48.35 -30.93 5.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 112.31 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.6 m -59.32 -22.46 61.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.497 0.719 . . . . 0.0 111.505 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.4 m -124.84 -34.58 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.378 1.071 . . . . 0.0 112.771 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -110.21 170.33 8.15 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.581 1.152 . . . . 0.0 114.081 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.4 m -141.89 166.05 25.78 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.427 1.091 . . . . 0.0 110.295 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mp -139.65 124.47 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 106.865 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.14 132.21 58.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.514 1.126 . . . . 0.0 110.175 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 154.01 71.74 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.58 -35.37 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.036 2.491 . . . . 0.0 112.097 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.81 -9.27 58.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.351 1.06 . . . . 0.0 113.144 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.31 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.999 -0.889 . . . . 0.0 113.404 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.7 m -62.39 108.28 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.489 1.644 . . . . 0.0 110.331 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.49 134.53 57.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.64 0.776 . . . . 0.0 110.659 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 mm -105.29 -50.34 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.08 96.47 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -84.21 70.17 10.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.94 -154.12 26.86 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.26 175.53 10.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -125.77 32.57 5.26 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.944 0.897 . . . . 0.0 109.232 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.3 m -64.73 -36.98 86.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.35 173.02 14.61 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.56 179.6 1.23 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.372 3.382 . . . . 0.0 113.91 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -92.34 103.85 16.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.261 1.024 . . . . 0.0 110.036 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.64 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -70.03 85.12 0.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.268 1.849 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.96 58.37 2.65 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.36 0.981 . . . . 0.0 113.265 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.37 -39.33 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 O-C-N 122.219 -0.577 . . . . 0.0 110.966 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.56 119.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.014 0.525 . . . . 0.0 110.504 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.08 -21.94 41.38 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.673 1.13 . . . . 0.0 111.602 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -68.26 138.24 55.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.441 1.12 . . . . 0.0 110.886 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 m -65.02 72.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.434 1.894 . . . . 0.0 111.675 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.59 -145.25 0.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.461 -0.774 . . . . 0.0 109.431 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.04 78.25 1.26 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -138.7 14.62 2.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.591 0.756 . . . . 0.0 111.621 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -64.96 127.01 92.33 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.36 172.12 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.403 2.068 . . . . 0.0 115.779 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 46.01 57.47 5.16 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.256 1.822 . . . . 0.0 111.825 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -164.37 122.46 1.77 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.489 0.316 . . . . 0.0 110.761 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.26 95.32 4.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.057 0.943 . . . . 0.0 110.24 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.2 -178.69 5.21 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.353 0.661 . . . . 0.0 111.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.92 177.48 4.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.23 -35.23 75.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.021 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 p -63.29 -66.65 0.51 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.556 1.142 . . . . 0.0 110.627 -173.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tt -57.43 -37.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.123 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.7 -47.58 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.55 84.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.056 0.389 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.8 tp -55.41 -50.11 70.61 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.11 -54.86 29.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.95 -31.56 60.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.113 0.965 . . . . 0.0 112.225 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -72.03 3.07 4.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.14 29.38 10.4 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.142 0.877 . . . . 0.0 111.616 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -90.76 140.44 29.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -60.37 148.37 37.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 123.053 0.541 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.7 p -142.71 166.31 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -54.8 -41.06 70.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.72 -56.13 15.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.108 0.963 . . . . 0.0 109.719 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.03 -52.15 61.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.278 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.5 mt -56.87 -54.69 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.67 -40.32 53.31 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.054 0.942 . . . . 0.0 111.667 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -70.75 -60.95 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -43.49 -51.92 6.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.061 1.344 . . . . 0.0 113.602 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.6 m -51.28 -38.49 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -90.81 -8.49 49.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.23 55.17 3.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.878 0.871 . . . . 0.0 111.576 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.66 147.17 85.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.917 1.745 . . . . 0.0 109.868 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.36 -64.46 4.26 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.7 61.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.389 0.676 . . . . 0.0 109.993 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -48.52 -51.54 26.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.774 1.23 . . . . 0.0 111.338 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.49 -58.94 4.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -49.5 -38.91 32.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 111.615 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -53.42 -39.91 64.7 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.456 0.702 . . . . 0.0 111.842 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -97.21 -53.32 3.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.318 1.047 . . . . 0.0 111.741 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.7 tp -78.86 -22.92 45.33 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.776 1.23 . . . . 0.0 113.228 -175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t0 41.57 63.62 1.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.486 1.914 . . . . 0.0 113.216 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.43 145.29 45.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 108.282 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.38 -38.46 58.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.188 0.995 . . . . 0.0 110.842 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.21 21.71 13.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.0 0.92 . . . . 0.0 112.855 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.84 5.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -126.22 142.52 51.5 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.429 1.492 . . . . 0.0 108.636 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -94.37 150.08 20.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.965 0.906 . . . . 0.0 109.164 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -55.02 -27.03 43.93 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.974 -0.454 . . . . 0.0 111.994 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.2 ttp -59.64 86.5 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 113.343 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.39 57.93 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.91 155.79 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.537 1.935 . . . . 0.0 106.331 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -145.35 170.94 15.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.2 tp -97.23 166.48 11.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.55 37.88 4.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -143.93 170.79 15.25 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.661 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -12.97 35.28 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.707 -1.052 . . . . 0.0 113.35 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.04 -32.07 1.76 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 118.475 1.138 . . . . 0.0 114.638 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.23 -38.41 3.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 113.281 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -61.13 -49.21 78.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.674 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.56 -41.72 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.39 90.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.699 0.4 . . . . 0.0 110.546 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.47 94.48 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.79 0.436 . . . . 0.0 109.932 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -55.9 -54.3 46.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.1 mt -57.32 -37.12 72.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.426 0.69 . . . . 0.0 111.716 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.4 89.06 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.457 -0.777 . . . . 0.0 109.146 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.4 t -59.73 -29.31 68.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.73 -0.606 . . . . 0.0 111.924 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.45 -29.35 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 O-C-N 121.845 -0.534 . . . . 0.0 110.749 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.44 91.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.501 1.12 . . . . 0.0 109.748 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm . . . . . 0 C--O 1.248 0.993 0 C-N-CA 126.199 1.8 . . . . 0.0 107.854 176.524 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.107 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.92 73.84 0.6 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.584 1.154 . . . . 0.0 111.707 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.98 -39.08 25.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.195 0.998 . . . . 0.0 111.949 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.43 82.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.391 0.676 . . . . 0.0 111.231 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.89 -41.72 77.9 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.88 -46.65 40.4 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.021 0.82 . . . . 0.0 111.94 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -52.52 -54.27 34.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.475 0.71 . . . . 0.0 110.527 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.47 -47.53 83.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.901 0.48 . . . . 0.0 110.159 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -53.86 -39.19 65.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.353 1.061 . . . . 0.0 109.849 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.16 -22.3 27.89 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.43 -31.29 54.99 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.646 -0.659 . . . . 0.0 110.048 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -71.33 -52.75 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 m -51.18 -43.0 61.22 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.656 1.182 . . . . 0.0 110.637 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -49.16 -25.88 2.46 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.131 1.772 . . . . 0.0 112.279 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -53.95 -42.58 69.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.211 1.368 . . . . 0.0 110.281 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.8 m -106.95 -42.22 4.97 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.743 0.817 . . . . 0.0 112.401 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -92.7 167.27 12.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.583 1.153 . . . . 0.0 112.885 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -140.15 147.21 39.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.32 124.98 73.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.86 133.99 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.332 1.853 . . . . 0.0 107.853 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.56 158.04 86.45 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.46 -38.7 74.78 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.943 2.429 . . . . 0.0 112.646 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -74.29 -10.54 59.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.164 1.385 . . . . 0.0 113.663 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.33 -18.65 32.84 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.83 -0.984 . . . . 0.0 113.63 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -57.18 118.71 5.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.698 . . . . 0.0 109.556 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.61 125.66 26.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.819 0.447 . . . . 0.0 110.405 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 mm -85.06 -52.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.0 m -146.57 136.12 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -113.36 135.55 53.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.72 -172.87 19.93 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 124.434 1.016 . . . . 0.0 110.977 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.02 44.89 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.596 -0.944 . . . . 0.0 109.611 175.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 tptp 15.94 57.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 130.28 3.432 . . . . 0.0 113.61 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.12 -32.16 14.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.3 167.85 12.46 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 174.05 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.421 3.414 . . . . 0.0 113.526 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.44 115.52 17.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.36 7.02 44.75 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -48.73 106.78 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.091 0.86 . . . . 0.0 111.58 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.03 42.96 95.26 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.12 -36.86 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 117.274 0.537 . . . . 0.0 111.565 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.5 116.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.57 -19.15 55.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.256 0.931 . . . . 0.0 111.802 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.05 148.09 32.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 117.731 0.765 . . . . 0.0 109.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 m -61.48 127.02 29.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.796 0.838 . . . . 0.0 109.931 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.88 154.8 41.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 111.758 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.52 27.1 63.04 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.023 -0.876 . . . . 0.0 114.749 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.8 t -155.32 20.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.676 1.238 . . . . 0.0 112.77 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.22 126.11 92.31 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.54 171.75 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 CA-C-N 121.099 1.428 . . . . 0.0 115.735 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 50.64 55.18 9.91 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.749 1.62 . . . . 0.0 111.404 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -166.04 123.4 1.42 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.169 -0.332 . . . . 0.0 111.377 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -83.42 99.64 10.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.498 1.119 . . . . 0.0 109.089 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -85.0 -170.39 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.856 0.862 . . . . 0.0 111.962 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.71 175.89 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.959 1.703 . . . . 0.0 109.552 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.93 -43.67 82.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.357 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 t -70.85 -47.93 56.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.091 0.472 . . . . 0.0 111.145 -173.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -67.02 -34.91 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.08 -45.56 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.79 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 111.406 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 mt -55.86 -49.16 74.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.41 39.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -37.29 74.31 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.274 1.029 . . . . 0.0 110.779 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 t -72.88 4.05 4.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.19 61.44 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 119.14 0.882 . . . . 0.0 111.934 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -71.99 108.28 5.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.984 0.892 . . . . 0.0 109.517 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.61 122.46 37.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -57.44 153.31 12.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p -133.77 169.8 16.51 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.554 1.141 . . . . 0.0 108.153 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -57.59 -46.42 84.04 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.665 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.1 -47.72 73.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.03 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.55 -49.73 76.65 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.87 -50.95 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 118.116 0.416 . . . . 0.0 110.106 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.38 -38.29 52.62 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.074 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -73.45 -58.29 3.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -44.68 -47.24 10.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.176 1.391 . . . . 0.0 113.74 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.44 -36.41 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 119.138 0.881 . . . . 0.0 113.308 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -100.14 2.26 42.88 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.842 0.857 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -142.35 56.52 5.46 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.408 1.483 . . . . 0.0 110.997 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.04 138.97 64.88 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.244 1.962 . . . . 0.0 109.436 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.1 -60.45 2.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.58 -45.47 9.48 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.692 1.597 . . . . 0.0 111.876 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.07 -44.74 96.02 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.151 -0.619 . . . . 0.0 111.663 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.92 -51.09 70.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.792 0.837 . . . . 0.0 109.012 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -52.56 -52.37 55.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.586 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -55.96 -53.36 57.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 111.12 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -66.92 -52.13 46.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.57 -18.54 48.01 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.7 t0 56.35 53.83 8.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.33 1.452 . . . . 0.0 109.275 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -134.27 128.41 33.77 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.615 1.166 . . . . 0.0 109.87 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.22 -37.2 79.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.525 1.13 . . . . 0.0 110.527 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -85.72 15.93 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.9 65.54 8.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.892 0.853 . . . . 0.0 110.439 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.37 108.25 19.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 109.666 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -63.11 156.4 25.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.75 -21.69 79.52 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.553 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 3.7 ttp -68.94 82.01 0.31 Allowed 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.725 -0.867 . . . . 0.0 112.755 -176.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.99 57.33 2.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.474 0.71 . . . . 0.0 109.479 174.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -163.13 148.19 11.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.808 1.643 . . . . 0.0 107.789 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -142.54 164.95 28.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.21 1.004 . . . . 0.0 109.589 173.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.32 115.56 26.15 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.25 55.05 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.89 0.476 . . . . 0.0 110.034 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -132.43 168.08 18.8 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 125.624 1.57 . . . . 0.0 108.721 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.06 -19.42 59.11 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.752 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.85 1.9 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.061 0.93 . . . . 0.0 113.703 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -41.11 -44.11 2.41 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.072 1.749 . . . . 0.0 113.832 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -62.14 -45.55 92.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.117 0.967 . . . . 0.0 110.986 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.32 -45.0 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.11 0.964 . . . . 0.0 108.897 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.02 91.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.346 0.658 . . . . 0.0 110.339 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.22 97.28 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.875 0.47 . . . . 0.0 110.01 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.86 -52.58 64.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.66 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -57.29 -42.36 81.54 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.011 -0.431 . . . . 0.0 111.117 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.48 -41.45 73.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.918 0.487 . . . . 0.0 110.174 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -63.19 -30.01 71.24 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.968 -0.457 . . . . 0.0 111.912 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.83 -29.97 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.063 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t -48.11 99.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 125.522 1.529 . . . . 0.0 112.72 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 C--O 1.251 1.145 0 C-N-CA 130.023 3.329 . . . . 0.0 104.161 174.528 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . 0.553 ' CHD' ' HG3' ' A' ' 96' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.065 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -90.37 106.01 18.2 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.876 1.27 . . . . 0.0 108.777 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.7 -31.43 26.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.329 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.54 12.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.354 0.979 . . . . 0.0 110.248 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -56.28 -38.56 71.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.768 -0.583 . . . . 0.0 109.551 174.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.99 -51.1 52.13 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.67 -47.89 82.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.279 1.032 . . . . 0.0 110.279 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -57.25 -52.71 64.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.164 0.185 . . . . 0.0 110.677 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.93 -35.96 67.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.518 1.127 . . . . 0.0 110.211 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.437 ' CZ ' ' CBB' ' A' ' 117' ' ' HEC . 0.3 OUTLIER -57.52 -27.16 62.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.069 0.548 . . . . 0.0 112.134 178.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -30.47 63.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.383 0.538 . . . . 0.0 110.043 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -93.13 -50.26 5.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.036 0.934 . . . . 0.0 109.48 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -33.92 42.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -58.58 -14.81 9.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 114.347 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -56.09 -17.76 7.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.246 -0.909 . . . . 0.0 112.338 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.4 m -124.02 -27.27 3.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.966 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -117.81 165.9 13.11 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.922 0.783 . . . . 0.0 112.941 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -140.39 164.68 29.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.289 1.035 . . . . 0.0 111.629 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.18 121.87 24.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 125.661 1.584 . . . . 0.0 107.854 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -116.54 134.39 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.602 1.561 . . . . 0.0 108.169 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.66 160.24 77.92 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 119.114 0.87 . . . . 0.0 108.94 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.31 -40.95 69.11 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.108 2.538 . . . . 0.0 112.7 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -74.52 -8.28 55.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.145 1.378 . . . . 0.0 113.594 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.79 -18.85 42.81 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.963 -0.909 . . . . 0.0 113.394 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -60.51 117.64 5.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.6 1.7 . . . . 0.0 108.867 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -68.18 129.97 41.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.83 -46.09 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.2 93.48 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -77.0 90.67 3.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.81 -148.28 23.95 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.73 177.84 8.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -129.34 34.11 4.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.676 0.79 . . . . 0.0 109.558 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -64.18 -41.1 97.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.81 164.14 13.33 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.96 164.06 3.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.497 2.798 . . . . 0.0 115.276 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -72.89 121.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.83 6.41 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.95 115.82 3.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.545 1.066 . . . . 0.0 108.561 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.36 23.68 72.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.965 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.61 -38.23 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 118.859 1.329 . . . . 0.0 109.553 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.15 103.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.86 -7.94 42.23 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.5 1.524 . . . . 0.0 112.205 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -72.6 142.79 48.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 117.971 0.885 . . . . 0.0 111.418 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -70.91 68.17 0.42 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.946 1.698 . . . . 0.0 113.508 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.74 -154.56 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 111.944 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.83 70.96 1.15 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 123.697 0.665 . . . . 0.0 112.777 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.8 p -137.93 23.16 2.84 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.381 0.672 . . . . 0.0 111.355 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.78 134.85 90.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.04 168.98 3.05 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.828 1.685 . . . . 0.0 114.846 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 42.46 56.47 3.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.609 1.964 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.9 118.53 2.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -79.7 109.16 13.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.891 0.876 . . . . 0.0 109.439 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -95.64 -172.26 2.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.573 0.749 . . . . 0.0 111.5 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.18 169.75 9.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.535 1.934 . . . . 0.0 107.682 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.97 -41.25 97.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.6 p -62.79 -60.62 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.665 1.586 . . . . 0.0 111.994 -171.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 tp -57.63 -27.98 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.278 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -76.17 -50.34 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.65 -38.05 53.08 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.431 1.093 . . . . 0.0 111.897 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.45 -50.48 69.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.0 0.818 . . . . 0.0 109.269 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.25 86.89 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.77 69.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.454 0.301 . . . . 0.0 111.112 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.2 t -74.36 1.04 12.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.943 0.897 . . . . 0.0 112.795 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.81 14.9 55.91 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 119.13 0.877 . . . . 0.0 112.973 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.44 156.56 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.415 1.107 . . . . 0.0 109.674 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.04 124.39 11.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.642 1.577 . . . . 0.0 107.121 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -59.82 150.66 27.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.1 p -137.0 166.45 23.64 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.526 1.53 . . . . 0.0 107.009 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -52.63 -49.79 64.43 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.718 0.807 . . . . 0.0 108.884 173.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.47 -61.04 2.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.135 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -54.54 -46.63 73.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.773 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -60.38 -53.67 45.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.96 -42.69 63.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.04 0.936 . . . . 0.0 110.335 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.9 m -66.72 -59.32 3.68 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -44.31 -50.44 9.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.694 1.598 . . . . 0.0 113.224 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -54.82 -35.35 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.113 0.87 . . . . 0.0 113.034 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -82.71 -18.9 39.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.748 -0.595 . . . . 0.0 112.141 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.34 56.39 7.34 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 124.456 1.102 . . . . 0.0 112.709 -172.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.63 143.44 87.2 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.161 1.241 . . . . 0.0 109.22 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.93 -60.98 4.61 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.82 -42.69 65.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.872 0.869 . . . . 0.0 110.479 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -50.37 -50.78 50.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 111.037 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -67.76 -52.88 32.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.218 0.607 . . . . 0.0 110.23 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -49.12 -33.67 12.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.334 0.653 . . . . 0.0 110.751 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.29 -64.18 1.08 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.177 0.591 . . . . 0.0 110.191 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.49 -56.21 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.33 -41.98 84.34 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.402 0.681 . . . . 0.0 110.929 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 55.15 65.97 1.35 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.088 1.355 . . . . 0.0 111.094 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -129.15 139.88 51.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.291 1.836 . . . . 0.0 107.807 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -50.51 -40.35 51.23 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.271 1.029 . . . . 0.0 110.502 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.46 37.42 2.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.76 0.824 . . . . 0.0 111.42 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.5 66.15 3.18 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.595 0.758 . . . . 0.0 110.557 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -113.72 178.68 4.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.346 1.058 . . . . 0.0 109.29 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 t -144.99 149.84 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -14.33 57.28 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.1 ttt -65.98 77.36 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.531 1.132 . . . . 0.0 113.174 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 58.2 3.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.902 0.881 . . . . 0.0 109.308 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -163.19 137.55 6.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.669 1.588 . . . . 0.0 107.65 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -122.65 160.18 26.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tp -103.04 139.57 38.41 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.89 57.5 1.11 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.807 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 79.99 154.23 0.13 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 126.618 1.967 . . . . 0.0 110.141 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.72 38.27 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.53 -35.38 44.79 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.708 1.147 . . . . 0.0 111.572 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.46 -48.11 82.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.482 0.713 . . . . 0.0 110.298 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.34 -48.25 82.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.933 0.893 . . . . 0.0 109.514 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.71 -42.79 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.84 0.456 . . . . 0.0 110.162 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.19 97.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.769 -0.582 . . . . 0.0 110.109 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.98 95.42 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -58.77 -48.58 80.75 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.848 -0.533 . . . . 0.0 110.049 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.92 -45.12 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.891 -0.506 . . . . 0.0 110.712 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -42.08 85.25 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.692 -0.63 . . . . 0.0 110.328 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -67.49 -30.13 69.74 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.768 -0.583 . . . . 0.0 111.671 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.75 -39.61 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.585 1.154 . . . . 0.0 111.651 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.66 80.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.64 0.733 . . . . 0.0 112.871 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 C-N-CA 126.274 1.83 . . . . 0.0 106.837 170.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . 0.437 ' CBB' ' CZ ' ' A' ' 10' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 N-CA-C 113.82 0.288 . . . . 0.0 113.82 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.54 91.28 2.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.7 11.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.789 0.836 . . . . 0.0 113.14 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.35 -49.36 67.19 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.799 0.727 . . . . 0.0 110.017 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.64 -35.58 76.55 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.72 46.17 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -54.55 -53.89 48.49 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.751 0.82 . . . . 0.0 109.657 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -52.02 -55.47 20.34 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -54.97 -40.33 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.524 1.129 . . . . 0.0 110.693 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -55.82 -25.74 43.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.324 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -58.98 -31.3 68.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 110.894 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -93.78 -49.22 5.94 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.188 0.595 . . . . 0.0 109.865 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.97 -34.23 41.43 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.929 0.892 . . . . 0.0 110.634 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -41.7 -40.27 1.92 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.679 2.392 . . . . 0.0 115.002 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.1 m -25.81 -48.73 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.198 2.199 . . . . 0.0 114.044 -171.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.61 -25.96 13.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.892 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -100.6 -172.0 2.12 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-O 121.467 0.651 . . . . 0.0 112.201 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 m -157.11 161.03 39.4 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.692 1.597 . . . . 0.0 108.645 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.98 122.71 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.891 1.676 . . . . 0.0 107.354 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.5 tp -106.25 131.53 55.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 C-N-CA 125.162 1.385 . . . . 0.0 108.607 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 160.21 82.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.35 -38.31 62.47 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.01 2.474 . . . . 0.0 112.785 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.8 -9.83 56.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.482 1.513 . . . . 0.0 114.099 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.47 57.71 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.174 0.897 . . . . 0.0 113.637 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 m -69.81 126.28 29.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.641 1.721 . . . . 0.0 108.991 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.02 96.62 5.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.81 0.844 . . . . 0.0 110.14 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.06 -48.25 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.7 126.46 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -124.91 82.09 2.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.237 1.815 . . . . 0.0 110.216 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.55 -168.18 40.14 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.09 43.26 0.85 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.885 -1.362 . . . . 0.0 111.771 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 13.45 59.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 129.84 3.256 . . . . 0.0 113.969 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -32.11 13.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.159 1.384 . . . . 0.0 109.086 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.48 162.14 12.55 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.9 140.01 77.25 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.375 3.384 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -55.25 119.87 6.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.72 -2.15 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -64.8 84.08 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.445 1.02 . . . . 0.0 111.718 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.61 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.23 1.395 . . . . 0.0 112.182 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.91 -46.26 96.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-N 119.415 1.607 . . . . 0.0 109.523 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.25 118.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.341 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -29.79 10.85 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.741 1.638 . . . . 0.0 111.028 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -73.78 147.94 42.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.624 0.712 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.7 m -71.11 136.78 48.38 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.48 141.34 37.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.727 -0.608 . . . . 0.0 109.888 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.99 77.37 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.945 -1.475 . . . . 0.0 114.043 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 p -137.33 -0.56 2.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.879 1.839 . . . . 0.0 115.48 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -62.26 129.4 92.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 121.57 1.987 . . . . 0.0 107.641 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -44.62 154.53 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.662 2.908 . . . . 0.0 116.58 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 50.27 66.52 1.12 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.561 1.945 . . . . 0.0 113.631 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -163.41 122.84 2.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.98 0.419 . . . . 0.0 111.112 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.91 83.73 2.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.111 0.964 . . . . 0.0 109.821 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.09 178.16 1.96 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.918 0.487 . . . . 0.0 111.804 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -111.0 171.4 7.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.54 1.162 . . . . 0.0 110.767 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -53.91 15.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 111.986 -2.37 . . . . 0.0 113.013 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.3 m -62.23 -52.89 61.94 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.067 0.937 . . . . 0.0 111.579 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 tt -69.81 -38.84 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.456 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.69 -39.45 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.2 88.44 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.077 -0.389 . . . . 0.0 110.341 177.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.35 -49.81 76.39 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.43 -45.81 8.43 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.519 1.533 . . . . 0.0 112.695 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.3 -28.04 17.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.569 1.548 . . . . 0.0 113.695 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.4 p -73.63 2.74 7.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.118 0.872 . . . . 0.0 112.259 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.75 35.76 21.24 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -77.21 86.6 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.244 -0.562 . . . . 0.0 111.039 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.91 120.32 18.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.499 1.12 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -62.98 122.48 16.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.276 0.23 . . . . 0.0 110.419 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 p -100.31 159.1 15.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -54.65 -37.8 66.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.011 0.434 . . . . 0.0 110.357 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.76 -51.11 68.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.997 0.919 . . . . 0.0 110.171 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -59.71 -47.45 85.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.967 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.6 mt -55.07 -52.16 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.782 0.719 . . . . 0.0 109.284 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.87 65.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.452 0.701 . . . . 0.0 110.743 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -64.99 -54.37 31.57 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.835 0.454 . . . . 0.0 110.239 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -46.2 -52.06 13.09 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.701 1.6 . . . . 0.0 111.253 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -51.3 -28.61 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.669 0.788 . . . . 0.0 112.993 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -78.2 -26.67 47.6 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.711 0.687 . . . . 0.0 112.645 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -154.54 69.16 5.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.992 0.814 . . . . 0.0 111.889 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.11 145.95 97.28 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.198 1.932 . . . . 0.0 110.868 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.27 -59.99 4.79 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.05 70.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -47.89 -52.25 20.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.699 0.8 . . . . 0.0 111.377 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.8 mt -61.49 -56.87 15.31 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.409 1.084 . . . . 0.0 109.704 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.5 -38.76 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.591 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -72.36 -59.5 2.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.875 0.47 . . . . 0.0 109.739 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.03 -41.03 82.32 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.5 tp -86.2 -4.39 59.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.222 1.009 . . . . 0.0 111.876 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 t0 48.06 43.69 18.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.988 1.315 . . . . 0.0 110.366 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.24 107.92 12.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.005 1.322 . . . . 0.0 109.29 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -57.14 -26.27 60.27 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 128.738 2.815 . . . . 0.0 111.752 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -104.85 15.51 27.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.835 0.854 . . . . 0.0 113.264 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.2 113.75 20.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -132.44 131.68 41.99 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.344 1.057 . . . . 0.0 111.151 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -85.02 156.2 21.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.96 -18.71 72.94 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 170.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.73 80.79 0.07 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.593 1.157 . . . . 0.0 113.089 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.72 57.8 2.61 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.057 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -160.84 139.33 9.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.8 1.64 . . . . 0.0 106.606 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -142.53 155.19 44.99 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.5 tp -150.2 111.28 4.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.066 0.947 . . . . 0.0 108.57 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.86 30.99 0.2 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.285 -0.884 . . . . 0.0 112.908 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -161.83 176.7 10.59 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 127.502 2.321 . . . . 0.0 106.1 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.87 -51.52 2.74 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.525 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.72 -56.52 0.12 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.71 2.1 . . . . 0.0 114.732 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -59.98 -51.67 68.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.616 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.25 -48.37 80.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 109.631 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.63 -44.16 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.564 1.146 . . . . 0.0 110.601 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.57 -45.68 93.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.881 -0.512 . . . . 0.0 109.912 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.42 96.11 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -57.81 -52.81 63.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.216 0.606 . . . . 0.0 109.693 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.2 mt -54.17 -53.63 50.78 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.57 65.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.555 0.342 . . . . 0.0 111.443 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.8 m -64.63 -44.76 89.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.668 0.387 . . . . 0.0 111.556 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.96 -39.06 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.815 1.246 . . . . 0.0 111.522 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.5 t -65.85 94.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 125.516 1.527 . . . . 0.0 111.193 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm . . . . . 0 C--O 1.256 1.433 0 CA-C-O 115.449 -2.215 . . . . 0.0 107.303 172.817 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -82.04 99.51 9.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.09 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.062 0.945 . . . . 0.0 113.241 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.53 -48.56 66.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.251 0.932 . . . . 0.0 110.011 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -56.84 -42.48 79.74 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.37 -49.0 66.16 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.67 -51.15 70.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.59 0.695 . . . . 0.0 110.597 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -59.73 -46.85 87.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.515 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -61.29 -27.86 68.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.443 1.097 . . . . 0.0 110.742 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -57.75 -18.13 19.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 111.344 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -55.67 -28.68 56.82 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.427 1.012 . . . . 0.0 110.627 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -68.68 -54.25 17.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.453 -0.779 . . . . 0.0 109.002 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.41 -47.29 56.55 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.023 1.729 . . . . 0.0 109.93 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -47.41 -31.62 4.27 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.296 2.638 . . . . 0.0 112.92 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -53.33 -32.16 47.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.6 m -121.82 -37.01 2.92 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.911 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -101.14 -176.01 3.03 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.673 0.789 . . . . 0.0 112.212 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t -153.13 179.46 8.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.953 1.301 . . . . 0.0 109.788 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -143.49 115.12 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.919 2.488 . . . . 0.0 106.985 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 tp -102.22 148.52 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.667 1.587 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.01 158.09 87.64 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.01 -34.07 98.97 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.063 1.842 . . . . 0.0 111.264 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -75.14 -11.62 60.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.442 1.097 . . . . 0.0 113.324 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 -13.54 35.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.139 -0.812 . . . . 0.0 114.063 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -60.88 127.61 32.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.71 1.755 . . . . 0.0 110.404 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -70.75 82.96 0.63 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.624 0.769 . . . . 0.0 111.191 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.33 -59.99 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 C-N-CA 122.577 0.351 . . . . 0.0 110.07 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.54 -39.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.197 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 57.43 47.32 16.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.94 0.876 . . . . 0.0 109.855 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.91 -172.16 48.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.09 170.8 14.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 110.407 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -124.83 30.81 5.82 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.767 . . . . 0.0 109.385 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -69.92 -40.82 75.34 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.83 167.15 13.31 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 170.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.27 173.25 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.16 2.573 . . . . 0.0 114.337 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -84.68 121.77 28.14 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.64 -2.0 56.85 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.42 113.79 2.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.03 20.41 59.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.954 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.66 -39.65 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 119.105 1.452 . . . . 0.0 108.935 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.37 106.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.543 0.737 . . . . 0.0 109.561 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.12 -17.37 31.97 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.833 1.682 . . . . 0.0 111.902 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -68.2 141.27 56.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.43 1.115 . . . . 0.0 111.217 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -71.88 74.31 0.87 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.907 1.283 . . . . 0.0 111.11 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 52.13 -144.81 0.58 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.889 0.876 . . . . 0.0 112.406 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.34 75.83 0.64 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 123.554 0.597 . . . . 0.0 113.064 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 p -130.24 5.66 4.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.582 1.153 . . . . 0.0 112.196 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 126.56 91.65 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.46 172.77 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.113 1.209 . . . . 0.0 113.274 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 47.0 46.89 16.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.16 1.384 . . . . 0.0 111.853 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -156.42 111.45 2.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.14 -0.35 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.08 89.1 5.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.634 0.773 . . . . 0.0 109.813 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -74.76 -174.81 2.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.594 0.711 . . . . 0.0 111.344 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.34 166.51 13.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.139 1.376 . . . . 0.0 108.675 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.55 -35.0 79.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.31 0.644 . . . . 0.0 112.498 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -58.19 -62.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.971 1.308 . . . . 0.0 111.256 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.56 -35.33 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.932 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -48.84 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.81 90.47 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.898 0.479 . . . . 0.0 110.319 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.59 -45.3 89.4 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.045 0.538 . . . . 0.0 109.735 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.28 -53.19 42.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.6 67.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.329 0.651 . . . . 0.0 111.731 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -67.41 -14.89 63.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.053 0.541 . . . . 0.0 111.952 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.77 14.16 12.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.981 1.277 . . . . 0.0 112.793 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.78 118.29 15.52 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.87 1.335 . . . . 0.0 111.158 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.3 129.45 54.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -66.1 126.88 30.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 159.52 37.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 107.863 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -42.57 -51.77 5.02 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.212 1.405 . . . . 0.0 112.885 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.38 -47.45 85.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.262 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.63 -48.3 81.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.66 0.784 . . . . 0.0 109.647 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.85 -54.03 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.59 -38.21 59.6 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.316 1.046 . . . . 0.0 111.504 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -72.93 -60.23 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -46.73 -43.79 18.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.054 1.342 . . . . 0.0 114.055 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.8 m -52.91 -34.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 119.445 1.02 . . . . 0.0 113.575 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -101.74 -3.38 28.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.059 0.944 . . . . 0.0 111.563 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -133.68 54.54 12.96 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.665 1.586 . . . . 0.0 111.634 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.16 138.19 70.87 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.366 2.711 . . . . 0.0 108.761 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.68 -64.1 3.34 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -45.01 -48.53 11.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.019 1.327 . . . . 0.0 112.646 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.32 -43.71 96.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.088 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.03 -55.51 28.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -49.01 -44.54 41.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.789 1.235 . . . . 0.0 110.432 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -63.8 -68.51 0.34 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.626 0.771 . . . . 0.0 110.304 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -54.84 -40.93 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 -0.55 57.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.666 1.186 . . . . 0.0 111.487 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t0 43.84 53.25 6.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.529 1.531 . . . . 0.0 110.702 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.65 115.36 9.09 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.341 1.056 . . . . 0.0 111.526 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -57.45 -29.41 64.19 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.722 1.209 . . . . 0.0 111.943 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -92.66 11.66 25.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.01 76.84 5.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.522 -0.736 . . . . 0.0 111.734 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.28 152.89 21.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.453 0.701 . . . . 0.0 109.964 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -112.33 151.62 29.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.98 -21.41 61.29 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 170.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ttt -68.13 74.98 0.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 112.438 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.86 58.87 2.98 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 175.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -168.7 146.79 4.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.797 1.639 . . . . 0.0 107.275 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.16 150.09 45.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.11 0.964 . . . . 0.0 108.399 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -111.92 106.37 15.05 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 44.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.159 -0.338 . . . . 0.0 111.633 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -177.41 -171.01 0.31 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.197 1.799 . . . . 0.0 107.444 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.27 -51.54 3.61 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.55 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.64 -75.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 C-N-CA 128.313 2.863 . . . . 0.0 115.952 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.23 -48.43 81.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.339 0.569 . . . . 0.0 112.472 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.79 -49.66 72.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.17 0.988 . . . . 0.0 109.447 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.49 -41.45 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.044 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.07 -48.84 79.84 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.912 -0.492 . . . . 0.0 110.117 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.32 80.91 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.57 -51.05 71.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.03 -36.57 68.15 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.101 0.56 . . . . 0.0 111.616 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.33 -52.3 48.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -53.99 -37.37 63.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.998 0.919 . . . . 0.0 112.593 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.98 -28.67 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.184 1.794 . . . . 0.0 111.961 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.89 83.53 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 118.434 0.561 . . . . 0.0 110.327 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm . . . . . 0 C--O 1.252 1.197 0 CA-C-O 114.45 -2.69 . . . . 0.0 106.233 177.196 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 N-CA-C 113.971 0.348 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -72.68 84.19 1.17 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.19 0.996 . . . . 0.0 109.517 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.45 -35.46 8.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.753 0.821 . . . . 0.0 112.859 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.21 69.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.61 0.641 . . . . 0.0 110.169 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -58.47 -40.96 84.12 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.06 -51.61 52.64 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.05 -50.94 71.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.936 0.894 . . . . 0.0 110.519 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -54.19 -54.03 45.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.01 -35.38 69.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.504 1.122 . . . . 0.0 110.87 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -58.52 -20.91 50.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -61.77 -23.25 66.06 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.647 -0.658 . . . . 0.0 111.027 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.04 -48.96 7.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 t -47.56 -38.55 14.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.321 1.848 . . . . 0.0 113.023 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -22.59 3.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.254 1.022 . . . . 0.0 113.304 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 m -58.76 -22.48 58.1 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -120.91 -34.27 3.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.885 0.874 . . . . 0.0 112.568 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -111.74 174.31 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.059 0.944 . . . . 0.0 113.544 -174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.5 t -145.41 161.75 38.94 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.599 0.76 . . . . 0.0 109.225 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -129.02 135.58 61.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.84 139.49 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.984 1.714 . . . . 0.0 108.946 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 161.08 79.42 Favored Pre-proline 0 C--O 1.232 0.159 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.71 -29.31 88.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.375 1.383 . . . . 0.0 109.434 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.23 -5.64 33.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.66 50.94 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.793 -1.192 . . . . 0.0 112.534 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -58.2 120.96 9.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.77 84.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.648 -0.658 . . . . 0.0 111.158 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.97 -66.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.45 80.44 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -69.69 56.14 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.291 1.436 . . . . 0.0 110.269 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.71 -170.34 46.95 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 164.7 26.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.356 0.598 . . . . 0.0 109.902 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -116.65 37.67 3.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -63.8 -39.48 94.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.51 167.81 12.41 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 171.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.0 151.57 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.755 2.97 . . . . 0.0 112.538 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.18 126.37 27.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.35 11.3 28.73 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.73 82.93 0.45 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.769 -1.207 . . . . 0.0 110.272 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.9 41.29 1.21 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.211 0.91 . . . . 0.0 113.23 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.3 -45.52 93.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -51.3 112.31 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.656 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 -18.17 57.95 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.585 1.088 . . . . 0.0 113.065 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.65 139.08 57.85 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.183 1.491 . . . . 0.0 110.425 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -67.38 72.82 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.265 1.426 . . . . 0.0 112.218 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.85 -148.12 0.49 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.62 -0.675 . . . . 0.0 109.88 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.45 1.1 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.5 p -136.39 10.98 3.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 0.0 111.204 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.26 133.33 94.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.09 155.74 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.026 2.484 . . . . 0.0 115.646 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 49.82 65.65 1.36 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.009 1.724 . . . . 0.0 113.603 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -162.04 123.45 2.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.62 89.44 2.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.965 0.906 . . . . 0.0 109.796 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -73.53 -172.03 1.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.836 0.827 . . . . 0.0 112.087 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.92 166.54 11.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.886 2.075 . . . . 0.0 107.358 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.96 -36.01 80.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.48 0.712 . . . . 0.0 112.18 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 -67.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.51 1.524 . . . . 0.0 110.976 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tp -54.2 -36.79 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.894 1.277 . . . . 0.0 110.935 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.88 -51.0 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.381 0.672 . . . . 0.0 109.38 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.82 69.34 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.903 0.481 . . . . 0.0 110.775 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.32 -48.83 75.92 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.21 70.07 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.37 53.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.067 0.547 . . . . 0.0 111.269 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -75.52 13.03 0.84 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.97 27.74 52.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.167 0.889 . . . . 0.0 112.752 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -88.75 123.2 32.94 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.755 0.777 . . . . 0.0 109.692 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.1 131.31 55.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -64.32 93.35 0.09 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.022 0.374 . . . . 0.0 111.659 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.8 p -79.92 168.71 18.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -57.71 -41.05 80.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.829 -0.545 . . . . 0.0 109.87 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.15 -49.36 72.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.317 1.047 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -58.13 -51.76 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.1 mt -54.77 -54.57 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.63 67.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.799 0.44 . . . . 0.0 111.321 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 m -67.95 -44.07 77.61 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.281 -0.262 . . . . 0.0 110.995 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -54.84 -44.37 73.87 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.317 -0.865 . . . . 0.0 111.062 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.15 -26.88 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.832 0.453 . . . . 0.0 111.475 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -89.23 -33.54 16.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.868 0.867 . . . . 0.0 111.577 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -137.59 67.34 51.64 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.65 144.67 97.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.956 1.771 . . . . 0.0 110.585 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.68 -63.37 4.01 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.61 67.36 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.552 0.741 . . . . 0.0 110.77 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.34 -40.44 90.68 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.642 0.258 . . . . 0.0 111.673 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.14 -60.29 3.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -41.82 -50.22 4.38 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.379 1.472 . . . . 0.0 110.995 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -39.88 -52.17 2.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.095 1.358 . . . . 0.0 112.128 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -89.6 -52.78 4.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.973 0.909 . . . . 0.0 112.322 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.7 tp -73.09 -21.74 60.7 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -172.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t0 45.2 46.3 9.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.771 2.029 . . . . 0.0 111.894 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.07 129.91 52.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -31.21 71.04 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 126.182 1.793 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -88.26 17.31 5.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 0.0 111.719 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.95 64.93 6.86 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.442 -1.411 . . . . 0.0 110.246 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -103.55 -176.73 3.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.412 1.485 . . . . 0.0 108.619 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.71 150.94 38.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.83 -18.74 57.51 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 ttt -65.0 81.2 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.572 1.149 . . . . 0.0 113.635 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.8 3.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.531 0.732 . . . . 0.0 109.343 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -161.73 142.15 10.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.739 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -152.41 175.1 13.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.428 1.091 . . . . 0.0 108.814 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -158.38 122.07 3.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.86 50.19 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.692 0.797 . . . . 0.0 111.443 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? 166.03 -174.1 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 129.6 3.16 . . . . 0.0 105.528 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.95 -54.29 4.44 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 111.534 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -36.17 -50.08 1.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.592 1.568 . . . . 0.0 113.342 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -55.11 -60.63 3.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.503 1.121 . . . . 0.0 112.348 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.34 -41.23 98.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.383 0.673 . . . . 0.0 111.066 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.8 t -59.59 -42.09 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.02 79.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.936 0.789 . . . . 0.0 110.147 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.31 86.21 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.384 -0.198 . . . . 0.0 110.499 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.44 -55.11 35.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.71 -40.12 68.89 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.376 0.67 . . . . 0.0 111.649 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.59 7.01 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.694 0.679 . . . . 0.0 109.871 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.8 p -56.24 -32.81 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.1 -32.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 111.595 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.86 83.62 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 C--O 1.249 1.052 0 C-N-CA 127.409 2.284 . . . . 0.0 106.953 178.38 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -86.55 103.21 14.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.91 -33.2 4.36 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 112.762 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.16 71.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.181 0.9 . . . . 0.0 110.167 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -38.72 90.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.81 -49.81 71.1 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -54.5 -53.44 54.29 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.673 0.789 . . . . 0.0 109.441 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -58.0 -49.06 78.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.649 0.261 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.25 -31.13 67.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.576 1.15 . . . . 0.0 110.92 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.47 -18.17 17.17 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.072 -0.392 . . . . 0.0 111.849 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -52.18 -29.15 20.97 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.384 0.674 . . . . 0.0 110.735 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.67 -55.86 5.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.8 m -48.69 -43.73 37.3 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.19 1.396 . . . . 0.0 112.415 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -52.73 -25.35 10.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 113.157 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 -25.77 59.95 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.866 -0.521 . . . . 0.0 110.745 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.03 -45.14 2.38 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.238 0.615 . . . . 0.0 110.81 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -91.8 -176.85 4.58 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -151.73 167.77 27.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.303 1.841 . . . . 0.0 110.139 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.3 mm -136.3 117.7 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.768 1.627 . . . . 0.0 108.043 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tp -115.72 126.97 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.159 1.384 . . . . 0.0 109.045 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 163.95 29.5 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.221 -0.924 . . . . 0.0 108.685 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.58 -36.92 98.34 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.446 2.097 . . . . 0.0 110.323 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.01 3.55 6.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.685 1.594 . . . . 0.0 113.119 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.88 90.53 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.688 -1.257 . . . . 0.0 112.7 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -71.44 114.12 9.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.6 1.2 . . . . 0.0 109.171 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.15 104.02 1.09 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.795 -0.566 . . . . 0.0 109.815 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.9 mm -76.21 -47.44 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.98 96.74 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 58.66 1.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.485 1.514 . . . . 0.0 108.216 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.44 -158.91 27.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 175.97 10.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -124.58 30.48 5.97 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -38.43 83.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.52 171.56 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -63.74 174.62 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.265 3.31 . . . . 0.0 112.387 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -87.24 121.2 29.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.6 mt -86.61 1.33 52.19 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.34 99.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.35 0.977 . . . . 0.0 109.616 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.97 33.16 21.81 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 119.085 -0.841 . . . . 0.0 113.32 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.75 -31.04 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.753 1.276 . . . . 0.0 108.69 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.44 113.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.198 0.999 . . . . 0.0 110.461 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.16 -10.26 75.42 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.177 1.37 . . . . 0.0 112.749 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.95 144.64 29.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.158 0.979 . . . . 0.0 110.005 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 m -63.86 134.1 54.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.31 141.45 54.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.659 -0.651 . . . . 0.0 110.613 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.61 33.78 81.97 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.968 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.2 p -132.03 -0.77 3.74 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.897 1.348 . . . . 0.0 114.151 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -64.56 126.72 91.31 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 120.342 1.428 . . . . 0.0 107.153 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.76 161.32 18.54 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.402 2.068 . . . . 0.0 113.327 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 56.27 55.08 7.01 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.411 1.485 . . . . 0.0 112.282 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -162.55 120.18 2.07 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.151 -0.343 . . . . 0.0 110.576 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -79.15 98.45 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.254 1.022 . . . . 0.0 110.246 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.99 -171.69 3.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.8 0.809 . . . . 0.0 111.553 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -105.28 157.91 16.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 109.279 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.53 -34.39 72.58 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.419 0.687 . . . . 0.0 112.43 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.8 p -63.95 -64.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.751 1.22 . . . . 0.0 109.779 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.2 tt -58.2 -37.22 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.624 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.55 -49.9 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.83 88.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.436 0.562 . . . . 0.0 110.802 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 tp -56.33 -47.34 78.94 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.1 -56.29 21.92 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.232 0.92 . . . . 0.0 111.012 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -31.22 61.74 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.265 1.426 . . . . 0.0 111.807 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 m -69.05 -0.63 6.01 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.57 27.77 8.89 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.374 1.464 . . . . 0.0 111.477 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -84.45 96.76 9.2 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 117.978 0.889 . . . . 0.0 111.18 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.62 127.44 35.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -67.35 103.98 1.41 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.977 0.353 . . . . 0.0 111.615 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.5 p -84.45 162.09 20.07 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -57.61 -37.11 72.7 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.738 0.415 . . . . 0.0 110.332 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -63.69 -55.42 23.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.76 -50.27 68.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.48 -54.52 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.05 -41.12 71.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.334 0.653 . . . . 0.0 111.842 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.8 m -69.76 -56.08 8.14 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -43.3 -51.93 6.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.714 1.606 . . . . 0.0 113.461 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.6 m -53.41 -30.98 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.81 -23.9 63.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.797 -0.621 . . . . 0.0 112.07 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -160.95 68.04 2.5 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 119.086 0.857 . . . . 0.0 112.56 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.58 151.79 81.35 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 120.979 1.12 . . . . 0.0 109.412 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.83 -61.09 4.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.15 78.88 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.282 -0.54 . . . . 0.0 109.673 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -51.52 -56.36 13.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.124 0.97 . . . . 0.0 110.523 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 mp -57.64 -48.66 78.85 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.167 0.587 . . . . 0.0 110.901 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -54.87 -51.27 66.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.154 0.433 . . . . 0.0 110.291 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -54.48 -51.9 63.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.856 0.863 . . . . 0.0 111.015 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -72.87 -49.66 28.64 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 tp -77.91 -24.2 48.42 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.511 1.125 . . . . 0.0 113.46 -174.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.09 50.64 16.14 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.564 1.546 . . . . 0.0 110.048 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -135.29 130.02 34.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.448 1.499 . . . . 0.0 109.514 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -58.52 -35.25 71.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.291 0.636 . . . . 0.0 110.53 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -84.47 15.67 3.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.22 66.18 4.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.639 0.775 . . . . 0.0 110.992 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -94.32 -179.71 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.118 1.367 . . . . 0.0 110.27 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -155.83 157.64 36.77 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.92 -11.95 84.9 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 172.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.3 ttt -69.35 77.22 0.38 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 118.787 1.293 . . . . 0.0 113.144 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.51 58.17 3.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.28 1.032 . . . . 0.0 109.606 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -162.94 139.69 7.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -138.82 160.53 39.48 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -157.19 107.1 2.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.48 43.8 0.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.517 0.727 . . . . 0.0 112.242 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -177.52 -177.99 0.72 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.006 1.723 . . . . 0.0 107.243 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.32 -50.22 2.75 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.604 -0.553 . . . . 0.0 113.367 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -28.1 -51.65 0.1 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 127.319 2.39 . . . . 0.0 115.329 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -61.22 -48.56 80.95 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.796 0.798 . . . . 0.0 111.012 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.52 -46.7 84.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.86 0.864 . . . . 0.0 109.152 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.49 -43.41 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.517 0.727 . . . . 0.0 110.329 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.86 92.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.864 -0.523 . . . . 0.0 109.603 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.31 91.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.527 0.203 . . . . 0.0 110.458 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.8 -52.99 62.9 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.928 0.491 . . . . 0.0 110.058 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.8 mt -57.11 -45.53 83.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.059 0.391 . . . . 0.0 110.776 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.28 81.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.237 0.615 . . . . 0.0 110.8 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.2 m -68.92 -42.37 76.9 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.029 -0.42 . . . . 0.0 110.691 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.26 -44.17 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.141 1.377 . . . . 0.0 112.247 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.05 82.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.8 pttm . . . . . 0 C--O 1.25 1.107 0 CA-C-O 115.99 -1.957 . . . . 0.0 108.974 172.666 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.46 115.17 27.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.32 1.448 . . . . 0.0 108.765 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.13 -33.78 53.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.511 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.97 -53.5 38.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.541 1.064 . . . . 0.0 110.06 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -54.77 -41.55 70.65 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.72 -50.72 56.75 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -56.17 -49.58 73.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.403 0.681 . . . . 0.0 109.268 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.2 -50.28 74.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.477 0.18 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -58.18 -32.45 68.24 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 124.953 1.301 . . . . 0.0 110.634 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -58.95 -21.26 57.98 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -21.55 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.829 -0.544 . . . . 0.0 110.284 174.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -86.71 -49.43 7.48 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.286 -0.884 . . . . 0.0 109.157 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.9 m -51.2 -40.17 58.1 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.478 1.111 . . . . 0.0 111.912 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.11 -21.45 4.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 113.254 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -56.81 -23.74 45.9 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.536 -0.728 . . . . 0.0 110.409 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m -125.54 -49.62 1.65 Allowed 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 122.984 0.513 . . . . 0.0 109.844 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.17 -174.78 4.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.194 0.997 . . . . 0.0 113.49 -172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 m -158.69 164.9 35.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.468 1.907 . . . . 0.0 108.737 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.9 mm -136.9 119.57 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.913 1.685 . . . . 0.0 107.23 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.98 132.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.201 0.6 . . . . 0.0 110.753 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.21 152.84 83.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.95 -34.05 90.84 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.96 2.44 . . . . 0.0 112.103 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.59 -9.11 57.72 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.406 1.082 . . . . 0.0 113.346 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.17 -14.07 44.2 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.837 -0.979 . . . . 0.0 113.576 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -60.06 112.27 1.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.651 1.725 . . . . 0.0 109.908 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.23 121.41 16.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.012 0.925 . . . . 0.0 109.794 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.08 -45.77 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.61 100.61 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -88.11 72.13 9.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.39 -178.67 45.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.87 68.95 7.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.78 -0.835 . . . . 0.0 109.081 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -35.47 62.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 1 C-N-CA 133.541 4.737 . . . . 0.0 115.934 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -96.17 -30.16 13.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.842 2.057 . . . . 0.0 108.586 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.8 169.66 13.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.54 163.71 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.945 3.097 . . . . 0.0 114.04 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -85.14 117.43 24.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.6 0.95 44.54 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.13 106.36 0.6 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.01 15.09 49.99 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.406 -1.219 . . . . 0.0 113.604 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.17 -38.67 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.938 1.869 . . . . 0.0 110.184 176.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.86 112.22 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -20.73 49.05 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.077 1.322 . . . . 0.0 112.024 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -72.96 140.54 47.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.045 0.923 . . . . 0.0 109.918 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 m -64.2 121.95 15.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.49 150.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.252 0.549 . . . . 0.0 111.789 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.73 13.16 60.77 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.09 -1.395 . . . . 0.0 113.753 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -142.44 35.27 1.48 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.679 1.74 . . . . 0.0 113.67 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -80.58 135.06 53.34 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 165.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -57.63 155.94 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.314 1.343 . . . . 0.0 113.144 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 55.86 64.14 1.82 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.898 1.679 . . . . 0.0 113.852 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -163.59 123.67 2.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.76 -0.587 . . . . 0.0 110.974 172.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -77.0 77.48 3.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.197 0.999 . . . . 0.0 110.149 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -69.31 -172.66 0.46 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.308 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -113.89 160.56 18.64 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.804 1.641 . . . . 0.0 110.857 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.57 -38.67 60.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.559 1.144 . . . . 0.0 113.525 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -65.91 -55.6 16.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.595 0.712 . . . . 0.0 110.67 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 tt -66.68 -35.26 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.75 -49.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.92 88.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.868 0.467 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.6 tp -56.15 -46.43 79.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.35 -55.66 25.56 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.29 0.948 . . . . 0.0 110.91 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.01 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.569 1.148 . . . . 0.0 111.497 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 m -72.67 6.48 2.45 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.43 25.42 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.196 1.379 . . . . 0.0 112.091 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -80.99 78.83 7.77 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.658 -0.907 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.55 116.8 14.55 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -59.58 121.2 11.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.0 p -99.87 164.97 11.79 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -55.91 -46.45 78.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.909 0.862 . . . . 0.0 109.639 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -58.83 -52.47 65.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.16 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -60.47 -46.76 88.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.57 -53.24 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.82 -37.99 64.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.178 0.991 . . . . 0.0 111.484 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 m -72.74 -58.91 2.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -43.98 -47.98 8.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.899 1.679 . . . . 0.0 113.245 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 m -51.93 -34.42 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -75.09 -25.05 58.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.0 112.095 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -145.63 61.79 7.93 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.892 0.877 . . . . 0.0 113.043 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.18 148.09 93.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.668 1.578 . . . . 0.0 109.446 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.96 -65.64 3.22 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.2 62.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.773 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -51.61 -54.48 27.29 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.656 0.782 . . . . 0.0 110.471 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 mp -60.34 -49.27 78.26 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 122.969 0.508 . . . . 0.0 111.174 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.35 -46.27 66.04 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.954 0.343 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.16 -65.94 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.25 0.62 . . . . 0.0 110.345 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -56.38 -41.24 75.92 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.7 -6.63 59.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.721 0.808 . . . . 0.0 111.581 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 48.28 52.87 12.73 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.291 1.436 . . . . 0.0 109.604 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -143.72 155.74 44.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.998 0.919 . . . . 0.0 110.801 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -91.44 -41.3 10.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.945 1.698 . . . . 0.0 108.619 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.03 39.7 0.51 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.857 0.863 . . . . 0.0 111.99 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.26 111.44 22.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.537 0.735 . . . . 0.0 109.412 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -124.46 -176.04 3.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.862 0.865 . . . . 0.0 112.066 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -159.75 147.05 16.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.37 64.15 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.6 ttt -66.98 79.84 0.12 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 118.452 1.126 . . . . 0.0 113.651 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.02 57.49 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.655 0.782 . . . . 0.0 109.438 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -165.22 125.92 1.94 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.648 1.179 . . . . 0.0 108.565 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -115.47 159.9 20.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.29 103.74 3.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.92 44.44 0.55 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.191 0.596 . . . . 0.0 111.413 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -174.85 -176.57 1.01 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.814 1.646 . . . . 0.0 107.581 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.15 -52.93 3.41 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.272 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -11.75 -72.07 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 128.525 2.965 . . . . 0.0 116.045 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.5 -45.97 90.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.126 0.963 . . . . 0.0 112.412 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.49 -49.7 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 109.116 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.69 -43.04 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.423 0.689 . . . . 0.0 109.945 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.39 93.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.998 -0.439 . . . . 0.0 110.102 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.77 93.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.041 0.382 . . . . 0.0 110.418 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -57.08 -53.1 61.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.95 -41.54 83.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.115 -0.366 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.58 85.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.638 0.775 . . . . 0.0 110.585 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -69.58 -41.04 76.35 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.039 -0.413 . . . . 0.0 110.343 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.52 -38.12 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.732 1.213 . . . . 0.0 112.425 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.42 85.07 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.238 0.926 . . . . 0.0 111.672 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.9 pttp . . . . . 0 C--O 1.254 1.329 0 CA-C-O 115.474 -2.203 . . . . 0.0 108.118 176.038 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.099 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.98 85.07 2.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.943 -0.74 . . . . 0.0 110.21 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.33 -35.88 40.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.739 0.816 . . . . 0.0 112.496 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.02 65.54 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.78 -0.575 . . . . 0.0 110.067 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -57.84 -41.53 82.51 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.82 -48.07 68.45 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -57.06 -50.37 72.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.285 0.543 . . . . 0.0 110.585 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -59.37 -51.04 71.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.234 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -56.07 -31.49 63.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.398 1.879 . . . . 0.0 110.621 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.88 -19.73 7.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.586 0.754 . . . . 0.0 112.125 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -51.0 -34.35 28.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.454 0.57 . . . . 0.0 110.667 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -77.7 -49.23 14.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -48.3 -49.09 35.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.307 1.043 . . . . 0.0 110.654 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.82 -11.5 27.72 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.6 m -56.63 -33.63 66.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.7 m -113.99 -39.64 3.9 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.437 0.695 . . . . 0.0 110.341 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -95.47 -172.42 2.63 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -159.96 172.83 16.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.984 2.113 . . . . 0.0 107.648 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -132.67 132.43 59.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 tp -116.32 143.9 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.853 1.661 . . . . 0.0 109.164 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.37 159.11 82.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.27 -42.44 47.35 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.138 2.559 . . . . 0.0 112.863 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -73.0 -11.91 60.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.311 1.444 . . . . 0.0 113.671 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -14.32 34.57 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.977 -0.901 . . . . 0.0 113.682 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.7 m -57.77 125.63 23.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.532 1.666 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.21 82.16 1.0 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 110.724 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.1 mm -57.7 -61.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.43 98.32 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.8 67.83 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.051 0.94 . . . . 0.0 109.188 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.22 -162.99 28.53 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.53 176.43 9.05 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -130.49 33.07 4.33 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -71.06 -35.9 72.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.745 1.218 . . . . 0.0 108.191 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.88 161.86 12.61 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 174.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.44 125.54 18.23 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.848 3.032 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.16 114.86 1.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 108.759 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.6 mt -72.19 -16.44 61.96 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -168.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -52.97 120.39 5.78 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.732 1.151 . . . . 0.0 108.946 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.6 12.31 72.65 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.809 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.44 -42.34 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.31 1.555 . . . . 0.0 109.544 174.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.73 118.09 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.195 0.598 . . . . 0.0 110.612 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.96 57.2 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.167 0.889 . . . . 0.0 112.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -70.7 148.69 47.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.059 1.429 . . . . 0.0 110.482 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -76.09 59.48 1.33 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.815 1.246 . . . . 0.0 110.424 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 36.57 -123.54 0.17 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.164 1.786 . . . . 0.0 113.465 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.67 73.16 0.0 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.017 1.77 . . . . 0.0 115.298 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.1 t -160.18 9.13 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.31 1.055 . . . . 0.0 113.433 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -64.24 134.53 95.99 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 120.979 -1.076 . . . . 0.0 108.63 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -64.32 157.22 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.416 1.41 . . . . 0.0 111.31 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 47.68 58.46 4.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.149 1.38 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -154.83 119.98 4.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.148 0.499 . . . . 0.0 109.873 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -73.1 77.25 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.475 1.11 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.83 -176.93 1.17 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 110.515 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -113.25 173.71 6.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.158 0.983 . . . . 0.0 108.799 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.25 -41.64 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.202 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 p -60.22 -64.88 0.79 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.975 1.31 . . . . 0.0 111.719 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -38.82 75.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.121 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.54 -49.28 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.16 91.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.571 0.349 . . . . 0.0 111.005 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.7 tp -55.96 -52.58 63.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.37 -54.63 28.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.68 48.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.53 1.132 . . . . 0.0 112.585 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -71.15 2.12 5.0 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.92 34.07 8.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.663 1.125 . . . . 0.0 110.923 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -97.54 117.4 31.73 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.206 0.503 . . . . 0.0 109.849 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.11 137.92 45.26 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.632 1.173 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -73.79 95.77 2.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.587 0.355 . . . . 0.0 111.915 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 p -78.77 167.55 21.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -55.97 -43.63 77.73 Favored 'General case' 0 N--CA 1.459 -0.017 0 CA-C-O 121.923 0.868 . . . . 0.0 109.893 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.58 -51.75 67.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.059 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.42 -49.38 78.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.361 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.98 -52.91 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.83 -42.0 75.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.078 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.5 m -67.26 -51.48 52.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.243 0.217 . . . . 0.0 110.54 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -43.62 -56.36 3.77 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 125.266 1.427 . . . . 0.0 112.9 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 m -52.35 -30.18 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -73.12 -28.68 62.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.005 0.522 . . . . 0.0 112.008 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -151.95 62.63 4.82 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 124.432 1.093 . . . . 0.0 111.215 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.78 159.14 53.61 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.53 -63.83 3.64 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.53 67.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.198 0.999 . . . . 0.0 110.464 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -52.41 -48.27 65.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.089 0.556 . . . . 0.0 110.554 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.63 -59.31 5.39 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -45.3 -48.39 13.03 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.633 1.173 . . . . 0.0 110.727 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.37 -70.46 0.17 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.303 1.041 . . . . 0.0 110.712 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -63.15 -31.53 72.69 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -171.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.48 -7.42 59.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.396 0.679 . . . . 0.0 111.256 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.24 54.37 10.38 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 109.286 -175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -138.62 152.16 47.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.588 1.155 . . . . 0.0 109.776 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -48.63 6.86 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.779 1.632 . . . . 0.0 108.13 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -80.96 30.18 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.07 67.27 8.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.277 -0.889 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.83 154.68 40.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.964 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -123.17 149.82 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.4 -26.25 74.45 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 15.5 ttp -68.48 80.78 0.26 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.642 0.721 . . . . 0.0 112.146 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 57.94 3.12 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.48 146.89 13.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -143.1 160.7 39.91 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.3 tp -161.05 112.49 1.82 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.2 33.92 0.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.662 -0.649 . . . . 0.0 112.56 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -159.49 179.54 8.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.202 2.201 . . . . 0.0 106.848 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.46 -55.13 4.39 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.05 -57.15 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 126.209 1.861 . . . . 0.0 114.075 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 3.6 pm0 -52.75 -58.2 7.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.038 1.335 . . . . 0.0 113.004 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.92 -40.51 79.03 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.781 -0.574 . . . . 0.0 111.019 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.97 -41.11 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.928 -0.483 . . . . 0.0 110.418 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.04 -46.64 87.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.754 -0.591 . . . . 0.0 109.749 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.18 -43.78 95.6 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.85 -49.22 77.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.37 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 mt -57.87 -45.54 86.19 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.222 0.465 . . . . 0.0 110.593 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.71 79.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.826 0.451 . . . . 0.0 110.642 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -70.15 -39.61 75.24 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.135 -0.353 . . . . 0.0 110.866 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.92 -38.93 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.677 1.591 . . . . 0.0 112.596 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.54 0.566 0 CA-C-N 119.499 1.045 . . . . 0.0 110.574 -179.493 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 CA-C-O 121.115 0.286 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -81.71 88.84 6.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.199 1.0 . . . . 0.0 108.853 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.53 -42.51 2.42 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.807 1.243 . . . . 0.0 112.978 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.59 73.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.597 0.759 . . . . 0.0 111.467 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -69.42 -37.21 77.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -51.47 -43.03 52.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.421 1.01 . . . . 0.0 111.228 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -52.5 -46.94 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.459 0.704 . . . . 0.0 110.848 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.96 -46.47 65.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.518 0.727 . . . . 0.0 109.567 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.21 -35.5 67.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.097 0.959 . . . . 0.0 110.579 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -56.91 -16.95 7.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.128 0.971 . . . . 0.0 112.428 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -52.2 -29.61 23.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.562 -0.711 . . . . 0.0 110.545 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -72.76 -55.61 6.49 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.46 -46.19 56.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.421 1.089 . . . . 0.0 112.889 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -55.86 -21.81 21.98 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -59.4 -26.12 64.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.3 m -118.83 -43.81 2.65 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.524 0.729 . . . . 0.0 111.09 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 37' ' ' LEU . 91.0 m-70 -97.98 -172.17 2.31 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.272 1.029 . . . . 0.0 112.85 -175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -151.04 169.05 22.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.571 1.548 . . . . 0.0 109.057 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.9 mt -133.31 124.08 48.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -145.61 134.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.932 0.893 . . . . 0.0 110.012 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.11 161.98 68.78 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -54.58 -37.0 90.62 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 110.982 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.41 -0.57 6.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.711 1.604 . . . . 0.0 113.315 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.85 -7.32 81.6 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 120.848 -1.158 . . . . 0.0 112.415 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -64.82 103.19 0.67 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.457 1.128 . . . . 0.0 109.125 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.03 120.78 14.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.699 0.4 . . . . 0.0 111.255 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.43 -45.92 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.84 106.37 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -72.16 56.5 0.33 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.039 1.336 . . . . 0.0 110.172 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.26 -173.61 13.0 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 167.94 7.46 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.098 -0.648 . . . . 0.0 111.085 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -117.09 30.66 7.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.731 0.812 . . . . 0.0 109.261 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -67.27 -44.11 80.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.53 171.72 17.65 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 107.636 -2.185 . . . . 0.0 107.636 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.77 177.27 1.87 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.243 3.295 . . . . 0.0 113.087 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 114.1 21.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 17' ' ' HIS . 95.2 mt -71.45 -16.93 62.39 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.75 116.0 2.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.99 15.27 70.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.56 -1.133 . . . . 0.0 114.837 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.5 -44.96 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.928 1.864 . . . . 0.0 108.892 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.65 113.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 -15.17 59.75 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.832 1.206 . . . . 0.0 112.744 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -90.31 144.65 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.541 1.17 . . . . 0.0 110.919 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -58.69 133.35 55.84 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.628 1.171 . . . . 0.0 109.126 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.81 159.33 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.534 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.92 23.53 31.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.975 1.274 . . . . 0.0 114.477 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.1 p -145.31 22.94 1.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.888 1.344 . . . . 0.0 113.01 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -67.32 137.44 93.84 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.06 154.35 10.64 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.311 2.007 . . . . 0.0 114.565 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 45.06 59.35 3.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.276 1.83 . . . . 0.0 113.269 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.31 118.57 2.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -82.88 98.27 9.1 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.028 0.931 . . . . 0.0 109.725 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -82.68 -172.83 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 111.152 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -96.35 -176.91 3.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.924 1.29 . . . . 0.0 108.546 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.77 -34.47 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.928 0.891 . . . . 0.0 113.12 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 p -60.42 -65.38 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.46 1.104 . . . . 0.0 110.387 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.54 -40.28 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.156 1.383 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.8 t -59.82 -50.74 78.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.2 97.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.123 0.42 . . . . 0.0 111.108 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -53.31 53.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.73 64.59 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 123.766 0.698 . . . . 0.0 111.836 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.72 -26.82 47.24 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.488 1.515 . . . . 0.0 112.033 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.2 m -69.56 0.59 5.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.01 0.368 . . . . 0.0 111.938 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.97 38.4 5.76 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 125.446 1.498 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -107.11 110.06 22.06 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.378 0.589 . . . . 0.0 111.676 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 128.11 43.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.218 1.407 . . . . 0.0 107.55 174.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -62.75 151.76 37.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 110.796 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.0 p -129.82 162.56 28.23 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.949 1.7 . . . . 0.0 106.452 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.38 -39.68 80.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.061 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.55 -52.53 64.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.551 0.741 . . . . 0.0 110.216 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -61.03 -45.34 95.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.431 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.1 -53.03 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 118.675 0.671 . . . . 0.0 109.335 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.75 -46.45 64.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.462 0.705 . . . . 0.0 110.052 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.5 m -62.24 -54.4 41.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 109.915 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -50.08 -48.45 53.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.816 1.246 . . . . 0.0 113.04 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.3 m -60.47 -28.13 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.331 0.969 . . . . 0.0 112.689 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.24 -13.4 52.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.663 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -139.54 57.71 10.59 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.989 1.716 . . . . 0.0 112.07 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.08 138.43 78.15 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.926 2.418 . . . . 0.0 109.663 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.6 -65.17 2.49 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.42 -45.65 9.14 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 125.924 1.69 . . . . 0.0 111.529 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -55.1 -55.49 30.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.898 0.479 . . . . 0.0 110.664 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 83' ' ' LEU . 6.2 mp -56.74 -53.03 62.46 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.208 0.603 . . . . 0.0 109.997 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -52.35 -44.2 65.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.765 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.09 -67.15 0.45 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.605 0.762 . . . . 0.0 110.22 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -53.86 -42.74 68.9 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.16 -4.05 59.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.117 0.567 . . . . 0.0 111.847 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.3 t0 47.6 45.11 17.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.094 1.358 . . . . 0.0 110.009 -174.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.24 111.61 11.01 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.459 1.104 . . . . 0.0 110.52 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -57.46 -26.05 60.63 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.002 2.521 . . . . 0.0 111.787 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -96.49 9.61 40.84 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.22 72.71 7.06 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.502 -0.749 . . . . 0.0 110.357 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -91.73 126.79 36.94 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.701 0.8 . . . . 0.0 109.976 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -80.78 161.94 24.29 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.15 0.5 . . . . 0.0 110.498 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.13 -22.76 70.35 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 169.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ttp -68.26 81.02 0.24 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.991 0.895 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.0 58.04 3.31 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -160.19 150.43 18.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.539 1.536 . . . . 0.0 107.387 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -141.98 158.34 43.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.319 1.048 . . . . 0.0 108.543 173.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.71 102.81 11.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.08 67.73 1.79 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.889 1.276 . . . . 0.0 109.958 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 89.3 139.45 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 129.195 2.998 . . . . 0.0 109.35 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.9 -21.76 7.83 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -49.48 -41.59 33.33 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.492 1.044 . . . . 0.0 112.63 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.45 -46.56 88.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.443 0.622 . . . . 0.0 110.868 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.6 -49.2 77.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.283 1.433 . . . . 0.0 110.17 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.59 -44.96 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.66 91.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.87 -0.518 . . . . 0.0 110.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.06 94.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -57.22 -49.42 76.07 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.908 -0.495 . . . . 0.0 110.269 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.27 -44.21 88.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.429 -0.794 . . . . 0.0 111.206 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.47 73.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.442 0.697 . . . . 0.0 110.752 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -72.38 -37.73 68.66 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.123 -0.36 . . . . 0.0 110.679 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -69.27 -47.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.806 1.242 . . . . 0.0 112.43 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 122.566 1.174 . . . . 0.0 111.841 -176.766 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -77.08 84.14 3.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -39.06 -41.6 0.81 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.604 1.561 . . . . 0.0 113.601 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.29 36.74 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.455 0.57 . . . . 0.0 110.627 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -57.25 -38.47 73.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.308 0.643 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.52 -52.05 47.75 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.74 -50.37 73.44 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.15 0.98 . . . . 0.0 110.165 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.57 -51.62 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.459 -0.201 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.95 -38.33 70.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.828 0.851 . . . . 0.0 109.627 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -56.97 -29.95 63.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -33.54 67.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.025 -0.422 . . . . 0.0 110.231 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -87.66 -48.66 7.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.742 0.817 . . . . 0.0 109.006 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.2 t -49.22 -37.57 23.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.588 1.555 . . . . 0.0 112.038 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 5.01 0.68 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -55.83 -30.53 61.58 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.798 -1.189 . . . . 0.0 110.213 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.18 -37.28 5.37 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.563 0.745 . . . . 0.0 112.593 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -105.71 -174.43 2.53 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.676 0.791 . . . . 0.0 112.337 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 m -150.67 171.25 17.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.015 1.326 . . . . 0.0 109.619 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -133.16 133.28 58.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tp -117.14 141.86 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.537 1.535 . . . . 0.0 109.247 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.26 154.76 88.22 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.53 -38.84 45.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.12 2.547 . . . . 0.0 113.537 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.57 -16.25 62.84 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.738 1.215 . . . . 0.0 113.779 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.48 -13.52 23.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.667 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.3 m -60.63 124.85 21.61 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.625 1.712 . . . . 0.0 110.014 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -72.74 77.35 1.12 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.673 0.789 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.2 mm -52.94 -55.43 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.17 86.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.28 65.25 0.84 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.143 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.24 -158.53 33.57 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.53 174.09 11.38 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -121.92 28.44 7.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 109.201 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -66.9 -43.42 83.45 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.13 171.03 18.38 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 170.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.69 -173.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.61 2.873 . . . . 0.0 114.049 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -117.63 89.99 3.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 108.594 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 6.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 119.208 3.04 . . . . 0.0 119.208 -169.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -59.75 102.44 0.15 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 121.29 1.859 . . . . 0.0 108.736 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.36 21.81 31.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.485 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.98 -40.69 89.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-N 118.599 1.199 . . . . 0.0 109.4 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.06 98.71 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -16.06 9.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.506 2.003 . . . . 0.0 111.569 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -71.48 136.19 47.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 117.987 0.893 . . . . 0.0 110.409 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -71.4 67.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.598 1.559 . . . . 0.0 111.794 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 62.54 -149.86 0.36 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.314 1.046 . . . . 0.0 111.621 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.84 80.99 0.18 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 123.155 0.407 . . . . 0.0 113.173 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 t -150.32 21.02 0.85 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -68.12 143.14 95.73 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.29 153.9 20.58 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.39 1.393 . . . . 0.0 114.012 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 47.47 65.24 1.32 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.25 1.82 . . . . 0.0 112.875 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -158.7 120.93 3.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.137 0.494 . . . . 0.0 110.607 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -75.21 78.12 2.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.37 1.068 . . . . 0.0 110.7 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -67.41 178.19 1.65 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.884 0.474 . . . . 0.0 111.315 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -112.15 174.91 5.66 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.735 1.214 . . . . 0.0 109.663 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.28 -39.49 87.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.298 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.1 p -65.89 -62.72 1.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.677 1.227 . . . . 0.0 110.835 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -61.75 -21.25 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.087 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.01 -47.92 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.73 64.17 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.134 0.974 . . . . 0.0 111.014 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.73 -51.54 48.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.944 0.897 . . . . 0.0 108.751 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.39 90.8 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.54 -39.59 73.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -71.98 -7.78 50.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.46 9.57 43.73 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.373 0.987 . . . . 0.0 113.054 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -74.46 142.21 44.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.186 1.493 . . . . 0.0 109.204 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.87 135.03 41.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.923 1.289 . . . . 0.0 107.682 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -64.14 128.47 35.95 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -113.87 167.3 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.868 1.667 . . . . 0.0 106.806 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -51.53 -52.65 45.3 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.949 0.88 . . . . 0.0 109.834 172.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.76 -48.3 82.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.547 -176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -63.69 -41.4 98.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.491 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.48 -53.2 47.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.62 -47.07 67.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.495 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -61.43 -54.93 37.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.751 0.31 . . . . 0.0 110.751 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -55.13 -42.18 72.67 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.456 -0.777 . . . . 0.0 111.925 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.68 -28.1 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.241 0.616 . . . . 0.0 111.506 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -90.25 -31.78 16.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.555 0.742 . . . . 0.0 111.067 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.61 69.17 72.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 124.664 1.186 . . . . 0.0 112.518 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -67.28 153.9 75.74 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.07 -64.38 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.06 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.854 1.262 . . . . 0.0 110.317 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -52.67 -50.37 63.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.948 0.499 . . . . 0.0 111.402 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.29 -49.5 69.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.622 -0.674 . . . . 0.0 109.824 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -51.14 -48.37 61.82 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.118 0.567 . . . . 0.0 111.341 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -43.49 -54.64 4.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.118 0.967 . . . . 0.0 111.553 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -84.26 -50.8 7.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.959 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -76.13 -23.05 54.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.961 0.904 . . . . 0.0 113.436 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 44.74 63.65 1.63 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.653 1.981 . . . . 0.0 111.725 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -150.29 137.34 19.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -52.13 -38.7 58.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.977 0.911 . . . . 0.0 110.646 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -82.44 13.07 3.86 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.65 61.2 4.25 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.235 -0.915 . . . . 0.0 109.178 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.78 -174.55 2.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.823 1.249 . . . . 0.0 110.057 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -152.57 151.7 30.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.72 -13.05 71.41 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.1 ttp -69.75 78.9 0.44 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 118.166 0.983 . . . . 0.0 113.21 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.56 56.83 2.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -164.21 144.6 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.869 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -152.7 171.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 tp -144.73 113.56 6.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.55 41.44 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.065 0.546 . . . . 0.0 111.367 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 pttp 179.71 178.87 0.53 Allowed 'General case' 0 C--O 1.231 0.11 0 C-N-CA 127.61 2.364 . . . . 0.0 105.793 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.98 -52.96 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 119.038 -0.868 . . . . 0.0 113.184 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.4 -54.01 0.09 OUTLIER Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.221 2.343 . . . . 0.0 115.102 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.7 pm0 -64.96 -45.04 87.39 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.032 0.916 . . . . 0.0 111.578 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.38 -47.69 78.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 108.839 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.22 -43.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.872 1.269 . . . . 0.0 109.603 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.98 88.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.954 -0.466 . . . . 0.0 110.219 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.12 -52.45 65.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.1 mt -55.59 -48.01 75.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.053 0.541 . . . . 0.0 110.718 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.87 -40.05 69.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 110.75 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 m -77.52 -14.05 59.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 t -87.05 -38.19 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 108.737 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.539 0.522 0 O-C-N 121.742 -0.599 . . . . 0.0 109.859 176.578 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.104 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.12 82.54 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.899 -0.765 . . . . 0.0 109.293 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -45.1 -40.37 6.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 112.313 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.95 81.25 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.283 0.633 . . . . 0.0 111.165 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -64.46 -43.68 93.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.34 -48.57 33.42 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.8 1.19 . . . . 0.0 111.526 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.01 -54.61 36.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.716 0.758 . . . . 0.0 110.213 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.67 -48.39 81.86 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.888 -0.508 . . . . 0.0 110.662 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -56.54 -33.82 66.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.876 1.271 . . . . 0.0 110.821 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.13 -21.05 7.72 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.041 0.937 . . . . 0.0 111.615 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -46.2 -36.25 5.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.846 0.748 . . . . 0.0 110.754 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -69.09 -57.88 4.83 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.59 -40.51 52.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.257 1.023 . . . . 0.0 111.292 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -45.22 -35.3 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.552 2.341 . . . . 0.0 112.394 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 m -55.16 -29.88 58.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.588 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.6 m -123.36 -27.2 4.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.517 1.127 . . . . 0.0 113.387 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.1 167.94 11.32 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.539 1.136 . . . . 0.0 112.639 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 p -145.57 168.49 20.5 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.202 1.801 . . . . 0.0 109.562 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mp -136.04 107.73 7.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 tt -129.04 137.31 57.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 124.212 1.005 . . . . 0.0 110.548 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 152.52 92.86 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.42 -40.06 44.59 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.438 2.759 . . . . 0.0 113.497 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.69 -13.31 61.99 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.798 1.239 . . . . 0.0 113.802 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.07 -7.29 29.08 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.703 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.8 m -61.15 102.34 0.21 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.002 1.901 . . . . 0.0 109.299 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.66 76.37 5.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.844 2.058 . . . . 0.0 111.471 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.49 -46.71 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.292 0.637 . . . . 0.0 109.381 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.43 106.79 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -75.38 55.41 0.79 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.737 1.615 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.6 -174.33 30.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.21 0.91 . . . . 0.0 111.2 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.58 -174.69 5.12 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.804 0.811 . . . . 0.0 112.046 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.51 28.27 3.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 110.242 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 m -61.67 -35.09 76.97 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.04 162.87 12.45 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 169.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -55.4 153.1 29.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.592 2.195 . . . . 0.0 113.441 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -66.03 127.45 32.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.76 16.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -63.43 87.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.243 0.929 . . . . 0.0 110.045 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.75 46.67 5.63 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.11 -31.65 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.77 118.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.711 0.804 . . . . 0.0 108.862 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.91 -10.18 74.74 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.024 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.85 136.78 53.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.44 1.12 . . . . 0.0 109.327 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -62.53 135.39 57.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.52 131.3 45.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.757 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.03 35.22 61.27 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.562 -1.132 . . . . 0.0 113.764 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.1 p -136.33 2.68 2.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.123 1.461 . . . . 0.0 114.644 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.35 128.01 90.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.409 1.459 . . . . 0.0 107.106 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -54.57 157.85 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.901 2.401 . . . . 0.0 114.479 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 49.97 66.19 1.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.373 1.869 . . . . 0.0 112.415 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -164.44 123.78 1.92 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.815 0.446 . . . . 0.0 109.868 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -79.93 93.79 5.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.041 0.936 . . . . 0.0 109.922 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -77.97 -170.24 1.85 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.649 0.738 . . . . 0.0 110.662 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -117.08 172.44 7.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.291 1.836 . . . . 0.0 108.495 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.58 -36.71 84.69 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.979 0.912 . . . . 0.0 113.383 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -60.99 -65.76 0.64 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 111.089 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.21 -37.96 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.37 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -48.04 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.73 91.65 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.652 0.66 . . . . 0.0 111.141 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -48.36 73.69 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.57 28.16 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.13 -27.79 55.36 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.629 1.572 . . . . 0.0 112.282 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -68.03 -4.6 13.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.77 35.8 4.19 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 125.32 1.438 . . . . 0.0 110.52 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -103.39 124.19 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 117.408 0.604 . . . . 0.0 110.957 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.58 130.25 56.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.154 1.782 . . . . 0.0 107.603 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -60.74 143.62 54.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 118.177 0.444 . . . . 0.0 110.613 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.0 p -128.27 170.13 13.4 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.004 1.722 . . . . 0.0 106.917 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -58.59 -45.23 89.55 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 122.978 0.511 . . . . 0.0 110.606 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.36 -46.9 75.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.576 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.27 -46.68 87.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.99 -52.74 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -47.31 69.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.616 0.367 . . . . 0.0 110.277 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.6 m -64.37 -44.23 92.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.815 -0.553 . . . . 0.0 110.829 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -55.75 -53.47 56.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.063 0.945 . . . . 0.0 111.286 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 m -56.99 -40.13 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.593 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -65.04 -24.55 67.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -158.02 73.35 4.04 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.732 1.151 . . . . 0.0 113.005 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.13 146.74 79.71 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.522 2.148 . . . . 0.0 110.636 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.9 -64.18 4.35 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.78 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 117.318 0.559 . . . . 0.0 110.297 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -51.78 -51.23 57.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.959 0.504 . . . . 0.0 111.656 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.41 -56.39 16.61 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.321 0.648 . . . . 0.0 109.296 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -46.58 -46.4 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.499 1.12 . . . . 0.0 110.747 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -51.88 -40.53 60.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.043 0.937 . . . . 0.0 111.973 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -90.9 -45.68 8.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.305 0.642 . . . . 0.0 112.129 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 -17.87 39.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.472 1.109 . . . . 0.0 113.189 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 48.25 62.66 2.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.399 1.88 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -143.76 150.14 38.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.679 1.592 . . . . 0.0 108.926 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -66.97 -48.33 68.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 108.432 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -80.3 11.58 3.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.03 -1.441 . . . . 0.0 114.619 -173.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.41 63.58 6.65 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.691 -1.256 . . . . 0.0 110.517 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -102.52 170.45 8.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.197 0.999 . . . . 0.0 109.942 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -131.7 154.07 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.61 -12.44 64.15 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.0 ttp -67.97 79.75 0.22 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 56.6 2.66 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.572 0.749 . . . . 0.0 110.122 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -154.28 116.06 4.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.839 1.256 . . . . 0.0 108.712 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -100.94 -179.14 3.97 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.6 156.89 47.94 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.49 53.32 0.8 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? 75.66 164.12 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.875 1.67 . . . . 0.0 110.619 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.98 -15.22 33.85 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.05 -35.62 33.36 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.425 1.488 . . . . 0.0 112.29 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.65 -47.37 86.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 117.518 0.659 . . . . 0.0 110.586 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -64.32 -44.39 91.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.42 -47.1 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.5 -48.14 77.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.955 -0.466 . . . . 0.0 109.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.18 -46.09 79.5 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -57.0 -51.23 70.06 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.073 -0.392 . . . . 0.0 110.869 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.37 -43.58 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.848 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.67 91.61 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.325 -0.234 . . . . 0.0 110.964 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.5 m -69.85 -50.05 46.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.738 HG13 ' H ' ' A' ' 115' ' ' VAL . 11.4 p -59.68 -81.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.738 ' H ' HG13 ' A' ' 114' ' ' VAL . 7.2 p . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 129.722 3.209 . . . . 0.0 113.655 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.89 74.59 0.62 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.62 1.168 . . . . 0.0 111.449 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.39 -40.64 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.509 1.124 . . . . 0.0 112.618 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.54 85.79 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.733 -0.604 . . . . 0.0 111.044 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -63.98 -38.16 90.06 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.67 -48.35 82.16 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.19 -49.81 72.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.74 0.816 . . . . 0.0 109.736 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.7 -48.33 82.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.435 0.16 . . . . 0.0 110.691 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.15 -34.56 68.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.491 1.116 . . . . 0.0 110.464 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.98 -16.67 7.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.958 0.903 . . . . 0.0 112.564 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -51.28 -30.84 19.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.449 0.7 . . . . 0.0 110.387 172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -76.96 -59.02 2.95 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.62 -0.675 . . . . 0.0 109.349 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.9 m -45.36 -47.68 13.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.768 1.627 . . . . 0.0 111.961 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -51.02 -26.27 5.92 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.924 1.29 . . . . 0.0 113.805 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -58.6 -40.57 83.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.472 0.578 . . . . 0.0 109.56 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.1 m -99.39 -48.69 4.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.419 1.088 . . . . 0.0 112.133 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -84.07 176.83 8.55 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.159 0.983 . . . . 0.0 112.473 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.4 m -147.98 159.23 44.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.818 0.847 . . . . 0.0 108.764 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -142.93 122.19 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.36 130.52 60.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 O-C-N 121.86 -0.525 . . . . 0.0 110.009 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.04 158.87 60.36 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.98 -39.25 79.74 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.269 2.646 . . . . 0.0 112.53 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.7 -8.6 55.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.375 1.47 . . . . 0.0 113.717 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.49 -13.25 51.07 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -59.92 114.81 3.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.66 1.73 . . . . 0.0 109.677 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.24 118.74 11.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.467 0.707 . . . . 0.0 109.949 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 mm -89.86 -42.52 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.9 t -141.19 129.58 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -127.6 74.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.69 -168.4 3.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.28 44.22 1.01 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.977 -1.307 . . . . 0.0 110.11 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 tptp 13.79 57.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 130.648 3.579 . . . . 0.0 113.79 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -89.48 -30.95 17.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.69 0.796 . . . . 0.0 108.915 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.5 170.27 13.98 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.84 167.22 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 112.21 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.49 125.7 30.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -92.9 4.43 53.92 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -67.55 87.15 0.2 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.296 0.953 . . . . 0.0 109.483 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 115' ' ' VAL . . . 112.05 23.14 5.66 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.947 0.784 . . . . 0.0 111.577 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.91 -42.73 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.519 1.16 . . . . 0.0 110.05 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 115' ' ' VAL . 58.1 t -61.63 114.44 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.11 63.56 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.013 1.292 . . . . 0.0 111.654 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -68.92 138.61 54.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.6 1.2 . . . . 0.0 109.897 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 m -67.4 70.4 0.11 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.781 1.632 . . . . 0.0 111.508 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.53 -144.91 0.64 Allowed 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.875 -0.516 . . . . 0.0 110.232 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.62 73.73 0.61 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.514 1.054 . . . . 0.0 112.645 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.4 p -138.81 2.73 2.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.239 1.015 . . . . 0.0 111.922 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -62.22 132.9 94.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.57 161.67 11.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.151 1.9 . . . . 0.0 114.006 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 57.55 58.64 3.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.794 1.638 . . . . 0.0 112.916 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -165.88 123.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.746 0.418 . . . . 0.0 110.488 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.24 88.93 4.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.976 0.91 . . . . 0.0 109.553 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.91 -174.17 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.521 0.677 . . . . 0.0 111.455 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -106.12 -178.46 3.66 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.492 1.517 . . . . 0.0 108.322 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.65 -38.03 67.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.713 0.805 . . . . 0.0 112.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -60.74 -63.06 1.43 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 111.078 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.54 -35.65 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.9 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.55 -48.27 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.91 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 110.586 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.3 tp -55.77 -49.65 72.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.45 -52.75 48.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.84 -36.83 65.46 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.2 1.0 . . . . 0.0 112.591 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -67.32 -11.58 57.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.89 10.92 15.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.889 1.233 . . . . 0.0 112.595 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -77.0 141.27 40.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.739 1.27 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.51 34.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.454 1.501 . . . . 0.0 107.923 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -62.54 143.26 57.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.33 166.45 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.035 1.734 . . . . 0.0 106.596 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.98 -43.76 77.91 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.304 0.573 . . . . 0.0 110.775 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.62 -47.69 68.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.102 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.11 -46.05 90.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.252 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.3 mt -57.22 -54.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.69 -46.13 29.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.636 0.774 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -63.43 -65.32 0.7 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.255 0.622 . . . . 0.0 110.472 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -43.38 -48.83 7.06 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.011 1.724 . . . . 0.0 112.811 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 t -53.2 -25.73 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.64 14.87 15.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.601 1.091 . . . . 0.0 112.32 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -159.37 56.79 0.95 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.576 1.15 . . . . 0.0 111.904 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -66.82 157.39 61.55 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 108.75 -1.288 . . . . 0.0 108.75 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 -66.82 3.04 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.04 -47.68 53.22 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.411 1.084 . . . . 0.0 111.342 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -51.59 -52.39 47.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.64 -56.2 24.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.622 1.169 . . . . 0.0 109.73 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.02 -47.62 44.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.575 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -63.95 -66.96 0.47 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.467 0.707 . . . . 0.0 110.369 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -53.99 -39.81 66.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.7 tp -92.24 -0.41 57.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.938 0.895 . . . . 0.0 111.982 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 43.45 58.39 3.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.327 1.451 . . . . 0.0 109.94 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -143.68 157.88 44.08 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 124.305 1.042 . . . . 0.0 110.836 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -92.41 -50.22 5.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.272 1.829 . . . . 0.0 108.115 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -79.53 42.2 0.51 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.89 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.37 90.94 3.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -131.46 132.72 44.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.054 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.92 154.48 19.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.12 -16.9 62.86 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttp -64.96 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.244 1.022 . . . . 0.0 113.309 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.56 59.21 4.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -160.43 150.72 18.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.329 1.851 . . . . 0.0 107.426 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -143.81 164.23 31.1 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.846 1.259 . . . . 0.0 107.812 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.88 169.38 9.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.92 37.51 4.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -147.33 170.52 17.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.217 1.807 . . . . 0.0 106.172 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.75 -10.05 57.41 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.874 -0.959 . . . . 0.0 112.622 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.67 13.56 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 118.708 1.254 . . . . 0.0 113.889 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -61.71 -46.1 91.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.362 1.081 . . . . 0.0 109.452 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -55.28 -52.61 62.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.296 1.438 . . . . 0.0 110.57 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.21 -46.2 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.451 1.101 . . . . 0.0 110.184 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.37 90.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.148 -0.345 . . . . 0.0 110.376 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.25 99.17 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.499 0.319 . . . . 0.0 110.309 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -57.66 -52.26 66.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 115' ' ' VAL . 54.6 mt -58.7 -44.13 90.26 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.854 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.35 76.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.5 m -61.58 -38.13 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.012 -0.43 . . . . 0.0 111.094 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -37.06 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.855 -0.528 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.567 HG21 ' HB ' ' A' ' 41' ' ' VAL . 65.3 t . . . . . 0 CA--C 1.531 0.225 0 C-N-CA 124.305 1.042 . . . . 0.0 110.235 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 N-CA-C 114.043 0.377 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.69 72.48 0.77 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.461 1.505 . . . . 0.0 111.506 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.1 -39.97 10.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.679 1.191 . . . . 0.0 112.591 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.26 94.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.541 0.736 . . . . 0.0 111.452 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.38 -43.6 69.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.86 -44.61 40.34 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.99 -46.13 71.64 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 111.659 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -71.36 -47.99 52.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.659 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -57.62 -30.66 65.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.935 0.894 . . . . 0.0 110.719 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.67 -16.46 4.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.618 1.167 . . . . 0.0 112.144 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -53.52 -33.22 53.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.333 0.969 . . . . 0.0 111.087 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -72.85 -26.64 61.54 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.77 -0.581 . . . . 0.0 111.391 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.9 m -77.4 -45.62 25.31 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -46.23 -32.88 3.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 111.904 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -53.0 -31.31 40.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.121 0.968 . . . . 0.0 111.76 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -120.2 -38.34 2.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.487 1.515 . . . . 0.0 112.366 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -103.7 -173.47 2.32 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 125.634 1.574 . . . . 0.0 111.386 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -157.24 168.48 27.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.408 1.483 . . . . 0.0 109.01 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 133.07 54.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.06 1.744 . . . . 0.0 106.692 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 26' ' ' GLU . 1.4 tp -111.6 149.74 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.653 1.981 . . . . 0.0 109.16 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 161.95 48.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.76 -36.99 27.28 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.592 2.861 . . . . 0.0 112.124 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.09 13.68 0.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.996 1.718 . . . . 0.0 113.325 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.44 31.98 60.42 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.664 1.125 . . . . 0.0 111.656 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -112.2 126.24 55.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 20' ' ' ILE . 51.6 mt-10 -63.44 121.82 14.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.538 0.335 . . . . 0.0 110.469 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.1 mm -98.62 -60.18 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.67 77.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.62 70.61 0.19 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.749 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.42 -158.17 30.76 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 173.82 11.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.9 33.06 5.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.468 1.107 . . . . 0.0 108.977 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.7 m -69.38 -38.12 77.88 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.7 165.27 12.03 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -59.45 141.66 97.81 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.891 3.061 . . . . 0.0 111.199 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.07 119.4 7.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -85.86 15.91 4.51 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -170.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -75.54 80.41 2.56 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.563 -1.335 . . . . 0.0 109.442 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.93 46.35 0.34 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.127 0.87 . . . . 0.0 113.453 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.89 -48.43 33.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 t -53.52 112.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.786 0.835 . . . . 0.0 110.431 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 -15.68 61.39 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.922 1.249 . . . . 0.0 113.058 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -68.12 140.56 56.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.94 1.37 . . . . 0.0 110.789 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 m -70.2 72.73 0.46 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 110.611 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.07 -139.47 1.02 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.942 0.497 . . . . 0.0 109.707 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.96 77.51 1.13 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 123.731 0.682 . . . . 0.0 112.536 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 p -136.21 16.36 3.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.713 0.805 . . . . 0.0 112.121 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -67.08 141.81 96.73 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.022 -1.049 . . . . 0.0 108.928 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.37 155.98 23.18 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.279 1.319 . . . . 0.0 113.916 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 46.73 62.57 2.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.475 1.51 . . . . 0.0 113.587 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -158.44 120.5 3.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.867 -0.52 . . . . 0.0 110.023 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -73.49 82.18 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.446 0.698 . . . . 0.0 110.495 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.11 169.69 11.45 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.165 0.507 . . . . 0.0 110.513 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -96.52 175.58 6.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.87 -35.78 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.272 0.629 . . . . 0.0 112.635 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -59.24 -66.47 0.5 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.228 1.411 . . . . 0.0 111.173 -174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 tt -58.1 -37.94 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.806 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.11 -49.41 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.55 87.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.923 0.329 . . . . 0.0 110.711 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -47.26 84.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.58 -56.65 22.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 173.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.93 -32.61 54.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.08 1.352 . . . . 0.0 113.387 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.7 p -66.68 -12.97 60.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.86 0.755 . . . . 0.0 112.056 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.73 33.43 1.88 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.398 1.475 . . . . 0.0 110.861 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -96.11 143.61 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.787 0.794 . . . . 0.0 109.532 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.44 128.59 31.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -61.01 99.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.016 0.526 . . . . 0.0 111.831 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.4 p -83.19 167.85 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -58.17 -37.81 75.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.045 0.45 . . . . 0.0 109.846 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -64.41 -49.57 71.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -56.88 -52.74 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.15 -53.53 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.59 -46.28 63.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.499 0.72 . . . . 0.0 111.184 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.9 m -66.88 -54.91 17.56 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -51.78 -42.82 62.71 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.413 1.085 . . . . 0.0 113.068 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.6 t -53.98 -31.67 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.118 0.567 . . . . 0.0 111.519 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -105.6 14.13 28.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.28 1.432 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -161.21 49.16 0.26 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.269 1.027 . . . . 0.0 111.809 -175.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -56.16 136.08 73.27 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.67 2.914 . . . . 0.0 110.04 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.63 -55.39 2.08 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.55 -0.583 . . . . 0.0 111.959 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 -38.55 68.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.501 1.151 . . . . 0.0 111.26 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -63.46 -44.74 93.6 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 110.721 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.97 -54.72 41.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.702 0.801 . . . . 0.0 108.941 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -47.8 -48.46 30.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.881 1.272 . . . . 0.0 110.244 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -61.03 -68.43 0.31 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.056 0.942 . . . . 0.0 110.513 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.27 -37.04 81.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 tp -85.86 -3.69 58.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.6 0.76 . . . . 0.0 111.344 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 t0 44.13 54.2 6.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.435 1.494 . . . . 0.0 110.017 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -145.95 119.24 8.94 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.534 0.734 . . . . 0.0 111.85 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.94 -32.23 69.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.241 1.016 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -80.51 4.93 16.7 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.39 65.28 6.46 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.485 -0.76 . . . . 0.0 111.355 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.54 136.83 32.81 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.382 -0.824 . . . . 0.0 109.253 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.6 t -87.91 155.13 20.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.36 -25.31 72.48 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 21.2 ttp -65.44 82.63 0.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.976 0.888 . . . . 0.0 112.324 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 58.29 3.24 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -163.61 145.93 9.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.328 1.851 . . . . 0.0 107.044 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.84 155.14 46.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.9 109.54 13.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.38 46.72 0.76 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.532 -0.73 . . . . 0.0 111.669 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? 175.59 -165.63 0.03 OUTLIER 'General case' 0 C--O 1.231 0.117 0 C-N-CA 128.091 2.556 . . . . 0.0 106.225 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.22 -59.01 3.63 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.993 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -4.77 -70.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.372 2.891 . . . . 0.0 115.294 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.23 -57.22 13.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.181 0.992 . . . . 0.0 112.639 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.64 -35.18 80.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.092 0.557 . . . . 0.0 110.904 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.92 -46.55 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.281 0.632 . . . . 0.0 109.632 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.34 94.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.889 -0.507 . . . . 0.0 109.702 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -43.46 86.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -59.2 -51.47 69.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.8 mt -56.46 -38.23 71.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.792 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.78 -52.46 60.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.152 0.887 . . . . 0.0 109.573 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.6 m -53.88 -34.88 60.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 112.618 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.14 -30.82 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.863 1.265 . . . . 0.0 111.697 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 CA--C 1.536 0.411 0 CA-C-N 119.064 0.847 . . . . 0.0 110.482 -178.691 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -92.08 106.93 18.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.315 1.046 . . . . 0.0 108.498 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.72 -34.75 5.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.672 1.189 . . . . 0.0 112.476 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.04 74.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.761 0.71 . . . . 0.0 110.324 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.61 -38.52 87.94 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.49 -52.24 51.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.08 -49.15 77.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.232 0.613 . . . . 0.0 110.553 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -55.87 -50.92 69.32 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.4 -35.52 72.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.422 0.689 . . . . 0.0 109.951 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.87 -19.93 32.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -52.98 -31.82 42.82 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.604 0.638 . . . . 0.0 110.985 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -52.72 6.06 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.06 -38.18 10.7 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.563 1.945 . . . . 0.0 113.645 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -52.43 -25.18 9.34 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.15 . . . . 0.0 112.817 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 m -61.91 -21.97 65.19 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.612 -0.68 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -119.16 -38.76 3.0 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.85 0.86 . . . . 0.0 112.619 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.75 169.7 8.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 112.404 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.3 p -141.38 164.21 30.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.785 1.234 . . . . 0.0 111.272 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.43 119.05 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -139.5 133.63 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.229 0.612 . . . . 0.0 110.86 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 162.85 63.03 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.83 -37.82 95.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.14 2.56 . . . . 0.0 112.394 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.25 -15.94 58.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.979 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.2 -3.11 56.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.41 110.96 2.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.6 114.57 13.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.888 0.875 . . . . 0.0 111.48 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.0 -45.16 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.7 t -135.2 103.31 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -76.96 54.79 1.05 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.781 1.232 . . . . 0.0 109.043 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.19 -176.4 50.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.21 177.94 6.12 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.327 0.584 . . . . 0.0 110.923 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -125.95 39.88 3.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.09 0.956 . . . . 0.0 109.368 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.2 m -65.57 -34.65 78.74 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.36 13.42 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 168.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.46 173.24 0.76 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.444 2.096 . . . . 0.0 113.494 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -83.32 135.09 34.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.77 10.84 37.64 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -64.8 88.61 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.275 0.943 . . . . 0.0 109.478 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.91 40.94 5.11 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -72.58 -36.39 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.39 107.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.72 -13.51 50.19 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.308 1.432 . . . . 0.0 112.069 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -73.07 137.5 45.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.841 0.821 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -63.47 128.9 37.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.39 154.89 12.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.829 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.07 22.76 72.65 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.867 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.1 t -156.16 28.72 0.35 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.539 1.67 . . . . 0.0 113.416 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -72.26 129.35 87.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 167.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -45.49 154.7 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.166 2.577 . . . . 0.0 116.094 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 54.7 65.57 1.47 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.298 1.439 . . . . 0.0 112.605 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -166.83 125.42 1.39 Allowed 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.854 -0.529 . . . . 0.0 111.713 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -79.36 90.7 5.01 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.64 1.176 . . . . 0.0 109.66 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -73.55 -177.57 2.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.464 0.705 . . . . 0.0 112.509 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -105.55 -178.03 3.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.004 1.322 . . . . 0.0 108.167 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.32 -37.17 66.25 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.512 -0.742 . . . . 0.0 112.792 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -62.24 -66.2 0.57 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.506 1.122 . . . . 0.0 111.167 -173.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -55.5 -38.09 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.897 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.01 -43.58 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 O-C-N 121.813 -0.555 . . . . 0.0 109.512 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.8 87.74 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.299 0.5 . . . . 0.0 110.318 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.04 -52.43 65.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.15 -48.29 10.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.096 1.331 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.14 29.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.237 1.415 . . . . 0.0 113.819 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -73.3 -0.5 14.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.471 1.032 . . . . 0.0 112.183 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 33.88 9.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -79.19 80.82 5.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.069 -0.665 . . . . 0.0 110.916 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.14 115.0 11.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.002 1.321 . . . . 0.0 107.865 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -56.3 146.77 22.89 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 109.259 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.2 p -127.18 164.0 22.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.08 -40.65 73.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.069 0.548 . . . . 0.0 110.213 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.61 -52.42 57.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.317 0.647 . . . . 0.0 110.604 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -61.03 -45.48 94.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.56 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.8 mm -56.18 -53.7 36.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.34 -47.16 66.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.678 0.391 . . . . 0.0 110.612 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 m -62.35 -55.49 27.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.21 0.528 . . . . 0.0 110.454 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.39 -44.63 45.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.331 1.453 . . . . 0.0 112.143 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.4 t -54.26 -30.5 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.41 0.684 . . . . 0.0 111.906 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -95.37 -26.38 15.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.616 0.766 . . . . 0.0 111.37 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -127.43 63.7 59.78 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 125.204 1.402 . . . . 0.0 112.693 -171.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.77 143.27 60.87 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.779 1.653 . . . . 0.0 108.809 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -63.57 3.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.25 -45.22 44.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.688 1.195 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -54.85 -53.03 60.61 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.686 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.6 -53.48 57.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.123 -0.361 . . . . 0.0 110.32 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -47.64 -50.6 24.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.98 0.912 . . . . 0.0 110.491 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.0 -58.32 6.35 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.01 0.524 . . . . 0.0 111.025 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -67.45 -51.47 51.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.86 -25.59 40.66 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.755 1.222 . . . . 0.0 114.219 -172.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.81 55.51 7.75 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.405 1.482 . . . . 0.0 109.892 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -136.21 135.92 39.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.248 1.419 . . . . 0.0 109.543 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.88 -41.35 97.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.411 1.084 . . . . 0.0 111.107 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -85.69 18.76 2.71 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 70.41 4.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.442 0.697 . . . . 0.0 110.444 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -113.41 128.46 56.46 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.54 1.536 . . . . 0.0 109.121 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.2 t -82.18 158.52 23.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.65 -19.85 69.53 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.5 ttp -68.76 82.72 0.29 Allowed 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.996 -0.708 . . . . 0.0 112.797 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.62 3.09 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -160.21 149.73 17.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.168 1.787 . . . . 0.0 108.084 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -156.3 172.57 18.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.142 1.377 . . . . 0.0 108.861 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -143.29 115.72 8.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.031 1.332 . . . . 0.0 107.625 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.48 45.58 0.78 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.665 -0.647 . . . . 0.0 111.868 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? 175.04 -172.22 0.06 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 128.301 2.64 . . . . 0.0 105.705 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.37 -52.49 2.25 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.686 -1.064 . . . . 0.0 113.523 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -24.84 -55.1 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.179 2.323 . . . . 0.0 114.997 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -62.14 -52.38 64.1 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.526 0.73 . . . . 0.0 111.493 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.72 -48.35 79.82 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.5 1.12 . . . . 0.0 109.456 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.22 -46.38 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.653 1.181 . . . . 0.0 109.697 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.71 87.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.874 -0.516 . . . . 0.0 110.07 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.8 93.91 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -58.5 -50.41 73.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.979 -0.45 . . . . 0.0 110.534 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.94 -46.13 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.954 0.902 . . . . 0.0 110.434 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.7 78.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.021 0.528 . . . . 0.0 110.556 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -69.07 -38.71 79.18 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.964 -0.46 . . . . 0.0 111.07 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -42.49 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 125.329 1.452 . . . . 0.0 111.46 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 122.069 0.937 . . . . 0.0 110.363 -179.696 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 121.798 0.665 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -73.67 80.59 1.53 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.863 -0.786 . . . . 0.0 111.152 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.52 63.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.9 0.88 . . . . 0.0 111.741 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.15 74.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.635 0.374 . . . . 0.0 110.407 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -63.87 -44.56 92.71 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -48.05 -45.53 26.56 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.13 0.871 . . . . 0.0 112.001 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -54.05 -47.22 71.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.285 0.634 . . . . 0.0 110.938 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -69.19 -44.74 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.94 -34.93 57.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.207 1.403 . . . . 0.0 109.641 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.52 -20.34 2.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.02 -27.67 33.45 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.816 -0.553 . . . . 0.0 111.456 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.35 -55.04 5.74 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.01 -42.82 29.12 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.993 1.317 . . . . 0.0 112.33 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -57.32 -21.07 32.67 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -54.52 -32.63 58.51 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.731 -0.606 . . . . 0.0 110.288 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 m -112.48 -44.35 3.37 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.338 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -90.84 -176.15 4.58 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 m -156.3 165.41 36.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.147 1.779 . . . . 0.0 108.732 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.6 mt -131.95 126.86 57.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' N ' HD21 ' A' ' 36' ' ' ASN . 1.1 tp -118.85 135.75 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.322 1.449 . . . . 0.0 109.998 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.24 82.34 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 119.015 0.825 . . . . 0.0 108.973 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.07 -41.25 73.19 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.16 2.573 . . . . 0.0 112.561 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -72.66 -10.96 60.42 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.172 1.389 . . . . 0.0 113.407 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.85 -17.15 35.96 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.023 -0.876 . . . . 0.0 113.443 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.8 m -60.71 116.32 4.31 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.522 1.661 . . . . 0.0 109.923 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -64.4 122.17 16.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.822 0.449 . . . . 0.0 110.341 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.44 -52.15 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.45 97.98 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -78.11 70.14 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.825 1.25 . . . . 0.0 107.801 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.39 -151.34 27.4 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.58 -179.33 5.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -123.51 22.45 9.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 108.89 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -30.13 70.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.225 1.01 . . . . 0.0 108.998 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.18 172.08 14.49 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.7 175.05 0.64 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 124.108 3.205 . . . . 0.0 113.307 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 20' ' ' ILE . 1.5 t30 -105.4 81.77 1.74 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.055 0.942 . . . . 0.0 111.086 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mp -37.32 -0.91 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.542 1 C-N-CA 133.424 4.689 . . . . 0.0 121.464 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -69.07 80.86 0.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 121.058 1.754 . . . . 0.0 110.049 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 115' ' ' VAL . . . 122.22 32.76 0.95 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.903 -0.943 . . . . 0.0 115.014 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.67 -49.12 81.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.7 1.75 . . . . 0.0 111.789 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 115' ' ' VAL . 88.7 t -53.38 121.56 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 121.5 -0.75 . . . . 0.0 110.537 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.02 -19.21 54.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.744 1.164 . . . . 0.0 111.737 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -64.8 135.43 55.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.136 0.968 . . . . 0.0 110.042 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.2 m -73.15 80.75 1.27 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' CA ' ' A' ' 61' ' ' GLY . . . 51.68 -145.1 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.099 0.959 . . . . 0.0 110.963 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.0 78.81 0.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 124.82 1.2 . . . . 0.0 111.945 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.0 p -134.57 5.38 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.832 0.853 . . . . 0.0 111.805 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.06 134.99 93.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.07 164.75 9.76 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.486 2.124 . . . . 0.0 114.426 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.98 52.95 7.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.846 1.658 . . . . 0.0 112.057 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -161.49 118.42 2.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.991 -0.443 . . . . 0.0 111.81 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -78.77 79.9 5.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.064 0.946 . . . . 0.0 109.599 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -64.31 163.88 12.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.958 0.503 . . . . 0.0 111.385 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -96.47 176.39 6.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.144 0.973 . . . . 0.0 110.986 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.15 -36.62 73.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.804 1.641 . . . . 0.0 113.584 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 p -64.07 -67.61 0.42 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.029 0.919 . . . . 0.0 109.823 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 tt -59.25 -33.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.64 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.99 -50.89 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.637 -0.664 . . . . 0.0 109.663 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -40.3 82.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.416 0.553 . . . . 0.0 110.283 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -57.42 -44.33 84.55 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . -58.86 -49.21 80.38 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.19 -35.47 64.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.335 0.568 . . . . 0.0 111.719 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.1 p -76.34 5.92 6.36 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 30.65 36.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.362 0.982 . . . . 0.0 112.33 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -74.99 82.61 2.22 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.77 -0.841 . . . . 0.0 112.296 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.81 107.97 5.52 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -52.35 116.48 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.627 0.771 . . . . 0.0 111.719 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.5 p -94.33 161.89 14.06 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.95 -38.0 81.16 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.91 -54.7 44.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.965 0.906 . . . . 0.0 109.249 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -58.44 -47.11 85.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.787 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -54.03 -53.65 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.67 62.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.008 0.523 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -60.07 -53.58 56.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -52.5 -44.56 65.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.191 0.996 . . . . 0.0 111.575 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.41 -20.15 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.096 0.958 . . . . 0.0 112.418 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -103.33 -14.11 16.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.561 1.144 . . . . 0.0 111.988 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -142.08 58.81 8.38 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.632 1.173 . . . . 0.0 111.929 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.67 135.62 70.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.109 2.539 . . . . 0.0 109.585 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.51 -59.04 4.11 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.562 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.25 -42.28 66.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.991 0.896 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -51.43 -59.62 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.366 1.066 . . . . 0.0 111.042 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.31 -50.17 73.79 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.245 1.018 . . . . 0.0 110.935 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -59.69 -35.95 75.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 110.264 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.79 -59.93 2.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.625 0.77 . . . . 0.0 109.188 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -54.44 -44.99 72.96 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.75 0.23 56.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.962 0.505 . . . . 0.0 111.738 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 46.73 49.94 13.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.203 1.401 . . . . 0.0 110.666 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -138.23 117.18 12.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.455 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -51.64 -37.34 49.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.554 1.142 . . . . 0.0 111.272 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -89.14 4.34 48.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.88 86.38 7.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -116.05 153.93 30.82 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.656 1.182 . . . . 0.0 110.228 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -97.27 157.29 16.03 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 123.904 0.882 . . . . 0.0 110.439 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.48 -19.99 79.21 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.6 ttt -65.02 81.68 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.521 1.128 . . . . 0.0 112.777 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 58.13 3.03 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.85 143.88 5.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.099 1.36 . . . . 0.0 108.877 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -141.24 166.87 23.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.554 1.542 . . . . 0.0 107.106 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.02 165.92 13.75 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.6 56.8 3.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.392 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 75.54 -172.11 0.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.839 2.055 . . . . 0.0 111.349 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.32 -78.37 1.93 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.22 -53.87 0.18 Allowed Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.99 1.281 . . . . 0.0 112.96 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -44.73 -37.88 4.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.397 1.879 . . . . 0.0 113.31 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -58.96 -48.13 82.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.412 0.685 . . . . 0.0 110.551 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.69 -39.71 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.32 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.303 -0.248 . . . . 0.0 110.629 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.52 95.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.558 0.743 . . . . 0.0 109.599 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.27 -51.01 69.73 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 115' ' ' VAL . 51.7 mt -58.49 -44.95 89.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.71 -0.619 . . . . 0.0 110.823 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.94 79.12 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.968 -0.457 . . . . 0.0 110.083 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -61.8 -41.09 97.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.634 0.373 . . . . 0.0 110.68 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.54 -31.23 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.752 0.821 . . . . 0.0 111.26 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.594 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.5 t . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 121.686 0.755 . . . . 0.0 109.133 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.869 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.0 92.21 5.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.6 -40.88 20.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.894 0.877 . . . . 0.0 112.94 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.63 72.97 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.898 -0.502 . . . . 0.0 110.126 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.18 -39.64 90.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.75 -47.12 38.92 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.011 1.291 . . . . 0.0 111.255 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.94 -48.19 73.49 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.113 0.456 . . . . 0.0 110.237 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -65.34 -46.17 81.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.403 0.281 . . . . 0.0 110.373 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -57.28 -33.18 67.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.607 1.163 . . . . 0.0 110.261 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.89 -21.39 57.41 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -27.49 56.26 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.585 0.629 . . . . 0.0 109.82 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -80.58 -49.78 10.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.9 m -53.11 -41.92 65.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.701 0.801 . . . . 0.0 112.358 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -62.19 -11.5 14.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.6 m -59.05 -22.92 61.5 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.8 m -129.74 -46.25 1.16 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.885 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.82 -173.53 3.53 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.689 0.757 . . . . 0.0 112.976 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.4 m -159.89 167.99 26.8 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.504 1.922 . . . . 0.0 109.838 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.8 mm -140.73 126.07 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.416 1.487 . . . . 0.0 108.508 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 tp -120.78 136.73 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.898 1.279 . . . . 0.0 109.244 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.11 47.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.273 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.96 -34.53 92.34 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.961 2.44 . . . . 0.0 110.696 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.83 14.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.988 1.715 . . . . 0.0 112.821 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.01 63.16 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.975 -1.078 . . . . 0.0 111.832 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -107.99 123.36 48.53 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.51 114.9 5.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.809 0.444 . . . . 0.0 111.355 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.42 -43.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.98 97.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -81.63 66.85 7.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.85 174.56 54.21 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.31 72.75 7.18 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.802 -0.822 . . . . 0.0 109.033 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -40.87 71.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.963 3.705 . . . . 0.0 114.478 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -100.56 -27.33 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.701 2.4 . . . . 0.0 108.261 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.94 173.11 14.55 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.14 1.829 . . . . 0.0 108.736 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.46 171.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.604 3.536 . . . . 0.0 114.706 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -94.21 126.43 39.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.9 mt -97.22 7.4 46.66 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.31 82.66 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.928 1.24 . . . . 0.0 111.058 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.21 28.9 5.64 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.233 0.921 . . . . 0.0 113.145 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.22 -35.83 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 118.76 1.28 . . . . 0.0 108.652 171.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.08 115.23 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.799 0.839 . . . . 0.0 110.259 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.4 -14.83 62.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.069 1.319 . . . . 0.0 112.6 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -84.51 146.89 27.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.382 1.091 . . . . 0.0 111.213 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -60.12 132.12 52.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.854 0.862 . . . . 0.0 109.085 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.36 149.18 29.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.932 -0.48 . . . . 0.0 110.965 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 29.49 73.93 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.265 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.7 p -131.43 -6.96 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.073 1.437 . . . . 0.0 114.27 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -64.44 129.93 94.42 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.02 1.282 . . . . 0.0 108.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -59.66 166.68 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.282 1.988 . . . . 0.0 113.403 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 59.28 51.14 7.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.133 1.373 . . . . 0.0 112.021 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -164.14 120.43 1.62 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.86 87.29 6.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -70.0 -172.07 0.5 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.664 0.745 . . . . 0.0 111.405 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.33 157.94 22.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.732 1.613 . . . . 0.0 110.259 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -51.83 -36.02 46.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.7 1.2 . . . . 0.0 113.545 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -63.71 -66.77 0.5 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.076 0.95 . . . . 0.0 110.01 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -58.76 -35.77 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.486 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.57 -50.7 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.92 93.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.443 0.565 . . . . 0.0 110.602 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.54 -47.32 79.66 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.81 -55.33 28.19 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.445 1.022 . . . . 0.0 111.007 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.42 -31.44 55.17 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.782 1.233 . . . . 0.0 111.522 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -72.1 6.04 2.4 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.24 28.63 22.19 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.949 1.262 . . . . 0.0 111.646 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -80.74 82.5 6.72 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.868 -0.783 . . . . 0.0 111.356 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.55 120.33 20.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -65.29 107.59 1.66 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -86.66 165.44 16.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.07 -41.85 84.25 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.495 0.664 . . . . 0.0 109.6 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -60.09 -51.87 67.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.976 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -59.14 -49.92 76.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.9 mt -54.37 -53.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.2 -41.99 72.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.647 0.779 . . . . 0.0 111.564 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.74 -53.49 15.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.37 0.268 . . . . 0.0 110.522 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -45.88 -46.99 16.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.069 1.347 . . . . 0.0 113.588 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.6 -31.42 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -82.89 -14.99 53.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.158 0.983 . . . . 0.0 111.925 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -145.28 54.17 2.3 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.752 1.221 . . . . 0.0 112.693 -173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.41 141.17 94.94 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.253 1.969 . . . . 0.0 109.313 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.75 -63.8 3.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -48.69 -44.59 38.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 111.242 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -53.42 -54.47 36.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 110.445 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.23 -48.75 80.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.061 0.544 . . . . 0.0 110.377 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -54.64 -49.59 70.17 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.283 0.633 . . . . 0.0 110.757 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -50.01 -47.92 52.77 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.53 0.732 . . . . 0.0 111.234 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.27 -55.56 4.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.9 tp -74.93 -24.13 58.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.483 1.113 . . . . 0.0 113.69 -173.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 t0 52.23 56.78 7.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.717 1.607 . . . . 0.0 111.414 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -146.45 135.42 22.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.363 1.065 . . . . 0.0 108.198 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.116 0.566 . . . . 0.0 109.935 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.86 3.72 11.39 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.99 61.23 3.12 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.688 0.795 . . . . 0.0 110.029 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -95.65 -178.57 4.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.871 1.268 . . . . 0.0 109.559 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 t -147.66 150.02 33.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -17.69 68.23 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 ttt -66.83 78.4 0.12 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.044 0.938 . . . . 0.0 113.023 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.45 58.1 3.06 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.003 0.921 . . . . 0.0 109.163 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -165.79 140.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.547 1.539 . . . . 0.0 107.452 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.61 163.32 31.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.4 tp -155.98 111.32 2.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.19 32.51 0.28 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.7 -0.625 . . . . 0.0 112.347 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -160.02 -178.01 6.71 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 127.589 2.355 . . . . 0.0 106.432 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.2 -56.01 3.2 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.387 -0.674 . . . . 0.0 112.829 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -18.78 -63.9 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.892 2.663 . . . . 0.0 115.933 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 2.0 pm0 -61.92 -46.36 89.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.146 0.979 . . . . 0.0 111.622 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -62.77 -48.14 80.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.137 0.975 . . . . 0.0 108.719 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.33 -44.32 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.0 0.52 . . . . 0.0 109.754 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.46 -47.28 82.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.813 0.733 . . . . 0.0 110.617 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.36 93.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.898 0.38 . . . . 0.0 110.753 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -56.17 -52.16 65.4 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.869 0.468 . . . . 0.0 109.873 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.85 -45.06 90.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.579 -0.7 . . . . 0.0 110.984 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.99 87.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.622 0.769 . . . . 0.0 111.28 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.1 p -71.8 -34.75 69.62 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.049 -0.407 . . . . 0.0 111.256 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.96 -47.66 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.768 1.227 . . . . 0.0 111.916 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.831 0.824 . . . . 0.0 112.35 -175.913 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.228 0.349 . . . . 0.0 113.619 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.04 84.11 0.98 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 109.94 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.85 -37.25 29.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.851 0.86 . . . . 0.0 112.443 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.36 -52.51 63.35 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.657 -0.652 . . . . 0.0 109.94 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -57.97 -39.22 77.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.6 -48.61 69.87 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.7 -49.03 74.09 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.973 0.509 . . . . 0.0 109.741 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -61.61 -47.96 83.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.625 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -54.31 -38.77 66.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 110.323 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -56.08 -17.39 6.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.709 0.804 . . . . 0.0 112.984 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -56.03 -26.06 47.31 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.286 -0.884 . . . . 0.0 111.297 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -77.8 -51.58 10.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.0 m -50.96 -42.08 59.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.311 1.044 . . . . 0.0 111.941 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -56.68 -21.91 31.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 m -56.4 -27.71 57.16 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.922 -0.486 . . . . 0.0 110.304 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -118.66 -43.83 2.67 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.613 0.765 . . . . 0.0 111.441 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -93.85 174.94 6.92 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 124.767 1.227 . . . . 0.0 113.32 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -141.27 161.76 37.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.717 1.207 . . . . 0.0 109.872 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.1 mt -138.15 106.88 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 103.412 -2.811 . . . . 0.0 103.412 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -122.77 125.69 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.463 1.105 . . . . 0.0 109.9 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 159.17 20.61 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.406 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.18 -38.38 81.16 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.775 2.317 . . . . 0.0 110.916 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.52 3.89 4.43 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.513 1.525 . . . . 0.0 113.128 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.52 65.98 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 120.733 -1.23 . . . . 0.0 112.873 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -57.07 114.45 2.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.556 1.178 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -74.29 73.12 1.81 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.455 0.702 . . . . 0.0 111.356 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.1 mm -50.27 -48.19 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.774 0.83 . . . . 0.0 109.175 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.3 102.46 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -76.12 58.51 1.23 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 108.963 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.81 174.21 42.43 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.92 176.11 3.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.161 0.505 . . . . 0.0 111.529 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -118.59 24.11 11.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.369 1.068 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -64.37 -38.29 90.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.98 169.88 13.35 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 169.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.63 178.24 1.02 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.717 3.612 . . . . 0.0 114.431 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -92.61 89.53 6.74 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.804 1.242 . . . . 0.0 111.356 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.36 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.687 2.395 . . . . 0.0 116.19 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -64.22 85.31 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 120.653 1.57 . . . . 0.0 109.61 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.58 56.9 3.73 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -33.34 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 117.673 0.737 . . . . 0.0 109.796 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.6 t -54.29 118.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.096 0.958 . . . . 0.0 110.265 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 -17.29 59.58 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.576 1.084 . . . . 0.0 112.33 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 138.88 40.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.139 1.469 . . . . 0.0 110.005 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.3 m -62.43 133.39 54.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.36 137.42 52.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.002 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.56 29.88 65.11 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.272 -1.293 . . . . 0.0 114.23 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.3 p -133.89 -3.78 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.403 1.602 . . . . 0.0 115.076 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.68 122.36 76.1 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.777 1.626 . . . . 0.0 107.341 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -56.29 162.12 8.21 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.386 2.057 . . . . 0.0 114.418 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 61.3 56.39 2.68 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.848 1.659 . . . . 0.0 111.871 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -164.22 121.12 1.65 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.88 0.371 . . . . 0.0 111.828 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -74.93 87.46 2.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.664 0.786 . . . . 0.0 109.456 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.47 167.69 14.28 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -99.78 156.39 17.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.925 0.89 . . . . 0.0 110.122 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -48.88 -43.28 38.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.085 1.354 . . . . 0.0 113.69 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 m -65.14 -52.99 51.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.845 0.355 . . . . 0.0 111.085 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 tt -65.05 -36.72 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.548 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.64 -48.45 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.14 96.72 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.035 -0.416 . . . . 0.0 111.246 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -50.61 65.93 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.06 -53.01 47.87 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.028 0.823 . . . . 0.0 111.94 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.88 -26.67 37.24 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 125.286 1.435 . . . . 0.0 111.874 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -71.83 3.71 3.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 175.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.76 40.51 7.64 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.383 1.468 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -102.79 105.23 15.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.79 129.07 40.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.986 1.314 . . . . 0.0 108.501 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -62.78 109.53 1.46 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.119 0.418 . . . . 0.0 111.751 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.3 p -91.35 164.07 13.98 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.43 -43.38 75.31 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.401 0.619 . . . . 0.0 110.876 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.97 -46.16 72.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.62 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -57.13 -50.09 73.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.671 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.74 -55.58 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.325 0.511 . . . . 0.0 109.851 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.89 -37.4 60.56 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.447 0.699 . . . . 0.0 111.628 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.6 m -72.53 -63.44 1.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -36.17 -54.08 0.8 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.448 2.299 . . . . 0.0 113.8 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 m -48.78 -32.97 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.27 -33.53 65.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.483 0.713 . . . . 0.0 112.684 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -135.98 57.05 16.44 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -60.41 145.78 98.01 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.29 1.327 . . . . 0.0 110.835 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.07 -64.04 4.11 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.44 80.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.94 0.496 . . . . 0.0 110.131 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -54.46 -53.85 48.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.961 0.904 . . . . 0.0 110.327 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -57.57 -53.83 53.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.601 0.36 . . . . 0.0 110.427 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -47.78 -47.38 30.74 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 110.601 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.03 -66.31 0.56 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.091 0.556 . . . . 0.0 110.51 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -53.9 -43.12 69.42 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -84.79 -5.22 59.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.968 0.907 . . . . 0.0 111.825 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t0 48.63 56.36 7.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.024 1.33 . . . . 0.0 109.609 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -142.49 157.13 45.07 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.097 0.959 . . . . 0.0 110.298 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -95.1 -46.83 6.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.94 2.096 . . . . 0.0 107.628 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -76.43 43.71 0.32 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.485 1.514 . . . . 0.0 111.78 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.73 118.25 29.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.006 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -151.23 140.3 21.13 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.12 0.968 . . . . 0.0 108.738 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -103.55 156.22 17.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -24.16 58.44 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.6 ttp -63.21 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.789 0.795 . . . . 0.0 113.095 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.62 57.3 3.29 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -160.44 149.91 17.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.444 1.898 . . . . 0.0 106.372 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -143.42 158.81 43.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.5 tp -130.89 115.75 16.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.94 50.47 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.159 0.984 . . . . 0.0 112.067 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -133.82 135.21 43.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.33 1.452 . . . . 0.0 107.839 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.12 61.26 4.38 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.558 -2.617 . . . . 0.0 106.558 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.94 65.01 0.0 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 129.794 3.569 . . . . 0.0 117.192 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.66 -34.58 78.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.087 0.955 . . . . 0.0 109.255 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -61.09 -52.09 66.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.098 1.359 . . . . 0.0 109.618 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.66 -45.52 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 123.784 0.834 . . . . 0.0 109.592 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.25 85.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.141 -0.349 . . . . 0.0 110.777 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.036 -0.415 . . . . 0.0 110.544 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -58.55 -54.23 49.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.77 -32.88 67.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.247 0.619 . . . . 0.0 111.522 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.9 -54.21 24.37 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.547 0.612 . . . . 0.0 109.783 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 97.4 p -57.75 -32.29 67.32 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.906 -0.497 . . . . 0.0 112.236 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.28 -26.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.715 0.806 . . . . 0.0 111.412 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 t . . . . . 0 CA--C 1.538 0.507 0 CA-C-N 119.122 0.874 . . . . 0.0 108.965 176.594 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 CA-C-O 122.025 0.792 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.0 68.95 0.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.153 1.781 . . . . 0.0 111.659 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.073 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.55 79.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.749 0.82 . . . . 0.0 111.594 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -71.78 -41.0 68.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.43 -44.09 45.03 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.179 0.895 . . . . 0.0 111.751 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -51.51 -53.46 37.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.732 0.813 . . . . 0.0 110.446 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -65.34 -46.62 79.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.476 0.711 . . . . 0.0 109.971 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.63 -39.77 65.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.305 1.042 . . . . 0.0 109.604 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -57.66 -19.37 26.18 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -30.76 62.43 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.327 -0.858 . . . . 0.0 109.775 174.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.79 -54.97 9.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.2 m -50.23 -41.06 49.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.636 1.574 . . . . 0.0 111.274 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -46.98 -31.69 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.389 1.875 . . . . 0.0 112.663 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.0 m -56.51 -28.98 61.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.384 0.673 . . . . 0.0 111.557 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.5 m -121.66 -36.19 3.09 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.952 0.901 . . . . 0.0 112.646 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -105.64 168.77 8.88 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.77 1.228 . . . . 0.0 112.791 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.2 p -138.13 166.82 23.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.956 1.302 . . . . 0.0 110.359 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.4 114.37 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.4 ' N ' HD21 ' A' ' 36' ' ' ASN . 2.6 tp -109.8 134.45 51.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.636 1.174 . . . . 0.0 110.072 -175.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.92 159.97 82.07 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 121.126 -0.984 . . . . 0.0 108.416 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.18 -40.93 68.11 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.906 2.404 . . . . 0.0 112.519 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.5 -8.06 55.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.373 1.469 . . . . 0.0 113.58 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.89 -17.24 45.61 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.947 -0.918 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.2 m -58.63 121.83 11.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.66 1.73 . . . . 0.0 109.44 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.99 113.55 5.78 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.24 -50.36 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.24 99.65 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' H ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -74.5 56.76 0.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.503 1.921 . . . . 0.0 109.507 176.428 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.61 -179.06 42.28 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.72 174.04 5.55 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.116 0.484 . . . . 0.0 111.419 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -118.36 26.88 9.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 109.896 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -65.44 -42.16 92.69 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.18 173.37 20.53 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.74 -177.1 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.163 3.242 . . . . 0.0 112.227 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 20' ' ' ILE . 18.2 t-20 -100.71 104.96 16.26 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.5 14.04 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -71.1 81.6 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.261 1.391 . . . . 0.0 109.254 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 53.79 1.01 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.794 0.711 . . . . 0.0 114.175 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.13 -41.84 31.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 117.461 0.63 . . . . 0.0 109.711 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t -52.56 119.41 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 121.215 -0.928 . . . . 0.0 110.896 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 -18.88 56.69 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.879 1.228 . . . . 0.0 111.832 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -65.78 138.9 58.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.9 0.85 . . . . 0.0 111.074 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -71.66 70.82 0.7 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 0.0 111.058 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 58.08 -143.58 0.64 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.638 0.775 . . . . 0.0 109.938 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.3 83.35 0.13 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.54 1.067 . . . . 0.0 113.284 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.2 t -147.51 40.98 1.03 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.016 0.408 . . . . 0.0 111.9 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.97 128.89 58.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -55.97 155.29 23.81 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.374 1.383 . . . . 0.0 112.395 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 54.58 57.94 5.32 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 0.0 112.62 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -158.45 119.11 3.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.785 0.434 . . . . 0.0 110.001 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -79.15 86.72 4.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.387 0.675 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -68.17 -174.63 0.51 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.47 0.652 . . . . 0.0 110.967 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -114.75 172.74 6.85 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.991 1.316 . . . . 0.0 109.83 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.55 -41.92 86.68 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.958 1.303 . . . . 0.0 112.435 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 p -63.17 -65.42 0.69 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.286 1.435 . . . . 0.0 110.564 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.23 -35.01 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.638 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.82 -50.57 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.28 81.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.068 -0.395 . . . . 0.0 111.311 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -55.72 -50.76 69.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.3 -53.93 39.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.36 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.831 0.852 . . . . 0.0 112.742 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.8 p -68.63 -9.16 48.22 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.68 7.62 23.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.436 1.017 . . . . 0.0 112.805 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -68.44 138.25 55.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.744 1.272 . . . . 0.0 109.26 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.27 128.03 39.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 106.994 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -60.49 147.42 41.29 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -142.25 166.43 24.72 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.415 1.886 . . . . 0.0 106.207 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.48 -41.47 73.04 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.799 0.272 . . . . 0.0 110.48 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.62 -51.48 62.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.351 0.66 . . . . 0.0 110.595 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.13 -48.08 81.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.181 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mm -57.22 -55.6 19.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.72 -41.08 42.75 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.828 1.251 . . . . 0.0 111.19 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -71.52 -55.86 7.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.831 0.348 . . . . 0.0 110.224 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -50.68 -45.62 58.29 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.3 -33.58 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.95 2.98 53.86 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.423 0.689 . . . . 0.0 112.761 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -148.3 62.68 6.73 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.229 1.012 . . . . 0.0 112.428 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.16 140.69 93.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.171 1.914 . . . . 0.0 109.772 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.38 -64.7 1.03 Allowed Glycine 0 CA--C 1.533 1.18 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.0 -45.61 7.94 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.991 1.716 . . . . 0.0 111.346 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.0 -55.92 25.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.165 0.586 . . . . 0.0 110.938 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -57.95 -46.42 85.13 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.389 0.675 . . . . 0.0 110.693 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -53.81 -53.01 58.37 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -54.13 -57.36 11.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.221 0.608 . . . . 0.0 111.009 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.31 -54.54 39.15 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -88.87 -25.06 22.35 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -170.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 54.44 49.5 18.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.749 1.219 . . . . 0.0 110.036 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -117.42 128.57 55.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 108.761 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -51.37 -43.52 61.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.651 1.18 . . . . 0.0 111.057 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -91.13 27.09 1.96 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.79 65.46 1.03 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.599 0.714 . . . . 0.0 111.845 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -91.0 -177.94 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.785 2.034 . . . . 0.0 109.434 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 t -158.46 150.47 21.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.41 -26.18 71.66 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 16.4 ttp -65.32 82.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.36 58.36 4.06 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.206 -0.934 . . . . 0.0 109.201 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -165.89 151.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.404 1.482 . . . . 0.0 107.184 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -143.42 166.51 24.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.225 0.466 . . . . 0.0 110.205 170.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.11 115.97 28.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.75 52.81 2.0 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.594 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.93 169.8 17.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.345 1.458 . . . . 0.0 107.764 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.33 -17.89 68.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.382 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.53 1.99 73.13 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 118.157 0.978 . . . . 0.0 114.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -46.29 88.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.674 1.237 . . . . 0.0 111.194 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -55.08 -51.43 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.264 1.426 . . . . 0.0 110.72 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.89 -50.87 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.76 1.224 . . . . 0.0 110.247 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.72 -46.49 81.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.391 -0.193 . . . . 0.0 110.615 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.48 93.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.852 0.461 . . . . 0.0 110.17 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -59.33 -49.04 79.37 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.036 -0.415 . . . . 0.0 110.67 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.3 mt -60.02 -45.74 91.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.647 0.658 . . . . 0.0 110.758 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.22 79.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.387 0.275 . . . . 0.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.7 m -66.59 -40.66 89.01 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.123 -0.361 . . . . 0.0 111.321 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.1 -43.56 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.747 1.219 . . . . 0.0 112.675 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.481 0.658 . . . . 0.0 112.291 -175.131 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.06 93.32 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.785 -0.832 . . . . 0.0 109.005 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.39 34.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 112.808 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.83 -54.99 22.35 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.913 0.778 . . . . 0.0 109.695 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -56.69 -41.2 76.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 0.0 110.123 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.64 -49.56 57.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -54.97 -52.2 63.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.551 0.74 . . . . 0.0 110.041 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -57.67 -53.13 61.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.2 -26.11 62.41 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 126.478 1.911 . . . . 0.0 112.09 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -56.63 -18.97 13.93 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.184 0.447 . . . . 0.0 110.98 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -53.38 -32.9 51.6 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.657 -0.652 . . . . 0.0 111.134 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.73 -53.16 29.67 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -51.46 -45.01 62.58 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.308 1.043 . . . . 0.0 110.889 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -47.85 -30.54 4.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 113.061 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -52.59 -38.03 59.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.057 0.543 . . . . 0.0 110.978 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -112.61 -40.3 4.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.481 ' CG ' HD21 ' A' ' 37' ' ' LEU . 97.3 m-70 -100.55 -174.01 2.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.247 1.019 . . . . 0.0 113.233 -170.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -152.16 173.17 15.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.574 1.549 . . . . 0.0 109.025 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.95 131.41 52.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 tp -116.79 145.37 22.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.753 1.621 . . . . 0.0 109.536 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.19 160.01 76.76 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 119.432 1.015 . . . . 0.0 108.321 173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.99 -36.86 93.6 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.439 2.093 . . . . 0.0 110.214 172.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.13 -1.4 7.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.398 1.879 . . . . 0.0 113.135 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.22 -18.36 45.72 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 120.728 -1.232 . . . . 0.0 112.362 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -53.99 122.13 9.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.205 1.002 . . . . 0.0 110.906 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.86 78.74 1.14 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.326 0.65 . . . . 0.0 110.616 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.85 -60.47 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.01 98.75 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.09 63.23 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.735 1.214 . . . . 0.0 109.738 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.87 -156.77 32.98 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.88 6.7 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -124.68 33.84 5.14 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.53 -34.88 76.63 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.27 176.8 17.69 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 168.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.0 -171.07 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.676 2.917 . . . . 0.0 111.698 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -117.48 101.37 8.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -68.55 0.94 3.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.01 109.87 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.97 1.259 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.53 20.02 55.31 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.573 -0.571 . . . . 0.0 112.391 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.87 -37.82 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.354 1.077 . . . . 0.0 109.047 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.4 107.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.059 0.944 . . . . 0.0 110.428 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 -5.7 72.08 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 112.482 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -92.41 138.16 31.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.84 0.82 . . . . 0.0 110.367 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -56.41 127.21 29.95 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.937 1.295 . . . . 0.0 111.347 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.99 149.29 19.22 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.615 -0.678 . . . . 0.0 111.153 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.47 42.43 99.0 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.332 -1.26 . . . . 0.0 115.187 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.7 p -142.17 1.04 1.4 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.465 1.632 . . . . 0.0 114.846 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -69.19 134.71 89.27 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 120.445 1.475 . . . . 0.0 109.723 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.27 154.37 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.989 2.46 . . . . 0.0 115.685 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.27 60.8 3.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.078 1.751 . . . . 0.0 112.66 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -154.66 118.9 4.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.026 0.441 . . . . 0.0 110.837 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.29 80.28 1.84 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.99 0.916 . . . . 0.0 110.586 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -68.55 176.26 3.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.484 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -107.45 170.58 7.88 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.937 0.895 . . . . 0.0 109.942 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.1 -46.41 89.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.173 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 p -60.96 -65.39 0.7 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.845 1.258 . . . . 0.0 111.069 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.99 -42.88 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.095 0.958 . . . . 0.0 110.837 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -44.83 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.997 . . . . 0.0 110.032 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.4 82.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.705 0.684 . . . . 0.0 110.528 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.9 tp -57.85 -48.26 80.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.28 -56.29 17.88 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 123.887 0.756 . . . . 0.0 111.755 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.88 55.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.438 1.495 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 m -71.53 5.18 2.51 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.88 21.33 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.146 1.355 . . . . 0.0 111.242 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -82.54 77.9 9.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.788 -0.83 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 116.6 13.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -57.81 139.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -122.64 162.9 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.208 1.403 . . . . 0.0 107.385 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -54.2 -43.29 70.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -53.46 54.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.589 0.756 . . . . 0.0 110.407 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -60.48 -45.13 94.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.993 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.1 mt -58.0 -55.94 18.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.65 -40.17 62.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.868 0.867 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.7 m -68.04 -63.99 0.95 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.51 -51.87 2.87 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.094 1.757 . . . . 0.0 112.925 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.0 m -54.67 -33.59 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -72.39 -29.56 63.85 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.77 -0.581 . . . . 0.0 111.862 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -138.47 61.89 27.2 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -65.35 153.59 77.53 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 CA-C-N 120.086 1.066 . . . . 0.0 110.588 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.43 -66.65 2.62 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.07 -44.2 51.61 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.284 1.034 . . . . 0.0 111.243 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -51.95 -57.17 10.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.647 0.779 . . . . 0.0 110.106 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.511 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 5.3 mp -56.82 -54.21 49.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.857 0.463 . . . . 0.0 110.755 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -50.37 -42.4 53.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.04 0.536 . . . . 0.0 110.989 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.75 -66.35 0.57 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.354 0.662 . . . . 0.0 110.19 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -54.5 -43.38 71.79 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -88.85 1.07 55.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.703 1.201 . . . . 0.0 111.255 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t0 41.92 54.44 3.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.964 1.706 . . . . 0.0 110.967 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -147.91 122.06 9.53 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.631 0.772 . . . . 0.0 112.534 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -53.47 -45.23 69.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.626 1.57 . . . . 0.0 110.301 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -73.92 5.63 4.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 83' ' ' LEU . . . -82.08 72.15 9.13 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.377 -1.452 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -82.46 164.3 21.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.459 1.104 . . . . 0.0 108.827 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.4 t -142.02 149.45 40.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.29 -29.84 72.44 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 ttp -62.05 83.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.8 57.38 3.79 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -159.73 149.85 18.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -139.37 153.26 47.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.8 tp -113.37 107.81 16.37 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.08 66.72 3.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.918 0.887 . . . . 0.0 109.89 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 84.14 146.13 0.07 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 128.583 2.753 . . . . 0.0 109.988 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.77 -26.54 5.1 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.02 -40.76 10.18 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.401 1.476 . . . . 0.0 113.085 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.57 -48.9 79.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.717 0.758 . . . . 0.0 110.579 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -61.14 -48.33 82.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.211 1.004 . . . . 0.0 109.456 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.41 -40.87 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.701 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.6 89.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.604 -0.685 . . . . 0.0 109.963 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.42 90.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.08 -53.23 59.54 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.1 mt -55.27 -47.81 74.95 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.117 0.417 . . . . 0.0 110.913 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.38 77.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.4 m -70.36 -40.58 73.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.032 -0.417 . . . . 0.0 110.674 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.23 -44.68 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.468 1.507 . . . . 0.0 112.698 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 121.744 0.783 . . . . 0.0 112.592 -176.247 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.079 0.266 . . . . 0.0 112.814 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.19 76.69 0.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.717 1.607 . . . . 0.0 111.044 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.11 10.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.432 1.093 . . . . 0.0 112.18 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.4 -54.17 49.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.535 0.734 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.03 -34.47 74.89 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.89 -56.24 24.95 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.31 -37.4 87.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.165 0.983 . . . . 0.0 111.357 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -60.96 -50.9 71.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.729 0.695 . . . . 0.0 109.737 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -57.2 -34.11 68.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.7 1.2 . . . . 0.0 110.273 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 19' ' ' ILE . 3.6 t80 -56.16 -21.73 24.59 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -55.38 -36.3 66.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.668 0.667 . . . . 0.0 110.278 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -69.82 -52.68 22.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.9 m -50.72 -40.8 55.29 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.378 1.071 . . . . 0.0 111.749 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -48.35 -30.93 5.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 112.31 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.6 m -59.32 -22.46 61.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.497 0.719 . . . . 0.0 111.505 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.4 m -124.84 -34.58 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.378 1.071 . . . . 0.0 112.771 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -110.21 170.33 8.15 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.581 1.152 . . . . 0.0 114.081 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.4 m -141.89 166.05 25.78 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.427 1.091 . . . . 0.0 110.295 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.457 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 2.3 mp -139.65 124.47 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 106.865 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.14 132.21 58.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.514 1.126 . . . . 0.0 110.175 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 154.01 71.74 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.58 -35.37 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.036 2.491 . . . . 0.0 112.097 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.81 -9.27 58.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.351 1.06 . . . . 0.0 113.144 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.31 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.999 -0.889 . . . . 0.0 113.404 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.7 m -62.39 108.28 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.489 1.644 . . . . 0.0 110.331 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.49 134.53 57.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.64 0.776 . . . . 0.0 110.659 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 mm -105.29 -50.34 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.08 96.47 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -84.21 70.17 10.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.94 -154.12 26.86 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.26 175.53 10.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -125.77 32.57 5.26 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.944 0.897 . . . . 0.0 109.232 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.3 m -64.73 -36.98 86.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.35 173.02 14.61 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.56 179.6 1.23 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.372 3.382 . . . . 0.0 113.91 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -92.34 103.85 16.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.261 1.024 . . . . 0.0 110.036 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.64 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -70.03 85.12 0.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.268 1.849 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.96 58.37 2.65 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.36 0.981 . . . . 0.0 113.265 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.37 -39.33 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 O-C-N 122.219 -0.577 . . . . 0.0 110.966 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.56 119.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.014 0.525 . . . . 0.0 110.504 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.08 -21.94 41.38 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.673 1.13 . . . . 0.0 111.602 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' NH1' ' H ' ' A' ' 44' ' ' THR . 3.9 tpm_? -68.26 138.24 55.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.441 1.12 . . . . 0.0 110.886 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.413 ' H ' ' NH1' ' A' ' 43' ' ' ARG . 2.7 m -65.02 72.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.434 1.894 . . . . 0.0 111.675 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.59 -145.25 0.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.461 -0.774 . . . . 0.0 109.431 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.04 78.25 1.26 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -138.7 14.62 2.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.591 0.756 . . . . 0.0 111.621 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -64.96 127.01 92.33 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.36 172.12 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.403 2.068 . . . . 0.0 115.779 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 46.01 57.47 5.16 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.256 1.822 . . . . 0.0 111.825 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -164.37 122.46 1.77 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.489 0.316 . . . . 0.0 110.761 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.26 95.32 4.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.057 0.943 . . . . 0.0 110.24 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.2 -178.69 5.21 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.353 0.661 . . . . 0.0 111.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.92 177.48 4.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.23 -35.23 75.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.021 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 p -63.29 -66.65 0.51 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.556 1.142 . . . . 0.0 110.627 -173.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tt -57.43 -37.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.123 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.7 -47.58 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.55 84.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.056 0.389 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.8 tp -55.41 -50.11 70.61 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.11 -54.86 29.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.95 -31.56 60.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.113 0.965 . . . . 0.0 112.225 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -72.03 3.07 4.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.14 29.38 10.4 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.142 0.877 . . . . 0.0 111.616 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -90.76 140.44 29.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -60.37 148.37 37.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 123.053 0.541 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.7 p -142.71 166.31 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -54.8 -41.06 70.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.72 -56.13 15.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.108 0.963 . . . . 0.0 109.719 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.03 -52.15 61.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.278 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.5 mt -56.87 -54.69 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.67 -40.32 53.31 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.054 0.942 . . . . 0.0 111.667 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -70.75 -60.95 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -43.49 -51.92 6.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.061 1.344 . . . . 0.0 113.602 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.6 m -51.28 -38.49 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -90.81 -8.49 49.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.23 55.17 3.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.878 0.871 . . . . 0.0 111.576 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.66 147.17 85.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.917 1.745 . . . . 0.0 109.868 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.36 -64.46 4.26 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.7 61.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.389 0.676 . . . . 0.0 109.993 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -48.52 -51.54 26.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.774 1.23 . . . . 0.0 111.338 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.49 -58.94 4.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -49.5 -38.91 32.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 111.615 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -53.42 -39.91 64.7 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.456 0.702 . . . . 0.0 111.842 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -97.21 -53.32 3.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.318 1.047 . . . . 0.0 111.741 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.7 tp -78.86 -22.92 45.33 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.776 1.23 . . . . 0.0 113.228 -175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t0 41.57 63.62 1.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.486 1.914 . . . . 0.0 113.216 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.43 145.29 45.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 108.282 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.38 -38.46 58.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.188 0.995 . . . . 0.0 110.842 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.21 21.71 13.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.0 0.92 . . . . 0.0 112.855 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.84 5.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -126.22 142.52 51.5 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.429 1.492 . . . . 0.0 108.636 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -94.37 150.08 20.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.965 0.906 . . . . 0.0 109.164 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -55.02 -27.03 43.93 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.974 -0.454 . . . . 0.0 111.994 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.2 ttp -59.64 86.5 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 113.343 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.39 57.93 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.91 155.79 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.537 1.935 . . . . 0.0 106.331 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -145.35 170.94 15.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.2 tp -97.23 166.48 11.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.55 37.88 4.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -143.93 170.79 15.25 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.661 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -12.97 35.28 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.707 -1.052 . . . . 0.0 113.35 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.04 -32.07 1.76 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 118.475 1.138 . . . . 0.0 114.638 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.23 -38.41 3.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 113.281 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -61.13 -49.21 78.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.674 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.56 -41.72 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.39 90.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.699 0.4 . . . . 0.0 110.546 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.47 94.48 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.79 0.436 . . . . 0.0 109.932 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -55.9 -54.3 46.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.1 mt -57.32 -37.12 72.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.426 0.69 . . . . 0.0 111.716 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.4 89.06 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.457 -0.777 . . . . 0.0 109.146 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.4 t -59.73 -29.31 68.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.73 -0.606 . . . . 0.0 111.924 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.45 -29.35 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 O-C-N 121.845 -0.534 . . . . 0.0 110.749 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 124.501 1.12 . . . . 0.0 109.748 178.121 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.107 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.92 73.84 0.6 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.584 1.154 . . . . 0.0 111.707 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.98 -39.08 25.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.195 0.998 . . . . 0.0 111.949 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.43 82.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.391 0.676 . . . . 0.0 111.231 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.89 -41.72 77.9 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.88 -46.65 40.4 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.021 0.82 . . . . 0.0 111.94 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -52.52 -54.27 34.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.475 0.71 . . . . 0.0 110.527 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.47 -47.53 83.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.901 0.48 . . . . 0.0 110.159 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -53.86 -39.19 65.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.353 1.061 . . . . 0.0 109.849 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.16 -22.3 27.89 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.43 -31.29 54.99 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.646 -0.659 . . . . 0.0 110.048 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -71.33 -52.75 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 m -51.18 -43.0 61.22 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.656 1.182 . . . . 0.0 110.637 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -49.16 -25.88 2.46 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.131 1.772 . . . . 0.0 112.279 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -53.95 -42.58 69.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.211 1.368 . . . . 0.0 110.281 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.8 m -106.95 -42.22 4.97 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.743 0.817 . . . . 0.0 112.401 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -92.7 167.27 12.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.583 1.153 . . . . 0.0 112.885 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -140.15 147.21 39.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.32 124.98 73.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.86 133.99 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.332 1.853 . . . . 0.0 107.853 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.56 158.04 86.45 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.46 -38.7 74.78 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.943 2.429 . . . . 0.0 112.646 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -74.29 -10.54 59.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.164 1.385 . . . . 0.0 113.663 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.33 -18.65 32.84 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.83 -0.984 . . . . 0.0 113.63 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -57.18 118.71 5.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.698 . . . . 0.0 109.556 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.61 125.66 26.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.819 0.447 . . . . 0.0 110.405 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 mm -85.06 -52.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.0 m -146.57 136.12 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -113.36 135.55 53.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.72 -172.87 19.93 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 124.434 1.016 . . . . 0.0 110.977 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.02 44.89 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.596 -0.944 . . . . 0.0 109.611 175.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 tptp 15.94 57.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 130.28 3.432 . . . . 0.0 113.61 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.12 -32.16 14.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.3 167.85 12.46 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 174.05 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.421 3.414 . . . . 0.0 113.526 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.44 115.52 17.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.36 7.02 44.75 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -48.73 106.78 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.091 0.86 . . . . 0.0 111.58 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.03 42.96 95.26 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.12 -36.86 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 117.274 0.537 . . . . 0.0 111.565 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.5 116.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.57 -19.15 55.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.256 0.931 . . . . 0.0 111.802 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.05 148.09 32.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 117.731 0.765 . . . . 0.0 109.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 m -61.48 127.02 29.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.796 0.838 . . . . 0.0 109.931 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.88 154.8 41.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 111.758 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.52 27.1 63.04 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.023 -0.876 . . . . 0.0 114.749 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.8 t -155.32 20.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.676 1.238 . . . . 0.0 112.77 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.22 126.11 92.31 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.54 171.75 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 CA-C-N 121.099 1.428 . . . . 0.0 115.735 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 50.64 55.18 9.91 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.749 1.62 . . . . 0.0 111.404 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -166.04 123.4 1.42 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.169 -0.332 . . . . 0.0 111.377 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -83.42 99.64 10.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.498 1.119 . . . . 0.0 109.089 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -85.0 -170.39 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.856 0.862 . . . . 0.0 111.962 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.71 175.89 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.959 1.703 . . . . 0.0 109.552 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.93 -43.67 82.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.357 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 t -70.85 -47.93 56.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.091 0.472 . . . . 0.0 111.145 -173.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -67.02 -34.91 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.08 -45.56 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.79 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 111.406 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 mt -55.86 -49.16 74.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.41 39.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -37.29 74.31 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.274 1.029 . . . . 0.0 110.779 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 t -72.88 4.05 4.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.19 61.44 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 119.14 0.882 . . . . 0.0 111.934 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -71.99 108.28 5.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.984 0.892 . . . . 0.0 109.517 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.61 122.46 37.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -57.44 153.31 12.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p -133.77 169.8 16.51 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.554 1.141 . . . . 0.0 108.153 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -57.59 -46.42 84.04 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.665 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.1 -47.72 73.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.03 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.55 -49.73 76.65 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.87 -50.95 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 118.116 0.416 . . . . 0.0 110.106 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.38 -38.29 52.62 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.074 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -73.45 -58.29 3.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -44.68 -47.24 10.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.176 1.391 . . . . 0.0 113.74 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.44 -36.41 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 119.138 0.881 . . . . 0.0 113.308 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -100.14 2.26 42.88 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.842 0.857 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -142.35 56.52 5.46 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.408 1.483 . . . . 0.0 110.997 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.04 138.97 64.88 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.244 1.962 . . . . 0.0 109.436 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.1 -60.45 2.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.58 -45.47 9.48 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.692 1.597 . . . . 0.0 111.876 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.07 -44.74 96.02 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.151 -0.619 . . . . 0.0 111.663 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.92 -51.09 70.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.792 0.837 . . . . 0.0 109.012 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -52.56 -52.37 55.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.586 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -55.96 -53.36 57.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 111.12 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -66.92 -52.13 46.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.57 -18.54 48.01 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.7 t0 56.35 53.83 8.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.33 1.452 . . . . 0.0 109.275 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -134.27 128.41 33.77 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.615 1.166 . . . . 0.0 109.87 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.22 -37.2 79.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.525 1.13 . . . . 0.0 110.527 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -85.72 15.93 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.9 65.54 8.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.892 0.853 . . . . 0.0 110.439 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.37 108.25 19.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 109.666 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -63.11 156.4 25.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.75 -21.69 79.52 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.7 ttp -68.94 82.01 0.31 Allowed 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.725 -0.867 . . . . 0.0 112.755 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.99 57.33 2.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.474 0.71 . . . . 0.0 109.479 174.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -163.13 148.19 11.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.808 1.643 . . . . 0.0 107.789 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -142.54 164.95 28.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.21 1.004 . . . . 0.0 109.589 173.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.32 115.56 26.15 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.25 55.05 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.89 0.476 . . . . 0.0 110.034 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -132.43 168.08 18.8 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 125.624 1.57 . . . . 0.0 108.721 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.06 -19.42 59.11 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.752 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.85 1.9 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.061 0.93 . . . . 0.0 113.703 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -41.11 -44.11 2.41 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.072 1.749 . . . . 0.0 113.832 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -62.14 -45.55 92.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.117 0.967 . . . . 0.0 110.986 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.32 -45.0 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.11 0.964 . . . . 0.0 108.897 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.02 91.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.346 0.658 . . . . 0.0 110.339 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.22 97.28 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.875 0.47 . . . . 0.0 110.01 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.86 -52.58 64.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.66 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -57.29 -42.36 81.54 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.011 -0.431 . . . . 0.0 111.117 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.48 -41.45 73.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.918 0.487 . . . . 0.0 110.174 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -63.19 -30.01 71.24 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.968 -0.457 . . . . 0.0 111.912 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.83 -29.97 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.063 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.342 0.26 0 C-N-CA 125.522 1.529 . . . . 0.0 112.72 -176.981 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.065 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -90.37 106.01 18.2 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.876 1.27 . . . . 0.0 108.777 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.7 -31.43 26.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.329 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.54 12.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.354 0.979 . . . . 0.0 110.248 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -56.28 -38.56 71.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.768 -0.583 . . . . 0.0 109.551 174.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.99 -51.1 52.13 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.67 -47.89 82.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.279 1.032 . . . . 0.0 110.279 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -57.25 -52.71 64.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.164 0.185 . . . . 0.0 110.677 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.93 -35.96 67.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.518 1.127 . . . . 0.0 110.211 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.52 -27.16 62.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.069 0.548 . . . . 0.0 112.134 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -30.47 63.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.383 0.538 . . . . 0.0 110.043 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -93.13 -50.26 5.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.036 0.934 . . . . 0.0 109.48 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -33.92 42.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -58.58 -14.81 9.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 114.347 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -56.09 -17.76 7.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.246 -0.909 . . . . 0.0 112.338 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.4 m -124.02 -27.27 3.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.966 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -117.81 165.9 13.11 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.922 0.783 . . . . 0.0 112.941 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -140.39 164.68 29.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.289 1.035 . . . . 0.0 111.629 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.18 121.87 24.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 125.661 1.584 . . . . 0.0 107.854 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -116.54 134.39 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.602 1.561 . . . . 0.0 108.169 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.66 160.24 77.92 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 119.114 0.87 . . . . 0.0 108.94 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.31 -40.95 69.11 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.108 2.538 . . . . 0.0 112.7 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -74.52 -8.28 55.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.145 1.378 . . . . 0.0 113.594 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.79 -18.85 42.81 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.963 -0.909 . . . . 0.0 113.394 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -60.51 117.64 5.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.6 1.7 . . . . 0.0 108.867 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -68.18 129.97 41.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.83 -46.09 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.2 93.48 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -77.0 90.67 3.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.81 -148.28 23.95 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.73 177.84 8.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -129.34 34.11 4.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.676 0.79 . . . . 0.0 109.558 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -64.18 -41.1 97.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.81 164.14 13.33 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.96 164.06 3.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.497 2.798 . . . . 0.0 115.276 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -72.89 121.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.83 6.41 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.95 115.82 3.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.545 1.066 . . . . 0.0 108.561 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.36 23.68 72.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.965 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.61 -38.23 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 118.859 1.329 . . . . 0.0 109.553 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.15 103.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.86 -7.94 42.23 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.5 1.524 . . . . 0.0 112.205 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -72.6 142.79 48.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 117.971 0.885 . . . . 0.0 111.418 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -70.91 68.17 0.42 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.946 1.698 . . . . 0.0 113.508 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.74 -154.56 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 111.944 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.83 70.96 1.15 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 123.697 0.665 . . . . 0.0 112.777 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.8 p -137.93 23.16 2.84 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.381 0.672 . . . . 0.0 111.355 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.78 134.85 90.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.04 168.98 3.05 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.828 1.685 . . . . 0.0 114.846 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 42.46 56.47 3.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.609 1.964 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.9 118.53 2.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -79.7 109.16 13.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.891 0.876 . . . . 0.0 109.439 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -95.64 -172.26 2.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.573 0.749 . . . . 0.0 111.5 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.18 169.75 9.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.535 1.934 . . . . 0.0 107.682 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.97 -41.25 97.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.6 p -62.79 -60.62 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.665 1.586 . . . . 0.0 111.994 -171.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 tp -57.63 -27.98 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.278 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -76.17 -50.34 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.65 -38.05 53.08 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.431 1.093 . . . . 0.0 111.897 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.45 -50.48 69.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.0 0.818 . . . . 0.0 109.269 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.25 86.89 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.77 69.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.454 0.301 . . . . 0.0 111.112 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.2 t -74.36 1.04 12.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.943 0.897 . . . . 0.0 112.795 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.81 14.9 55.91 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 119.13 0.877 . . . . 0.0 112.973 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.44 156.56 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.415 1.107 . . . . 0.0 109.674 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.04 124.39 11.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.642 1.577 . . . . 0.0 107.121 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -59.82 150.66 27.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.1 p -137.0 166.45 23.64 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.526 1.53 . . . . 0.0 107.009 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -52.63 -49.79 64.43 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.718 0.807 . . . . 0.0 108.884 173.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.47 -61.04 2.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.135 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -54.54 -46.63 73.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.773 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -60.38 -53.67 45.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.96 -42.69 63.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.04 0.936 . . . . 0.0 110.335 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.9 m -66.72 -59.32 3.68 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -44.31 -50.44 9.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.694 1.598 . . . . 0.0 113.224 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -54.82 -35.35 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.113 0.87 . . . . 0.0 113.034 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -82.71 -18.9 39.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.748 -0.595 . . . . 0.0 112.141 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.34 56.39 7.34 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 124.456 1.102 . . . . 0.0 112.709 -172.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.63 143.44 87.2 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.161 1.241 . . . . 0.0 109.22 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.93 -60.98 4.61 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.82 -42.69 65.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.872 0.869 . . . . 0.0 110.479 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -50.37 -50.78 50.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 111.037 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -67.76 -52.88 32.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.218 0.607 . . . . 0.0 110.23 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -49.12 -33.67 12.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.334 0.653 . . . . 0.0 110.751 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.29 -64.18 1.08 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.177 0.591 . . . . 0.0 110.191 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.49 -56.21 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.33 -41.98 84.34 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.402 0.681 . . . . 0.0 110.929 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 55.15 65.97 1.35 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.088 1.355 . . . . 0.0 111.094 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -129.15 139.88 51.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.291 1.836 . . . . 0.0 107.807 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -50.51 -40.35 51.23 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.271 1.029 . . . . 0.0 110.502 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.46 37.42 2.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.76 0.824 . . . . 0.0 111.42 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.5 66.15 3.18 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.595 0.758 . . . . 0.0 110.557 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -113.72 178.68 4.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.346 1.058 . . . . 0.0 109.29 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 t -144.99 149.84 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -14.33 57.28 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.1 ttt -65.98 77.36 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.531 1.132 . . . . 0.0 113.174 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 58.2 3.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.902 0.881 . . . . 0.0 109.308 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -163.19 137.55 6.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.669 1.588 . . . . 0.0 107.65 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -122.65 160.18 26.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tp -103.04 139.57 38.41 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.89 57.5 1.11 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.807 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 79.99 154.23 0.13 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 126.618 1.967 . . . . 0.0 110.141 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.72 38.27 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.53 -35.38 44.79 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.708 1.147 . . . . 0.0 111.572 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.46 -48.11 82.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.482 0.713 . . . . 0.0 110.298 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.34 -48.25 82.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.933 0.893 . . . . 0.0 109.514 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.71 -42.79 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.84 0.456 . . . . 0.0 110.162 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.19 97.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.769 -0.582 . . . . 0.0 110.109 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.98 95.42 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -58.77 -48.58 80.75 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.848 -0.533 . . . . 0.0 110.049 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.92 -45.12 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.891 -0.506 . . . . 0.0 110.712 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -42.08 85.25 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.692 -0.63 . . . . 0.0 110.328 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -67.49 -30.13 69.74 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.768 -0.583 . . . . 0.0 111.671 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.75 -39.61 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.585 1.154 . . . . 0.0 111.651 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 121.64 0.733 . . . . 0.0 112.871 -175.867 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 N-CA-C 113.82 0.288 . . . . 0.0 113.82 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.54 91.28 2.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.7 11.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.789 0.836 . . . . 0.0 113.14 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.35 -49.36 67.19 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.799 0.727 . . . . 0.0 110.017 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.64 -35.58 76.55 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.72 46.17 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -54.55 -53.89 48.49 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.751 0.82 . . . . 0.0 109.657 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -52.02 -55.47 20.34 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -54.97 -40.33 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.524 1.129 . . . . 0.0 110.693 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -55.82 -25.74 43.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.324 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -58.98 -31.3 68.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 110.894 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -93.78 -49.22 5.94 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.188 0.595 . . . . 0.0 109.865 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.97 -34.23 41.43 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.929 0.892 . . . . 0.0 110.634 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -41.7 -40.27 1.92 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.679 2.392 . . . . 0.0 115.002 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.1 m -25.81 -48.73 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.198 2.199 . . . . 0.0 114.044 -171.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.61 -25.96 13.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.892 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -100.6 -172.0 2.12 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-O 121.467 0.651 . . . . 0.0 112.201 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 m -157.11 161.03 39.4 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.692 1.597 . . . . 0.0 108.645 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.98 122.71 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.891 1.676 . . . . 0.0 107.354 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.5 tp -106.25 131.53 55.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 C-N-CA 125.162 1.385 . . . . 0.0 108.607 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 160.21 82.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.35 -38.31 62.47 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.01 2.474 . . . . 0.0 112.785 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.8 -9.83 56.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.482 1.513 . . . . 0.0 114.099 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.47 57.71 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.174 0.897 . . . . 0.0 113.637 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 m -69.81 126.28 29.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.641 1.721 . . . . 0.0 108.991 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.02 96.62 5.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.81 0.844 . . . . 0.0 110.14 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.06 -48.25 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.7 126.46 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -124.91 82.09 2.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.237 1.815 . . . . 0.0 110.216 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.55 -168.18 40.14 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.09 43.26 0.85 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.885 -1.362 . . . . 0.0 111.771 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 13.45 59.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 129.84 3.256 . . . . 0.0 113.969 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -32.11 13.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.159 1.384 . . . . 0.0 109.086 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.48 162.14 12.55 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.9 140.01 77.25 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.375 3.384 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -55.25 119.87 6.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.72 -2.15 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -64.8 84.08 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.445 1.02 . . . . 0.0 111.718 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.61 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.23 1.395 . . . . 0.0 112.182 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.91 -46.26 96.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-N 119.415 1.607 . . . . 0.0 109.523 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.25 118.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.341 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -29.79 10.85 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.741 1.638 . . . . 0.0 111.028 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -73.78 147.94 42.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.624 0.712 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.7 m -71.11 136.78 48.38 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.48 141.34 37.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.727 -0.608 . . . . 0.0 109.888 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.99 77.37 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.945 -1.475 . . . . 0.0 114.043 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 p -137.33 -0.56 2.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.879 1.839 . . . . 0.0 115.48 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -62.26 129.4 92.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 121.57 1.987 . . . . 0.0 107.641 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -44.62 154.53 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.662 2.908 . . . . 0.0 116.58 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 50.27 66.52 1.12 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.561 1.945 . . . . 0.0 113.631 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -163.41 122.84 2.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.98 0.419 . . . . 0.0 111.112 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.91 83.73 2.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.111 0.964 . . . . 0.0 109.821 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.09 178.16 1.96 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.918 0.487 . . . . 0.0 111.804 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -111.0 171.4 7.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.54 1.162 . . . . 0.0 110.767 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -53.91 15.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 111.986 -2.37 . . . . 0.0 113.013 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.3 m -62.23 -52.89 61.94 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.067 0.937 . . . . 0.0 111.579 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 tt -69.81 -38.84 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.456 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.69 -39.45 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.2 88.44 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.077 -0.389 . . . . 0.0 110.341 177.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.35 -49.81 76.39 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.43 -45.81 8.43 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.519 1.533 . . . . 0.0 112.695 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.3 -28.04 17.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.569 1.548 . . . . 0.0 113.695 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.4 p -73.63 2.74 7.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.118 0.872 . . . . 0.0 112.259 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.75 35.76 21.24 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -77.21 86.6 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.244 -0.562 . . . . 0.0 111.039 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.91 120.32 18.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.499 1.12 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -62.98 122.48 16.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.276 0.23 . . . . 0.0 110.419 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 p -100.31 159.1 15.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -54.65 -37.8 66.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.011 0.434 . . . . 0.0 110.357 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.76 -51.11 68.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.997 0.919 . . . . 0.0 110.171 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -59.71 -47.45 85.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.967 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.6 mt -55.07 -52.16 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.782 0.719 . . . . 0.0 109.284 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.87 65.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.452 0.701 . . . . 0.0 110.743 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -64.99 -54.37 31.57 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.835 0.454 . . . . 0.0 110.239 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -46.2 -52.06 13.09 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.701 1.6 . . . . 0.0 111.253 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -51.3 -28.61 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.669 0.788 . . . . 0.0 112.993 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -78.2 -26.67 47.6 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.711 0.687 . . . . 0.0 112.645 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -154.54 69.16 5.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.992 0.814 . . . . 0.0 111.889 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.11 145.95 97.28 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.198 1.932 . . . . 0.0 110.868 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.27 -59.99 4.79 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.05 70.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -47.89 -52.25 20.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.699 0.8 . . . . 0.0 111.377 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.8 mt -61.49 -56.87 15.31 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.409 1.084 . . . . 0.0 109.704 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.5 -38.76 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.591 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -72.36 -59.5 2.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.875 0.47 . . . . 0.0 109.739 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.03 -41.03 82.32 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.5 tp -86.2 -4.39 59.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.222 1.009 . . . . 0.0 111.876 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 t0 48.06 43.69 18.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.988 1.315 . . . . 0.0 110.366 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.24 107.92 12.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.005 1.322 . . . . 0.0 109.29 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 90' ' ' LYS . 13.4 mptt -57.14 -26.27 60.27 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 128.738 2.815 . . . . 0.0 111.752 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -104.85 15.51 27.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.835 0.854 . . . . 0.0 113.264 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.2 113.75 20.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -132.44 131.68 41.99 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.344 1.057 . . . . 0.0 111.151 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -85.02 156.2 21.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.96 -18.71 72.94 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 170.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.73 80.79 0.07 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.593 1.157 . . . . 0.0 113.089 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.72 57.8 2.61 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.057 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -160.84 139.33 9.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.8 1.64 . . . . 0.0 106.606 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -142.53 155.19 44.99 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.5 tp -150.2 111.28 4.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.066 0.947 . . . . 0.0 108.57 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.86 30.99 0.2 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.285 -0.884 . . . . 0.0 112.908 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -161.83 176.7 10.59 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 127.502 2.321 . . . . 0.0 106.1 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.87 -51.52 2.74 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.525 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.72 -56.52 0.12 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.71 2.1 . . . . 0.0 114.732 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -59.98 -51.67 68.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.616 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.25 -48.37 80.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 109.631 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.63 -44.16 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.564 1.146 . . . . 0.0 110.601 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.57 -45.68 93.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.881 -0.512 . . . . 0.0 109.912 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.42 96.11 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -57.81 -52.81 63.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.216 0.606 . . . . 0.0 109.693 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.2 mt -54.17 -53.63 50.78 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.57 65.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.555 0.342 . . . . 0.0 111.443 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.8 m -64.63 -44.76 89.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.668 0.387 . . . . 0.0 111.556 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.96 -39.06 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.815 1.246 . . . . 0.0 111.522 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.437 -1.091 0 C-N-CA 125.516 1.527 . . . . 0.0 111.193 -177.251 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -82.04 99.51 9.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.09 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.062 0.945 . . . . 0.0 113.241 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.53 -48.56 66.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.251 0.932 . . . . 0.0 110.011 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -56.84 -42.48 79.74 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.37 -49.0 66.16 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.67 -51.15 70.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.59 0.695 . . . . 0.0 110.597 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -59.73 -46.85 87.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.515 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -61.29 -27.86 68.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.443 1.097 . . . . 0.0 110.742 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -57.75 -18.13 19.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 111.344 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -55.67 -28.68 56.82 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.427 1.012 . . . . 0.0 110.627 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -68.68 -54.25 17.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.453 -0.779 . . . . 0.0 109.002 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.41 -47.29 56.55 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.023 1.729 . . . . 0.0 109.93 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -47.41 -31.62 4.27 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.296 2.638 . . . . 0.0 112.92 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -53.33 -32.16 47.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.6 m -121.82 -37.01 2.92 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.911 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -101.14 -176.01 3.03 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.673 0.789 . . . . 0.0 112.212 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t -153.13 179.46 8.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.953 1.301 . . . . 0.0 109.788 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -143.49 115.12 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.919 2.488 . . . . 0.0 106.985 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 tp -102.22 148.52 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.667 1.587 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.01 158.09 87.64 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.01 -34.07 98.97 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.063 1.842 . . . . 0.0 111.264 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -75.14 -11.62 60.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.442 1.097 . . . . 0.0 113.324 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 -13.54 35.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.139 -0.812 . . . . 0.0 114.063 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -60.88 127.61 32.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.71 1.755 . . . . 0.0 110.404 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -70.75 82.96 0.63 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.624 0.769 . . . . 0.0 111.191 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.33 -59.99 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 C-N-CA 122.577 0.351 . . . . 0.0 110.07 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.54 -39.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.197 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 57.43 47.32 16.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.94 0.876 . . . . 0.0 109.855 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.91 -172.16 48.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.09 170.8 14.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 110.407 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -124.83 30.81 5.82 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.767 . . . . 0.0 109.385 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -69.92 -40.82 75.34 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.83 167.15 13.31 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 170.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.27 173.25 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.16 2.573 . . . . 0.0 114.337 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -84.68 121.77 28.14 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.64 -2.0 56.85 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.42 113.79 2.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.03 20.41 59.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.954 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.66 -39.65 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 119.105 1.452 . . . . 0.0 108.935 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.37 106.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.543 0.737 . . . . 0.0 109.561 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.12 -17.37 31.97 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.833 1.682 . . . . 0.0 111.902 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -68.2 141.27 56.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.43 1.115 . . . . 0.0 111.217 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -71.88 74.31 0.87 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.907 1.283 . . . . 0.0 111.11 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB3' ' CA ' ' A' ' 61' ' ' GLY . . . 52.13 -144.81 0.58 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.889 0.876 . . . . 0.0 112.406 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.34 75.83 0.64 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 123.554 0.597 . . . . 0.0 113.064 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 p -130.24 5.66 4.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.582 1.153 . . . . 0.0 112.196 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 126.56 91.65 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.46 172.77 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.113 1.209 . . . . 0.0 113.274 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 47.0 46.89 16.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.16 1.384 . . . . 0.0 111.853 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -156.42 111.45 2.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.14 -0.35 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.08 89.1 5.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.634 0.773 . . . . 0.0 109.813 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -74.76 -174.81 2.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.594 0.711 . . . . 0.0 111.344 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.34 166.51 13.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.139 1.376 . . . . 0.0 108.675 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.55 -35.0 79.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.31 0.644 . . . . 0.0 112.498 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -58.19 -62.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.971 1.308 . . . . 0.0 111.256 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.56 -35.33 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.932 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -48.84 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.81 90.47 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.898 0.479 . . . . 0.0 110.319 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.59 -45.3 89.4 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.045 0.538 . . . . 0.0 109.735 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . -55.28 -53.19 42.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.6 67.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.329 0.651 . . . . 0.0 111.731 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -67.41 -14.89 63.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.053 0.541 . . . . 0.0 111.952 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.77 14.16 12.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.981 1.277 . . . . 0.0 112.793 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.78 118.29 15.52 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.87 1.335 . . . . 0.0 111.158 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.3 129.45 54.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -66.1 126.88 30.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 159.52 37.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 107.863 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -42.57 -51.77 5.02 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.212 1.405 . . . . 0.0 112.885 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.38 -47.45 85.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.262 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.63 -48.3 81.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.66 0.784 . . . . 0.0 109.647 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.85 -54.03 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.59 -38.21 59.6 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.316 1.046 . . . . 0.0 111.504 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -72.93 -60.23 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -46.73 -43.79 18.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.054 1.342 . . . . 0.0 114.055 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.8 m -52.91 -34.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 119.445 1.02 . . . . 0.0 113.575 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -101.74 -3.38 28.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.059 0.944 . . . . 0.0 111.563 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -133.68 54.54 12.96 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.665 1.586 . . . . 0.0 111.634 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.16 138.19 70.87 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.366 2.711 . . . . 0.0 108.761 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.68 -64.1 3.34 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -45.01 -48.53 11.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.019 1.327 . . . . 0.0 112.646 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.32 -43.71 96.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.088 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.03 -55.51 28.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -49.01 -44.54 41.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.789 1.235 . . . . 0.0 110.432 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -63.8 -68.51 0.34 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.626 0.771 . . . . 0.0 110.304 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -54.84 -40.93 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 -0.55 57.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.666 1.186 . . . . 0.0 111.487 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t0 43.84 53.25 6.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.529 1.531 . . . . 0.0 110.702 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.65 115.36 9.09 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.341 1.056 . . . . 0.0 111.526 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -57.45 -29.41 64.19 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.722 1.209 . . . . 0.0 111.943 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -92.66 11.66 25.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.01 76.84 5.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.522 -0.736 . . . . 0.0 111.734 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.28 152.89 21.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.453 0.701 . . . . 0.0 109.964 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -112.33 151.62 29.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.98 -21.41 61.29 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 170.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ttt -68.13 74.98 0.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 112.438 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.86 58.87 2.98 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 175.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -168.7 146.79 4.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.797 1.639 . . . . 0.0 107.275 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.16 150.09 45.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.11 0.964 . . . . 0.0 108.399 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -111.92 106.37 15.05 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 44.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.159 -0.338 . . . . 0.0 111.633 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -177.41 -171.01 0.31 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.197 1.799 . . . . 0.0 107.444 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.27 -51.54 3.61 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.55 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.64 -75.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 C-N-CA 128.313 2.863 . . . . 0.0 115.952 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.23 -48.43 81.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.339 0.569 . . . . 0.0 112.472 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.79 -49.66 72.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.17 0.988 . . . . 0.0 109.447 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.49 -41.45 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.044 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.07 -48.84 79.84 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.912 -0.492 . . . . 0.0 110.117 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.32 80.91 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.57 -51.05 71.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.03 -36.57 68.15 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.101 0.56 . . . . 0.0 111.616 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.33 -52.3 48.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -53.99 -37.37 63.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.998 0.919 . . . . 0.0 112.593 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.98 -28.67 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.184 1.794 . . . . 0.0 111.961 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 CA--C 1.537 0.454 0 CA-C-N 118.434 0.561 . . . . 0.0 110.327 179.603 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 N-CA-C 113.971 0.348 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -72.68 84.19 1.17 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.19 0.996 . . . . 0.0 109.517 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.45 -35.46 8.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.753 0.821 . . . . 0.0 112.859 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.21 69.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.61 0.641 . . . . 0.0 110.169 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -58.47 -40.96 84.12 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.06 -51.61 52.64 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.05 -50.94 71.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.936 0.894 . . . . 0.0 110.519 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -54.19 -54.03 45.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.01 -35.38 69.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.504 1.122 . . . . 0.0 110.87 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -58.52 -20.91 50.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -61.77 -23.25 66.06 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.647 -0.658 . . . . 0.0 111.027 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.04 -48.96 7.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 t -47.56 -38.55 14.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.321 1.848 . . . . 0.0 113.023 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -22.59 3.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.254 1.022 . . . . 0.0 113.304 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 m -58.76 -22.48 58.1 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -120.91 -34.27 3.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.885 0.874 . . . . 0.0 112.568 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -111.74 174.31 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.059 0.944 . . . . 0.0 113.544 -174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.5 t -145.41 161.75 38.94 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.599 0.76 . . . . 0.0 109.225 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -129.02 135.58 61.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.84 139.49 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.984 1.714 . . . . 0.0 108.946 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 161.08 79.42 Favored Pre-proline 0 C--O 1.232 0.159 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.71 -29.31 88.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.375 1.383 . . . . 0.0 109.434 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.23 -5.64 33.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.66 50.94 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.793 -1.192 . . . . 0.0 112.534 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -58.2 120.96 9.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.77 84.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.648 -0.658 . . . . 0.0 111.158 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.97 -66.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.45 80.44 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -69.69 56.14 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.291 1.436 . . . . 0.0 110.269 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.71 -170.34 46.95 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 164.7 26.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.356 0.598 . . . . 0.0 109.902 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -116.65 37.67 3.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -63.8 -39.48 94.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.51 167.81 12.41 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 171.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.0 151.57 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.755 2.97 . . . . 0.0 112.538 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.18 126.37 27.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.35 11.3 28.73 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.73 82.93 0.45 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.769 -1.207 . . . . 0.0 110.272 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.9 41.29 1.21 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.211 0.91 . . . . 0.0 113.23 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.3 -45.52 93.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -51.3 112.31 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.656 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 -18.17 57.95 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.585 1.088 . . . . 0.0 113.065 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.65 139.08 57.85 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.183 1.491 . . . . 0.0 110.425 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -67.38 72.82 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.265 1.426 . . . . 0.0 112.218 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.85 -148.12 0.49 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.62 -0.675 . . . . 0.0 109.88 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.45 1.1 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.5 p -136.39 10.98 3.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 0.0 111.204 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.26 133.33 94.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.09 155.74 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.026 2.484 . . . . 0.0 115.646 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 49.82 65.65 1.36 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.009 1.724 . . . . 0.0 113.603 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -162.04 123.45 2.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.62 89.44 2.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.965 0.906 . . . . 0.0 109.796 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -73.53 -172.03 1.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.836 0.827 . . . . 0.0 112.087 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.92 166.54 11.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.886 2.075 . . . . 0.0 107.358 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.96 -36.01 80.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.48 0.712 . . . . 0.0 112.18 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 -67.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.51 1.524 . . . . 0.0 110.976 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tp -54.2 -36.79 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.894 1.277 . . . . 0.0 110.935 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.88 -51.0 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.381 0.672 . . . . 0.0 109.38 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.82 69.34 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.903 0.481 . . . . 0.0 110.775 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.32 -48.83 75.92 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.21 70.07 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.37 53.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.067 0.547 . . . . 0.0 111.269 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -75.52 13.03 0.84 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.97 27.74 52.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.167 0.889 . . . . 0.0 112.752 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -88.75 123.2 32.94 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.755 0.777 . . . . 0.0 109.692 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.1 131.31 55.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -64.32 93.35 0.09 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.022 0.374 . . . . 0.0 111.659 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.8 p -79.92 168.71 18.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -57.71 -41.05 80.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.829 -0.545 . . . . 0.0 109.87 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.15 -49.36 72.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.317 1.047 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -58.13 -51.76 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.1 mt -54.77 -54.57 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.63 67.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.799 0.44 . . . . 0.0 111.321 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 m -67.95 -44.07 77.61 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.281 -0.262 . . . . 0.0 110.995 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -54.84 -44.37 73.87 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.317 -0.865 . . . . 0.0 111.062 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.15 -26.88 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.832 0.453 . . . . 0.0 111.475 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -89.23 -33.54 16.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.868 0.867 . . . . 0.0 111.577 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -137.59 67.34 51.64 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.65 144.67 97.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.956 1.771 . . . . 0.0 110.585 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.68 -63.37 4.01 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.61 67.36 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.552 0.741 . . . . 0.0 110.77 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.34 -40.44 90.68 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.642 0.258 . . . . 0.0 111.673 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.14 -60.29 3.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -41.82 -50.22 4.38 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.379 1.472 . . . . 0.0 110.995 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -39.88 -52.17 2.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.095 1.358 . . . . 0.0 112.128 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -89.6 -52.78 4.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.973 0.909 . . . . 0.0 112.322 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.7 tp -73.09 -21.74 60.7 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -172.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t0 45.2 46.3 9.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.771 2.029 . . . . 0.0 111.894 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.07 129.91 52.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -31.21 71.04 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 126.182 1.793 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -88.26 17.31 5.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 0.0 111.719 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.95 64.93 6.86 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.442 -1.411 . . . . 0.0 110.246 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -103.55 -176.73 3.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.412 1.485 . . . . 0.0 108.619 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.71 150.94 38.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.83 -18.74 57.51 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 ttt -65.0 81.2 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.572 1.149 . . . . 0.0 113.635 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.8 3.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.531 0.732 . . . . 0.0 109.343 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -161.73 142.15 10.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.739 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -152.41 175.1 13.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.428 1.091 . . . . 0.0 108.814 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -158.38 122.07 3.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.86 50.19 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.692 0.797 . . . . 0.0 111.443 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? 166.03 -174.1 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 129.6 3.16 . . . . 0.0 105.528 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.95 -54.29 4.44 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 111.534 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -36.17 -50.08 1.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.592 1.568 . . . . 0.0 113.342 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -55.11 -60.63 3.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.503 1.121 . . . . 0.0 112.348 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.34 -41.23 98.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.383 0.673 . . . . 0.0 111.066 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.8 t -59.59 -42.09 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.02 79.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.936 0.789 . . . . 0.0 110.147 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.31 86.21 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.384 -0.198 . . . . 0.0 110.499 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.44 -55.11 35.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.71 -40.12 68.89 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.376 0.67 . . . . 0.0 111.649 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.59 7.01 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.694 0.679 . . . . 0.0 109.871 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.8 p -56.24 -32.81 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.1 -32.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 111.595 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -86.55 103.21 14.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.91 -33.2 4.36 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 112.762 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.16 71.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.181 0.9 . . . . 0.0 110.167 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -38.72 90.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.81 -49.81 71.1 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -54.5 -53.44 54.29 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.673 0.789 . . . . 0.0 109.441 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -58.0 -49.06 78.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.649 0.261 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.25 -31.13 67.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.576 1.15 . . . . 0.0 110.92 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.47 -18.17 17.17 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.072 -0.392 . . . . 0.0 111.849 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -52.18 -29.15 20.97 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.384 0.674 . . . . 0.0 110.735 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.67 -55.86 5.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.8 m -48.69 -43.73 37.3 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.19 1.396 . . . . 0.0 112.415 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -52.73 -25.35 10.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 113.157 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 -25.77 59.95 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.866 -0.521 . . . . 0.0 110.745 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.03 -45.14 2.38 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.238 0.615 . . . . 0.0 110.81 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -91.8 -176.85 4.58 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -151.73 167.77 27.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.303 1.841 . . . . 0.0 110.139 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.3 mm -136.3 117.7 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.768 1.627 . . . . 0.0 108.043 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tp -115.72 126.97 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.159 1.384 . . . . 0.0 109.045 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 163.95 29.5 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.221 -0.924 . . . . 0.0 108.685 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.58 -36.92 98.34 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.446 2.097 . . . . 0.0 110.323 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.01 3.55 6.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.685 1.594 . . . . 0.0 113.119 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.88 90.53 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.688 -1.257 . . . . 0.0 112.7 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -71.44 114.12 9.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.6 1.2 . . . . 0.0 109.171 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.15 104.02 1.09 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.795 -0.566 . . . . 0.0 109.815 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.9 mm -76.21 -47.44 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.98 96.74 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 58.66 1.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.485 1.514 . . . . 0.0 108.216 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.44 -158.91 27.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 175.97 10.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -124.58 30.48 5.97 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -38.43 83.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.52 171.56 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -63.74 174.62 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.265 3.31 . . . . 0.0 112.387 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -87.24 121.2 29.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.6 mt -86.61 1.33 52.19 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.34 99.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.35 0.977 . . . . 0.0 109.616 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.97 33.16 21.81 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 119.085 -0.841 . . . . 0.0 113.32 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.75 -31.04 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.753 1.276 . . . . 0.0 108.69 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.44 113.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.198 0.999 . . . . 0.0 110.461 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.16 -10.26 75.42 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.177 1.37 . . . . 0.0 112.749 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.95 144.64 29.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.158 0.979 . . . . 0.0 110.005 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 m -63.86 134.1 54.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.31 141.45 54.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.659 -0.651 . . . . 0.0 110.613 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.61 33.78 81.97 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.968 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.2 p -132.03 -0.77 3.74 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.897 1.348 . . . . 0.0 114.151 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -64.56 126.72 91.31 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 120.342 1.428 . . . . 0.0 107.153 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.76 161.32 18.54 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.402 2.068 . . . . 0.0 113.327 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 56.27 55.08 7.01 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.411 1.485 . . . . 0.0 112.282 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -162.55 120.18 2.07 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.151 -0.343 . . . . 0.0 110.576 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -79.15 98.45 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.254 1.022 . . . . 0.0 110.246 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.99 -171.69 3.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.8 0.809 . . . . 0.0 111.553 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -105.28 157.91 16.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 109.279 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.53 -34.39 72.58 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.419 0.687 . . . . 0.0 112.43 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.8 p -63.95 -64.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.751 1.22 . . . . 0.0 109.779 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.2 tt -58.2 -37.22 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.624 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.55 -49.9 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.83 88.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.436 0.562 . . . . 0.0 110.802 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 tp -56.33 -47.34 78.94 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.1 -56.29 21.92 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.232 0.92 . . . . 0.0 111.012 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -31.22 61.74 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.265 1.426 . . . . 0.0 111.807 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 m -69.05 -0.63 6.01 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.57 27.77 8.89 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.374 1.464 . . . . 0.0 111.477 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -84.45 96.76 9.2 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 117.978 0.889 . . . . 0.0 111.18 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.62 127.44 35.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -67.35 103.98 1.41 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.977 0.353 . . . . 0.0 111.615 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.5 p -84.45 162.09 20.07 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -57.61 -37.11 72.7 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.738 0.415 . . . . 0.0 110.332 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -63.69 -55.42 23.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.76 -50.27 68.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.48 -54.52 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.05 -41.12 71.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.334 0.653 . . . . 0.0 111.842 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.8 m -69.76 -56.08 8.14 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -43.3 -51.93 6.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.714 1.606 . . . . 0.0 113.461 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.6 m -53.41 -30.98 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.81 -23.9 63.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.797 -0.621 . . . . 0.0 112.07 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -160.95 68.04 2.5 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 119.086 0.857 . . . . 0.0 112.56 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.58 151.79 81.35 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 120.979 1.12 . . . . 0.0 109.412 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.83 -61.09 4.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.15 78.88 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.282 -0.54 . . . . 0.0 109.673 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -51.52 -56.36 13.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.124 0.97 . . . . 0.0 110.523 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 mp -57.64 -48.66 78.85 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.167 0.587 . . . . 0.0 110.901 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -54.87 -51.27 66.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.154 0.433 . . . . 0.0 110.291 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -54.48 -51.9 63.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.856 0.863 . . . . 0.0 111.015 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -72.87 -49.66 28.64 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 tp -77.91 -24.2 48.42 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.511 1.125 . . . . 0.0 113.46 -174.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.09 50.64 16.14 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.564 1.546 . . . . 0.0 110.048 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -135.29 130.02 34.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.448 1.499 . . . . 0.0 109.514 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -58.52 -35.25 71.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.291 0.636 . . . . 0.0 110.53 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -84.47 15.67 3.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.22 66.18 4.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.639 0.775 . . . . 0.0 110.992 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -94.32 -179.71 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.118 1.367 . . . . 0.0 110.27 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -155.83 157.64 36.77 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.92 -11.95 84.9 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 172.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.3 ttt -69.35 77.22 0.38 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 118.787 1.293 . . . . 0.0 113.144 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.51 58.17 3.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.28 1.032 . . . . 0.0 109.606 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -162.94 139.69 7.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -138.82 160.53 39.48 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -157.19 107.1 2.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.48 43.8 0.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.517 0.727 . . . . 0.0 112.242 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -177.52 -177.99 0.72 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.006 1.723 . . . . 0.0 107.243 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.32 -50.22 2.75 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.604 -0.553 . . . . 0.0 113.367 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -28.1 -51.65 0.1 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 127.319 2.39 . . . . 0.0 115.329 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 2.1 pm0 -61.22 -48.56 80.95 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.796 0.798 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.52 -46.7 84.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.86 0.864 . . . . 0.0 109.152 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.49 -43.41 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.517 0.727 . . . . 0.0 110.329 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.86 92.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.864 -0.523 . . . . 0.0 109.603 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.31 91.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.527 0.203 . . . . 0.0 110.458 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.8 -52.99 62.9 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.928 0.491 . . . . 0.0 110.058 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.8 mt -57.11 -45.53 83.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.059 0.391 . . . . 0.0 110.776 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.28 81.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.237 0.615 . . . . 0.0 110.8 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.2 m -68.92 -42.37 76.9 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.029 -0.42 . . . . 0.0 110.691 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.26 -44.17 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.141 1.377 . . . . 0.0 112.247 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.0 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.46 115.17 27.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.32 1.448 . . . . 0.0 108.765 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.13 -33.78 53.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.511 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.97 -53.5 38.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.541 1.064 . . . . 0.0 110.06 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -54.77 -41.55 70.65 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.72 -50.72 56.75 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -56.17 -49.58 73.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.403 0.681 . . . . 0.0 109.268 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.2 -50.28 74.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.477 0.18 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -58.18 -32.45 68.24 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 124.953 1.301 . . . . 0.0 110.634 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -58.95 -21.26 57.98 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -21.55 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.829 -0.544 . . . . 0.0 110.284 174.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -86.71 -49.43 7.48 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.286 -0.884 . . . . 0.0 109.157 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.9 m -51.2 -40.17 58.1 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.478 1.111 . . . . 0.0 111.912 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.11 -21.45 4.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 113.254 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -56.81 -23.74 45.9 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.536 -0.728 . . . . 0.0 110.409 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m -125.54 -49.62 1.65 Allowed 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 122.984 0.513 . . . . 0.0 109.844 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.17 -174.78 4.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.194 0.997 . . . . 0.0 113.49 -172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 m -158.69 164.9 35.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.468 1.907 . . . . 0.0 108.737 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.9 mm -136.9 119.57 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.913 1.685 . . . . 0.0 107.23 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.98 132.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.201 0.6 . . . . 0.0 110.753 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.21 152.84 83.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.95 -34.05 90.84 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.96 2.44 . . . . 0.0 112.103 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.59 -9.11 57.72 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.406 1.082 . . . . 0.0 113.346 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.17 -14.07 44.2 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.837 -0.979 . . . . 0.0 113.576 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -60.06 112.27 1.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.651 1.725 . . . . 0.0 109.908 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.23 121.41 16.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.012 0.925 . . . . 0.0 109.794 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.08 -45.77 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.61 100.61 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -88.11 72.13 9.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.39 -178.67 45.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.87 68.95 7.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.78 -0.835 . . . . 0.0 109.081 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -35.47 62.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 1 C-N-CA 133.541 4.737 . . . . 0.0 115.934 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -96.17 -30.16 13.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.842 2.057 . . . . 0.0 108.586 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.8 169.66 13.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.54 163.71 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.945 3.097 . . . . 0.0 114.04 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -85.14 117.43 24.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.6 0.95 44.54 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.13 106.36 0.6 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.01 15.09 49.99 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.406 -1.219 . . . . 0.0 113.604 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.17 -38.67 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.938 1.869 . . . . 0.0 110.184 176.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.86 112.22 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -20.73 49.05 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.077 1.322 . . . . 0.0 112.024 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -72.96 140.54 47.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.045 0.923 . . . . 0.0 109.918 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 m -64.2 121.95 15.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.49 150.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.252 0.549 . . . . 0.0 111.789 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.73 13.16 60.77 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.09 -1.395 . . . . 0.0 113.753 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -142.44 35.27 1.48 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.679 1.74 . . . . 0.0 113.67 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -80.58 135.06 53.34 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 165.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -57.63 155.94 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.314 1.343 . . . . 0.0 113.144 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 55.86 64.14 1.82 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.898 1.679 . . . . 0.0 113.852 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -163.59 123.67 2.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.76 -0.587 . . . . 0.0 110.974 172.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -77.0 77.48 3.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.197 0.999 . . . . 0.0 110.149 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -69.31 -172.66 0.46 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.308 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -113.89 160.56 18.64 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.804 1.641 . . . . 0.0 110.857 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.57 -38.67 60.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.559 1.144 . . . . 0.0 113.525 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -65.91 -55.6 16.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.595 0.712 . . . . 0.0 110.67 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 tt -66.68 -35.26 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.75 -49.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.92 88.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.868 0.467 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.6 tp -56.15 -46.43 79.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.35 -55.66 25.56 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.29 0.948 . . . . 0.0 110.91 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.01 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.569 1.148 . . . . 0.0 111.497 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 m -72.67 6.48 2.45 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.43 25.42 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.196 1.379 . . . . 0.0 112.091 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -80.99 78.83 7.77 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.658 -0.907 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.55 116.8 14.55 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -59.58 121.2 11.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.0 p -99.87 164.97 11.79 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -55.91 -46.45 78.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.909 0.862 . . . . 0.0 109.639 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -58.83 -52.47 65.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.16 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -60.47 -46.76 88.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.57 -53.24 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.82 -37.99 64.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.178 0.991 . . . . 0.0 111.484 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 m -72.74 -58.91 2.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -43.98 -47.98 8.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.899 1.679 . . . . 0.0 113.245 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 m -51.93 -34.42 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -75.09 -25.05 58.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.0 112.095 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -145.63 61.79 7.93 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.892 0.877 . . . . 0.0 113.043 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.18 148.09 93.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.668 1.578 . . . . 0.0 109.446 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.96 -65.64 3.22 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.2 62.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.773 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -51.61 -54.48 27.29 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.656 0.782 . . . . 0.0 110.471 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 mp -60.34 -49.27 78.26 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 122.969 0.508 . . . . 0.0 111.174 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.35 -46.27 66.04 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.954 0.343 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.16 -65.94 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.25 0.62 . . . . 0.0 110.345 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -56.38 -41.24 75.92 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.7 -6.63 59.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.721 0.808 . . . . 0.0 111.581 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 48.28 52.87 12.73 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.291 1.436 . . . . 0.0 109.604 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -143.72 155.74 44.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.998 0.919 . . . . 0.0 110.801 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -91.44 -41.3 10.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.945 1.698 . . . . 0.0 108.619 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.03 39.7 0.51 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.857 0.863 . . . . 0.0 111.99 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.26 111.44 22.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.537 0.735 . . . . 0.0 109.412 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -124.46 -176.04 3.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.862 0.865 . . . . 0.0 112.066 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -159.75 147.05 16.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.37 64.15 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.6 ttt -66.98 79.84 0.12 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 118.452 1.126 . . . . 0.0 113.651 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.02 57.49 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.655 0.782 . . . . 0.0 109.438 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -165.22 125.92 1.94 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.648 1.179 . . . . 0.0 108.565 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -115.47 159.9 20.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.29 103.74 3.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.92 44.44 0.55 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.191 0.596 . . . . 0.0 111.413 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -174.85 -176.57 1.01 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.814 1.646 . . . . 0.0 107.581 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.15 -52.93 3.41 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.272 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -11.75 -72.07 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 128.525 2.965 . . . . 0.0 116.045 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.5 -45.97 90.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.126 0.963 . . . . 0.0 112.412 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.49 -49.7 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 109.116 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.69 -43.04 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.423 0.689 . . . . 0.0 109.945 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.39 93.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.998 -0.439 . . . . 0.0 110.102 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.77 93.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.041 0.382 . . . . 0.0 110.418 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -57.08 -53.1 61.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.95 -41.54 83.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.115 -0.366 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.58 85.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.638 0.775 . . . . 0.0 110.585 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -69.58 -41.04 76.35 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.039 -0.413 . . . . 0.0 110.343 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.52 -38.12 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.732 1.213 . . . . 0.0 112.425 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.538 0.511 0 CA-C-N 119.238 0.926 . . . . 0.0 111.672 -178.69 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.099 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.98 85.07 2.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.943 -0.74 . . . . 0.0 110.21 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.33 -35.88 40.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.739 0.816 . . . . 0.0 112.496 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.02 65.54 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.78 -0.575 . . . . 0.0 110.067 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -57.84 -41.53 82.51 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.82 -48.07 68.45 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -57.06 -50.37 72.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.285 0.543 . . . . 0.0 110.585 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -59.37 -51.04 71.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.234 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -56.07 -31.49 63.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.398 1.879 . . . . 0.0 110.621 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.88 -19.73 7.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.586 0.754 . . . . 0.0 112.125 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -51.0 -34.35 28.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.454 0.57 . . . . 0.0 110.667 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -77.7 -49.23 14.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -48.3 -49.09 35.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.307 1.043 . . . . 0.0 110.654 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.82 -11.5 27.72 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.6 m -56.63 -33.63 66.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.7 m -113.99 -39.64 3.9 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.437 0.695 . . . . 0.0 110.341 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -95.47 -172.42 2.63 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -159.96 172.83 16.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.984 2.113 . . . . 0.0 107.648 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -132.67 132.43 59.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 tp -116.32 143.9 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.853 1.661 . . . . 0.0 109.164 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.37 159.11 82.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.27 -42.44 47.35 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.138 2.559 . . . . 0.0 112.863 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -73.0 -11.91 60.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.311 1.444 . . . . 0.0 113.671 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -14.32 34.57 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.977 -0.901 . . . . 0.0 113.682 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.7 m -57.77 125.63 23.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.532 1.666 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.21 82.16 1.0 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 110.724 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.1 mm -57.7 -61.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.43 98.32 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.8 67.83 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.051 0.94 . . . . 0.0 109.188 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.22 -162.99 28.53 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.53 176.43 9.05 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -130.49 33.07 4.33 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -71.06 -35.9 72.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.745 1.218 . . . . 0.0 108.191 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.88 161.86 12.61 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 174.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.44 125.54 18.23 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.848 3.032 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.16 114.86 1.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 108.759 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.6 mt -72.19 -16.44 61.96 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -168.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -52.97 120.39 5.78 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.732 1.151 . . . . 0.0 108.946 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.6 12.31 72.65 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.809 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.44 -42.34 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.31 1.555 . . . . 0.0 109.544 174.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.73 118.09 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.195 0.598 . . . . 0.0 110.612 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.96 57.2 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.167 0.889 . . . . 0.0 112.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -70.7 148.69 47.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.059 1.429 . . . . 0.0 110.482 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -76.09 59.48 1.33 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.815 1.246 . . . . 0.0 110.424 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 36.57 -123.54 0.17 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.164 1.786 . . . . 0.0 113.465 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.67 73.16 0.0 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.017 1.77 . . . . 0.0 115.298 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.1 t -160.18 9.13 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.31 1.055 . . . . 0.0 113.433 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -64.24 134.53 95.99 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 120.979 -1.076 . . . . 0.0 108.63 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -64.32 157.22 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.416 1.41 . . . . 0.0 111.31 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 47.68 58.46 4.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.149 1.38 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -154.83 119.98 4.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.148 0.499 . . . . 0.0 109.873 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -73.1 77.25 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.475 1.11 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.83 -176.93 1.17 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 110.515 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -113.25 173.71 6.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.158 0.983 . . . . 0.0 108.799 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.25 -41.64 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.202 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 p -60.22 -64.88 0.79 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.975 1.31 . . . . 0.0 111.719 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -38.82 75.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.121 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.54 -49.28 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.16 91.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.571 0.349 . . . . 0.0 111.005 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.7 tp -55.96 -52.58 63.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.37 -54.63 28.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.68 48.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.53 1.132 . . . . 0.0 112.585 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -71.15 2.12 5.0 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.92 34.07 8.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.663 1.125 . . . . 0.0 110.923 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -97.54 117.4 31.73 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.206 0.503 . . . . 0.0 109.849 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.11 137.92 45.26 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.632 1.173 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -73.79 95.77 2.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.587 0.355 . . . . 0.0 111.915 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 p -78.77 167.55 21.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -55.97 -43.63 77.73 Favored 'General case' 0 N--CA 1.459 -0.017 0 CA-C-O 121.923 0.868 . . . . 0.0 109.893 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.58 -51.75 67.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.059 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.42 -49.38 78.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.361 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.98 -52.91 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.83 -42.0 75.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.078 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.5 m -67.26 -51.48 52.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.243 0.217 . . . . 0.0 110.54 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -43.62 -56.36 3.77 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 125.266 1.427 . . . . 0.0 112.9 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 m -52.35 -30.18 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -73.12 -28.68 62.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.005 0.522 . . . . 0.0 112.008 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -151.95 62.63 4.82 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 124.432 1.093 . . . . 0.0 111.215 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.78 159.14 53.61 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.53 -63.83 3.64 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.53 67.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.198 0.999 . . . . 0.0 110.464 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -52.41 -48.27 65.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.089 0.556 . . . . 0.0 110.554 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.63 -59.31 5.39 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -45.3 -48.39 13.03 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.633 1.173 . . . . 0.0 110.727 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.37 -70.46 0.17 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.303 1.041 . . . . 0.0 110.712 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -63.15 -31.53 72.69 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -171.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.48 -7.42 59.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.396 0.679 . . . . 0.0 111.256 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.24 54.37 10.38 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 109.286 -175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -138.62 152.16 47.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.588 1.155 . . . . 0.0 109.776 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -48.63 6.86 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.779 1.632 . . . . 0.0 108.13 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -80.96 30.18 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.07 67.27 8.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.277 -0.889 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.83 154.68 40.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.964 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -123.17 149.82 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.4 -26.25 74.45 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 15.5 ttp -68.48 80.78 0.26 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.642 0.721 . . . . 0.0 112.146 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 57.94 3.12 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.48 146.89 13.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -143.1 160.7 39.91 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.3 tp -161.05 112.49 1.82 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.2 33.92 0.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.662 -0.649 . . . . 0.0 112.56 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -159.49 179.54 8.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.202 2.201 . . . . 0.0 106.848 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.46 -55.13 4.39 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.05 -57.15 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 126.209 1.861 . . . . 0.0 114.075 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 3.6 pm0 -52.75 -58.2 7.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.038 1.335 . . . . 0.0 113.004 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.92 -40.51 79.03 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.781 -0.574 . . . . 0.0 111.019 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.573 HG11 HMB1 ' A' ' 117' ' ' HEC . 82.4 t -61.97 -41.11 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.928 -0.483 . . . . 0.0 110.418 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.04 -46.64 87.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.754 -0.591 . . . . 0.0 109.749 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.18 -43.78 95.6 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.85 -49.22 77.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.37 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 mt -57.87 -45.54 86.19 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.222 0.465 . . . . 0.0 110.593 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.71 79.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.826 0.451 . . . . 0.0 110.642 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -70.15 -39.61 75.24 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.135 -0.353 . . . . 0.0 110.866 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.92 -38.93 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.677 1.591 . . . . 0.0 112.596 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.6 82.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.499 1.045 . . . . 0.0 110.574 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.1 pttp . . . . . 0 C--O 1.249 1.041 0 C-N-CA 127.964 2.506 . . . . 0.0 107.696 -178.934 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.591 HBB2 ' HHC' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 CA-C-O 121.115 0.286 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -81.71 88.84 6.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.199 1.0 . . . . 0.0 108.853 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.53 -42.51 2.42 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.807 1.243 . . . . 0.0 112.978 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.59 73.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.597 0.759 . . . . 0.0 111.467 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -69.42 -37.21 77.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -51.47 -43.03 52.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.421 1.01 . . . . 0.0 111.228 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -52.5 -46.94 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.459 0.704 . . . . 0.0 110.848 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.96 -46.47 65.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.518 0.727 . . . . 0.0 109.567 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.21 -35.5 67.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.097 0.959 . . . . 0.0 110.579 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -56.91 -16.95 7.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.128 0.971 . . . . 0.0 112.428 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -52.2 -29.61 23.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.562 -0.711 . . . . 0.0 110.545 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -72.76 -55.61 6.49 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.46 -46.19 56.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.421 1.089 . . . . 0.0 112.889 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -55.86 -21.81 21.98 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -59.4 -26.12 64.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.3 m -118.83 -43.81 2.65 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.524 0.729 . . . . 0.0 111.09 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 37' ' ' LEU . 91.0 m-70 -97.98 -172.17 2.31 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.272 1.029 . . . . 0.0 112.85 -175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -151.04 169.05 22.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.571 1.548 . . . . 0.0 109.057 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.9 mt -133.31 124.08 48.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -145.61 134.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.932 0.893 . . . . 0.0 110.012 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.11 161.98 68.78 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -54.58 -37.0 90.62 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 110.982 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.41 -0.57 6.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.711 1.604 . . . . 0.0 113.315 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.85 -7.32 81.6 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 120.848 -1.158 . . . . 0.0 112.415 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -64.82 103.19 0.67 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.457 1.128 . . . . 0.0 109.125 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.03 120.78 14.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.699 0.4 . . . . 0.0 111.255 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.43 -45.92 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.84 106.37 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -72.16 56.5 0.33 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.039 1.336 . . . . 0.0 110.172 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.26 -173.61 13.0 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 167.94 7.46 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.098 -0.648 . . . . 0.0 111.085 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -117.09 30.66 7.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.731 0.812 . . . . 0.0 109.261 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -67.27 -44.11 80.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.53 171.72 17.65 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 107.636 -2.185 . . . . 0.0 107.636 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.77 177.27 1.87 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.243 3.295 . . . . 0.0 113.087 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 114.1 21.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 17' ' ' HIS . 95.2 mt -71.45 -16.93 62.39 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.75 116.0 2.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.99 15.27 70.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.56 -1.133 . . . . 0.0 114.837 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG11 HMA3 ' A' ' 117' ' ' HEC . 55.7 t -62.5 -44.96 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.928 1.864 . . . . 0.0 108.892 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.65 113.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 -15.17 59.75 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.832 1.206 . . . . 0.0 112.744 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -90.31 144.65 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.541 1.17 . . . . 0.0 110.919 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -58.69 133.35 55.84 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.628 1.171 . . . . 0.0 109.126 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.81 159.33 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.534 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.92 23.53 31.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.975 1.274 . . . . 0.0 114.477 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.1 p -145.31 22.94 1.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.888 1.344 . . . . 0.0 113.01 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -67.32 137.44 93.84 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.06 154.35 10.64 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.311 2.007 . . . . 0.0 114.565 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 45.06 59.35 3.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.276 1.83 . . . . 0.0 113.269 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.31 118.57 2.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -82.88 98.27 9.1 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.028 0.931 . . . . 0.0 109.725 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -82.68 -172.83 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 111.152 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -96.35 -176.91 3.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.924 1.29 . . . . 0.0 108.546 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.77 -34.47 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.928 0.891 . . . . 0.0 113.12 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 p -60.42 -65.38 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.46 1.104 . . . . 0.0 110.387 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.54 -40.28 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.156 1.383 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.8 t -59.82 -50.74 78.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.2 97.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.123 0.42 . . . . 0.0 111.108 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -53.31 53.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.73 64.59 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 123.766 0.698 . . . . 0.0 111.836 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.72 -26.82 47.24 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.488 1.515 . . . . 0.0 112.033 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.2 m -69.56 0.59 5.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.01 0.368 . . . . 0.0 111.938 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.97 38.4 5.76 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 125.446 1.498 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -107.11 110.06 22.06 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.378 0.589 . . . . 0.0 111.676 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 128.11 43.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.218 1.407 . . . . 0.0 107.55 174.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -62.75 151.76 37.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 110.796 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.0 p -129.82 162.56 28.23 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.949 1.7 . . . . 0.0 106.452 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.38 -39.68 80.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.061 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.55 -52.53 64.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.551 0.741 . . . . 0.0 110.216 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -61.03 -45.34 95.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.431 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.1 -53.03 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 118.675 0.671 . . . . 0.0 109.335 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.75 -46.45 64.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.462 0.705 . . . . 0.0 110.052 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.5 m -62.24 -54.4 41.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 109.915 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -50.08 -48.45 53.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.816 1.246 . . . . 0.0 113.04 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.3 m -60.47 -28.13 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.331 0.969 . . . . 0.0 112.689 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.24 -13.4 52.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.663 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -139.54 57.71 10.59 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.989 1.716 . . . . 0.0 112.07 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.08 138.43 78.15 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.926 2.418 . . . . 0.0 109.663 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.6 -65.17 2.49 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.42 -45.65 9.14 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 125.924 1.69 . . . . 0.0 111.529 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -55.1 -55.49 30.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.898 0.479 . . . . 0.0 110.664 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 83' ' ' LEU . 6.2 mp -56.74 -53.03 62.46 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.208 0.603 . . . . 0.0 109.997 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -52.35 -44.2 65.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.765 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.09 -67.15 0.45 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.605 0.762 . . . . 0.0 110.22 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -53.86 -42.74 68.9 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.16 -4.05 59.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.117 0.567 . . . . 0.0 111.847 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.3 t0 47.6 45.11 17.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.094 1.358 . . . . 0.0 110.009 -174.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.24 111.61 11.01 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.459 1.104 . . . . 0.0 110.52 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -57.46 -26.05 60.63 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.002 2.521 . . . . 0.0 111.787 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -96.49 9.61 40.84 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.22 72.71 7.06 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.502 -0.749 . . . . 0.0 110.357 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -91.73 126.79 36.94 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.701 0.8 . . . . 0.0 109.976 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -80.78 161.94 24.29 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.15 0.5 . . . . 0.0 110.498 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.13 -22.76 70.35 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 169.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ttp -68.26 81.02 0.24 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.991 0.895 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.0 58.04 3.31 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -160.19 150.43 18.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.539 1.536 . . . . 0.0 107.387 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -141.98 158.34 43.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.319 1.048 . . . . 0.0 108.543 173.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.418 HD22 HBB1 ' A' ' 117' ' ' HEC . 11.8 tp -111.71 102.81 11.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.08 67.73 1.79 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.889 1.276 . . . . 0.0 109.958 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 89.3 139.45 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 129.195 2.998 . . . . 0.0 109.35 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.9 -21.76 7.83 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -49.48 -41.59 33.33 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.492 1.044 . . . . 0.0 112.63 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.45 -46.56 88.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.443 0.622 . . . . 0.0 110.868 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.6 -49.2 77.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.283 1.433 . . . . 0.0 110.17 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.585 HG11 HMB1 ' A' ' 117' ' ' HEC . 96.2 t -63.59 -44.96 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.66 91.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.87 -0.518 . . . . 0.0 110.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.06 94.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -57.22 -49.42 76.07 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.908 -0.495 . . . . 0.0 110.269 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.27 -44.21 88.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.429 -0.794 . . . . 0.0 111.206 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.47 73.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.442 0.697 . . . . 0.0 110.752 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -72.38 -37.73 68.66 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.123 -0.36 . . . . 0.0 110.679 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -69.27 -47.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.806 1.242 . . . . 0.0 112.43 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.36 118.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 122.566 1.174 . . . . 0.0 111.841 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.376 0 C-N-CA 129.391 3.076 . . . . 0.0 106.789 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.623 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -77.08 84.14 3.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -39.06 -41.6 0.81 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.604 1.561 . . . . 0.0 113.601 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.29 36.74 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.455 0.57 . . . . 0.0 110.627 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -57.25 -38.47 73.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.308 0.643 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.52 -52.05 47.75 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.74 -50.37 73.44 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.15 0.98 . . . . 0.0 110.165 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.57 -51.62 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.459 -0.201 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.95 -38.33 70.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.828 0.851 . . . . 0.0 109.627 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -56.97 -29.95 63.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -33.54 67.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.025 -0.422 . . . . 0.0 110.231 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -87.66 -48.66 7.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.742 0.817 . . . . 0.0 109.006 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.2 t -49.22 -37.57 23.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.588 1.555 . . . . 0.0 112.038 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 5.01 0.68 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -55.83 -30.53 61.58 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.798 -1.189 . . . . 0.0 110.213 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.18 -37.28 5.37 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.563 0.745 . . . . 0.0 112.593 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -105.71 -174.43 2.53 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.676 0.791 . . . . 0.0 112.337 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 m -150.67 171.25 17.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.015 1.326 . . . . 0.0 109.619 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -133.16 133.28 58.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tp -117.14 141.86 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.537 1.535 . . . . 0.0 109.247 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.26 154.76 88.22 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.53 -38.84 45.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.12 2.547 . . . . 0.0 113.537 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.57 -16.25 62.84 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.738 1.215 . . . . 0.0 113.779 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.48 -13.52 23.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.667 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.3 m -60.63 124.85 21.61 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.625 1.712 . . . . 0.0 110.014 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -72.74 77.35 1.12 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.673 0.789 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.2 mm -52.94 -55.43 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.17 86.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.28 65.25 0.84 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.143 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.24 -158.53 33.57 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.53 174.09 11.38 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -121.92 28.44 7.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 109.201 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -66.9 -43.42 83.45 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.13 171.03 18.38 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 170.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.69 -173.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.61 2.873 . . . . 0.0 114.049 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -117.63 89.99 3.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 108.594 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 6.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 119.208 3.04 . . . . 0.0 119.208 -169.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -59.75 102.44 0.15 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 121.29 1.859 . . . . 0.0 108.736 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.36 21.81 31.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.485 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.98 -40.69 89.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-N 118.599 1.199 . . . . 0.0 109.4 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.06 98.71 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -16.06 9.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.506 2.003 . . . . 0.0 111.569 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -71.48 136.19 47.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 117.987 0.893 . . . . 0.0 110.409 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -71.4 67.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.598 1.559 . . . . 0.0 111.794 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 62.54 -149.86 0.36 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.314 1.046 . . . . 0.0 111.621 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.84 80.99 0.18 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 123.155 0.407 . . . . 0.0 113.173 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 t -150.32 21.02 0.85 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -68.12 143.14 95.73 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.29 153.9 20.58 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.39 1.393 . . . . 0.0 114.012 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 47.47 65.24 1.32 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.25 1.82 . . . . 0.0 112.875 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -158.7 120.93 3.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.137 0.494 . . . . 0.0 110.607 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -75.21 78.12 2.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.37 1.068 . . . . 0.0 110.7 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -67.41 178.19 1.65 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.884 0.474 . . . . 0.0 111.315 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -112.15 174.91 5.66 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.735 1.214 . . . . 0.0 109.663 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.28 -39.49 87.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.298 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.1 p -65.89 -62.72 1.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.677 1.227 . . . . 0.0 110.835 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -61.75 -21.25 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.087 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.01 -47.92 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.73 64.17 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.134 0.974 . . . . 0.0 111.014 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.73 -51.54 48.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.944 0.897 . . . . 0.0 108.751 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.39 90.8 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.54 -39.59 73.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -71.98 -7.78 50.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.46 9.57 43.73 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.373 0.987 . . . . 0.0 113.054 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -74.46 142.21 44.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.186 1.493 . . . . 0.0 109.204 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.87 135.03 41.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.923 1.289 . . . . 0.0 107.682 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -64.14 128.47 35.95 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -113.87 167.3 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.868 1.667 . . . . 0.0 106.806 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -51.53 -52.65 45.3 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.949 0.88 . . . . 0.0 109.834 172.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.76 -48.3 82.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.547 -176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -63.69 -41.4 98.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.491 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.48 -53.2 47.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.62 -47.07 67.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.495 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -61.43 -54.93 37.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.751 0.31 . . . . 0.0 110.751 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -55.13 -42.18 72.67 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.456 -0.777 . . . . 0.0 111.925 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.68 -28.1 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.241 0.616 . . . . 0.0 111.506 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -90.25 -31.78 16.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.555 0.742 . . . . 0.0 111.067 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.61 69.17 72.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 124.664 1.186 . . . . 0.0 112.518 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -67.28 153.9 75.74 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.07 -64.38 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.06 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.854 1.262 . . . . 0.0 110.317 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -52.67 -50.37 63.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.948 0.499 . . . . 0.0 111.402 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.29 -49.5 69.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.622 -0.674 . . . . 0.0 109.824 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -51.14 -48.37 61.82 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.118 0.567 . . . . 0.0 111.341 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -43.49 -54.64 4.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.118 0.967 . . . . 0.0 111.553 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -84.26 -50.8 7.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.959 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -76.13 -23.05 54.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.961 0.904 . . . . 0.0 113.436 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 44.74 63.65 1.63 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.653 1.981 . . . . 0.0 111.725 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -150.29 137.34 19.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -52.13 -38.7 58.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.977 0.911 . . . . 0.0 110.646 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -82.44 13.07 3.86 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.65 61.2 4.25 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.235 -0.915 . . . . 0.0 109.178 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.78 -174.55 2.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.823 1.249 . . . . 0.0 110.057 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -152.57 151.7 30.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.72 -13.05 71.41 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.539 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 3.1 ttp -69.75 78.9 0.44 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 118.166 0.983 . . . . 0.0 113.21 -177.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.56 56.83 2.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -164.21 144.6 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.869 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -152.7 171.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 tp -144.73 113.56 6.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.55 41.44 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.065 0.546 . . . . 0.0 111.367 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 pttp 179.71 178.87 0.53 Allowed 'General case' 0 C--O 1.231 0.11 0 C-N-CA 127.61 2.364 . . . . 0.0 105.793 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.98 -52.96 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 119.038 -0.868 . . . . 0.0 113.184 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.4 -54.01 0.09 OUTLIER Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.221 2.343 . . . . 0.0 115.102 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.7 pm0 -64.96 -45.04 87.39 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.032 0.916 . . . . 0.0 111.578 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.38 -47.69 78.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 108.839 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.22 -43.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.872 1.269 . . . . 0.0 109.603 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.98 88.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.954 -0.466 . . . . 0.0 110.219 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.12 -52.45 65.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.1 mt -55.59 -48.01 75.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.053 0.541 . . . . 0.0 110.718 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.87 -40.05 69.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 110.75 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 m -77.52 -14.05 59.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 t -87.05 -38.19 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 108.737 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.55 66.73 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.742 -0.599 . . . . 0.0 109.859 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? . . . . . 0 C--O 1.251 1.136 0 CA-C-O 115.969 -1.967 . . . . 0.0 109.73 -177.982 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.539 ' CHD' ' HG3' ' A' ' 96' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.104 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.12 82.54 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.899 -0.765 . . . . 0.0 109.293 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -45.1 -40.37 6.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 112.313 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.95 81.25 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.283 0.633 . . . . 0.0 111.165 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -64.46 -43.68 93.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.34 -48.57 33.42 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.8 1.19 . . . . 0.0 111.526 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.01 -54.61 36.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.716 0.758 . . . . 0.0 110.213 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.67 -48.39 81.86 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.888 -0.508 . . . . 0.0 110.662 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -56.54 -33.82 66.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.876 1.271 . . . . 0.0 110.821 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.13 -21.05 7.72 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.041 0.937 . . . . 0.0 111.615 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -46.2 -36.25 5.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.846 0.748 . . . . 0.0 110.754 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -69.09 -57.88 4.83 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.59 -40.51 52.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.257 1.023 . . . . 0.0 111.292 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -45.22 -35.3 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.552 2.341 . . . . 0.0 112.394 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 m -55.16 -29.88 58.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.588 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.6 m -123.36 -27.2 4.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.517 1.127 . . . . 0.0 113.387 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.1 167.94 11.32 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.539 1.136 . . . . 0.0 112.639 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 p -145.57 168.49 20.5 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.202 1.801 . . . . 0.0 109.562 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mp -136.04 107.73 7.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 tt -129.04 137.31 57.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 124.212 1.005 . . . . 0.0 110.548 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 152.52 92.86 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.42 -40.06 44.59 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.438 2.759 . . . . 0.0 113.497 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.69 -13.31 61.99 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.798 1.239 . . . . 0.0 113.802 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.07 -7.29 29.08 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.703 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.8 m -61.15 102.34 0.21 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.002 1.901 . . . . 0.0 109.299 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.66 76.37 5.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.844 2.058 . . . . 0.0 111.471 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.49 -46.71 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.292 0.637 . . . . 0.0 109.381 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.43 106.79 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -75.38 55.41 0.79 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.737 1.615 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.6 -174.33 30.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.21 0.91 . . . . 0.0 111.2 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.58 -174.69 5.12 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.804 0.811 . . . . 0.0 112.046 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.51 28.27 3.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 110.242 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 m -61.67 -35.09 76.97 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.04 162.87 12.45 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 169.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -55.4 153.1 29.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.592 2.195 . . . . 0.0 113.441 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -66.03 127.45 32.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.76 16.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -63.43 87.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.243 0.929 . . . . 0.0 110.045 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.75 46.67 5.63 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.11 -31.65 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.77 118.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.711 0.804 . . . . 0.0 108.862 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.91 -10.18 74.74 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.024 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.85 136.78 53.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.44 1.12 . . . . 0.0 109.327 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -62.53 135.39 57.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.52 131.3 45.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.757 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.03 35.22 61.27 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.562 -1.132 . . . . 0.0 113.764 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.1 p -136.33 2.68 2.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.123 1.461 . . . . 0.0 114.644 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.35 128.01 90.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.409 1.459 . . . . 0.0 107.106 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -54.57 157.85 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.901 2.401 . . . . 0.0 114.479 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 49.97 66.19 1.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.373 1.869 . . . . 0.0 112.415 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -164.44 123.78 1.92 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.815 0.446 . . . . 0.0 109.868 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -79.93 93.79 5.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.041 0.936 . . . . 0.0 109.922 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -77.97 -170.24 1.85 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.649 0.738 . . . . 0.0 110.662 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -117.08 172.44 7.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.291 1.836 . . . . 0.0 108.495 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.58 -36.71 84.69 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.979 0.912 . . . . 0.0 113.383 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -60.99 -65.76 0.64 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 111.089 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.21 -37.96 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.37 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -48.04 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.73 91.65 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.652 0.66 . . . . 0.0 111.141 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -48.36 73.69 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.57 28.16 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.13 -27.79 55.36 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.629 1.572 . . . . 0.0 112.282 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -68.03 -4.6 13.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.77 35.8 4.19 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 125.32 1.438 . . . . 0.0 110.52 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -103.39 124.19 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 117.408 0.604 . . . . 0.0 110.957 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.58 130.25 56.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.154 1.782 . . . . 0.0 107.603 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -60.74 143.62 54.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 118.177 0.444 . . . . 0.0 110.613 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.0 p -128.27 170.13 13.4 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.004 1.722 . . . . 0.0 106.917 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -58.59 -45.23 89.55 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 122.978 0.511 . . . . 0.0 110.606 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.36 -46.9 75.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.576 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.27 -46.68 87.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.99 -52.74 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -47.31 69.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.616 0.367 . . . . 0.0 110.277 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.6 m -64.37 -44.23 92.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.815 -0.553 . . . . 0.0 110.829 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -55.75 -53.47 56.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.063 0.945 . . . . 0.0 111.286 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 m -56.99 -40.13 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.593 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -65.04 -24.55 67.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -158.02 73.35 4.04 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.732 1.151 . . . . 0.0 113.005 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.13 146.74 79.71 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.522 2.148 . . . . 0.0 110.636 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.9 -64.18 4.35 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.78 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 117.318 0.559 . . . . 0.0 110.297 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -51.78 -51.23 57.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.959 0.504 . . . . 0.0 111.656 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.41 -56.39 16.61 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.321 0.648 . . . . 0.0 109.296 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -46.58 -46.4 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.499 1.12 . . . . 0.0 110.747 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -51.88 -40.53 60.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.043 0.937 . . . . 0.0 111.973 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -90.9 -45.68 8.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.305 0.642 . . . . 0.0 112.129 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 -17.87 39.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.472 1.109 . . . . 0.0 113.189 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 48.25 62.66 2.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.399 1.88 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -143.76 150.14 38.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.679 1.592 . . . . 0.0 108.926 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -66.97 -48.33 68.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 108.432 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -80.3 11.58 3.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.03 -1.441 . . . . 0.0 114.619 -173.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.41 63.58 6.65 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.691 -1.256 . . . . 0.0 110.517 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -102.52 170.45 8.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.197 0.999 . . . . 0.0 109.942 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -131.7 154.07 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.61 -12.44 64.15 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.552 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 4.0 ttp -67.97 79.75 0.22 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 56.6 2.66 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.572 0.749 . . . . 0.0 110.122 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 48.4 t80 -154.28 116.06 4.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.839 1.256 . . . . 0.0 108.712 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -100.94 -179.14 3.97 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.6 156.89 47.94 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.49 53.32 0.8 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? 75.66 164.12 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.875 1.67 . . . . 0.0 110.619 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.98 -15.22 33.85 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.05 -35.62 33.36 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.425 1.488 . . . . 0.0 112.29 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.65 -47.37 86.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 117.518 0.659 . . . . 0.0 110.586 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -64.32 -44.39 91.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.576 HG11 HMB1 ' A' ' 117' ' ' HEC . 98.7 t -60.42 -47.1 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.5 -48.14 77.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.955 -0.466 . . . . 0.0 109.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.18 -46.09 79.5 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -57.0 -51.23 70.06 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.073 -0.392 . . . . 0.0 110.869 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.37 -43.58 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.848 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.67 91.61 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.325 -0.234 . . . . 0.0 110.964 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.5 m -69.85 -50.05 46.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.738 HG13 ' H ' ' A' ' 115' ' ' VAL . 11.4 p -59.68 -81.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.738 ' H ' HG13 ' A' ' 114' ' ' VAL . 7.2 p 8.28 70.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 129.722 3.209 . . . . 0.0 113.655 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.237 0 CA-C-O 113.901 -2.952 . . . . 0.0 104.203 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.601 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.89 74.59 0.62 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.62 1.168 . . . . 0.0 111.449 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.39 -40.64 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.509 1.124 . . . . 0.0 112.618 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.54 85.79 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.733 -0.604 . . . . 0.0 111.044 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -63.98 -38.16 90.06 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.67 -48.35 82.16 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.19 -49.81 72.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.74 0.816 . . . . 0.0 109.736 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.7 -48.33 82.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.435 0.16 . . . . 0.0 110.691 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.15 -34.56 68.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.491 1.116 . . . . 0.0 110.464 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.98 -16.67 7.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.958 0.903 . . . . 0.0 112.564 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -51.28 -30.84 19.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.449 0.7 . . . . 0.0 110.387 172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -76.96 -59.02 2.95 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.62 -0.675 . . . . 0.0 109.349 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.9 m -45.36 -47.68 13.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.768 1.627 . . . . 0.0 111.961 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -51.02 -26.27 5.92 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.924 1.29 . . . . 0.0 113.805 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -58.6 -40.57 83.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.472 0.578 . . . . 0.0 109.56 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.1 m -99.39 -48.69 4.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.419 1.088 . . . . 0.0 112.133 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -84.07 176.83 8.55 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.159 0.983 . . . . 0.0 112.473 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.4 m -147.98 159.23 44.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.818 0.847 . . . . 0.0 108.764 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -142.93 122.19 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.36 130.52 60.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 O-C-N 121.86 -0.525 . . . . 0.0 110.009 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.04 158.87 60.36 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.98 -39.25 79.74 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.269 2.646 . . . . 0.0 112.53 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.7 -8.6 55.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.375 1.47 . . . . 0.0 113.717 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.49 -13.25 51.07 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -59.92 114.81 3.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.66 1.73 . . . . 0.0 109.677 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.24 118.74 11.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.467 0.707 . . . . 0.0 109.949 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 mm -89.86 -42.52 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.9 t -141.19 129.58 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -127.6 74.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.69 -168.4 3.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.28 44.22 1.01 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.977 -1.307 . . . . 0.0 110.11 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 tptp 13.79 57.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 130.648 3.579 . . . . 0.0 113.79 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -89.48 -30.95 17.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.69 0.796 . . . . 0.0 108.915 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.5 170.27 13.98 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.84 167.22 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 112.21 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.49 125.7 30.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -92.9 4.43 53.92 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -67.55 87.15 0.2 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.296 0.953 . . . . 0.0 109.483 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 115' ' ' VAL . . . 112.05 23.14 5.66 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.947 0.784 . . . . 0.0 111.577 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.91 -42.73 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.519 1.16 . . . . 0.0 110.05 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 115' ' ' VAL . 58.1 t -61.63 114.44 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.11 63.56 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.013 1.292 . . . . 0.0 111.654 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -68.92 138.61 54.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.6 1.2 . . . . 0.0 109.897 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 m -67.4 70.4 0.11 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.781 1.632 . . . . 0.0 111.508 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.53 -144.91 0.64 Allowed 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.875 -0.516 . . . . 0.0 110.232 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.62 73.73 0.61 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.514 1.054 . . . . 0.0 112.645 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.4 p -138.81 2.73 2.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.239 1.015 . . . . 0.0 111.922 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -62.22 132.9 94.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.57 161.67 11.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.151 1.9 . . . . 0.0 114.006 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 57.55 58.64 3.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.794 1.638 . . . . 0.0 112.916 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -165.88 123.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.746 0.418 . . . . 0.0 110.488 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.24 88.93 4.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.976 0.91 . . . . 0.0 109.553 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.91 -174.17 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.521 0.677 . . . . 0.0 111.455 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -106.12 -178.46 3.66 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.492 1.517 . . . . 0.0 108.322 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.65 -38.03 67.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.713 0.805 . . . . 0.0 112.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -60.74 -63.06 1.43 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 111.078 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.54 -35.65 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.9 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.55 -48.27 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.91 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 110.586 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.3 tp -55.77 -49.65 72.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.45 -52.75 48.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.84 -36.83 65.46 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.2 1.0 . . . . 0.0 112.591 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -67.32 -11.58 57.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.89 10.92 15.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.889 1.233 . . . . 0.0 112.595 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -77.0 141.27 40.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.739 1.27 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.51 34.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.454 1.501 . . . . 0.0 107.923 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -62.54 143.26 57.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.33 166.45 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.035 1.734 . . . . 0.0 106.596 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.98 -43.76 77.91 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.304 0.573 . . . . 0.0 110.775 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.62 -47.69 68.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.102 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.11 -46.05 90.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.252 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.3 mt -57.22 -54.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.69 -46.13 29.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.636 0.774 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -63.43 -65.32 0.7 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.255 0.622 . . . . 0.0 110.472 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -43.38 -48.83 7.06 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.011 1.724 . . . . 0.0 112.811 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 t -53.2 -25.73 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.64 14.87 15.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.601 1.091 . . . . 0.0 112.32 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -159.37 56.79 0.95 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.576 1.15 . . . . 0.0 111.904 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -66.82 157.39 61.55 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 108.75 -1.288 . . . . 0.0 108.75 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 -66.82 3.04 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.04 -47.68 53.22 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.411 1.084 . . . . 0.0 111.342 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -51.59 -52.39 47.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.64 -56.2 24.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.622 1.169 . . . . 0.0 109.73 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.02 -47.62 44.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.575 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -63.95 -66.96 0.47 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.467 0.707 . . . . 0.0 110.369 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -53.99 -39.81 66.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.7 tp -92.24 -0.41 57.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.938 0.895 . . . . 0.0 111.982 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 43.45 58.39 3.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.327 1.451 . . . . 0.0 109.94 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -143.68 157.88 44.08 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 124.305 1.042 . . . . 0.0 110.836 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -92.41 -50.22 5.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.272 1.829 . . . . 0.0 108.115 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -79.53 42.2 0.51 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.89 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.37 90.94 3.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -131.46 132.72 44.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.054 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.92 154.48 19.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.12 -16.9 62.86 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttp -64.96 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.244 1.022 . . . . 0.0 113.309 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.56 59.21 4.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -160.43 150.72 18.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.329 1.851 . . . . 0.0 107.426 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -143.81 164.23 31.1 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.846 1.259 . . . . 0.0 107.812 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.88 169.38 9.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.92 37.51 4.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -147.33 170.52 17.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.217 1.807 . . . . 0.0 106.172 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.75 -10.05 57.41 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.874 -0.959 . . . . 0.0 112.622 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.67 13.56 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 118.708 1.254 . . . . 0.0 113.889 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -61.71 -46.1 91.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.362 1.081 . . . . 0.0 109.452 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -55.28 -52.61 62.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.296 1.438 . . . . 0.0 110.57 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.21 -46.2 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.451 1.101 . . . . 0.0 110.184 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.37 90.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.148 -0.345 . . . . 0.0 110.376 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.25 99.17 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.499 0.319 . . . . 0.0 110.309 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -57.66 -52.26 66.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 115' ' ' VAL . 54.6 mt -58.7 -44.13 90.26 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.854 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.35 76.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.5 m -61.58 -38.13 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.012 -0.43 . . . . 0.0 111.094 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -37.06 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.855 -0.528 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.567 HG21 ' HB ' ' A' ' 41' ' ' VAL . 65.3 t -69.88 94.07 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.305 1.042 . . . . 0.0 110.235 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.0 pttm . . . . . 0 C--O 1.253 1.253 0 CA-C-O 115.229 -2.32 . . . . 0.0 107.436 175.88 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 N-CA-C 114.043 0.377 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.69 72.48 0.77 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.461 1.505 . . . . 0.0 111.506 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.1 -39.97 10.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.679 1.191 . . . . 0.0 112.591 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.26 94.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.541 0.736 . . . . 0.0 111.452 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.38 -43.6 69.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.86 -44.61 40.34 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.99 -46.13 71.64 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 111.659 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -71.36 -47.99 52.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.659 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -57.62 -30.66 65.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.935 0.894 . . . . 0.0 110.719 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.67 -16.46 4.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.618 1.167 . . . . 0.0 112.144 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -53.52 -33.22 53.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.333 0.969 . . . . 0.0 111.087 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -72.85 -26.64 61.54 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.77 -0.581 . . . . 0.0 111.391 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.9 m -77.4 -45.62 25.31 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -46.23 -32.88 3.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 111.904 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -53.0 -31.31 40.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.121 0.968 . . . . 0.0 111.76 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -120.2 -38.34 2.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.487 1.515 . . . . 0.0 112.366 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -103.7 -173.47 2.32 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 125.634 1.574 . . . . 0.0 111.386 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -157.24 168.48 27.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.408 1.483 . . . . 0.0 109.01 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 133.07 54.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.06 1.744 . . . . 0.0 106.692 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 26' ' ' GLU . 1.4 tp -111.6 149.74 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.653 1.981 . . . . 0.0 109.16 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 161.95 48.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.76 -36.99 27.28 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.592 2.861 . . . . 0.0 112.124 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.09 13.68 0.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.996 1.718 . . . . 0.0 113.325 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.44 31.98 60.42 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.664 1.125 . . . . 0.0 111.656 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -112.2 126.24 55.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 20' ' ' ILE . 51.6 mt-10 -63.44 121.82 14.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.538 0.335 . . . . 0.0 110.469 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.1 mm -98.62 -60.18 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.67 77.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.62 70.61 0.19 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.749 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.42 -158.17 30.76 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 173.82 11.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.9 33.06 5.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.468 1.107 . . . . 0.0 108.977 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.7 m -69.38 -38.12 77.88 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.7 165.27 12.03 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -59.45 141.66 97.81 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.891 3.061 . . . . 0.0 111.199 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.07 119.4 7.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -85.86 15.91 4.51 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -170.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -75.54 80.41 2.56 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.563 -1.335 . . . . 0.0 109.442 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.93 46.35 0.34 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.127 0.87 . . . . 0.0 113.453 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.89 -48.43 33.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 t -53.52 112.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.786 0.835 . . . . 0.0 110.431 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 -15.68 61.39 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.922 1.249 . . . . 0.0 113.058 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -68.12 140.56 56.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.94 1.37 . . . . 0.0 110.789 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 m -70.2 72.73 0.46 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 110.611 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.07 -139.47 1.02 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.942 0.497 . . . . 0.0 109.707 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.96 77.51 1.13 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 123.731 0.682 . . . . 0.0 112.536 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 p -136.21 16.36 3.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.713 0.805 . . . . 0.0 112.121 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -67.08 141.81 96.73 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.022 -1.049 . . . . 0.0 108.928 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.37 155.98 23.18 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.279 1.319 . . . . 0.0 113.916 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 46.73 62.57 2.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.475 1.51 . . . . 0.0 113.587 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -158.44 120.5 3.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.867 -0.52 . . . . 0.0 110.023 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -73.49 82.18 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.446 0.698 . . . . 0.0 110.495 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.11 169.69 11.45 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.165 0.507 . . . . 0.0 110.513 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -96.52 175.58 6.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.87 -35.78 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.272 0.629 . . . . 0.0 112.635 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -59.24 -66.47 0.5 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.228 1.411 . . . . 0.0 111.173 -174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 tt -58.1 -37.94 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.806 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.11 -49.41 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.55 87.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.923 0.329 . . . . 0.0 110.711 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -47.26 84.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.58 -56.65 22.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 173.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.93 -32.61 54.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.08 1.352 . . . . 0.0 113.387 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.7 p -66.68 -12.97 60.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.86 0.755 . . . . 0.0 112.056 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.73 33.43 1.88 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.398 1.475 . . . . 0.0 110.861 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -96.11 143.61 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.787 0.794 . . . . 0.0 109.532 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.44 128.59 31.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -61.01 99.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.016 0.526 . . . . 0.0 111.831 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.4 p -83.19 167.85 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -58.17 -37.81 75.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.045 0.45 . . . . 0.0 109.846 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -64.41 -49.57 71.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -56.88 -52.74 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.15 -53.53 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.59 -46.28 63.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.499 0.72 . . . . 0.0 111.184 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.9 m -66.88 -54.91 17.56 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -51.78 -42.82 62.71 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.413 1.085 . . . . 0.0 113.068 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.6 t -53.98 -31.67 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.118 0.567 . . . . 0.0 111.519 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -105.6 14.13 28.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.28 1.432 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -161.21 49.16 0.26 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.269 1.027 . . . . 0.0 111.809 -175.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -56.16 136.08 73.27 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.67 2.914 . . . . 0.0 110.04 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.63 -55.39 2.08 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.55 -0.583 . . . . 0.0 111.959 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 -38.55 68.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.501 1.151 . . . . 0.0 111.26 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -63.46 -44.74 93.6 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 110.721 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.97 -54.72 41.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.702 0.801 . . . . 0.0 108.941 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -47.8 -48.46 30.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.881 1.272 . . . . 0.0 110.244 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -61.03 -68.43 0.31 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.056 0.942 . . . . 0.0 110.513 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.27 -37.04 81.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 tp -85.86 -3.69 58.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.6 0.76 . . . . 0.0 111.344 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 t0 44.13 54.2 6.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.435 1.494 . . . . 0.0 110.017 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -145.95 119.24 8.94 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.534 0.734 . . . . 0.0 111.85 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.94 -32.23 69.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.241 1.016 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -80.51 4.93 16.7 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.39 65.28 6.46 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.485 -0.76 . . . . 0.0 111.355 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.54 136.83 32.81 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.382 -0.824 . . . . 0.0 109.253 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.6 t -87.91 155.13 20.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.36 -25.31 72.48 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 21.2 ttp -65.44 82.63 0.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.976 0.888 . . . . 0.0 112.324 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 58.29 3.24 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -163.61 145.93 9.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.328 1.851 . . . . 0.0 107.044 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.84 155.14 46.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.9 109.54 13.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.38 46.72 0.76 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.532 -0.73 . . . . 0.0 111.669 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? 175.59 -165.63 0.03 OUTLIER 'General case' 0 C--O 1.231 0.117 0 C-N-CA 128.091 2.556 . . . . 0.0 106.225 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.22 -59.01 3.63 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.993 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -4.77 -70.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.372 2.891 . . . . 0.0 115.294 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.23 -57.22 13.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.181 0.992 . . . . 0.0 112.639 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.64 -35.18 80.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.092 0.557 . . . . 0.0 110.904 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.92 -46.55 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.281 0.632 . . . . 0.0 109.632 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.34 94.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.889 -0.507 . . . . 0.0 109.702 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -43.46 86.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -59.2 -51.47 69.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.8 mt -56.46 -38.23 71.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.792 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.78 -52.46 60.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.152 0.887 . . . . 0.0 109.573 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.6 m -53.88 -34.88 60.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 112.618 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.14 -30.82 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.863 1.265 . . . . 0.0 111.697 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 t -69.07 82.78 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.064 0.847 . . . . 0.0 110.482 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.353 0 C-N-CA 127.532 2.333 . . . . 0.0 106.743 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -92.08 106.93 18.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.315 1.046 . . . . 0.0 108.498 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.72 -34.75 5.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.672 1.189 . . . . 0.0 112.476 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.04 74.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.761 0.71 . . . . 0.0 110.324 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.61 -38.52 87.94 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.49 -52.24 51.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.08 -49.15 77.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.232 0.613 . . . . 0.0 110.553 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -55.87 -50.92 69.32 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.4 -35.52 72.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.422 0.689 . . . . 0.0 109.951 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.87 -19.93 32.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -52.98 -31.82 42.82 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.604 0.638 . . . . 0.0 110.985 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -52.72 6.06 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.06 -38.18 10.7 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.563 1.945 . . . . 0.0 113.645 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -52.43 -25.18 9.34 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.15 . . . . 0.0 112.817 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 m -61.91 -21.97 65.19 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.612 -0.68 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -119.16 -38.76 3.0 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.85 0.86 . . . . 0.0 112.619 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.75 169.7 8.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 112.404 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.3 p -141.38 164.21 30.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.785 1.234 . . . . 0.0 111.272 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.43 119.05 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -139.5 133.63 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.229 0.612 . . . . 0.0 110.86 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 162.85 63.03 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.83 -37.82 95.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.14 2.56 . . . . 0.0 112.394 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.25 -15.94 58.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.979 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.2 -3.11 56.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.41 110.96 2.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.6 114.57 13.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.888 0.875 . . . . 0.0 111.48 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.0 -45.16 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.7 t -135.2 103.31 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -76.96 54.79 1.05 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.781 1.232 . . . . 0.0 109.043 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.19 -176.4 50.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.21 177.94 6.12 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.327 0.584 . . . . 0.0 110.923 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -125.95 39.88 3.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.09 0.956 . . . . 0.0 109.368 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.2 m -65.57 -34.65 78.74 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.36 13.42 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 168.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.46 173.24 0.76 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.444 2.096 . . . . 0.0 113.494 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -83.32 135.09 34.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.77 10.84 37.64 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -64.8 88.61 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.275 0.943 . . . . 0.0 109.478 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.91 40.94 5.11 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.516 HG21 HMA3 ' A' ' 117' ' ' HEC . 3.5 p -72.58 -36.39 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 171.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.39 107.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.72 -13.51 50.19 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.308 1.432 . . . . 0.0 112.069 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -73.07 137.5 45.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.841 0.821 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -63.47 128.9 37.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.39 154.89 12.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.829 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.07 22.76 72.65 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.867 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.1 t -156.16 28.72 0.35 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.539 1.67 . . . . 0.0 113.416 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -72.26 129.35 87.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 167.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -45.49 154.7 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.166 2.577 . . . . 0.0 116.094 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 54.7 65.57 1.47 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.298 1.439 . . . . 0.0 112.605 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -166.83 125.42 1.39 Allowed 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.854 -0.529 . . . . 0.0 111.713 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -79.36 90.7 5.01 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.64 1.176 . . . . 0.0 109.66 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -73.55 -177.57 2.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.464 0.705 . . . . 0.0 112.509 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -105.55 -178.03 3.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.004 1.322 . . . . 0.0 108.167 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.32 -37.17 66.25 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.512 -0.742 . . . . 0.0 112.792 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -62.24 -66.2 0.57 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.506 1.122 . . . . 0.0 111.167 -173.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -55.5 -38.09 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.897 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.01 -43.58 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 O-C-N 121.813 -0.555 . . . . 0.0 109.512 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.8 87.74 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.299 0.5 . . . . 0.0 110.318 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.04 -52.43 65.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.15 -48.29 10.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.096 1.331 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.14 29.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.237 1.415 . . . . 0.0 113.819 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -73.3 -0.5 14.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.471 1.032 . . . . 0.0 112.183 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 33.88 9.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -79.19 80.82 5.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.069 -0.665 . . . . 0.0 110.916 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.14 115.0 11.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.002 1.321 . . . . 0.0 107.865 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -56.3 146.77 22.89 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 109.259 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.2 p -127.18 164.0 22.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.08 -40.65 73.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.069 0.548 . . . . 0.0 110.213 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.61 -52.42 57.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.317 0.647 . . . . 0.0 110.604 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -61.03 -45.48 94.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.56 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.8 mm -56.18 -53.7 36.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.34 -47.16 66.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.678 0.391 . . . . 0.0 110.612 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 m -62.35 -55.49 27.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.21 0.528 . . . . 0.0 110.454 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.39 -44.63 45.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.331 1.453 . . . . 0.0 112.143 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.4 t -54.26 -30.5 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.41 0.684 . . . . 0.0 111.906 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -95.37 -26.38 15.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.616 0.766 . . . . 0.0 111.37 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -127.43 63.7 59.78 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 125.204 1.402 . . . . 0.0 112.693 -171.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.77 143.27 60.87 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.779 1.653 . . . . 0.0 108.809 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -63.57 3.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.25 -45.22 44.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.688 1.195 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -54.85 -53.03 60.61 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.686 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.6 -53.48 57.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.123 -0.361 . . . . 0.0 110.32 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -47.64 -50.6 24.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.98 0.912 . . . . 0.0 110.491 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.0 -58.32 6.35 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.01 0.524 . . . . 0.0 111.025 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -67.45 -51.47 51.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.86 -25.59 40.66 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.755 1.222 . . . . 0.0 114.219 -172.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.81 55.51 7.75 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.405 1.482 . . . . 0.0 109.892 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -136.21 135.92 39.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.248 1.419 . . . . 0.0 109.543 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.88 -41.35 97.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.411 1.084 . . . . 0.0 111.107 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -85.69 18.76 2.71 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 70.41 4.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.442 0.697 . . . . 0.0 110.444 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -113.41 128.46 56.46 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.54 1.536 . . . . 0.0 109.121 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.2 t -82.18 158.52 23.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.65 -19.85 69.53 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.559 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 26.5 ttp -68.76 82.72 0.29 Allowed 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.996 -0.708 . . . . 0.0 112.797 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.62 3.09 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -160.21 149.73 17.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.168 1.787 . . . . 0.0 108.084 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -156.3 172.57 18.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.142 1.377 . . . . 0.0 108.861 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -143.29 115.72 8.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.031 1.332 . . . . 0.0 107.625 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.48 45.58 0.78 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.665 -0.647 . . . . 0.0 111.868 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? 175.04 -172.22 0.06 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 128.301 2.64 . . . . 0.0 105.705 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.37 -52.49 2.25 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.686 -1.064 . . . . 0.0 113.523 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -24.84 -55.1 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.179 2.323 . . . . 0.0 114.997 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -62.14 -52.38 64.1 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.526 0.73 . . . . 0.0 111.493 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.72 -48.35 79.82 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.5 1.12 . . . . 0.0 109.456 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.483 HG11 HMB1 ' A' ' 117' ' ' HEC . 59.4 t -59.22 -46.38 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.653 1.181 . . . . 0.0 109.697 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.71 87.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.874 -0.516 . . . . 0.0 110.07 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.8 93.91 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -58.5 -50.41 73.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.979 -0.45 . . . . 0.0 110.534 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.94 -46.13 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.954 0.902 . . . . 0.0 110.434 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.7 78.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.021 0.528 . . . . 0.0 110.556 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -69.07 -38.71 79.18 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.964 -0.46 . . . . 0.0 111.07 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -42.49 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 125.329 1.452 . . . . 0.0 111.46 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.46 80.48 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.069 0.937 . . . . 0.0 110.363 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.3 pttm . . . . . 0 C--O 1.253 1.271 0 C-N-CA 128.178 2.591 . . . . 0.0 106.953 179.181 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.803 HMB1 HBB3 ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 121.798 0.665 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -73.67 80.59 1.53 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.863 -0.786 . . . . 0.0 111.152 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.52 63.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.9 0.88 . . . . 0.0 111.741 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.15 74.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.635 0.374 . . . . 0.0 110.407 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -63.87 -44.56 92.71 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -48.05 -45.53 26.56 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.13 0.871 . . . . 0.0 112.001 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -54.05 -47.22 71.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.285 0.634 . . . . 0.0 110.938 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -69.19 -44.74 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.625 ' OE1' HBB1 ' A' ' 117' ' ' HEC . 2.0 tm-20 -52.94 -34.93 57.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.207 1.403 . . . . 0.0 109.641 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.52 -20.34 2.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.02 -27.67 33.45 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.816 -0.553 . . . . 0.0 111.456 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.35 -55.04 5.74 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.01 -42.82 29.12 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.993 1.317 . . . . 0.0 112.33 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -57.32 -21.07 32.67 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -54.52 -32.63 58.51 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.731 -0.606 . . . . 0.0 110.288 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 m -112.48 -44.35 3.37 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.338 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -90.84 -176.15 4.58 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 m -156.3 165.41 36.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.147 1.779 . . . . 0.0 108.732 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.6 mt -131.95 126.86 57.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' N ' HD21 ' A' ' 36' ' ' ASN . 1.1 tp -118.85 135.75 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.322 1.449 . . . . 0.0 109.998 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.24 82.34 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 119.015 0.825 . . . . 0.0 108.973 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.07 -41.25 73.19 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.16 2.573 . . . . 0.0 112.561 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -72.66 -10.96 60.42 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.172 1.389 . . . . 0.0 113.407 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.85 -17.15 35.96 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.023 -0.876 . . . . 0.0 113.443 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.8 m -60.71 116.32 4.31 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.522 1.661 . . . . 0.0 109.923 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -64.4 122.17 16.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.822 0.449 . . . . 0.0 110.341 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.44 -52.15 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.45 97.98 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -78.11 70.14 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.825 1.25 . . . . 0.0 107.801 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.39 -151.34 27.4 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.58 -179.33 5.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -123.51 22.45 9.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 108.89 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -30.13 70.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.225 1.01 . . . . 0.0 108.998 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.18 172.08 14.49 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.7 175.05 0.64 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 124.108 3.205 . . . . 0.0 113.307 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 20' ' ' ILE . 1.5 t30 -105.4 81.77 1.74 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.055 0.942 . . . . 0.0 111.086 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mp -37.32 -0.91 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.542 1 C-N-CA 133.424 4.689 . . . . 0.0 121.464 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -69.07 80.86 0.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 121.058 1.754 . . . . 0.0 110.049 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 115' ' ' VAL . . . 122.22 32.76 0.95 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.903 -0.943 . . . . 0.0 115.014 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.4 HG11 HMA3 ' A' ' 117' ' ' HEC . 56.7 t -64.67 -49.12 81.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.7 1.75 . . . . 0.0 111.789 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 115' ' ' VAL . 88.7 t -53.38 121.56 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 121.5 -0.75 . . . . 0.0 110.537 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.02 -19.21 54.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.744 1.164 . . . . 0.0 111.737 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -64.8 135.43 55.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.136 0.968 . . . . 0.0 110.042 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.2 m -73.15 80.75 1.27 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' CA ' ' A' ' 61' ' ' GLY . . . 51.68 -145.1 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.099 0.959 . . . . 0.0 110.963 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.0 78.81 0.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 124.82 1.2 . . . . 0.0 111.945 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.0 p -134.57 5.38 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.832 0.853 . . . . 0.0 111.805 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.06 134.99 93.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.07 164.75 9.76 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.486 2.124 . . . . 0.0 114.426 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.98 52.95 7.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.846 1.658 . . . . 0.0 112.057 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -161.49 118.42 2.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.991 -0.443 . . . . 0.0 111.81 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -78.77 79.9 5.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.064 0.946 . . . . 0.0 109.599 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -64.31 163.88 12.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.958 0.503 . . . . 0.0 111.385 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -96.47 176.39 6.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.144 0.973 . . . . 0.0 110.986 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.15 -36.62 73.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.804 1.641 . . . . 0.0 113.584 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 p -64.07 -67.61 0.42 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.029 0.919 . . . . 0.0 109.823 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 tt -59.25 -33.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.64 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.99 -50.89 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.637 -0.664 . . . . 0.0 109.663 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -40.3 82.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.416 0.553 . . . . 0.0 110.283 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -57.42 -44.33 84.55 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . -58.86 -49.21 80.38 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.19 -35.47 64.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.335 0.568 . . . . 0.0 111.719 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.1 p -76.34 5.92 6.36 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 30.65 36.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.362 0.982 . . . . 0.0 112.33 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -74.99 82.61 2.22 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.77 -0.841 . . . . 0.0 112.296 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.81 107.97 5.52 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -52.35 116.48 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.627 0.771 . . . . 0.0 111.719 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.5 p -94.33 161.89 14.06 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.95 -38.0 81.16 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.91 -54.7 44.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.965 0.906 . . . . 0.0 109.249 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -58.44 -47.11 85.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.787 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -54.03 -53.65 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.67 62.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.008 0.523 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -60.07 -53.58 56.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -52.5 -44.56 65.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.191 0.996 . . . . 0.0 111.575 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.41 -20.15 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.096 0.958 . . . . 0.0 112.418 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -103.33 -14.11 16.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.561 1.144 . . . . 0.0 111.988 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -142.08 58.81 8.38 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.632 1.173 . . . . 0.0 111.929 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.67 135.62 70.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.109 2.539 . . . . 0.0 109.585 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.51 -59.04 4.11 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.562 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.25 -42.28 66.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.991 0.896 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -51.43 -59.62 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.366 1.066 . . . . 0.0 111.042 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.31 -50.17 73.79 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.245 1.018 . . . . 0.0 110.935 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -59.69 -35.95 75.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 110.264 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.79 -59.93 2.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.625 0.77 . . . . 0.0 109.188 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -54.44 -44.99 72.96 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.75 0.23 56.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.962 0.505 . . . . 0.0 111.738 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 46.73 49.94 13.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.203 1.401 . . . . 0.0 110.666 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -138.23 117.18 12.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.455 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -51.64 -37.34 49.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.554 1.142 . . . . 0.0 111.272 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -89.14 4.34 48.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.88 86.38 7.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -116.05 153.93 30.82 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.656 1.182 . . . . 0.0 110.228 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -97.27 157.29 16.03 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 123.904 0.882 . . . . 0.0 110.439 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.48 -19.99 79.21 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.6 ttt -65.02 81.68 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.521 1.128 . . . . 0.0 112.777 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 58.13 3.03 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.484 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 25.2 t80 -165.85 143.88 5.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.099 1.36 . . . . 0.0 108.877 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -141.24 166.87 23.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.554 1.542 . . . . 0.0 107.106 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.02 165.92 13.75 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.6 56.8 3.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.392 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 75.54 -172.11 0.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.839 2.055 . . . . 0.0 111.349 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.32 -78.37 1.93 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.22 -53.87 0.18 Allowed Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.99 1.281 . . . . 0.0 112.96 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -44.73 -37.88 4.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.397 1.879 . . . . 0.0 113.31 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -58.96 -48.13 82.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.412 0.685 . . . . 0.0 110.551 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.596 HG11 HMB1 ' A' ' 117' ' ' HEC . 2.8 t -71.69 -39.71 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.32 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.303 -0.248 . . . . 0.0 110.629 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.52 95.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.558 0.743 . . . . 0.0 109.599 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.27 -51.01 69.73 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 115' ' ' VAL . 51.7 mt -58.49 -44.95 89.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.71 -0.619 . . . . 0.0 110.823 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.94 79.12 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.968 -0.457 . . . . 0.0 110.083 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -61.8 -41.09 97.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.634 0.373 . . . . 0.0 110.68 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.54 -31.23 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.752 0.821 . . . . 0.0 111.26 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.594 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.5 t -68.08 87.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.686 0.755 . . . . 0.0 109.133 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? . . . . . 0 C--O 1.253 1.281 0 C-N-CA 128.135 2.574 . . . . 0.0 106.887 178.286 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.625 HBB1 ' OE1' ' A' ' 9' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.869 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.0 92.21 5.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.6 -40.88 20.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.894 0.877 . . . . 0.0 112.94 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.63 72.97 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.898 -0.502 . . . . 0.0 110.126 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.18 -39.64 90.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.75 -47.12 38.92 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.011 1.291 . . . . 0.0 111.255 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.94 -48.19 73.49 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.113 0.456 . . . . 0.0 110.237 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -65.34 -46.17 81.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.403 0.281 . . . . 0.0 110.373 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -57.28 -33.18 67.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.607 1.163 . . . . 0.0 110.261 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.89 -21.39 57.41 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -27.49 56.26 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.585 0.629 . . . . 0.0 109.82 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -80.58 -49.78 10.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.9 m -53.11 -41.92 65.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.701 0.801 . . . . 0.0 112.358 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -62.19 -11.5 14.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.6 m -59.05 -22.92 61.5 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.8 m -129.74 -46.25 1.16 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.885 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.82 -173.53 3.53 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.689 0.757 . . . . 0.0 112.976 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.4 m -159.89 167.99 26.8 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.504 1.922 . . . . 0.0 109.838 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.8 mm -140.73 126.07 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.416 1.487 . . . . 0.0 108.508 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 tp -120.78 136.73 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.898 1.279 . . . . 0.0 109.244 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.11 47.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.273 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.96 -34.53 92.34 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.961 2.44 . . . . 0.0 110.696 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.83 14.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.988 1.715 . . . . 0.0 112.821 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.01 63.16 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.975 -1.078 . . . . 0.0 111.832 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -107.99 123.36 48.53 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.51 114.9 5.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.809 0.444 . . . . 0.0 111.355 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.42 -43.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.98 97.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -81.63 66.85 7.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.85 174.56 54.21 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.31 72.75 7.18 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.802 -0.822 . . . . 0.0 109.033 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -40.87 71.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.963 3.705 . . . . 0.0 114.478 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -100.56 -27.33 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.701 2.4 . . . . 0.0 108.261 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.94 173.11 14.55 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.14 1.829 . . . . 0.0 108.736 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.46 171.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.604 3.536 . . . . 0.0 114.706 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -94.21 126.43 39.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.9 mt -97.22 7.4 46.66 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.31 82.66 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.928 1.24 . . . . 0.0 111.058 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.21 28.9 5.64 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.233 0.921 . . . . 0.0 113.145 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.22 -35.83 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 118.76 1.28 . . . . 0.0 108.652 171.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.08 115.23 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.799 0.839 . . . . 0.0 110.259 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.4 -14.83 62.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.069 1.319 . . . . 0.0 112.6 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -84.51 146.89 27.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.382 1.091 . . . . 0.0 111.213 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -60.12 132.12 52.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.854 0.862 . . . . 0.0 109.085 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.36 149.18 29.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.932 -0.48 . . . . 0.0 110.965 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 29.49 73.93 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.265 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.7 p -131.43 -6.96 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.073 1.437 . . . . 0.0 114.27 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -64.44 129.93 94.42 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.02 1.282 . . . . 0.0 108.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -59.66 166.68 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.282 1.988 . . . . 0.0 113.403 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 59.28 51.14 7.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.133 1.373 . . . . 0.0 112.021 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -164.14 120.43 1.62 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.86 87.29 6.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -70.0 -172.07 0.5 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.664 0.745 . . . . 0.0 111.405 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.33 157.94 22.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.732 1.613 . . . . 0.0 110.259 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -51.83 -36.02 46.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.7 1.2 . . . . 0.0 113.545 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -63.71 -66.77 0.5 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.076 0.95 . . . . 0.0 110.01 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -58.76 -35.77 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.486 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.57 -50.7 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.92 93.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.443 0.565 . . . . 0.0 110.602 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.54 -47.32 79.66 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.81 -55.33 28.19 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.445 1.022 . . . . 0.0 111.007 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.42 -31.44 55.17 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.782 1.233 . . . . 0.0 111.522 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -72.1 6.04 2.4 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.24 28.63 22.19 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.949 1.262 . . . . 0.0 111.646 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -80.74 82.5 6.72 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.868 -0.783 . . . . 0.0 111.356 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.55 120.33 20.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -65.29 107.59 1.66 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -86.66 165.44 16.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.07 -41.85 84.25 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.495 0.664 . . . . 0.0 109.6 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -60.09 -51.87 67.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.976 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -59.14 -49.92 76.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.9 mt -54.37 -53.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.2 -41.99 72.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.647 0.779 . . . . 0.0 111.564 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.74 -53.49 15.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.37 0.268 . . . . 0.0 110.522 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -45.88 -46.99 16.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.069 1.347 . . . . 0.0 113.588 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.6 -31.42 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -82.89 -14.99 53.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.158 0.983 . . . . 0.0 111.925 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -145.28 54.17 2.3 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.752 1.221 . . . . 0.0 112.693 -173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.41 141.17 94.94 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.253 1.969 . . . . 0.0 109.313 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.75 -63.8 3.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -48.69 -44.59 38.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 111.242 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -53.42 -54.47 36.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 110.445 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.23 -48.75 80.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.061 0.544 . . . . 0.0 110.377 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -54.64 -49.59 70.17 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.283 0.633 . . . . 0.0 110.757 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -50.01 -47.92 52.77 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.53 0.732 . . . . 0.0 111.234 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.27 -55.56 4.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.9 tp -74.93 -24.13 58.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.483 1.113 . . . . 0.0 113.69 -173.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 t0 52.23 56.78 7.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.717 1.607 . . . . 0.0 111.414 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -146.45 135.42 22.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.363 1.065 . . . . 0.0 108.198 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.116 0.566 . . . . 0.0 109.935 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.86 3.72 11.39 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.99 61.23 3.12 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.688 0.795 . . . . 0.0 110.029 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -95.65 -178.57 4.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.871 1.268 . . . . 0.0 109.559 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 t -147.66 150.02 33.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -17.69 68.23 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 ttt -66.83 78.4 0.12 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.044 0.938 . . . . 0.0 113.023 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.45 58.1 3.06 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.003 0.921 . . . . 0.0 109.163 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -165.79 140.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.547 1.539 . . . . 0.0 107.452 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.61 163.32 31.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.4 tp -155.98 111.32 2.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.19 32.51 0.28 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.7 -0.625 . . . . 0.0 112.347 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -160.02 -178.01 6.71 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 127.589 2.355 . . . . 0.0 106.432 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.2 -56.01 3.2 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.387 -0.674 . . . . 0.0 112.829 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -18.78 -63.9 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.892 2.663 . . . . 0.0 115.933 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 2.0 pm0 -61.92 -46.36 89.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.146 0.979 . . . . 0.0 111.622 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -62.77 -48.14 80.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.137 0.975 . . . . 0.0 108.719 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.452 HG11 HMB1 ' A' ' 117' ' ' HEC . 84.7 t -60.33 -44.32 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.0 0.52 . . . . 0.0 109.754 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.46 -47.28 82.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.813 0.733 . . . . 0.0 110.617 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.36 93.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.898 0.38 . . . . 0.0 110.753 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -56.17 -52.16 65.4 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.869 0.468 . . . . 0.0 109.873 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.85 -45.06 90.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.579 -0.7 . . . . 0.0 110.984 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.99 87.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.622 0.769 . . . . 0.0 111.28 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.1 p -71.8 -34.75 69.62 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.049 -0.407 . . . . 0.0 111.256 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.96 -47.66 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.768 1.227 . . . . 0.0 111.916 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.84 89.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.831 0.824 . . . . 0.0 112.35 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt . . . . . 0 C--O 1.248 1.02 0 C-N-CA 126.619 1.968 . . . . 0.0 109.63 176.922 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.673 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.228 0.349 . . . . 0.0 113.619 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.04 84.11 0.98 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 109.94 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.85 -37.25 29.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.851 0.86 . . . . 0.0 112.443 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.36 -52.51 63.35 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.657 -0.652 . . . . 0.0 109.94 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -57.97 -39.22 77.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.6 -48.61 69.87 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.7 -49.03 74.09 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.973 0.509 . . . . 0.0 109.741 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -61.61 -47.96 83.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.625 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -54.31 -38.77 66.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 110.323 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -56.08 -17.39 6.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.709 0.804 . . . . 0.0 112.984 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -56.03 -26.06 47.31 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.286 -0.884 . . . . 0.0 111.297 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -77.8 -51.58 10.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.0 m -50.96 -42.08 59.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.311 1.044 . . . . 0.0 111.941 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -56.68 -21.91 31.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 m -56.4 -27.71 57.16 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.922 -0.486 . . . . 0.0 110.304 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -118.66 -43.83 2.67 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.613 0.765 . . . . 0.0 111.441 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -93.85 174.94 6.92 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 124.767 1.227 . . . . 0.0 113.32 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -141.27 161.76 37.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.717 1.207 . . . . 0.0 109.872 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.1 mt -138.15 106.88 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 103.412 -2.811 . . . . 0.0 103.412 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -122.77 125.69 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.463 1.105 . . . . 0.0 109.9 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 159.17 20.61 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.406 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.18 -38.38 81.16 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.775 2.317 . . . . 0.0 110.916 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.52 3.89 4.43 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.513 1.525 . . . . 0.0 113.128 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.52 65.98 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 120.733 -1.23 . . . . 0.0 112.873 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -57.07 114.45 2.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.556 1.178 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -74.29 73.12 1.81 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.455 0.702 . . . . 0.0 111.356 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.1 mm -50.27 -48.19 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.774 0.83 . . . . 0.0 109.175 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.3 102.46 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -76.12 58.51 1.23 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 108.963 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.81 174.21 42.43 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.92 176.11 3.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.161 0.505 . . . . 0.0 111.529 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -118.59 24.11 11.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.369 1.068 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -64.37 -38.29 90.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.98 169.88 13.35 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 169.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.63 178.24 1.02 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.717 3.612 . . . . 0.0 114.431 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -92.61 89.53 6.74 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.804 1.242 . . . . 0.0 111.356 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.36 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.687 2.395 . . . . 0.0 116.19 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -64.22 85.31 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 120.653 1.57 . . . . 0.0 109.61 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.58 56.9 3.73 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -33.34 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 117.673 0.737 . . . . 0.0 109.796 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.6 t -54.29 118.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.096 0.958 . . . . 0.0 110.265 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 -17.29 59.58 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.576 1.084 . . . . 0.0 112.33 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 138.88 40.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.139 1.469 . . . . 0.0 110.005 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.3 m -62.43 133.39 54.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.36 137.42 52.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.002 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.56 29.88 65.11 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.272 -1.293 . . . . 0.0 114.23 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.3 p -133.89 -3.78 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.403 1.602 . . . . 0.0 115.076 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.68 122.36 76.1 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.777 1.626 . . . . 0.0 107.341 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -56.29 162.12 8.21 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.386 2.057 . . . . 0.0 114.418 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 61.3 56.39 2.68 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.848 1.659 . . . . 0.0 111.871 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -164.22 121.12 1.65 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.88 0.371 . . . . 0.0 111.828 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -74.93 87.46 2.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.664 0.786 . . . . 0.0 109.456 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.47 167.69 14.28 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -99.78 156.39 17.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.925 0.89 . . . . 0.0 110.122 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -48.88 -43.28 38.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.085 1.354 . . . . 0.0 113.69 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 m -65.14 -52.99 51.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.845 0.355 . . . . 0.0 111.085 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 tt -65.05 -36.72 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.548 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.64 -48.45 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.14 96.72 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.035 -0.416 . . . . 0.0 111.246 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -50.61 65.93 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.06 -53.01 47.87 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.028 0.823 . . . . 0.0 111.94 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.88 -26.67 37.24 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 125.286 1.435 . . . . 0.0 111.874 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -71.83 3.71 3.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 175.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.76 40.51 7.64 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.383 1.468 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -102.79 105.23 15.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.79 129.07 40.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.986 1.314 . . . . 0.0 108.501 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -62.78 109.53 1.46 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.119 0.418 . . . . 0.0 111.751 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.3 p -91.35 164.07 13.98 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.43 -43.38 75.31 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.401 0.619 . . . . 0.0 110.876 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.97 -46.16 72.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.62 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -57.13 -50.09 73.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.671 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.74 -55.58 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.325 0.511 . . . . 0.0 109.851 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.89 -37.4 60.56 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.447 0.699 . . . . 0.0 111.628 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.6 m -72.53 -63.44 1.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -36.17 -54.08 0.8 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.448 2.299 . . . . 0.0 113.8 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 m -48.78 -32.97 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.27 -33.53 65.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.483 0.713 . . . . 0.0 112.684 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -135.98 57.05 16.44 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -60.41 145.78 98.01 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.29 1.327 . . . . 0.0 110.835 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.07 -64.04 4.11 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.44 80.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.94 0.496 . . . . 0.0 110.131 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -54.46 -53.85 48.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.961 0.904 . . . . 0.0 110.327 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -57.57 -53.83 53.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.601 0.36 . . . . 0.0 110.427 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -47.78 -47.38 30.74 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 110.601 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.03 -66.31 0.56 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.091 0.556 . . . . 0.0 110.51 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -53.9 -43.12 69.42 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -84.79 -5.22 59.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.968 0.907 . . . . 0.0 111.825 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t0 48.63 56.36 7.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.024 1.33 . . . . 0.0 109.609 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -142.49 157.13 45.07 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.097 0.959 . . . . 0.0 110.298 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -95.1 -46.83 6.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.94 2.096 . . . . 0.0 107.628 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -76.43 43.71 0.32 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.485 1.514 . . . . 0.0 111.78 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.73 118.25 29.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.006 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -151.23 140.3 21.13 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.12 0.968 . . . . 0.0 108.738 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -103.55 156.22 17.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -24.16 58.44 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.6 ttp -63.21 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.789 0.795 . . . . 0.0 113.095 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.62 57.3 3.29 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -160.44 149.91 17.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.444 1.898 . . . . 0.0 106.372 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -143.42 158.81 43.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.5 tp -130.89 115.75 16.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.94 50.47 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.159 0.984 . . . . 0.0 112.067 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -133.82 135.21 43.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.33 1.452 . . . . 0.0 107.839 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.12 61.26 4.38 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.558 -2.617 . . . . 0.0 106.558 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.94 65.01 0.0 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 129.794 3.569 . . . . 0.0 117.192 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.66 -34.58 78.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.087 0.955 . . . . 0.0 109.255 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -61.09 -52.09 66.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.098 1.359 . . . . 0.0 109.618 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.66 -45.52 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 123.784 0.834 . . . . 0.0 109.592 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.25 85.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.141 -0.349 . . . . 0.0 110.777 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.036 -0.415 . . . . 0.0 110.544 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -58.55 -54.23 49.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.77 -32.88 67.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.247 0.619 . . . . 0.0 111.522 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.9 -54.21 24.37 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.547 0.612 . . . . 0.0 109.783 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 97.4 p -57.75 -32.29 67.32 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.906 -0.497 . . . . 0.0 112.236 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.28 -26.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.715 0.806 . . . . 0.0 111.412 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 t -66.38 84.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 119.122 0.874 . . . . 0.0 108.965 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 C--O 1.253 1.25 0 CA-C-O 115.254 -2.308 . . . . 0.0 107.657 178.277 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 CA-C-O 122.025 0.792 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.0 68.95 0.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.153 1.781 . . . . 0.0 111.659 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.073 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.55 79.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.749 0.82 . . . . 0.0 111.594 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -71.78 -41.0 68.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.43 -44.09 45.03 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.179 0.895 . . . . 0.0 111.751 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -51.51 -53.46 37.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.732 0.813 . . . . 0.0 110.446 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -65.34 -46.62 79.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.476 0.711 . . . . 0.0 109.971 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.485 ' OE1' HBB1 ' A' ' 117' ' ' HEC . 3.1 tm-20 -53.63 -39.77 65.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.305 1.042 . . . . 0.0 109.604 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -57.66 -19.37 26.18 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -30.76 62.43 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.327 -0.858 . . . . 0.0 109.775 174.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.79 -54.97 9.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.2 m -50.23 -41.06 49.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.636 1.574 . . . . 0.0 111.274 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -46.98 -31.69 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.389 1.875 . . . . 0.0 112.663 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.0 m -56.51 -28.98 61.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.384 0.673 . . . . 0.0 111.557 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.5 m -121.66 -36.19 3.09 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.952 0.901 . . . . 0.0 112.646 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -105.64 168.77 8.88 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.77 1.228 . . . . 0.0 112.791 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.2 p -138.13 166.82 23.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.956 1.302 . . . . 0.0 110.359 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.4 114.37 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.4 ' N ' HD21 ' A' ' 36' ' ' ASN . 2.6 tp -109.8 134.45 51.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.636 1.174 . . . . 0.0 110.072 -175.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.92 159.97 82.07 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 121.126 -0.984 . . . . 0.0 108.416 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.18 -40.93 68.11 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.906 2.404 . . . . 0.0 112.519 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.5 -8.06 55.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.373 1.469 . . . . 0.0 113.58 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.89 -17.24 45.61 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.947 -0.918 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.2 m -58.63 121.83 11.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.66 1.73 . . . . 0.0 109.44 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.99 113.55 5.78 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.24 -50.36 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.24 99.65 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' H ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -74.5 56.76 0.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.503 1.921 . . . . 0.0 109.507 176.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.61 -179.06 42.28 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.72 174.04 5.55 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.116 0.484 . . . . 0.0 111.419 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -118.36 26.88 9.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 109.896 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -65.44 -42.16 92.69 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.18 173.37 20.53 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.74 -177.1 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.163 3.242 . . . . 0.0 112.227 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 20' ' ' ILE . 18.2 t-20 -100.71 104.96 16.26 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.5 14.04 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -71.1 81.6 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.261 1.391 . . . . 0.0 109.254 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 53.79 1.01 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.794 0.711 . . . . 0.0 114.175 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.13 -41.84 31.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 117.461 0.63 . . . . 0.0 109.711 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t -52.56 119.41 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 121.215 -0.928 . . . . 0.0 110.896 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 -18.88 56.69 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.879 1.228 . . . . 0.0 111.832 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -65.78 138.9 58.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.9 0.85 . . . . 0.0 111.074 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -71.66 70.82 0.7 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 0.0 111.058 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 58.08 -143.58 0.64 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.638 0.775 . . . . 0.0 109.938 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.3 83.35 0.13 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.54 1.067 . . . . 0.0 113.284 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.2 t -147.51 40.98 1.03 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.016 0.408 . . . . 0.0 111.9 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.97 128.89 58.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -55.97 155.29 23.81 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.374 1.383 . . . . 0.0 112.395 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 54.58 57.94 5.32 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 0.0 112.62 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -158.45 119.11 3.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.785 0.434 . . . . 0.0 110.001 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -79.15 86.72 4.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.387 0.675 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -68.17 -174.63 0.51 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.47 0.652 . . . . 0.0 110.967 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -114.75 172.74 6.85 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.991 1.316 . . . . 0.0 109.83 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.55 -41.92 86.68 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.958 1.303 . . . . 0.0 112.435 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 p -63.17 -65.42 0.69 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.286 1.435 . . . . 0.0 110.564 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.23 -35.01 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.638 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.82 -50.57 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.28 81.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.068 -0.395 . . . . 0.0 111.311 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -55.72 -50.76 69.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.3 -53.93 39.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.36 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.831 0.852 . . . . 0.0 112.742 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.8 p -68.63 -9.16 48.22 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.68 7.62 23.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.436 1.017 . . . . 0.0 112.805 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -68.44 138.25 55.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.744 1.272 . . . . 0.0 109.26 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.27 128.03 39.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 106.994 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -60.49 147.42 41.29 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -142.25 166.43 24.72 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.415 1.886 . . . . 0.0 106.207 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.48 -41.47 73.04 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.799 0.272 . . . . 0.0 110.48 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.62 -51.48 62.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.351 0.66 . . . . 0.0 110.595 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.13 -48.08 81.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.181 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mm -57.22 -55.6 19.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.72 -41.08 42.75 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.828 1.251 . . . . 0.0 111.19 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -71.52 -55.86 7.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.831 0.348 . . . . 0.0 110.224 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -50.68 -45.62 58.29 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.3 -33.58 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.95 2.98 53.86 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.423 0.689 . . . . 0.0 112.761 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -148.3 62.68 6.73 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.229 1.012 . . . . 0.0 112.428 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.16 140.69 93.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.171 1.914 . . . . 0.0 109.772 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.38 -64.7 1.03 Allowed Glycine 0 CA--C 1.533 1.18 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.0 -45.61 7.94 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.991 1.716 . . . . 0.0 111.346 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.0 -55.92 25.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.165 0.586 . . . . 0.0 110.938 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -57.95 -46.42 85.13 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.389 0.675 . . . . 0.0 110.693 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -53.81 -53.01 58.37 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -54.13 -57.36 11.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.221 0.608 . . . . 0.0 111.009 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.31 -54.54 39.15 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -88.87 -25.06 22.35 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -170.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 54.44 49.5 18.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.749 1.219 . . . . 0.0 110.036 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -117.42 128.57 55.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 108.761 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -51.37 -43.52 61.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.651 1.18 . . . . 0.0 111.057 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -91.13 27.09 1.96 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.79 65.46 1.03 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.599 0.714 . . . . 0.0 111.845 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -91.0 -177.94 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.785 2.034 . . . . 0.0 109.434 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 t -158.46 150.47 21.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.41 -26.18 71.66 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 16.4 ttp -65.32 82.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.36 58.36 4.06 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.206 -0.934 . . . . 0.0 109.201 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -165.89 151.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.404 1.482 . . . . 0.0 107.184 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -143.42 166.51 24.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.225 0.466 . . . . 0.0 110.205 170.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.11 115.97 28.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.75 52.81 2.0 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.594 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.93 169.8 17.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.345 1.458 . . . . 0.0 107.764 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.33 -17.89 68.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.382 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.53 1.99 73.13 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 118.157 0.978 . . . . 0.0 114.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -46.29 88.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.674 1.237 . . . . 0.0 111.194 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -55.08 -51.43 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.264 1.426 . . . . 0.0 110.72 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.89 -50.87 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.76 1.224 . . . . 0.0 110.247 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.72 -46.49 81.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.391 -0.193 . . . . 0.0 110.615 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.48 93.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.852 0.461 . . . . 0.0 110.17 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -59.33 -49.04 79.37 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.036 -0.415 . . . . 0.0 110.67 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.3 mt -60.02 -45.74 91.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.647 0.658 . . . . 0.0 110.758 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.22 79.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.387 0.275 . . . . 0.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.7 m -66.59 -40.66 89.01 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.123 -0.361 . . . . 0.0 111.321 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.1 -43.56 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.747 1.219 . . . . 0.0 112.675 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.86 78.69 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.481 0.658 . . . . 0.0 112.291 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.333 0 CA-C-O 116.04 -1.933 . . . . 0.0 108.767 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.592 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.06 93.32 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.785 -0.832 . . . . 0.0 109.005 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.39 34.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 112.808 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.83 -54.99 22.35 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.913 0.778 . . . . 0.0 109.695 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -56.69 -41.2 76.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 0.0 110.123 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.64 -49.56 57.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -54.97 -52.2 63.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.551 0.74 . . . . 0.0 110.041 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -57.67 -53.13 61.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.2 -26.11 62.41 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 126.478 1.911 . . . . 0.0 112.09 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -56.63 -18.97 13.93 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.184 0.447 . . . . 0.0 110.98 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -53.38 -32.9 51.6 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.657 -0.652 . . . . 0.0 111.134 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.73 -53.16 29.67 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -51.46 -45.01 62.58 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.308 1.043 . . . . 0.0 110.889 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -47.85 -30.54 4.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 113.061 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -52.59 -38.03 59.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.057 0.543 . . . . 0.0 110.978 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -112.61 -40.3 4.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.481 ' CG ' HD21 ' A' ' 37' ' ' LEU . 97.3 m-70 -100.55 -174.01 2.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.247 1.019 . . . . 0.0 113.233 -170.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -152.16 173.17 15.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.574 1.549 . . . . 0.0 109.025 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.95 131.41 52.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 tp -116.79 145.37 22.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.753 1.621 . . . . 0.0 109.536 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.19 160.01 76.76 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 119.432 1.015 . . . . 0.0 108.321 173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.99 -36.86 93.6 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.439 2.093 . . . . 0.0 110.214 172.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.13 -1.4 7.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.398 1.879 . . . . 0.0 113.135 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.22 -18.36 45.72 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 120.728 -1.232 . . . . 0.0 112.362 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -53.99 122.13 9.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.205 1.002 . . . . 0.0 110.906 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.86 78.74 1.14 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.326 0.65 . . . . 0.0 110.616 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.85 -60.47 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.01 98.75 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.09 63.23 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.735 1.214 . . . . 0.0 109.738 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.87 -156.77 32.98 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.88 6.7 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -124.68 33.84 5.14 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.53 -34.88 76.63 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.27 176.8 17.69 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 168.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.0 -171.07 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.676 2.917 . . . . 0.0 111.698 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -117.48 101.37 8.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -68.55 0.94 3.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.01 109.87 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.97 1.259 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.53 20.02 55.31 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.573 -0.571 . . . . 0.0 112.391 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.87 -37.82 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.354 1.077 . . . . 0.0 109.047 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.4 107.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.059 0.944 . . . . 0.0 110.428 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 -5.7 72.08 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 112.482 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -92.41 138.16 31.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.84 0.82 . . . . 0.0 110.367 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -56.41 127.21 29.95 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.937 1.295 . . . . 0.0 111.347 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.99 149.29 19.22 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.615 -0.678 . . . . 0.0 111.153 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.47 42.43 99.0 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.332 -1.26 . . . . 0.0 115.187 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.7 p -142.17 1.04 1.4 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.465 1.632 . . . . 0.0 114.846 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -69.19 134.71 89.27 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 120.445 1.475 . . . . 0.0 109.723 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.27 154.37 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.989 2.46 . . . . 0.0 115.685 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.27 60.8 3.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.078 1.751 . . . . 0.0 112.66 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -154.66 118.9 4.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.026 0.441 . . . . 0.0 110.837 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.29 80.28 1.84 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.99 0.916 . . . . 0.0 110.586 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -68.55 176.26 3.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.484 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -107.45 170.58 7.88 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.937 0.895 . . . . 0.0 109.942 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.1 -46.41 89.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.173 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 p -60.96 -65.39 0.7 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.845 1.258 . . . . 0.0 111.069 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.99 -42.88 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.095 0.958 . . . . 0.0 110.837 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -44.83 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.997 . . . . 0.0 110.032 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.4 82.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.705 0.684 . . . . 0.0 110.528 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.9 tp -57.85 -48.26 80.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.28 -56.29 17.88 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 123.887 0.756 . . . . 0.0 111.755 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.88 55.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.438 1.495 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 m -71.53 5.18 2.51 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.88 21.33 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.146 1.355 . . . . 0.0 111.242 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -82.54 77.9 9.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.788 -0.83 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 116.6 13.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -57.81 139.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -122.64 162.9 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.208 1.403 . . . . 0.0 107.385 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -54.2 -43.29 70.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -53.46 54.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.589 0.756 . . . . 0.0 110.407 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -60.48 -45.13 94.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.993 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.1 mt -58.0 -55.94 18.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.65 -40.17 62.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.868 0.867 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.7 m -68.04 -63.99 0.95 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.51 -51.87 2.87 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.094 1.757 . . . . 0.0 112.925 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.0 m -54.67 -33.59 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -72.39 -29.56 63.85 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.77 -0.581 . . . . 0.0 111.862 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -138.47 61.89 27.2 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -65.35 153.59 77.53 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 CA-C-N 120.086 1.066 . . . . 0.0 110.588 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.43 -66.65 2.62 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.07 -44.2 51.61 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.284 1.034 . . . . 0.0 111.243 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -51.95 -57.17 10.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.647 0.779 . . . . 0.0 110.106 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.511 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 5.3 mp -56.82 -54.21 49.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.857 0.463 . . . . 0.0 110.755 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -50.37 -42.4 53.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.04 0.536 . . . . 0.0 110.989 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.75 -66.35 0.57 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.354 0.662 . . . . 0.0 110.19 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -54.5 -43.38 71.79 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -88.85 1.07 55.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.703 1.201 . . . . 0.0 111.255 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t0 41.92 54.44 3.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.964 1.706 . . . . 0.0 110.967 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -147.91 122.06 9.53 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.631 0.772 . . . . 0.0 112.534 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -53.47 -45.23 69.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.626 1.57 . . . . 0.0 110.301 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -73.92 5.63 4.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 83' ' ' LEU . . . -82.08 72.15 9.13 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.377 -1.452 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -82.46 164.3 21.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.459 1.104 . . . . 0.0 108.827 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.4 t -142.02 149.45 40.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.29 -29.84 72.44 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 ttp -62.05 83.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.8 57.38 3.79 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -159.73 149.85 18.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -139.37 153.26 47.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.8 tp -113.37 107.81 16.37 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.08 66.72 3.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.918 0.887 . . . . 0.0 109.89 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 84.14 146.13 0.07 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 128.583 2.753 . . . . 0.0 109.988 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.77 -26.54 5.1 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.02 -40.76 10.18 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.401 1.476 . . . . 0.0 113.085 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.57 -48.9 79.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.717 0.758 . . . . 0.0 110.579 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -61.14 -48.33 82.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.211 1.004 . . . . 0.0 109.456 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.416 HG11 HMB1 ' A' ' 117' ' ' HEC . 57.6 t -62.41 -40.87 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.701 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.6 89.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.604 -0.685 . . . . 0.0 109.963 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.42 90.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.08 -53.23 59.54 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.1 mt -55.27 -47.81 74.95 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.117 0.417 . . . . 0.0 110.913 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.38 77.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.4 m -70.36 -40.58 73.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.032 -0.417 . . . . 0.0 110.674 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.23 -44.68 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.468 1.507 . . . . 0.0 112.698 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.86 94.64 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.744 0.783 . . . . 0.0 112.592 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.5 pttt . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.637 1.975 . . . . 0.0 109.661 173.482 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.416 HMB1 HG11 ' A' ' 107' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.079 0.266 . . . . 0.0 112.814 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.19 76.69 0.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.717 1.607 . . . . 0.0 111.044 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.11 10.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.432 1.093 . . . . 0.0 112.18 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.4 -54.17 49.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.535 0.734 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.03 -34.47 74.89 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.89 -56.24 24.95 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.31 -37.4 87.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.165 0.983 . . . . 0.0 111.357 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -60.96 -50.9 71.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.729 0.695 . . . . 0.0 109.737 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -57.2 -34.11 68.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.7 1.2 . . . . 0.0 110.273 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 19' ' ' ILE . 3.6 t80 -56.16 -21.73 24.59 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -55.38 -36.3 66.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.668 0.667 . . . . 0.0 110.278 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -69.82 -52.68 22.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.9 m -50.72 -40.8 55.29 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.378 1.071 . . . . 0.0 111.749 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -48.35 -30.93 5.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 112.31 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.6 m -59.32 -22.46 61.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.497 0.719 . . . . 0.0 111.505 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.4 m -124.84 -34.58 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.378 1.071 . . . . 0.0 112.771 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -110.21 170.33 8.15 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.581 1.152 . . . . 0.0 114.081 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.4 m -141.89 166.05 25.78 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.427 1.091 . . . . 0.0 110.295 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.457 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 2.3 mp -139.65 124.47 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 106.865 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.14 132.21 58.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.514 1.126 . . . . 0.0 110.175 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 154.01 71.74 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.58 -35.37 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.036 2.491 . . . . 0.0 112.097 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.81 -9.27 58.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.351 1.06 . . . . 0.0 113.144 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.31 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.999 -0.889 . . . . 0.0 113.404 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.7 m -62.39 108.28 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.489 1.644 . . . . 0.0 110.331 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.49 134.53 57.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.64 0.776 . . . . 0.0 110.659 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 mm -105.29 -50.34 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.08 96.47 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -84.21 70.17 10.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.94 -154.12 26.86 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.26 175.53 10.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -125.77 32.57 5.26 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.944 0.897 . . . . 0.0 109.232 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.3 m -64.73 -36.98 86.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.35 173.02 14.61 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.56 179.6 1.23 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.372 3.382 . . . . 0.0 113.91 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -92.34 103.85 16.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.261 1.024 . . . . 0.0 110.036 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.64 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -70.03 85.12 0.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.268 1.849 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.96 58.37 2.65 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.36 0.981 . . . . 0.0 113.265 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.37 -39.33 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 O-C-N 122.219 -0.577 . . . . 0.0 110.966 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.56 119.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.014 0.525 . . . . 0.0 110.504 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.08 -21.94 41.38 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.673 1.13 . . . . 0.0 111.602 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' NH1' ' H ' ' A' ' 44' ' ' THR . 3.9 tpm_? -68.26 138.24 55.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.441 1.12 . . . . 0.0 110.886 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.413 ' H ' ' NH1' ' A' ' 43' ' ' ARG . 2.7 m -65.02 72.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.434 1.894 . . . . 0.0 111.675 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.59 -145.25 0.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.461 -0.774 . . . . 0.0 109.431 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.04 78.25 1.26 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -138.7 14.62 2.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.591 0.756 . . . . 0.0 111.621 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -64.96 127.01 92.33 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.36 172.12 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.403 2.068 . . . . 0.0 115.779 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 46.01 57.47 5.16 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.256 1.822 . . . . 0.0 111.825 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -164.37 122.46 1.77 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.489 0.316 . . . . 0.0 110.761 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.26 95.32 4.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.057 0.943 . . . . 0.0 110.24 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.2 -178.69 5.21 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.353 0.661 . . . . 0.0 111.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.92 177.48 4.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.23 -35.23 75.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.021 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 p -63.29 -66.65 0.51 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.556 1.142 . . . . 0.0 110.627 -173.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tt -57.43 -37.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.123 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.7 -47.58 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.55 84.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.056 0.389 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.8 tp -55.41 -50.11 70.61 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.11 -54.86 29.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.95 -31.56 60.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.113 0.965 . . . . 0.0 112.225 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -72.03 3.07 4.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.14 29.38 10.4 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.142 0.877 . . . . 0.0 111.616 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -90.76 140.44 29.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -60.37 148.37 37.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 123.053 0.541 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.7 p -142.71 166.31 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -54.8 -41.06 70.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.72 -56.13 15.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.108 0.963 . . . . 0.0 109.719 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.03 -52.15 61.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.278 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.5 mt -56.87 -54.69 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.67 -40.32 53.31 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.054 0.942 . . . . 0.0 111.667 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -70.75 -60.95 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -43.49 -51.92 6.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.061 1.344 . . . . 0.0 113.602 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.6 m -51.28 -38.49 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -90.81 -8.49 49.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.23 55.17 3.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.878 0.871 . . . . 0.0 111.576 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.66 147.17 85.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.917 1.745 . . . . 0.0 109.868 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.36 -64.46 4.26 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.7 61.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.389 0.676 . . . . 0.0 109.993 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -48.52 -51.54 26.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.774 1.23 . . . . 0.0 111.338 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.49 -58.94 4.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -49.5 -38.91 32.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 111.615 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -53.42 -39.91 64.7 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.456 0.702 . . . . 0.0 111.842 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -97.21 -53.32 3.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.318 1.047 . . . . 0.0 111.741 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.7 tp -78.86 -22.92 45.33 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.776 1.23 . . . . 0.0 113.228 -175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t0 41.57 63.62 1.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.486 1.914 . . . . 0.0 113.216 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.43 145.29 45.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 108.282 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.38 -38.46 58.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.188 0.995 . . . . 0.0 110.842 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.21 21.71 13.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.0 0.92 . . . . 0.0 112.855 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.84 5.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -126.22 142.52 51.5 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.429 1.492 . . . . 0.0 108.636 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -94.37 150.08 20.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.965 0.906 . . . . 0.0 109.164 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -55.02 -27.03 43.93 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.974 -0.454 . . . . 0.0 111.994 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.2 ttp -59.64 86.5 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 113.343 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.39 57.93 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.91 155.79 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.537 1.935 . . . . 0.0 106.331 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -145.35 170.94 15.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.2 tp -97.23 166.48 11.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.55 37.88 4.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -143.93 170.79 15.25 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.661 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -12.97 35.28 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.707 -1.052 . . . . 0.0 113.35 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.04 -32.07 1.76 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 118.475 1.138 . . . . 0.0 114.638 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.23 -38.41 3.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 113.281 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -61.13 -49.21 78.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.674 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.424 HG11 HMB1 ' A' ' 117' ' ' HEC . 15.4 t -66.56 -41.72 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.39 90.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.699 0.4 . . . . 0.0 110.546 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.47 94.48 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.79 0.436 . . . . 0.0 109.932 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -55.9 -54.3 46.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.1 mt -57.32 -37.12 72.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.426 0.69 . . . . 0.0 111.716 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.4 89.06 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.457 -0.777 . . . . 0.0 109.146 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.4 t -59.73 -29.31 68.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.73 -0.606 . . . . 0.0 111.924 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.45 -29.35 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 O-C-N 121.845 -0.534 . . . . 0.0 110.749 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.44 91.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.501 1.12 . . . . 0.0 109.748 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm . . . . . 0 C--O 1.248 0.993 0 C-N-CA 126.199 1.8 . . . . 0.0 107.854 176.524 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.672 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.107 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.92 73.84 0.6 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.584 1.154 . . . . 0.0 111.707 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.98 -39.08 25.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.195 0.998 . . . . 0.0 111.949 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.43 82.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.391 0.676 . . . . 0.0 111.231 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.89 -41.72 77.9 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.88 -46.65 40.4 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.021 0.82 . . . . 0.0 111.94 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -52.52 -54.27 34.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.475 0.71 . . . . 0.0 110.527 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.47 -47.53 83.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.901 0.48 . . . . 0.0 110.159 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -53.86 -39.19 65.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.353 1.061 . . . . 0.0 109.849 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.16 -22.3 27.89 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.43 -31.29 54.99 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.646 -0.659 . . . . 0.0 110.048 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -71.33 -52.75 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 m -51.18 -43.0 61.22 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.656 1.182 . . . . 0.0 110.637 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -49.16 -25.88 2.46 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.131 1.772 . . . . 0.0 112.279 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -53.95 -42.58 69.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.211 1.368 . . . . 0.0 110.281 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.8 m -106.95 -42.22 4.97 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.743 0.817 . . . . 0.0 112.401 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -92.7 167.27 12.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.583 1.153 . . . . 0.0 112.885 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -140.15 147.21 39.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.32 124.98 73.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.86 133.99 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.332 1.853 . . . . 0.0 107.853 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.56 158.04 86.45 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.46 -38.7 74.78 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.943 2.429 . . . . 0.0 112.646 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -74.29 -10.54 59.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.164 1.385 . . . . 0.0 113.663 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.33 -18.65 32.84 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.83 -0.984 . . . . 0.0 113.63 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -57.18 118.71 5.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.698 . . . . 0.0 109.556 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.61 125.66 26.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.819 0.447 . . . . 0.0 110.405 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 mm -85.06 -52.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.0 m -146.57 136.12 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -113.36 135.55 53.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.72 -172.87 19.93 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 124.434 1.016 . . . . 0.0 110.977 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.02 44.89 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.596 -0.944 . . . . 0.0 109.611 175.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 tptp 15.94 57.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 130.28 3.432 . . . . 0.0 113.61 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.12 -32.16 14.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.3 167.85 12.46 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 174.05 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.421 3.414 . . . . 0.0 113.526 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.44 115.52 17.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.36 7.02 44.75 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -48.73 106.78 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.091 0.86 . . . . 0.0 111.58 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.03 42.96 95.26 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.12 -36.86 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 117.274 0.537 . . . . 0.0 111.565 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.5 116.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.57 -19.15 55.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.256 0.931 . . . . 0.0 111.802 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.05 148.09 32.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 117.731 0.765 . . . . 0.0 109.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 m -61.48 127.02 29.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.796 0.838 . . . . 0.0 109.931 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.88 154.8 41.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 111.758 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.52 27.1 63.04 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.023 -0.876 . . . . 0.0 114.749 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.8 t -155.32 20.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.676 1.238 . . . . 0.0 112.77 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.22 126.11 92.31 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.54 171.75 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 CA-C-N 121.099 1.428 . . . . 0.0 115.735 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 50.64 55.18 9.91 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.749 1.62 . . . . 0.0 111.404 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -166.04 123.4 1.42 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.169 -0.332 . . . . 0.0 111.377 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -83.42 99.64 10.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.498 1.119 . . . . 0.0 109.089 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -85.0 -170.39 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.856 0.862 . . . . 0.0 111.962 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.71 175.89 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.959 1.703 . . . . 0.0 109.552 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.93 -43.67 82.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.357 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 t -70.85 -47.93 56.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.091 0.472 . . . . 0.0 111.145 -173.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -67.02 -34.91 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.08 -45.56 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.79 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 111.406 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 mt -55.86 -49.16 74.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.41 39.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -37.29 74.31 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.274 1.029 . . . . 0.0 110.779 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 t -72.88 4.05 4.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.19 61.44 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 119.14 0.882 . . . . 0.0 111.934 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -71.99 108.28 5.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.984 0.892 . . . . 0.0 109.517 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.61 122.46 37.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.411 ' HE1' ' CGA' ' A' ' 117' ' ' HEC . 17.4 m95 -57.44 153.31 12.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p -133.77 169.8 16.51 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.554 1.141 . . . . 0.0 108.153 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -57.59 -46.42 84.04 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.665 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.1 -47.72 73.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.03 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.55 -49.73 76.65 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.87 -50.95 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 118.116 0.416 . . . . 0.0 110.106 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.38 -38.29 52.62 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.074 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -73.45 -58.29 3.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -44.68 -47.24 10.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.176 1.391 . . . . 0.0 113.74 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.44 -36.41 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 119.138 0.881 . . . . 0.0 113.308 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -100.14 2.26 42.88 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.842 0.857 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -142.35 56.52 5.46 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.408 1.483 . . . . 0.0 110.997 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.04 138.97 64.88 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.244 1.962 . . . . 0.0 109.436 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.1 -60.45 2.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.58 -45.47 9.48 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.692 1.597 . . . . 0.0 111.876 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.07 -44.74 96.02 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.151 -0.619 . . . . 0.0 111.663 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.92 -51.09 70.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.792 0.837 . . . . 0.0 109.012 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -52.56 -52.37 55.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.586 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -55.96 -53.36 57.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 111.12 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -66.92 -52.13 46.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.57 -18.54 48.01 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.7 t0 56.35 53.83 8.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.33 1.452 . . . . 0.0 109.275 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -134.27 128.41 33.77 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.615 1.166 . . . . 0.0 109.87 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.22 -37.2 79.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.525 1.13 . . . . 0.0 110.527 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -85.72 15.93 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.9 65.54 8.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.892 0.853 . . . . 0.0 110.439 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.37 108.25 19.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 109.666 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -63.11 156.4 25.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.75 -21.69 79.52 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.548 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 3.7 ttp -68.94 82.01 0.31 Allowed 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.725 -0.867 . . . . 0.0 112.755 -176.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.99 57.33 2.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.474 0.71 . . . . 0.0 109.479 174.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -163.13 148.19 11.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.808 1.643 . . . . 0.0 107.789 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -142.54 164.95 28.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.21 1.004 . . . . 0.0 109.589 173.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.32 115.56 26.15 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.25 55.05 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.89 0.476 . . . . 0.0 110.034 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -132.43 168.08 18.8 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 125.624 1.57 . . . . 0.0 108.721 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.06 -19.42 59.11 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.752 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.85 1.9 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.061 0.93 . . . . 0.0 113.703 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -41.11 -44.11 2.41 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.072 1.749 . . . . 0.0 113.832 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -62.14 -45.55 92.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.117 0.967 . . . . 0.0 110.986 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.32 -45.0 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.11 0.964 . . . . 0.0 108.897 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.02 91.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.346 0.658 . . . . 0.0 110.339 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.22 97.28 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.875 0.47 . . . . 0.0 110.01 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.86 -52.58 64.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.66 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -57.29 -42.36 81.54 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.011 -0.431 . . . . 0.0 111.117 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.48 -41.45 73.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.918 0.487 . . . . 0.0 110.174 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -63.19 -30.01 71.24 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.968 -0.457 . . . . 0.0 111.912 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.83 -29.97 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.063 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t -48.11 99.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 125.522 1.529 . . . . 0.0 112.72 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 C--O 1.251 1.145 0 C-N-CA 130.023 3.329 . . . . 0.0 104.161 174.528 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.548 ' CHD' ' HG3' ' A' ' 96' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.065 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -90.37 106.01 18.2 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.876 1.27 . . . . 0.0 108.777 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.7 -31.43 26.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.329 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.54 12.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.354 0.979 . . . . 0.0 110.248 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -56.28 -38.56 71.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.768 -0.583 . . . . 0.0 109.551 174.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.99 -51.1 52.13 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.67 -47.89 82.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.279 1.032 . . . . 0.0 110.279 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -57.25 -52.71 64.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.164 0.185 . . . . 0.0 110.677 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.93 -35.96 67.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.518 1.127 . . . . 0.0 110.211 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.437 ' CZ ' ' CBB' ' A' ' 117' ' ' HEC . 0.3 OUTLIER -57.52 -27.16 62.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.069 0.548 . . . . 0.0 112.134 178.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -30.47 63.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.383 0.538 . . . . 0.0 110.043 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -93.13 -50.26 5.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.036 0.934 . . . . 0.0 109.48 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -33.92 42.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -58.58 -14.81 9.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 114.347 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -56.09 -17.76 7.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.246 -0.909 . . . . 0.0 112.338 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.4 m -124.02 -27.27 3.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.966 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -117.81 165.9 13.11 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.922 0.783 . . . . 0.0 112.941 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -140.39 164.68 29.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.289 1.035 . . . . 0.0 111.629 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.18 121.87 24.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 125.661 1.584 . . . . 0.0 107.854 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -116.54 134.39 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.602 1.561 . . . . 0.0 108.169 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.66 160.24 77.92 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 119.114 0.87 . . . . 0.0 108.94 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.31 -40.95 69.11 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.108 2.538 . . . . 0.0 112.7 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -74.52 -8.28 55.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.145 1.378 . . . . 0.0 113.594 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.79 -18.85 42.81 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.963 -0.909 . . . . 0.0 113.394 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -60.51 117.64 5.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.6 1.7 . . . . 0.0 108.867 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -68.18 129.97 41.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.83 -46.09 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.2 93.48 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -77.0 90.67 3.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.81 -148.28 23.95 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.73 177.84 8.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -129.34 34.11 4.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.676 0.79 . . . . 0.0 109.558 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -64.18 -41.1 97.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.81 164.14 13.33 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.96 164.06 3.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.497 2.798 . . . . 0.0 115.276 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -72.89 121.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.83 6.41 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.95 115.82 3.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.545 1.066 . . . . 0.0 108.561 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.36 23.68 72.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.965 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG21 HMA3 ' A' ' 117' ' ' HEC . 9.3 p -61.61 -38.23 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 118.859 1.329 . . . . 0.0 109.553 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.15 103.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.86 -7.94 42.23 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.5 1.524 . . . . 0.0 112.205 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -72.6 142.79 48.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 117.971 0.885 . . . . 0.0 111.418 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -70.91 68.17 0.42 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.946 1.698 . . . . 0.0 113.508 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.74 -154.56 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 111.944 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.83 70.96 1.15 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 123.697 0.665 . . . . 0.0 112.777 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.8 p -137.93 23.16 2.84 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.381 0.672 . . . . 0.0 111.355 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.78 134.85 90.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.04 168.98 3.05 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.828 1.685 . . . . 0.0 114.846 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 42.46 56.47 3.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.609 1.964 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.9 118.53 2.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -79.7 109.16 13.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.891 0.876 . . . . 0.0 109.439 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -95.64 -172.26 2.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.573 0.749 . . . . 0.0 111.5 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.18 169.75 9.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.535 1.934 . . . . 0.0 107.682 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.97 -41.25 97.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.6 p -62.79 -60.62 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.665 1.586 . . . . 0.0 111.994 -171.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 tp -57.63 -27.98 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.278 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -76.17 -50.34 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.65 -38.05 53.08 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.431 1.093 . . . . 0.0 111.897 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.45 -50.48 69.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.0 0.818 . . . . 0.0 109.269 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.25 86.89 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.77 69.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.454 0.301 . . . . 0.0 111.112 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.2 t -74.36 1.04 12.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.943 0.897 . . . . 0.0 112.795 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.81 14.9 55.91 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 119.13 0.877 . . . . 0.0 112.973 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.44 156.56 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.415 1.107 . . . . 0.0 109.674 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.04 124.39 11.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.642 1.577 . . . . 0.0 107.121 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -59.82 150.66 27.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.1 p -137.0 166.45 23.64 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.526 1.53 . . . . 0.0 107.009 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -52.63 -49.79 64.43 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.718 0.807 . . . . 0.0 108.884 173.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.47 -61.04 2.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.135 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -54.54 -46.63 73.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.773 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -60.38 -53.67 45.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.96 -42.69 63.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.04 0.936 . . . . 0.0 110.335 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.9 m -66.72 -59.32 3.68 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -44.31 -50.44 9.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.694 1.598 . . . . 0.0 113.224 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -54.82 -35.35 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.113 0.87 . . . . 0.0 113.034 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -82.71 -18.9 39.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.748 -0.595 . . . . 0.0 112.141 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.34 56.39 7.34 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 124.456 1.102 . . . . 0.0 112.709 -172.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.63 143.44 87.2 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.161 1.241 . . . . 0.0 109.22 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.93 -60.98 4.61 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.82 -42.69 65.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.872 0.869 . . . . 0.0 110.479 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -50.37 -50.78 50.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 111.037 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -67.76 -52.88 32.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.218 0.607 . . . . 0.0 110.23 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -49.12 -33.67 12.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.334 0.653 . . . . 0.0 110.751 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.29 -64.18 1.08 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.177 0.591 . . . . 0.0 110.191 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.49 -56.21 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.33 -41.98 84.34 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.402 0.681 . . . . 0.0 110.929 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 55.15 65.97 1.35 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.088 1.355 . . . . 0.0 111.094 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -129.15 139.88 51.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.291 1.836 . . . . 0.0 107.807 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -50.51 -40.35 51.23 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.271 1.029 . . . . 0.0 110.502 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.46 37.42 2.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.76 0.824 . . . . 0.0 111.42 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.5 66.15 3.18 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.595 0.758 . . . . 0.0 110.557 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -113.72 178.68 4.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.346 1.058 . . . . 0.0 109.29 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 t -144.99 149.84 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -14.33 57.28 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.1 ttt -65.98 77.36 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.531 1.132 . . . . 0.0 113.174 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 58.2 3.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.902 0.881 . . . . 0.0 109.308 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -163.19 137.55 6.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.669 1.588 . . . . 0.0 107.65 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -122.65 160.18 26.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tp -103.04 139.57 38.41 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.89 57.5 1.11 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.807 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 79.99 154.23 0.13 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 126.618 1.967 . . . . 0.0 110.141 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.72 38.27 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.53 -35.38 44.79 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.708 1.147 . . . . 0.0 111.572 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.46 -48.11 82.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.482 0.713 . . . . 0.0 110.298 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.34 -48.25 82.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.933 0.893 . . . . 0.0 109.514 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.71 -42.79 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.84 0.456 . . . . 0.0 110.162 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.19 97.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.769 -0.582 . . . . 0.0 110.109 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.98 95.42 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -58.77 -48.58 80.75 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.848 -0.533 . . . . 0.0 110.049 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.92 -45.12 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.891 -0.506 . . . . 0.0 110.712 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -42.08 85.25 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.692 -0.63 . . . . 0.0 110.328 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -67.49 -30.13 69.74 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.768 -0.583 . . . . 0.0 111.671 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.75 -39.61 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.585 1.154 . . . . 0.0 111.651 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.66 80.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.64 0.733 . . . . 0.0 112.871 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 C-N-CA 126.274 1.83 . . . . 0.0 106.837 170.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.466 HBB2 HMB1 ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 N-CA-C 113.82 0.288 . . . . 0.0 113.82 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.54 91.28 2.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.7 11.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.789 0.836 . . . . 0.0 113.14 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.35 -49.36 67.19 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.799 0.727 . . . . 0.0 110.017 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.64 -35.58 76.55 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.72 46.17 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -54.55 -53.89 48.49 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.751 0.82 . . . . 0.0 109.657 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -52.02 -55.47 20.34 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -54.97 -40.33 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.524 1.129 . . . . 0.0 110.693 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -55.82 -25.74 43.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.324 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -58.98 -31.3 68.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 110.894 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -93.78 -49.22 5.94 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.188 0.595 . . . . 0.0 109.865 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.97 -34.23 41.43 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.929 0.892 . . . . 0.0 110.634 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -41.7 -40.27 1.92 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.679 2.392 . . . . 0.0 115.002 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.1 m -25.81 -48.73 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.198 2.199 . . . . 0.0 114.044 -171.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.61 -25.96 13.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.892 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -100.6 -172.0 2.12 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-O 121.467 0.651 . . . . 0.0 112.201 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 m -157.11 161.03 39.4 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.692 1.597 . . . . 0.0 108.645 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.98 122.71 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.891 1.676 . . . . 0.0 107.354 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.5 tp -106.25 131.53 55.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 C-N-CA 125.162 1.385 . . . . 0.0 108.607 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 160.21 82.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.35 -38.31 62.47 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.01 2.474 . . . . 0.0 112.785 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.8 -9.83 56.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.482 1.513 . . . . 0.0 114.099 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.47 57.71 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.174 0.897 . . . . 0.0 113.637 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 m -69.81 126.28 29.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.641 1.721 . . . . 0.0 108.991 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.02 96.62 5.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.81 0.844 . . . . 0.0 110.14 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.06 -48.25 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.7 126.46 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -124.91 82.09 2.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.237 1.815 . . . . 0.0 110.216 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.55 -168.18 40.14 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.09 43.26 0.85 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.885 -1.362 . . . . 0.0 111.771 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 13.45 59.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 129.84 3.256 . . . . 0.0 113.969 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -32.11 13.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.159 1.384 . . . . 0.0 109.086 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.48 162.14 12.55 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.9 140.01 77.25 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.375 3.384 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -55.25 119.87 6.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.72 -2.15 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -64.8 84.08 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.445 1.02 . . . . 0.0 111.718 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.61 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.23 1.395 . . . . 0.0 112.182 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG21 HMA3 ' A' ' 117' ' ' HEC . 7.6 p -62.91 -46.26 96.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-N 119.415 1.607 . . . . 0.0 109.523 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.25 118.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.341 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -29.79 10.85 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.741 1.638 . . . . 0.0 111.028 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -73.78 147.94 42.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.624 0.712 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.7 m -71.11 136.78 48.38 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.48 141.34 37.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.727 -0.608 . . . . 0.0 109.888 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.99 77.37 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.945 -1.475 . . . . 0.0 114.043 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 p -137.33 -0.56 2.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.879 1.839 . . . . 0.0 115.48 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -62.26 129.4 92.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 121.57 1.987 . . . . 0.0 107.641 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -44.62 154.53 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.662 2.908 . . . . 0.0 116.58 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 50.27 66.52 1.12 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.561 1.945 . . . . 0.0 113.631 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -163.41 122.84 2.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.98 0.419 . . . . 0.0 111.112 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.91 83.73 2.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.111 0.964 . . . . 0.0 109.821 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.09 178.16 1.96 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.918 0.487 . . . . 0.0 111.804 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -111.0 171.4 7.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.54 1.162 . . . . 0.0 110.767 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -53.91 15.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 111.986 -2.37 . . . . 0.0 113.013 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.3 m -62.23 -52.89 61.94 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.067 0.937 . . . . 0.0 111.579 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 tt -69.81 -38.84 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.456 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.69 -39.45 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.2 88.44 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.077 -0.389 . . . . 0.0 110.341 177.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.35 -49.81 76.39 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.43 -45.81 8.43 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.519 1.533 . . . . 0.0 112.695 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.3 -28.04 17.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.569 1.548 . . . . 0.0 113.695 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.4 p -73.63 2.74 7.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.118 0.872 . . . . 0.0 112.259 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.75 35.76 21.24 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -77.21 86.6 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.244 -0.562 . . . . 0.0 111.039 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.91 120.32 18.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.499 1.12 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -62.98 122.48 16.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.276 0.23 . . . . 0.0 110.419 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 p -100.31 159.1 15.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -54.65 -37.8 66.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.011 0.434 . . . . 0.0 110.357 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.76 -51.11 68.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.997 0.919 . . . . 0.0 110.171 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -59.71 -47.45 85.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.967 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.6 mt -55.07 -52.16 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.782 0.719 . . . . 0.0 109.284 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.87 65.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.452 0.701 . . . . 0.0 110.743 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -64.99 -54.37 31.57 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.835 0.454 . . . . 0.0 110.239 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -46.2 -52.06 13.09 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.701 1.6 . . . . 0.0 111.253 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -51.3 -28.61 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.669 0.788 . . . . 0.0 112.993 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -78.2 -26.67 47.6 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.711 0.687 . . . . 0.0 112.645 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -154.54 69.16 5.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.992 0.814 . . . . 0.0 111.889 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.11 145.95 97.28 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.198 1.932 . . . . 0.0 110.868 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.27 -59.99 4.79 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.05 70.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -47.89 -52.25 20.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.699 0.8 . . . . 0.0 111.377 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.8 mt -61.49 -56.87 15.31 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.409 1.084 . . . . 0.0 109.704 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.5 -38.76 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.591 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -72.36 -59.5 2.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.875 0.47 . . . . 0.0 109.739 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.03 -41.03 82.32 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.5 tp -86.2 -4.39 59.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.222 1.009 . . . . 0.0 111.876 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 t0 48.06 43.69 18.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.988 1.315 . . . . 0.0 110.366 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.24 107.92 12.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.005 1.322 . . . . 0.0 109.29 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 90' ' ' LYS . 13.4 mptt -57.14 -26.27 60.27 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 128.738 2.815 . . . . 0.0 111.752 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -104.85 15.51 27.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.835 0.854 . . . . 0.0 113.264 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.2 113.75 20.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -132.44 131.68 41.99 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.344 1.057 . . . . 0.0 111.151 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -85.02 156.2 21.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.96 -18.71 72.94 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 170.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.73 80.79 0.07 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.593 1.157 . . . . 0.0 113.089 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.72 57.8 2.61 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.057 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -160.84 139.33 9.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.8 1.64 . . . . 0.0 106.606 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -142.53 155.19 44.99 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.5 tp -150.2 111.28 4.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.066 0.947 . . . . 0.0 108.57 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.86 30.99 0.2 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.285 -0.884 . . . . 0.0 112.908 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -161.83 176.7 10.59 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 127.502 2.321 . . . . 0.0 106.1 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.87 -51.52 2.74 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.525 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.72 -56.52 0.12 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.71 2.1 . . . . 0.0 114.732 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -59.98 -51.67 68.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.616 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.25 -48.37 80.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 109.631 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.449 HG11 HMB1 ' A' ' 117' ' ' HEC . 55.1 t -61.63 -44.16 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.564 1.146 . . . . 0.0 110.601 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.57 -45.68 93.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.881 -0.512 . . . . 0.0 109.912 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.42 96.11 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -57.81 -52.81 63.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.216 0.606 . . . . 0.0 109.693 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.2 mt -54.17 -53.63 50.78 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.57 65.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.555 0.342 . . . . 0.0 111.443 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.8 m -64.63 -44.76 89.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.668 0.387 . . . . 0.0 111.556 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.96 -39.06 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.815 1.246 . . . . 0.0 111.522 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.5 t -65.85 94.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 125.516 1.527 . . . . 0.0 111.193 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm . . . . . 0 C--O 1.256 1.433 0 CA-C-O 115.449 -2.215 . . . . 0.0 107.303 172.817 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.53 HMA3 HG21 ' A' ' 40' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -82.04 99.51 9.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.09 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.062 0.945 . . . . 0.0 113.241 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.53 -48.56 66.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.251 0.932 . . . . 0.0 110.011 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -56.84 -42.48 79.74 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.37 -49.0 66.16 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.67 -51.15 70.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.59 0.695 . . . . 0.0 110.597 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -59.73 -46.85 87.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.515 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -61.29 -27.86 68.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.443 1.097 . . . . 0.0 110.742 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -57.75 -18.13 19.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 111.344 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -55.67 -28.68 56.82 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.427 1.012 . . . . 0.0 110.627 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -68.68 -54.25 17.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.453 -0.779 . . . . 0.0 109.002 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.41 -47.29 56.55 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.023 1.729 . . . . 0.0 109.93 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -47.41 -31.62 4.27 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.296 2.638 . . . . 0.0 112.92 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -53.33 -32.16 47.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.6 m -121.82 -37.01 2.92 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.911 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -101.14 -176.01 3.03 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.673 0.789 . . . . 0.0 112.212 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t -153.13 179.46 8.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.953 1.301 . . . . 0.0 109.788 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -143.49 115.12 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.919 2.488 . . . . 0.0 106.985 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 tp -102.22 148.52 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.667 1.587 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.01 158.09 87.64 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.01 -34.07 98.97 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.063 1.842 . . . . 0.0 111.264 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -75.14 -11.62 60.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.442 1.097 . . . . 0.0 113.324 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 -13.54 35.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.139 -0.812 . . . . 0.0 114.063 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -60.88 127.61 32.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.71 1.755 . . . . 0.0 110.404 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -70.75 82.96 0.63 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.624 0.769 . . . . 0.0 111.191 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.33 -59.99 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 C-N-CA 122.577 0.351 . . . . 0.0 110.07 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.54 -39.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.197 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 57.43 47.32 16.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.94 0.876 . . . . 0.0 109.855 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.91 -172.16 48.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.09 170.8 14.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 110.407 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -124.83 30.81 5.82 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.767 . . . . 0.0 109.385 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -69.92 -40.82 75.34 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.83 167.15 13.31 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 170.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.27 173.25 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.16 2.573 . . . . 0.0 114.337 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -84.68 121.77 28.14 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.64 -2.0 56.85 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.42 113.79 2.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.03 20.41 59.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.954 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.4 HG21 HMA3 ' A' ' 117' ' ' HEC . 2.3 p -62.66 -39.65 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 119.105 1.452 . . . . 0.0 108.935 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.37 106.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.543 0.737 . . . . 0.0 109.561 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.12 -17.37 31.97 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.833 1.682 . . . . 0.0 111.902 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -68.2 141.27 56.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.43 1.115 . . . . 0.0 111.217 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -71.88 74.31 0.87 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.907 1.283 . . . . 0.0 111.11 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB3' ' CA ' ' A' ' 61' ' ' GLY . . . 52.13 -144.81 0.58 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.889 0.876 . . . . 0.0 112.406 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.34 75.83 0.64 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 123.554 0.597 . . . . 0.0 113.064 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 p -130.24 5.66 4.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.582 1.153 . . . . 0.0 112.196 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 126.56 91.65 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.46 172.77 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.113 1.209 . . . . 0.0 113.274 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 47.0 46.89 16.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.16 1.384 . . . . 0.0 111.853 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -156.42 111.45 2.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.14 -0.35 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.08 89.1 5.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.634 0.773 . . . . 0.0 109.813 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -74.76 -174.81 2.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.594 0.711 . . . . 0.0 111.344 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.34 166.51 13.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.139 1.376 . . . . 0.0 108.675 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.55 -35.0 79.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.31 0.644 . . . . 0.0 112.498 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -58.19 -62.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.971 1.308 . . . . 0.0 111.256 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.56 -35.33 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.932 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -48.84 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.81 90.47 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.898 0.479 . . . . 0.0 110.319 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.59 -45.3 89.4 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.045 0.538 . . . . 0.0 109.735 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . -55.28 -53.19 42.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.6 67.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.329 0.651 . . . . 0.0 111.731 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -67.41 -14.89 63.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.053 0.541 . . . . 0.0 111.952 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.77 14.16 12.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.981 1.277 . . . . 0.0 112.793 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.78 118.29 15.52 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.87 1.335 . . . . 0.0 111.158 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.3 129.45 54.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -66.1 126.88 30.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 159.52 37.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 107.863 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -42.57 -51.77 5.02 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.212 1.405 . . . . 0.0 112.885 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.38 -47.45 85.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.262 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.63 -48.3 81.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.66 0.784 . . . . 0.0 109.647 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.85 -54.03 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.59 -38.21 59.6 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.316 1.046 . . . . 0.0 111.504 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -72.93 -60.23 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -46.73 -43.79 18.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.054 1.342 . . . . 0.0 114.055 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.8 m -52.91 -34.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 119.445 1.02 . . . . 0.0 113.575 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -101.74 -3.38 28.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.059 0.944 . . . . 0.0 111.563 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -133.68 54.54 12.96 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.665 1.586 . . . . 0.0 111.634 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.16 138.19 70.87 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.366 2.711 . . . . 0.0 108.761 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.68 -64.1 3.34 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -45.01 -48.53 11.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.019 1.327 . . . . 0.0 112.646 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.32 -43.71 96.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.088 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.03 -55.51 28.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -49.01 -44.54 41.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.789 1.235 . . . . 0.0 110.432 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -63.8 -68.51 0.34 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.626 0.771 . . . . 0.0 110.304 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -54.84 -40.93 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 -0.55 57.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.666 1.186 . . . . 0.0 111.487 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t0 43.84 53.25 6.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.529 1.531 . . . . 0.0 110.702 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.65 115.36 9.09 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.341 1.056 . . . . 0.0 111.526 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -57.45 -29.41 64.19 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.722 1.209 . . . . 0.0 111.943 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -92.66 11.66 25.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.01 76.84 5.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.522 -0.736 . . . . 0.0 111.734 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.28 152.89 21.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.453 0.701 . . . . 0.0 109.964 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -112.33 151.62 29.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.98 -21.41 61.29 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 170.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ttt -68.13 74.98 0.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 112.438 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.86 58.87 2.98 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 175.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.45 ' CD1' HMC2 ' A' ' 117' ' ' HEC . 4.6 t80 -168.7 146.79 4.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.797 1.639 . . . . 0.0 107.275 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.16 150.09 45.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.11 0.964 . . . . 0.0 108.399 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -111.92 106.37 15.05 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 44.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.159 -0.338 . . . . 0.0 111.633 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -177.41 -171.01 0.31 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.197 1.799 . . . . 0.0 107.444 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.27 -51.54 3.61 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.55 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.64 -75.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 C-N-CA 128.313 2.863 . . . . 0.0 115.952 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.23 -48.43 81.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.339 0.569 . . . . 0.0 112.472 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.79 -49.66 72.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.17 0.988 . . . . 0.0 109.447 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.49 -41.45 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.044 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.07 -48.84 79.84 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.912 -0.492 . . . . 0.0 110.117 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.32 80.91 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.57 -51.05 71.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.03 -36.57 68.15 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.101 0.56 . . . . 0.0 111.616 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.33 -52.3 48.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -53.99 -37.37 63.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.998 0.919 . . . . 0.0 112.593 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.98 -28.67 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.184 1.794 . . . . 0.0 111.961 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.89 83.53 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 118.434 0.561 . . . . 0.0 110.327 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm . . . . . 0 C--O 1.252 1.197 0 CA-C-O 114.45 -2.69 . . . . 0.0 106.233 177.196 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.684 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 N-CA-C 113.971 0.348 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -72.68 84.19 1.17 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.19 0.996 . . . . 0.0 109.517 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.45 -35.46 8.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.753 0.821 . . . . 0.0 112.859 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.21 69.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.61 0.641 . . . . 0.0 110.169 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -58.47 -40.96 84.12 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.06 -51.61 52.64 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.05 -50.94 71.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.936 0.894 . . . . 0.0 110.519 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -54.19 -54.03 45.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.01 -35.38 69.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.504 1.122 . . . . 0.0 110.87 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -58.52 -20.91 50.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -61.77 -23.25 66.06 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.647 -0.658 . . . . 0.0 111.027 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.04 -48.96 7.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 t -47.56 -38.55 14.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.321 1.848 . . . . 0.0 113.023 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -22.59 3.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.254 1.022 . . . . 0.0 113.304 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 m -58.76 -22.48 58.1 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -120.91 -34.27 3.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.885 0.874 . . . . 0.0 112.568 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -111.74 174.31 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.059 0.944 . . . . 0.0 113.544 -174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.5 t -145.41 161.75 38.94 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.599 0.76 . . . . 0.0 109.225 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -129.02 135.58 61.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.84 139.49 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.984 1.714 . . . . 0.0 108.946 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 161.08 79.42 Favored Pre-proline 0 C--O 1.232 0.159 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.71 -29.31 88.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.375 1.383 . . . . 0.0 109.434 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.23 -5.64 33.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.66 50.94 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.793 -1.192 . . . . 0.0 112.534 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -58.2 120.96 9.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.77 84.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.648 -0.658 . . . . 0.0 111.158 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.97 -66.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.45 80.44 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -69.69 56.14 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.291 1.436 . . . . 0.0 110.269 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.71 -170.34 46.95 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 164.7 26.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.356 0.598 . . . . 0.0 109.902 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -116.65 37.67 3.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -63.8 -39.48 94.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.51 167.81 12.41 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 171.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.0 151.57 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.755 2.97 . . . . 0.0 112.538 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.18 126.37 27.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.35 11.3 28.73 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.73 82.93 0.45 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.769 -1.207 . . . . 0.0 110.272 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.9 41.29 1.21 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.211 0.91 . . . . 0.0 113.23 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.3 -45.52 93.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -51.3 112.31 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.656 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 -18.17 57.95 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.585 1.088 . . . . 0.0 113.065 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.65 139.08 57.85 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.183 1.491 . . . . 0.0 110.425 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -67.38 72.82 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.265 1.426 . . . . 0.0 112.218 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.85 -148.12 0.49 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.62 -0.675 . . . . 0.0 109.88 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.45 1.1 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.5 p -136.39 10.98 3.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 0.0 111.204 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.26 133.33 94.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.09 155.74 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.026 2.484 . . . . 0.0 115.646 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 49.82 65.65 1.36 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.009 1.724 . . . . 0.0 113.603 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -162.04 123.45 2.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.62 89.44 2.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.965 0.906 . . . . 0.0 109.796 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -73.53 -172.03 1.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.836 0.827 . . . . 0.0 112.087 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.92 166.54 11.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.886 2.075 . . . . 0.0 107.358 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.96 -36.01 80.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.48 0.712 . . . . 0.0 112.18 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 -67.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.51 1.524 . . . . 0.0 110.976 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tp -54.2 -36.79 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.894 1.277 . . . . 0.0 110.935 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.88 -51.0 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.381 0.672 . . . . 0.0 109.38 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.82 69.34 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.903 0.481 . . . . 0.0 110.775 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.32 -48.83 75.92 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.21 70.07 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.37 53.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.067 0.547 . . . . 0.0 111.269 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -75.52 13.03 0.84 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.97 27.74 52.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.167 0.889 . . . . 0.0 112.752 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -88.75 123.2 32.94 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.755 0.777 . . . . 0.0 109.692 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.1 131.31 55.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -64.32 93.35 0.09 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.022 0.374 . . . . 0.0 111.659 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.8 p -79.92 168.71 18.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -57.71 -41.05 80.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.829 -0.545 . . . . 0.0 109.87 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.15 -49.36 72.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.317 1.047 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -58.13 -51.76 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.1 mt -54.77 -54.57 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.63 67.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.799 0.44 . . . . 0.0 111.321 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 m -67.95 -44.07 77.61 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.281 -0.262 . . . . 0.0 110.995 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -54.84 -44.37 73.87 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.317 -0.865 . . . . 0.0 111.062 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.15 -26.88 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.832 0.453 . . . . 0.0 111.475 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -89.23 -33.54 16.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.868 0.867 . . . . 0.0 111.577 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -137.59 67.34 51.64 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.65 144.67 97.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.956 1.771 . . . . 0.0 110.585 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.68 -63.37 4.01 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.61 67.36 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.552 0.741 . . . . 0.0 110.77 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.34 -40.44 90.68 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.642 0.258 . . . . 0.0 111.673 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.14 -60.29 3.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -41.82 -50.22 4.38 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.379 1.472 . . . . 0.0 110.995 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -39.88 -52.17 2.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.095 1.358 . . . . 0.0 112.128 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -89.6 -52.78 4.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.973 0.909 . . . . 0.0 112.322 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.7 tp -73.09 -21.74 60.7 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -172.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t0 45.2 46.3 9.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.771 2.029 . . . . 0.0 111.894 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.07 129.91 52.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -31.21 71.04 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 126.182 1.793 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -88.26 17.31 5.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 0.0 111.719 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.95 64.93 6.86 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.442 -1.411 . . . . 0.0 110.246 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -103.55 -176.73 3.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.412 1.485 . . . . 0.0 108.619 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.71 150.94 38.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.83 -18.74 57.51 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 ttt -65.0 81.2 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.572 1.149 . . . . 0.0 113.635 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.8 3.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.531 0.732 . . . . 0.0 109.343 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.531 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 43.6 t80 -161.73 142.15 10.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.739 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -152.41 175.1 13.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.428 1.091 . . . . 0.0 108.814 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -158.38 122.07 3.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.86 50.19 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.692 0.797 . . . . 0.0 111.443 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? 166.03 -174.1 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 129.6 3.16 . . . . 0.0 105.528 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.95 -54.29 4.44 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 111.534 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -36.17 -50.08 1.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.592 1.568 . . . . 0.0 113.342 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -55.11 -60.63 3.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.503 1.121 . . . . 0.0 112.348 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.34 -41.23 98.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.383 0.673 . . . . 0.0 111.066 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.505 HG11 HMB1 ' A' ' 117' ' ' HEC . 65.8 t -59.59 -42.09 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.02 79.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.936 0.789 . . . . 0.0 110.147 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.31 86.21 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.384 -0.198 . . . . 0.0 110.499 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.44 -55.11 35.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.71 -40.12 68.89 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.376 0.67 . . . . 0.0 111.649 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.59 7.01 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.694 0.679 . . . . 0.0 109.871 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.8 p -56.24 -32.81 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.1 -32.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 111.595 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.86 83.62 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 C--O 1.249 1.052 0 C-N-CA 127.409 2.284 . . . . 0.0 106.953 178.38 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.802 HMB1 HBB3 ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -86.55 103.21 14.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.91 -33.2 4.36 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 112.762 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.16 71.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.181 0.9 . . . . 0.0 110.167 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -38.72 90.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.81 -49.81 71.1 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -54.5 -53.44 54.29 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.673 0.789 . . . . 0.0 109.441 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -58.0 -49.06 78.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.649 0.261 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.25 -31.13 67.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.576 1.15 . . . . 0.0 110.92 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.47 -18.17 17.17 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.072 -0.392 . . . . 0.0 111.849 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -52.18 -29.15 20.97 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.384 0.674 . . . . 0.0 110.735 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.67 -55.86 5.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.8 m -48.69 -43.73 37.3 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.19 1.396 . . . . 0.0 112.415 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -52.73 -25.35 10.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 113.157 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 -25.77 59.95 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.866 -0.521 . . . . 0.0 110.745 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.03 -45.14 2.38 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.238 0.615 . . . . 0.0 110.81 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -91.8 -176.85 4.58 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -151.73 167.77 27.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.303 1.841 . . . . 0.0 110.139 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.3 mm -136.3 117.7 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.768 1.627 . . . . 0.0 108.043 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tp -115.72 126.97 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.159 1.384 . . . . 0.0 109.045 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 163.95 29.5 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.221 -0.924 . . . . 0.0 108.685 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.58 -36.92 98.34 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.446 2.097 . . . . 0.0 110.323 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.01 3.55 6.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.685 1.594 . . . . 0.0 113.119 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.88 90.53 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.688 -1.257 . . . . 0.0 112.7 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -71.44 114.12 9.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.6 1.2 . . . . 0.0 109.171 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.15 104.02 1.09 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.795 -0.566 . . . . 0.0 109.815 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.9 mm -76.21 -47.44 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.98 96.74 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 58.66 1.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.485 1.514 . . . . 0.0 108.216 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.44 -158.91 27.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 175.97 10.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -124.58 30.48 5.97 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -38.43 83.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.52 171.56 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -63.74 174.62 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.265 3.31 . . . . 0.0 112.387 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -87.24 121.2 29.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.6 mt -86.61 1.33 52.19 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.34 99.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.35 0.977 . . . . 0.0 109.616 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.97 33.16 21.81 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 119.085 -0.841 . . . . 0.0 113.32 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.75 -31.04 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.753 1.276 . . . . 0.0 108.69 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.44 113.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.198 0.999 . . . . 0.0 110.461 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.16 -10.26 75.42 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.177 1.37 . . . . 0.0 112.749 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.95 144.64 29.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.158 0.979 . . . . 0.0 110.005 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 m -63.86 134.1 54.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.31 141.45 54.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.659 -0.651 . . . . 0.0 110.613 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.61 33.78 81.97 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.968 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.2 p -132.03 -0.77 3.74 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.897 1.348 . . . . 0.0 114.151 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -64.56 126.72 91.31 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 120.342 1.428 . . . . 0.0 107.153 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.76 161.32 18.54 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.402 2.068 . . . . 0.0 113.327 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 56.27 55.08 7.01 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.411 1.485 . . . . 0.0 112.282 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -162.55 120.18 2.07 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.151 -0.343 . . . . 0.0 110.576 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -79.15 98.45 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.254 1.022 . . . . 0.0 110.246 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.99 -171.69 3.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.8 0.809 . . . . 0.0 111.553 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -105.28 157.91 16.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 109.279 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.53 -34.39 72.58 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.419 0.687 . . . . 0.0 112.43 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.8 p -63.95 -64.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.751 1.22 . . . . 0.0 109.779 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.2 tt -58.2 -37.22 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.624 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.55 -49.9 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.83 88.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.436 0.562 . . . . 0.0 110.802 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 tp -56.33 -47.34 78.94 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.1 -56.29 21.92 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.232 0.92 . . . . 0.0 111.012 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -31.22 61.74 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.265 1.426 . . . . 0.0 111.807 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 m -69.05 -0.63 6.01 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.57 27.77 8.89 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.374 1.464 . . . . 0.0 111.477 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -84.45 96.76 9.2 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 117.978 0.889 . . . . 0.0 111.18 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.62 127.44 35.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -67.35 103.98 1.41 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.977 0.353 . . . . 0.0 111.615 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.5 p -84.45 162.09 20.07 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -57.61 -37.11 72.7 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.738 0.415 . . . . 0.0 110.332 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -63.69 -55.42 23.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.76 -50.27 68.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.48 -54.52 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.05 -41.12 71.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.334 0.653 . . . . 0.0 111.842 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.8 m -69.76 -56.08 8.14 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -43.3 -51.93 6.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.714 1.606 . . . . 0.0 113.461 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.6 m -53.41 -30.98 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.81 -23.9 63.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.797 -0.621 . . . . 0.0 112.07 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -160.95 68.04 2.5 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 119.086 0.857 . . . . 0.0 112.56 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.58 151.79 81.35 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 120.979 1.12 . . . . 0.0 109.412 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.83 -61.09 4.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.15 78.88 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.282 -0.54 . . . . 0.0 109.673 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -51.52 -56.36 13.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.124 0.97 . . . . 0.0 110.523 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 mp -57.64 -48.66 78.85 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.167 0.587 . . . . 0.0 110.901 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -54.87 -51.27 66.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.154 0.433 . . . . 0.0 110.291 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -54.48 -51.9 63.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.856 0.863 . . . . 0.0 111.015 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -72.87 -49.66 28.64 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 tp -77.91 -24.2 48.42 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.511 1.125 . . . . 0.0 113.46 -174.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.09 50.64 16.14 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.564 1.546 . . . . 0.0 110.048 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -135.29 130.02 34.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.448 1.499 . . . . 0.0 109.514 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -58.52 -35.25 71.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.291 0.636 . . . . 0.0 110.53 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -84.47 15.67 3.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.22 66.18 4.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.639 0.775 . . . . 0.0 110.992 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -94.32 -179.71 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.118 1.367 . . . . 0.0 110.27 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -155.83 157.64 36.77 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.92 -11.95 84.9 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 172.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.3 ttt -69.35 77.22 0.38 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 118.787 1.293 . . . . 0.0 113.144 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.51 58.17 3.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.28 1.032 . . . . 0.0 109.606 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.548 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 27.0 t80 -162.94 139.69 7.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -138.82 160.53 39.48 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -157.19 107.1 2.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.48 43.8 0.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.517 0.727 . . . . 0.0 112.242 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -177.52 -177.99 0.72 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.006 1.723 . . . . 0.0 107.243 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.32 -50.22 2.75 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.604 -0.553 . . . . 0.0 113.367 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -28.1 -51.65 0.1 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 127.319 2.39 . . . . 0.0 115.329 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 2.1 pm0 -61.22 -48.56 80.95 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.796 0.798 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.52 -46.7 84.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.86 0.864 . . . . 0.0 109.152 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.605 HG11 HMB1 ' A' ' 117' ' ' HEC . 93.7 t -59.49 -43.41 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.517 0.727 . . . . 0.0 110.329 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.86 92.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.864 -0.523 . . . . 0.0 109.603 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.31 91.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.527 0.203 . . . . 0.0 110.458 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.8 -52.99 62.9 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.928 0.491 . . . . 0.0 110.058 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.8 mt -57.11 -45.53 83.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.059 0.391 . . . . 0.0 110.776 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.28 81.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.237 0.615 . . . . 0.0 110.8 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.2 m -68.92 -42.37 76.9 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.029 -0.42 . . . . 0.0 110.691 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.26 -44.17 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.141 1.377 . . . . 0.0 112.247 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.05 82.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.8 pttm . . . . . 0 C--O 1.25 1.107 0 CA-C-O 115.99 -1.957 . . . . 0.0 108.974 172.666 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.605 HMB1 HG11 ' A' ' 107' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.46 115.17 27.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.32 1.448 . . . . 0.0 108.765 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.13 -33.78 53.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.511 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.97 -53.5 38.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.541 1.064 . . . . 0.0 110.06 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -54.77 -41.55 70.65 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.72 -50.72 56.75 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -56.17 -49.58 73.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.403 0.681 . . . . 0.0 109.268 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.2 -50.28 74.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.477 0.18 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -58.18 -32.45 68.24 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 124.953 1.301 . . . . 0.0 110.634 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -58.95 -21.26 57.98 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -21.55 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.829 -0.544 . . . . 0.0 110.284 174.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -86.71 -49.43 7.48 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.286 -0.884 . . . . 0.0 109.157 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.9 m -51.2 -40.17 58.1 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.478 1.111 . . . . 0.0 111.912 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.11 -21.45 4.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 113.254 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -56.81 -23.74 45.9 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.536 -0.728 . . . . 0.0 110.409 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m -125.54 -49.62 1.65 Allowed 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 122.984 0.513 . . . . 0.0 109.844 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.17 -174.78 4.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.194 0.997 . . . . 0.0 113.49 -172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 m -158.69 164.9 35.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.468 1.907 . . . . 0.0 108.737 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.9 mm -136.9 119.57 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.913 1.685 . . . . 0.0 107.23 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.98 132.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.201 0.6 . . . . 0.0 110.753 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.21 152.84 83.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.95 -34.05 90.84 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.96 2.44 . . . . 0.0 112.103 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.59 -9.11 57.72 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.406 1.082 . . . . 0.0 113.346 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.17 -14.07 44.2 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.837 -0.979 . . . . 0.0 113.576 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -60.06 112.27 1.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.651 1.725 . . . . 0.0 109.908 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.23 121.41 16.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.012 0.925 . . . . 0.0 109.794 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.08 -45.77 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.61 100.61 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -88.11 72.13 9.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.39 -178.67 45.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.87 68.95 7.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.78 -0.835 . . . . 0.0 109.081 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -35.47 62.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 1 C-N-CA 133.541 4.737 . . . . 0.0 115.934 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -96.17 -30.16 13.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.842 2.057 . . . . 0.0 108.586 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.8 169.66 13.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.54 163.71 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.945 3.097 . . . . 0.0 114.04 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -85.14 117.43 24.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.6 0.95 44.54 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.13 106.36 0.6 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.01 15.09 49.99 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.406 -1.219 . . . . 0.0 113.604 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.17 -38.67 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.938 1.869 . . . . 0.0 110.184 176.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.86 112.22 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -20.73 49.05 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.077 1.322 . . . . 0.0 112.024 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -72.96 140.54 47.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.045 0.923 . . . . 0.0 109.918 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 m -64.2 121.95 15.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.49 150.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.252 0.549 . . . . 0.0 111.789 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.73 13.16 60.77 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.09 -1.395 . . . . 0.0 113.753 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -142.44 35.27 1.48 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.679 1.74 . . . . 0.0 113.67 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -80.58 135.06 53.34 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 165.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -57.63 155.94 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.314 1.343 . . . . 0.0 113.144 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 55.86 64.14 1.82 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.898 1.679 . . . . 0.0 113.852 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -163.59 123.67 2.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.76 -0.587 . . . . 0.0 110.974 172.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -77.0 77.48 3.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.197 0.999 . . . . 0.0 110.149 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -69.31 -172.66 0.46 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.308 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -113.89 160.56 18.64 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.804 1.641 . . . . 0.0 110.857 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.57 -38.67 60.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.559 1.144 . . . . 0.0 113.525 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -65.91 -55.6 16.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.595 0.712 . . . . 0.0 110.67 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 tt -66.68 -35.26 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.75 -49.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.92 88.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.868 0.467 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.6 tp -56.15 -46.43 79.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.35 -55.66 25.56 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.29 0.948 . . . . 0.0 110.91 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.01 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.569 1.148 . . . . 0.0 111.497 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 m -72.67 6.48 2.45 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.43 25.42 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.196 1.379 . . . . 0.0 112.091 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -80.99 78.83 7.77 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.658 -0.907 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.55 116.8 14.55 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -59.58 121.2 11.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.0 p -99.87 164.97 11.79 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -55.91 -46.45 78.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.909 0.862 . . . . 0.0 109.639 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -58.83 -52.47 65.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.16 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -60.47 -46.76 88.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.57 -53.24 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.82 -37.99 64.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.178 0.991 . . . . 0.0 111.484 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 m -72.74 -58.91 2.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -43.98 -47.98 8.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.899 1.679 . . . . 0.0 113.245 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 m -51.93 -34.42 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -75.09 -25.05 58.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.0 112.095 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -145.63 61.79 7.93 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.892 0.877 . . . . 0.0 113.043 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.18 148.09 93.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.668 1.578 . . . . 0.0 109.446 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.96 -65.64 3.22 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.2 62.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.773 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -51.61 -54.48 27.29 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.656 0.782 . . . . 0.0 110.471 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 mp -60.34 -49.27 78.26 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 122.969 0.508 . . . . 0.0 111.174 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.35 -46.27 66.04 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.954 0.343 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.16 -65.94 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.25 0.62 . . . . 0.0 110.345 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -56.38 -41.24 75.92 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.7 -6.63 59.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.721 0.808 . . . . 0.0 111.581 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 48.28 52.87 12.73 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.291 1.436 . . . . 0.0 109.604 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -143.72 155.74 44.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.998 0.919 . . . . 0.0 110.801 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -91.44 -41.3 10.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.945 1.698 . . . . 0.0 108.619 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.03 39.7 0.51 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.857 0.863 . . . . 0.0 111.99 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.26 111.44 22.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.537 0.735 . . . . 0.0 109.412 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -124.46 -176.04 3.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.862 0.865 . . . . 0.0 112.066 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -159.75 147.05 16.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.37 64.15 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.6 ttt -66.98 79.84 0.12 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 118.452 1.126 . . . . 0.0 113.651 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.02 57.49 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.655 0.782 . . . . 0.0 109.438 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 36.7 t80 -165.22 125.92 1.94 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.648 1.179 . . . . 0.0 108.565 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -115.47 159.9 20.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.29 103.74 3.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.92 44.44 0.55 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.191 0.596 . . . . 0.0 111.413 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -174.85 -176.57 1.01 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.814 1.646 . . . . 0.0 107.581 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.15 -52.93 3.41 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.272 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -11.75 -72.07 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 128.525 2.965 . . . . 0.0 116.045 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.5 -45.97 90.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.126 0.963 . . . . 0.0 112.412 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.49 -49.7 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 109.116 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.623 HG11 HMB1 ' A' ' 117' ' ' HEC . 96.5 t -59.69 -43.04 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.423 0.689 . . . . 0.0 109.945 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.39 93.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.998 -0.439 . . . . 0.0 110.102 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.77 93.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.041 0.382 . . . . 0.0 110.418 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -57.08 -53.1 61.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.95 -41.54 83.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.115 -0.366 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.58 85.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.638 0.775 . . . . 0.0 110.585 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -69.58 -41.04 76.35 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.039 -0.413 . . . . 0.0 110.343 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.52 -38.12 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.732 1.213 . . . . 0.0 112.425 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.42 85.07 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.238 0.926 . . . . 0.0 111.672 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.9 pttp . . . . . 0 C--O 1.254 1.329 0 CA-C-O 115.474 -2.203 . . . . 0.0 108.118 176.038 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HEC . . . . . 0.623 HMB1 HG11 ' A' ' 107' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.099 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.98 85.07 2.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.943 -0.74 . . . . 0.0 110.21 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.33 -35.88 40.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.739 0.816 . . . . 0.0 112.496 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.02 65.54 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.78 -0.575 . . . . 0.0 110.067 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -57.84 -41.53 82.51 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.82 -48.07 68.45 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -57.06 -50.37 72.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.285 0.543 . . . . 0.0 110.585 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -59.37 -51.04 71.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.234 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -56.07 -31.49 63.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.398 1.879 . . . . 0.0 110.621 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.88 -19.73 7.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.586 0.754 . . . . 0.0 112.125 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -51.0 -34.35 28.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.454 0.57 . . . . 0.0 110.667 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -77.7 -49.23 14.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -48.3 -49.09 35.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.307 1.043 . . . . 0.0 110.654 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.82 -11.5 27.72 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.6 m -56.63 -33.63 66.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.7 m -113.99 -39.64 3.9 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.437 0.695 . . . . 0.0 110.341 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -95.47 -172.42 2.63 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -159.96 172.83 16.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.984 2.113 . . . . 0.0 107.648 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -132.67 132.43 59.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 tp -116.32 143.9 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.853 1.661 . . . . 0.0 109.164 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.37 159.11 82.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.27 -42.44 47.35 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.138 2.559 . . . . 0.0 112.863 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -73.0 -11.91 60.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.311 1.444 . . . . 0.0 113.671 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -14.32 34.57 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.977 -0.901 . . . . 0.0 113.682 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.7 m -57.77 125.63 23.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.532 1.666 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.21 82.16 1.0 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 110.724 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.1 mm -57.7 -61.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.43 98.32 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.8 67.83 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.051 0.94 . . . . 0.0 109.188 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.22 -162.99 28.53 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.53 176.43 9.05 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -130.49 33.07 4.33 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -71.06 -35.9 72.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.745 1.218 . . . . 0.0 108.191 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.88 161.86 12.61 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 174.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.44 125.54 18.23 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.848 3.032 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.16 114.86 1.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 108.759 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.6 mt -72.19 -16.44 61.96 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -168.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -52.97 120.39 5.78 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.732 1.151 . . . . 0.0 108.946 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.6 12.31 72.65 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.809 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.44 -42.34 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.31 1.555 . . . . 0.0 109.544 174.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.73 118.09 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.195 0.598 . . . . 0.0 110.612 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.96 57.2 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.167 0.889 . . . . 0.0 112.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -70.7 148.69 47.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.059 1.429 . . . . 0.0 110.482 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -76.09 59.48 1.33 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.815 1.246 . . . . 0.0 110.424 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 36.57 -123.54 0.17 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.164 1.786 . . . . 0.0 113.465 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.67 73.16 0.0 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.017 1.77 . . . . 0.0 115.298 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.1 t -160.18 9.13 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.31 1.055 . . . . 0.0 113.433 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -64.24 134.53 95.99 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 120.979 -1.076 . . . . 0.0 108.63 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -64.32 157.22 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.416 1.41 . . . . 0.0 111.31 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 47.68 58.46 4.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.149 1.38 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -154.83 119.98 4.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.148 0.499 . . . . 0.0 109.873 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -73.1 77.25 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.475 1.11 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.83 -176.93 1.17 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 110.515 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -113.25 173.71 6.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.158 0.983 . . . . 0.0 108.799 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.25 -41.64 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.202 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 p -60.22 -64.88 0.79 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.975 1.31 . . . . 0.0 111.719 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -38.82 75.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.121 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.54 -49.28 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.16 91.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.571 0.349 . . . . 0.0 111.005 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.7 tp -55.96 -52.58 63.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.37 -54.63 28.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.68 48.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.53 1.132 . . . . 0.0 112.585 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -71.15 2.12 5.0 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.92 34.07 8.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.663 1.125 . . . . 0.0 110.923 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -97.54 117.4 31.73 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.206 0.503 . . . . 0.0 109.849 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.11 137.92 45.26 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.632 1.173 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -73.79 95.77 2.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.587 0.355 . . . . 0.0 111.915 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 p -78.77 167.55 21.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -55.97 -43.63 77.73 Favored 'General case' 0 N--CA 1.459 -0.017 0 CA-C-O 121.923 0.868 . . . . 0.0 109.893 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.58 -51.75 67.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.059 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.42 -49.38 78.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.361 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.98 -52.91 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.83 -42.0 75.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.078 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.5 m -67.26 -51.48 52.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.243 0.217 . . . . 0.0 110.54 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -43.62 -56.36 3.77 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 125.266 1.427 . . . . 0.0 112.9 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 m -52.35 -30.18 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -73.12 -28.68 62.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.005 0.522 . . . . 0.0 112.008 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -151.95 62.63 4.82 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 124.432 1.093 . . . . 0.0 111.215 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.78 159.14 53.61 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.53 -63.83 3.64 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.53 67.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.198 0.999 . . . . 0.0 110.464 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -52.41 -48.27 65.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.089 0.556 . . . . 0.0 110.554 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.63 -59.31 5.39 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -45.3 -48.39 13.03 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.633 1.173 . . . . 0.0 110.727 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.37 -70.46 0.17 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.303 1.041 . . . . 0.0 110.712 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -63.15 -31.53 72.69 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -171.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.48 -7.42 59.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.396 0.679 . . . . 0.0 111.256 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.24 54.37 10.38 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 109.286 -175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -138.62 152.16 47.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.588 1.155 . . . . 0.0 109.776 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -48.63 6.86 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.779 1.632 . . . . 0.0 108.13 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -80.96 30.18 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.07 67.27 8.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.277 -0.889 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.83 154.68 40.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.964 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -123.17 149.82 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.4 -26.25 74.45 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 15.5 ttp -68.48 80.78 0.26 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.642 0.721 . . . . 0.0 112.146 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 57.94 3.12 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.48 146.89 13.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -143.1 160.7 39.91 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.3 tp -161.05 112.49 1.82 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.2 33.92 0.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.662 -0.649 . . . . 0.0 112.56 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -159.49 179.54 8.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.202 2.201 . . . . 0.0 106.848 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.46 -55.13 4.39 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.05 -57.15 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 126.209 1.861 . . . . 0.0 114.075 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 3.6 pm0 -52.75 -58.2 7.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.038 1.335 . . . . 0.0 113.004 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.92 -40.51 79.03 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.781 -0.574 . . . . 0.0 111.019 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.97 -41.11 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.928 -0.483 . . . . 0.0 110.418 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.04 -46.64 87.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.754 -0.591 . . . . 0.0 109.749 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.18 -43.78 95.6 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.85 -49.22 77.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.37 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 mt -57.87 -45.54 86.19 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.222 0.465 . . . . 0.0 110.593 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.71 79.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.826 0.451 . . . . 0.0 110.642 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -70.15 -39.61 75.24 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.135 -0.353 . . . . 0.0 110.866 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.92 -38.93 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.677 1.591 . . . . 0.0 112.596 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.54 0.566 0 CA-C-N 119.499 1.045 . . . . 0.0 110.574 -179.493 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 CA-C-O 121.115 0.286 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -81.71 88.84 6.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.199 1.0 . . . . 0.0 108.853 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.53 -42.51 2.42 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.807 1.243 . . . . 0.0 112.978 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.59 73.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.597 0.759 . . . . 0.0 111.467 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -69.42 -37.21 77.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -51.47 -43.03 52.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.421 1.01 . . . . 0.0 111.228 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -52.5 -46.94 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.459 0.704 . . . . 0.0 110.848 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.96 -46.47 65.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.518 0.727 . . . . 0.0 109.567 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.21 -35.5 67.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.097 0.959 . . . . 0.0 110.579 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -56.91 -16.95 7.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.128 0.971 . . . . 0.0 112.428 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -52.2 -29.61 23.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.562 -0.711 . . . . 0.0 110.545 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -72.76 -55.61 6.49 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.46 -46.19 56.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.421 1.089 . . . . 0.0 112.889 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -55.86 -21.81 21.98 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -59.4 -26.12 64.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.3 m -118.83 -43.81 2.65 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.524 0.729 . . . . 0.0 111.09 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 37' ' ' LEU . 91.0 m-70 -97.98 -172.17 2.31 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.272 1.029 . . . . 0.0 112.85 -175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -151.04 169.05 22.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.571 1.548 . . . . 0.0 109.057 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.9 mt -133.31 124.08 48.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -145.61 134.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.932 0.893 . . . . 0.0 110.012 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.11 161.98 68.78 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -54.58 -37.0 90.62 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 110.982 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.41 -0.57 6.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.711 1.604 . . . . 0.0 113.315 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.85 -7.32 81.6 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 120.848 -1.158 . . . . 0.0 112.415 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -64.82 103.19 0.67 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.457 1.128 . . . . 0.0 109.125 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.03 120.78 14.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.699 0.4 . . . . 0.0 111.255 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.43 -45.92 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.84 106.37 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -72.16 56.5 0.33 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.039 1.336 . . . . 0.0 110.172 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.26 -173.61 13.0 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 167.94 7.46 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.098 -0.648 . . . . 0.0 111.085 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -117.09 30.66 7.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.731 0.812 . . . . 0.0 109.261 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -67.27 -44.11 80.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.53 171.72 17.65 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 107.636 -2.185 . . . . 0.0 107.636 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.77 177.27 1.87 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.243 3.295 . . . . 0.0 113.087 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 114.1 21.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 17' ' ' HIS . 95.2 mt -71.45 -16.93 62.39 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.75 116.0 2.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.99 15.27 70.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.56 -1.133 . . . . 0.0 114.837 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.5 -44.96 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.928 1.864 . . . . 0.0 108.892 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.65 113.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 -15.17 59.75 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.832 1.206 . . . . 0.0 112.744 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -90.31 144.65 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.541 1.17 . . . . 0.0 110.919 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -58.69 133.35 55.84 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.628 1.171 . . . . 0.0 109.126 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.81 159.33 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.534 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.92 23.53 31.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.975 1.274 . . . . 0.0 114.477 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.1 p -145.31 22.94 1.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.888 1.344 . . . . 0.0 113.01 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -67.32 137.44 93.84 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.06 154.35 10.64 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.311 2.007 . . . . 0.0 114.565 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 45.06 59.35 3.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.276 1.83 . . . . 0.0 113.269 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.31 118.57 2.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -82.88 98.27 9.1 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.028 0.931 . . . . 0.0 109.725 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -82.68 -172.83 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 111.152 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -96.35 -176.91 3.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.924 1.29 . . . . 0.0 108.546 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.77 -34.47 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.928 0.891 . . . . 0.0 113.12 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 p -60.42 -65.38 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.46 1.104 . . . . 0.0 110.387 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.54 -40.28 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.156 1.383 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.8 t -59.82 -50.74 78.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.2 97.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.123 0.42 . . . . 0.0 111.108 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -53.31 53.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.73 64.59 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 123.766 0.698 . . . . 0.0 111.836 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.72 -26.82 47.24 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.488 1.515 . . . . 0.0 112.033 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.2 m -69.56 0.59 5.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.01 0.368 . . . . 0.0 111.938 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.97 38.4 5.76 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 125.446 1.498 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -107.11 110.06 22.06 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.378 0.589 . . . . 0.0 111.676 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 128.11 43.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.218 1.407 . . . . 0.0 107.55 174.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -62.75 151.76 37.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 110.796 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.0 p -129.82 162.56 28.23 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.949 1.7 . . . . 0.0 106.452 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.38 -39.68 80.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.061 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.55 -52.53 64.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.551 0.741 . . . . 0.0 110.216 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -61.03 -45.34 95.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.431 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.1 -53.03 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 118.675 0.671 . . . . 0.0 109.335 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.75 -46.45 64.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.462 0.705 . . . . 0.0 110.052 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.5 m -62.24 -54.4 41.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 109.915 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -50.08 -48.45 53.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.816 1.246 . . . . 0.0 113.04 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.3 m -60.47 -28.13 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.331 0.969 . . . . 0.0 112.689 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.24 -13.4 52.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.663 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -139.54 57.71 10.59 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.989 1.716 . . . . 0.0 112.07 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.08 138.43 78.15 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.926 2.418 . . . . 0.0 109.663 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.6 -65.17 2.49 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.42 -45.65 9.14 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 125.924 1.69 . . . . 0.0 111.529 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -55.1 -55.49 30.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.898 0.479 . . . . 0.0 110.664 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 83' ' ' LEU . 6.2 mp -56.74 -53.03 62.46 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.208 0.603 . . . . 0.0 109.997 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -52.35 -44.2 65.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.765 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.09 -67.15 0.45 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.605 0.762 . . . . 0.0 110.22 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -53.86 -42.74 68.9 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.16 -4.05 59.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.117 0.567 . . . . 0.0 111.847 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.3 t0 47.6 45.11 17.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.094 1.358 . . . . 0.0 110.009 -174.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.24 111.61 11.01 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.459 1.104 . . . . 0.0 110.52 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -57.46 -26.05 60.63 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.002 2.521 . . . . 0.0 111.787 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -96.49 9.61 40.84 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.22 72.71 7.06 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.502 -0.749 . . . . 0.0 110.357 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -91.73 126.79 36.94 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.701 0.8 . . . . 0.0 109.976 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -80.78 161.94 24.29 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.15 0.5 . . . . 0.0 110.498 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.13 -22.76 70.35 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 169.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ttp -68.26 81.02 0.24 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.991 0.895 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.0 58.04 3.31 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -160.19 150.43 18.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.539 1.536 . . . . 0.0 107.387 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -141.98 158.34 43.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.319 1.048 . . . . 0.0 108.543 173.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.71 102.81 11.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.08 67.73 1.79 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.889 1.276 . . . . 0.0 109.958 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 89.3 139.45 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 129.195 2.998 . . . . 0.0 109.35 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.9 -21.76 7.83 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -49.48 -41.59 33.33 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.492 1.044 . . . . 0.0 112.63 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.45 -46.56 88.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.443 0.622 . . . . 0.0 110.868 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.6 -49.2 77.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.283 1.433 . . . . 0.0 110.17 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.59 -44.96 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.66 91.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.87 -0.518 . . . . 0.0 110.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.06 94.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -57.22 -49.42 76.07 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.908 -0.495 . . . . 0.0 110.269 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.27 -44.21 88.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.429 -0.794 . . . . 0.0 111.206 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.47 73.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.442 0.697 . . . . 0.0 110.752 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -72.38 -37.73 68.66 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.123 -0.36 . . . . 0.0 110.679 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -69.27 -47.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.806 1.242 . . . . 0.0 112.43 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 122.566 1.174 . . . . 0.0 111.841 -176.766 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -77.08 84.14 3.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -39.06 -41.6 0.81 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.604 1.561 . . . . 0.0 113.601 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.29 36.74 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.455 0.57 . . . . 0.0 110.627 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -57.25 -38.47 73.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.308 0.643 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.52 -52.05 47.75 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.74 -50.37 73.44 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.15 0.98 . . . . 0.0 110.165 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.57 -51.62 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.459 -0.201 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.95 -38.33 70.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.828 0.851 . . . . 0.0 109.627 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -56.97 -29.95 63.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -33.54 67.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.025 -0.422 . . . . 0.0 110.231 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -87.66 -48.66 7.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.742 0.817 . . . . 0.0 109.006 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.2 t -49.22 -37.57 23.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.588 1.555 . . . . 0.0 112.038 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 5.01 0.68 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -55.83 -30.53 61.58 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.798 -1.189 . . . . 0.0 110.213 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.18 -37.28 5.37 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.563 0.745 . . . . 0.0 112.593 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -105.71 -174.43 2.53 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.676 0.791 . . . . 0.0 112.337 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 m -150.67 171.25 17.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.015 1.326 . . . . 0.0 109.619 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -133.16 133.28 58.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tp -117.14 141.86 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.537 1.535 . . . . 0.0 109.247 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.26 154.76 88.22 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.53 -38.84 45.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.12 2.547 . . . . 0.0 113.537 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.57 -16.25 62.84 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.738 1.215 . . . . 0.0 113.779 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.48 -13.52 23.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.667 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.3 m -60.63 124.85 21.61 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.625 1.712 . . . . 0.0 110.014 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -72.74 77.35 1.12 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.673 0.789 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.2 mm -52.94 -55.43 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.17 86.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.28 65.25 0.84 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.143 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.24 -158.53 33.57 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.53 174.09 11.38 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -121.92 28.44 7.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 109.201 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -66.9 -43.42 83.45 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.13 171.03 18.38 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 170.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.69 -173.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.61 2.873 . . . . 0.0 114.049 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -117.63 89.99 3.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 108.594 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 6.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 119.208 3.04 . . . . 0.0 119.208 -169.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -59.75 102.44 0.15 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 121.29 1.859 . . . . 0.0 108.736 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.36 21.81 31.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.485 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.98 -40.69 89.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-N 118.599 1.199 . . . . 0.0 109.4 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.06 98.71 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -16.06 9.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.506 2.003 . . . . 0.0 111.569 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -71.48 136.19 47.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 117.987 0.893 . . . . 0.0 110.409 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -71.4 67.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.598 1.559 . . . . 0.0 111.794 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 62.54 -149.86 0.36 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.314 1.046 . . . . 0.0 111.621 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.84 80.99 0.18 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 123.155 0.407 . . . . 0.0 113.173 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 t -150.32 21.02 0.85 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -68.12 143.14 95.73 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.29 153.9 20.58 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.39 1.393 . . . . 0.0 114.012 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 47.47 65.24 1.32 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.25 1.82 . . . . 0.0 112.875 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -158.7 120.93 3.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.137 0.494 . . . . 0.0 110.607 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -75.21 78.12 2.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.37 1.068 . . . . 0.0 110.7 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -67.41 178.19 1.65 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.884 0.474 . . . . 0.0 111.315 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -112.15 174.91 5.66 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.735 1.214 . . . . 0.0 109.663 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.28 -39.49 87.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.298 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.1 p -65.89 -62.72 1.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.677 1.227 . . . . 0.0 110.835 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -61.75 -21.25 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.087 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.01 -47.92 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.73 64.17 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.134 0.974 . . . . 0.0 111.014 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.73 -51.54 48.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.944 0.897 . . . . 0.0 108.751 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.39 90.8 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.54 -39.59 73.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -71.98 -7.78 50.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.46 9.57 43.73 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.373 0.987 . . . . 0.0 113.054 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -74.46 142.21 44.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.186 1.493 . . . . 0.0 109.204 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.87 135.03 41.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.923 1.289 . . . . 0.0 107.682 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -64.14 128.47 35.95 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -113.87 167.3 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.868 1.667 . . . . 0.0 106.806 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -51.53 -52.65 45.3 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.949 0.88 . . . . 0.0 109.834 172.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.76 -48.3 82.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.547 -176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -63.69 -41.4 98.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.491 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.48 -53.2 47.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.62 -47.07 67.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.495 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -61.43 -54.93 37.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.751 0.31 . . . . 0.0 110.751 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -55.13 -42.18 72.67 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.456 -0.777 . . . . 0.0 111.925 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.68 -28.1 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.241 0.616 . . . . 0.0 111.506 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -90.25 -31.78 16.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.555 0.742 . . . . 0.0 111.067 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.61 69.17 72.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 124.664 1.186 . . . . 0.0 112.518 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -67.28 153.9 75.74 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.07 -64.38 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.06 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.854 1.262 . . . . 0.0 110.317 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -52.67 -50.37 63.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.948 0.499 . . . . 0.0 111.402 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.29 -49.5 69.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.622 -0.674 . . . . 0.0 109.824 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -51.14 -48.37 61.82 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.118 0.567 . . . . 0.0 111.341 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -43.49 -54.64 4.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.118 0.967 . . . . 0.0 111.553 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -84.26 -50.8 7.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.959 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -76.13 -23.05 54.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.961 0.904 . . . . 0.0 113.436 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 44.74 63.65 1.63 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.653 1.981 . . . . 0.0 111.725 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -150.29 137.34 19.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -52.13 -38.7 58.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.977 0.911 . . . . 0.0 110.646 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -82.44 13.07 3.86 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.65 61.2 4.25 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.235 -0.915 . . . . 0.0 109.178 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.78 -174.55 2.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.823 1.249 . . . . 0.0 110.057 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -152.57 151.7 30.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.72 -13.05 71.41 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.1 ttp -69.75 78.9 0.44 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 118.166 0.983 . . . . 0.0 113.21 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.56 56.83 2.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -164.21 144.6 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.869 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -152.7 171.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 tp -144.73 113.56 6.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.55 41.44 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.065 0.546 . . . . 0.0 111.367 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 pttp 179.71 178.87 0.53 Allowed 'General case' 0 C--O 1.231 0.11 0 C-N-CA 127.61 2.364 . . . . 0.0 105.793 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.98 -52.96 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 119.038 -0.868 . . . . 0.0 113.184 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.4 -54.01 0.09 OUTLIER Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.221 2.343 . . . . 0.0 115.102 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.7 pm0 -64.96 -45.04 87.39 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.032 0.916 . . . . 0.0 111.578 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.38 -47.69 78.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 108.839 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.22 -43.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.872 1.269 . . . . 0.0 109.603 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.98 88.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.954 -0.466 . . . . 0.0 110.219 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.12 -52.45 65.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.1 mt -55.59 -48.01 75.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.053 0.541 . . . . 0.0 110.718 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.87 -40.05 69.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 110.75 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 m -77.52 -14.05 59.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 t -87.05 -38.19 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 108.737 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.539 0.522 0 O-C-N 121.742 -0.599 . . . . 0.0 109.859 176.578 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.104 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.12 82.54 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.899 -0.765 . . . . 0.0 109.293 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -45.1 -40.37 6.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 112.313 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.95 81.25 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.283 0.633 . . . . 0.0 111.165 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -64.46 -43.68 93.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.34 -48.57 33.42 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.8 1.19 . . . . 0.0 111.526 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.01 -54.61 36.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.716 0.758 . . . . 0.0 110.213 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.67 -48.39 81.86 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.888 -0.508 . . . . 0.0 110.662 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -56.54 -33.82 66.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.876 1.271 . . . . 0.0 110.821 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.13 -21.05 7.72 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.041 0.937 . . . . 0.0 111.615 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -46.2 -36.25 5.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.846 0.748 . . . . 0.0 110.754 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -69.09 -57.88 4.83 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.59 -40.51 52.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.257 1.023 . . . . 0.0 111.292 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -45.22 -35.3 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.552 2.341 . . . . 0.0 112.394 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 m -55.16 -29.88 58.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.588 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.6 m -123.36 -27.2 4.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.517 1.127 . . . . 0.0 113.387 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.1 167.94 11.32 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.539 1.136 . . . . 0.0 112.639 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 p -145.57 168.49 20.5 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.202 1.801 . . . . 0.0 109.562 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mp -136.04 107.73 7.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 tt -129.04 137.31 57.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 124.212 1.005 . . . . 0.0 110.548 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 152.52 92.86 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.42 -40.06 44.59 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.438 2.759 . . . . 0.0 113.497 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.69 -13.31 61.99 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.798 1.239 . . . . 0.0 113.802 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.07 -7.29 29.08 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.703 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.8 m -61.15 102.34 0.21 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.002 1.901 . . . . 0.0 109.299 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.66 76.37 5.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.844 2.058 . . . . 0.0 111.471 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.49 -46.71 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.292 0.637 . . . . 0.0 109.381 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.43 106.79 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -75.38 55.41 0.79 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.737 1.615 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.6 -174.33 30.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.21 0.91 . . . . 0.0 111.2 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.58 -174.69 5.12 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.804 0.811 . . . . 0.0 112.046 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.51 28.27 3.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 110.242 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 m -61.67 -35.09 76.97 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.04 162.87 12.45 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 169.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -55.4 153.1 29.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.592 2.195 . . . . 0.0 113.441 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -66.03 127.45 32.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.76 16.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -63.43 87.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.243 0.929 . . . . 0.0 110.045 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.75 46.67 5.63 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.11 -31.65 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.77 118.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.711 0.804 . . . . 0.0 108.862 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.91 -10.18 74.74 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.024 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.85 136.78 53.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.44 1.12 . . . . 0.0 109.327 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -62.53 135.39 57.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.52 131.3 45.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.757 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.03 35.22 61.27 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.562 -1.132 . . . . 0.0 113.764 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.1 p -136.33 2.68 2.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.123 1.461 . . . . 0.0 114.644 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.35 128.01 90.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.409 1.459 . . . . 0.0 107.106 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -54.57 157.85 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.901 2.401 . . . . 0.0 114.479 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 49.97 66.19 1.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.373 1.869 . . . . 0.0 112.415 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -164.44 123.78 1.92 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.815 0.446 . . . . 0.0 109.868 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -79.93 93.79 5.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.041 0.936 . . . . 0.0 109.922 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -77.97 -170.24 1.85 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.649 0.738 . . . . 0.0 110.662 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -117.08 172.44 7.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.291 1.836 . . . . 0.0 108.495 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.58 -36.71 84.69 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.979 0.912 . . . . 0.0 113.383 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -60.99 -65.76 0.64 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 111.089 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.21 -37.96 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.37 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -48.04 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.73 91.65 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.652 0.66 . . . . 0.0 111.141 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -48.36 73.69 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.57 28.16 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.13 -27.79 55.36 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.629 1.572 . . . . 0.0 112.282 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -68.03 -4.6 13.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.77 35.8 4.19 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 125.32 1.438 . . . . 0.0 110.52 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -103.39 124.19 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 117.408 0.604 . . . . 0.0 110.957 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.58 130.25 56.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.154 1.782 . . . . 0.0 107.603 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -60.74 143.62 54.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 118.177 0.444 . . . . 0.0 110.613 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.0 p -128.27 170.13 13.4 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.004 1.722 . . . . 0.0 106.917 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -58.59 -45.23 89.55 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 122.978 0.511 . . . . 0.0 110.606 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.36 -46.9 75.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.576 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.27 -46.68 87.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.99 -52.74 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -47.31 69.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.616 0.367 . . . . 0.0 110.277 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.6 m -64.37 -44.23 92.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.815 -0.553 . . . . 0.0 110.829 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -55.75 -53.47 56.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.063 0.945 . . . . 0.0 111.286 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 m -56.99 -40.13 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.593 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -65.04 -24.55 67.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -158.02 73.35 4.04 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.732 1.151 . . . . 0.0 113.005 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.13 146.74 79.71 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.522 2.148 . . . . 0.0 110.636 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.9 -64.18 4.35 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.78 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 117.318 0.559 . . . . 0.0 110.297 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -51.78 -51.23 57.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.959 0.504 . . . . 0.0 111.656 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.41 -56.39 16.61 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.321 0.648 . . . . 0.0 109.296 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -46.58 -46.4 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.499 1.12 . . . . 0.0 110.747 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -51.88 -40.53 60.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.043 0.937 . . . . 0.0 111.973 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -90.9 -45.68 8.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.305 0.642 . . . . 0.0 112.129 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 -17.87 39.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.472 1.109 . . . . 0.0 113.189 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 48.25 62.66 2.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.399 1.88 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -143.76 150.14 38.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.679 1.592 . . . . 0.0 108.926 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -66.97 -48.33 68.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 108.432 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -80.3 11.58 3.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.03 -1.441 . . . . 0.0 114.619 -173.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.41 63.58 6.65 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.691 -1.256 . . . . 0.0 110.517 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -102.52 170.45 8.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.197 0.999 . . . . 0.0 109.942 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -131.7 154.07 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.61 -12.44 64.15 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.0 ttp -67.97 79.75 0.22 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 56.6 2.66 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.572 0.749 . . . . 0.0 110.122 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -154.28 116.06 4.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.839 1.256 . . . . 0.0 108.712 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -100.94 -179.14 3.97 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.6 156.89 47.94 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.49 53.32 0.8 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? 75.66 164.12 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.875 1.67 . . . . 0.0 110.619 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.98 -15.22 33.85 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.05 -35.62 33.36 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.425 1.488 . . . . 0.0 112.29 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.65 -47.37 86.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 117.518 0.659 . . . . 0.0 110.586 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -64.32 -44.39 91.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.42 -47.1 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.5 -48.14 77.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.955 -0.466 . . . . 0.0 109.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.18 -46.09 79.5 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -57.0 -51.23 70.06 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.073 -0.392 . . . . 0.0 110.869 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.37 -43.58 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.848 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.67 91.61 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.325 -0.234 . . . . 0.0 110.964 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.5 m -69.85 -50.05 46.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.738 HG13 ' H ' ' A' ' 115' ' ' VAL . 11.4 p -59.68 -81.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.738 ' H ' HG13 ' A' ' 114' ' ' VAL . 7.2 p . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 129.722 3.209 . . . . 0.0 113.655 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.89 74.59 0.62 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.62 1.168 . . . . 0.0 111.449 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.39 -40.64 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.509 1.124 . . . . 0.0 112.618 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.54 85.79 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.733 -0.604 . . . . 0.0 111.044 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -63.98 -38.16 90.06 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.67 -48.35 82.16 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.19 -49.81 72.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.74 0.816 . . . . 0.0 109.736 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.7 -48.33 82.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.435 0.16 . . . . 0.0 110.691 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.15 -34.56 68.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.491 1.116 . . . . 0.0 110.464 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.98 -16.67 7.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.958 0.903 . . . . 0.0 112.564 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -51.28 -30.84 19.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.449 0.7 . . . . 0.0 110.387 172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -76.96 -59.02 2.95 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.62 -0.675 . . . . 0.0 109.349 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.9 m -45.36 -47.68 13.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.768 1.627 . . . . 0.0 111.961 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -51.02 -26.27 5.92 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.924 1.29 . . . . 0.0 113.805 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -58.6 -40.57 83.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.472 0.578 . . . . 0.0 109.56 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.1 m -99.39 -48.69 4.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.419 1.088 . . . . 0.0 112.133 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -84.07 176.83 8.55 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.159 0.983 . . . . 0.0 112.473 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.4 m -147.98 159.23 44.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.818 0.847 . . . . 0.0 108.764 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -142.93 122.19 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.36 130.52 60.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 O-C-N 121.86 -0.525 . . . . 0.0 110.009 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.04 158.87 60.36 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.98 -39.25 79.74 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.269 2.646 . . . . 0.0 112.53 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.7 -8.6 55.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.375 1.47 . . . . 0.0 113.717 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.49 -13.25 51.07 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -59.92 114.81 3.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.66 1.73 . . . . 0.0 109.677 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.24 118.74 11.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.467 0.707 . . . . 0.0 109.949 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 mm -89.86 -42.52 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.9 t -141.19 129.58 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -127.6 74.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.69 -168.4 3.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.28 44.22 1.01 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.977 -1.307 . . . . 0.0 110.11 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 tptp 13.79 57.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 130.648 3.579 . . . . 0.0 113.79 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -89.48 -30.95 17.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.69 0.796 . . . . 0.0 108.915 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.5 170.27 13.98 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.84 167.22 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 112.21 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.49 125.7 30.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -92.9 4.43 53.92 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -67.55 87.15 0.2 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.296 0.953 . . . . 0.0 109.483 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 115' ' ' VAL . . . 112.05 23.14 5.66 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.947 0.784 . . . . 0.0 111.577 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.91 -42.73 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.519 1.16 . . . . 0.0 110.05 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 115' ' ' VAL . 58.1 t -61.63 114.44 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.11 63.56 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.013 1.292 . . . . 0.0 111.654 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -68.92 138.61 54.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.6 1.2 . . . . 0.0 109.897 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 m -67.4 70.4 0.11 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.781 1.632 . . . . 0.0 111.508 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.53 -144.91 0.64 Allowed 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.875 -0.516 . . . . 0.0 110.232 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.62 73.73 0.61 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.514 1.054 . . . . 0.0 112.645 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.4 p -138.81 2.73 2.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.239 1.015 . . . . 0.0 111.922 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -62.22 132.9 94.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.57 161.67 11.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.151 1.9 . . . . 0.0 114.006 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 57.55 58.64 3.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.794 1.638 . . . . 0.0 112.916 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -165.88 123.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.746 0.418 . . . . 0.0 110.488 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.24 88.93 4.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.976 0.91 . . . . 0.0 109.553 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.91 -174.17 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.521 0.677 . . . . 0.0 111.455 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -106.12 -178.46 3.66 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.492 1.517 . . . . 0.0 108.322 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.65 -38.03 67.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.713 0.805 . . . . 0.0 112.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -60.74 -63.06 1.43 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 111.078 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.54 -35.65 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.9 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.55 -48.27 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.91 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 110.586 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.3 tp -55.77 -49.65 72.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.45 -52.75 48.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.84 -36.83 65.46 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.2 1.0 . . . . 0.0 112.591 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -67.32 -11.58 57.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.89 10.92 15.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.889 1.233 . . . . 0.0 112.595 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -77.0 141.27 40.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.739 1.27 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.51 34.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.454 1.501 . . . . 0.0 107.923 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -62.54 143.26 57.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.33 166.45 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.035 1.734 . . . . 0.0 106.596 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.98 -43.76 77.91 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.304 0.573 . . . . 0.0 110.775 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.62 -47.69 68.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.102 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.11 -46.05 90.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.252 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.3 mt -57.22 -54.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.69 -46.13 29.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.636 0.774 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -63.43 -65.32 0.7 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.255 0.622 . . . . 0.0 110.472 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -43.38 -48.83 7.06 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.011 1.724 . . . . 0.0 112.811 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 t -53.2 -25.73 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.64 14.87 15.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.601 1.091 . . . . 0.0 112.32 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -159.37 56.79 0.95 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.576 1.15 . . . . 0.0 111.904 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -66.82 157.39 61.55 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 108.75 -1.288 . . . . 0.0 108.75 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 -66.82 3.04 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.04 -47.68 53.22 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.411 1.084 . . . . 0.0 111.342 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -51.59 -52.39 47.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.64 -56.2 24.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.622 1.169 . . . . 0.0 109.73 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.02 -47.62 44.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.575 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -63.95 -66.96 0.47 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.467 0.707 . . . . 0.0 110.369 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -53.99 -39.81 66.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.7 tp -92.24 -0.41 57.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.938 0.895 . . . . 0.0 111.982 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 43.45 58.39 3.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.327 1.451 . . . . 0.0 109.94 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -143.68 157.88 44.08 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 124.305 1.042 . . . . 0.0 110.836 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -92.41 -50.22 5.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.272 1.829 . . . . 0.0 108.115 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -79.53 42.2 0.51 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.89 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.37 90.94 3.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -131.46 132.72 44.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.054 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.92 154.48 19.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.12 -16.9 62.86 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttp -64.96 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.244 1.022 . . . . 0.0 113.309 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.56 59.21 4.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -160.43 150.72 18.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.329 1.851 . . . . 0.0 107.426 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -143.81 164.23 31.1 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.846 1.259 . . . . 0.0 107.812 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.88 169.38 9.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.92 37.51 4.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -147.33 170.52 17.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.217 1.807 . . . . 0.0 106.172 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.75 -10.05 57.41 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.874 -0.959 . . . . 0.0 112.622 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.67 13.56 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 118.708 1.254 . . . . 0.0 113.889 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -61.71 -46.1 91.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.362 1.081 . . . . 0.0 109.452 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -55.28 -52.61 62.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.296 1.438 . . . . 0.0 110.57 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.21 -46.2 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.451 1.101 . . . . 0.0 110.184 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.37 90.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.148 -0.345 . . . . 0.0 110.376 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.25 99.17 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.499 0.319 . . . . 0.0 110.309 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -57.66 -52.26 66.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 115' ' ' VAL . 54.6 mt -58.7 -44.13 90.26 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.854 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.35 76.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.5 m -61.58 -38.13 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.012 -0.43 . . . . 0.0 111.094 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -37.06 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.855 -0.528 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.567 HG21 ' HB ' ' A' ' 41' ' ' VAL . 65.3 t . . . . . 0 CA--C 1.531 0.225 0 C-N-CA 124.305 1.042 . . . . 0.0 110.235 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 N-CA-C 114.043 0.377 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.69 72.48 0.77 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.461 1.505 . . . . 0.0 111.506 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.1 -39.97 10.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.679 1.191 . . . . 0.0 112.591 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.26 94.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.541 0.736 . . . . 0.0 111.452 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.38 -43.6 69.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.86 -44.61 40.34 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.99 -46.13 71.64 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 111.659 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -71.36 -47.99 52.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.659 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -57.62 -30.66 65.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.935 0.894 . . . . 0.0 110.719 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.67 -16.46 4.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.618 1.167 . . . . 0.0 112.144 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -53.52 -33.22 53.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.333 0.969 . . . . 0.0 111.087 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -72.85 -26.64 61.54 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.77 -0.581 . . . . 0.0 111.391 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.9 m -77.4 -45.62 25.31 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -46.23 -32.88 3.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 111.904 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -53.0 -31.31 40.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.121 0.968 . . . . 0.0 111.76 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -120.2 -38.34 2.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.487 1.515 . . . . 0.0 112.366 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -103.7 -173.47 2.32 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 125.634 1.574 . . . . 0.0 111.386 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -157.24 168.48 27.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.408 1.483 . . . . 0.0 109.01 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 133.07 54.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.06 1.744 . . . . 0.0 106.692 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 26' ' ' GLU . 1.4 tp -111.6 149.74 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.653 1.981 . . . . 0.0 109.16 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 161.95 48.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.76 -36.99 27.28 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.592 2.861 . . . . 0.0 112.124 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.09 13.68 0.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.996 1.718 . . . . 0.0 113.325 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.44 31.98 60.42 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.664 1.125 . . . . 0.0 111.656 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -112.2 126.24 55.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 20' ' ' ILE . 51.6 mt-10 -63.44 121.82 14.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.538 0.335 . . . . 0.0 110.469 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.1 mm -98.62 -60.18 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.67 77.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.62 70.61 0.19 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.749 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.42 -158.17 30.76 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 173.82 11.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.9 33.06 5.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.468 1.107 . . . . 0.0 108.977 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.7 m -69.38 -38.12 77.88 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.7 165.27 12.03 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -59.45 141.66 97.81 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.891 3.061 . . . . 0.0 111.199 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.07 119.4 7.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -85.86 15.91 4.51 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -170.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -75.54 80.41 2.56 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.563 -1.335 . . . . 0.0 109.442 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.93 46.35 0.34 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.127 0.87 . . . . 0.0 113.453 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.89 -48.43 33.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 t -53.52 112.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.786 0.835 . . . . 0.0 110.431 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 -15.68 61.39 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.922 1.249 . . . . 0.0 113.058 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -68.12 140.56 56.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.94 1.37 . . . . 0.0 110.789 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 m -70.2 72.73 0.46 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 110.611 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.07 -139.47 1.02 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.942 0.497 . . . . 0.0 109.707 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.96 77.51 1.13 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 123.731 0.682 . . . . 0.0 112.536 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 p -136.21 16.36 3.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.713 0.805 . . . . 0.0 112.121 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -67.08 141.81 96.73 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.022 -1.049 . . . . 0.0 108.928 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.37 155.98 23.18 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.279 1.319 . . . . 0.0 113.916 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 46.73 62.57 2.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.475 1.51 . . . . 0.0 113.587 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -158.44 120.5 3.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.867 -0.52 . . . . 0.0 110.023 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -73.49 82.18 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.446 0.698 . . . . 0.0 110.495 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.11 169.69 11.45 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.165 0.507 . . . . 0.0 110.513 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -96.52 175.58 6.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.87 -35.78 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.272 0.629 . . . . 0.0 112.635 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -59.24 -66.47 0.5 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.228 1.411 . . . . 0.0 111.173 -174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 tt -58.1 -37.94 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.806 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.11 -49.41 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.55 87.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.923 0.329 . . . . 0.0 110.711 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -47.26 84.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.58 -56.65 22.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 173.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.93 -32.61 54.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.08 1.352 . . . . 0.0 113.387 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.7 p -66.68 -12.97 60.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.86 0.755 . . . . 0.0 112.056 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.73 33.43 1.88 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.398 1.475 . . . . 0.0 110.861 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -96.11 143.61 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.787 0.794 . . . . 0.0 109.532 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.44 128.59 31.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -61.01 99.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.016 0.526 . . . . 0.0 111.831 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.4 p -83.19 167.85 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -58.17 -37.81 75.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.045 0.45 . . . . 0.0 109.846 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -64.41 -49.57 71.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -56.88 -52.74 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.15 -53.53 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.59 -46.28 63.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.499 0.72 . . . . 0.0 111.184 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.9 m -66.88 -54.91 17.56 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -51.78 -42.82 62.71 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.413 1.085 . . . . 0.0 113.068 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.6 t -53.98 -31.67 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.118 0.567 . . . . 0.0 111.519 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -105.6 14.13 28.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.28 1.432 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -161.21 49.16 0.26 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.269 1.027 . . . . 0.0 111.809 -175.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -56.16 136.08 73.27 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.67 2.914 . . . . 0.0 110.04 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.63 -55.39 2.08 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.55 -0.583 . . . . 0.0 111.959 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 -38.55 68.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.501 1.151 . . . . 0.0 111.26 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -63.46 -44.74 93.6 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 110.721 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.97 -54.72 41.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.702 0.801 . . . . 0.0 108.941 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -47.8 -48.46 30.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.881 1.272 . . . . 0.0 110.244 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -61.03 -68.43 0.31 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.056 0.942 . . . . 0.0 110.513 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.27 -37.04 81.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 tp -85.86 -3.69 58.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.6 0.76 . . . . 0.0 111.344 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 t0 44.13 54.2 6.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.435 1.494 . . . . 0.0 110.017 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -145.95 119.24 8.94 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.534 0.734 . . . . 0.0 111.85 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.94 -32.23 69.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.241 1.016 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -80.51 4.93 16.7 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.39 65.28 6.46 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.485 -0.76 . . . . 0.0 111.355 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.54 136.83 32.81 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.382 -0.824 . . . . 0.0 109.253 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.6 t -87.91 155.13 20.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.36 -25.31 72.48 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 21.2 ttp -65.44 82.63 0.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.976 0.888 . . . . 0.0 112.324 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 58.29 3.24 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -163.61 145.93 9.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.328 1.851 . . . . 0.0 107.044 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.84 155.14 46.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.9 109.54 13.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.38 46.72 0.76 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.532 -0.73 . . . . 0.0 111.669 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? 175.59 -165.63 0.03 OUTLIER 'General case' 0 C--O 1.231 0.117 0 C-N-CA 128.091 2.556 . . . . 0.0 106.225 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.22 -59.01 3.63 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.993 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -4.77 -70.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.372 2.891 . . . . 0.0 115.294 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.23 -57.22 13.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.181 0.992 . . . . 0.0 112.639 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.64 -35.18 80.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.092 0.557 . . . . 0.0 110.904 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.92 -46.55 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.281 0.632 . . . . 0.0 109.632 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.34 94.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.889 -0.507 . . . . 0.0 109.702 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -43.46 86.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -59.2 -51.47 69.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.8 mt -56.46 -38.23 71.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.792 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.78 -52.46 60.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.152 0.887 . . . . 0.0 109.573 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.6 m -53.88 -34.88 60.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 112.618 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.14 -30.82 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.863 1.265 . . . . 0.0 111.697 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 CA--C 1.536 0.411 0 CA-C-N 119.064 0.847 . . . . 0.0 110.482 -178.691 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -92.08 106.93 18.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.315 1.046 . . . . 0.0 108.498 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.72 -34.75 5.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.672 1.189 . . . . 0.0 112.476 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.04 74.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.761 0.71 . . . . 0.0 110.324 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.61 -38.52 87.94 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.49 -52.24 51.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.08 -49.15 77.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.232 0.613 . . . . 0.0 110.553 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -55.87 -50.92 69.32 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.4 -35.52 72.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.422 0.689 . . . . 0.0 109.951 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.87 -19.93 32.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -52.98 -31.82 42.82 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.604 0.638 . . . . 0.0 110.985 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -52.72 6.06 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.06 -38.18 10.7 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.563 1.945 . . . . 0.0 113.645 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -52.43 -25.18 9.34 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.15 . . . . 0.0 112.817 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 m -61.91 -21.97 65.19 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.612 -0.68 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -119.16 -38.76 3.0 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.85 0.86 . . . . 0.0 112.619 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.75 169.7 8.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 112.404 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.3 p -141.38 164.21 30.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.785 1.234 . . . . 0.0 111.272 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.43 119.05 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -139.5 133.63 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.229 0.612 . . . . 0.0 110.86 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 162.85 63.03 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.83 -37.82 95.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.14 2.56 . . . . 0.0 112.394 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.25 -15.94 58.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.979 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.2 -3.11 56.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.41 110.96 2.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.6 114.57 13.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.888 0.875 . . . . 0.0 111.48 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.0 -45.16 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.7 t -135.2 103.31 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -76.96 54.79 1.05 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.781 1.232 . . . . 0.0 109.043 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.19 -176.4 50.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.21 177.94 6.12 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.327 0.584 . . . . 0.0 110.923 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -125.95 39.88 3.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.09 0.956 . . . . 0.0 109.368 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.2 m -65.57 -34.65 78.74 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.36 13.42 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 168.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.46 173.24 0.76 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.444 2.096 . . . . 0.0 113.494 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -83.32 135.09 34.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.77 10.84 37.64 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -64.8 88.61 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.275 0.943 . . . . 0.0 109.478 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.91 40.94 5.11 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -72.58 -36.39 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.39 107.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.72 -13.51 50.19 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.308 1.432 . . . . 0.0 112.069 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -73.07 137.5 45.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.841 0.821 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -63.47 128.9 37.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.39 154.89 12.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.829 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.07 22.76 72.65 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.867 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.1 t -156.16 28.72 0.35 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.539 1.67 . . . . 0.0 113.416 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -72.26 129.35 87.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 167.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -45.49 154.7 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.166 2.577 . . . . 0.0 116.094 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 54.7 65.57 1.47 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.298 1.439 . . . . 0.0 112.605 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -166.83 125.42 1.39 Allowed 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.854 -0.529 . . . . 0.0 111.713 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -79.36 90.7 5.01 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.64 1.176 . . . . 0.0 109.66 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -73.55 -177.57 2.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.464 0.705 . . . . 0.0 112.509 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -105.55 -178.03 3.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.004 1.322 . . . . 0.0 108.167 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.32 -37.17 66.25 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.512 -0.742 . . . . 0.0 112.792 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -62.24 -66.2 0.57 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.506 1.122 . . . . 0.0 111.167 -173.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -55.5 -38.09 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.897 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.01 -43.58 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 O-C-N 121.813 -0.555 . . . . 0.0 109.512 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.8 87.74 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.299 0.5 . . . . 0.0 110.318 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.04 -52.43 65.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.15 -48.29 10.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.096 1.331 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.14 29.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.237 1.415 . . . . 0.0 113.819 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -73.3 -0.5 14.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.471 1.032 . . . . 0.0 112.183 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 33.88 9.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -79.19 80.82 5.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.069 -0.665 . . . . 0.0 110.916 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.14 115.0 11.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.002 1.321 . . . . 0.0 107.865 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -56.3 146.77 22.89 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 109.259 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.2 p -127.18 164.0 22.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.08 -40.65 73.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.069 0.548 . . . . 0.0 110.213 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.61 -52.42 57.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.317 0.647 . . . . 0.0 110.604 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -61.03 -45.48 94.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.56 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.8 mm -56.18 -53.7 36.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.34 -47.16 66.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.678 0.391 . . . . 0.0 110.612 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 m -62.35 -55.49 27.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.21 0.528 . . . . 0.0 110.454 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.39 -44.63 45.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.331 1.453 . . . . 0.0 112.143 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.4 t -54.26 -30.5 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.41 0.684 . . . . 0.0 111.906 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -95.37 -26.38 15.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.616 0.766 . . . . 0.0 111.37 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -127.43 63.7 59.78 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 125.204 1.402 . . . . 0.0 112.693 -171.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.77 143.27 60.87 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.779 1.653 . . . . 0.0 108.809 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -63.57 3.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.25 -45.22 44.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.688 1.195 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -54.85 -53.03 60.61 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.686 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.6 -53.48 57.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.123 -0.361 . . . . 0.0 110.32 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -47.64 -50.6 24.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.98 0.912 . . . . 0.0 110.491 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.0 -58.32 6.35 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.01 0.524 . . . . 0.0 111.025 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -67.45 -51.47 51.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.86 -25.59 40.66 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.755 1.222 . . . . 0.0 114.219 -172.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.81 55.51 7.75 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.405 1.482 . . . . 0.0 109.892 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -136.21 135.92 39.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.248 1.419 . . . . 0.0 109.543 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.88 -41.35 97.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.411 1.084 . . . . 0.0 111.107 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -85.69 18.76 2.71 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 70.41 4.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.442 0.697 . . . . 0.0 110.444 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -113.41 128.46 56.46 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.54 1.536 . . . . 0.0 109.121 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.2 t -82.18 158.52 23.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.65 -19.85 69.53 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.5 ttp -68.76 82.72 0.29 Allowed 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.996 -0.708 . . . . 0.0 112.797 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.62 3.09 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -160.21 149.73 17.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.168 1.787 . . . . 0.0 108.084 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -156.3 172.57 18.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.142 1.377 . . . . 0.0 108.861 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -143.29 115.72 8.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.031 1.332 . . . . 0.0 107.625 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.48 45.58 0.78 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.665 -0.647 . . . . 0.0 111.868 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? 175.04 -172.22 0.06 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 128.301 2.64 . . . . 0.0 105.705 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.37 -52.49 2.25 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.686 -1.064 . . . . 0.0 113.523 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -24.84 -55.1 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.179 2.323 . . . . 0.0 114.997 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -62.14 -52.38 64.1 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.526 0.73 . . . . 0.0 111.493 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.72 -48.35 79.82 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.5 1.12 . . . . 0.0 109.456 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.22 -46.38 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.653 1.181 . . . . 0.0 109.697 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.71 87.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.874 -0.516 . . . . 0.0 110.07 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.8 93.91 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -58.5 -50.41 73.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.979 -0.45 . . . . 0.0 110.534 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.94 -46.13 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.954 0.902 . . . . 0.0 110.434 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.7 78.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.021 0.528 . . . . 0.0 110.556 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -69.07 -38.71 79.18 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.964 -0.46 . . . . 0.0 111.07 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -42.49 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 125.329 1.452 . . . . 0.0 111.46 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 122.069 0.937 . . . . 0.0 110.363 -179.696 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 121.798 0.665 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -73.67 80.59 1.53 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.863 -0.786 . . . . 0.0 111.152 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.52 63.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.9 0.88 . . . . 0.0 111.741 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.15 74.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.635 0.374 . . . . 0.0 110.407 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -63.87 -44.56 92.71 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -48.05 -45.53 26.56 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.13 0.871 . . . . 0.0 112.001 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -54.05 -47.22 71.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.285 0.634 . . . . 0.0 110.938 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -69.19 -44.74 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.94 -34.93 57.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.207 1.403 . . . . 0.0 109.641 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.52 -20.34 2.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.02 -27.67 33.45 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.816 -0.553 . . . . 0.0 111.456 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.35 -55.04 5.74 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.01 -42.82 29.12 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.993 1.317 . . . . 0.0 112.33 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -57.32 -21.07 32.67 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -54.52 -32.63 58.51 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.731 -0.606 . . . . 0.0 110.288 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 m -112.48 -44.35 3.37 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.338 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -90.84 -176.15 4.58 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 m -156.3 165.41 36.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.147 1.779 . . . . 0.0 108.732 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.6 mt -131.95 126.86 57.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' N ' HD21 ' A' ' 36' ' ' ASN . 1.1 tp -118.85 135.75 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.322 1.449 . . . . 0.0 109.998 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.24 82.34 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 119.015 0.825 . . . . 0.0 108.973 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.07 -41.25 73.19 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.16 2.573 . . . . 0.0 112.561 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -72.66 -10.96 60.42 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.172 1.389 . . . . 0.0 113.407 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.85 -17.15 35.96 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.023 -0.876 . . . . 0.0 113.443 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.8 m -60.71 116.32 4.31 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.522 1.661 . . . . 0.0 109.923 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -64.4 122.17 16.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.822 0.449 . . . . 0.0 110.341 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.44 -52.15 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.45 97.98 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -78.11 70.14 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.825 1.25 . . . . 0.0 107.801 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.39 -151.34 27.4 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.58 -179.33 5.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -123.51 22.45 9.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 108.89 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -30.13 70.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.225 1.01 . . . . 0.0 108.998 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.18 172.08 14.49 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.7 175.05 0.64 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 124.108 3.205 . . . . 0.0 113.307 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 20' ' ' ILE . 1.5 t30 -105.4 81.77 1.74 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.055 0.942 . . . . 0.0 111.086 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mp -37.32 -0.91 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.542 1 C-N-CA 133.424 4.689 . . . . 0.0 121.464 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -69.07 80.86 0.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 121.058 1.754 . . . . 0.0 110.049 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 115' ' ' VAL . . . 122.22 32.76 0.95 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.903 -0.943 . . . . 0.0 115.014 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.67 -49.12 81.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.7 1.75 . . . . 0.0 111.789 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 115' ' ' VAL . 88.7 t -53.38 121.56 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 121.5 -0.75 . . . . 0.0 110.537 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.02 -19.21 54.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.744 1.164 . . . . 0.0 111.737 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -64.8 135.43 55.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.136 0.968 . . . . 0.0 110.042 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.2 m -73.15 80.75 1.27 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' CA ' ' A' ' 61' ' ' GLY . . . 51.68 -145.1 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.099 0.959 . . . . 0.0 110.963 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.0 78.81 0.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 124.82 1.2 . . . . 0.0 111.945 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.0 p -134.57 5.38 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.832 0.853 . . . . 0.0 111.805 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.06 134.99 93.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.07 164.75 9.76 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.486 2.124 . . . . 0.0 114.426 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.98 52.95 7.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.846 1.658 . . . . 0.0 112.057 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -161.49 118.42 2.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.991 -0.443 . . . . 0.0 111.81 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -78.77 79.9 5.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.064 0.946 . . . . 0.0 109.599 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -64.31 163.88 12.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.958 0.503 . . . . 0.0 111.385 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -96.47 176.39 6.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.144 0.973 . . . . 0.0 110.986 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.15 -36.62 73.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.804 1.641 . . . . 0.0 113.584 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 p -64.07 -67.61 0.42 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.029 0.919 . . . . 0.0 109.823 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 tt -59.25 -33.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.64 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.99 -50.89 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.637 -0.664 . . . . 0.0 109.663 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -40.3 82.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.416 0.553 . . . . 0.0 110.283 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -57.42 -44.33 84.55 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . -58.86 -49.21 80.38 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.19 -35.47 64.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.335 0.568 . . . . 0.0 111.719 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.1 p -76.34 5.92 6.36 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 30.65 36.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.362 0.982 . . . . 0.0 112.33 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -74.99 82.61 2.22 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.77 -0.841 . . . . 0.0 112.296 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.81 107.97 5.52 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -52.35 116.48 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.627 0.771 . . . . 0.0 111.719 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.5 p -94.33 161.89 14.06 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.95 -38.0 81.16 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.91 -54.7 44.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.965 0.906 . . . . 0.0 109.249 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -58.44 -47.11 85.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.787 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -54.03 -53.65 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.67 62.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.008 0.523 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -60.07 -53.58 56.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -52.5 -44.56 65.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.191 0.996 . . . . 0.0 111.575 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.41 -20.15 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.096 0.958 . . . . 0.0 112.418 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -103.33 -14.11 16.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.561 1.144 . . . . 0.0 111.988 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -142.08 58.81 8.38 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.632 1.173 . . . . 0.0 111.929 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.67 135.62 70.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.109 2.539 . . . . 0.0 109.585 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.51 -59.04 4.11 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.562 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.25 -42.28 66.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.991 0.896 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -51.43 -59.62 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.366 1.066 . . . . 0.0 111.042 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.31 -50.17 73.79 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.245 1.018 . . . . 0.0 110.935 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -59.69 -35.95 75.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 110.264 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.79 -59.93 2.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.625 0.77 . . . . 0.0 109.188 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -54.44 -44.99 72.96 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.75 0.23 56.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.962 0.505 . . . . 0.0 111.738 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 46.73 49.94 13.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.203 1.401 . . . . 0.0 110.666 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -138.23 117.18 12.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.455 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -51.64 -37.34 49.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.554 1.142 . . . . 0.0 111.272 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -89.14 4.34 48.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.88 86.38 7.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -116.05 153.93 30.82 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.656 1.182 . . . . 0.0 110.228 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -97.27 157.29 16.03 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 123.904 0.882 . . . . 0.0 110.439 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.48 -19.99 79.21 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.6 ttt -65.02 81.68 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.521 1.128 . . . . 0.0 112.777 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 58.13 3.03 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.85 143.88 5.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.099 1.36 . . . . 0.0 108.877 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -141.24 166.87 23.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.554 1.542 . . . . 0.0 107.106 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.02 165.92 13.75 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.6 56.8 3.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.392 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 75.54 -172.11 0.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.839 2.055 . . . . 0.0 111.349 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.32 -78.37 1.93 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.22 -53.87 0.18 Allowed Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.99 1.281 . . . . 0.0 112.96 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -44.73 -37.88 4.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.397 1.879 . . . . 0.0 113.31 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -58.96 -48.13 82.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.412 0.685 . . . . 0.0 110.551 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.69 -39.71 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.32 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.303 -0.248 . . . . 0.0 110.629 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.52 95.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.558 0.743 . . . . 0.0 109.599 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.27 -51.01 69.73 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 115' ' ' VAL . 51.7 mt -58.49 -44.95 89.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.71 -0.619 . . . . 0.0 110.823 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.94 79.12 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.968 -0.457 . . . . 0.0 110.083 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -61.8 -41.09 97.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.634 0.373 . . . . 0.0 110.68 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.54 -31.23 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.752 0.821 . . . . 0.0 111.26 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.594 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.5 t . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 121.686 0.755 . . . . 0.0 109.133 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.869 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.0 92.21 5.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.6 -40.88 20.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.894 0.877 . . . . 0.0 112.94 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.63 72.97 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.898 -0.502 . . . . 0.0 110.126 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.18 -39.64 90.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.75 -47.12 38.92 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.011 1.291 . . . . 0.0 111.255 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.94 -48.19 73.49 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.113 0.456 . . . . 0.0 110.237 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -65.34 -46.17 81.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.403 0.281 . . . . 0.0 110.373 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -57.28 -33.18 67.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.607 1.163 . . . . 0.0 110.261 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.89 -21.39 57.41 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -27.49 56.26 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.585 0.629 . . . . 0.0 109.82 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -80.58 -49.78 10.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.9 m -53.11 -41.92 65.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.701 0.801 . . . . 0.0 112.358 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -62.19 -11.5 14.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.6 m -59.05 -22.92 61.5 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.8 m -129.74 -46.25 1.16 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.885 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.82 -173.53 3.53 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.689 0.757 . . . . 0.0 112.976 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.4 m -159.89 167.99 26.8 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.504 1.922 . . . . 0.0 109.838 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.8 mm -140.73 126.07 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.416 1.487 . . . . 0.0 108.508 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 tp -120.78 136.73 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.898 1.279 . . . . 0.0 109.244 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.11 47.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.273 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.96 -34.53 92.34 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.961 2.44 . . . . 0.0 110.696 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.83 14.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.988 1.715 . . . . 0.0 112.821 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.01 63.16 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.975 -1.078 . . . . 0.0 111.832 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -107.99 123.36 48.53 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.51 114.9 5.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.809 0.444 . . . . 0.0 111.355 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.42 -43.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.98 97.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -81.63 66.85 7.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.85 174.56 54.21 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.31 72.75 7.18 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.802 -0.822 . . . . 0.0 109.033 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -40.87 71.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.963 3.705 . . . . 0.0 114.478 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -100.56 -27.33 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.701 2.4 . . . . 0.0 108.261 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.94 173.11 14.55 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.14 1.829 . . . . 0.0 108.736 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.46 171.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.604 3.536 . . . . 0.0 114.706 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -94.21 126.43 39.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.9 mt -97.22 7.4 46.66 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.31 82.66 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.928 1.24 . . . . 0.0 111.058 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.21 28.9 5.64 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.233 0.921 . . . . 0.0 113.145 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.22 -35.83 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 118.76 1.28 . . . . 0.0 108.652 171.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.08 115.23 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.799 0.839 . . . . 0.0 110.259 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.4 -14.83 62.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.069 1.319 . . . . 0.0 112.6 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -84.51 146.89 27.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.382 1.091 . . . . 0.0 111.213 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -60.12 132.12 52.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.854 0.862 . . . . 0.0 109.085 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.36 149.18 29.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.932 -0.48 . . . . 0.0 110.965 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 29.49 73.93 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.265 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.7 p -131.43 -6.96 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.073 1.437 . . . . 0.0 114.27 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -64.44 129.93 94.42 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.02 1.282 . . . . 0.0 108.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -59.66 166.68 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.282 1.988 . . . . 0.0 113.403 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 59.28 51.14 7.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.133 1.373 . . . . 0.0 112.021 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -164.14 120.43 1.62 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.86 87.29 6.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -70.0 -172.07 0.5 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.664 0.745 . . . . 0.0 111.405 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.33 157.94 22.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.732 1.613 . . . . 0.0 110.259 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -51.83 -36.02 46.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.7 1.2 . . . . 0.0 113.545 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -63.71 -66.77 0.5 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.076 0.95 . . . . 0.0 110.01 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -58.76 -35.77 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.486 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.57 -50.7 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.92 93.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.443 0.565 . . . . 0.0 110.602 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.54 -47.32 79.66 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.81 -55.33 28.19 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.445 1.022 . . . . 0.0 111.007 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.42 -31.44 55.17 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.782 1.233 . . . . 0.0 111.522 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -72.1 6.04 2.4 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.24 28.63 22.19 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.949 1.262 . . . . 0.0 111.646 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -80.74 82.5 6.72 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.868 -0.783 . . . . 0.0 111.356 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.55 120.33 20.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -65.29 107.59 1.66 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -86.66 165.44 16.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.07 -41.85 84.25 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.495 0.664 . . . . 0.0 109.6 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -60.09 -51.87 67.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.976 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -59.14 -49.92 76.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.9 mt -54.37 -53.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.2 -41.99 72.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.647 0.779 . . . . 0.0 111.564 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.74 -53.49 15.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.37 0.268 . . . . 0.0 110.522 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -45.88 -46.99 16.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.069 1.347 . . . . 0.0 113.588 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.6 -31.42 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -82.89 -14.99 53.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.158 0.983 . . . . 0.0 111.925 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -145.28 54.17 2.3 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.752 1.221 . . . . 0.0 112.693 -173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.41 141.17 94.94 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.253 1.969 . . . . 0.0 109.313 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.75 -63.8 3.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -48.69 -44.59 38.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 111.242 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -53.42 -54.47 36.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 110.445 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.23 -48.75 80.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.061 0.544 . . . . 0.0 110.377 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -54.64 -49.59 70.17 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.283 0.633 . . . . 0.0 110.757 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -50.01 -47.92 52.77 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.53 0.732 . . . . 0.0 111.234 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.27 -55.56 4.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.9 tp -74.93 -24.13 58.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.483 1.113 . . . . 0.0 113.69 -173.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 t0 52.23 56.78 7.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.717 1.607 . . . . 0.0 111.414 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -146.45 135.42 22.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.363 1.065 . . . . 0.0 108.198 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.116 0.566 . . . . 0.0 109.935 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.86 3.72 11.39 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.99 61.23 3.12 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.688 0.795 . . . . 0.0 110.029 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -95.65 -178.57 4.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.871 1.268 . . . . 0.0 109.559 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 t -147.66 150.02 33.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -17.69 68.23 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 ttt -66.83 78.4 0.12 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.044 0.938 . . . . 0.0 113.023 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.45 58.1 3.06 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.003 0.921 . . . . 0.0 109.163 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -165.79 140.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.547 1.539 . . . . 0.0 107.452 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.61 163.32 31.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.4 tp -155.98 111.32 2.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.19 32.51 0.28 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.7 -0.625 . . . . 0.0 112.347 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -160.02 -178.01 6.71 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 127.589 2.355 . . . . 0.0 106.432 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.2 -56.01 3.2 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.387 -0.674 . . . . 0.0 112.829 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -18.78 -63.9 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.892 2.663 . . . . 0.0 115.933 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 2.0 pm0 -61.92 -46.36 89.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.146 0.979 . . . . 0.0 111.622 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -62.77 -48.14 80.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.137 0.975 . . . . 0.0 108.719 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.33 -44.32 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.0 0.52 . . . . 0.0 109.754 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.46 -47.28 82.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.813 0.733 . . . . 0.0 110.617 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.36 93.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.898 0.38 . . . . 0.0 110.753 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -56.17 -52.16 65.4 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.869 0.468 . . . . 0.0 109.873 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.85 -45.06 90.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.579 -0.7 . . . . 0.0 110.984 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.99 87.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.622 0.769 . . . . 0.0 111.28 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.1 p -71.8 -34.75 69.62 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.049 -0.407 . . . . 0.0 111.256 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.96 -47.66 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.768 1.227 . . . . 0.0 111.916 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.831 0.824 . . . . 0.0 112.35 -175.913 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.228 0.349 . . . . 0.0 113.619 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.04 84.11 0.98 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 109.94 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.85 -37.25 29.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.851 0.86 . . . . 0.0 112.443 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.36 -52.51 63.35 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.657 -0.652 . . . . 0.0 109.94 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -57.97 -39.22 77.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.6 -48.61 69.87 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.7 -49.03 74.09 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.973 0.509 . . . . 0.0 109.741 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -61.61 -47.96 83.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.625 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -54.31 -38.77 66.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 110.323 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -56.08 -17.39 6.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.709 0.804 . . . . 0.0 112.984 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -56.03 -26.06 47.31 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.286 -0.884 . . . . 0.0 111.297 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -77.8 -51.58 10.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.0 m -50.96 -42.08 59.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.311 1.044 . . . . 0.0 111.941 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -56.68 -21.91 31.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 m -56.4 -27.71 57.16 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.922 -0.486 . . . . 0.0 110.304 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -118.66 -43.83 2.67 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.613 0.765 . . . . 0.0 111.441 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -93.85 174.94 6.92 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 124.767 1.227 . . . . 0.0 113.32 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -141.27 161.76 37.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.717 1.207 . . . . 0.0 109.872 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.1 mt -138.15 106.88 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 103.412 -2.811 . . . . 0.0 103.412 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -122.77 125.69 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.463 1.105 . . . . 0.0 109.9 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 159.17 20.61 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.406 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.18 -38.38 81.16 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.775 2.317 . . . . 0.0 110.916 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.52 3.89 4.43 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.513 1.525 . . . . 0.0 113.128 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.52 65.98 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 120.733 -1.23 . . . . 0.0 112.873 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -57.07 114.45 2.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.556 1.178 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -74.29 73.12 1.81 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.455 0.702 . . . . 0.0 111.356 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.1 mm -50.27 -48.19 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.774 0.83 . . . . 0.0 109.175 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.3 102.46 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -76.12 58.51 1.23 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 108.963 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.81 174.21 42.43 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.92 176.11 3.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.161 0.505 . . . . 0.0 111.529 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -118.59 24.11 11.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.369 1.068 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -64.37 -38.29 90.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.98 169.88 13.35 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 169.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.63 178.24 1.02 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.717 3.612 . . . . 0.0 114.431 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -92.61 89.53 6.74 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.804 1.242 . . . . 0.0 111.356 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.36 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.687 2.395 . . . . 0.0 116.19 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -64.22 85.31 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 120.653 1.57 . . . . 0.0 109.61 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.58 56.9 3.73 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -33.34 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 117.673 0.737 . . . . 0.0 109.796 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.6 t -54.29 118.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.096 0.958 . . . . 0.0 110.265 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 -17.29 59.58 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.576 1.084 . . . . 0.0 112.33 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 138.88 40.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.139 1.469 . . . . 0.0 110.005 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.3 m -62.43 133.39 54.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.36 137.42 52.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.002 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.56 29.88 65.11 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.272 -1.293 . . . . 0.0 114.23 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.3 p -133.89 -3.78 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.403 1.602 . . . . 0.0 115.076 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.68 122.36 76.1 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.777 1.626 . . . . 0.0 107.341 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -56.29 162.12 8.21 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.386 2.057 . . . . 0.0 114.418 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 61.3 56.39 2.68 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.848 1.659 . . . . 0.0 111.871 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -164.22 121.12 1.65 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.88 0.371 . . . . 0.0 111.828 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -74.93 87.46 2.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.664 0.786 . . . . 0.0 109.456 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.47 167.69 14.28 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -99.78 156.39 17.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.925 0.89 . . . . 0.0 110.122 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -48.88 -43.28 38.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.085 1.354 . . . . 0.0 113.69 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 m -65.14 -52.99 51.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.845 0.355 . . . . 0.0 111.085 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 tt -65.05 -36.72 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.548 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.64 -48.45 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.14 96.72 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.035 -0.416 . . . . 0.0 111.246 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -50.61 65.93 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.06 -53.01 47.87 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.028 0.823 . . . . 0.0 111.94 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.88 -26.67 37.24 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 125.286 1.435 . . . . 0.0 111.874 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -71.83 3.71 3.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 175.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.76 40.51 7.64 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.383 1.468 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -102.79 105.23 15.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.79 129.07 40.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.986 1.314 . . . . 0.0 108.501 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -62.78 109.53 1.46 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.119 0.418 . . . . 0.0 111.751 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.3 p -91.35 164.07 13.98 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.43 -43.38 75.31 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.401 0.619 . . . . 0.0 110.876 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.97 -46.16 72.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.62 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -57.13 -50.09 73.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.671 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.74 -55.58 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.325 0.511 . . . . 0.0 109.851 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.89 -37.4 60.56 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.447 0.699 . . . . 0.0 111.628 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.6 m -72.53 -63.44 1.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -36.17 -54.08 0.8 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.448 2.299 . . . . 0.0 113.8 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 m -48.78 -32.97 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.27 -33.53 65.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.483 0.713 . . . . 0.0 112.684 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -135.98 57.05 16.44 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -60.41 145.78 98.01 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.29 1.327 . . . . 0.0 110.835 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.07 -64.04 4.11 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.44 80.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.94 0.496 . . . . 0.0 110.131 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -54.46 -53.85 48.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.961 0.904 . . . . 0.0 110.327 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -57.57 -53.83 53.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.601 0.36 . . . . 0.0 110.427 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -47.78 -47.38 30.74 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 110.601 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.03 -66.31 0.56 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.091 0.556 . . . . 0.0 110.51 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -53.9 -43.12 69.42 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -84.79 -5.22 59.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.968 0.907 . . . . 0.0 111.825 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t0 48.63 56.36 7.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.024 1.33 . . . . 0.0 109.609 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -142.49 157.13 45.07 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.097 0.959 . . . . 0.0 110.298 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -95.1 -46.83 6.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.94 2.096 . . . . 0.0 107.628 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -76.43 43.71 0.32 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.485 1.514 . . . . 0.0 111.78 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.73 118.25 29.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.006 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -151.23 140.3 21.13 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.12 0.968 . . . . 0.0 108.738 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -103.55 156.22 17.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -24.16 58.44 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.6 ttp -63.21 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.789 0.795 . . . . 0.0 113.095 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.62 57.3 3.29 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -160.44 149.91 17.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.444 1.898 . . . . 0.0 106.372 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -143.42 158.81 43.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.5 tp -130.89 115.75 16.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.94 50.47 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.159 0.984 . . . . 0.0 112.067 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -133.82 135.21 43.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.33 1.452 . . . . 0.0 107.839 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.12 61.26 4.38 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.558 -2.617 . . . . 0.0 106.558 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.94 65.01 0.0 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 129.794 3.569 . . . . 0.0 117.192 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.66 -34.58 78.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.087 0.955 . . . . 0.0 109.255 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -61.09 -52.09 66.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.098 1.359 . . . . 0.0 109.618 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.66 -45.52 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 123.784 0.834 . . . . 0.0 109.592 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.25 85.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.141 -0.349 . . . . 0.0 110.777 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.036 -0.415 . . . . 0.0 110.544 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -58.55 -54.23 49.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.77 -32.88 67.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.247 0.619 . . . . 0.0 111.522 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.9 -54.21 24.37 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.547 0.612 . . . . 0.0 109.783 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 97.4 p -57.75 -32.29 67.32 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.906 -0.497 . . . . 0.0 112.236 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.28 -26.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.715 0.806 . . . . 0.0 111.412 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 t . . . . . 0 CA--C 1.538 0.507 0 CA-C-N 119.122 0.874 . . . . 0.0 108.965 176.594 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 CA-C-O 122.025 0.792 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.0 68.95 0.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.153 1.781 . . . . 0.0 111.659 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.073 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.55 79.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.749 0.82 . . . . 0.0 111.594 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -71.78 -41.0 68.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.43 -44.09 45.03 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.179 0.895 . . . . 0.0 111.751 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -51.51 -53.46 37.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.732 0.813 . . . . 0.0 110.446 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -65.34 -46.62 79.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.476 0.711 . . . . 0.0 109.971 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.63 -39.77 65.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.305 1.042 . . . . 0.0 109.604 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -57.66 -19.37 26.18 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -30.76 62.43 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.327 -0.858 . . . . 0.0 109.775 174.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.79 -54.97 9.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.2 m -50.23 -41.06 49.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.636 1.574 . . . . 0.0 111.274 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -46.98 -31.69 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.389 1.875 . . . . 0.0 112.663 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.0 m -56.51 -28.98 61.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.384 0.673 . . . . 0.0 111.557 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.5 m -121.66 -36.19 3.09 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.952 0.901 . . . . 0.0 112.646 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -105.64 168.77 8.88 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.77 1.228 . . . . 0.0 112.791 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.2 p -138.13 166.82 23.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.956 1.302 . . . . 0.0 110.359 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.4 114.37 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.4 ' N ' HD21 ' A' ' 36' ' ' ASN . 2.6 tp -109.8 134.45 51.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.636 1.174 . . . . 0.0 110.072 -175.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.92 159.97 82.07 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 121.126 -0.984 . . . . 0.0 108.416 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.18 -40.93 68.11 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.906 2.404 . . . . 0.0 112.519 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.5 -8.06 55.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.373 1.469 . . . . 0.0 113.58 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.89 -17.24 45.61 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.947 -0.918 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.2 m -58.63 121.83 11.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.66 1.73 . . . . 0.0 109.44 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.99 113.55 5.78 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.24 -50.36 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.24 99.65 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' H ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -74.5 56.76 0.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.503 1.921 . . . . 0.0 109.507 176.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.61 -179.06 42.28 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.72 174.04 5.55 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.116 0.484 . . . . 0.0 111.419 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -118.36 26.88 9.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 109.896 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -65.44 -42.16 92.69 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.18 173.37 20.53 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.74 -177.1 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.163 3.242 . . . . 0.0 112.227 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 20' ' ' ILE . 18.2 t-20 -100.71 104.96 16.26 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.5 14.04 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -71.1 81.6 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.261 1.391 . . . . 0.0 109.254 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 53.79 1.01 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.794 0.711 . . . . 0.0 114.175 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.13 -41.84 31.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 117.461 0.63 . . . . 0.0 109.711 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t -52.56 119.41 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 121.215 -0.928 . . . . 0.0 110.896 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 -18.88 56.69 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.879 1.228 . . . . 0.0 111.832 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -65.78 138.9 58.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.9 0.85 . . . . 0.0 111.074 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -71.66 70.82 0.7 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 0.0 111.058 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 58.08 -143.58 0.64 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.638 0.775 . . . . 0.0 109.938 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.3 83.35 0.13 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.54 1.067 . . . . 0.0 113.284 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.2 t -147.51 40.98 1.03 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.016 0.408 . . . . 0.0 111.9 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.97 128.89 58.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -55.97 155.29 23.81 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.374 1.383 . . . . 0.0 112.395 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 54.58 57.94 5.32 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 0.0 112.62 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -158.45 119.11 3.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.785 0.434 . . . . 0.0 110.001 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -79.15 86.72 4.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.387 0.675 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -68.17 -174.63 0.51 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.47 0.652 . . . . 0.0 110.967 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -114.75 172.74 6.85 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.991 1.316 . . . . 0.0 109.83 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.55 -41.92 86.68 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.958 1.303 . . . . 0.0 112.435 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 p -63.17 -65.42 0.69 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.286 1.435 . . . . 0.0 110.564 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.23 -35.01 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.638 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.82 -50.57 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.28 81.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.068 -0.395 . . . . 0.0 111.311 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -55.72 -50.76 69.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.3 -53.93 39.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.36 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.831 0.852 . . . . 0.0 112.742 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.8 p -68.63 -9.16 48.22 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.68 7.62 23.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.436 1.017 . . . . 0.0 112.805 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -68.44 138.25 55.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.744 1.272 . . . . 0.0 109.26 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.27 128.03 39.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 106.994 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -60.49 147.42 41.29 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -142.25 166.43 24.72 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.415 1.886 . . . . 0.0 106.207 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.48 -41.47 73.04 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.799 0.272 . . . . 0.0 110.48 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.62 -51.48 62.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.351 0.66 . . . . 0.0 110.595 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.13 -48.08 81.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.181 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mm -57.22 -55.6 19.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.72 -41.08 42.75 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.828 1.251 . . . . 0.0 111.19 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -71.52 -55.86 7.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.831 0.348 . . . . 0.0 110.224 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -50.68 -45.62 58.29 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.3 -33.58 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.95 2.98 53.86 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.423 0.689 . . . . 0.0 112.761 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -148.3 62.68 6.73 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.229 1.012 . . . . 0.0 112.428 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.16 140.69 93.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.171 1.914 . . . . 0.0 109.772 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.38 -64.7 1.03 Allowed Glycine 0 CA--C 1.533 1.18 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.0 -45.61 7.94 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.991 1.716 . . . . 0.0 111.346 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.0 -55.92 25.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.165 0.586 . . . . 0.0 110.938 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -57.95 -46.42 85.13 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.389 0.675 . . . . 0.0 110.693 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -53.81 -53.01 58.37 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -54.13 -57.36 11.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.221 0.608 . . . . 0.0 111.009 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.31 -54.54 39.15 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -88.87 -25.06 22.35 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -170.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 54.44 49.5 18.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.749 1.219 . . . . 0.0 110.036 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -117.42 128.57 55.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 108.761 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -51.37 -43.52 61.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.651 1.18 . . . . 0.0 111.057 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -91.13 27.09 1.96 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.79 65.46 1.03 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.599 0.714 . . . . 0.0 111.845 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -91.0 -177.94 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.785 2.034 . . . . 0.0 109.434 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 t -158.46 150.47 21.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.41 -26.18 71.66 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 16.4 ttp -65.32 82.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.36 58.36 4.06 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.206 -0.934 . . . . 0.0 109.201 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -165.89 151.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.404 1.482 . . . . 0.0 107.184 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -143.42 166.51 24.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.225 0.466 . . . . 0.0 110.205 170.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.11 115.97 28.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.75 52.81 2.0 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.594 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.93 169.8 17.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.345 1.458 . . . . 0.0 107.764 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.33 -17.89 68.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.382 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.53 1.99 73.13 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 118.157 0.978 . . . . 0.0 114.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -46.29 88.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.674 1.237 . . . . 0.0 111.194 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -55.08 -51.43 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.264 1.426 . . . . 0.0 110.72 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.89 -50.87 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.76 1.224 . . . . 0.0 110.247 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.72 -46.49 81.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.391 -0.193 . . . . 0.0 110.615 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.48 93.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.852 0.461 . . . . 0.0 110.17 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -59.33 -49.04 79.37 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.036 -0.415 . . . . 0.0 110.67 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.3 mt -60.02 -45.74 91.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.647 0.658 . . . . 0.0 110.758 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.22 79.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.387 0.275 . . . . 0.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.7 m -66.59 -40.66 89.01 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.123 -0.361 . . . . 0.0 111.321 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.1 -43.56 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.747 1.219 . . . . 0.0 112.675 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.481 0.658 . . . . 0.0 112.291 -175.131 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.06 93.32 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.785 -0.832 . . . . 0.0 109.005 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.39 34.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 112.808 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.83 -54.99 22.35 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.913 0.778 . . . . 0.0 109.695 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -56.69 -41.2 76.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 0.0 110.123 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.64 -49.56 57.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -54.97 -52.2 63.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.551 0.74 . . . . 0.0 110.041 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -57.67 -53.13 61.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.2 -26.11 62.41 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 126.478 1.911 . . . . 0.0 112.09 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -56.63 -18.97 13.93 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.184 0.447 . . . . 0.0 110.98 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -53.38 -32.9 51.6 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.657 -0.652 . . . . 0.0 111.134 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.73 -53.16 29.67 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -51.46 -45.01 62.58 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.308 1.043 . . . . 0.0 110.889 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -47.85 -30.54 4.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 113.061 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -52.59 -38.03 59.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.057 0.543 . . . . 0.0 110.978 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -112.61 -40.3 4.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.481 ' CG ' HD21 ' A' ' 37' ' ' LEU . 97.3 m-70 -100.55 -174.01 2.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.247 1.019 . . . . 0.0 113.233 -170.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -152.16 173.17 15.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.574 1.549 . . . . 0.0 109.025 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.95 131.41 52.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 tp -116.79 145.37 22.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.753 1.621 . . . . 0.0 109.536 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.19 160.01 76.76 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 119.432 1.015 . . . . 0.0 108.321 173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.99 -36.86 93.6 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.439 2.093 . . . . 0.0 110.214 172.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.13 -1.4 7.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.398 1.879 . . . . 0.0 113.135 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.22 -18.36 45.72 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 120.728 -1.232 . . . . 0.0 112.362 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -53.99 122.13 9.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.205 1.002 . . . . 0.0 110.906 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.86 78.74 1.14 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.326 0.65 . . . . 0.0 110.616 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.85 -60.47 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.01 98.75 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.09 63.23 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.735 1.214 . . . . 0.0 109.738 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.87 -156.77 32.98 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.88 6.7 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -124.68 33.84 5.14 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.53 -34.88 76.63 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.27 176.8 17.69 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 168.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.0 -171.07 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.676 2.917 . . . . 0.0 111.698 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -117.48 101.37 8.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -68.55 0.94 3.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.01 109.87 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.97 1.259 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.53 20.02 55.31 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.573 -0.571 . . . . 0.0 112.391 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.87 -37.82 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.354 1.077 . . . . 0.0 109.047 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.4 107.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.059 0.944 . . . . 0.0 110.428 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 -5.7 72.08 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 112.482 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -92.41 138.16 31.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.84 0.82 . . . . 0.0 110.367 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -56.41 127.21 29.95 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.937 1.295 . . . . 0.0 111.347 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.99 149.29 19.22 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.615 -0.678 . . . . 0.0 111.153 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.47 42.43 99.0 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.332 -1.26 . . . . 0.0 115.187 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.7 p -142.17 1.04 1.4 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.465 1.632 . . . . 0.0 114.846 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -69.19 134.71 89.27 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 120.445 1.475 . . . . 0.0 109.723 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.27 154.37 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.989 2.46 . . . . 0.0 115.685 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.27 60.8 3.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.078 1.751 . . . . 0.0 112.66 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -154.66 118.9 4.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.026 0.441 . . . . 0.0 110.837 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.29 80.28 1.84 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.99 0.916 . . . . 0.0 110.586 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -68.55 176.26 3.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.484 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -107.45 170.58 7.88 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.937 0.895 . . . . 0.0 109.942 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.1 -46.41 89.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.173 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 p -60.96 -65.39 0.7 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.845 1.258 . . . . 0.0 111.069 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.99 -42.88 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.095 0.958 . . . . 0.0 110.837 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -44.83 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.997 . . . . 0.0 110.032 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.4 82.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.705 0.684 . . . . 0.0 110.528 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.9 tp -57.85 -48.26 80.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.28 -56.29 17.88 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 123.887 0.756 . . . . 0.0 111.755 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.88 55.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.438 1.495 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 m -71.53 5.18 2.51 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.88 21.33 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.146 1.355 . . . . 0.0 111.242 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -82.54 77.9 9.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.788 -0.83 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 116.6 13.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -57.81 139.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -122.64 162.9 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.208 1.403 . . . . 0.0 107.385 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -54.2 -43.29 70.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -53.46 54.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.589 0.756 . . . . 0.0 110.407 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -60.48 -45.13 94.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.993 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.1 mt -58.0 -55.94 18.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.65 -40.17 62.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.868 0.867 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.7 m -68.04 -63.99 0.95 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.51 -51.87 2.87 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.094 1.757 . . . . 0.0 112.925 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.0 m -54.67 -33.59 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -72.39 -29.56 63.85 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.77 -0.581 . . . . 0.0 111.862 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -138.47 61.89 27.2 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -65.35 153.59 77.53 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 CA-C-N 120.086 1.066 . . . . 0.0 110.588 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.43 -66.65 2.62 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.07 -44.2 51.61 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.284 1.034 . . . . 0.0 111.243 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -51.95 -57.17 10.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.647 0.779 . . . . 0.0 110.106 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.511 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 5.3 mp -56.82 -54.21 49.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.857 0.463 . . . . 0.0 110.755 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -50.37 -42.4 53.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.04 0.536 . . . . 0.0 110.989 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.75 -66.35 0.57 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.354 0.662 . . . . 0.0 110.19 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -54.5 -43.38 71.79 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -88.85 1.07 55.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.703 1.201 . . . . 0.0 111.255 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t0 41.92 54.44 3.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.964 1.706 . . . . 0.0 110.967 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -147.91 122.06 9.53 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.631 0.772 . . . . 0.0 112.534 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -53.47 -45.23 69.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.626 1.57 . . . . 0.0 110.301 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -73.92 5.63 4.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 83' ' ' LEU . . . -82.08 72.15 9.13 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.377 -1.452 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -82.46 164.3 21.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.459 1.104 . . . . 0.0 108.827 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.4 t -142.02 149.45 40.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.29 -29.84 72.44 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 ttp -62.05 83.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.8 57.38 3.79 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -159.73 149.85 18.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -139.37 153.26 47.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.8 tp -113.37 107.81 16.37 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.08 66.72 3.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.918 0.887 . . . . 0.0 109.89 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 84.14 146.13 0.07 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 128.583 2.753 . . . . 0.0 109.988 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.77 -26.54 5.1 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.02 -40.76 10.18 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.401 1.476 . . . . 0.0 113.085 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.57 -48.9 79.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.717 0.758 . . . . 0.0 110.579 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -61.14 -48.33 82.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.211 1.004 . . . . 0.0 109.456 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.41 -40.87 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.701 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.6 89.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.604 -0.685 . . . . 0.0 109.963 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.42 90.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.08 -53.23 59.54 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.1 mt -55.27 -47.81 74.95 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.117 0.417 . . . . 0.0 110.913 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.38 77.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.4 m -70.36 -40.58 73.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.032 -0.417 . . . . 0.0 110.674 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.23 -44.68 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.468 1.507 . . . . 0.0 112.698 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 121.744 0.783 . . . . 0.0 112.592 -176.247 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.079 0.266 . . . . 0.0 112.814 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.19 76.69 0.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.717 1.607 . . . . 0.0 111.044 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.11 10.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.432 1.093 . . . . 0.0 112.18 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.4 -54.17 49.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.535 0.734 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.03 -34.47 74.89 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.89 -56.24 24.95 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.31 -37.4 87.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.165 0.983 . . . . 0.0 111.357 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -60.96 -50.9 71.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.729 0.695 . . . . 0.0 109.737 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -57.2 -34.11 68.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.7 1.2 . . . . 0.0 110.273 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 19' ' ' ILE . 3.6 t80 -56.16 -21.73 24.59 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -55.38 -36.3 66.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.668 0.667 . . . . 0.0 110.278 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -69.82 -52.68 22.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.9 m -50.72 -40.8 55.29 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.378 1.071 . . . . 0.0 111.749 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -48.35 -30.93 5.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 112.31 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.6 m -59.32 -22.46 61.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.497 0.719 . . . . 0.0 111.505 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.4 m -124.84 -34.58 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.378 1.071 . . . . 0.0 112.771 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -110.21 170.33 8.15 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.581 1.152 . . . . 0.0 114.081 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.4 m -141.89 166.05 25.78 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.427 1.091 . . . . 0.0 110.295 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.457 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 2.3 mp -139.65 124.47 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 106.865 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.14 132.21 58.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.514 1.126 . . . . 0.0 110.175 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 154.01 71.74 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.58 -35.37 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.036 2.491 . . . . 0.0 112.097 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.81 -9.27 58.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.351 1.06 . . . . 0.0 113.144 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.31 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.999 -0.889 . . . . 0.0 113.404 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.7 m -62.39 108.28 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.489 1.644 . . . . 0.0 110.331 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.49 134.53 57.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.64 0.776 . . . . 0.0 110.659 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 mm -105.29 -50.34 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.08 96.47 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -84.21 70.17 10.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.94 -154.12 26.86 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.26 175.53 10.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -125.77 32.57 5.26 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.944 0.897 . . . . 0.0 109.232 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.3 m -64.73 -36.98 86.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.35 173.02 14.61 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.56 179.6 1.23 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.372 3.382 . . . . 0.0 113.91 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -92.34 103.85 16.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.261 1.024 . . . . 0.0 110.036 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.64 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -70.03 85.12 0.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.268 1.849 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.96 58.37 2.65 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.36 0.981 . . . . 0.0 113.265 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.37 -39.33 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 O-C-N 122.219 -0.577 . . . . 0.0 110.966 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.56 119.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.014 0.525 . . . . 0.0 110.504 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.08 -21.94 41.38 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.673 1.13 . . . . 0.0 111.602 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' NH1' ' H ' ' A' ' 44' ' ' THR . 3.9 tpm_? -68.26 138.24 55.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.441 1.12 . . . . 0.0 110.886 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.413 ' H ' ' NH1' ' A' ' 43' ' ' ARG . 2.7 m -65.02 72.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.434 1.894 . . . . 0.0 111.675 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.59 -145.25 0.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.461 -0.774 . . . . 0.0 109.431 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.04 78.25 1.26 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -138.7 14.62 2.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.591 0.756 . . . . 0.0 111.621 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -64.96 127.01 92.33 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.36 172.12 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.403 2.068 . . . . 0.0 115.779 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 46.01 57.47 5.16 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.256 1.822 . . . . 0.0 111.825 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -164.37 122.46 1.77 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.489 0.316 . . . . 0.0 110.761 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.26 95.32 4.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.057 0.943 . . . . 0.0 110.24 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.2 -178.69 5.21 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.353 0.661 . . . . 0.0 111.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.92 177.48 4.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.23 -35.23 75.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.021 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 p -63.29 -66.65 0.51 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.556 1.142 . . . . 0.0 110.627 -173.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tt -57.43 -37.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.123 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.7 -47.58 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.55 84.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.056 0.389 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.8 tp -55.41 -50.11 70.61 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.11 -54.86 29.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.95 -31.56 60.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.113 0.965 . . . . 0.0 112.225 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -72.03 3.07 4.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.14 29.38 10.4 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.142 0.877 . . . . 0.0 111.616 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -90.76 140.44 29.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -60.37 148.37 37.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 123.053 0.541 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.7 p -142.71 166.31 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -54.8 -41.06 70.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.72 -56.13 15.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.108 0.963 . . . . 0.0 109.719 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.03 -52.15 61.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.278 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.5 mt -56.87 -54.69 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.67 -40.32 53.31 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.054 0.942 . . . . 0.0 111.667 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -70.75 -60.95 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -43.49 -51.92 6.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.061 1.344 . . . . 0.0 113.602 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.6 m -51.28 -38.49 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -90.81 -8.49 49.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.23 55.17 3.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.878 0.871 . . . . 0.0 111.576 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.66 147.17 85.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.917 1.745 . . . . 0.0 109.868 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.36 -64.46 4.26 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.7 61.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.389 0.676 . . . . 0.0 109.993 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -48.52 -51.54 26.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.774 1.23 . . . . 0.0 111.338 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.49 -58.94 4.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -49.5 -38.91 32.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 111.615 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -53.42 -39.91 64.7 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.456 0.702 . . . . 0.0 111.842 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -97.21 -53.32 3.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.318 1.047 . . . . 0.0 111.741 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.7 tp -78.86 -22.92 45.33 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.776 1.23 . . . . 0.0 113.228 -175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t0 41.57 63.62 1.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.486 1.914 . . . . 0.0 113.216 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.43 145.29 45.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 108.282 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.38 -38.46 58.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.188 0.995 . . . . 0.0 110.842 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.21 21.71 13.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.0 0.92 . . . . 0.0 112.855 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.84 5.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -126.22 142.52 51.5 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.429 1.492 . . . . 0.0 108.636 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -94.37 150.08 20.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.965 0.906 . . . . 0.0 109.164 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -55.02 -27.03 43.93 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.974 -0.454 . . . . 0.0 111.994 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.2 ttp -59.64 86.5 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 113.343 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.39 57.93 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.91 155.79 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.537 1.935 . . . . 0.0 106.331 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -145.35 170.94 15.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.2 tp -97.23 166.48 11.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.55 37.88 4.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -143.93 170.79 15.25 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.661 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -12.97 35.28 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.707 -1.052 . . . . 0.0 113.35 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.04 -32.07 1.76 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 118.475 1.138 . . . . 0.0 114.638 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.23 -38.41 3.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 113.281 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -61.13 -49.21 78.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.674 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.56 -41.72 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.39 90.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.699 0.4 . . . . 0.0 110.546 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.47 94.48 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.79 0.436 . . . . 0.0 109.932 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -55.9 -54.3 46.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.1 mt -57.32 -37.12 72.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.426 0.69 . . . . 0.0 111.716 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.4 89.06 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.457 -0.777 . . . . 0.0 109.146 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.4 t -59.73 -29.31 68.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.73 -0.606 . . . . 0.0 111.924 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.45 -29.35 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 O-C-N 121.845 -0.534 . . . . 0.0 110.749 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 124.501 1.12 . . . . 0.0 109.748 178.121 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.107 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.92 73.84 0.6 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.584 1.154 . . . . 0.0 111.707 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.98 -39.08 25.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.195 0.998 . . . . 0.0 111.949 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.43 82.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.391 0.676 . . . . 0.0 111.231 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.89 -41.72 77.9 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.88 -46.65 40.4 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.021 0.82 . . . . 0.0 111.94 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -52.52 -54.27 34.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.475 0.71 . . . . 0.0 110.527 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.47 -47.53 83.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.901 0.48 . . . . 0.0 110.159 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -53.86 -39.19 65.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.353 1.061 . . . . 0.0 109.849 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.16 -22.3 27.89 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.43 -31.29 54.99 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.646 -0.659 . . . . 0.0 110.048 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -71.33 -52.75 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 m -51.18 -43.0 61.22 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.656 1.182 . . . . 0.0 110.637 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -49.16 -25.88 2.46 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.131 1.772 . . . . 0.0 112.279 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -53.95 -42.58 69.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.211 1.368 . . . . 0.0 110.281 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.8 m -106.95 -42.22 4.97 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.743 0.817 . . . . 0.0 112.401 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -92.7 167.27 12.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.583 1.153 . . . . 0.0 112.885 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -140.15 147.21 39.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.32 124.98 73.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.86 133.99 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.332 1.853 . . . . 0.0 107.853 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.56 158.04 86.45 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.46 -38.7 74.78 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.943 2.429 . . . . 0.0 112.646 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -74.29 -10.54 59.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.164 1.385 . . . . 0.0 113.663 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.33 -18.65 32.84 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.83 -0.984 . . . . 0.0 113.63 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -57.18 118.71 5.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.698 . . . . 0.0 109.556 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.61 125.66 26.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.819 0.447 . . . . 0.0 110.405 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 mm -85.06 -52.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.0 m -146.57 136.12 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -113.36 135.55 53.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.72 -172.87 19.93 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 124.434 1.016 . . . . 0.0 110.977 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.02 44.89 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.596 -0.944 . . . . 0.0 109.611 175.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 tptp 15.94 57.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 130.28 3.432 . . . . 0.0 113.61 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.12 -32.16 14.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.3 167.85 12.46 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 174.05 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.421 3.414 . . . . 0.0 113.526 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.44 115.52 17.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.36 7.02 44.75 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -48.73 106.78 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.091 0.86 . . . . 0.0 111.58 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.03 42.96 95.26 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.12 -36.86 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 117.274 0.537 . . . . 0.0 111.565 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.5 116.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.57 -19.15 55.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.256 0.931 . . . . 0.0 111.802 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.05 148.09 32.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 117.731 0.765 . . . . 0.0 109.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 m -61.48 127.02 29.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.796 0.838 . . . . 0.0 109.931 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.88 154.8 41.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 111.758 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.52 27.1 63.04 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.023 -0.876 . . . . 0.0 114.749 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.8 t -155.32 20.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.676 1.238 . . . . 0.0 112.77 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.22 126.11 92.31 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.54 171.75 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 CA-C-N 121.099 1.428 . . . . 0.0 115.735 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 50.64 55.18 9.91 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.749 1.62 . . . . 0.0 111.404 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -166.04 123.4 1.42 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.169 -0.332 . . . . 0.0 111.377 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -83.42 99.64 10.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.498 1.119 . . . . 0.0 109.089 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -85.0 -170.39 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.856 0.862 . . . . 0.0 111.962 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.71 175.89 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.959 1.703 . . . . 0.0 109.552 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.93 -43.67 82.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.357 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 t -70.85 -47.93 56.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.091 0.472 . . . . 0.0 111.145 -173.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -67.02 -34.91 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.08 -45.56 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.79 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 111.406 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 mt -55.86 -49.16 74.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.41 39.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -37.29 74.31 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.274 1.029 . . . . 0.0 110.779 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 t -72.88 4.05 4.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.19 61.44 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 119.14 0.882 . . . . 0.0 111.934 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -71.99 108.28 5.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.984 0.892 . . . . 0.0 109.517 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.61 122.46 37.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -57.44 153.31 12.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p -133.77 169.8 16.51 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.554 1.141 . . . . 0.0 108.153 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -57.59 -46.42 84.04 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.665 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.1 -47.72 73.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.03 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.55 -49.73 76.65 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.87 -50.95 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 118.116 0.416 . . . . 0.0 110.106 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.38 -38.29 52.62 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.074 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -73.45 -58.29 3.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -44.68 -47.24 10.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.176 1.391 . . . . 0.0 113.74 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.44 -36.41 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 119.138 0.881 . . . . 0.0 113.308 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -100.14 2.26 42.88 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.842 0.857 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -142.35 56.52 5.46 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.408 1.483 . . . . 0.0 110.997 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.04 138.97 64.88 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.244 1.962 . . . . 0.0 109.436 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.1 -60.45 2.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.58 -45.47 9.48 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.692 1.597 . . . . 0.0 111.876 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.07 -44.74 96.02 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.151 -0.619 . . . . 0.0 111.663 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.92 -51.09 70.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.792 0.837 . . . . 0.0 109.012 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -52.56 -52.37 55.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.586 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -55.96 -53.36 57.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 111.12 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -66.92 -52.13 46.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.57 -18.54 48.01 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.7 t0 56.35 53.83 8.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.33 1.452 . . . . 0.0 109.275 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -134.27 128.41 33.77 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.615 1.166 . . . . 0.0 109.87 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.22 -37.2 79.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.525 1.13 . . . . 0.0 110.527 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -85.72 15.93 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.9 65.54 8.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.892 0.853 . . . . 0.0 110.439 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.37 108.25 19.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 109.666 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -63.11 156.4 25.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.75 -21.69 79.52 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.7 ttp -68.94 82.01 0.31 Allowed 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.725 -0.867 . . . . 0.0 112.755 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.99 57.33 2.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.474 0.71 . . . . 0.0 109.479 174.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -163.13 148.19 11.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.808 1.643 . . . . 0.0 107.789 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -142.54 164.95 28.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.21 1.004 . . . . 0.0 109.589 173.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.32 115.56 26.15 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.25 55.05 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.89 0.476 . . . . 0.0 110.034 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -132.43 168.08 18.8 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 125.624 1.57 . . . . 0.0 108.721 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.06 -19.42 59.11 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.752 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.85 1.9 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.061 0.93 . . . . 0.0 113.703 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -41.11 -44.11 2.41 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.072 1.749 . . . . 0.0 113.832 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -62.14 -45.55 92.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.117 0.967 . . . . 0.0 110.986 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.32 -45.0 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.11 0.964 . . . . 0.0 108.897 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.02 91.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.346 0.658 . . . . 0.0 110.339 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.22 97.28 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.875 0.47 . . . . 0.0 110.01 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.86 -52.58 64.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.66 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -57.29 -42.36 81.54 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.011 -0.431 . . . . 0.0 111.117 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.48 -41.45 73.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.918 0.487 . . . . 0.0 110.174 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -63.19 -30.01 71.24 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.968 -0.457 . . . . 0.0 111.912 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.83 -29.97 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.063 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.342 0.26 0 C-N-CA 125.522 1.529 . . . . 0.0 112.72 -176.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.065 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -90.37 106.01 18.2 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.876 1.27 . . . . 0.0 108.777 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.7 -31.43 26.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.329 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.54 12.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.354 0.979 . . . . 0.0 110.248 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -56.28 -38.56 71.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.768 -0.583 . . . . 0.0 109.551 174.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.99 -51.1 52.13 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.67 -47.89 82.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.279 1.032 . . . . 0.0 110.279 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -57.25 -52.71 64.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.164 0.185 . . . . 0.0 110.677 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.93 -35.96 67.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.518 1.127 . . . . 0.0 110.211 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.52 -27.16 62.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.069 0.548 . . . . 0.0 112.134 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -30.47 63.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.383 0.538 . . . . 0.0 110.043 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -93.13 -50.26 5.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.036 0.934 . . . . 0.0 109.48 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -33.92 42.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -58.58 -14.81 9.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 114.347 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -56.09 -17.76 7.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.246 -0.909 . . . . 0.0 112.338 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.4 m -124.02 -27.27 3.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.966 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -117.81 165.9 13.11 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.922 0.783 . . . . 0.0 112.941 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -140.39 164.68 29.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.289 1.035 . . . . 0.0 111.629 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.18 121.87 24.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 125.661 1.584 . . . . 0.0 107.854 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -116.54 134.39 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.602 1.561 . . . . 0.0 108.169 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.66 160.24 77.92 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 119.114 0.87 . . . . 0.0 108.94 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.31 -40.95 69.11 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.108 2.538 . . . . 0.0 112.7 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -74.52 -8.28 55.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.145 1.378 . . . . 0.0 113.594 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.79 -18.85 42.81 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.963 -0.909 . . . . 0.0 113.394 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -60.51 117.64 5.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.6 1.7 . . . . 0.0 108.867 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -68.18 129.97 41.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.83 -46.09 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.2 93.48 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -77.0 90.67 3.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.81 -148.28 23.95 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.73 177.84 8.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -129.34 34.11 4.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.676 0.79 . . . . 0.0 109.558 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -64.18 -41.1 97.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.81 164.14 13.33 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.96 164.06 3.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.497 2.798 . . . . 0.0 115.276 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -72.89 121.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.83 6.41 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.95 115.82 3.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.545 1.066 . . . . 0.0 108.561 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.36 23.68 72.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.965 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.61 -38.23 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 118.859 1.329 . . . . 0.0 109.553 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.15 103.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.86 -7.94 42.23 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.5 1.524 . . . . 0.0 112.205 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -72.6 142.79 48.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 117.971 0.885 . . . . 0.0 111.418 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -70.91 68.17 0.42 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.946 1.698 . . . . 0.0 113.508 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.74 -154.56 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 111.944 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.83 70.96 1.15 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 123.697 0.665 . . . . 0.0 112.777 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.8 p -137.93 23.16 2.84 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.381 0.672 . . . . 0.0 111.355 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.78 134.85 90.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.04 168.98 3.05 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.828 1.685 . . . . 0.0 114.846 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 42.46 56.47 3.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.609 1.964 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.9 118.53 2.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -79.7 109.16 13.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.891 0.876 . . . . 0.0 109.439 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -95.64 -172.26 2.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.573 0.749 . . . . 0.0 111.5 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.18 169.75 9.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.535 1.934 . . . . 0.0 107.682 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.97 -41.25 97.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.6 p -62.79 -60.62 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.665 1.586 . . . . 0.0 111.994 -171.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 tp -57.63 -27.98 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.278 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -76.17 -50.34 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.65 -38.05 53.08 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.431 1.093 . . . . 0.0 111.897 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.45 -50.48 69.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.0 0.818 . . . . 0.0 109.269 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.25 86.89 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.77 69.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.454 0.301 . . . . 0.0 111.112 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.2 t -74.36 1.04 12.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.943 0.897 . . . . 0.0 112.795 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.81 14.9 55.91 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 119.13 0.877 . . . . 0.0 112.973 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.44 156.56 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.415 1.107 . . . . 0.0 109.674 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.04 124.39 11.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.642 1.577 . . . . 0.0 107.121 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -59.82 150.66 27.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.1 p -137.0 166.45 23.64 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.526 1.53 . . . . 0.0 107.009 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -52.63 -49.79 64.43 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.718 0.807 . . . . 0.0 108.884 173.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.47 -61.04 2.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.135 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -54.54 -46.63 73.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.773 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -60.38 -53.67 45.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.96 -42.69 63.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.04 0.936 . . . . 0.0 110.335 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.9 m -66.72 -59.32 3.68 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -44.31 -50.44 9.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.694 1.598 . . . . 0.0 113.224 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -54.82 -35.35 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.113 0.87 . . . . 0.0 113.034 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -82.71 -18.9 39.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.748 -0.595 . . . . 0.0 112.141 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.34 56.39 7.34 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 124.456 1.102 . . . . 0.0 112.709 -172.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.63 143.44 87.2 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.161 1.241 . . . . 0.0 109.22 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.93 -60.98 4.61 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.82 -42.69 65.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.872 0.869 . . . . 0.0 110.479 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -50.37 -50.78 50.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 111.037 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -67.76 -52.88 32.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.218 0.607 . . . . 0.0 110.23 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -49.12 -33.67 12.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.334 0.653 . . . . 0.0 110.751 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.29 -64.18 1.08 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.177 0.591 . . . . 0.0 110.191 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.49 -56.21 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.33 -41.98 84.34 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.402 0.681 . . . . 0.0 110.929 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 55.15 65.97 1.35 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.088 1.355 . . . . 0.0 111.094 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -129.15 139.88 51.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.291 1.836 . . . . 0.0 107.807 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -50.51 -40.35 51.23 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.271 1.029 . . . . 0.0 110.502 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.46 37.42 2.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.76 0.824 . . . . 0.0 111.42 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.5 66.15 3.18 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.595 0.758 . . . . 0.0 110.557 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -113.72 178.68 4.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.346 1.058 . . . . 0.0 109.29 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 t -144.99 149.84 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -14.33 57.28 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.1 ttt -65.98 77.36 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.531 1.132 . . . . 0.0 113.174 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 58.2 3.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.902 0.881 . . . . 0.0 109.308 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -163.19 137.55 6.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.669 1.588 . . . . 0.0 107.65 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -122.65 160.18 26.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tp -103.04 139.57 38.41 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.89 57.5 1.11 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.807 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 79.99 154.23 0.13 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 126.618 1.967 . . . . 0.0 110.141 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.72 38.27 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.53 -35.38 44.79 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.708 1.147 . . . . 0.0 111.572 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.46 -48.11 82.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.482 0.713 . . . . 0.0 110.298 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.34 -48.25 82.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.933 0.893 . . . . 0.0 109.514 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.71 -42.79 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.84 0.456 . . . . 0.0 110.162 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.19 97.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.769 -0.582 . . . . 0.0 110.109 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.98 95.42 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -58.77 -48.58 80.75 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.848 -0.533 . . . . 0.0 110.049 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.92 -45.12 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.891 -0.506 . . . . 0.0 110.712 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -42.08 85.25 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.692 -0.63 . . . . 0.0 110.328 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -67.49 -30.13 69.74 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.768 -0.583 . . . . 0.0 111.671 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.75 -39.61 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.585 1.154 . . . . 0.0 111.651 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 121.64 0.733 . . . . 0.0 112.871 -175.867 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 N-CA-C 113.82 0.288 . . . . 0.0 113.82 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.54 91.28 2.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.7 11.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.789 0.836 . . . . 0.0 113.14 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.35 -49.36 67.19 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.799 0.727 . . . . 0.0 110.017 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.64 -35.58 76.55 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.72 46.17 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -54.55 -53.89 48.49 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.751 0.82 . . . . 0.0 109.657 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -52.02 -55.47 20.34 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -54.97 -40.33 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.524 1.129 . . . . 0.0 110.693 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -55.82 -25.74 43.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.324 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -58.98 -31.3 68.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 110.894 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -93.78 -49.22 5.94 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.188 0.595 . . . . 0.0 109.865 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.97 -34.23 41.43 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.929 0.892 . . . . 0.0 110.634 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -41.7 -40.27 1.92 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.679 2.392 . . . . 0.0 115.002 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.1 m -25.81 -48.73 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.198 2.199 . . . . 0.0 114.044 -171.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.61 -25.96 13.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.892 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -100.6 -172.0 2.12 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-O 121.467 0.651 . . . . 0.0 112.201 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 m -157.11 161.03 39.4 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.692 1.597 . . . . 0.0 108.645 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.98 122.71 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.891 1.676 . . . . 0.0 107.354 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.5 tp -106.25 131.53 55.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 C-N-CA 125.162 1.385 . . . . 0.0 108.607 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 160.21 82.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.35 -38.31 62.47 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.01 2.474 . . . . 0.0 112.785 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.8 -9.83 56.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.482 1.513 . . . . 0.0 114.099 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.47 57.71 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.174 0.897 . . . . 0.0 113.637 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 m -69.81 126.28 29.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.641 1.721 . . . . 0.0 108.991 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.02 96.62 5.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.81 0.844 . . . . 0.0 110.14 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.06 -48.25 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.7 126.46 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -124.91 82.09 2.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.237 1.815 . . . . 0.0 110.216 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.55 -168.18 40.14 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.09 43.26 0.85 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.885 -1.362 . . . . 0.0 111.771 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 13.45 59.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 129.84 3.256 . . . . 0.0 113.969 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -32.11 13.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.159 1.384 . . . . 0.0 109.086 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.48 162.14 12.55 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.9 140.01 77.25 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.375 3.384 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -55.25 119.87 6.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.72 -2.15 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -64.8 84.08 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.445 1.02 . . . . 0.0 111.718 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.61 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.23 1.395 . . . . 0.0 112.182 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.91 -46.26 96.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-N 119.415 1.607 . . . . 0.0 109.523 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.25 118.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.341 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -29.79 10.85 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.741 1.638 . . . . 0.0 111.028 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -73.78 147.94 42.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.624 0.712 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.7 m -71.11 136.78 48.38 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.48 141.34 37.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.727 -0.608 . . . . 0.0 109.888 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.99 77.37 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.945 -1.475 . . . . 0.0 114.043 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 p -137.33 -0.56 2.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.879 1.839 . . . . 0.0 115.48 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -62.26 129.4 92.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 121.57 1.987 . . . . 0.0 107.641 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -44.62 154.53 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.662 2.908 . . . . 0.0 116.58 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 50.27 66.52 1.12 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.561 1.945 . . . . 0.0 113.631 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -163.41 122.84 2.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.98 0.419 . . . . 0.0 111.112 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.91 83.73 2.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.111 0.964 . . . . 0.0 109.821 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.09 178.16 1.96 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.918 0.487 . . . . 0.0 111.804 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -111.0 171.4 7.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.54 1.162 . . . . 0.0 110.767 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -53.91 15.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 111.986 -2.37 . . . . 0.0 113.013 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.3 m -62.23 -52.89 61.94 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.067 0.937 . . . . 0.0 111.579 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 tt -69.81 -38.84 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.456 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.69 -39.45 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.2 88.44 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.077 -0.389 . . . . 0.0 110.341 177.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.35 -49.81 76.39 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.43 -45.81 8.43 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.519 1.533 . . . . 0.0 112.695 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.3 -28.04 17.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.569 1.548 . . . . 0.0 113.695 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.4 p -73.63 2.74 7.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.118 0.872 . . . . 0.0 112.259 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.75 35.76 21.24 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -77.21 86.6 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.244 -0.562 . . . . 0.0 111.039 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.91 120.32 18.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.499 1.12 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -62.98 122.48 16.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.276 0.23 . . . . 0.0 110.419 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 p -100.31 159.1 15.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -54.65 -37.8 66.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.011 0.434 . . . . 0.0 110.357 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.76 -51.11 68.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.997 0.919 . . . . 0.0 110.171 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -59.71 -47.45 85.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.967 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.6 mt -55.07 -52.16 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.782 0.719 . . . . 0.0 109.284 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.87 65.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.452 0.701 . . . . 0.0 110.743 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -64.99 -54.37 31.57 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.835 0.454 . . . . 0.0 110.239 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -46.2 -52.06 13.09 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.701 1.6 . . . . 0.0 111.253 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -51.3 -28.61 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.669 0.788 . . . . 0.0 112.993 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -78.2 -26.67 47.6 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.711 0.687 . . . . 0.0 112.645 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -154.54 69.16 5.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.992 0.814 . . . . 0.0 111.889 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.11 145.95 97.28 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.198 1.932 . . . . 0.0 110.868 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.27 -59.99 4.79 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.05 70.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -47.89 -52.25 20.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.699 0.8 . . . . 0.0 111.377 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.8 mt -61.49 -56.87 15.31 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.409 1.084 . . . . 0.0 109.704 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.5 -38.76 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.591 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -72.36 -59.5 2.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.875 0.47 . . . . 0.0 109.739 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.03 -41.03 82.32 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.5 tp -86.2 -4.39 59.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.222 1.009 . . . . 0.0 111.876 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 t0 48.06 43.69 18.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.988 1.315 . . . . 0.0 110.366 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.24 107.92 12.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.005 1.322 . . . . 0.0 109.29 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 90' ' ' LYS . 13.4 mptt -57.14 -26.27 60.27 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 128.738 2.815 . . . . 0.0 111.752 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -104.85 15.51 27.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.835 0.854 . . . . 0.0 113.264 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.2 113.75 20.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -132.44 131.68 41.99 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.344 1.057 . . . . 0.0 111.151 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -85.02 156.2 21.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.96 -18.71 72.94 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 170.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.73 80.79 0.07 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.593 1.157 . . . . 0.0 113.089 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.72 57.8 2.61 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.057 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -160.84 139.33 9.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.8 1.64 . . . . 0.0 106.606 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -142.53 155.19 44.99 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.5 tp -150.2 111.28 4.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.066 0.947 . . . . 0.0 108.57 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.86 30.99 0.2 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.285 -0.884 . . . . 0.0 112.908 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -161.83 176.7 10.59 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 127.502 2.321 . . . . 0.0 106.1 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.87 -51.52 2.74 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.525 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.72 -56.52 0.12 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.71 2.1 . . . . 0.0 114.732 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -59.98 -51.67 68.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.616 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.25 -48.37 80.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 109.631 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.63 -44.16 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.564 1.146 . . . . 0.0 110.601 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.57 -45.68 93.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.881 -0.512 . . . . 0.0 109.912 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.42 96.11 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -57.81 -52.81 63.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.216 0.606 . . . . 0.0 109.693 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.2 mt -54.17 -53.63 50.78 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.57 65.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.555 0.342 . . . . 0.0 111.443 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.8 m -64.63 -44.76 89.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.668 0.387 . . . . 0.0 111.556 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.96 -39.06 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.815 1.246 . . . . 0.0 111.522 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.437 -1.091 0 C-N-CA 125.516 1.527 . . . . 0.0 111.193 -177.251 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -82.04 99.51 9.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.09 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.062 0.945 . . . . 0.0 113.241 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.53 -48.56 66.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.251 0.932 . . . . 0.0 110.011 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -56.84 -42.48 79.74 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.37 -49.0 66.16 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.67 -51.15 70.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.59 0.695 . . . . 0.0 110.597 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -59.73 -46.85 87.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.515 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -61.29 -27.86 68.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.443 1.097 . . . . 0.0 110.742 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -57.75 -18.13 19.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 111.344 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -55.67 -28.68 56.82 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.427 1.012 . . . . 0.0 110.627 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -68.68 -54.25 17.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.453 -0.779 . . . . 0.0 109.002 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.41 -47.29 56.55 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.023 1.729 . . . . 0.0 109.93 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -47.41 -31.62 4.27 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.296 2.638 . . . . 0.0 112.92 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -53.33 -32.16 47.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.6 m -121.82 -37.01 2.92 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.911 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -101.14 -176.01 3.03 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.673 0.789 . . . . 0.0 112.212 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t -153.13 179.46 8.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.953 1.301 . . . . 0.0 109.788 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -143.49 115.12 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.919 2.488 . . . . 0.0 106.985 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 tp -102.22 148.52 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.667 1.587 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.01 158.09 87.64 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.01 -34.07 98.97 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.063 1.842 . . . . 0.0 111.264 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -75.14 -11.62 60.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.442 1.097 . . . . 0.0 113.324 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 -13.54 35.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.139 -0.812 . . . . 0.0 114.063 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -60.88 127.61 32.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.71 1.755 . . . . 0.0 110.404 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -70.75 82.96 0.63 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.624 0.769 . . . . 0.0 111.191 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.33 -59.99 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 C-N-CA 122.577 0.351 . . . . 0.0 110.07 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.54 -39.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.197 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 57.43 47.32 16.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.94 0.876 . . . . 0.0 109.855 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.91 -172.16 48.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.09 170.8 14.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 110.407 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -124.83 30.81 5.82 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.767 . . . . 0.0 109.385 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -69.92 -40.82 75.34 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.83 167.15 13.31 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 170.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.27 173.25 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.16 2.573 . . . . 0.0 114.337 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -84.68 121.77 28.14 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.64 -2.0 56.85 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.42 113.79 2.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.03 20.41 59.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.954 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.66 -39.65 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 119.105 1.452 . . . . 0.0 108.935 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.37 106.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.543 0.737 . . . . 0.0 109.561 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.12 -17.37 31.97 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.833 1.682 . . . . 0.0 111.902 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -68.2 141.27 56.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.43 1.115 . . . . 0.0 111.217 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -71.88 74.31 0.87 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.907 1.283 . . . . 0.0 111.11 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB3' ' CA ' ' A' ' 61' ' ' GLY . . . 52.13 -144.81 0.58 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.889 0.876 . . . . 0.0 112.406 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.34 75.83 0.64 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 123.554 0.597 . . . . 0.0 113.064 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 p -130.24 5.66 4.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.582 1.153 . . . . 0.0 112.196 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 126.56 91.65 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.46 172.77 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.113 1.209 . . . . 0.0 113.274 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 47.0 46.89 16.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.16 1.384 . . . . 0.0 111.853 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -156.42 111.45 2.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.14 -0.35 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.08 89.1 5.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.634 0.773 . . . . 0.0 109.813 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -74.76 -174.81 2.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.594 0.711 . . . . 0.0 111.344 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.34 166.51 13.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.139 1.376 . . . . 0.0 108.675 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.55 -35.0 79.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.31 0.644 . . . . 0.0 112.498 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -58.19 -62.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.971 1.308 . . . . 0.0 111.256 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.56 -35.33 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.932 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -48.84 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.81 90.47 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.898 0.479 . . . . 0.0 110.319 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.59 -45.3 89.4 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.045 0.538 . . . . 0.0 109.735 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . -55.28 -53.19 42.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.6 67.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.329 0.651 . . . . 0.0 111.731 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -67.41 -14.89 63.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.053 0.541 . . . . 0.0 111.952 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.77 14.16 12.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.981 1.277 . . . . 0.0 112.793 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.78 118.29 15.52 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.87 1.335 . . . . 0.0 111.158 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.3 129.45 54.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -66.1 126.88 30.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 159.52 37.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 107.863 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -42.57 -51.77 5.02 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.212 1.405 . . . . 0.0 112.885 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.38 -47.45 85.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.262 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.63 -48.3 81.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.66 0.784 . . . . 0.0 109.647 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.85 -54.03 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.59 -38.21 59.6 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.316 1.046 . . . . 0.0 111.504 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -72.93 -60.23 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -46.73 -43.79 18.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.054 1.342 . . . . 0.0 114.055 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.8 m -52.91 -34.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 119.445 1.02 . . . . 0.0 113.575 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -101.74 -3.38 28.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.059 0.944 . . . . 0.0 111.563 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -133.68 54.54 12.96 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.665 1.586 . . . . 0.0 111.634 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.16 138.19 70.87 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.366 2.711 . . . . 0.0 108.761 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.68 -64.1 3.34 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -45.01 -48.53 11.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.019 1.327 . . . . 0.0 112.646 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.32 -43.71 96.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.088 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.03 -55.51 28.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -49.01 -44.54 41.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.789 1.235 . . . . 0.0 110.432 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -63.8 -68.51 0.34 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.626 0.771 . . . . 0.0 110.304 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -54.84 -40.93 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 -0.55 57.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.666 1.186 . . . . 0.0 111.487 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t0 43.84 53.25 6.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.529 1.531 . . . . 0.0 110.702 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.65 115.36 9.09 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.341 1.056 . . . . 0.0 111.526 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -57.45 -29.41 64.19 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.722 1.209 . . . . 0.0 111.943 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -92.66 11.66 25.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.01 76.84 5.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.522 -0.736 . . . . 0.0 111.734 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.28 152.89 21.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.453 0.701 . . . . 0.0 109.964 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -112.33 151.62 29.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.98 -21.41 61.29 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 170.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ttt -68.13 74.98 0.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 112.438 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.86 58.87 2.98 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 175.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -168.7 146.79 4.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.797 1.639 . . . . 0.0 107.275 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.16 150.09 45.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.11 0.964 . . . . 0.0 108.399 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -111.92 106.37 15.05 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 44.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.159 -0.338 . . . . 0.0 111.633 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -177.41 -171.01 0.31 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.197 1.799 . . . . 0.0 107.444 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.27 -51.54 3.61 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.55 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.64 -75.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 C-N-CA 128.313 2.863 . . . . 0.0 115.952 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.23 -48.43 81.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.339 0.569 . . . . 0.0 112.472 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.79 -49.66 72.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.17 0.988 . . . . 0.0 109.447 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.49 -41.45 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.044 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.07 -48.84 79.84 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.912 -0.492 . . . . 0.0 110.117 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.32 80.91 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.57 -51.05 71.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.03 -36.57 68.15 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.101 0.56 . . . . 0.0 111.616 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.33 -52.3 48.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -53.99 -37.37 63.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.998 0.919 . . . . 0.0 112.593 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.98 -28.67 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.184 1.794 . . . . 0.0 111.961 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 CA--C 1.537 0.454 0 CA-C-N 118.434 0.561 . . . . 0.0 110.327 179.603 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 N-CA-C 113.971 0.348 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -72.68 84.19 1.17 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.19 0.996 . . . . 0.0 109.517 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.45 -35.46 8.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.753 0.821 . . . . 0.0 112.859 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.21 69.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.61 0.641 . . . . 0.0 110.169 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -58.47 -40.96 84.12 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.06 -51.61 52.64 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.05 -50.94 71.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.936 0.894 . . . . 0.0 110.519 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -54.19 -54.03 45.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.01 -35.38 69.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.504 1.122 . . . . 0.0 110.87 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -58.52 -20.91 50.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -61.77 -23.25 66.06 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.647 -0.658 . . . . 0.0 111.027 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.04 -48.96 7.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 t -47.56 -38.55 14.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.321 1.848 . . . . 0.0 113.023 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -22.59 3.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.254 1.022 . . . . 0.0 113.304 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 m -58.76 -22.48 58.1 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -120.91 -34.27 3.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.885 0.874 . . . . 0.0 112.568 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -111.74 174.31 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.059 0.944 . . . . 0.0 113.544 -174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.5 t -145.41 161.75 38.94 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.599 0.76 . . . . 0.0 109.225 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -129.02 135.58 61.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.84 139.49 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.984 1.714 . . . . 0.0 108.946 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 161.08 79.42 Favored Pre-proline 0 C--O 1.232 0.159 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.71 -29.31 88.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.375 1.383 . . . . 0.0 109.434 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.23 -5.64 33.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.66 50.94 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.793 -1.192 . . . . 0.0 112.534 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -58.2 120.96 9.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.77 84.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.648 -0.658 . . . . 0.0 111.158 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.97 -66.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.45 80.44 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -69.69 56.14 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.291 1.436 . . . . 0.0 110.269 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.71 -170.34 46.95 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 164.7 26.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.356 0.598 . . . . 0.0 109.902 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -116.65 37.67 3.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -63.8 -39.48 94.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.51 167.81 12.41 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 171.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.0 151.57 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.755 2.97 . . . . 0.0 112.538 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.18 126.37 27.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.35 11.3 28.73 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.73 82.93 0.45 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.769 -1.207 . . . . 0.0 110.272 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.9 41.29 1.21 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.211 0.91 . . . . 0.0 113.23 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.3 -45.52 93.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -51.3 112.31 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.656 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 -18.17 57.95 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.585 1.088 . . . . 0.0 113.065 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.65 139.08 57.85 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.183 1.491 . . . . 0.0 110.425 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -67.38 72.82 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.265 1.426 . . . . 0.0 112.218 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.85 -148.12 0.49 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.62 -0.675 . . . . 0.0 109.88 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.45 1.1 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.5 p -136.39 10.98 3.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 0.0 111.204 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.26 133.33 94.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.09 155.74 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.026 2.484 . . . . 0.0 115.646 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 49.82 65.65 1.36 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.009 1.724 . . . . 0.0 113.603 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -162.04 123.45 2.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.62 89.44 2.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.965 0.906 . . . . 0.0 109.796 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -73.53 -172.03 1.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.836 0.827 . . . . 0.0 112.087 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.92 166.54 11.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.886 2.075 . . . . 0.0 107.358 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.96 -36.01 80.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.48 0.712 . . . . 0.0 112.18 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 -67.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.51 1.524 . . . . 0.0 110.976 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tp -54.2 -36.79 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.894 1.277 . . . . 0.0 110.935 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.88 -51.0 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.381 0.672 . . . . 0.0 109.38 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.82 69.34 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.903 0.481 . . . . 0.0 110.775 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.32 -48.83 75.92 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.21 70.07 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.37 53.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.067 0.547 . . . . 0.0 111.269 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -75.52 13.03 0.84 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.97 27.74 52.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.167 0.889 . . . . 0.0 112.752 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -88.75 123.2 32.94 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.755 0.777 . . . . 0.0 109.692 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.1 131.31 55.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -64.32 93.35 0.09 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.022 0.374 . . . . 0.0 111.659 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.8 p -79.92 168.71 18.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -57.71 -41.05 80.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.829 -0.545 . . . . 0.0 109.87 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.15 -49.36 72.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.317 1.047 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -58.13 -51.76 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.1 mt -54.77 -54.57 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.63 67.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.799 0.44 . . . . 0.0 111.321 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 m -67.95 -44.07 77.61 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.281 -0.262 . . . . 0.0 110.995 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -54.84 -44.37 73.87 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.317 -0.865 . . . . 0.0 111.062 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.15 -26.88 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.832 0.453 . . . . 0.0 111.475 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -89.23 -33.54 16.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.868 0.867 . . . . 0.0 111.577 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -137.59 67.34 51.64 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.65 144.67 97.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.956 1.771 . . . . 0.0 110.585 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.68 -63.37 4.01 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.61 67.36 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.552 0.741 . . . . 0.0 110.77 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.34 -40.44 90.68 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.642 0.258 . . . . 0.0 111.673 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.14 -60.29 3.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -41.82 -50.22 4.38 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.379 1.472 . . . . 0.0 110.995 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -39.88 -52.17 2.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.095 1.358 . . . . 0.0 112.128 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -89.6 -52.78 4.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.973 0.909 . . . . 0.0 112.322 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.7 tp -73.09 -21.74 60.7 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -172.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t0 45.2 46.3 9.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.771 2.029 . . . . 0.0 111.894 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.07 129.91 52.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -31.21 71.04 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 126.182 1.793 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -88.26 17.31 5.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 0.0 111.719 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.95 64.93 6.86 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.442 -1.411 . . . . 0.0 110.246 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -103.55 -176.73 3.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.412 1.485 . . . . 0.0 108.619 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.71 150.94 38.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.83 -18.74 57.51 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 ttt -65.0 81.2 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.572 1.149 . . . . 0.0 113.635 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.8 3.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.531 0.732 . . . . 0.0 109.343 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -161.73 142.15 10.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.739 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -152.41 175.1 13.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.428 1.091 . . . . 0.0 108.814 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -158.38 122.07 3.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.86 50.19 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.692 0.797 . . . . 0.0 111.443 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? 166.03 -174.1 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 129.6 3.16 . . . . 0.0 105.528 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.95 -54.29 4.44 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 111.534 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -36.17 -50.08 1.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.592 1.568 . . . . 0.0 113.342 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -55.11 -60.63 3.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.503 1.121 . . . . 0.0 112.348 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.34 -41.23 98.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.383 0.673 . . . . 0.0 111.066 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.8 t -59.59 -42.09 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.02 79.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.936 0.789 . . . . 0.0 110.147 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.31 86.21 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.384 -0.198 . . . . 0.0 110.499 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.44 -55.11 35.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.71 -40.12 68.89 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.376 0.67 . . . . 0.0 111.649 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.59 7.01 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.694 0.679 . . . . 0.0 109.871 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.8 p -56.24 -32.81 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.1 -32.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 111.595 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -86.55 103.21 14.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.91 -33.2 4.36 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 112.762 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.16 71.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.181 0.9 . . . . 0.0 110.167 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -38.72 90.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.81 -49.81 71.1 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -54.5 -53.44 54.29 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.673 0.789 . . . . 0.0 109.441 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -58.0 -49.06 78.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.649 0.261 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.25 -31.13 67.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.576 1.15 . . . . 0.0 110.92 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.47 -18.17 17.17 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.072 -0.392 . . . . 0.0 111.849 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -52.18 -29.15 20.97 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.384 0.674 . . . . 0.0 110.735 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.67 -55.86 5.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.8 m -48.69 -43.73 37.3 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.19 1.396 . . . . 0.0 112.415 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -52.73 -25.35 10.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 113.157 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 -25.77 59.95 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.866 -0.521 . . . . 0.0 110.745 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.03 -45.14 2.38 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.238 0.615 . . . . 0.0 110.81 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -91.8 -176.85 4.58 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -151.73 167.77 27.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.303 1.841 . . . . 0.0 110.139 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.3 mm -136.3 117.7 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.768 1.627 . . . . 0.0 108.043 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tp -115.72 126.97 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.159 1.384 . . . . 0.0 109.045 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 163.95 29.5 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.221 -0.924 . . . . 0.0 108.685 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.58 -36.92 98.34 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.446 2.097 . . . . 0.0 110.323 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.01 3.55 6.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.685 1.594 . . . . 0.0 113.119 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.88 90.53 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.688 -1.257 . . . . 0.0 112.7 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -71.44 114.12 9.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.6 1.2 . . . . 0.0 109.171 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.15 104.02 1.09 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.795 -0.566 . . . . 0.0 109.815 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.9 mm -76.21 -47.44 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.98 96.74 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 58.66 1.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.485 1.514 . . . . 0.0 108.216 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.44 -158.91 27.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 175.97 10.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -124.58 30.48 5.97 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -38.43 83.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.52 171.56 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -63.74 174.62 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.265 3.31 . . . . 0.0 112.387 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -87.24 121.2 29.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.6 mt -86.61 1.33 52.19 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.34 99.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.35 0.977 . . . . 0.0 109.616 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.97 33.16 21.81 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 119.085 -0.841 . . . . 0.0 113.32 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.75 -31.04 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.753 1.276 . . . . 0.0 108.69 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.44 113.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.198 0.999 . . . . 0.0 110.461 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.16 -10.26 75.42 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.177 1.37 . . . . 0.0 112.749 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.95 144.64 29.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.158 0.979 . . . . 0.0 110.005 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 m -63.86 134.1 54.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.31 141.45 54.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.659 -0.651 . . . . 0.0 110.613 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.61 33.78 81.97 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.968 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.2 p -132.03 -0.77 3.74 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.897 1.348 . . . . 0.0 114.151 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -64.56 126.72 91.31 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 120.342 1.428 . . . . 0.0 107.153 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.76 161.32 18.54 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.402 2.068 . . . . 0.0 113.327 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 56.27 55.08 7.01 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.411 1.485 . . . . 0.0 112.282 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -162.55 120.18 2.07 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.151 -0.343 . . . . 0.0 110.576 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -79.15 98.45 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.254 1.022 . . . . 0.0 110.246 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.99 -171.69 3.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.8 0.809 . . . . 0.0 111.553 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -105.28 157.91 16.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 109.279 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.53 -34.39 72.58 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.419 0.687 . . . . 0.0 112.43 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.8 p -63.95 -64.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.751 1.22 . . . . 0.0 109.779 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.2 tt -58.2 -37.22 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.624 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.55 -49.9 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.83 88.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.436 0.562 . . . . 0.0 110.802 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 tp -56.33 -47.34 78.94 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.1 -56.29 21.92 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.232 0.92 . . . . 0.0 111.012 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -31.22 61.74 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.265 1.426 . . . . 0.0 111.807 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 m -69.05 -0.63 6.01 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.57 27.77 8.89 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.374 1.464 . . . . 0.0 111.477 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -84.45 96.76 9.2 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 117.978 0.889 . . . . 0.0 111.18 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.62 127.44 35.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -67.35 103.98 1.41 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.977 0.353 . . . . 0.0 111.615 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.5 p -84.45 162.09 20.07 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -57.61 -37.11 72.7 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.738 0.415 . . . . 0.0 110.332 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -63.69 -55.42 23.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.76 -50.27 68.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.48 -54.52 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.05 -41.12 71.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.334 0.653 . . . . 0.0 111.842 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.8 m -69.76 -56.08 8.14 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -43.3 -51.93 6.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.714 1.606 . . . . 0.0 113.461 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.6 m -53.41 -30.98 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.81 -23.9 63.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.797 -0.621 . . . . 0.0 112.07 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -160.95 68.04 2.5 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 119.086 0.857 . . . . 0.0 112.56 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.58 151.79 81.35 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 120.979 1.12 . . . . 0.0 109.412 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.83 -61.09 4.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.15 78.88 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.282 -0.54 . . . . 0.0 109.673 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -51.52 -56.36 13.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.124 0.97 . . . . 0.0 110.523 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 mp -57.64 -48.66 78.85 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.167 0.587 . . . . 0.0 110.901 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -54.87 -51.27 66.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.154 0.433 . . . . 0.0 110.291 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -54.48 -51.9 63.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.856 0.863 . . . . 0.0 111.015 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -72.87 -49.66 28.64 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 tp -77.91 -24.2 48.42 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.511 1.125 . . . . 0.0 113.46 -174.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.09 50.64 16.14 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.564 1.546 . . . . 0.0 110.048 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -135.29 130.02 34.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.448 1.499 . . . . 0.0 109.514 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -58.52 -35.25 71.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.291 0.636 . . . . 0.0 110.53 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -84.47 15.67 3.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.22 66.18 4.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.639 0.775 . . . . 0.0 110.992 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -94.32 -179.71 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.118 1.367 . . . . 0.0 110.27 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -155.83 157.64 36.77 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.92 -11.95 84.9 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 172.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.3 ttt -69.35 77.22 0.38 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 118.787 1.293 . . . . 0.0 113.144 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.51 58.17 3.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.28 1.032 . . . . 0.0 109.606 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -162.94 139.69 7.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -138.82 160.53 39.48 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -157.19 107.1 2.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.48 43.8 0.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.517 0.727 . . . . 0.0 112.242 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -177.52 -177.99 0.72 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.006 1.723 . . . . 0.0 107.243 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.32 -50.22 2.75 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.604 -0.553 . . . . 0.0 113.367 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -28.1 -51.65 0.1 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 127.319 2.39 . . . . 0.0 115.329 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 2.1 pm0 -61.22 -48.56 80.95 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.796 0.798 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.52 -46.7 84.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.86 0.864 . . . . 0.0 109.152 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.49 -43.41 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.517 0.727 . . . . 0.0 110.329 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.86 92.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.864 -0.523 . . . . 0.0 109.603 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.31 91.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.527 0.203 . . . . 0.0 110.458 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.8 -52.99 62.9 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.928 0.491 . . . . 0.0 110.058 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.8 mt -57.11 -45.53 83.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.059 0.391 . . . . 0.0 110.776 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.28 81.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.237 0.615 . . . . 0.0 110.8 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.2 m -68.92 -42.37 76.9 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.029 -0.42 . . . . 0.0 110.691 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.26 -44.17 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.141 1.377 . . . . 0.0 112.247 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.0 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.46 115.17 27.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.32 1.448 . . . . 0.0 108.765 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.13 -33.78 53.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.511 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.97 -53.5 38.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.541 1.064 . . . . 0.0 110.06 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -54.77 -41.55 70.65 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.72 -50.72 56.75 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -56.17 -49.58 73.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.403 0.681 . . . . 0.0 109.268 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.2 -50.28 74.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.477 0.18 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -58.18 -32.45 68.24 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 124.953 1.301 . . . . 0.0 110.634 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -58.95 -21.26 57.98 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -21.55 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.829 -0.544 . . . . 0.0 110.284 174.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -86.71 -49.43 7.48 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.286 -0.884 . . . . 0.0 109.157 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.9 m -51.2 -40.17 58.1 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.478 1.111 . . . . 0.0 111.912 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.11 -21.45 4.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 113.254 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -56.81 -23.74 45.9 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.536 -0.728 . . . . 0.0 110.409 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m -125.54 -49.62 1.65 Allowed 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 122.984 0.513 . . . . 0.0 109.844 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.17 -174.78 4.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.194 0.997 . . . . 0.0 113.49 -172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 m -158.69 164.9 35.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.468 1.907 . . . . 0.0 108.737 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.9 mm -136.9 119.57 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.913 1.685 . . . . 0.0 107.23 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.98 132.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.201 0.6 . . . . 0.0 110.753 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.21 152.84 83.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.95 -34.05 90.84 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.96 2.44 . . . . 0.0 112.103 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.59 -9.11 57.72 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.406 1.082 . . . . 0.0 113.346 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.17 -14.07 44.2 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.837 -0.979 . . . . 0.0 113.576 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -60.06 112.27 1.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.651 1.725 . . . . 0.0 109.908 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.23 121.41 16.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.012 0.925 . . . . 0.0 109.794 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.08 -45.77 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.61 100.61 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -88.11 72.13 9.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.39 -178.67 45.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.87 68.95 7.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.78 -0.835 . . . . 0.0 109.081 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -35.47 62.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 1 C-N-CA 133.541 4.737 . . . . 0.0 115.934 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -96.17 -30.16 13.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.842 2.057 . . . . 0.0 108.586 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.8 169.66 13.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.54 163.71 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.945 3.097 . . . . 0.0 114.04 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -85.14 117.43 24.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.6 0.95 44.54 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.13 106.36 0.6 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.01 15.09 49.99 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.406 -1.219 . . . . 0.0 113.604 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.17 -38.67 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.938 1.869 . . . . 0.0 110.184 176.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.86 112.22 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -20.73 49.05 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.077 1.322 . . . . 0.0 112.024 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -72.96 140.54 47.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.045 0.923 . . . . 0.0 109.918 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 m -64.2 121.95 15.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.49 150.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.252 0.549 . . . . 0.0 111.789 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.73 13.16 60.77 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.09 -1.395 . . . . 0.0 113.753 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -142.44 35.27 1.48 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.679 1.74 . . . . 0.0 113.67 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -80.58 135.06 53.34 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 165.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -57.63 155.94 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.314 1.343 . . . . 0.0 113.144 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 55.86 64.14 1.82 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.898 1.679 . . . . 0.0 113.852 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -163.59 123.67 2.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.76 -0.587 . . . . 0.0 110.974 172.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -77.0 77.48 3.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.197 0.999 . . . . 0.0 110.149 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -69.31 -172.66 0.46 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.308 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -113.89 160.56 18.64 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.804 1.641 . . . . 0.0 110.857 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.57 -38.67 60.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.559 1.144 . . . . 0.0 113.525 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -65.91 -55.6 16.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.595 0.712 . . . . 0.0 110.67 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 tt -66.68 -35.26 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.75 -49.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.92 88.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.868 0.467 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.6 tp -56.15 -46.43 79.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.35 -55.66 25.56 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.29 0.948 . . . . 0.0 110.91 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.01 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.569 1.148 . . . . 0.0 111.497 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 m -72.67 6.48 2.45 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.43 25.42 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.196 1.379 . . . . 0.0 112.091 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -80.99 78.83 7.77 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.658 -0.907 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.55 116.8 14.55 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -59.58 121.2 11.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.0 p -99.87 164.97 11.79 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -55.91 -46.45 78.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.909 0.862 . . . . 0.0 109.639 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -58.83 -52.47 65.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.16 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -60.47 -46.76 88.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.57 -53.24 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.82 -37.99 64.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.178 0.991 . . . . 0.0 111.484 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 m -72.74 -58.91 2.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -43.98 -47.98 8.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.899 1.679 . . . . 0.0 113.245 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 m -51.93 -34.42 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -75.09 -25.05 58.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.0 112.095 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -145.63 61.79 7.93 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.892 0.877 . . . . 0.0 113.043 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.18 148.09 93.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.668 1.578 . . . . 0.0 109.446 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.96 -65.64 3.22 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.2 62.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.773 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -51.61 -54.48 27.29 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.656 0.782 . . . . 0.0 110.471 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 mp -60.34 -49.27 78.26 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 122.969 0.508 . . . . 0.0 111.174 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.35 -46.27 66.04 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.954 0.343 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.16 -65.94 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.25 0.62 . . . . 0.0 110.345 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -56.38 -41.24 75.92 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.7 -6.63 59.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.721 0.808 . . . . 0.0 111.581 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 48.28 52.87 12.73 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.291 1.436 . . . . 0.0 109.604 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -143.72 155.74 44.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.998 0.919 . . . . 0.0 110.801 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -91.44 -41.3 10.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.945 1.698 . . . . 0.0 108.619 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.03 39.7 0.51 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.857 0.863 . . . . 0.0 111.99 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.26 111.44 22.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.537 0.735 . . . . 0.0 109.412 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -124.46 -176.04 3.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.862 0.865 . . . . 0.0 112.066 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -159.75 147.05 16.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.37 64.15 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.6 ttt -66.98 79.84 0.12 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 118.452 1.126 . . . . 0.0 113.651 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.02 57.49 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.655 0.782 . . . . 0.0 109.438 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -165.22 125.92 1.94 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.648 1.179 . . . . 0.0 108.565 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -115.47 159.9 20.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.29 103.74 3.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.92 44.44 0.55 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.191 0.596 . . . . 0.0 111.413 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -174.85 -176.57 1.01 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.814 1.646 . . . . 0.0 107.581 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.15 -52.93 3.41 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.272 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -11.75 -72.07 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 128.525 2.965 . . . . 0.0 116.045 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.5 -45.97 90.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.126 0.963 . . . . 0.0 112.412 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.49 -49.7 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 109.116 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.69 -43.04 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.423 0.689 . . . . 0.0 109.945 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.39 93.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.998 -0.439 . . . . 0.0 110.102 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.77 93.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.041 0.382 . . . . 0.0 110.418 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -57.08 -53.1 61.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.95 -41.54 83.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.115 -0.366 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.58 85.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.638 0.775 . . . . 0.0 110.585 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -69.58 -41.04 76.35 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.039 -0.413 . . . . 0.0 110.343 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.52 -38.12 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.732 1.213 . . . . 0.0 112.425 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.538 0.511 0 CA-C-N 119.238 0.926 . . . . 0.0 111.672 -178.69 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.099 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.98 85.07 2.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.943 -0.74 . . . . 0.0 110.21 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.33 -35.88 40.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.739 0.816 . . . . 0.0 112.496 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.02 65.54 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.78 -0.575 . . . . 0.0 110.067 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -57.84 -41.53 82.51 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.82 -48.07 68.45 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -57.06 -50.37 72.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.285 0.543 . . . . 0.0 110.585 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -59.37 -51.04 71.62 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.234 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -56.07 -31.49 63.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.398 1.879 . . . . 0.0 110.621 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.88 -19.73 7.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.586 0.754 . . . . 0.0 112.125 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -51.0 -34.35 28.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.454 0.57 . . . . 0.0 110.667 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -77.7 -49.23 14.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -48.3 -49.09 35.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.307 1.043 . . . . 0.0 110.654 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -63.82 -11.5 27.72 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.6 m -56.63 -33.63 66.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.7 m -113.99 -39.64 3.9 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.437 0.695 . . . . 0.0 110.341 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -95.47 -172.42 2.63 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -159.96 172.83 16.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.984 2.113 . . . . 0.0 107.648 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -132.67 132.43 59.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 tp -116.32 143.9 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.853 1.661 . . . . 0.0 109.164 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.37 159.11 82.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.27 -42.44 47.35 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.138 2.559 . . . . 0.0 112.863 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -73.0 -11.91 60.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.311 1.444 . . . . 0.0 113.671 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.85 -14.32 34.57 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.977 -0.901 . . . . 0.0 113.682 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.7 m -57.77 125.63 23.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.532 1.666 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.21 82.16 1.0 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 110.724 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.1 mm -57.7 -61.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.43 98.32 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.8 67.83 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.051 0.94 . . . . 0.0 109.188 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.22 -162.99 28.53 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.53 176.43 9.05 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -130.49 33.07 4.33 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -71.06 -35.9 72.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.745 1.218 . . . . 0.0 108.191 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.88 161.86 12.61 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 174.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.44 125.54 18.23 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.848 3.032 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.16 114.86 1.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 108.759 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.6 mt -72.19 -16.44 61.96 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -168.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -52.97 120.39 5.78 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.732 1.151 . . . . 0.0 108.946 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.6 12.31 72.65 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.809 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.44 -42.34 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.31 1.555 . . . . 0.0 109.544 174.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.73 118.09 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.195 0.598 . . . . 0.0 110.612 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.96 57.2 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.167 0.889 . . . . 0.0 112.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -70.7 148.69 47.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.059 1.429 . . . . 0.0 110.482 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -76.09 59.48 1.33 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.815 1.246 . . . . 0.0 110.424 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 36.57 -123.54 0.17 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.164 1.786 . . . . 0.0 113.465 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.67 73.16 0.0 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.017 1.77 . . . . 0.0 115.298 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.1 t -160.18 9.13 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.31 1.055 . . . . 0.0 113.433 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -64.24 134.53 95.99 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 120.979 -1.076 . . . . 0.0 108.63 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -64.32 157.22 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.416 1.41 . . . . 0.0 111.31 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 47.68 58.46 4.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.149 1.38 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -154.83 119.98 4.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.148 0.499 . . . . 0.0 109.873 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -73.1 77.25 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.475 1.11 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.83 -176.93 1.17 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 110.515 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -113.25 173.71 6.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.158 0.983 . . . . 0.0 108.799 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.25 -41.64 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.202 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 p -60.22 -64.88 0.79 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.975 1.31 . . . . 0.0 111.719 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -38.82 75.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.121 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.54 -49.28 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.16 91.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.571 0.349 . . . . 0.0 111.005 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.7 tp -55.96 -52.58 63.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.37 -54.63 28.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.68 48.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.53 1.132 . . . . 0.0 112.585 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -71.15 2.12 5.0 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.92 34.07 8.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.663 1.125 . . . . 0.0 110.923 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -97.54 117.4 31.73 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.206 0.503 . . . . 0.0 109.849 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.11 137.92 45.26 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.632 1.173 . . . . 0.0 110.421 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -73.79 95.77 2.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.587 0.355 . . . . 0.0 111.915 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 p -78.77 167.55 21.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -55.97 -43.63 77.73 Favored 'General case' 0 N--CA 1.459 -0.017 0 CA-C-O 121.923 0.868 . . . . 0.0 109.893 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.58 -51.75 67.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.059 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.42 -49.38 78.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.361 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.98 -52.91 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.83 -42.0 75.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.078 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.5 m -67.26 -51.48 52.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.243 0.217 . . . . 0.0 110.54 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -43.62 -56.36 3.77 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 125.266 1.427 . . . . 0.0 112.9 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 m -52.35 -30.18 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -73.12 -28.68 62.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.005 0.522 . . . . 0.0 112.008 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -151.95 62.63 4.82 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 124.432 1.093 . . . . 0.0 111.215 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.78 159.14 53.61 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.53 -63.83 3.64 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.53 67.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.198 0.999 . . . . 0.0 110.464 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -52.41 -48.27 65.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.089 0.556 . . . . 0.0 110.554 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.63 -59.31 5.39 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -45.3 -48.39 13.03 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.633 1.173 . . . . 0.0 110.727 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.37 -70.46 0.17 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.303 1.041 . . . . 0.0 110.712 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -63.15 -31.53 72.69 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -171.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.48 -7.42 59.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.396 0.679 . . . . 0.0 111.256 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.24 54.37 10.38 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 109.286 -175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -138.62 152.16 47.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.588 1.155 . . . . 0.0 109.776 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -48.63 6.86 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.779 1.632 . . . . 0.0 108.13 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -80.96 30.18 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.07 67.27 8.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.277 -0.889 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.83 154.68 40.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.964 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -123.17 149.82 44.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.4 -26.25 74.45 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 15.5 ttp -68.48 80.78 0.26 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.642 0.721 . . . . 0.0 112.146 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 57.94 3.12 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.48 146.89 13.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -143.1 160.7 39.91 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.3 tp -161.05 112.49 1.82 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.2 33.92 0.24 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.662 -0.649 . . . . 0.0 112.56 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -159.49 179.54 8.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.202 2.201 . . . . 0.0 106.848 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.46 -55.13 4.39 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.05 -57.15 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 126.209 1.861 . . . . 0.0 114.075 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 3.6 pm0 -52.75 -58.2 7.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.038 1.335 . . . . 0.0 113.004 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -68.92 -40.51 79.03 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.781 -0.574 . . . . 0.0 111.019 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.573 HG11 HMB1 ' A' ' 117' ' ' HEC . 82.4 t -61.97 -41.11 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.928 -0.483 . . . . 0.0 110.418 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.04 -46.64 87.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.754 -0.591 . . . . 0.0 109.749 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.18 -43.78 95.6 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -57.85 -49.22 77.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.37 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 mt -57.87 -45.54 86.19 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.222 0.465 . . . . 0.0 110.593 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.71 79.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.826 0.451 . . . . 0.0 110.642 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -70.15 -39.61 75.24 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.135 -0.353 . . . . 0.0 110.866 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.92 -38.93 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.677 1.591 . . . . 0.0 112.596 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.6 82.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.499 1.045 . . . . 0.0 110.574 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.1 pttp . . . . . 0 C--O 1.249 1.041 0 C-N-CA 127.964 2.506 . . . . 0.0 107.696 -178.934 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.591 HBB2 ' HHC' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 CA-C-O 121.115 0.286 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -81.71 88.84 6.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.199 1.0 . . . . 0.0 108.853 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.53 -42.51 2.42 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.807 1.243 . . . . 0.0 112.978 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.59 73.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.597 0.759 . . . . 0.0 111.467 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -69.42 -37.21 77.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -51.47 -43.03 52.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.421 1.01 . . . . 0.0 111.228 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -52.5 -46.94 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.459 0.704 . . . . 0.0 110.848 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.96 -46.47 65.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.518 0.727 . . . . 0.0 109.567 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.21 -35.5 67.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.097 0.959 . . . . 0.0 110.579 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -56.91 -16.95 7.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.128 0.971 . . . . 0.0 112.428 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -52.2 -29.61 23.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.562 -0.711 . . . . 0.0 110.545 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -72.76 -55.61 6.49 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.46 -46.19 56.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.421 1.089 . . . . 0.0 112.889 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -55.86 -21.81 21.98 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -59.4 -26.12 64.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.3 m -118.83 -43.81 2.65 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.524 0.729 . . . . 0.0 111.09 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 37' ' ' LEU . 91.0 m-70 -97.98 -172.17 2.31 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.272 1.029 . . . . 0.0 112.85 -175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -151.04 169.05 22.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.571 1.548 . . . . 0.0 109.057 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.9 mt -133.31 124.08 48.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -145.61 134.55 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.932 0.893 . . . . 0.0 110.012 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.11 161.98 68.78 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -54.58 -37.0 90.62 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 110.982 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.41 -0.57 6.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.711 1.604 . . . . 0.0 113.315 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.85 -7.32 81.6 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 120.848 -1.158 . . . . 0.0 112.415 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -64.82 103.19 0.67 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.457 1.128 . . . . 0.0 109.125 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.03 120.78 14.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.699 0.4 . . . . 0.0 111.255 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.43 -45.92 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.84 106.37 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -72.16 56.5 0.33 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.039 1.336 . . . . 0.0 110.172 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.26 -173.61 13.0 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 167.94 7.46 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.098 -0.648 . . . . 0.0 111.085 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -117.09 30.66 7.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.731 0.812 . . . . 0.0 109.261 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -67.27 -44.11 80.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.53 171.72 17.65 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 107.636 -2.185 . . . . 0.0 107.636 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.77 177.27 1.87 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.243 3.295 . . . . 0.0 113.087 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 114.1 21.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 17' ' ' HIS . 95.2 mt -71.45 -16.93 62.39 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.75 116.0 2.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.99 15.27 70.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.56 -1.133 . . . . 0.0 114.837 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG11 HMA3 ' A' ' 117' ' ' HEC . 55.7 t -62.5 -44.96 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.928 1.864 . . . . 0.0 108.892 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.65 113.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 -15.17 59.75 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.832 1.206 . . . . 0.0 112.744 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -90.31 144.65 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.541 1.17 . . . . 0.0 110.919 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -58.69 133.35 55.84 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.628 1.171 . . . . 0.0 109.126 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.81 159.33 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.534 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.92 23.53 31.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.975 1.274 . . . . 0.0 114.477 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.1 p -145.31 22.94 1.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.888 1.344 . . . . 0.0 113.01 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -67.32 137.44 93.84 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 172.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.06 154.35 10.64 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.311 2.007 . . . . 0.0 114.565 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 45.06 59.35 3.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.276 1.83 . . . . 0.0 113.269 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.31 118.57 2.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -82.88 98.27 9.1 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.028 0.931 . . . . 0.0 109.725 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -82.68 -172.83 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 111.152 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -96.35 -176.91 3.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.924 1.29 . . . . 0.0 108.546 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.77 -34.47 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.928 0.891 . . . . 0.0 113.12 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 p -60.42 -65.38 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.46 1.104 . . . . 0.0 110.387 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.54 -40.28 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.156 1.383 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.8 t -59.82 -50.74 78.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.2 97.3 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.123 0.42 . . . . 0.0 111.108 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -53.31 53.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.73 64.59 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 123.766 0.698 . . . . 0.0 111.836 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.72 -26.82 47.24 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.488 1.515 . . . . 0.0 112.033 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.2 m -69.56 0.59 5.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.01 0.368 . . . . 0.0 111.938 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.97 38.4 5.76 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 125.446 1.498 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -107.11 110.06 22.06 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.378 0.589 . . . . 0.0 111.676 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 128.11 43.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.218 1.407 . . . . 0.0 107.55 174.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -62.75 151.76 37.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 110.796 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.0 p -129.82 162.56 28.23 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.949 1.7 . . . . 0.0 106.452 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.38 -39.68 80.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.061 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.55 -52.53 64.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.551 0.741 . . . . 0.0 110.216 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -61.03 -45.34 95.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.431 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.1 -53.03 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 118.675 0.671 . . . . 0.0 109.335 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.75 -46.45 64.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.462 0.705 . . . . 0.0 110.052 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.5 m -62.24 -54.4 41.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 109.915 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -50.08 -48.45 53.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.816 1.246 . . . . 0.0 113.04 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.3 m -60.47 -28.13 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.331 0.969 . . . . 0.0 112.689 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.24 -13.4 52.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.663 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -139.54 57.71 10.59 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.989 1.716 . . . . 0.0 112.07 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.08 138.43 78.15 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.926 2.418 . . . . 0.0 109.663 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.6 -65.17 2.49 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.42 -45.65 9.14 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 125.924 1.69 . . . . 0.0 111.529 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -55.1 -55.49 30.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.898 0.479 . . . . 0.0 110.664 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 83' ' ' LEU . 6.2 mp -56.74 -53.03 62.46 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.208 0.603 . . . . 0.0 109.997 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -52.35 -44.2 65.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.765 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.09 -67.15 0.45 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.605 0.762 . . . . 0.0 110.22 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -53.86 -42.74 68.9 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.16 -4.05 59.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.117 0.567 . . . . 0.0 111.847 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.3 t0 47.6 45.11 17.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.094 1.358 . . . . 0.0 110.009 -174.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.24 111.61 11.01 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.459 1.104 . . . . 0.0 110.52 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -57.46 -26.05 60.63 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.002 2.521 . . . . 0.0 111.787 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -96.49 9.61 40.84 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.22 72.71 7.06 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.502 -0.749 . . . . 0.0 110.357 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -91.73 126.79 36.94 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.701 0.8 . . . . 0.0 109.976 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -80.78 161.94 24.29 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.15 0.5 . . . . 0.0 110.498 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.13 -22.76 70.35 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 169.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ttp -68.26 81.02 0.24 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.991 0.895 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.0 58.04 3.31 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -160.19 150.43 18.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.539 1.536 . . . . 0.0 107.387 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -141.98 158.34 43.88 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.319 1.048 . . . . 0.0 108.543 173.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.418 HD22 HBB1 ' A' ' 117' ' ' HEC . 11.8 tp -111.71 102.81 11.08 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.08 67.73 1.79 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.889 1.276 . . . . 0.0 109.958 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 89.3 139.45 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 129.195 2.998 . . . . 0.0 109.35 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.9 -21.76 7.83 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -49.48 -41.59 33.33 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.492 1.044 . . . . 0.0 112.63 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.45 -46.56 88.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.443 0.622 . . . . 0.0 110.868 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.6 -49.2 77.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.283 1.433 . . . . 0.0 110.17 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.585 HG11 HMB1 ' A' ' 117' ' ' HEC . 96.2 t -63.59 -44.96 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.66 91.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.87 -0.518 . . . . 0.0 110.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.06 94.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -57.22 -49.42 76.07 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.908 -0.495 . . . . 0.0 110.269 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.27 -44.21 88.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.429 -0.794 . . . . 0.0 111.206 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.47 73.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.442 0.697 . . . . 0.0 110.752 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -72.38 -37.73 68.66 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.123 -0.36 . . . . 0.0 110.679 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 t -69.27 -47.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.806 1.242 . . . . 0.0 112.43 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.36 118.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 122.566 1.174 . . . . 0.0 111.841 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.376 0 C-N-CA 129.391 3.076 . . . . 0.0 106.789 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.623 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -77.08 84.14 3.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -39.06 -41.6 0.81 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.604 1.561 . . . . 0.0 113.601 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.79 -55.29 36.74 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.455 0.57 . . . . 0.0 110.627 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -57.25 -38.47 73.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.308 0.643 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.52 -52.05 47.75 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.74 -50.37 73.44 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.15 0.98 . . . . 0.0 110.165 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.57 -51.62 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.459 -0.201 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.95 -38.33 70.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.828 0.851 . . . . 0.0 109.627 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -56.97 -29.95 63.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -33.54 67.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.025 -0.422 . . . . 0.0 110.231 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -87.66 -48.66 7.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.742 0.817 . . . . 0.0 109.006 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.2 t -49.22 -37.57 23.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.588 1.555 . . . . 0.0 112.038 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 5.01 0.68 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -55.83 -30.53 61.58 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.798 -1.189 . . . . 0.0 110.213 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.18 -37.28 5.37 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.563 0.745 . . . . 0.0 112.593 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -105.71 -174.43 2.53 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.676 0.791 . . . . 0.0 112.337 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 m -150.67 171.25 17.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.015 1.326 . . . . 0.0 109.619 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -133.16 133.28 58.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tp -117.14 141.86 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.537 1.535 . . . . 0.0 109.247 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.26 154.76 88.22 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.53 -38.84 45.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.12 2.547 . . . . 0.0 113.537 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.57 -16.25 62.84 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.738 1.215 . . . . 0.0 113.779 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.48 -13.52 23.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.667 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.3 m -60.63 124.85 21.61 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.625 1.712 . . . . 0.0 110.014 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -72.74 77.35 1.12 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.673 0.789 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.2 mm -52.94 -55.43 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.17 86.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.28 65.25 0.84 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.143 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.24 -158.53 33.57 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.53 174.09 11.38 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -121.92 28.44 7.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 109.201 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -66.9 -43.42 83.45 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.13 171.03 18.38 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 170.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.69 -173.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.61 2.873 . . . . 0.0 114.049 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -117.63 89.99 3.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 108.594 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 6.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 119.208 3.04 . . . . 0.0 119.208 -169.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -59.75 102.44 0.15 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 121.29 1.859 . . . . 0.0 108.736 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.36 21.81 31.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.485 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.98 -40.69 89.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-N 118.599 1.199 . . . . 0.0 109.4 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.06 98.71 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -16.06 9.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.506 2.003 . . . . 0.0 111.569 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -71.48 136.19 47.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 117.987 0.893 . . . . 0.0 110.409 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -71.4 67.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.598 1.559 . . . . 0.0 111.794 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 62.54 -149.86 0.36 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.314 1.046 . . . . 0.0 111.621 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.84 80.99 0.18 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 123.155 0.407 . . . . 0.0 113.173 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 t -150.32 21.02 0.85 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -68.12 143.14 95.73 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.29 153.9 20.58 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.39 1.393 . . . . 0.0 114.012 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 47.47 65.24 1.32 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.25 1.82 . . . . 0.0 112.875 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -158.7 120.93 3.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.137 0.494 . . . . 0.0 110.607 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -75.21 78.12 2.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.37 1.068 . . . . 0.0 110.7 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -67.41 178.19 1.65 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.884 0.474 . . . . 0.0 111.315 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -112.15 174.91 5.66 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.735 1.214 . . . . 0.0 109.663 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.28 -39.49 87.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.298 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.1 p -65.89 -62.72 1.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.677 1.227 . . . . 0.0 110.835 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -61.75 -21.25 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.087 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.01 -47.92 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.73 64.17 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.134 0.974 . . . . 0.0 111.014 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.73 -51.54 48.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.944 0.897 . . . . 0.0 108.751 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.39 90.8 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.54 -39.59 73.66 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -71.98 -7.78 50.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.46 9.57 43.73 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.373 0.987 . . . . 0.0 113.054 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -74.46 142.21 44.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.186 1.493 . . . . 0.0 109.204 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.87 135.03 41.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.923 1.289 . . . . 0.0 107.682 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -64.14 128.47 35.95 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -113.87 167.3 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.868 1.667 . . . . 0.0 106.806 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -51.53 -52.65 45.3 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.949 0.88 . . . . 0.0 109.834 172.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -60.76 -48.3 82.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.547 -176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -63.69 -41.4 98.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.491 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.48 -53.2 47.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.62 -47.07 67.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.495 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -61.43 -54.93 37.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.751 0.31 . . . . 0.0 110.751 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -55.13 -42.18 72.67 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.456 -0.777 . . . . 0.0 111.925 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.68 -28.1 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.241 0.616 . . . . 0.0 111.506 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -90.25 -31.78 16.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.555 0.742 . . . . 0.0 111.067 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.61 69.17 72.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 124.664 1.186 . . . . 0.0 112.518 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -67.28 153.9 75.74 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.07 -64.38 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.06 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.854 1.262 . . . . 0.0 110.317 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -52.67 -50.37 63.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.948 0.499 . . . . 0.0 111.402 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.29 -49.5 69.28 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.622 -0.674 . . . . 0.0 109.824 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -51.14 -48.37 61.82 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.118 0.567 . . . . 0.0 111.341 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -43.49 -54.64 4.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.118 0.967 . . . . 0.0 111.553 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -84.26 -50.8 7.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.959 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -76.13 -23.05 54.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.961 0.904 . . . . 0.0 113.436 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 44.74 63.65 1.63 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.653 1.981 . . . . 0.0 111.725 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -150.29 137.34 19.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -52.13 -38.7 58.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.977 0.911 . . . . 0.0 110.646 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -82.44 13.07 3.86 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.65 61.2 4.25 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.235 -0.915 . . . . 0.0 109.178 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.78 -174.55 2.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.823 1.249 . . . . 0.0 110.057 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -152.57 151.7 30.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.72 -13.05 71.41 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.539 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 3.1 ttp -69.75 78.9 0.44 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 118.166 0.983 . . . . 0.0 113.21 -177.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.56 56.83 2.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -164.21 144.6 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.869 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -152.7 171.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 tp -144.73 113.56 6.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.55 41.44 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.065 0.546 . . . . 0.0 111.367 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 pttp 179.71 178.87 0.53 Allowed 'General case' 0 C--O 1.231 0.11 0 C-N-CA 127.61 2.364 . . . . 0.0 105.793 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.98 -52.96 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 119.038 -0.868 . . . . 0.0 113.184 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.4 -54.01 0.09 OUTLIER Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.221 2.343 . . . . 0.0 115.102 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.7 pm0 -64.96 -45.04 87.39 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.032 0.916 . . . . 0.0 111.578 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -64.38 -47.69 78.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 108.839 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.22 -43.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.872 1.269 . . . . 0.0 109.603 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.98 88.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.954 -0.466 . . . . 0.0 110.219 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.78 93.56 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.12 -52.45 65.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.1 mt -55.59 -48.01 75.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.053 0.541 . . . . 0.0 110.718 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.87 -40.05 69.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 110.75 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 m -77.52 -14.05 59.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 t -87.05 -38.19 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 108.737 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.55 66.73 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.742 -0.599 . . . . 0.0 109.859 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? . . . . . 0 C--O 1.251 1.136 0 CA-C-O 115.969 -1.967 . . . . 0.0 109.73 -177.982 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.539 ' CHD' ' HG3' ' A' ' 96' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.104 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.12 82.54 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.899 -0.765 . . . . 0.0 109.293 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -45.1 -40.37 6.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 112.313 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.95 81.25 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.283 0.633 . . . . 0.0 111.165 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -64.46 -43.68 93.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.34 -48.57 33.42 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.8 1.19 . . . . 0.0 111.526 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.01 -54.61 36.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.716 0.758 . . . . 0.0 110.213 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.67 -48.39 81.86 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.888 -0.508 . . . . 0.0 110.662 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -56.54 -33.82 66.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.876 1.271 . . . . 0.0 110.821 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.13 -21.05 7.72 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.041 0.937 . . . . 0.0 111.615 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -46.2 -36.25 5.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.846 0.748 . . . . 0.0 110.754 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -69.09 -57.88 4.83 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.8 m -50.59 -40.51 52.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.257 1.023 . . . . 0.0 111.292 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -45.22 -35.3 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.552 2.341 . . . . 0.0 112.394 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 m -55.16 -29.88 58.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.588 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.6 m -123.36 -27.2 4.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.517 1.127 . . . . 0.0 113.387 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.1 167.94 11.32 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.539 1.136 . . . . 0.0 112.639 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 p -145.57 168.49 20.5 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.202 1.801 . . . . 0.0 109.562 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mp -136.04 107.73 7.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 tt -129.04 137.31 57.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 124.212 1.005 . . . . 0.0 110.548 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 152.52 92.86 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.42 -40.06 44.59 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.438 2.759 . . . . 0.0 113.497 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.69 -13.31 61.99 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.798 1.239 . . . . 0.0 113.802 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.07 -7.29 29.08 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.703 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.8 m -61.15 102.34 0.21 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.002 1.901 . . . . 0.0 109.299 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.66 76.37 5.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.844 2.058 . . . . 0.0 111.471 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.49 -46.71 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.292 0.637 . . . . 0.0 109.381 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.43 106.79 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -75.38 55.41 0.79 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.737 1.615 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.6 -174.33 30.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.21 0.91 . . . . 0.0 111.2 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.58 -174.69 5.12 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.804 0.811 . . . . 0.0 112.046 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.51 28.27 3.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 110.242 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 m -61.67 -35.09 76.97 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.04 162.87 12.45 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 169.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -55.4 153.1 29.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.592 2.195 . . . . 0.0 113.441 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -66.03 127.45 32.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.76 16.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -63.43 87.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.243 0.929 . . . . 0.0 110.045 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.75 46.67 5.63 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.11 -31.65 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.77 118.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.711 0.804 . . . . 0.0 108.862 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.91 -10.18 74.74 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.024 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -68.85 136.78 53.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.44 1.12 . . . . 0.0 109.327 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -62.53 135.39 57.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.52 131.3 45.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.757 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.03 35.22 61.27 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.562 -1.132 . . . . 0.0 113.764 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.1 p -136.33 2.68 2.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.123 1.461 . . . . 0.0 114.644 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.35 128.01 90.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.409 1.459 . . . . 0.0 107.106 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -54.57 157.85 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.901 2.401 . . . . 0.0 114.479 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 49.97 66.19 1.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.373 1.869 . . . . 0.0 112.415 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -164.44 123.78 1.92 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.815 0.446 . . . . 0.0 109.868 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -79.93 93.79 5.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.041 0.936 . . . . 0.0 109.922 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -77.97 -170.24 1.85 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.649 0.738 . . . . 0.0 110.662 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -117.08 172.44 7.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.291 1.836 . . . . 0.0 108.495 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.58 -36.71 84.69 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.979 0.912 . . . . 0.0 113.383 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -60.99 -65.76 0.64 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 111.089 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.21 -37.96 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.37 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -48.04 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.73 91.65 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.652 0.66 . . . . 0.0 111.141 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -48.36 73.69 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.57 28.16 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.13 -27.79 55.36 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.629 1.572 . . . . 0.0 112.282 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -68.03 -4.6 13.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.77 35.8 4.19 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 125.32 1.438 . . . . 0.0 110.52 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -103.39 124.19 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 117.408 0.604 . . . . 0.0 110.957 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.58 130.25 56.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.154 1.782 . . . . 0.0 107.603 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -60.74 143.62 54.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 118.177 0.444 . . . . 0.0 110.613 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.0 p -128.27 170.13 13.4 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.004 1.722 . . . . 0.0 106.917 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -58.59 -45.23 89.55 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 122.978 0.511 . . . . 0.0 110.606 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.36 -46.9 75.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.576 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.27 -46.68 87.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.99 -52.74 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -47.31 69.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.616 0.367 . . . . 0.0 110.277 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.6 m -64.37 -44.23 92.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.815 -0.553 . . . . 0.0 110.829 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -55.75 -53.47 56.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.063 0.945 . . . . 0.0 111.286 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 m -56.99 -40.13 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.593 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -65.04 -24.55 67.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -158.02 73.35 4.04 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.732 1.151 . . . . 0.0 113.005 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.13 146.74 79.71 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.522 2.148 . . . . 0.0 110.636 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.9 -64.18 4.35 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.78 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 117.318 0.559 . . . . 0.0 110.297 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -51.78 -51.23 57.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.959 0.504 . . . . 0.0 111.656 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.41 -56.39 16.61 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.321 0.648 . . . . 0.0 109.296 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -46.58 -46.4 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.499 1.12 . . . . 0.0 110.747 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -51.88 -40.53 60.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.043 0.937 . . . . 0.0 111.973 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -90.9 -45.68 8.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.305 0.642 . . . . 0.0 112.129 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 -17.87 39.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.472 1.109 . . . . 0.0 113.189 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 48.25 62.66 2.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.399 1.88 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -143.76 150.14 38.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.679 1.592 . . . . 0.0 108.926 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -66.97 -48.33 68.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 108.432 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -80.3 11.58 3.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.03 -1.441 . . . . 0.0 114.619 -173.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.41 63.58 6.65 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.691 -1.256 . . . . 0.0 110.517 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -102.52 170.45 8.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.197 0.999 . . . . 0.0 109.942 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -131.7 154.07 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.61 -12.44 64.15 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.552 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 4.0 ttp -67.97 79.75 0.22 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 56.6 2.66 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.572 0.749 . . . . 0.0 110.122 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 48.4 t80 -154.28 116.06 4.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.839 1.256 . . . . 0.0 108.712 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -100.94 -179.14 3.97 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.6 156.89 47.94 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.49 53.32 0.8 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? 75.66 164.12 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.875 1.67 . . . . 0.0 110.619 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.98 -15.22 33.85 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.05 -35.62 33.36 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.425 1.488 . . . . 0.0 112.29 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.65 -47.37 86.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 117.518 0.659 . . . . 0.0 110.586 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -64.32 -44.39 91.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.576 HG11 HMB1 ' A' ' 117' ' ' HEC . 98.7 t -60.42 -47.1 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.5 -48.14 77.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.955 -0.466 . . . . 0.0 109.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.18 -46.09 79.5 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -57.0 -51.23 70.06 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.073 -0.392 . . . . 0.0 110.869 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.37 -43.58 79.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.848 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.67 91.61 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.325 -0.234 . . . . 0.0 110.964 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.5 m -69.85 -50.05 46.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.738 HG13 ' H ' ' A' ' 115' ' ' VAL . 11.4 p -59.68 -81.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.738 ' H ' HG13 ' A' ' 114' ' ' VAL . 7.2 p 8.28 70.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 129.722 3.209 . . . . 0.0 113.655 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.237 0 CA-C-O 113.901 -2.952 . . . . 0.0 104.203 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.601 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.89 74.59 0.62 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.62 1.168 . . . . 0.0 111.449 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.39 -40.64 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.509 1.124 . . . . 0.0 112.618 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.54 85.79 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.733 -0.604 . . . . 0.0 111.044 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -63.98 -38.16 90.06 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.67 -48.35 82.16 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.19 -49.81 72.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.74 0.816 . . . . 0.0 109.736 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -59.7 -48.33 82.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.435 0.16 . . . . 0.0 110.691 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.15 -34.56 68.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.491 1.116 . . . . 0.0 110.464 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.98 -16.67 7.42 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.958 0.903 . . . . 0.0 112.564 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -51.28 -30.84 19.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.449 0.7 . . . . 0.0 110.387 172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -76.96 -59.02 2.95 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.62 -0.675 . . . . 0.0 109.349 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.9 m -45.36 -47.68 13.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.768 1.627 . . . . 0.0 111.961 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -51.02 -26.27 5.92 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.924 1.29 . . . . 0.0 113.805 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -58.6 -40.57 83.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.472 0.578 . . . . 0.0 109.56 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.1 m -99.39 -48.69 4.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.419 1.088 . . . . 0.0 112.133 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -84.07 176.83 8.55 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.159 0.983 . . . . 0.0 112.473 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.4 m -147.98 159.23 44.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.818 0.847 . . . . 0.0 108.764 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -142.93 122.19 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.36 130.52 60.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 O-C-N 121.86 -0.525 . . . . 0.0 110.009 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.04 158.87 60.36 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.98 -39.25 79.74 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.269 2.646 . . . . 0.0 112.53 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.7 -8.6 55.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.375 1.47 . . . . 0.0 113.717 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.49 -13.25 51.07 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -59.92 114.81 3.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.66 1.73 . . . . 0.0 109.677 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.24 118.74 11.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.467 0.707 . . . . 0.0 109.949 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 mm -89.86 -42.52 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.9 t -141.19 129.58 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -127.6 74.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.69 -168.4 3.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.28 44.22 1.01 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.977 -1.307 . . . . 0.0 110.11 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 tptp 13.79 57.45 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 130.648 3.579 . . . . 0.0 113.79 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -89.48 -30.95 17.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.69 0.796 . . . . 0.0 108.915 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.5 170.27 13.98 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.84 167.22 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.003 3.136 . . . . 0.0 112.21 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.49 125.7 30.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -92.9 4.43 53.92 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -67.55 87.15 0.2 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.296 0.953 . . . . 0.0 109.483 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 115' ' ' VAL . . . 112.05 23.14 5.66 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.947 0.784 . . . . 0.0 111.577 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.91 -42.73 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.519 1.16 . . . . 0.0 110.05 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 115' ' ' VAL . 58.1 t -61.63 114.44 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.11 63.56 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.013 1.292 . . . . 0.0 111.654 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -68.92 138.61 54.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.6 1.2 . . . . 0.0 109.897 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 m -67.4 70.4 0.11 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.781 1.632 . . . . 0.0 111.508 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.53 -144.91 0.64 Allowed 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.875 -0.516 . . . . 0.0 110.232 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.62 73.73 0.61 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.514 1.054 . . . . 0.0 112.645 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.4 p -138.81 2.73 2.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.239 1.015 . . . . 0.0 111.922 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -62.22 132.9 94.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.57 161.67 11.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.151 1.9 . . . . 0.0 114.006 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 57.55 58.64 3.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.794 1.638 . . . . 0.0 112.916 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -165.88 123.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.746 0.418 . . . . 0.0 110.488 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -79.24 88.93 4.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.976 0.91 . . . . 0.0 109.553 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.91 -174.17 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.521 0.677 . . . . 0.0 111.455 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -106.12 -178.46 3.66 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.492 1.517 . . . . 0.0 108.322 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.65 -38.03 67.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.713 0.805 . . . . 0.0 112.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -60.74 -63.06 1.43 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 111.078 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.54 -35.65 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.9 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.55 -48.27 77.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.91 78.18 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 110.586 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.3 tp -55.77 -49.65 72.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.45 -52.75 48.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.84 -36.83 65.46 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.2 1.0 . . . . 0.0 112.591 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -67.32 -11.58 57.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.89 10.92 15.08 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.889 1.233 . . . . 0.0 112.595 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -77.0 141.27 40.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.739 1.27 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.51 34.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.454 1.501 . . . . 0.0 107.923 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -62.54 143.26 57.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.33 166.45 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.035 1.734 . . . . 0.0 106.596 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.98 -43.76 77.91 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.304 0.573 . . . . 0.0 110.775 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.62 -47.69 68.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.102 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.11 -46.05 90.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.252 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.3 mt -57.22 -54.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.69 -46.13 29.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.636 0.774 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -63.43 -65.32 0.7 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.255 0.622 . . . . 0.0 110.472 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -43.38 -48.83 7.06 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.011 1.724 . . . . 0.0 112.811 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 t -53.2 -25.73 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.64 14.87 15.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.601 1.091 . . . . 0.0 112.32 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -159.37 56.79 0.95 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.576 1.15 . . . . 0.0 111.904 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -66.82 157.39 61.55 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 108.75 -1.288 . . . . 0.0 108.75 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 -66.82 3.04 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.04 -47.68 53.22 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.411 1.084 . . . . 0.0 111.342 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -51.59 -52.39 47.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.64 -56.2 24.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.622 1.169 . . . . 0.0 109.73 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.02 -47.62 44.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.575 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -63.95 -66.96 0.47 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.467 0.707 . . . . 0.0 110.369 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -53.99 -39.81 66.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.7 tp -92.24 -0.41 57.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.938 0.895 . . . . 0.0 111.982 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 43.45 58.39 3.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.327 1.451 . . . . 0.0 109.94 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -143.68 157.88 44.08 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 124.305 1.042 . . . . 0.0 110.836 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -92.41 -50.22 5.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.272 1.829 . . . . 0.0 108.115 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -79.53 42.2 0.51 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.89 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.37 90.94 3.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -131.46 132.72 44.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.054 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.92 154.48 19.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.12 -16.9 62.86 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 172.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttp -64.96 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.244 1.022 . . . . 0.0 113.309 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.56 59.21 4.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -160.43 150.72 18.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.329 1.851 . . . . 0.0 107.426 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -143.81 164.23 31.1 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.846 1.259 . . . . 0.0 107.812 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.88 169.38 9.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.92 37.51 4.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -147.33 170.52 17.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.217 1.807 . . . . 0.0 106.172 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.75 -10.05 57.41 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.874 -0.959 . . . . 0.0 112.622 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.67 13.56 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 118.708 1.254 . . . . 0.0 113.889 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -61.71 -46.1 91.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.362 1.081 . . . . 0.0 109.452 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -55.28 -52.61 62.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.296 1.438 . . . . 0.0 110.57 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.21 -46.2 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.451 1.101 . . . . 0.0 110.184 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.37 90.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.148 -0.345 . . . . 0.0 110.376 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.25 99.17 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.499 0.319 . . . . 0.0 110.309 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -57.66 -52.26 66.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 115' ' ' VAL . 54.6 mt -58.7 -44.13 90.26 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.854 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.35 76.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.801 -0.562 . . . . 0.0 110.147 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.5 m -61.58 -38.13 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.012 -0.43 . . . . 0.0 111.094 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -37.06 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.855 -0.528 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.567 HG21 ' HB ' ' A' ' 41' ' ' VAL . 65.3 t -69.88 94.07 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.305 1.042 . . . . 0.0 110.235 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.0 pttm . . . . . 0 C--O 1.253 1.253 0 CA-C-O 115.229 -2.32 . . . . 0.0 107.436 175.88 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 N-CA-C 114.043 0.377 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.69 72.48 0.77 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.461 1.505 . . . . 0.0 111.506 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.1 -39.97 10.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.679 1.191 . . . . 0.0 112.591 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.26 94.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.541 0.736 . . . . 0.0 111.452 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.38 -43.6 69.77 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.86 -44.61 40.34 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.99 -46.13 71.64 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 111.659 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -71.36 -47.99 52.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.659 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -57.62 -30.66 65.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.935 0.894 . . . . 0.0 110.719 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.67 -16.46 4.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.618 1.167 . . . . 0.0 112.144 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -53.52 -33.22 53.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.333 0.969 . . . . 0.0 111.087 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -72.85 -26.64 61.54 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.77 -0.581 . . . . 0.0 111.391 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.9 m -77.4 -45.62 25.31 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -46.23 -32.88 3.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 111.904 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -53.0 -31.31 40.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.121 0.968 . . . . 0.0 111.76 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -120.2 -38.34 2.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.487 1.515 . . . . 0.0 112.366 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -103.7 -173.47 2.32 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 125.634 1.574 . . . . 0.0 111.386 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -157.24 168.48 27.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.408 1.483 . . . . 0.0 109.01 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 133.07 54.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.06 1.744 . . . . 0.0 106.692 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 26' ' ' GLU . 1.4 tp -111.6 149.74 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.653 1.981 . . . . 0.0 109.16 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.73 161.95 48.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.76 -36.99 27.28 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.592 2.861 . . . . 0.0 112.124 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.09 13.68 0.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.996 1.718 . . . . 0.0 113.325 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.44 31.98 60.42 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.664 1.125 . . . . 0.0 111.656 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -112.2 126.24 55.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 20' ' ' ILE . 51.6 mt-10 -63.44 121.82 14.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.538 0.335 . . . . 0.0 110.469 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.1 mm -98.62 -60.18 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.67 77.84 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -68.62 70.61 0.19 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.749 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.42 -158.17 30.76 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 173.82 11.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.9 33.06 5.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.468 1.107 . . . . 0.0 108.977 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.7 m -69.38 -38.12 77.88 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.7 165.27 12.03 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -59.45 141.66 97.81 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.891 3.061 . . . . 0.0 111.199 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.07 119.4 7.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -85.86 15.91 4.51 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -170.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -75.54 80.41 2.56 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.563 -1.335 . . . . 0.0 109.442 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.93 46.35 0.34 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.127 0.87 . . . . 0.0 113.453 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.89 -48.43 33.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 t -53.52 112.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.786 0.835 . . . . 0.0 110.431 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 -15.68 61.39 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.922 1.249 . . . . 0.0 113.058 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -68.12 140.56 56.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.94 1.37 . . . . 0.0 110.789 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 m -70.2 72.73 0.46 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 110.611 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.07 -139.47 1.02 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.942 0.497 . . . . 0.0 109.707 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.96 77.51 1.13 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 123.731 0.682 . . . . 0.0 112.536 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 p -136.21 16.36 3.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.713 0.805 . . . . 0.0 112.121 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -67.08 141.81 96.73 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.022 -1.049 . . . . 0.0 108.928 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.37 155.98 23.18 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.279 1.319 . . . . 0.0 113.916 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 46.73 62.57 2.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.475 1.51 . . . . 0.0 113.587 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -158.44 120.5 3.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.867 -0.52 . . . . 0.0 110.023 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -73.49 82.18 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.446 0.698 . . . . 0.0 110.495 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.11 169.69 11.45 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.165 0.507 . . . . 0.0 110.513 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -96.52 175.58 6.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.87 -35.78 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.272 0.629 . . . . 0.0 112.635 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -59.24 -66.47 0.5 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.228 1.411 . . . . 0.0 111.173 -174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 tt -58.1 -37.94 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.806 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.11 -49.41 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.55 87.69 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.923 0.329 . . . . 0.0 110.711 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -47.26 84.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.58 -56.65 22.6 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 173.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.93 -32.61 54.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.08 1.352 . . . . 0.0 113.387 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.7 p -66.68 -12.97 60.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.86 0.755 . . . . 0.0 112.056 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.73 33.43 1.88 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.398 1.475 . . . . 0.0 110.861 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -96.11 143.61 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.787 0.794 . . . . 0.0 109.532 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.44 128.59 31.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -61.01 99.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.016 0.526 . . . . 0.0 111.831 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.4 p -83.19 167.85 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -58.17 -37.81 75.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.045 0.45 . . . . 0.0 109.846 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -64.41 -49.57 71.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -56.88 -52.74 63.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.15 -53.53 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.59 -46.28 63.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.499 0.72 . . . . 0.0 111.184 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.9 m -66.88 -54.91 17.56 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -51.78 -42.82 62.71 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.413 1.085 . . . . 0.0 113.068 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.6 t -53.98 -31.67 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.118 0.567 . . . . 0.0 111.519 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -105.6 14.13 28.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.28 1.432 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -161.21 49.16 0.26 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.269 1.027 . . . . 0.0 111.809 -175.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -56.16 136.08 73.27 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.67 2.914 . . . . 0.0 110.04 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.63 -55.39 2.08 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.55 -0.583 . . . . 0.0 111.959 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 -38.55 68.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.501 1.151 . . . . 0.0 111.26 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -63.46 -44.74 93.6 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 110.721 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.97 -54.72 41.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.702 0.801 . . . . 0.0 108.941 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -47.8 -48.46 30.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.881 1.272 . . . . 0.0 110.244 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -61.03 -68.43 0.31 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.056 0.942 . . . . 0.0 110.513 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.27 -37.04 81.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 tp -85.86 -3.69 58.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.6 0.76 . . . . 0.0 111.344 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 t0 44.13 54.2 6.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.435 1.494 . . . . 0.0 110.017 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -145.95 119.24 8.94 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.534 0.734 . . . . 0.0 111.85 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.94 -32.23 69.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.241 1.016 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -80.51 4.93 16.7 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.39 65.28 6.46 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.485 -0.76 . . . . 0.0 111.355 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -90.54 136.83 32.81 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.382 -0.824 . . . . 0.0 109.253 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.6 t -87.91 155.13 20.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.36 -25.31 72.48 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 21.2 ttp -65.44 82.63 0.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.976 0.888 . . . . 0.0 112.324 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.69 58.29 3.24 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -163.61 145.93 9.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.328 1.851 . . . . 0.0 107.044 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.84 155.14 46.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.9 109.54 13.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.38 46.72 0.76 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.532 -0.73 . . . . 0.0 111.669 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? 175.59 -165.63 0.03 OUTLIER 'General case' 0 C--O 1.231 0.117 0 C-N-CA 128.091 2.556 . . . . 0.0 106.225 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.22 -59.01 3.63 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.993 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -4.77 -70.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.372 2.891 . . . . 0.0 115.294 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.23 -57.22 13.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.181 0.992 . . . . 0.0 112.639 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.64 -35.18 80.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.092 0.557 . . . . 0.0 110.904 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.92 -46.55 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.281 0.632 . . . . 0.0 109.632 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.34 94.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.889 -0.507 . . . . 0.0 109.702 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -43.46 86.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -59.2 -51.47 69.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.8 mt -56.46 -38.23 71.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.792 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.78 -52.46 60.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.152 0.887 . . . . 0.0 109.573 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.6 m -53.88 -34.88 60.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 112.618 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.14 -30.82 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.863 1.265 . . . . 0.0 111.697 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 t -69.07 82.78 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.064 0.847 . . . . 0.0 110.482 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.353 0 C-N-CA 127.532 2.333 . . . . 0.0 106.743 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -92.08 106.93 18.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.315 1.046 . . . . 0.0 108.498 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.72 -34.75 5.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.672 1.189 . . . . 0.0 112.476 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.04 74.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.761 0.71 . . . . 0.0 110.324 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.61 -38.52 87.94 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.49 -52.24 51.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.08 -49.15 77.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.232 0.613 . . . . 0.0 110.553 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -55.87 -50.92 69.32 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.4 -35.52 72.15 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.422 0.689 . . . . 0.0 109.951 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.87 -19.93 32.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -52.98 -31.82 42.82 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.604 0.638 . . . . 0.0 110.985 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -52.72 6.06 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.06 -38.18 10.7 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.563 1.945 . . . . 0.0 113.645 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -52.43 -25.18 9.34 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.576 1.15 . . . . 0.0 112.817 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 m -61.91 -21.97 65.19 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.612 -0.68 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -119.16 -38.76 3.0 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.85 0.86 . . . . 0.0 112.619 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.75 169.7 8.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 112.404 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.3 p -141.38 164.21 30.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.785 1.234 . . . . 0.0 111.272 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.43 119.05 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 tt -139.5 133.63 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.229 0.612 . . . . 0.0 110.86 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 162.85 63.03 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -55.83 -37.82 95.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.14 2.56 . . . . 0.0 112.394 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.25 -15.94 58.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.979 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.2 -3.11 56.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.41 110.96 2.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.6 114.57 13.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.888 0.875 . . . . 0.0 111.48 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.0 -45.16 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.7 t -135.2 103.31 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -76.96 54.79 1.05 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.781 1.232 . . . . 0.0 109.043 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.19 -176.4 50.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.21 177.94 6.12 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.327 0.584 . . . . 0.0 110.923 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -125.95 39.88 3.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.09 0.956 . . . . 0.0 109.368 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.2 m -65.57 -34.65 78.74 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.36 13.42 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 168.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.46 173.24 0.76 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.444 2.096 . . . . 0.0 113.494 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -83.32 135.09 34.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.77 10.84 37.64 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -64.8 88.61 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.275 0.943 . . . . 0.0 109.478 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.91 40.94 5.11 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.516 HG21 HMA3 ' A' ' 117' ' ' HEC . 3.5 p -72.58 -36.39 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 171.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.39 107.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.72 -13.51 50.19 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.308 1.432 . . . . 0.0 112.069 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -73.07 137.5 45.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.841 0.821 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -63.47 128.9 37.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.39 154.89 12.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.829 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.07 22.76 72.65 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.867 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.1 t -156.16 28.72 0.35 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.539 1.67 . . . . 0.0 113.416 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -72.26 129.35 87.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 167.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -45.49 154.7 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.166 2.577 . . . . 0.0 116.094 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 54.7 65.57 1.47 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.298 1.439 . . . . 0.0 112.605 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -166.83 125.42 1.39 Allowed 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.854 -0.529 . . . . 0.0 111.713 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -79.36 90.7 5.01 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.64 1.176 . . . . 0.0 109.66 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -73.55 -177.57 2.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.464 0.705 . . . . 0.0 112.509 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -105.55 -178.03 3.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.004 1.322 . . . . 0.0 108.167 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.32 -37.17 66.25 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.512 -0.742 . . . . 0.0 112.792 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -62.24 -66.2 0.57 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.506 1.122 . . . . 0.0 111.167 -173.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -55.5 -38.09 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.897 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.01 -43.58 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 O-C-N 121.813 -0.555 . . . . 0.0 109.512 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.8 87.74 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.299 0.5 . . . . 0.0 110.318 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.04 -52.43 65.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.15 -48.29 10.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.096 1.331 . . . . 0.0 112.001 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.14 29.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.237 1.415 . . . . 0.0 113.819 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -73.3 -0.5 14.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.471 1.032 . . . . 0.0 112.183 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 33.88 9.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -79.19 80.82 5.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.069 -0.665 . . . . 0.0 110.916 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.14 115.0 11.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.002 1.321 . . . . 0.0 107.865 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -56.3 146.77 22.89 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 109.259 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.2 p -127.18 164.0 22.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.08 -40.65 73.93 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.069 0.548 . . . . 0.0 110.213 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.61 -52.42 57.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.317 0.647 . . . . 0.0 110.604 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -61.03 -45.48 94.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.56 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.8 mm -56.18 -53.7 36.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.34 -47.16 66.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.678 0.391 . . . . 0.0 110.612 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 m -62.35 -55.49 27.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.21 0.528 . . . . 0.0 110.454 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -49.39 -44.63 45.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.331 1.453 . . . . 0.0 112.143 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.4 t -54.26 -30.5 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.41 0.684 . . . . 0.0 111.906 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -95.37 -26.38 15.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.616 0.766 . . . . 0.0 111.37 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -127.43 63.7 59.78 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 125.204 1.402 . . . . 0.0 112.693 -171.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.77 143.27 60.87 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.779 1.653 . . . . 0.0 108.809 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -63.57 3.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.25 -45.22 44.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.688 1.195 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -54.85 -53.03 60.61 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.686 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.6 -53.48 57.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.123 -0.361 . . . . 0.0 110.32 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -47.64 -50.6 24.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.98 0.912 . . . . 0.0 110.491 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.0 -58.32 6.35 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.01 0.524 . . . . 0.0 111.025 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -67.45 -51.47 51.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.86 -25.59 40.66 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.755 1.222 . . . . 0.0 114.219 -172.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.81 55.51 7.75 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.405 1.482 . . . . 0.0 109.892 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -136.21 135.92 39.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.248 1.419 . . . . 0.0 109.543 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.88 -41.35 97.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.411 1.084 . . . . 0.0 111.107 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -85.69 18.76 2.71 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 70.41 4.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.442 0.697 . . . . 0.0 110.444 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -113.41 128.46 56.46 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.54 1.536 . . . . 0.0 109.121 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.2 t -82.18 158.52 23.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.65 -19.85 69.53 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.559 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 26.5 ttp -68.76 82.72 0.29 Allowed 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.996 -0.708 . . . . 0.0 112.797 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.62 3.09 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -160.21 149.73 17.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.168 1.787 . . . . 0.0 108.084 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -156.3 172.57 18.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.142 1.377 . . . . 0.0 108.861 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -143.29 115.72 8.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.031 1.332 . . . . 0.0 107.625 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.48 45.58 0.78 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.665 -0.647 . . . . 0.0 111.868 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? 175.04 -172.22 0.06 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 128.301 2.64 . . . . 0.0 105.705 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.37 -52.49 2.25 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.686 -1.064 . . . . 0.0 113.523 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -24.84 -55.1 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.179 2.323 . . . . 0.0 114.997 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -62.14 -52.38 64.1 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.526 0.73 . . . . 0.0 111.493 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.72 -48.35 79.82 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.5 1.12 . . . . 0.0 109.456 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.483 HG11 HMB1 ' A' ' 117' ' ' HEC . 59.4 t -59.22 -46.38 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.653 1.181 . . . . 0.0 109.697 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.71 87.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.874 -0.516 . . . . 0.0 110.07 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.8 93.91 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -58.5 -50.41 73.87 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.979 -0.45 . . . . 0.0 110.534 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.94 -46.13 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.954 0.902 . . . . 0.0 110.434 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.7 78.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.021 0.528 . . . . 0.0 110.556 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.7 m -69.07 -38.71 79.18 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.964 -0.46 . . . . 0.0 111.07 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -42.49 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 125.329 1.452 . . . . 0.0 111.46 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.46 80.48 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.069 0.937 . . . . 0.0 110.363 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.3 pttm . . . . . 0 C--O 1.253 1.271 0 C-N-CA 128.178 2.591 . . . . 0.0 106.953 179.181 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.803 HMB1 HBB3 ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 121.798 0.665 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -73.67 80.59 1.53 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.863 -0.786 . . . . 0.0 111.152 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.52 63.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.9 0.88 . . . . 0.0 111.741 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.15 74.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.635 0.374 . . . . 0.0 110.407 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -63.87 -44.56 92.71 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -48.05 -45.53 26.56 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.13 0.871 . . . . 0.0 112.001 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -54.05 -47.22 71.84 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.285 0.634 . . . . 0.0 110.938 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -69.19 -44.74 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.625 ' OE1' HBB1 ' A' ' 117' ' ' HEC . 2.0 tm-20 -52.94 -34.93 57.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.207 1.403 . . . . 0.0 109.641 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.52 -20.34 2.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.02 -27.67 33.45 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.816 -0.553 . . . . 0.0 111.456 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.35 -55.04 5.74 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.01 -42.82 29.12 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.993 1.317 . . . . 0.0 112.33 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -57.32 -21.07 32.67 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -54.52 -32.63 58.51 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.731 -0.606 . . . . 0.0 110.288 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 m -112.48 -44.35 3.37 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.338 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -90.84 -176.15 4.58 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 m -156.3 165.41 36.44 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.147 1.779 . . . . 0.0 108.732 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.6 mt -131.95 126.86 57.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' N ' HD21 ' A' ' 36' ' ' ASN . 1.1 tp -118.85 135.75 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.322 1.449 . . . . 0.0 109.998 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.24 82.34 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 119.015 0.825 . . . . 0.0 108.973 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.07 -41.25 73.19 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.16 2.573 . . . . 0.0 112.561 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -72.66 -10.96 60.42 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.172 1.389 . . . . 0.0 113.407 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.85 -17.15 35.96 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.023 -0.876 . . . . 0.0 113.443 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.8 m -60.71 116.32 4.31 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.522 1.661 . . . . 0.0 109.923 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -64.4 122.17 16.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.822 0.449 . . . . 0.0 110.341 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.44 -52.15 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.45 97.98 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -78.11 70.14 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.825 1.25 . . . . 0.0 107.801 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.39 -151.34 27.4 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.58 -179.33 5.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -123.51 22.45 9.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 108.89 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -30.13 70.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.225 1.01 . . . . 0.0 108.998 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.18 172.08 14.49 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.7 175.05 0.64 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 124.108 3.205 . . . . 0.0 113.307 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 20' ' ' ILE . 1.5 t30 -105.4 81.77 1.74 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.055 0.942 . . . . 0.0 111.086 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mp -37.32 -0.91 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.542 1 C-N-CA 133.424 4.689 . . . . 0.0 121.464 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -69.07 80.86 0.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 121.058 1.754 . . . . 0.0 110.049 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 115' ' ' VAL . . . 122.22 32.76 0.95 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.903 -0.943 . . . . 0.0 115.014 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.4 HG11 HMA3 ' A' ' 117' ' ' HEC . 56.7 t -64.67 -49.12 81.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.7 1.75 . . . . 0.0 111.789 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 115' ' ' VAL . 88.7 t -53.38 121.56 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 121.5 -0.75 . . . . 0.0 110.537 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.02 -19.21 54.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.744 1.164 . . . . 0.0 111.737 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -64.8 135.43 55.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.136 0.968 . . . . 0.0 110.042 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.2 m -73.15 80.75 1.27 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' CA ' ' A' ' 61' ' ' GLY . . . 51.68 -145.1 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.099 0.959 . . . . 0.0 110.963 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.0 78.81 0.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 124.82 1.2 . . . . 0.0 111.945 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.0 p -134.57 5.38 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.832 0.853 . . . . 0.0 111.805 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.06 134.99 93.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.07 164.75 9.76 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.486 2.124 . . . . 0.0 114.426 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.98 52.95 7.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.846 1.658 . . . . 0.0 112.057 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -161.49 118.42 2.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.991 -0.443 . . . . 0.0 111.81 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -78.77 79.9 5.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.064 0.946 . . . . 0.0 109.599 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -64.31 163.88 12.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.958 0.503 . . . . 0.0 111.385 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -96.47 176.39 6.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.144 0.973 . . . . 0.0 110.986 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.15 -36.62 73.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.804 1.641 . . . . 0.0 113.584 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 p -64.07 -67.61 0.42 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.029 0.919 . . . . 0.0 109.823 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 tt -59.25 -33.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.64 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.99 -50.89 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.637 -0.664 . . . . 0.0 109.663 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -40.3 82.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.416 0.553 . . . . 0.0 110.283 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -57.42 -44.33 84.55 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . -58.86 -49.21 80.38 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.19 -35.47 64.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.335 0.568 . . . . 0.0 111.719 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.1 p -76.34 5.92 6.36 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 30.65 36.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.362 0.982 . . . . 0.0 112.33 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -74.99 82.61 2.22 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.77 -0.841 . . . . 0.0 112.296 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.81 107.97 5.52 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -52.35 116.48 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.627 0.771 . . . . 0.0 111.719 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.5 p -94.33 161.89 14.06 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.95 -38.0 81.16 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.91 -54.7 44.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.965 0.906 . . . . 0.0 109.249 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -58.44 -47.11 85.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.787 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -54.03 -53.65 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.67 62.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.008 0.523 . . . . 0.0 110.282 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -60.07 -53.58 56.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -52.5 -44.56 65.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.191 0.996 . . . . 0.0 111.575 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.41 -20.15 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.096 0.958 . . . . 0.0 112.418 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -103.33 -14.11 16.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.561 1.144 . . . . 0.0 111.988 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -142.08 58.81 8.38 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.632 1.173 . . . . 0.0 111.929 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.67 135.62 70.54 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.109 2.539 . . . . 0.0 109.585 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.51 -59.04 4.11 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.562 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.25 -42.28 66.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.991 0.896 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -51.43 -59.62 4.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.366 1.066 . . . . 0.0 111.042 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.31 -50.17 73.79 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.245 1.018 . . . . 0.0 110.935 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -59.69 -35.95 75.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 110.264 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.79 -59.93 2.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.625 0.77 . . . . 0.0 109.188 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -54.44 -44.99 72.96 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.75 0.23 56.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.962 0.505 . . . . 0.0 111.738 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 46.73 49.94 13.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.203 1.401 . . . . 0.0 110.666 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -138.23 117.18 12.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.455 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -51.64 -37.34 49.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.554 1.142 . . . . 0.0 111.272 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -89.14 4.34 48.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.88 86.38 7.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -116.05 153.93 30.82 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.656 1.182 . . . . 0.0 110.228 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -97.27 157.29 16.03 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 123.904 0.882 . . . . 0.0 110.439 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.48 -19.99 79.21 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.6 ttt -65.02 81.68 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.521 1.128 . . . . 0.0 112.777 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 58.13 3.03 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.484 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 25.2 t80 -165.85 143.88 5.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.099 1.36 . . . . 0.0 108.877 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -141.24 166.87 23.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.554 1.542 . . . . 0.0 107.106 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.02 165.92 13.75 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.6 56.8 3.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.392 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 75.54 -172.11 0.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.839 2.055 . . . . 0.0 111.349 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.32 -78.37 1.93 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.22 -53.87 0.18 Allowed Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.99 1.281 . . . . 0.0 112.96 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -44.73 -37.88 4.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.397 1.879 . . . . 0.0 113.31 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -58.96 -48.13 82.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.412 0.685 . . . . 0.0 110.551 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.596 HG11 HMB1 ' A' ' 117' ' ' HEC . 2.8 t -71.69 -39.71 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.32 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.303 -0.248 . . . . 0.0 110.629 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.52 95.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.558 0.743 . . . . 0.0 109.599 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.27 -51.01 69.73 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 115' ' ' VAL . 51.7 mt -58.49 -44.95 89.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.71 -0.619 . . . . 0.0 110.823 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.23 -43.94 79.12 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.968 -0.457 . . . . 0.0 110.083 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -61.8 -41.09 97.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.634 0.373 . . . . 0.0 110.68 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.54 -31.23 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.752 0.821 . . . . 0.0 111.26 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.594 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.5 t -68.08 87.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.686 0.755 . . . . 0.0 109.133 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? . . . . . 0 C--O 1.253 1.281 0 C-N-CA 128.135 2.574 . . . . 0.0 106.887 178.286 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.625 HBB1 ' OE1' ' A' ' 9' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.869 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.0 92.21 5.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.6 -40.88 20.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.894 0.877 . . . . 0.0 112.94 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.63 72.97 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.898 -0.502 . . . . 0.0 110.126 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.18 -39.64 90.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.75 -47.12 38.92 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.011 1.291 . . . . 0.0 111.255 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.94 -48.19 73.49 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.113 0.456 . . . . 0.0 110.237 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -65.34 -46.17 81.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.403 0.281 . . . . 0.0 110.373 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -57.28 -33.18 67.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.607 1.163 . . . . 0.0 110.261 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.89 -21.39 57.41 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -27.49 56.26 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.585 0.629 . . . . 0.0 109.82 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -80.58 -49.78 10.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.9 m -53.11 -41.92 65.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.701 0.801 . . . . 0.0 112.358 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -62.19 -11.5 14.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.6 m -59.05 -22.92 61.5 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.8 m -129.74 -46.25 1.16 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.885 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.82 -173.53 3.53 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.689 0.757 . . . . 0.0 112.976 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.4 m -159.89 167.99 26.8 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.504 1.922 . . . . 0.0 109.838 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.8 mm -140.73 126.07 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.416 1.487 . . . . 0.0 108.508 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 tp -120.78 136.73 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.898 1.279 . . . . 0.0 109.244 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 166.11 47.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.273 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.96 -34.53 92.34 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.961 2.44 . . . . 0.0 110.696 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.83 14.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.988 1.715 . . . . 0.0 112.821 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.01 63.16 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.975 -1.078 . . . . 0.0 111.832 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -107.99 123.36 48.53 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -65.51 114.9 5.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.809 0.444 . . . . 0.0 111.355 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.42 -43.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.98 97.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -81.63 66.85 7.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.85 174.56 54.21 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.31 72.75 7.18 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.802 -0.822 . . . . 0.0 109.033 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -40.87 71.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.963 3.705 . . . . 0.0 114.478 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -100.56 -27.33 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.701 2.4 . . . . 0.0 108.261 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.94 173.11 14.55 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.14 1.829 . . . . 0.0 108.736 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.46 171.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.604 3.536 . . . . 0.0 114.706 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -94.21 126.43 39.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.9 mt -97.22 7.4 46.66 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.31 82.66 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.928 1.24 . . . . 0.0 111.058 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.21 28.9 5.64 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.233 0.921 . . . . 0.0 113.145 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.22 -35.83 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 118.76 1.28 . . . . 0.0 108.652 171.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.08 115.23 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.799 0.839 . . . . 0.0 110.259 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.4 -14.83 62.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.069 1.319 . . . . 0.0 112.6 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -84.51 146.89 27.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.382 1.091 . . . . 0.0 111.213 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -60.12 132.12 52.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.854 0.862 . . . . 0.0 109.085 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.36 149.18 29.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.932 -0.48 . . . . 0.0 110.965 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 29.49 73.93 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.265 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.7 p -131.43 -6.96 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.073 1.437 . . . . 0.0 114.27 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -64.44 129.93 94.42 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 120.02 1.282 . . . . 0.0 108.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -59.66 166.68 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.282 1.988 . . . . 0.0 113.403 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 59.28 51.14 7.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.133 1.373 . . . . 0.0 112.021 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -164.14 120.43 1.62 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.86 87.29 6.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -70.0 -172.07 0.5 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.664 0.745 . . . . 0.0 111.405 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.33 157.94 22.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.732 1.613 . . . . 0.0 110.259 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -51.83 -36.02 46.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.7 1.2 . . . . 0.0 113.545 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -63.71 -66.77 0.5 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.076 0.95 . . . . 0.0 110.01 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -58.76 -35.77 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.486 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.57 -50.7 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.92 93.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.443 0.565 . . . . 0.0 110.602 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.54 -47.32 79.66 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.81 -55.33 28.19 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.445 1.022 . . . . 0.0 111.007 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.42 -31.44 55.17 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.782 1.233 . . . . 0.0 111.522 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -72.1 6.04 2.4 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.24 28.63 22.19 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.949 1.262 . . . . 0.0 111.646 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -80.74 82.5 6.72 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.868 -0.783 . . . . 0.0 111.356 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.55 120.33 20.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -65.29 107.59 1.66 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -86.66 165.44 16.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.07 -41.85 84.25 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.495 0.664 . . . . 0.0 109.6 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -60.09 -51.87 67.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.976 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -59.14 -49.92 76.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.258 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.9 mt -54.37 -53.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.2 -41.99 72.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.647 0.779 . . . . 0.0 111.564 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.74 -53.49 15.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.37 0.268 . . . . 0.0 110.522 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -45.88 -46.99 16.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.069 1.347 . . . . 0.0 113.588 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.6 -31.42 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -82.89 -14.99 53.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.158 0.983 . . . . 0.0 111.925 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -145.28 54.17 2.3 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.752 1.221 . . . . 0.0 112.693 -173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.41 141.17 94.94 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.253 1.969 . . . . 0.0 109.313 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.75 -63.8 3.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -48.69 -44.59 38.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 111.242 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -53.42 -54.47 36.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 110.445 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.23 -48.75 80.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.061 0.544 . . . . 0.0 110.377 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -54.64 -49.59 70.17 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.283 0.633 . . . . 0.0 110.757 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -50.01 -47.92 52.77 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.53 0.732 . . . . 0.0 111.234 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.27 -55.56 4.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.9 tp -74.93 -24.13 58.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.483 1.113 . . . . 0.0 113.69 -173.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 t0 52.23 56.78 7.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.717 1.607 . . . . 0.0 111.414 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -146.45 135.42 22.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.363 1.065 . . . . 0.0 108.198 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.116 0.566 . . . . 0.0 109.935 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.86 3.72 11.39 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.99 61.23 3.12 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.688 0.795 . . . . 0.0 110.029 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -95.65 -178.57 4.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.871 1.268 . . . . 0.0 109.559 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 t -147.66 150.02 33.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -17.69 68.23 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 ttt -66.83 78.4 0.12 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.044 0.938 . . . . 0.0 113.023 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.45 58.1 3.06 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.003 0.921 . . . . 0.0 109.163 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -165.79 140.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.547 1.539 . . . . 0.0 107.452 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.61 163.32 31.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.4 tp -155.98 111.32 2.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.19 32.51 0.28 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.7 -0.625 . . . . 0.0 112.347 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -160.02 -178.01 6.71 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 127.589 2.355 . . . . 0.0 106.432 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.2 -56.01 3.2 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.387 -0.674 . . . . 0.0 112.829 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -18.78 -63.9 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.892 2.663 . . . . 0.0 115.933 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 2.0 pm0 -61.92 -46.36 89.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.146 0.979 . . . . 0.0 111.622 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -62.77 -48.14 80.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.137 0.975 . . . . 0.0 108.719 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.452 HG11 HMB1 ' A' ' 117' ' ' HEC . 84.7 t -60.33 -44.32 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.0 0.52 . . . . 0.0 109.754 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.46 -47.28 82.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.813 0.733 . . . . 0.0 110.617 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.36 93.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.898 0.38 . . . . 0.0 110.753 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -56.17 -52.16 65.4 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.869 0.468 . . . . 0.0 109.873 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.85 -45.06 90.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.579 -0.7 . . . . 0.0 110.984 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.99 87.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.622 0.769 . . . . 0.0 111.28 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.1 p -71.8 -34.75 69.62 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.049 -0.407 . . . . 0.0 111.256 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.96 -47.66 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.768 1.227 . . . . 0.0 111.916 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.84 89.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.831 0.824 . . . . 0.0 112.35 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt . . . . . 0 C--O 1.248 1.02 0 C-N-CA 126.619 1.968 . . . . 0.0 109.63 176.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.673 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.228 0.349 . . . . 0.0 113.619 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.04 84.11 0.98 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 109.94 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.85 -37.25 29.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.851 0.86 . . . . 0.0 112.443 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.36 -52.51 63.35 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.657 -0.652 . . . . 0.0 109.94 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -57.97 -39.22 77.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.6 -48.61 69.87 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.7 -49.03 74.09 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.973 0.509 . . . . 0.0 109.741 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -61.61 -47.96 83.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.625 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -54.31 -38.77 66.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 110.323 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -56.08 -17.39 6.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.709 0.804 . . . . 0.0 112.984 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -56.03 -26.06 47.31 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.286 -0.884 . . . . 0.0 111.297 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -77.8 -51.58 10.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.0 m -50.96 -42.08 59.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.311 1.044 . . . . 0.0 111.941 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -56.68 -21.91 31.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 m -56.4 -27.71 57.16 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.922 -0.486 . . . . 0.0 110.304 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -118.66 -43.83 2.67 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.613 0.765 . . . . 0.0 111.441 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -93.85 174.94 6.92 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 124.767 1.227 . . . . 0.0 113.32 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -141.27 161.76 37.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.717 1.207 . . . . 0.0 109.872 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.1 mt -138.15 106.88 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 103.412 -2.811 . . . . 0.0 103.412 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -122.77 125.69 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.463 1.105 . . . . 0.0 109.9 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 159.17 20.61 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.406 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.18 -38.38 81.16 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.775 2.317 . . . . 0.0 110.916 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.52 3.89 4.43 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.513 1.525 . . . . 0.0 113.128 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.52 65.98 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 120.733 -1.23 . . . . 0.0 112.873 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -57.07 114.45 2.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.556 1.178 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -74.29 73.12 1.81 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.455 0.702 . . . . 0.0 111.356 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.1 mm -50.27 -48.19 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.774 0.83 . . . . 0.0 109.175 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.3 102.46 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -76.12 58.51 1.23 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 108.963 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.81 174.21 42.43 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.92 176.11 3.93 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.161 0.505 . . . . 0.0 111.529 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -118.59 24.11 11.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.369 1.068 . . . . 0.0 109.765 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -64.37 -38.29 90.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.98 169.88 13.35 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 169.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.63 178.24 1.02 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.717 3.612 . . . . 0.0 114.431 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -92.61 89.53 6.74 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.804 1.242 . . . . 0.0 111.356 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.36 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.687 2.395 . . . . 0.0 116.19 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -64.22 85.31 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 120.653 1.57 . . . . 0.0 109.61 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.58 56.9 3.73 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -33.34 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 117.673 0.737 . . . . 0.0 109.796 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.6 t -54.29 118.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.096 0.958 . . . . 0.0 110.265 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 -17.29 59.58 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.576 1.084 . . . . 0.0 112.33 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 138.88 40.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.139 1.469 . . . . 0.0 110.005 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.3 m -62.43 133.39 54.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.36 137.42 52.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.002 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.56 29.88 65.11 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.272 -1.293 . . . . 0.0 114.23 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.3 p -133.89 -3.78 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.403 1.602 . . . . 0.0 115.076 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.68 122.36 76.1 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.777 1.626 . . . . 0.0 107.341 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -56.29 162.12 8.21 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.386 2.057 . . . . 0.0 114.418 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 61.3 56.39 2.68 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.848 1.659 . . . . 0.0 111.871 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -164.22 121.12 1.65 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.88 0.371 . . . . 0.0 111.828 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -74.93 87.46 2.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.664 0.786 . . . . 0.0 109.456 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.47 167.69 14.28 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -99.78 156.39 17.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.925 0.89 . . . . 0.0 110.122 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -48.88 -43.28 38.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.085 1.354 . . . . 0.0 113.69 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 m -65.14 -52.99 51.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.845 0.355 . . . . 0.0 111.085 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 tt -65.05 -36.72 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.548 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.64 -48.45 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.14 96.72 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.035 -0.416 . . . . 0.0 111.246 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -50.61 65.93 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.06 -53.01 47.87 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.028 0.823 . . . . 0.0 111.94 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.88 -26.67 37.24 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 125.286 1.435 . . . . 0.0 111.874 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -71.83 3.71 3.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 175.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.76 40.51 7.64 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.383 1.468 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -102.79 105.23 15.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.79 129.07 40.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.986 1.314 . . . . 0.0 108.501 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -62.78 109.53 1.46 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.119 0.418 . . . . 0.0 111.751 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.3 p -91.35 164.07 13.98 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.43 -43.38 75.31 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.401 0.619 . . . . 0.0 110.876 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.97 -46.16 72.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.62 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -57.13 -50.09 73.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.671 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.74 -55.58 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.325 0.511 . . . . 0.0 109.851 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.89 -37.4 60.56 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.447 0.699 . . . . 0.0 111.628 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.6 m -72.53 -63.44 1.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -36.17 -54.08 0.8 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.448 2.299 . . . . 0.0 113.8 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 m -48.78 -32.97 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.27 -33.53 65.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.483 0.713 . . . . 0.0 112.684 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -135.98 57.05 16.44 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -60.41 145.78 98.01 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.29 1.327 . . . . 0.0 110.835 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.07 -64.04 4.11 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.44 80.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.94 0.496 . . . . 0.0 110.131 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -54.46 -53.85 48.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.961 0.904 . . . . 0.0 110.327 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -57.57 -53.83 53.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.601 0.36 . . . . 0.0 110.427 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -47.78 -47.38 30.74 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 110.601 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.03 -66.31 0.56 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.091 0.556 . . . . 0.0 110.51 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -53.9 -43.12 69.42 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -84.79 -5.22 59.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.968 0.907 . . . . 0.0 111.825 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t0 48.63 56.36 7.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.024 1.33 . . . . 0.0 109.609 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -142.49 157.13 45.07 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.097 0.959 . . . . 0.0 110.298 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -95.1 -46.83 6.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.94 2.096 . . . . 0.0 107.628 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -76.43 43.71 0.32 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.485 1.514 . . . . 0.0 111.78 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.73 118.25 29.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.006 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -151.23 140.3 21.13 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.12 0.968 . . . . 0.0 108.738 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -103.55 156.22 17.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -24.16 58.44 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.6 ttp -63.21 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.789 0.795 . . . . 0.0 113.095 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.62 57.3 3.29 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -160.44 149.91 17.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.444 1.898 . . . . 0.0 106.372 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -143.42 158.81 43.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.5 tp -130.89 115.75 16.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.94 50.47 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.159 0.984 . . . . 0.0 112.067 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -133.82 135.21 43.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.33 1.452 . . . . 0.0 107.839 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.12 61.26 4.38 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.558 -2.617 . . . . 0.0 106.558 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.94 65.01 0.0 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 129.794 3.569 . . . . 0.0 117.192 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.66 -34.58 78.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.087 0.955 . . . . 0.0 109.255 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -61.09 -52.09 66.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.098 1.359 . . . . 0.0 109.618 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.66 -45.52 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 123.784 0.834 . . . . 0.0 109.592 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.25 85.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.141 -0.349 . . . . 0.0 110.777 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.036 -0.415 . . . . 0.0 110.544 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -58.55 -54.23 49.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.77 -32.88 67.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.247 0.619 . . . . 0.0 111.522 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.9 -54.21 24.37 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.547 0.612 . . . . 0.0 109.783 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 97.4 p -57.75 -32.29 67.32 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.906 -0.497 . . . . 0.0 112.236 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.28 -26.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.715 0.806 . . . . 0.0 111.412 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 t -66.38 84.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 119.122 0.874 . . . . 0.0 108.965 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 C--O 1.253 1.25 0 CA-C-O 115.254 -2.308 . . . . 0.0 107.657 178.277 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 CA-C-O 122.025 0.792 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.0 68.95 0.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.153 1.781 . . . . 0.0 111.659 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.073 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.55 79.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.749 0.82 . . . . 0.0 111.594 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -71.78 -41.0 68.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.43 -44.09 45.03 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.179 0.895 . . . . 0.0 111.751 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -51.51 -53.46 37.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.732 0.813 . . . . 0.0 110.446 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -65.34 -46.62 79.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.476 0.711 . . . . 0.0 109.971 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.485 ' OE1' HBB1 ' A' ' 117' ' ' HEC . 3.1 tm-20 -53.63 -39.77 65.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.305 1.042 . . . . 0.0 109.604 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -57.66 -19.37 26.18 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -30.76 62.43 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.327 -0.858 . . . . 0.0 109.775 174.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.79 -54.97 9.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.2 m -50.23 -41.06 49.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.636 1.574 . . . . 0.0 111.274 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -46.98 -31.69 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.389 1.875 . . . . 0.0 112.663 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.0 m -56.51 -28.98 61.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.384 0.673 . . . . 0.0 111.557 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.5 m -121.66 -36.19 3.09 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.952 0.901 . . . . 0.0 112.646 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -105.64 168.77 8.88 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.77 1.228 . . . . 0.0 112.791 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.2 p -138.13 166.82 23.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.956 1.302 . . . . 0.0 110.359 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.4 114.37 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.4 ' N ' HD21 ' A' ' 36' ' ' ASN . 2.6 tp -109.8 134.45 51.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.636 1.174 . . . . 0.0 110.072 -175.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.92 159.97 82.07 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 121.126 -0.984 . . . . 0.0 108.416 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.18 -40.93 68.11 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.906 2.404 . . . . 0.0 112.519 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.5 -8.06 55.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.373 1.469 . . . . 0.0 113.58 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.89 -17.24 45.61 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.947 -0.918 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.2 m -58.63 121.83 11.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.66 1.73 . . . . 0.0 109.44 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.99 113.55 5.78 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.24 -50.36 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.24 99.65 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' H ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -74.5 56.76 0.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.503 1.921 . . . . 0.0 109.507 176.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.61 -179.06 42.28 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.72 174.04 5.55 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.116 0.484 . . . . 0.0 111.419 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -118.36 26.88 9.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 109.896 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -65.44 -42.16 92.69 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.18 173.37 20.53 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -63.74 -177.1 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.163 3.242 . . . . 0.0 112.227 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 20' ' ' ILE . 18.2 t-20 -100.71 104.96 16.26 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.5 14.04 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -71.1 81.6 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.261 1.391 . . . . 0.0 109.254 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 53.79 1.01 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.794 0.711 . . . . 0.0 114.175 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.13 -41.84 31.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 117.461 0.63 . . . . 0.0 109.711 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t -52.56 119.41 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 121.215 -0.928 . . . . 0.0 110.896 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 -18.88 56.69 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.879 1.228 . . . . 0.0 111.832 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -65.78 138.9 58.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.9 0.85 . . . . 0.0 111.074 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -71.66 70.82 0.7 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 0.0 111.058 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 58.08 -143.58 0.64 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.638 0.775 . . . . 0.0 109.938 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.3 83.35 0.13 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.54 1.067 . . . . 0.0 113.284 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.2 t -147.51 40.98 1.03 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.016 0.408 . . . . 0.0 111.9 174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.97 128.89 58.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -55.97 155.29 23.81 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.374 1.383 . . . . 0.0 112.395 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 54.58 57.94 5.32 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 0.0 112.62 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -158.45 119.11 3.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.785 0.434 . . . . 0.0 110.001 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -79.15 86.72 4.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.387 0.675 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -68.17 -174.63 0.51 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.47 0.652 . . . . 0.0 110.967 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -114.75 172.74 6.85 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.991 1.316 . . . . 0.0 109.83 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.55 -41.92 86.68 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.958 1.303 . . . . 0.0 112.435 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 p -63.17 -65.42 0.69 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.286 1.435 . . . . 0.0 110.564 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.23 -35.01 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.638 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.82 -50.57 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.28 81.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.068 -0.395 . . . . 0.0 111.311 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -55.72 -50.76 69.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.3 -53.93 39.47 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.36 64.14 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.831 0.852 . . . . 0.0 112.742 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.8 p -68.63 -9.16 48.22 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.68 7.62 23.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.436 1.017 . . . . 0.0 112.805 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -68.44 138.25 55.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.744 1.272 . . . . 0.0 109.26 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.27 128.03 39.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 106.994 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -60.49 147.42 41.29 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -142.25 166.43 24.72 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.415 1.886 . . . . 0.0 106.207 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.48 -41.47 73.04 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.799 0.272 . . . . 0.0 110.48 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.62 -51.48 62.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.351 0.66 . . . . 0.0 110.595 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -58.13 -48.08 81.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.181 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mm -57.22 -55.6 19.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.72 -41.08 42.75 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.828 1.251 . . . . 0.0 111.19 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -71.52 -55.86 7.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.831 0.348 . . . . 0.0 110.224 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -50.68 -45.62 58.29 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.3 -33.58 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.95 2.98 53.86 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.423 0.689 . . . . 0.0 112.761 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -148.3 62.68 6.73 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.229 1.012 . . . . 0.0 112.428 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.16 140.69 93.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.171 1.914 . . . . 0.0 109.772 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.38 -64.7 1.03 Allowed Glycine 0 CA--C 1.533 1.18 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.0 -45.61 7.94 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.991 1.716 . . . . 0.0 111.346 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.0 -55.92 25.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.165 0.586 . . . . 0.0 110.938 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -57.95 -46.42 85.13 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.389 0.675 . . . . 0.0 110.693 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -53.81 -53.01 58.37 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -54.13 -57.36 11.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.221 0.608 . . . . 0.0 111.009 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.31 -54.54 39.15 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -88.87 -25.06 22.35 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -170.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 54.44 49.5 18.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.749 1.219 . . . . 0.0 110.036 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -117.42 128.57 55.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 108.761 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -51.37 -43.52 61.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.651 1.18 . . . . 0.0 111.057 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -91.13 27.09 1.96 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.79 65.46 1.03 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.599 0.714 . . . . 0.0 111.845 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -91.0 -177.94 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.785 2.034 . . . . 0.0 109.434 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 t -158.46 150.47 21.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.41 -26.18 71.66 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 16.4 ttp -65.32 82.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.36 58.36 4.06 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.206 -0.934 . . . . 0.0 109.201 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -165.89 151.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.404 1.482 . . . . 0.0 107.184 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -143.42 166.51 24.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.225 0.466 . . . . 0.0 110.205 170.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.11 115.97 28.38 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.75 52.81 2.0 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.594 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.93 169.8 17.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.345 1.458 . . . . 0.0 107.764 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.33 -17.89 68.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.382 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.53 1.99 73.13 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 118.157 0.978 . . . . 0.0 114.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -46.29 88.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.674 1.237 . . . . 0.0 111.194 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -55.08 -51.43 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.264 1.426 . . . . 0.0 110.72 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.89 -50.87 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.76 1.224 . . . . 0.0 110.247 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.72 -46.49 81.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.391 -0.193 . . . . 0.0 110.615 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.48 93.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.852 0.461 . . . . 0.0 110.17 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -59.33 -49.04 79.37 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.036 -0.415 . . . . 0.0 110.67 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.3 mt -60.02 -45.74 91.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.647 0.658 . . . . 0.0 110.758 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.22 79.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.387 0.275 . . . . 0.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.7 m -66.59 -40.66 89.01 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.123 -0.361 . . . . 0.0 111.321 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.1 -43.56 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.747 1.219 . . . . 0.0 112.675 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.86 78.69 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.481 0.658 . . . . 0.0 112.291 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.333 0 CA-C-O 116.04 -1.933 . . . . 0.0 108.767 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.592 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.06 93.32 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.785 -0.832 . . . . 0.0 109.005 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.39 -34.39 34.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 112.808 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.83 -54.99 22.35 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.913 0.778 . . . . 0.0 109.695 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -56.69 -41.2 76.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 0.0 110.123 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.64 -49.56 57.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -54.97 -52.2 63.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.551 0.74 . . . . 0.0 110.041 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -57.67 -53.13 61.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.2 -26.11 62.41 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 126.478 1.911 . . . . 0.0 112.09 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -56.63 -18.97 13.93 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.184 0.447 . . . . 0.0 110.98 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -53.38 -32.9 51.6 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.657 -0.652 . . . . 0.0 111.134 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.73 -53.16 29.67 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -51.46 -45.01 62.58 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.308 1.043 . . . . 0.0 110.889 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -47.85 -30.54 4.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 113.061 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -52.59 -38.03 59.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.057 0.543 . . . . 0.0 110.978 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -112.61 -40.3 4.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.481 ' CG ' HD21 ' A' ' 37' ' ' LEU . 97.3 m-70 -100.55 -174.01 2.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.247 1.019 . . . . 0.0 113.233 -170.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -152.16 173.17 15.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.574 1.549 . . . . 0.0 109.025 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.95 131.41 52.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 tp -116.79 145.37 22.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.753 1.621 . . . . 0.0 109.536 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.19 160.01 76.76 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 119.432 1.015 . . . . 0.0 108.321 173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.99 -36.86 93.6 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.439 2.093 . . . . 0.0 110.214 172.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.13 -1.4 7.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.398 1.879 . . . . 0.0 113.135 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.22 -18.36 45.72 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 120.728 -1.232 . . . . 0.0 112.362 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -53.99 122.13 9.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.205 1.002 . . . . 0.0 110.906 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.86 78.74 1.14 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.326 0.65 . . . . 0.0 110.616 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.85 -60.47 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.01 98.75 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.09 63.23 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.735 1.214 . . . . 0.0 109.738 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.87 -156.77 32.98 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.88 6.7 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -124.68 33.84 5.14 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.53 -34.88 76.63 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.27 176.8 17.69 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 168.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.0 -171.07 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.676 2.917 . . . . 0.0 111.698 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -117.48 101.37 8.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -68.55 0.94 3.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.01 109.87 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.97 1.259 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.53 20.02 55.31 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.573 -0.571 . . . . 0.0 112.391 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.87 -37.82 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.354 1.077 . . . . 0.0 109.047 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.4 107.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.059 0.944 . . . . 0.0 110.428 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 -5.7 72.08 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 112.482 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -92.41 138.16 31.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.84 0.82 . . . . 0.0 110.367 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -56.41 127.21 29.95 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.937 1.295 . . . . 0.0 111.347 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.99 149.29 19.22 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.615 -0.678 . . . . 0.0 111.153 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.47 42.43 99.0 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.332 -1.26 . . . . 0.0 115.187 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.7 p -142.17 1.04 1.4 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.465 1.632 . . . . 0.0 114.846 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -69.19 134.71 89.27 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 120.445 1.475 . . . . 0.0 109.723 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.27 154.37 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.989 2.46 . . . . 0.0 115.685 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.27 60.8 3.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.078 1.751 . . . . 0.0 112.66 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -154.66 118.9 4.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.026 0.441 . . . . 0.0 110.837 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.29 80.28 1.84 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.99 0.916 . . . . 0.0 110.586 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -68.55 176.26 3.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.484 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -107.45 170.58 7.88 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.937 0.895 . . . . 0.0 109.942 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.1 -46.41 89.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.173 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 p -60.96 -65.39 0.7 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.845 1.258 . . . . 0.0 111.069 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.99 -42.88 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.095 0.958 . . . . 0.0 110.837 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.23 -44.83 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.997 . . . . 0.0 110.032 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.4 82.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.705 0.684 . . . . 0.0 110.528 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.9 tp -57.85 -48.26 80.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.28 -56.29 17.88 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 123.887 0.756 . . . . 0.0 111.755 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.88 55.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.438 1.495 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 m -71.53 5.18 2.51 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.88 21.33 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.146 1.355 . . . . 0.0 111.242 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -82.54 77.9 9.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.788 -0.83 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 116.6 13.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -57.81 139.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -122.64 162.9 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.208 1.403 . . . . 0.0 107.385 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -54.2 -43.29 70.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.7 -53.46 54.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.589 0.756 . . . . 0.0 110.407 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -60.48 -45.13 94.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.993 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.1 mt -58.0 -55.94 18.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.65 -40.17 62.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.868 0.867 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.7 m -68.04 -63.99 0.95 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.51 -51.87 2.87 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.094 1.757 . . . . 0.0 112.925 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.0 m -54.67 -33.59 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -72.39 -29.56 63.85 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.77 -0.581 . . . . 0.0 111.862 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -138.47 61.89 27.2 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -65.35 153.59 77.53 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 CA-C-N 120.086 1.066 . . . . 0.0 110.588 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.43 -66.65 2.62 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.07 -44.2 51.61 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.284 1.034 . . . . 0.0 111.243 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -51.95 -57.17 10.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.647 0.779 . . . . 0.0 110.106 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.511 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 5.3 mp -56.82 -54.21 49.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.857 0.463 . . . . 0.0 110.755 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -50.37 -42.4 53.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.04 0.536 . . . . 0.0 110.989 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.75 -66.35 0.57 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.354 0.662 . . . . 0.0 110.19 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -54.5 -43.38 71.79 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.9 tp -88.85 1.07 55.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.703 1.201 . . . . 0.0 111.255 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t0 41.92 54.44 3.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.964 1.706 . . . . 0.0 110.967 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -147.91 122.06 9.53 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.631 0.772 . . . . 0.0 112.534 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -53.47 -45.23 69.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.626 1.57 . . . . 0.0 110.301 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -73.92 5.63 4.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 83' ' ' LEU . . . -82.08 72.15 9.13 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.377 -1.452 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -82.46 164.3 21.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.459 1.104 . . . . 0.0 108.827 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.4 t -142.02 149.45 40.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.29 -29.84 72.44 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 ttp -62.05 83.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.8 57.38 3.79 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -159.73 149.85 18.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -139.37 153.26 47.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.8 tp -113.37 107.81 16.37 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.08 66.72 3.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.918 0.887 . . . . 0.0 109.89 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 84.14 146.13 0.07 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 128.583 2.753 . . . . 0.0 109.988 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.77 -26.54 5.1 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -46.02 -40.76 10.18 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.401 1.476 . . . . 0.0 113.085 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.57 -48.9 79.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.717 0.758 . . . . 0.0 110.579 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -61.14 -48.33 82.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.211 1.004 . . . . 0.0 109.456 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.416 HG11 HMB1 ' A' ' 117' ' ' HEC . 57.6 t -62.41 -40.87 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.701 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.6 89.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.604 -0.685 . . . . 0.0 109.963 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.42 90.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.08 -53.23 59.54 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.1 mt -55.27 -47.81 74.95 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.117 0.417 . . . . 0.0 110.913 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.38 77.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.4 m -70.36 -40.58 73.95 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.032 -0.417 . . . . 0.0 110.674 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.23 -44.68 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.468 1.507 . . . . 0.0 112.698 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.86 94.64 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.744 0.783 . . . . 0.0 112.592 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.5 pttt . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.637 1.975 . . . . 0.0 109.661 173.482 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.416 HMB1 HG11 ' A' ' 107' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 121.079 0.266 . . . . 0.0 112.814 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.19 76.69 0.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.717 1.607 . . . . 0.0 111.044 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.29 -37.11 10.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.432 1.093 . . . . 0.0 112.18 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.4 -54.17 49.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.535 0.734 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.03 -34.47 74.89 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.89 -56.24 24.95 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.31 -37.4 87.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.165 0.983 . . . . 0.0 111.357 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -60.96 -50.9 71.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.729 0.695 . . . . 0.0 109.737 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -57.2 -34.11 68.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.7 1.2 . . . . 0.0 110.273 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 19' ' ' ILE . 3.6 t80 -56.16 -21.73 24.59 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -55.38 -36.3 66.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.668 0.667 . . . . 0.0 110.278 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -69.82 -52.68 22.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.9 m -50.72 -40.8 55.29 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.378 1.071 . . . . 0.0 111.749 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -48.35 -30.93 5.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 112.31 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.6 m -59.32 -22.46 61.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.497 0.719 . . . . 0.0 111.505 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.4 m -124.84 -34.58 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.378 1.071 . . . . 0.0 112.771 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -110.21 170.33 8.15 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.581 1.152 . . . . 0.0 114.081 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.4 m -141.89 166.05 25.78 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.427 1.091 . . . . 0.0 110.295 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.457 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 2.3 mp -139.65 124.47 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 106.865 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.14 132.21 58.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.514 1.126 . . . . 0.0 110.175 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 154.01 71.74 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.58 -35.37 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.036 2.491 . . . . 0.0 112.097 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.81 -9.27 58.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.351 1.06 . . . . 0.0 113.144 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.31 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.999 -0.889 . . . . 0.0 113.404 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.7 m -62.39 108.28 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.489 1.644 . . . . 0.0 110.331 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.49 134.53 57.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.64 0.776 . . . . 0.0 110.659 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 mm -105.29 -50.34 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.08 96.47 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -84.21 70.17 10.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.94 -154.12 26.86 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.26 175.53 10.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -125.77 32.57 5.26 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.944 0.897 . . . . 0.0 109.232 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.3 m -64.73 -36.98 86.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.35 173.02 14.61 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.56 179.6 1.23 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.372 3.382 . . . . 0.0 113.91 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -92.34 103.85 16.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.261 1.024 . . . . 0.0 110.036 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.64 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -70.03 85.12 0.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.268 1.849 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.96 58.37 2.65 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.36 0.981 . . . . 0.0 113.265 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.37 -39.33 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 O-C-N 122.219 -0.577 . . . . 0.0 110.966 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.56 119.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.014 0.525 . . . . 0.0 110.504 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.08 -21.94 41.38 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.673 1.13 . . . . 0.0 111.602 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' NH1' ' H ' ' A' ' 44' ' ' THR . 3.9 tpm_? -68.26 138.24 55.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.441 1.12 . . . . 0.0 110.886 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.413 ' H ' ' NH1' ' A' ' 43' ' ' ARG . 2.7 m -65.02 72.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.434 1.894 . . . . 0.0 111.675 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.59 -145.25 0.6 Allowed 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.461 -0.774 . . . . 0.0 109.431 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.04 78.25 1.26 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -138.7 14.62 2.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.591 0.756 . . . . 0.0 111.621 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -64.96 127.01 92.33 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.36 172.12 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.403 2.068 . . . . 0.0 115.779 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 46.01 57.47 5.16 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.256 1.822 . . . . 0.0 111.825 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -164.37 122.46 1.77 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.489 0.316 . . . . 0.0 110.761 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.26 95.32 4.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.057 0.943 . . . . 0.0 110.24 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.2 -178.69 5.21 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.353 0.661 . . . . 0.0 111.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.92 177.48 4.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.23 -35.23 75.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.021 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 p -63.29 -66.65 0.51 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.556 1.142 . . . . 0.0 110.627 -173.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 tt -57.43 -37.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.123 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.7 -47.58 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.55 84.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.056 0.389 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.8 tp -55.41 -50.11 70.61 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.11 -54.86 29.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.95 -31.56 60.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.113 0.965 . . . . 0.0 112.225 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -72.03 3.07 4.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.14 29.38 10.4 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.142 0.877 . . . . 0.0 111.616 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -90.76 140.44 29.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.92 128.6 28.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -60.37 148.37 37.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 123.053 0.541 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.7 p -142.71 166.31 25.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -54.8 -41.06 70.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.72 -56.13 15.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.108 0.963 . . . . 0.0 109.719 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.03 -52.15 61.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.278 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.5 mt -56.87 -54.69 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.67 -40.32 53.31 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.054 0.942 . . . . 0.0 111.667 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -70.75 -60.95 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -43.49 -51.92 6.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.061 1.344 . . . . 0.0 113.602 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.6 m -51.28 -38.49 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -90.81 -8.49 49.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.23 55.17 3.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 123.878 0.871 . . . . 0.0 111.576 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.66 147.17 85.82 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.917 1.745 . . . . 0.0 109.868 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.36 -64.46 4.26 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.7 61.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.389 0.676 . . . . 0.0 109.993 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -48.52 -51.54 26.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.774 1.23 . . . . 0.0 111.338 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.49 -58.94 4.17 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -49.5 -38.91 32.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 111.615 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -53.42 -39.91 64.7 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.456 0.702 . . . . 0.0 111.842 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -97.21 -53.32 3.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.318 1.047 . . . . 0.0 111.741 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.7 tp -78.86 -22.92 45.33 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.776 1.23 . . . . 0.0 113.228 -175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t0 41.57 63.62 1.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.486 1.914 . . . . 0.0 113.216 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.43 145.29 45.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 108.282 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.38 -38.46 58.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.188 0.995 . . . . 0.0 110.842 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.21 21.71 13.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.0 0.92 . . . . 0.0 112.855 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.84 5.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -126.22 142.52 51.5 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.429 1.492 . . . . 0.0 108.636 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -94.37 150.08 20.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.965 0.906 . . . . 0.0 109.164 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -55.02 -27.03 43.93 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.974 -0.454 . . . . 0.0 111.994 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.2 ttp -59.64 86.5 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 113.343 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.39 57.93 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.91 155.79 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.537 1.935 . . . . 0.0 106.331 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -145.35 170.94 15.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.2 tp -97.23 166.48 11.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.55 37.88 4.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -143.93 170.79 15.25 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.661 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -12.97 35.28 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.707 -1.052 . . . . 0.0 113.35 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.04 -32.07 1.76 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 118.475 1.138 . . . . 0.0 114.638 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.23 -38.41 3.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 113.281 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -61.13 -49.21 78.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.674 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.424 HG11 HMB1 ' A' ' 117' ' ' HEC . 15.4 t -66.56 -41.72 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.39 90.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.699 0.4 . . . . 0.0 110.546 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.47 94.48 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.79 0.436 . . . . 0.0 109.932 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -55.9 -54.3 46.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.1 mt -57.32 -37.12 72.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.426 0.69 . . . . 0.0 111.716 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.4 89.06 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.457 -0.777 . . . . 0.0 109.146 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.4 t -59.73 -29.31 68.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.73 -0.606 . . . . 0.0 111.924 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.45 -29.35 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 O-C-N 121.845 -0.534 . . . . 0.0 110.749 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.44 91.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.501 1.12 . . . . 0.0 109.748 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm . . . . . 0 C--O 1.248 0.993 0 C-N-CA 126.199 1.8 . . . . 0.0 107.854 176.524 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.672 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.107 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.92 73.84 0.6 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.584 1.154 . . . . 0.0 111.707 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.98 -39.08 25.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.195 0.998 . . . . 0.0 111.949 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.43 82.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.391 0.676 . . . . 0.0 111.231 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.89 -41.72 77.9 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -49.88 -46.65 40.4 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.021 0.82 . . . . 0.0 111.94 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -52.52 -54.27 34.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.475 0.71 . . . . 0.0 110.527 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.47 -47.53 83.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.901 0.48 . . . . 0.0 110.159 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -53.86 -39.19 65.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.353 1.061 . . . . 0.0 109.849 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.16 -22.3 27.89 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.43 -31.29 54.99 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.646 -0.659 . . . . 0.0 110.048 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -71.33 -52.75 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 m -51.18 -43.0 61.22 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.656 1.182 . . . . 0.0 110.637 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -49.16 -25.88 2.46 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.131 1.772 . . . . 0.0 112.279 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -53.95 -42.58 69.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.211 1.368 . . . . 0.0 110.281 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.8 m -106.95 -42.22 4.97 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.743 0.817 . . . . 0.0 112.401 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -92.7 167.27 12.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.583 1.153 . . . . 0.0 112.885 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -140.15 147.21 39.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.32 124.98 73.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 174.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -124.86 133.99 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.332 1.853 . . . . 0.0 107.853 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.56 158.04 86.45 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.46 -38.7 74.78 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.943 2.429 . . . . 0.0 112.646 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -74.29 -10.54 59.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.164 1.385 . . . . 0.0 113.663 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.33 -18.65 32.84 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.83 -0.984 . . . . 0.0 113.63 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -57.18 118.71 5.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.698 . . . . 0.0 109.556 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.61 125.66 26.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.819 0.447 . . . . 0.0 110.405 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 mm -85.06 -52.02 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.0 m -146.57 136.12 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -113.36 135.55 53.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.72 -172.87 19.93 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 124.434 1.016 . . . . 0.0 110.977 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.02 44.89 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.596 -0.944 . . . . 0.0 109.611 175.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 tptp 15.94 57.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 130.28 3.432 . . . . 0.0 113.61 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.12 -32.16 14.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.3 167.85 12.46 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 174.05 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.421 3.414 . . . . 0.0 113.526 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.44 115.52 17.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.36 7.02 44.75 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -48.73 106.78 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.091 0.86 . . . . 0.0 111.58 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.03 42.96 95.26 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.12 -36.86 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 117.274 0.537 . . . . 0.0 111.565 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.5 116.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.57 -19.15 55.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.256 0.931 . . . . 0.0 111.802 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -79.05 148.09 32.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 117.731 0.765 . . . . 0.0 109.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 m -61.48 127.02 29.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.796 0.838 . . . . 0.0 109.931 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.88 154.8 41.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 111.758 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.52 27.1 63.04 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 119.023 -0.876 . . . . 0.0 114.749 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.8 t -155.32 20.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.676 1.238 . . . . 0.0 112.77 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.22 126.11 92.31 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.54 171.75 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 CA-C-N 121.099 1.428 . . . . 0.0 115.735 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 50.64 55.18 9.91 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.749 1.62 . . . . 0.0 111.404 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -166.04 123.4 1.42 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.169 -0.332 . . . . 0.0 111.377 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -83.42 99.64 10.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.498 1.119 . . . . 0.0 109.089 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -85.0 -170.39 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.856 0.862 . . . . 0.0 111.962 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.71 175.89 5.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.959 1.703 . . . . 0.0 109.552 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.93 -43.67 82.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.357 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 t -70.85 -47.93 56.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.091 0.472 . . . . 0.0 111.145 -173.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -67.02 -34.91 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.08 -45.56 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.79 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 111.406 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 mt -55.86 -49.16 74.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.41 39.47 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -37.29 74.31 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.274 1.029 . . . . 0.0 110.779 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 t -72.88 4.05 4.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.19 61.44 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 119.14 0.882 . . . . 0.0 111.934 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -71.99 108.28 5.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.984 0.892 . . . . 0.0 109.517 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.61 122.46 37.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.411 ' HE1' ' CGA' ' A' ' 117' ' ' HEC . 17.4 m95 -57.44 153.31 12.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p -133.77 169.8 16.51 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.554 1.141 . . . . 0.0 108.153 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -57.59 -46.42 84.04 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.665 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.1 -47.72 73.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.03 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.55 -49.73 76.65 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.87 -50.95 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 118.116 0.416 . . . . 0.0 110.106 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.38 -38.29 52.62 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.074 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -73.45 -58.29 3.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -44.68 -47.24 10.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.176 1.391 . . . . 0.0 113.74 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.44 -36.41 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 119.138 0.881 . . . . 0.0 113.308 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -100.14 2.26 42.88 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.842 0.857 . . . . 0.0 111.679 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -142.35 56.52 5.46 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.408 1.483 . . . . 0.0 110.997 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.04 138.97 64.88 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.244 1.962 . . . . 0.0 109.436 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.1 -60.45 2.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -44.58 -45.47 9.48 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.692 1.597 . . . . 0.0 111.876 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.07 -44.74 96.02 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.151 -0.619 . . . . 0.0 111.663 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.92 -51.09 70.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.792 0.837 . . . . 0.0 109.012 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -52.56 -52.37 55.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.586 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -55.96 -53.36 57.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 111.12 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -66.92 -52.13 46.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.57 -18.54 48.01 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.7 t0 56.35 53.83 8.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.33 1.452 . . . . 0.0 109.275 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -134.27 128.41 33.77 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.615 1.166 . . . . 0.0 109.87 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -60.22 -37.2 79.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.525 1.13 . . . . 0.0 110.527 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -85.72 15.93 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.9 65.54 8.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.892 0.853 . . . . 0.0 110.439 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.37 108.25 19.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 109.666 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -63.11 156.4 25.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.75 -21.69 79.52 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.548 ' HG3' ' CHD' ' A' ' 117' ' ' HEC . 3.7 ttp -68.94 82.01 0.31 Allowed 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.725 -0.867 . . . . 0.0 112.755 -176.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.99 57.33 2.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.474 0.71 . . . . 0.0 109.479 174.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -163.13 148.19 11.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.808 1.643 . . . . 0.0 107.789 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -142.54 164.95 28.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.21 1.004 . . . . 0.0 109.589 173.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.32 115.56 26.15 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.25 55.05 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.89 0.476 . . . . 0.0 110.034 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -132.43 168.08 18.8 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 125.624 1.57 . . . . 0.0 108.721 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.06 -19.42 59.11 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.752 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.85 1.9 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.061 0.93 . . . . 0.0 113.703 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -41.11 -44.11 2.41 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.072 1.749 . . . . 0.0 113.832 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -62.14 -45.55 92.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.117 0.967 . . . . 0.0 110.986 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.32 -45.0 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.11 0.964 . . . . 0.0 108.897 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.02 91.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.346 0.658 . . . . 0.0 110.339 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.22 97.28 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.875 0.47 . . . . 0.0 110.01 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.86 -52.58 64.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.66 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -57.29 -42.36 81.54 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.011 -0.431 . . . . 0.0 111.117 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.48 -41.45 73.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.918 0.487 . . . . 0.0 110.174 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -63.19 -30.01 71.24 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.968 -0.457 . . . . 0.0 111.912 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.83 -29.97 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.063 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t -48.11 99.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 125.522 1.529 . . . . 0.0 112.72 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 C--O 1.251 1.145 0 C-N-CA 130.023 3.329 . . . . 0.0 104.161 174.528 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.548 ' CHD' ' HG3' ' A' ' 96' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.065 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -90.37 106.01 18.2 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.876 1.27 . . . . 0.0 108.777 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.7 -31.43 26.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.329 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.54 12.13 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.354 0.979 . . . . 0.0 110.248 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -56.28 -38.56 71.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.768 -0.583 . . . . 0.0 109.551 174.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.99 -51.1 52.13 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.67 -47.89 82.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.279 1.032 . . . . 0.0 110.279 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -57.25 -52.71 64.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.164 0.185 . . . . 0.0 110.677 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.93 -35.96 67.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.518 1.127 . . . . 0.0 110.211 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.437 ' CZ ' ' CBB' ' A' ' 117' ' ' HEC . 0.3 OUTLIER -57.52 -27.16 62.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.069 0.548 . . . . 0.0 112.134 178.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -30.47 63.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.383 0.538 . . . . 0.0 110.043 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -93.13 -50.26 5.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.036 0.934 . . . . 0.0 109.48 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -33.92 42.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -58.58 -14.81 9.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 114.347 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -56.09 -17.76 7.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.246 -0.909 . . . . 0.0 112.338 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.4 m -124.02 -27.27 3.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.966 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -117.81 165.9 13.11 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.922 0.783 . . . . 0.0 112.941 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.4 m -140.39 164.68 29.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.289 1.035 . . . . 0.0 111.629 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.18 121.87 24.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 125.661 1.584 . . . . 0.0 107.854 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tp -116.54 134.39 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.602 1.561 . . . . 0.0 108.169 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.66 160.24 77.92 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 119.114 0.87 . . . . 0.0 108.94 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.31 -40.95 69.11 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.108 2.538 . . . . 0.0 112.7 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -74.52 -8.28 55.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.145 1.378 . . . . 0.0 113.594 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.79 -18.85 42.81 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.963 -0.909 . . . . 0.0 113.394 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -60.51 117.64 5.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.6 1.7 . . . . 0.0 108.867 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -68.18 129.97 41.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.83 -46.09 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.2 93.48 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -77.0 90.67 3.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.81 -148.28 23.95 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.73 177.84 8.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -129.34 34.11 4.43 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.676 0.79 . . . . 0.0 109.558 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -64.18 -41.1 97.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -106.81 164.14 13.33 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.96 164.06 3.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.497 2.798 . . . . 0.0 115.276 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -72.89 121.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.83 6.41 31.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.95 115.82 3.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.545 1.066 . . . . 0.0 108.561 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.36 23.68 72.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.965 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG21 HMA3 ' A' ' 117' ' ' HEC . 9.3 p -61.61 -38.23 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 118.859 1.329 . . . . 0.0 109.553 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.15 103.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.86 -7.94 42.23 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.5 1.524 . . . . 0.0 112.205 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -72.6 142.79 48.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 117.971 0.885 . . . . 0.0 111.418 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -70.91 68.17 0.42 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.946 1.698 . . . . 0.0 113.508 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 53.74 -154.56 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 111.944 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.83 70.96 1.15 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 123.697 0.665 . . . . 0.0 112.777 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.8 p -137.93 23.16 2.84 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.381 0.672 . . . . 0.0 111.355 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.78 134.85 90.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.04 168.98 3.05 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.828 1.685 . . . . 0.0 114.846 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 42.46 56.47 3.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.609 1.964 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.9 118.53 2.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -79.7 109.16 13.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.891 0.876 . . . . 0.0 109.439 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -95.64 -172.26 2.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.573 0.749 . . . . 0.0 111.5 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.18 169.75 9.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.535 1.934 . . . . 0.0 107.682 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.97 -41.25 97.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.6 p -62.79 -60.62 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.665 1.586 . . . . 0.0 111.994 -171.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 tp -57.63 -27.98 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.278 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -76.17 -50.34 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.65 -38.05 53.08 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.431 1.093 . . . . 0.0 111.897 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.45 -50.48 69.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.0 0.818 . . . . 0.0 109.269 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.43 -48.25 86.89 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.77 69.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.454 0.301 . . . . 0.0 111.112 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.2 t -74.36 1.04 12.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.943 0.897 . . . . 0.0 112.795 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.81 14.9 55.91 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 119.13 0.877 . . . . 0.0 112.973 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.44 156.56 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.415 1.107 . . . . 0.0 109.674 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.04 124.39 11.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.642 1.577 . . . . 0.0 107.121 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -59.82 150.66 27.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.1 p -137.0 166.45 23.64 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.526 1.53 . . . . 0.0 107.009 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -52.63 -49.79 64.43 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.718 0.807 . . . . 0.0 108.884 173.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.47 -61.04 2.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.135 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -54.54 -46.63 73.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.773 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -60.38 -53.67 45.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.96 -42.69 63.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.04 0.936 . . . . 0.0 110.335 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.9 m -66.72 -59.32 3.68 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -44.31 -50.44 9.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.694 1.598 . . . . 0.0 113.224 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -54.82 -35.35 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.113 0.87 . . . . 0.0 113.034 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -82.71 -18.9 39.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.748 -0.595 . . . . 0.0 112.141 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.34 56.39 7.34 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 124.456 1.102 . . . . 0.0 112.709 -172.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.63 143.44 87.2 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.161 1.241 . . . . 0.0 109.22 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.93 -60.98 4.61 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.82 -42.69 65.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.872 0.869 . . . . 0.0 110.479 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -50.37 -50.78 50.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 111.037 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -67.76 -52.88 32.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.218 0.607 . . . . 0.0 110.23 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -49.12 -33.67 12.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.334 0.653 . . . . 0.0 110.751 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.29 -64.18 1.08 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.177 0.591 . . . . 0.0 110.191 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.49 -56.21 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.33 -41.98 84.34 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.402 0.681 . . . . 0.0 110.929 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 55.15 65.97 1.35 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.088 1.355 . . . . 0.0 111.094 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -129.15 139.88 51.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.291 1.836 . . . . 0.0 107.807 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -50.51 -40.35 51.23 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.271 1.029 . . . . 0.0 110.502 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.46 37.42 2.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.76 0.824 . . . . 0.0 111.42 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.5 66.15 3.18 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.595 0.758 . . . . 0.0 110.557 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -113.72 178.68 4.2 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.346 1.058 . . . . 0.0 109.29 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 t -144.99 149.84 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -14.33 57.28 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.1 ttt -65.98 77.36 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.531 1.132 . . . . 0.0 113.174 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.58 58.2 3.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.902 0.881 . . . . 0.0 109.308 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -163.19 137.55 6.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.669 1.588 . . . . 0.0 107.65 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -122.65 160.18 26.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tp -103.04 139.57 38.41 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.89 57.5 1.11 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.807 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 79.99 154.23 0.13 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 126.618 1.967 . . . . 0.0 110.141 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.72 38.27 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.53 -35.38 44.79 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.708 1.147 . . . . 0.0 111.572 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.46 -48.11 82.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.482 0.713 . . . . 0.0 110.298 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.34 -48.25 82.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.933 0.893 . . . . 0.0 109.514 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.71 -42.79 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.84 0.456 . . . . 0.0 110.162 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.19 97.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.769 -0.582 . . . . 0.0 110.109 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.98 95.42 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -58.77 -48.58 80.75 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.848 -0.533 . . . . 0.0 110.049 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.8 mt -57.92 -45.12 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.891 -0.506 . . . . 0.0 110.712 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -42.08 85.25 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.692 -0.63 . . . . 0.0 110.328 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -67.49 -30.13 69.74 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.768 -0.583 . . . . 0.0 111.671 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.75 -39.61 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.585 1.154 . . . . 0.0 111.651 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.66 80.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.64 0.733 . . . . 0.0 112.871 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 C-N-CA 126.274 1.83 . . . . 0.0 106.837 170.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.466 HBB2 HMB1 ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 N-CA-C 113.82 0.288 . . . . 0.0 113.82 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.54 91.28 2.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.7 11.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.789 0.836 . . . . 0.0 113.14 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.35 -49.36 67.19 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.799 0.727 . . . . 0.0 110.017 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.64 -35.58 76.55 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.72 46.17 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -54.55 -53.89 48.49 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.751 0.82 . . . . 0.0 109.657 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -52.02 -55.47 20.34 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -54.97 -40.33 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.524 1.129 . . . . 0.0 110.693 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -55.82 -25.74 43.08 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.324 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -58.98 -31.3 68.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 110.894 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -93.78 -49.22 5.94 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.188 0.595 . . . . 0.0 109.865 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.97 -34.23 41.43 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.929 0.892 . . . . 0.0 110.634 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -41.7 -40.27 1.92 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.679 2.392 . . . . 0.0 115.002 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.1 m -25.81 -48.73 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.198 2.199 . . . . 0.0 114.044 -171.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.61 -25.96 13.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.892 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -100.6 -172.0 2.12 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-O 121.467 0.651 . . . . 0.0 112.201 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 m -157.11 161.03 39.4 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.692 1.597 . . . . 0.0 108.645 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.98 122.71 23.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.891 1.676 . . . . 0.0 107.354 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.5 tp -106.25 131.53 55.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.142 0 C-N-CA 125.162 1.385 . . . . 0.0 108.607 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.54 160.21 82.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.35 -38.31 62.47 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.01 2.474 . . . . 0.0 112.785 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.8 -9.83 56.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.482 1.513 . . . . 0.0 114.099 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.47 57.71 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.174 0.897 . . . . 0.0 113.637 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 m -69.81 126.28 29.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.641 1.721 . . . . 0.0 108.991 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -78.02 96.62 5.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.81 0.844 . . . . 0.0 110.14 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.06 -48.25 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.7 126.46 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -124.91 82.09 2.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.237 1.815 . . . . 0.0 110.216 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.55 -168.18 40.14 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.09 43.26 0.85 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.885 -1.362 . . . . 0.0 111.771 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 13.45 59.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 129.84 3.256 . . . . 0.0 113.969 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -32.11 13.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.159 1.384 . . . . 0.0 109.086 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.48 162.14 12.55 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.9 140.01 77.25 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.375 3.384 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -55.25 119.87 6.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.72 -2.15 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -64.8 84.08 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.445 1.02 . . . . 0.0 111.718 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.61 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.23 1.395 . . . . 0.0 112.182 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG21 HMA3 ' A' ' 117' ' ' HEC . 7.6 p -62.91 -46.26 96.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-N 119.415 1.607 . . . . 0.0 109.523 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.25 118.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.341 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -29.79 10.85 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.741 1.638 . . . . 0.0 111.028 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -73.78 147.94 42.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.624 0.712 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.7 m -71.11 136.78 48.38 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.48 141.34 37.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.727 -0.608 . . . . 0.0 109.888 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.99 77.37 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.945 -1.475 . . . . 0.0 114.043 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 p -137.33 -0.56 2.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.879 1.839 . . . . 0.0 115.48 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -62.26 129.4 92.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 121.57 1.987 . . . . 0.0 107.641 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -44.62 154.53 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.662 2.908 . . . . 0.0 116.58 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 50.27 66.52 1.12 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.561 1.945 . . . . 0.0 113.631 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -163.41 122.84 2.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.98 0.419 . . . . 0.0 111.112 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.91 83.73 2.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.111 0.964 . . . . 0.0 109.821 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.09 178.16 1.96 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.918 0.487 . . . . 0.0 111.804 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -111.0 171.4 7.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.54 1.162 . . . . 0.0 110.767 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -53.91 15.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 111.986 -2.37 . . . . 0.0 113.013 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.3 m -62.23 -52.89 61.94 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.067 0.937 . . . . 0.0 111.579 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 tt -69.81 -38.84 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.456 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.69 -39.45 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.2 88.44 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 122.077 -0.389 . . . . 0.0 110.341 177.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.35 -49.81 76.39 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.43 -45.81 8.43 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.519 1.533 . . . . 0.0 112.695 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.3 -28.04 17.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.569 1.548 . . . . 0.0 113.695 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.4 p -73.63 2.74 7.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.118 0.872 . . . . 0.0 112.259 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.75 35.76 21.24 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -77.21 86.6 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.244 -0.562 . . . . 0.0 111.039 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.91 120.32 18.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.499 1.12 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -62.98 122.48 16.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.276 0.23 . . . . 0.0 110.419 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 p -100.31 159.1 15.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -54.65 -37.8 66.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.011 0.434 . . . . 0.0 110.357 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.76 -51.11 68.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.997 0.919 . . . . 0.0 110.171 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -59.71 -47.45 85.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.967 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.6 mt -55.07 -52.16 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.782 0.719 . . . . 0.0 109.284 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.87 65.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.452 0.701 . . . . 0.0 110.743 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -64.99 -54.37 31.57 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.835 0.454 . . . . 0.0 110.239 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -46.2 -52.06 13.09 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.701 1.6 . . . . 0.0 111.253 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -51.3 -28.61 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.669 0.788 . . . . 0.0 112.993 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -78.2 -26.67 47.6 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.711 0.687 . . . . 0.0 112.645 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -154.54 69.16 5.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.992 0.814 . . . . 0.0 111.889 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.11 145.95 97.28 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.198 1.932 . . . . 0.0 110.868 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.27 -59.99 4.79 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.05 70.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -47.89 -52.25 20.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.699 0.8 . . . . 0.0 111.377 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.8 mt -61.49 -56.87 15.31 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.409 1.084 . . . . 0.0 109.704 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.5 -38.76 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.591 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -72.36 -59.5 2.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.875 0.47 . . . . 0.0 109.739 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.03 -41.03 82.32 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.5 tp -86.2 -4.39 59.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.222 1.009 . . . . 0.0 111.876 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 t0 48.06 43.69 18.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.988 1.315 . . . . 0.0 110.366 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.24 107.92 12.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.005 1.322 . . . . 0.0 109.29 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 90' ' ' LYS . 13.4 mptt -57.14 -26.27 60.27 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 128.738 2.815 . . . . 0.0 111.752 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -104.85 15.51 27.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.835 0.854 . . . . 0.0 113.264 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.2 113.75 20.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -132.44 131.68 41.99 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.344 1.057 . . . . 0.0 111.151 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -85.02 156.2 21.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.96 -18.71 72.94 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 170.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.73 80.79 0.07 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.593 1.157 . . . . 0.0 113.089 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.72 57.8 2.61 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.057 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -160.84 139.33 9.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.8 1.64 . . . . 0.0 106.606 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -142.53 155.19 44.99 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.5 tp -150.2 111.28 4.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.066 0.947 . . . . 0.0 108.57 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.86 30.99 0.2 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.285 -0.884 . . . . 0.0 112.908 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -161.83 176.7 10.59 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 127.502 2.321 . . . . 0.0 106.1 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.87 -51.52 2.74 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.525 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -27.72 -56.52 0.12 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.71 2.1 . . . . 0.0 114.732 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -59.98 -51.67 68.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.616 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.25 -48.37 80.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 109.631 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.449 HG11 HMB1 ' A' ' 117' ' ' HEC . 55.1 t -61.63 -44.16 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.564 1.146 . . . . 0.0 110.601 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.57 -45.68 93.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.881 -0.512 . . . . 0.0 109.912 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.42 96.11 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -57.81 -52.81 63.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.216 0.606 . . . . 0.0 109.693 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.2 mt -54.17 -53.63 50.78 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.57 65.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.555 0.342 . . . . 0.0 111.443 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.8 m -64.63 -44.76 89.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.668 0.387 . . . . 0.0 111.556 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.96 -39.06 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.815 1.246 . . . . 0.0 111.522 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.5 t -65.85 94.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 125.516 1.527 . . . . 0.0 111.193 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm . . . . . 0 C--O 1.256 1.433 0 CA-C-O 115.449 -2.215 . . . . 0.0 107.303 172.817 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.53 HMA3 HG21 ' A' ' 40' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.927 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -82.04 99.51 9.2 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.09 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.062 0.945 . . . . 0.0 113.241 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.53 -48.56 66.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.251 0.932 . . . . 0.0 110.011 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -56.84 -42.48 79.74 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.37 -49.0 66.16 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.67 -51.15 70.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.59 0.695 . . . . 0.0 110.597 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -59.73 -46.85 87.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.515 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -61.29 -27.86 68.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.443 1.097 . . . . 0.0 110.742 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -57.75 -18.13 19.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 111.344 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -55.67 -28.68 56.82 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.427 1.012 . . . . 0.0 110.627 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -68.68 -54.25 17.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.453 -0.779 . . . . 0.0 109.002 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.8 m -50.41 -47.29 56.55 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.023 1.729 . . . . 0.0 109.93 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -47.41 -31.62 4.27 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.296 2.638 . . . . 0.0 112.92 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -53.33 -32.16 47.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.6 m -121.82 -37.01 2.92 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.911 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -101.14 -176.01 3.03 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.673 0.789 . . . . 0.0 112.212 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t -153.13 179.46 8.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.953 1.301 . . . . 0.0 109.788 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 mt -143.49 115.12 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.919 2.488 . . . . 0.0 106.985 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 tp -102.22 148.52 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.667 1.587 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.01 158.09 87.64 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.01 -34.07 98.97 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.063 1.842 . . . . 0.0 111.264 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -75.14 -11.62 60.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.442 1.097 . . . . 0.0 113.324 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 -13.54 35.98 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.139 -0.812 . . . . 0.0 114.063 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -60.88 127.61 32.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.71 1.755 . . . . 0.0 110.404 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -70.75 82.96 0.63 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.624 0.769 . . . . 0.0 111.191 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.33 -59.99 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 C-N-CA 122.577 0.351 . . . . 0.0 110.07 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.54 -39.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.197 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 57.43 47.32 16.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.94 0.876 . . . . 0.0 109.855 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.91 -172.16 48.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.09 170.8 14.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 110.407 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -124.83 30.81 5.82 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.616 0.767 . . . . 0.0 109.385 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -69.92 -40.82 75.34 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.83 167.15 13.31 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 170.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.27 173.25 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.16 2.573 . . . . 0.0 114.337 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -84.68 121.77 28.14 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.64 -2.0 56.85 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.42 113.79 2.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.03 20.41 59.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.954 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.4 HG21 HMA3 ' A' ' 117' ' ' HEC . 2.3 p -62.66 -39.65 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 119.105 1.452 . . . . 0.0 108.935 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.37 106.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.543 0.737 . . . . 0.0 109.561 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.12 -17.37 31.97 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.833 1.682 . . . . 0.0 111.902 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -68.2 141.27 56.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.43 1.115 . . . . 0.0 111.217 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 m -71.88 74.31 0.87 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.907 1.283 . . . . 0.0 111.11 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB3' ' CA ' ' A' ' 61' ' ' GLY . . . 52.13 -144.81 0.58 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.889 0.876 . . . . 0.0 112.406 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.34 75.83 0.64 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 123.554 0.597 . . . . 0.0 113.064 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 p -130.24 5.66 4.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.582 1.153 . . . . 0.0 112.196 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 126.56 91.65 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.46 172.77 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.113 1.209 . . . . 0.0 113.274 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 47.0 46.89 16.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.16 1.384 . . . . 0.0 111.853 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -156.42 111.45 2.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.14 -0.35 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -80.08 89.1 5.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.634 0.773 . . . . 0.0 109.813 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -74.76 -174.81 2.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.594 0.711 . . . . 0.0 111.344 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.34 166.51 13.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.139 1.376 . . . . 0.0 108.675 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.55 -35.0 79.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.31 0.644 . . . . 0.0 112.498 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -58.19 -62.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.971 1.308 . . . . 0.0 111.256 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.56 -35.33 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.932 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -48.84 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.81 90.47 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.898 0.479 . . . . 0.0 110.319 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.59 -45.3 89.4 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.045 0.538 . . . . 0.0 109.735 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . -55.28 -53.19 42.35 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.6 67.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.329 0.651 . . . . 0.0 111.731 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -67.41 -14.89 63.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.053 0.541 . . . . 0.0 111.952 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.77 14.16 12.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.981 1.277 . . . . 0.0 112.793 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.78 118.29 15.52 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.87 1.335 . . . . 0.0 111.158 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.3 129.45 54.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -66.1 126.88 30.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 159.52 37.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 107.863 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -42.57 -51.77 5.02 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.212 1.405 . . . . 0.0 112.885 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.38 -47.45 85.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.262 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.63 -48.3 81.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.66 0.784 . . . . 0.0 109.647 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.85 -54.03 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.59 -38.21 59.6 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.316 1.046 . . . . 0.0 111.504 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -72.93 -60.23 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -46.73 -43.79 18.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.054 1.342 . . . . 0.0 114.055 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.8 m -52.91 -34.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 119.445 1.02 . . . . 0.0 113.575 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -101.74 -3.38 28.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.059 0.944 . . . . 0.0 111.563 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -133.68 54.54 12.96 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.665 1.586 . . . . 0.0 111.634 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.16 138.19 70.87 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.366 2.711 . . . . 0.0 108.761 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.68 -64.1 3.34 Favored Glycine 0 C--O 1.221 -0.686 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -45.01 -48.53 11.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.019 1.327 . . . . 0.0 112.646 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.32 -43.71 96.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.088 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.03 -55.51 28.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -49.01 -44.54 41.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.789 1.235 . . . . 0.0 110.432 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -63.8 -68.51 0.34 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.626 0.771 . . . . 0.0 110.304 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -54.84 -40.93 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 -0.55 57.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.666 1.186 . . . . 0.0 111.487 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t0 43.84 53.25 6.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.529 1.531 . . . . 0.0 110.702 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.65 115.36 9.09 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.341 1.056 . . . . 0.0 111.526 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -57.45 -29.41 64.19 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.722 1.209 . . . . 0.0 111.943 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -92.66 11.66 25.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.01 76.84 5.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.522 -0.736 . . . . 0.0 111.734 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.28 152.89 21.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.453 0.701 . . . . 0.0 109.964 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -112.33 151.62 29.52 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.98 -21.41 61.29 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 170.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ttt -68.13 74.98 0.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 112.438 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.86 58.87 2.98 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 175.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.45 ' CD1' HMC2 ' A' ' 117' ' ' HEC . 4.6 t80 -168.7 146.79 4.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.797 1.639 . . . . 0.0 107.275 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.16 150.09 45.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.11 0.964 . . . . 0.0 108.399 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -111.92 106.37 15.05 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 44.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.159 -0.338 . . . . 0.0 111.633 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -177.41 -171.01 0.31 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.197 1.799 . . . . 0.0 107.444 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.27 -51.54 3.61 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.55 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.64 -75.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 C-N-CA 128.313 2.863 . . . . 0.0 115.952 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.23 -48.43 81.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.339 0.569 . . . . 0.0 112.472 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.79 -49.66 72.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.17 0.988 . . . . 0.0 109.447 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.49 -41.45 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.044 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.07 -48.84 79.84 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.912 -0.492 . . . . 0.0 110.117 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.32 80.91 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -60.57 -51.05 71.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.03 -36.57 68.15 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.101 0.56 . . . . 0.0 111.616 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.33 -52.3 48.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -53.99 -37.37 63.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.998 0.919 . . . . 0.0 112.593 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.5 t -55.98 -28.67 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.184 1.794 . . . . 0.0 111.961 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.89 83.53 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 118.434 0.561 . . . . 0.0 110.327 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm . . . . . 0 C--O 1.252 1.197 0 CA-C-O 114.45 -2.69 . . . . 0.0 106.233 177.196 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.684 HBC2 ' HHD' ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 N-CA-C 113.971 0.348 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -72.68 84.19 1.17 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.19 0.996 . . . . 0.0 109.517 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.45 -35.46 8.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.753 0.821 . . . . 0.0 112.859 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.21 69.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.61 0.641 . . . . 0.0 110.169 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -58.47 -40.96 84.12 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.06 -51.61 52.64 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.05 -50.94 71.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.936 0.894 . . . . 0.0 110.519 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -54.19 -54.03 45.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.01 -35.38 69.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.504 1.122 . . . . 0.0 110.87 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -58.52 -20.91 50.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -61.77 -23.25 66.06 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.647 -0.658 . . . . 0.0 111.027 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.04 -48.96 7.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 t -47.56 -38.55 14.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.321 1.848 . . . . 0.0 113.023 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -22.59 3.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.254 1.022 . . . . 0.0 113.304 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 m -58.76 -22.48 58.1 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -120.91 -34.27 3.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.885 0.874 . . . . 0.0 112.568 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -111.74 174.31 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.059 0.944 . . . . 0.0 113.544 -174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.5 t -145.41 161.75 38.94 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.599 0.76 . . . . 0.0 109.225 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -129.02 135.58 61.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.84 139.49 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.984 1.714 . . . . 0.0 108.946 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 161.08 79.42 Favored Pre-proline 0 C--O 1.232 0.159 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.71 -29.31 88.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.375 1.383 . . . . 0.0 109.434 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.23 -5.64 33.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.66 50.94 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.793 -1.192 . . . . 0.0 112.534 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -58.2 120.96 9.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.77 84.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.648 -0.658 . . . . 0.0 111.158 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.97 -66.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.45 80.44 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -69.69 56.14 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.291 1.436 . . . . 0.0 110.269 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.71 -170.34 46.95 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 164.7 26.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.356 0.598 . . . . 0.0 109.902 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -116.65 37.67 3.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -63.8 -39.48 94.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.51 167.81 12.41 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 171.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.0 151.57 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.755 2.97 . . . . 0.0 112.538 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.18 126.37 27.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.35 11.3 28.73 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.73 82.93 0.45 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.769 -1.207 . . . . 0.0 110.272 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.9 41.29 1.21 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.211 0.91 . . . . 0.0 113.23 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.3 -45.52 93.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -51.3 112.31 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.361 1.064 . . . . 0.0 110.656 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 -18.17 57.95 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.585 1.088 . . . . 0.0 113.065 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.65 139.08 57.85 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.183 1.491 . . . . 0.0 110.425 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 m -67.38 72.82 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.265 1.426 . . . . 0.0 112.218 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.85 -148.12 0.49 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.62 -0.675 . . . . 0.0 109.88 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.45 1.1 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.5 p -136.39 10.98 3.24 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 0.0 111.204 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.26 133.33 94.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.09 155.74 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.026 2.484 . . . . 0.0 115.646 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 49.82 65.65 1.36 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.009 1.724 . . . . 0.0 113.603 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -162.04 123.45 2.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.62 89.44 2.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.965 0.906 . . . . 0.0 109.796 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -73.53 -172.03 1.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.836 0.827 . . . . 0.0 112.087 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.92 166.54 11.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.886 2.075 . . . . 0.0 107.358 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.96 -36.01 80.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.48 0.712 . . . . 0.0 112.18 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 -67.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.51 1.524 . . . . 0.0 110.976 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tp -54.2 -36.79 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.894 1.277 . . . . 0.0 110.935 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.88 -51.0 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.381 0.672 . . . . 0.0 109.38 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.82 69.34 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.903 0.481 . . . . 0.0 110.775 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.32 -48.83 75.92 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.9 -50.21 70.07 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.37 53.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.067 0.547 . . . . 0.0 111.269 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -75.52 13.03 0.84 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.97 27.74 52.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.167 0.889 . . . . 0.0 112.752 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -88.75 123.2 32.94 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.755 0.777 . . . . 0.0 109.692 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.1 131.31 55.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -64.32 93.35 0.09 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.022 0.374 . . . . 0.0 111.659 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.8 p -79.92 168.71 18.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -57.71 -41.05 80.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.829 -0.545 . . . . 0.0 109.87 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.15 -49.36 72.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.317 1.047 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -58.13 -51.76 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.1 mt -54.77 -54.57 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.63 67.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.799 0.44 . . . . 0.0 111.321 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 m -67.95 -44.07 77.61 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.281 -0.262 . . . . 0.0 110.995 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -54.84 -44.37 73.87 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.317 -0.865 . . . . 0.0 111.062 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.15 -26.88 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.832 0.453 . . . . 0.0 111.475 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -89.23 -33.54 16.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.868 0.867 . . . . 0.0 111.577 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -137.59 67.34 51.64 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.65 144.67 97.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.956 1.771 . . . . 0.0 110.585 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.68 -63.37 4.01 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.61 67.36 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.552 0.741 . . . . 0.0 110.77 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.34 -40.44 90.68 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.642 0.258 . . . . 0.0 111.673 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.14 -60.29 3.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -41.82 -50.22 4.38 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.379 1.472 . . . . 0.0 110.995 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -39.88 -52.17 2.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.095 1.358 . . . . 0.0 112.128 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -89.6 -52.78 4.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.973 0.909 . . . . 0.0 112.322 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.7 tp -73.09 -21.74 60.7 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -172.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t0 45.2 46.3 9.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.771 2.029 . . . . 0.0 111.894 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.07 129.91 52.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -31.21 71.04 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 126.182 1.793 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -88.26 17.31 5.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 0.0 111.719 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.95 64.93 6.86 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.442 -1.411 . . . . 0.0 110.246 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -103.55 -176.73 3.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.412 1.485 . . . . 0.0 108.619 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.71 150.94 38.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.83 -18.74 57.51 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 ttt -65.0 81.2 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.572 1.149 . . . . 0.0 113.635 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.85 57.8 3.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.531 0.732 . . . . 0.0 109.343 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.531 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 43.6 t80 -161.73 142.15 10.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.739 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -152.41 175.1 13.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.428 1.091 . . . . 0.0 108.814 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -158.38 122.07 3.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.86 50.19 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.692 0.797 . . . . 0.0 111.443 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? 166.03 -174.1 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 129.6 3.16 . . . . 0.0 105.528 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.95 -54.29 4.44 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 111.534 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -36.17 -50.08 1.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.592 1.568 . . . . 0.0 113.342 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -55.11 -60.63 3.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.503 1.121 . . . . 0.0 112.348 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.34 -41.23 98.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.383 0.673 . . . . 0.0 111.066 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.505 HG11 HMB1 ' A' ' 117' ' ' HEC . 65.8 t -59.59 -42.09 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.02 79.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.936 0.789 . . . . 0.0 110.147 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.31 86.21 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.384 -0.198 . . . . 0.0 110.499 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -55.44 -55.11 35.51 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.71 -40.12 68.89 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.376 0.67 . . . . 0.0 111.649 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.59 7.01 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.694 0.679 . . . . 0.0 109.871 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.8 p -56.24 -32.81 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.1 -32.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.513 1.525 . . . . 0.0 111.595 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.86 83.62 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 C--O 1.249 1.052 0 C-N-CA 127.409 2.284 . . . . 0.0 106.953 178.38 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.802 HMB1 HBB3 ' A' ' 117' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -86.55 103.21 14.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.91 -33.2 4.36 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 112.762 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.16 71.89 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.181 0.9 . . . . 0.0 110.167 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -38.72 90.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.81 -49.81 71.1 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -54.5 -53.44 54.29 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.673 0.789 . . . . 0.0 109.441 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -58.0 -49.06 78.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.649 0.261 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.25 -31.13 67.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.576 1.15 . . . . 0.0 110.92 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.47 -18.17 17.17 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.072 -0.392 . . . . 0.0 111.849 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -52.18 -29.15 20.97 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.384 0.674 . . . . 0.0 110.735 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.67 -55.86 5.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.8 m -48.69 -43.73 37.3 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.19 1.396 . . . . 0.0 112.415 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -52.73 -25.35 10.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 113.157 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 -25.77 59.95 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.866 -0.521 . . . . 0.0 110.745 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.03 -45.14 2.38 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.238 0.615 . . . . 0.0 110.81 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -91.8 -176.85 4.58 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -151.73 167.77 27.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.303 1.841 . . . . 0.0 110.139 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.3 mm -136.3 117.7 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.768 1.627 . . . . 0.0 108.043 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tp -115.72 126.97 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.159 1.384 . . . . 0.0 109.045 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 163.95 29.5 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.221 -0.924 . . . . 0.0 108.685 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.58 -36.92 98.34 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.446 2.097 . . . . 0.0 110.323 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.01 3.55 6.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.685 1.594 . . . . 0.0 113.119 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.88 90.53 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.688 -1.257 . . . . 0.0 112.7 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -71.44 114.12 9.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.6 1.2 . . . . 0.0 109.171 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.15 104.02 1.09 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.795 -0.566 . . . . 0.0 109.815 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.9 mm -76.21 -47.44 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.98 96.74 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 58.66 1.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.485 1.514 . . . . 0.0 108.216 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.44 -158.91 27.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 175.97 10.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -124.58 30.48 5.97 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -38.43 83.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.52 171.56 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -63.74 174.62 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.265 3.31 . . . . 0.0 112.387 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -87.24 121.2 29.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.6 mt -86.61 1.33 52.19 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.34 99.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.35 0.977 . . . . 0.0 109.616 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.97 33.16 21.81 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 119.085 -0.841 . . . . 0.0 113.32 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.75 -31.04 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.753 1.276 . . . . 0.0 108.69 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.44 113.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.198 0.999 . . . . 0.0 110.461 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.16 -10.26 75.42 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.177 1.37 . . . . 0.0 112.749 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.95 144.64 29.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.158 0.979 . . . . 0.0 110.005 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 m -63.86 134.1 54.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.31 141.45 54.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.659 -0.651 . . . . 0.0 110.613 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.61 33.78 81.97 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.968 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.2 p -132.03 -0.77 3.74 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.897 1.348 . . . . 0.0 114.151 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -64.56 126.72 91.31 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 120.342 1.428 . . . . 0.0 107.153 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.76 161.32 18.54 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.402 2.068 . . . . 0.0 113.327 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 56.27 55.08 7.01 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.411 1.485 . . . . 0.0 112.282 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -162.55 120.18 2.07 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.151 -0.343 . . . . 0.0 110.576 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -79.15 98.45 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.254 1.022 . . . . 0.0 110.246 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.99 -171.69 3.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.8 0.809 . . . . 0.0 111.553 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -105.28 157.91 16.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 109.279 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.53 -34.39 72.58 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.419 0.687 . . . . 0.0 112.43 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.8 p -63.95 -64.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.751 1.22 . . . . 0.0 109.779 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.2 tt -58.2 -37.22 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.624 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.55 -49.9 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.83 88.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.436 0.562 . . . . 0.0 110.802 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 tp -56.33 -47.34 78.94 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.1 -56.29 21.92 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.232 0.92 . . . . 0.0 111.012 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -31.22 61.74 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.265 1.426 . . . . 0.0 111.807 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 m -69.05 -0.63 6.01 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.57 27.77 8.89 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.374 1.464 . . . . 0.0 111.477 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -84.45 96.76 9.2 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 117.978 0.889 . . . . 0.0 111.18 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.62 127.44 35.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -67.35 103.98 1.41 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.977 0.353 . . . . 0.0 111.615 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.5 p -84.45 162.09 20.07 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -57.61 -37.11 72.7 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.738 0.415 . . . . 0.0 110.332 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -63.69 -55.42 23.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.76 -50.27 68.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.48 -54.52 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.05 -41.12 71.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.334 0.653 . . . . 0.0 111.842 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.8 m -69.76 -56.08 8.14 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -43.3 -51.93 6.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.714 1.606 . . . . 0.0 113.461 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.6 m -53.41 -30.98 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.81 -23.9 63.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.797 -0.621 . . . . 0.0 112.07 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -160.95 68.04 2.5 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 119.086 0.857 . . . . 0.0 112.56 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.58 151.79 81.35 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 120.979 1.12 . . . . 0.0 109.412 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.83 -61.09 4.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.15 78.88 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.282 -0.54 . . . . 0.0 109.673 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -51.52 -56.36 13.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.124 0.97 . . . . 0.0 110.523 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 mp -57.64 -48.66 78.85 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.167 0.587 . . . . 0.0 110.901 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -54.87 -51.27 66.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.154 0.433 . . . . 0.0 110.291 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -54.48 -51.9 63.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.856 0.863 . . . . 0.0 111.015 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -72.87 -49.66 28.64 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 tp -77.91 -24.2 48.42 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.511 1.125 . . . . 0.0 113.46 -174.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 54.09 50.64 16.14 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.564 1.546 . . . . 0.0 110.048 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -135.29 130.02 34.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.448 1.499 . . . . 0.0 109.514 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -58.52 -35.25 71.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.291 0.636 . . . . 0.0 110.53 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -84.47 15.67 3.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.22 66.18 4.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.639 0.775 . . . . 0.0 110.992 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -94.32 -179.71 5.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.118 1.367 . . . . 0.0 110.27 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -155.83 157.64 36.77 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.92 -11.95 84.9 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 172.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.3 ttt -69.35 77.22 0.38 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 118.787 1.293 . . . . 0.0 113.144 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.51 58.17 3.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.28 1.032 . . . . 0.0 109.606 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.548 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 27.0 t80 -162.94 139.69 7.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -138.82 160.53 39.48 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.2 tp -157.19 107.1 2.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.48 43.8 0.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.517 0.727 . . . . 0.0 112.242 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -177.52 -177.99 0.72 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.006 1.723 . . . . 0.0 107.243 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.32 -50.22 2.75 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.604 -0.553 . . . . 0.0 113.367 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -28.1 -51.65 0.1 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 127.319 2.39 . . . . 0.0 115.329 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 2.1 pm0 -61.22 -48.56 80.95 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.796 0.798 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.52 -46.7 84.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.86 0.864 . . . . 0.0 109.152 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.605 HG11 HMB1 ' A' ' 117' ' ' HEC . 93.7 t -59.49 -43.41 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.517 0.727 . . . . 0.0 110.329 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.86 92.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.864 -0.523 . . . . 0.0 109.603 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.99 -44.31 91.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.527 0.203 . . . . 0.0 110.458 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -56.8 -52.99 62.9 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.928 0.491 . . . . 0.0 110.058 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.8 mt -57.11 -45.53 83.35 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.059 0.391 . . . . 0.0 110.776 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.28 81.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.237 0.615 . . . . 0.0 110.8 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.2 m -68.92 -42.37 76.9 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.029 -0.42 . . . . 0.0 110.691 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.26 -44.17 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.141 1.377 . . . . 0.0 112.247 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.05 82.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.8 pttm . . . . . 0 C--O 1.25 1.107 0 CA-C-O 115.99 -1.957 . . . . 0.0 108.974 172.666 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.605 HMB1 HG11 ' A' ' 107' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.46 115.17 27.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.32 1.448 . . . . 0.0 108.765 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.13 -33.78 53.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.511 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.97 -53.5 38.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.541 1.064 . . . . 0.0 110.06 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -54.77 -41.55 70.65 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.72 -50.72 56.75 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -56.17 -49.58 73.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.403 0.681 . . . . 0.0 109.268 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -58.2 -50.28 74.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.477 0.18 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -58.18 -32.45 68.24 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 124.953 1.301 . . . . 0.0 110.634 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -58.95 -21.26 57.98 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -21.55 37.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.829 -0.544 . . . . 0.0 110.284 174.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -86.71 -49.43 7.48 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.286 -0.884 . . . . 0.0 109.157 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.9 m -51.2 -40.17 58.1 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.478 1.111 . . . . 0.0 111.912 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.11 -21.45 4.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 113.254 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -56.81 -23.74 45.9 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.536 -0.728 . . . . 0.0 110.409 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m -125.54 -49.62 1.65 Allowed 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 122.984 0.513 . . . . 0.0 109.844 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.17 -174.78 4.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.194 0.997 . . . . 0.0 113.49 -172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 m -158.69 164.9 35.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.468 1.907 . . . . 0.0 108.737 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.9 mm -136.9 119.57 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.913 1.685 . . . . 0.0 107.23 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.98 132.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.201 0.6 . . . . 0.0 110.753 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.21 152.84 83.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.95 -34.05 90.84 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.96 2.44 . . . . 0.0 112.103 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.59 -9.11 57.72 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.406 1.082 . . . . 0.0 113.346 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.17 -14.07 44.2 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.837 -0.979 . . . . 0.0 113.576 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -60.06 112.27 1.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.651 1.725 . . . . 0.0 109.908 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.23 121.41 16.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.012 0.925 . . . . 0.0 109.794 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.08 -45.77 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.61 100.61 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -88.11 72.13 9.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.39 -178.67 45.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.87 68.95 7.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.78 -0.835 . . . . 0.0 109.081 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -35.47 62.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 1 C-N-CA 133.541 4.737 . . . . 0.0 115.934 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -96.17 -30.16 13.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.842 2.057 . . . . 0.0 108.586 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.8 169.66 13.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.54 163.71 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.945 3.097 . . . . 0.0 114.04 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -85.14 117.43 24.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.6 0.95 44.54 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.13 106.36 0.6 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.01 15.09 49.99 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.406 -1.219 . . . . 0.0 113.604 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.17 -38.67 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.938 1.869 . . . . 0.0 110.184 176.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.86 112.22 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -20.73 49.05 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.077 1.322 . . . . 0.0 112.024 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -72.96 140.54 47.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.045 0.923 . . . . 0.0 109.918 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 m -64.2 121.95 15.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.49 150.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.252 0.549 . . . . 0.0 111.789 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.73 13.16 60.77 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.09 -1.395 . . . . 0.0 113.753 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -142.44 35.27 1.48 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.679 1.74 . . . . 0.0 113.67 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -80.58 135.06 53.34 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 165.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -57.63 155.94 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.314 1.343 . . . . 0.0 113.144 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 55.86 64.14 1.82 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.898 1.679 . . . . 0.0 113.852 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -163.59 123.67 2.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.76 -0.587 . . . . 0.0 110.974 172.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -77.0 77.48 3.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.197 0.999 . . . . 0.0 110.149 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -69.31 -172.66 0.46 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.308 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -113.89 160.56 18.64 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.804 1.641 . . . . 0.0 110.857 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.57 -38.67 60.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.559 1.144 . . . . 0.0 113.525 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -65.91 -55.6 16.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.595 0.712 . . . . 0.0 110.67 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 tt -66.68 -35.26 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.75 -49.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.92 88.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.868 0.467 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.6 tp -56.15 -46.43 79.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.35 -55.66 25.56 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.29 0.948 . . . . 0.0 110.91 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.01 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.569 1.148 . . . . 0.0 111.497 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 m -72.67 6.48 2.45 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.43 25.42 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 125.196 1.379 . . . . 0.0 112.091 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -80.99 78.83 7.77 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.658 -0.907 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.55 116.8 14.55 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -59.58 121.2 11.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.0 p -99.87 164.97 11.79 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -55.91 -46.45 78.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.909 0.862 . . . . 0.0 109.639 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -58.83 -52.47 65.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.16 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -60.47 -46.76 88.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -56.57 -53.24 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.82 -37.99 64.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.178 0.991 . . . . 0.0 111.484 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 m -72.74 -58.91 2.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -43.98 -47.98 8.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.899 1.679 . . . . 0.0 113.245 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 m -51.93 -34.42 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -75.09 -25.05 58.24 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.0 112.095 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -145.63 61.79 7.93 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.892 0.877 . . . . 0.0 113.043 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.18 148.09 93.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.668 1.578 . . . . 0.0 109.446 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.96 -65.64 3.22 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.2 62.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.773 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -51.61 -54.48 27.29 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.656 0.782 . . . . 0.0 110.471 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 mp -60.34 -49.27 78.26 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 122.969 0.508 . . . . 0.0 111.174 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.35 -46.27 66.04 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.954 0.343 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.16 -65.94 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.25 0.62 . . . . 0.0 110.345 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -56.38 -41.24 75.92 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.7 -6.63 59.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.721 0.808 . . . . 0.0 111.581 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t0 48.28 52.87 12.73 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.291 1.436 . . . . 0.0 109.604 -176.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -143.72 155.74 44.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.998 0.919 . . . . 0.0 110.801 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -91.44 -41.3 10.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.945 1.698 . . . . 0.0 108.619 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -81.03 39.7 0.51 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.857 0.863 . . . . 0.0 111.99 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.26 111.44 22.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.537 0.735 . . . . 0.0 109.412 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -124.46 -176.04 3.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.862 0.865 . . . . 0.0 112.066 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -159.75 147.05 16.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.37 64.15 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.6 ttt -66.98 79.84 0.12 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 118.452 1.126 . . . . 0.0 113.651 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.02 57.49 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.655 0.782 . . . . 0.0 109.438 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' CG ' HMC2 ' A' ' 117' ' ' HEC . 36.7 t80 -165.22 125.92 1.94 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.648 1.179 . . . . 0.0 108.565 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -115.47 159.9 20.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.29 103.74 3.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.92 44.44 0.55 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.191 0.596 . . . . 0.0 111.413 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -174.85 -176.57 1.01 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.814 1.646 . . . . 0.0 107.581 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.15 -52.93 3.41 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.272 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -11.75 -72.07 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 128.525 2.965 . . . . 0.0 116.045 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.5 -45.97 90.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.126 0.963 . . . . 0.0 112.412 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -63.49 -49.7 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 109.116 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.623 HG11 HMB1 ' A' ' 117' ' ' HEC . 96.5 t -59.69 -43.04 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.423 0.689 . . . . 0.0 109.945 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.39 93.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.998 -0.439 . . . . 0.0 110.102 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.77 93.69 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.041 0.382 . . . . 0.0 110.418 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -57.08 -53.1 61.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.95 -41.54 83.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.115 -0.366 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.58 85.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.638 0.775 . . . . 0.0 110.585 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -69.58 -41.04 76.35 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.039 -0.413 . . . . 0.0 110.343 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.52 -38.12 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.732 1.213 . . . . 0.0 112.425 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.42 85.07 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.238 0.926 . . . . 0.0 111.672 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.9 pttp . . . . . 0 C--O 1.254 1.329 0 CA-C-O 115.474 -2.203 . . . . 0.0 108.118 176.038 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HEC . . . . . 0.623 HMB1 HG11 ' A' ' 107' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_